gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	"Tissue RNA - cervix, uterine [NX]"	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	AP2 associated kinase 1	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	parathyroid gland: 109.7	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA017931, HPA020289"	Enhanced		Supported	"Plasma membrane,Cytosol"				Plasma membrane	Cytosol	"HPA017931: AB_1844406, HPA020289: AB_1844407"	unprognostic (2.11e-3)	unprognostic (3.18e-2)	unprognostic (3.67e-1)	unprognostic (1.01e-3)	unprognostic (5.06e-2)	unprognostic (4.04e-2)	unprognostic (4.23e-2)	unprognostic (1.14e-1)	unprognostic (3.52e-1)	prognostic unfavourable (3.19e-4)	unprognostic (1.24e-1)	unprognostic (7.65e-2)	unprognostic (4.18e-2)	unprognostic (1.30e-1)	unprognostic (5.40e-2)	unprognostic (6.76e-3)	unprognostic (1.18e-1)	5.1	5.9	11	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16	2.1	5.3	4.9	5.8	1	0.8	4.1	3.9	2.8	5.6	1.3	16.5	9.9	9.1	8.8	8.7	9.7	29.3	13.5	10.7	8.2	7.2	10	6.6	0.5	3.3	17.5	7.7	7	7	16.7	12.3	2.9	9	6	6.8	7.9	6.3	21.4	8.3	6.2	15.4	19.9	17.3	1.9	9.3	14.2	2.8	5.8	3.3	4.4	5.5	3.9	9.9	1.4	6.4	34.7	3	4.8	7.8	6	7	3.5	8.9	17.2	18.3	12.3	13.1	13.2	9.2	2.4	1	15.3	10.7	12.5	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4	3	0.8	1	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	Apoptosis associated tyrosine kinase	Q6ZMQ8	17	81117295-81166077	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 35.3;intestine: 28.7	Group enriched	Detected in some	6	CACO-2: 29.6;SH-SY5Y: 10.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	21	neutrophil: 3.6	Lineage enriched	Detected in single	21	granulocytes: 3.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA009073	Enhanced		Uncertain	Mitochondria				Mitochondria		HPA009073: AB_1078076	unprognostic (3.47e-3)	unprognostic (3.01e-2)	unprognostic (1.12e-1)	unprognostic (1.95e-4)	unprognostic (1.96e-1)	unprognostic (1.94e-1)	unprognostic (7.29e-2)	unprognostic (9.85e-2)	unprognostic (6.09e-2)	unprognostic (4.27e-2)	unprognostic (2.88e-3)	unprognostic (2.48e-1)	unprognostic (4.28e-6)	unprognostic (1.58e-3)	unprognostic (1.21e-1)	unprognostic (1.39e-1)	unprognostic (4.57e-2)	2.8	4.7	14.3	3.2	16.6	3.7	0.9	19	29	1.2	3.3	16.5	0	28.7	1	1.1	1.7	1.2	2.7	2.3	23.6	13.9	1.2	1.2	9.7	1.5	20.1	13.6	1	17.9	3.6	6.4	2.6	11	2.4	1.1	4.1	5.6	3.6	1.1	1.9	20.3	1.3	35.3	5.9	4.5	1.3	9.8	0	1.3	0	1	1.3	1.1	0	0	3.6	0.1	0	0	0	0	0.2	0.3	2.5	0	0	0.6	0	0	0	0	29.6	0	0	0.2	0	0	0.4	0	0	0	1.6	1.1	1.4	1.8	0	0	2.7	0	0	0	0	0	0	0.7	0	3.1	0	0.1	0.5	0.1	1.3	2.4	0.2	0	0	2.8	10.2	0.2	0	1.4	0.3	0.8	1.1	0	0.2	0.1	0	0	0	0	0	0.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	14.3	16.6	19	22.3	23.6	13.9	20.1	13.6	11	9.8
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713946-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nuclear bodies	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	unprognostic (4.82e-2)	unprognostic (3.99e-2)	unprognostic (5.55e-2)	unprognostic (4.72e-2)	unprognostic (1.16e-1)	unprognostic (1.46e-1)	unprognostic (3.75e-3)	unprognostic (1.89e-3)	unprognostic (2.34e-1)	unprognostic (2.54e-2)	unprognostic (1.09e-2)	unprognostic (1.48e-1)	unprognostic (3.96e-3)	unprognostic (1.10e-2)	unprognostic (1.47e-1)	unprognostic (1.22e-1)	unprognostic (1.06e-1)	20.1	11.6	12.4	15	18.1	10.7	22	6.7	16	28.9	34.3	29.1	12.1	11.9	26.6	16.9	21.4	20.8	30.9	14.2	10.3	8.4	9.9	6.7	13.8	8.7	24.1	9.4	24.2	12.2	27.7	14.5	13.6	17.1	27.3	15.8	19.4	14.6	18	10.8	14.2	17	66.6	14.3	10.8	21.9	9.8	21.2	5.8	19.5	11.4	9.1	35.8	31.9	3.1	3.1	1.1	5	2.4	2.6	1.6	7	15.7	16.9	20.4	24.8	30.3	6.2	12.4	19.5	14.6	12.4	12.3	9.2	11.6	7.2	16.5	13.7	8.5	11.5	10.8	7.3	5.3	7.6	26.9	10.5	16.9	11.7	10.7	22.1	12.7	26.1	16.2	20.2	42.6	9.3	17.8	13.4	14.8	9.6	18.7	11.6	17.2	21.9	12.6	14.7	8.3	15.8	19.7	20.8	8.1	10	15.9	10.8	23.1	56	14.5	21.4	19.5	2.8	6.6	15.6	23.1	9.7	17.7	0.2	2.1	1.1	2	1.2	2.6	3.1	2	1.9	2	1.4	1.9	1.7	0.2	2.4	5	3.1	0.9	1.6	12.4	18.1	6.7	16	10.3	8.4	24.1	9.4	17.1	21.2
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099327-179229684	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	Cell adhesion	"Kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		hTERT-HME1: 31.7;TIME: 29.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001866, CAB017106, HPA072754"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB017106: , HPA001866: AB_1078082, HPA072754: "	unprognostic (3.05e-1)	prognostic unfavourable (3.50e-4)	unprognostic (1.07e-1)	unprognostic (4.71e-2)	unprognostic (9.45e-2)	unprognostic (8.23e-3)	unprognostic (1.91e-2)	unprognostic (4.81e-3)	unprognostic (1.26e-1)	unprognostic (6.98e-2)	unprognostic (1.12e-1)	unprognostic (3.73e-1)	prognostic unfavourable (1.78e-7)	unprognostic (4.76e-2)	unprognostic (4.14e-2)	unprognostic (6.08e-2)	prognostic unfavourable (8.40e-4)	14.3	5.2	8.6	7.4	13.7	3.7	8.3	14.9	10.6	9.2	6.6	5.8	4.5	4	5.4	4.7	3.9	4.3	18.8	6.8	9.7	3.9	4.9	4.3	11.5	3.7	6.5	6.1	5.6	8.4	9.2	8.4	6.1	8.1	5.1	5.2	5.8	4.5	4.4	5.2	6.6	3.7	6.9	6.2	3.9	4.7	9.2	8.6	3.6	5.8	3.1	3.6	6.7	11.2	2.8	2	3.8	1.2	1.8	2.2	0.6	10	5.5	3.7	2.5	3.2	7.3	2.3	11.1	9.1	13.7	9.9	4	3.1	5.8	8.2	7.9	5	5.2	3.7	19.4	3.6	4.8	2.8	5	2	5.8	3.1	0.9	6.7	4.9	19.4	31.7	15.1	6.6	1.7	17.7	2.6	2.4	1.6	3.6	1.8	3.7	6.2	2.8	4.6	1.6	2.3	5.1	9.2	2.9	22.8	2.6	2.6	29.5	14.2	10.6	6.8	17.8	3.1	3.8	6	6.7	1.7	13.7	3.8	1.2	0.4	2.2	0.4	1	1.8	1.4	1.4	0.9	2.8	1.9	2	2.6	1.8	0.5	2	0.8	0.6	8.6	13.7	14.9	10.6	9.7	3.9	6.5	6.1	8.1	8.6
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	Activin A receptor type 1	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007505, HPA046514"	Approved		Approved	"Nucleoli,Cytosol"				Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: "	unprognostic (6.99e-2)	unprognostic (3.32e-2)	unprognostic (3.02e-1)	unprognostic (1.19e-2)	unprognostic (2.73e-1)	unprognostic (6.09e-2)	unprognostic (3.66e-3)	unprognostic (1.08e-1)	unprognostic (3.99e-1)	unprognostic (3.20e-1)	unprognostic (2.65e-2)	unprognostic (4.29e-2)	unprognostic (2.42e-1)	unprognostic (3.43e-3)	unprognostic (3.17e-1)	unprognostic (1.76e-2)	prognostic unfavourable (5.17e-4)	18.9	9.2	18	10	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10	1.6	2.1	4.2	4.9	6.4	25	26.1	6.9	15.1	25.2	12.1	13	3.3	4.7	0	7	16.4	5.9	3.5	8.2	13.1	14.5	3	8.6	2.5	4.8	19.8	0.6	10.2	32.6	15.6	24.9	31.8	13.2	3.1	2.4	15.3	3.7	0.1	0.2	7.4	7.7	1.4	6.6	1.8	15.8	7.9	4.4	5.4	5.8	3.3	20.7	1.7	2.3	19	18.5	6.1	9.1	5.7	1.6	1.2	0.1	19	0.5	19.9	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10	1.6	18	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	Activin A receptor type 1B	P36896	12	51951667-51997078	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB026126, HPA063761"	Approved		Approved	Cytosol				Cytosol		"CAB026126: , HPA063761: "	unprognostic (8.66e-2)	unprognostic (5.72e-2)	unprognostic (1.16e-1)	unprognostic (3.23e-3)	unprognostic (2.34e-1)	unprognostic (2.54e-1)	unprognostic (1.21e-3)	unprognostic (1.00e-1)	unprognostic (7.68e-2)	unprognostic (5.29e-2)	unprognostic (2.56e-1)	unprognostic (2.37e-1)	unprognostic (4.52e-2)	unprognostic (9.02e-2)	unprognostic (6.60e-2)	unprognostic (8.96e-2)	unprognostic (4.79e-2)	11.1	7.4	12	6.4	14.6	7.9	14.3	14.2	24.4	8.6	16.7	5.1	28	19.2	6.7	13.1	14.4	10.9	11.1	7.6	11.2	10.5	24.6	21	10.3	7.1	8.1	14.7	7.1	35.1	24.9	10.9	7.5	7.3	10	17.1	8.7	21.7	34.3	11.7	30.6	19.8	8.2	5.8	6.7	17.2	10.6	4.8	3.9	9.9	5.8	8.4	10.1	12.1	0.5	1.3	6.8	4	0.1	1.6	0.6	6.2	13.8	10.7	5.9	12.3	9.7	6.1	7.1	8.1	7.6	5.8	27.8	9.7	2.7	10	7.7	11.1	10.2	8.6	7.9	4	12	6.8	3.5	8.6	14.1	10.9	25.5	18.9	11.2	8.6	10.9	10.7	7.2	8.6	6.7	12.8	10.4	9.5	10.4	4.8	5.6	8.3	3.5	21.5	9.6	13.7	11.4	7.7	11	5	12.1	7.1	6.7	5.2	8	5.9	3.4	5.2	3.7	3.8	5.6	5.3	6.7	4.5	2.2	6.8	0.7	3.3	1	0.1	0.6	0.7	1.3	0.5	1.6	0.9	1.9	0.1	4	0.7	1	0.6	12	14.6	14.2	24.4	11.2	10.5	8.1	14.7	7.3	4.8
ACVR1C	"ACVRLK7, ALK7"	ENSG00000123612	Activin A receptor type 1C	Q8NER5	2	157526767-157629005	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		adipose tissue: 36.2;breast: 15.3	Group enriched	Detected in some	4	ASC diff: 15.1;HDLM-2: 6.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.8	Lineage enriched	Detected in single	4	T-cells: 2.8	Low region specificity	Detected in many			Group enriched	Detected in many	5	basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6	"HPA007982, HPA011933"	Approved				Intracellular and membrane					"HPA007982: AB_1078134, HPA011933: AB_1844754"	unprognostic (1.03e-1)	unprognostic (4.55e-2)	unprognostic (9.65e-2)	unprognostic (1.22e-1)	unprognostic (2.92e-1)	unprognostic (7.64e-2)	unprognostic (1.00e-1)	unprognostic (3.48e-1)	unprognostic (1.01e-1)	unprognostic (1.35e-1)	unprognostic (7.12e-3)	unprognostic (3.62e-1)	unprognostic (9.31e-6)	unprognostic (7.28e-2)	unprognostic (1.95e-1)	unprognostic (9.74e-2)	unprognostic (1.30e-1)	36.2	3.7	3.9	2.7	10.3	0.7	15.3	1.6	4.4	0.9	9.4	2.7	0	5.5	0.7	1	0.8	0.8	1.8	1	9.2	3.1	1.1	3.3	0.8	1.2	3.7	3.1	5.1	2.4	0.5	12	0.7	3.5	0.9	4.4	0	1.5	1	1.3	0.7	4.4	0.8	2.8	0.8	3.4	1.1	4	0	0.9	0.5	1	0.6	2.9	0.6	0	0	0	0	2.8	0.4	2	0	0	0.1	15.1	0.4	0.3	0.4	0.4	0.1	0.5	2.2	0.2	0	0.2	1.2	0	0.1	0	0.3	6.6	1	0	0	0.5	0	0	1.1	0.1	0	0.4	0	0	0	0.4	0.4	0.2	0	0	1.3	0.7	0	0.8	0.1	0	0	0.4	0	0	0	2.3	0	0.3	0	0.8	0.2	0	0.2	0.8	2.4	0	0.6	0	0.3	0	0	0	0.5	0	1	0.6	1.8	1.2	0	0.5	2.8	1.1	0	0	0	0	0	0.4	3.9	10.3	1.6	4.4	9.2	3.1	3.7	3.1	3.5	4
ACVR2A	"ACTRII, ACVR2"	ENSG00000121989	Activin A receptor type 2A	P27037	2	147844517-147930826	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HHSteC: 20.5;RH-30: 17.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046997	Approved		Approved	Cytosol				Cytosol		HPA046997: AB_10970077	unprognostic (4.55e-2)	unprognostic (2.26e-2)	unprognostic (2.09e-1)	unprognostic (7.34e-3)	unprognostic (2.75e-1)	unprognostic (1.17e-1)	unprognostic (4.41e-3)	unprognostic (8.73e-3)	unprognostic (1.30e-2)	unprognostic (3.61e-1)	unprognostic (1.34e-2)	unprognostic (1.52e-1)	prognostic favourable (1.62e-4)	unprognostic (1.16e-1)	unprognostic (1.40e-1)	unprognostic (3.95e-1)	unprognostic (3.99e-2)	12	6	13.6	8.2	9.9	3.8	10.7	14.5	14.2	10.2	14.1	4.7	9.7	10.4	9.3	9.9	13.6	7.6	17.7	5.6	10	9	9	10.3	7.5	4.7	5.9	10.6	7.6	9.8	8.6	15.9	10.6	7.3	12.2	9.1	7.6	12.2	12	19.6	29.5	17.8	13.8	5.4	6.5	9.3	11	6.4	1.5	9.5	6.9	6.8	13.5	11.8	0.7	3	0.5	3.6	7.7	4.6	1.4	1.3	1.5	9.8	3.6	5.8	3.7	4	3	3.6	5.2	9.1	4.2	5.9	0	2.7	4.8	4.6	8.9	4.4	6.7	1	5.4	0.6	2.7	7.3	20.5	0.6	0.7	6.2	5.6	3.3	6.7	3.9	1.4	2.5	3.5	3.4	0.3	0.5	11	2.6	0.1	17.1	0.9	4.2	8.3	9.7	5.5	2.5	3.1	3.7	1.9	1	3	4.8	5.7	4.5	2.1	0.7	0.2	1.8	3	0.3	3.8	0.4	3	0.5	1.2	3.6	0.5	0.3	4.6	2.1	2.3	0.7	3	0.7	0.1	7.7	3.1	3	0.4	1.4	13.6	9.9	14.5	14.2	10	9	5.9	10.6	7.3	6.4
ACVR2B	ActR-IIB	ENSG00000114739	Activin A receptor type 2B	Q13705	3	38453851-38493142	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Heterotaxy"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		AF22: 16.6;NTERA-2: 20.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA007398, CAB025115, HPA040384"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	Nuclear bodies	"CAB025115: , HPA007398: , HPA040384: "	unprognostic (5.11e-2)	unprognostic (1.54e-1)	unprognostic (3.47e-1)	unprognostic (8.73e-2)	unprognostic (9.24e-2)	unprognostic (2.21e-1)	unprognostic (1.32e-2)	unprognostic (1.25e-2)	unprognostic (1.88e-1)	unprognostic (1.53e-2)	unprognostic (5.14e-2)	unprognostic (1.30e-1)	unprognostic (4.08e-3)	unprognostic (1.64e-1)	unprognostic (1.98e-1)	unprognostic (1.83e-1)	unprognostic (4.75e-1)	2.8	7.4	5.5	4.6	7.9	1.1	5.5	13.2	7.5	5.2	3.4	7.2	4.5	2.8	4.7	5.1	2.5	5.6	3.3	3.9	5.9	5.4	5.3	5.4	6.9	2.2	5.9	5.4	8.3	6.1	11.3	5.1	16	6.5	3.9	3.6	5	4.6	4.2	15.9	2.4	2.8	4.6	4.7	3.1	4	9.1	9.1	12.8	4.8	1.7	2.2	4.2	10.3	0.3	0.3	0.5	0.2	0.5	1.6	0.3	0.8	1.4	16.6	1.4	0.6	0.4	8.9	0.3	0.5	0.3	0.7	2.4	1.1	0.1	1.3	0.4	1	6.3	1	0.9	2.4	4.1	4.2	2.6	3.5	0.8	3	1.6	0.7	0.9	0.5	1.8	1.1	7	1.4	0.3	1.3	5.1	1.9	20.5	0.7	1.7	5.5	1	1.1	2	3.9	6.8	0.5	2.5	2.2	1.4	4	0.9	0.6	2.7	0.4	1.4	4	5.4	0.9	0.6	2.5	1.1	0.5	0.1	0.1	0.4	0.2	0.6	0.2	1	0.5	0	0.3	1.6	1.5	0.3	0.5	0.2	0.3	0.7	0.3	5.5	7.9	13.2	7	5.9	5.4	5.9	5.4	6.5	9.1
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	Activin A receptor like type 1	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lung: 55.0	Cell line enhanced	Detected in some		ASC diff: 18.1;ASC TERT1: 12.4;EFO-21: 16.0;HUVEC TERT2: 58.5;TIME: 45.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	12	classical monocyte: 3.6;myeloid DC: 5.0	Group enriched	Detected in many	12	dendritic cells: 5.0;monocytes: 3.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007041	Approved				Intracellular and membrane					HPA007041: AB_1078097	unprognostic (2.50e-1)	unprognostic (4.83e-1)	unprognostic (3.79e-2)	unprognostic (3.61e-2)	unprognostic (4.98e-1)	unprognostic (4.06e-3)	unprognostic (2.79e-1)	unprognostic (1.35e-1)	unprognostic (5.80e-2)	unprognostic (5.10e-2)	unprognostic (4.60e-2)	unprognostic (4.64e-2)	unprognostic (1.12e-3)	unprognostic (1.39e-1)	unprognostic (7.98e-3)	unprognostic (2.79e-1)	unprognostic (1.10e-1)	25.5	5.1	3.2	9.3	4.3	0.2	15.6	1.6	3.6	15.1	20.1	3.7	13.1	4.9	12.7	11	12.1	13.9	11	15.4	3.7	3.2	13.6	3.4	55	19.1	4.9	3.6	5.9	6.1	21.6	2.7	44.1	5.3	12.3	14.7	12.3	6.9	10.6	14.2	8	11.1	8.2	3.7	14.8	8.1	3.5	3.6	1.7	12.9	6.8	5.4	9.3	11.2	0.1	5	0.3	3.6	0	0.1	0.7	0	0.2	0.1	0	18.1	12.4	0	0.8	1.6	0	0	0.1	0.1	0	16	6.8	0	0	0	0	0	0.6	0.4	0	0	2.7	0	0.4	5	0	0.1	0	58.5	0	0	0.4	0.1	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.1	45.2	0	0.1	0.2	0	0	0	0	0	0.2	0	0.1	3.6	0.1	0	0.1	0	0	0	0	5	0.1	0	0.1	0.3	0	0	0.1	0	0.7	3.2	4.3	1.6	3.6	3.7	3.2	4.9	3.6	5.3	3.6
ADCK1	FLJ39600	ENSG00000063761	AarF domain containing kinase 1	Q86TW2	14	77800083-77935012	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA051012, HPA055014"	Uncertain		Approved	Nucleoplasm	Secreted - unknown location			Nucleoplasm		"HPA051012: , HPA055014: "	unprognostic (6.36e-2)	unprognostic (7.09e-2)	unprognostic (6.00e-2)	unprognostic (1.76e-1)	unprognostic (2.24e-1)	unprognostic (1.46e-1)	prognostic unfavourable (1.70e-4)	prognostic favourable (4.11e-5)	unprognostic (2.33e-1)	unprognostic (1.64e-1)	unprognostic (4.57e-3)	unprognostic (1.38e-1)	prognostic favourable (5.82e-6)	unprognostic (6.30e-3)	unprognostic (2.06e-1)	unprognostic (9.57e-2)	unprognostic (4.06e-1)	7.2	11	11	7	15.2	7.4	6.9	6.8	20.5	5.6	10.3	19	7.7	11.2	7.7	10.3	7.7	7.1	9.1	11.1	12.4	10.4	8.8	10.5	6.2	6	13.5	9.4	6.6	9.8	11.3	11.3	7.8	15	8.2	10.3	13.8	10.6	8.9	13.7	8.5	8.5	10.5	10.6	9.7	7.5	5.5	11.5	10.8	9.1	7.8	7.5	6.9	5	4	8.9	1.4	7.2	3.4	5.3	3.1	3.3	5.4	3.2	10.8	8.1	4.6	4.3	3.4	5.7	3.1	3.7	2.9	8	7.3	5.5	6	6.4	17.8	5.4	2	4.2	5.6	1.9	3.4	4.8	8.3	2.8	4.1	5.7	10.1	1.2	3.9	4.4	6.9	4.5	4	16.8	3.4	5.6	6.4	6.4	5.6	0.5	5.8	4.4	8.5	7.2	4	6.6	9.2	4	13.3	6.2	3.9	2.9	2.3	5.9	3	4.6	5	4.1	4.4	4.9	3.7	1.4	4.7	1.3	5.3	7.2	3.5	1.7	2.2	3.1	8.9	4	2.5	4.6	0.4	3.4	2.8	7	3.7	3.1	11	15.2	6.8	20.5	12.4	10.4	13.5	9.4	15	11.5
ADCK2	MGC20727	ENSG00000133597	AarF domain containing kinase 2	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all							Low region specificity	Detected in all			HPA036036	Approved		Uncertain	"Centrosome,Cytosol"				"Centrosome, Cytosol"		HPA036036: AB_10672078	unprognostic (2.76e-1)	unprognostic (1.79e-1)	unprognostic (5.72e-2)	unprognostic (5.30e-2)	unprognostic (4.03e-3)	unprognostic (1.52e-1)	unprognostic (3.05e-2)	unprognostic (7.48e-2)	unprognostic (2.61e-1)	unprognostic (7.10e-3)	unprognostic (6.81e-3)	unprognostic (9.36e-3)	prognostic favourable (9.75e-5)	unprognostic (1.89e-2)	unprognostic (2.00e-1)	unprognostic (4.13e-1)	unprognostic (2.13e-1)	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18	20	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14	12.5	25.8	13	10.9	24	13.6	13	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12	3.2	5	5.1	7.3	2.2	15.9	11.5	2.7	12.7	10	11.4	16.4	8.3	10.1	8.7	5.8	10.5	11.3	21.4	12.6	5.8	13.2	13.8	9.4	2.6	15.8	14.2	4.5	4.5	5.1	13.9	3	11.3	9.5	28.9	4.9	6.9	7.4	7.9	10.5	3.1	19.9	22.4	7.4	4	12.5	17.7	0.1	10.4	4.7	16	10.8	7.5	11.4	16.6	11.4	14.7	6.1	7.8	10.9	3.8	18	16	7.3	11.2	15.8	16	12.1	12.9	0	3.7	3.2	5.4	5	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3	12	6	2.2	15.3	16.6	15.4	27	16.6	18.2	19.5	13.1	18.2	13.3
ADCK5	FLJ35454	ENSG00000173137	AarF domain containing kinase 5	Q3MIX3	8	144373101-144393242	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA025692, HPA028679"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA025692: AB_10599486, HPA028679: AB_10600226"	unprognostic (6.76e-2)	unprognostic (1.66e-1)	unprognostic (1.68e-2)	unprognostic (8.96e-2)	unprognostic (1.68e-2)	unprognostic (1.00e-1)	unprognostic (2.31e-3)	unprognostic (6.45e-2)	unprognostic (2.70e-1)	unprognostic (4.25e-2)	unprognostic (6.60e-2)	unprognostic (2.03e-2)	unprognostic (1.33e-3)	unprognostic (1.39e-2)	unprognostic (1.20e-1)	unprognostic (3.47e-1)	unprognostic (2.90e-2)	4.1	10	4.8	8.9	4.5	4.5	4.3	11.5	9.1	4.6	18.3	2.8	7.6	19.1	5.8	4.2	7.2	4.2	6.3	3.8	3.9	4.1	4.8	6.9	3.7	5	3.4	8.4	5.5	5.6	4.7	4.1	3.7	4.5	4.7	4	4.6	7.4	4.7	5.6	8.3	17	2.7	2.4	6.7	5.6	7.7	3.8	6.8	4.1	4.9	6.1	5.1	5	4.7	6.3	2.5	5.4	1.8	4.1	2.8	3.8	4.8	1	3.3	0.9	0.8	5.7	3.3	1.8	2.6	0.9	5.2	4.2	1.7	2.3	0.7	5.1	0.2	3.5	0.2	4.3	1.6	4.4	3.6	5.8	2.6	1	3.4	1.3	2.1	0.9	0.8	1.8	2.9	3	1.5	10.1	3.2	4.4	0.6	3.6	4.2	1.6	3	1.7	3.6	0.7	1.8	4.8	3.9	2.7	3.3	3	1.2	1.4	5.1	3.5	2.2	1.4	0.4	1.5	3.2	3.8	2	1.8	4.2	2.5	2.3	5.4	3	1.8	2.8	1.8	6.3	4.7	2.9	1.5	0.7	1.8	5	4	4.1	2.8	4.8	4.5	11.5	9.1	3.9	4.1	3.4	8.4	4.5	3.8
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	AKT serine/threonine kinase 1	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		MCF7: 113.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		eosinophil: 30.7	Lineage enriched	Detected in all	5	granulocytes: 30.7	Low region specificity	Detected in all							"HPA002891, CAB003765"	Supported		Supported	"Nucleoplasm,Microtubules"				Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	unprognostic (3.30e-2)	unprognostic (4.27e-2)	unprognostic (1.98e-1)	unprognostic (1.84e-1)	unprognostic (3.70e-1)	unprognostic (9.17e-3)	unprognostic (1.55e-3)	unprognostic (1.21e-1)	unprognostic (1.47e-1)	prognostic favourable (4.83e-4)	unprognostic (3.58e-2)	unprognostic (1.90e-2)	prognostic favourable (2.12e-4)	unprognostic (7.14e-2)	unprognostic (1.28e-1)	unprognostic (1.06e-1)	unprognostic (2.41e-1)	31.7	45.4	22.9	24.2	23.6	20.3	40	20.9	29.5	24.7	32.6	20	30.8	22.5	27	21.5	33	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21	22.1	14.7	25.9	43	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3	15.1	30.3	25	37.2	19.4	20.1	28	27.9	34	41.3	33.1	19.8	18.3	18.3	21.5	38.2	19.7	17.7	26	18	41.8	7.2	13.9	18.1	21.3	21.5	22.6	36.3	28.8	21.9	20.7	13.8	30.8	12.1	20.4	26.4	113.2	28.4	28.9	6.5	21.7	26.8	23.2	12.5	19.1	37.7	28.7	23.9	23.3	30.5	17.5	39.9	33.7	24.6	27.7	13.3	39.4	28	22.2	10.7	15.8	23.3	19.1	33.3	3.3	5.3	30.7	5.4	5.2	4	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8
AKT2		ENSG00000105221	AKT serine/threonine kinase 2	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004204, HPA064521"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cytosol"				"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: "	unprognostic (6.13e-2)	unprognostic (2.21e-1)	unprognostic (1.56e-1)	prognostic unfavourable (1.05e-6)	unprognostic (2.85e-1)	unprognostic (6.40e-3)	unprognostic (9.59e-2)	unprognostic (1.22e-2)	unprognostic (2.98e-2)	unprognostic (2.49e-2)	unprognostic (3.02e-1)	prognostic unfavourable (4.74e-4)	unprognostic (1.30e-2)	unprognostic (1.89e-1)	unprognostic (3.28e-1)	unprognostic (6.16e-2)	unprognostic (2.00e-1)	31.1	20.3	15.4	17.6	15.2	21.3	18.2	46.3	18.2	23.3	18.2	23.4	21.2	12.3	22.8	28	22.1	22.7	14	23.1	15.4	10	23	62.5	14.6	17.8	17.9	13.3	27.8	24.5	21.1	24	17.5	14.7	19.7	12.3	26.8	18.5	24.3	48.5	18.3	17.1	20	16.8	18.7	15.5	21.3	15.7	26.6	52.6	29.5	23.6	19.6	19.9	6.3	8.8	7.7	4.4	3.2	4.9	2.4	22.4	55.4	21.1	21.7	26.3	32.2	11.7	15	22.2	31.1	27.8	24.3	20.9	22.9	13.4	33.1	9.8	23.4	31.3	20.1	21.9	26.7	15	35.1	15.3	16.5	17.2	18.1	29.7	18.8	21.1	20.1	6.7	19.3	24	17.3	18.7	27.3	8.4	11.4	14.9	18.2	11.5	16.5	24.2	36.8	29.1	17.8	15.4	26.4	12.5	20.8	22.2	6.7	19	18.8	17	23.5	22.4	19.2	18.8	18.6	20.4	15.5	7.6	4.4	3.6	4.5	2	4.5	3.9	3.6	3	3	6.3	3.5	4.9	7.7	3.2	2.6	8.8	2.7	2.4	15.4	15.2	46.3	18.2	15.4	10	17.9	13.3	14.7	15.7
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	AKT serine/threonine kinase 3	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB013090, HPA026441"	Approved		Supported	Cytosol				Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	unprognostic (1.33e-1)	unprognostic (1.27e-1)	unprognostic (2.40e-2)	unprognostic (8.45e-2)	unprognostic (1.89e-1)	unprognostic (1.75e-1)	unprognostic (1.96e-1)	unprognostic (3.77e-1)	unprognostic (2.32e-1)	unprognostic (2.28e-1)	unprognostic (5.47e-3)	unprognostic (1.37e-1)	unprognostic (6.71e-2)	unprognostic (3.64e-3)	unprognostic (1.29e-1)	unprognostic (8.14e-2)	prognostic unfavourable (9.27e-4)	15.4	17	16	7.8	15.2	2.2	11	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10	11.8	12.1	9.8	15.5	13.6	12.8	4	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.5	2.4	14.9	0	11	12.6	7.9	13.3	12.2	8.6	7.6	0.1	9.7	0	0	16.8	0.3	8.2	5.3	11.4	5.9	6.4	0.3	0	0	5.7	0.1	2.6	6.5	0	10.7	9.7	17.6	0	0.1	3.9	0	5	1.1	6.3	3.7	2.7	9.1	0.1	2.9	0.8	19.1	25.3	0.1	0	23.8	0	8	13.8	15.3	11.8	0.1	11	1.3	0.4	2.8	11.2	1.2	12.8	1.2	0.9	0.5	2.3	0.3	3.6	1	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8
ALK	CD246	ENSG00000171094	ALK receptor tyrosine kinase	Q9UM73	2	29192774-29921566	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 8.1;pituitary gland: 17.9	Cell line enriched	Detected in some	6	SH-SY5Y: 26.4	Group enriched	Detected in some	5	glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA010694	Approved		Supported	Plasma membrane				Plasma membrane		HPA010694: AB_1078133	unprognostic (4.96e-2)	unprognostic (1.11e-2)	unprognostic (1.45e-1)	unprognostic (4.56e-7)	unprognostic (7.17e-2)	unprognostic (1.71e-1)	unprognostic (9.07e-3)	unprognostic (6.29e-3)	unprognostic (1.18e-1)	unprognostic (1.01e-1)	unprognostic (2.67e-4)	unprognostic (3.70e-2)	unprognostic (2.06e-2)	unprognostic (7.15e-2)	unprognostic (1.98e-1)	unprognostic (1.38e-1)	unprognostic (3.61e-2)	1.8	3.1	3.6	1.2	4.4	0.3	1.1	0.5	8.1	0.7	2.1	2	0	0.7	0.5	0.5	0.6	0.5	1.2	0.4	3.4	4.9	0.4	0.5	1.1	0.5	2.7	4.2	0.6	0.4	0.4	17.9	0.5	5.5	0.5	1.2	2.4	0.9	0.8	0.3	0.9	1.5	0.9	2.1	0.5	0.8	4.9	0.9	0	1.6	0	0.3	0.6	1.2	0	0	0	0.2	0	0.7	0	0	0	0.4	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0.5	0	3.5	0	0	0.1	0.3	26.4	0	0	0.6	0	0	0	0.2	0.1	0	0	0	0	0	3.1	0	4	0	0.1	0	0.7	0	0.2	0	0	0.4	0	0	0	0	0	0	0.2	0	0	0	3.6	4.4	0.5	5.9	3.4	4.9	2.7	4.2	5.5	0.9
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	Alpha kinase 1	Q96QP1	4	112285509-112442620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 16.3	Low lineage specificity	Detected in many			Low region specificity	Detected in many							"HPA027435, HPA027443"	Approved		Approved	Centrosome				Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	unprognostic (6.24e-2)	unprognostic (1.92e-1)	unprognostic (9.30e-2)	unprognostic (1.69e-2)	unprognostic (7.40e-2)	unprognostic (5.45e-2)	unprognostic (2.55e-2)	unprognostic (7.47e-2)	unprognostic (2.34e-1)	unprognostic (1.38e-1)	unprognostic (7.14e-2)	unprognostic (2.78e-1)	prognostic unfavourable (5.82e-7)	unprognostic (1.60e-1)	unprognostic (4.17e-2)	unprognostic (2.81e-1)	prognostic favourable (1.17e-4)	15.1	10.6	5.3	8.3	7.7	17.3	9.3	1.3	5.9	10.8	9.5	5.8	3	4.5	9.8	9.2	8.8	9.2	7.5	6.1	6.1	2.3	10.8	13.4	13.2	11.4	9.7	1	17.4	9.7	11	14	11.5	6.6	14	7.8	9.6	10.4	6.8	5	11.8	12.1	11.3	16.6	16.2	7.4	4.2	8.5	13.7	12.4	4.7	13.7	13.6	11.6	0.9	3.2	16.3	4.3	0.4	0.8	1.2	1.6	5	1.5	0.3	6.5	10.4	2	1.9	3.4	2.6	3.2	0.5	7.6	5	3.3	3.2	1.1	1.7	3	3.8	6.4	1.7	3.6	2	0.4	10.5	2.2	2.2	12.9	8.5	3.7	7.8	1	0.9	8.8	4.9	3	1.2	2	0.4	1.2	0.6	1.1	1.6	3.8	1.8	0.5	0.8	1.8	6.5	2.8	2.9	4	1.9	2.3	2.1	3.7	1.2	2.2	0.7	4.3	5.7	4.5	2.1	1.3	3.2	1.4	0.2	4.3	0.6	0.8	0.6	0.1	3.2	0.9	0.8	0.6	16.3	0.4	1.9	0.5	0	1.2	5.3	7.7	1.3	5.9	6.1	2.3	9.7	1	6.6	8.5
ALPK2	HAK	ENSG00000198796	Alpha kinase 2	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4	Cell line enhanced	Detected in many		BJ: 26.0;BJ hTERT+: 15.8;fHDF/TERT166: 23.5;U-138 MG: 13.3	Cancer enriched	Detected in some	6	renal cancer: 7.3	Not detected	Not detected			Cell type enhanced	Detected in single		non-classical monocyte: 1.8	Low lineage specificity	Detected in single			Region enhanced	Detected in single		cerebellum: 1.1	Low region specificity	Detected in many			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol				Cytosol		"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	unprognostic (7.35e-2)	unprognostic (4.91e-2)	unprognostic (1.64e-1)	unprognostic (4.60e-3)	unprognostic (2.64e-1)	unprognostic (8.27e-2)	unprognostic (1.22e-1)	unprognostic (1.41e-1)	unprognostic (3.44e-1)	unprognostic (1.06e-1)	unprognostic (5.13e-2)	unprognostic (1.33e-2)	prognostic unfavourable (8.20e-5)	unprognostic (5.27e-3)	unprognostic (2.50e-1)	unprognostic (4.73e-2)	unprognostic (3.20e-2)	0.8	0	0.1	2.8	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.9	0.8	0	0.4	35.3	0.1	0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0	0.1	0.5	0.1	0.1	0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0	0.5	0	1.8	0	0.3	0	0	6.9	0.5	0	0.2	1.8	0.1	26	15.8	11	9.5	1.6	0	0	2.7	23.5	0	0	0	11.3	5.6	0	0	2.1	0.9	1.4	0	0	1.6	0	3.3	0.1	0	0	0.2	7	0	0	0	0.1	0	0	5.7	0	0.2	0	0	0	0.2	0	0	0	0	0	13.3	5.8	1.8	4.4	10.7	9.2	0	2.6	0	0	0	0	0	0	0.8	0	0	0.3	0.1	0	0	0	0.1	0	0	1.8	0.5	0.1	0	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	Alpha kinase 3	Q96L96	15	84816680-84873482	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 18.4;skeletal muscle: 47.6	Cell line enhanced	Detected in some		BEWO: 9.2;HDLM-2: 6.9;HUVEC TERT2: 9.9;LHCN-M2: 13.6;NTERA-2: 8.3;RH-30: 24.4	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in single			Low region specificity	Detected in all			HPA026558	Uncertain		Approved	Nucleoplasm				Nucleoplasm		HPA026558: AB_1844774	unprognostic (2.69e-2)	unprognostic (1.42e-1)	unprognostic (2.71e-2)	unprognostic (4.61e-2)	unprognostic (2.08e-1)	unprognostic (6.53e-2)	unprognostic (1.44e-3)	unprognostic (1.42e-1)	unprognostic (1.68e-2)	unprognostic (1.82e-1)	unprognostic (1.74e-3)	unprognostic (1.23e-1)	prognostic favourable (3.95e-7)	unprognostic (1.76e-2)	unprognostic (1.77e-1)	unprognostic (2.96e-2)	unprognostic (4.87e-2)	3.7	1.8	0	0	0	0	0.7	0	0.1	0.5	1.4			0	0.1	1.7	0.8	0.2	0.3	18.4	0	0.6	1.6	1.3	1	0	0.1		0	2.1	8.8	6.9	0.6		0.4	0		0.4	0.2	47.6	0	0.2	0.8	0	0	1.2	0			0.6		0	0.5	0	0	0	0	0	0	0.3	0	1.1	0.1	0.1	0.1	0.2	0	9.2	0	0	0	0	0	4	0	0.2	0	0.7	0	0	0	6.9	1.1	1.1	0.2	0	0.1	0	0	0.9	0.1	0	0	9.9	0	0	13.6	0.5	0	0.1	8.3	0	0	24.4	0.1	0	2.5	0	0.1	0	1.3	0	0	6	0.2	0	0	0	0	0.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0										
AMHR2	"MISR2, MISRII"	ENSG00000135409	Anti-Mullerian hormone receptor type 2	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 27.1;ovary: 38.2;testis: 15.2	Group enriched	Detected in some	18	HEL: 27.6;K-562: 15.0	Cancer enhanced	Detected in single		testis cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Region enriched	Detected in single	10	hippocampal formation: 14.3	"HPA060228, HPA069636"			Approved	"Nucleoplasm,Vesicles,Centriolar satellite,Cytosol"				Vesicles	"Nucleoplasm, Centriolar satellite, Cytosol"	"HPA060228: , HPA069636: "	unprognostic (5.79e-2)	unprognostic (3.65e-1)	unprognostic (3.98e-1)	unprognostic (1.71e-1)	unprognostic (1.14e-1)	unprognostic (4.61e-3)	unprognostic (2.33e-1)	unprognostic (1.44e-2)	unprognostic (2.91e-1)	unprognostic (4.98e-2)	unprognostic (1.35e-1)	unprognostic (2.32e-1)	unprognostic (2.15e-2)	unprognostic (3.34e-2)	unprognostic (1.42e-1)	unprognostic (2.04e-1)	unprognostic (1.97e-1)	0.3	27.1	0.2	0.2	0.4	0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0	0.2	0.2	0.2	2.5	0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0	0	0.7	0	0	0	0.3	0	0.4	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	1.1	27.6	0	0.5	0	0	0.9	0	0	0	0	0	15	0	0	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.3	0.2	0.4	0.2	0.2	0.2	0	0.2	0.2	0.3	0.2
ANKK1	X-kinase	ENSG00000170209	Ankyrin repeat and kinase domain containing 1	Q8NFD2	11	113387791-113400418	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		skin 1: 9.7;tongue: 6.3	Cell line enhanced	Detected in some		HaCaT: 2.0;hTCEpi: 6.5;RT4: 3.1;U-266/70: 1.3	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in some		basophil: 1.4;naive B-cell: 1.3	Low lineage specificity	Detected in many			Not detected	Not detected							HPA012813	Uncertain									HPA012813: AB_1844832	unprognostic (5.63e-3)	unprognostic (6.67e-3)	unprognostic (5.09e-3)	unprognostic (6.27e-3)	unprognostic (5.56e-4)	unprognostic (7.02e-2)	unprognostic (2.07e-1)	unprognostic (1.75e-1)	unprognostic (4.50e-1)	unprognostic (3.15e-1)	unprognostic (3.36e-2)	unprognostic (2.18e-1)	unprognostic (5.39e-6)	unprognostic (3.17e-2)	unprognostic (3.83e-2)	unprognostic (2.79e-1)	unprognostic (4.65e-2)	0.6	0.5	0.6	0.6	2	0.4	1.2	0.6	1.4	1.5	0.6	0.6	0.6	0.4	0.7	0.9	0.6	3.3	0.6	0.6	0.6	1.2	0.6	0.6	0.6	1.1	0.6	0.6	1	0.6	0.4	4.7	0.6	0.6	1.9	0.1	0.6	1.8	1	0.7	9.7	0.6	0.6	2.3	0.9	0.2	1	0.6	0.6	1.2	6.3	1.5	0.6	1.2	1.3	0.2	1.4	0.1	0.1	0.4	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0	0.3	0	0	0.1	0	2	0.1	0.1	0	0.6	0	0	0	0	0	0	0	0.1	6.5	0	0.4	0	0	0.4	0	0.3	0	0.1	0.8	0	0	0.1	0.1	0.3	3.1	0.2	0.1	0	0	0	0.3	0	0	0	0.3	0.2	0	1.3	0.6	0	0	0.1	0	1.4	0.1	0.2	0.4	0.1	0.1	0	0.1	0	0	1.3	0.2	0.1	0.7	0.1	0	0.2	0	0.1	0.6	2	0.6	1.4	0.6	1.2	0.6	0.6	0.6	0.6
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561100-47571920	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA046188, HPA066326"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoli fibrillar center	Nucleoplasm	"HPA046188: AB_2679578, HPA066326: AB_2685659"	unprognostic (1.21e-1)	unprognostic (5.69e-3)	unprognostic (2.47e-2)	unprognostic (2.10e-2)	unprognostic (7.63e-2)	unprognostic (9.35e-2)	unprognostic (1.79e-2)	unprognostic (1.07e-1)	unprognostic (3.76e-2)	unprognostic (1.61e-1)	unprognostic (6.75e-2)	unprognostic (8.65e-2)	prognostic favourable (1.45e-6)	unprognostic (1.97e-1)	unprognostic (2.01e-1)	unprognostic (6.37e-2)	unprognostic (4.71e-2)	22.2	24.2	10.9	16.5	15.5	41.9	19.5	16	13.7	18	23.2	21.1	24.1	17.8	21.3	18.4	19.4	18.7	21	28.6	12.8	7.3	28	49.6	21.8	20.2	16.4	9.5	23.4	35.1	28.1	16.9	25.3	13.5	23.5	15.8	25.4	22.1	18.5	60.8	18.9	23.8	18.6	11.2	27.4	24.2	10.2	16.3	27.7	23.1	23.9	27.3	20.2	16.9	23.9	34.3	36.1	38.4	22.4	29.1	27.5	19.9	28.8	12.3	19.9	18.8	15	16.7	16.8	17.8	25.2	23.3	23.4	24.5	11.9	13.9	22.6	28.2	21.8	23.3	14.5	21.8	25.6	11.9	30.5	12.1	26.5	23.6	36.5	19.7	23.7	24	21.1	19.4	22	23.5	17	33.8	17.1	25.4	17.7	32.2	15.9	16.1	26.8	14.4	19.1	14	10.8	18.2	16.8	9.9	31.6	17.8	18.4	16.4	18.4	32.7	17	30.5	19.5	9.2	21.8	26.7	13	23.9	29	36.1	29.1	35.4	26.9	21.4	25.5	26.7	34.3	23.9	22.7	26.7	23.6	22.4	38.4	24.7	25.1	27.5	10.9	15.5	16	13.7	12.8	7.3	16.4	9.5	13.5	16.3
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	ATM serine/threonine kinase	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		U-698: 47.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB000102, HPA067142"	Supported		Enhanced	"Nucleoplasm,Vesicles"				"Nucleoplasm, Vesicles"		"CAB000102: , HPA067142: "	unprognostic (9.77e-2)	unprognostic (1.47e-1)	unprognostic (3.04e-1)	unprognostic (2.36e-1)	unprognostic (5.70e-2)	unprognostic (2.86e-2)	unprognostic (6.32e-3)	unprognostic (1.05e-1)	unprognostic (8.19e-2)	unprognostic (1.63e-1)	unprognostic (7.68e-2)	unprognostic (6.16e-2)	unprognostic (2.17e-3)	unprognostic (3.10e-1)	unprognostic (7.87e-2)	unprognostic (1.21e-1)	unprognostic (2.81e-1)	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.6	3.8	7.5	4	9.8	14.3	1.9	6	6.7	3.5	5.8	4.7	6.3	9.4	8.9	4.8	4	5.7	5	5.4	7.5	3.3	8.5	4.7	4.7	5.1	10.2	9.2	9.2	3.1	5.2	10.2	7.2	8.2	6.4	6.8	1.9	7	9.4	6.1	3.8	5.5	5.2	14.8	3.9	5.4	5.1	6.3	6.9	3.2	10.3	4.9	5.8	11.3	8.6	4.8	4.9	5.6	4.3	4.5	47.4	5.7	11.3	9.6	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	ATR serine/threonine kinase	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Golgi apparatus	HPA054320: 	unprognostic (1.47e-1)	unprognostic (8.90e-2)	unprognostic (2.90e-1)	unprognostic (4.23e-2)	unprognostic (2.25e-2)	unprognostic (6.42e-2)	prognostic unfavourable (8.39e-5)	unprognostic (3.44e-1)	unprognostic (1.67e-1)	unprognostic (3.02e-1)	prognostic unfavourable (1.23e-5)	unprognostic (1.94e-1)	unprognostic (5.61e-2)	unprognostic (1.06e-1)	unprognostic (3.55e-1)	unprognostic (1.69e-2)	unprognostic (1.43e-1)	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10	10.4	6	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12	10.3	16	10	8.1	12.3	13.6	18	22.5	8.8	12.5	11	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9	15.3	9.7	19	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4	6.7	6	0.8	22.5	11.1	7.4	8.4	10.6	11.6	8.8	12.4	7	9.3	9.6	5.2	7.2	18.4	12.9	8.8	14.6	10.9	11.5	14.1	5.9	7.2	10.1	8.4	5	4.7	16.9	5.7	9.1	6.4	8.8	10.5	9.6	7	8.3	9.5	9.9	12.7	7	7.1	7.9	10.6	10.8	13.3	9.4	10.5	5.3	5.3	22.9	8.3	8.1	12.1	6.9	12.4	9.5	4.8	12.3	13.3	10.8	6.4	17.1	12.3	6.6	7.5	0.7	2.7	2.2	4.4	4	6	3.1	3.2	4.2	2.8	5.8	4.1	4	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10	8.1	12.5	9.7
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	Aurora kinase A	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	lymphoid tissue: 32.3;testis: 41.1	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many							"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Centrosome,Cytosol"				"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	unprognostic (7.73e-2)	unprognostic (2.46e-2)	unprognostic (2.76e-2)	prognostic unfavourable (9.40e-5)	unprognostic (1.92e-1)	unprognostic (2.11e-2)	prognostic unfavourable (1.49e-4)	unprognostic (4.69e-3)	unprognostic (2.42e-1)	unprognostic (6.88e-2)	prognostic unfavourable (6.13e-4)	unprognostic (1.40e-1)	prognostic unfavourable (1.47e-8)	unprognostic (1.67e-1)	unprognostic (6.83e-2)	unprognostic (9.00e-2)	unprognostic (5.14e-2)	3.7	2.3	1.5	12.7	1.3	8.3	3	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6	8.7	2	6.6	2.6	32.5	24	16.1	11.3	0.9	2.1	20.4	26.7	12.5	64.7	27.3	67.2	22.8	10.7	18.4	10.9	26.3	28.5	17.9	69	9.6	10.9	19	24.6	41.8	0.5	25.4	26.8	1	1.9	22.4	20.1	15.1	21.5	8.5	27.5	33.2	15.2	19.7	14.7	24.8	11.6	31.1	11.8	10.3	8.6	13.9	7.5	37.3	43	17.9	25.5	15.9	8.6	28.1	27.9	15.5	37.6	11.9	13.8	18.5	15.2	14.8	23.2	0.2	5.3	6	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	Aurora kinase B	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 19.7;lymphoid tissue: 59.9	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Not detected	Not detected			Cell type enhanced	Detected in many		T-reg: 10.9	Lineage enriched	Detected in many	5	T-cells: 10.9	Low region specificity	Detected in single			Low region specificity	Detected in all			"CAB005862, HPA037708"	Enhanced		Supported	"Nucleoplasm,Midbody"				"Nucleoplasm, Midbody"		"CAB005862: AB_449204, HPA037708: "	unprognostic (4.76e-2)	unprognostic (3.61e-3)	unprognostic (2.25e-1)	unprognostic (3.14e-2)	unprognostic (2.27e-1)	unprognostic (6.05e-2)	prognostic unfavourable (1.24e-4)	unprognostic (1.99e-3)	unprognostic (9.41e-3)	unprognostic (3.47e-2)	unprognostic (4.61e-3)	unprognostic (1.01e-2)	prognostic unfavourable (0.00e+0)	unprognostic (7.77e-2)	unprognostic (2.93e-1)	unprognostic (6.76e-2)	unprognostic (3.77e-1)	1.2	1.3	0.4	22.1	0.6	19.7	2	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8	19.1	2.1	5	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41	28.2	42	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41	10.2	7.8	30.2	30.5	13.5	33.8	18	50.1	24.4	16.1	30.8	0.1	12.9	24	0.7	0.6	23.9	15	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17	8.9	8.1	9.1	13	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	Aurora kinase C	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	21	testis: 72.0	Cell line enriched	Detected in some	7	NTERA-2: 29.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many							Low region specificity	Detected in all			HPA034859	Uncertain									HPA034859: AB_10670298	unprognostic (7.27e-2)	unprognostic (1.76e-1)	unprognostic (6.45e-2)	unprognostic (8.07e-3)	unprognostic (3.29e-1)	unprognostic (5.99e-2)	unprognostic (1.11e-2)	unprognostic (7.02e-2)	unprognostic (1.13e-1)	unprognostic (2.09e-1)	unprognostic (1.47e-2)	unprognostic (2.51e-1)	unprognostic (1.20e-5)	unprognostic (4.26e-2)	unprognostic (1.61e-1)	unprognostic (1.55e-1)	unprognostic (6.46e-4)	0.6	0.5	0.9	0.9	1.2	0.7	1.5	0.7	2	0.4	0.6	0.6	0.2	0	0.8	1.3	0.5	0.6	2.6	0.9	0.9	1.1	0.8	1.8	1.3	2.2	1.2	0.2	0.4	0.5	0.1	1.3	1.2	1.7	0.5	0.8	1.1	0.5	0.9	2.3	0.6	0.4	1.1	2.1	3.4	0.4	72	0.6	0.7	0.8	1	1.3	0.5	0.4	2.1	1	1.7	1	1	0.6	0.2	0.2	0.1	0.7	0.3	0.2	0.7	0.3	1.2	0.6	0.9	3.4	0.8	0.1	0	0.1	0.5	0	0	0.7	0.6	0	3.7	0.1	0.3	0	1.1	0	0.2	0.9	0.7	0.7	0.5	0.6	0.1	0	1.2	0	1.1	0.6	29.3	0.8	0.1	0.2	0.6	0.6	1.2	1.4	0.4	0	0.2	0.1	0.1	1.3	0.3	0.2	4.1	0.3	0.7	1.4	1.8	0.6	0.8	0	0	0	0.1	1.7	0.6	1	0	1.9	0	0	0.9	2.1	0	0	0.1	1	0.3	1	0	0.2	0.9	1.2	0.7	1.6	0.9	1.1	1.2	0.2	1.7	0.6
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	AXL receptor tyrosine kinase	P30530	19	41219203-41261766	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Oncogene, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		fHDF/TERT166: 66.1;U-251 MG: 70.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		NK-cell: 8.8;plasmacytoid DC: 18.3	Group enriched	Detected in many	14	dendritic cells: 18.3;NK-cells: 8.8	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		61000000	61000000	Plasma membrane	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: , HPA075217: "	unprognostic (2.20e-1)	unprognostic (2.02e-1)	unprognostic (6.79e-3)	unprognostic (1.01e-1)	unprognostic (1.40e-1)	unprognostic (8.49e-3)	unprognostic (2.42e-1)	unprognostic (1.74e-1)	unprognostic (3.15e-2)	unprognostic (2.82e-2)	unprognostic (9.57e-3)	unprognostic (1.98e-1)	prognostic unfavourable (2.53e-7)	unprognostic (1.16e-3)	unprognostic (1.52e-2)	unprognostic (5.56e-2)	unprognostic (4.83e-3)	38	15.4	10.6	11.7	12.7	1.3	27.1	6.3	12.1	26.2	26.8	13.4	8.1	9.1	28	19.4	21.8	17.4	17.8	18.5	11.5	6.1	7.8	13	20	7.6	10.6	9.3	20.9	5.1	9.6	5.6	26.6	10.1	19.5	10.2	16.8	7.8	20.4	14.1	13.8	12.8	29.4	10.7	27.3	16.2	22.4	10.4	3.4	12	8.4	5.8	35.6	18.3	0.1	18.3	0.9	0.2	8.8	0.3	0.2	52.5	21.2	1.3	0.1	4.8	4.8	0	41.8	37.6	61.4	38.1	1.1	24.7	0	17	66.1	4.4	0	28.1	52.9	0	0	0	14	0.8	17.4	0	0	3.6	0.5	36.2	56.2	22.7	2	0	38	0	0	0	0.5	10.2	0	22.4	0	27.4	0	0	0	10.8	0	0.2	0.1	0.9	46.6	43.5	29.7	41.5	70.8	0	0.1	0.1	29	0	32.3	0.9	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	4.2	0.1	0.2	0.2	0.3	8.8	0.1	18.3	0.2	0.2	10.6	12.7	6.3	12.1	11.5	6.1	10.6	9.3	10.1	10.4
BCKDK		ENSG00000103507	Branched chain ketoacid dehydrogenase kinase	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Group enriched	Detected in all	4	dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA017995, HPA056067"	Supported		Supported	Mitochondria				Mitochondria		"HPA017995: AB_1845309, HPA056067: "	unprognostic (1.37e-1)	unprognostic (2.57e-1)	unprognostic (6.94e-2)	unprognostic (5.20e-2)	unprognostic (5.39e-2)	unprognostic (3.61e-2)	unprognostic (1.01e-1)	unprognostic (5.47e-2)	unprognostic (1.60e-1)	unprognostic (1.90e-1)	unprognostic (1.35e-1)	unprognostic (3.24e-2)	unprognostic (2.66e-3)	unprognostic (4.85e-2)	unprognostic (3.93e-2)	unprognostic (1.00e-1)	unprognostic (4.97e-2)	15.4	29.7	11.9	13.1	15	9.4	18.3	18.8	21.3	11.7	14.1	9.6	19.9	11.2	14.8	14.9	14.9	13.8	15.1	39.2	14.2	10.3	21.3	46.5	18.2	32.5	10.7	17.3	15.1	52.4	17.4	8.9	11.4	13.2	14.9	9.9	10.4	33.9	25.7	67.7	21.5	12.2	19.9	15.6	16	19.9	11.2	9.3	8	11.7	25.9	10.6	15.3	12	6.9	26.8	26.6	33	6.3	6.8	13.6	18.1	20.4	11.5	17.3	14.2	14.3	12.5	15.8	19.5	24.6	24.1	13.3	12.1	17	23	19.7	12.6	8.1	27.5	15.9	13.7	25.3	18.4	13.9	24.2	25.1	9.5	16.9	21	11.1	21.1	17.6	26.2	9.3	16.1	36.8	30.9	8.8	12.6	9.8	16.5	17.8	16.8	31.3	18.8	12.5	17.8	16.3	12.3	30.3	9.8	18.2	9.2	16.8	18.8	10.9	19.2	13.1	16.8	6	6	21.3	13.8	17.6	12.2	33	23.1	5.7	27.4	5.6	6.9	5.2	4.2	26.8	5.4	4.4	5	26.6	6.3	19.3	5.8	6.8	13.6	11.9	15	18.8	21.3	14.2	10.3	10.7	17.3	13.2	9.3
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564604	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8	Cell line enhanced	Detected in some		Daudi: 43.0;REH: 11.6;RPMI-8226: 14.2;U-698: 21.0;U-87 MG: 8.9	Low cancer specificity	Detected in some			Not detected	Not detected			Group enriched	Detected in some	4	memory B-cell: 47.8;naive B-cell: 33.9	Lineage enriched	Detected in many	5	B-cells: 47.8	Not detected	Not detected			Low region specificity	Detected in all			"CAB005093, HPA069571"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB005093: AB_2274756, HPA069571: "	unprognostic (6.50e-5)	unprognostic (4.22e-3)	unprognostic (5.64e-2)	unprognostic (1.42e-1)	unprognostic (3.45e-1)	unprognostic (5.98e-6)	unprognostic (1.59e-2)	unprognostic (8.94e-4)	unprognostic (1.02e-3)	unprognostic (9.83e-3)	unprognostic (1.22e-2)	unprognostic (4.66e-2)	unprognostic (9.05e-6)	unprognostic (5.62e-2)	unprognostic (5.43e-2)	unprognostic (2.19e-1)	unprognostic (1.16e-1)	0.5	0.2	0.1	32.3	0.1	1.7	0.2	0.1	0.1	0.1	1.2	0	0	0.3	0.1	0	1.9	0.2	0.4	0.3	0.1	0.1	1.3	0.5	0.6	27.6	0.1	0.1	0.1	0.1	0	0.1	0	0	0.4	0.4	0.3	2.4	0	0.1	0.1	23.5	0	0.1	31.9	1.4	0.2	0	3.9	0.7	0.4	39.8	2.5	0.4	47.8	4.3	0.1	0	0	9.8	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	43	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	11.6	0	14.2	0	0	0	0.2	0	0	0	0	0	0.5	0	0	0	0	2.2	3.7	21	8.9	0	0	0	0	0	0.5	0	9.8	47.8	0.3	1.1	0	33.9	0.2	0.1	0.1	0	0	4.3	0.4	1.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0
BMP2K	"BIKe, DKFZp434K0614"	ENSG00000138756	BMP2 inducible kinase	Q9NSY1	4	78776342-78916372	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		HEL: 37.9;HMC-1: 41.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026436, HPA026451, HPA026501"	Approved		Supported	Nuclear speckles				Nuclear speckles		"HPA026436: AB_10600102, HPA026451: AB_10600228, HPA026501: AB_10601341"	unprognostic (7.96e-2)	unprognostic (3.68e-1)	prognostic favourable (1.74e-4)	unprognostic (9.08e-2)	unprognostic (1.97e-1)	unprognostic (9.73e-3)	unprognostic (1.51e-2)	unprognostic (1.47e-1)	unprognostic (2.98e-1)	unprognostic (7.60e-2)	unprognostic (1.39e-1)	unprognostic (9.60e-2)	unprognostic (9.90e-2)	unprognostic (9.45e-2)	unprognostic (1.59e-1)	unprognostic (1.55e-2)	unprognostic (3.18e-2)	11.4	11.1	15.6	18.6	15	15.3	12	8.2	12.7	11.1	13.9	20.3	2.1	8	11.3	9.6	15.7	10	12.3	17	18	9.5	8.3	10.2	14.1	22.9	20.9	12	6.5	6.4	7.7	7.8	14.4	14.5	8.4	18.9	11.4	10.2	6	7.5	14.5	15.9	10.4	28.3	19.2	7.4	19.6	16.5	19.9	12.5	5.9	24.4	9.7	12.8	2.7	1.7	3.8	2.6	0.4	0.4	0.5	5.4	2	3	3.9	5.9	5.6	2.3	5.2	8.1	5.9	7.7	3.7	2.9	6.6	2.7	25.2	1.3	3.5	4.2	10.8	1.8	1.2	37.9	2.4	1.7	6.5	7.9	41.1	8.2	5.5	9.2	8.5	7.9	10.2	19	6.9	1.1	4.7	3.3	1.4	1.3	6.8	5.4	1.6	7.2	2.9	4.7	2.5	7.6	3.9	4.6	1.4	4.1	7.7	5.8	2.3	9.6	5.6	3.5	1.4	2.5	5.1	9.9	4	0.4	2.2	1.2	0.1	0.9	0.1	2.7	0.1	0	1.7	2.7	0.4	0.2	3.8	0.4	2.6	1.3	0	0.5	15.6	15	8.2	12.7	18	9.5	20.9	12	14.5	16.5
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	Bone morphogenetic protein receptor type 1A	P36894	10	86756601-86932838	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB019398	Approved		Approved	Cytosol				Cytosol		CAB019398: 	unprognostic (1.36e-1)	unprognostic (2.46e-1)	unprognostic (3.34e-1)	unprognostic (9.61e-2)	unprognostic (1.05e-3)	unprognostic (9.34e-2)	prognostic unfavourable (8.93e-4)	unprognostic (3.64e-1)	unprognostic (2.38e-2)	unprognostic (1.53e-1)	unprognostic (9.24e-2)	unprognostic (9.42e-2)	unprognostic (4.32e-2)	unprognostic (1.80e-1)	unprognostic (1.47e-1)	unprognostic (1.01e-2)	unprognostic (1.07e-1)	8.9	7	9.4	7.9	12.4	0.9	10.7	14.1	9.2	19.4	20.6	10.9	7.7	6.2	16.3	12.3	8.4	10.9	10.8	11	7.7	6.1	8.2	4.6	7.4	2.9	7.3	7.6	16.1	10.6	10	14	7.4	8.5	12.8	9.3	10.9	12.6	14.2	8.4	11.3	9.8	16.5	12.2	3.4	12.1	7.8	9.2	0.3	19.4	7.8	5.7	16	11.4	1.8	1.1	3.6	0.8	0.9	1.4	0.3	7.5	3.8	14.7	12.5	7.7	5	2.6	7.6	8	4.5	5.2	6.5	6.7	2.3	3.5	9.7	8.1	6.5	8.3	6.6	2.5	3.7	2.9	3.6	10.7	4.1	4	20.4	4.4	3.5	6	4.4	0	4.5	1.6	5.2	3.2	2.6	3.2	8	1.8	0	5.8	0	9.2	7.2	1.5	4.8	8.5	4.3	5.1	7.3	2	3.8	3.2	5.2	6.6	7	0.4	7	2.9	2.8	2.7	2.6	2	0.8	0.6	1.4	0.5	0.9	1.8	1.4	1.2	0.3	1.5	1	1.1	3.6	0.9	0.6	1.1	0.7	0.3	9.4	12.4	14.1	9.2	7.7	6.1	7.3	7.6	8.5	9.2
BMPR1B	"ALK6, CDw293"	ENSG00000138696	Bone morphogenetic protein receptor type 1B	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Dwarfism"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	Cell line enhanced	Detected in many		A549: 18.3;MCF7: 9.2;SH-SY5Y: 15.3	Cancer enhanced	Detected in many		breast cancer: 32.4;prostate cancer: 24.7	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all														unprognostic (2.25e-1)	unprognostic (1.80e-2)	unprognostic (1.40e-3)	prognostic favourable (2.84e-4)	unprognostic (1.57e-1)	unprognostic (4.22e-2)	unprognostic (1.92e-1)	unprognostic (2.86e-2)	unprognostic (2.95e-2)	unprognostic (1.01e-1)	unprognostic (3.97e-2)	unprognostic (3.93e-1)	unprognostic (1.62e-3)	unprognostic (7.89e-4)	unprognostic (6.22e-2)	unprognostic (3.81e-3)	unprognostic (2.63e-2)	1.1	5.6	12.7	0.8	15	0.7	1.7	11.6	12.7	28	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0	18.3	4.9	0	1.9	4.5	0.1	0.1	0	0.1	0.4	0	0.1	0	0.2	0.8	1	2.9	6.7	0	0	4.5	0	1.1	0	0.5	0.4	0	2.8	7.5	2.8	5.6	0	0	0	7	9.2	0.6	0.1	1.8	3.1	0.1	2.7	0.1	3.5	0.1	0.2	15.3	0.2	2.5	2.5	1.9	0	0	3.9	3.1	0.1	3.3	0	0	0	1.5	0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	Bone morphogenetic protein receptor type 2	Q13873	2	202376936-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"				Plasma membrane	Nucleoplasm	"HPA017385: AB_1845397, HPA049014: "	unprognostic (2.17e-1)	unprognostic (9.00e-2)	unprognostic (2.35e-1)	unprognostic (2.73e-1)	unprognostic (1.67e-1)	unprognostic (2.55e-1)	unprognostic (4.30e-2)	unprognostic (1.11e-1)	unprognostic (3.18e-2)	unprognostic (1.10e-2)	unprognostic (2.13e-2)	unprognostic (1.97e-1)	unprognostic (1.29e-2)	unprognostic (1.21e-3)	unprognostic (9.20e-2)	unprognostic (1.18e-1)	unprognostic (3.40e-1)	18.1	15	12.1	9.8	14.2	1.1	10.2	9.5	17.1	15.7	11.7	8.2	6.5	5.5	12.9	10.2	10.6	10.3	13.2	14.6	10.8	13.5	10.7	11.5	24.9	4.4	10.4	14.5	12	7	15.5	6.1	21.7	10.8	11	7.7	11.4	7.1	9.1	10.6	7.2	8.1	15.3	7.5	8.9	7.2	12.9	3.8	3.9	11.6	5.2	5.4	11.1	8.9	1.6	2.6	0.9	2.7	1.1	3.6	0.9	5.7	5.4	5.5	8.7	13.9	13.4	10.7	11.9	12	10.4	10.4	4.7	8.7	2	13.9	24	10.8	7.2	9.2	16.3	5.9	4.9	6	5.7	7.3	9.6	1.7	4.7	9.8	8.7	7.6	10.2	30	3.9	9.9	12.8	10.7	1.4	1.5	3	4.9	3.9	10.9	3	8.9	12.2	5.6	5.6	12.6	7.6	14	5.8	4	33	21.2	11.3	7.2	7.2	1.4	1.7	0.6	5.1	3.8	6.1	0.5	2	0.9	3.4	1.8	2.5	1.5	1.3	2.2	2.3	1.6	2.7	1.4	0.6	1.1	2.7	2.6	3.6	0.9	12.1	14.2	9.5	17.1	10.8	13.5	10.4	14.5	10.8	3.8
BMX	"ETK, PSCTK3"	ENSG00000102010	BMX non-receptor tyrosine kinase	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	epididymis: 57.1	Cell line enriched	Detected in single	121	HUVEC TERT2: 88.2	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in single	17	neutrophil: 10.5	Lineage enriched	Detected in single	105	granulocytes: 10.5	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				Plasma membrane	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	unprognostic (7.80e-2)	unprognostic (4.92e-3)	unprognostic (1.16e-2)	unprognostic (4.07e-3)	unprognostic (2.69e-1)	unprognostic (2.14e-1)	unprognostic (1.06e-3)	unprognostic (2.36e-1)	unprognostic (1.87e-1)	unprognostic (1.21e-1)	unprognostic (1.78e-1)	unprognostic (1.06e-1)	unprognostic (1.26e-2)	unprognostic (1.84e-2)	unprognostic (3.64e-2)	unprognostic (1.26e-1)	unprognostic (2.81e-2)	8.2	0.3	0.1	1	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0	0.2	0.9	3.7	6.5	0.4	0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0	0	10.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.4	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	10.5	0	0	0	0	0	0.1	0.7	0.1	0.3	0.5	0	0.4	0	0.7	0.1
BRAF	BRAF1	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924928	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001328, CAB004552, HPA071048"	Approved		Approved	"Vesicles,Cytosol"				Vesicles	Cytosol	"CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: "	unprognostic (2.98e-3)	unprognostic (5.66e-2)	unprognostic (2.20e-2)	unprognostic (2.66e-3)	unprognostic (2.44e-1)	unprognostic (1.48e-2)	unprognostic (2.07e-2)	unprognostic (4.23e-2)	unprognostic (4.07e-2)	unprognostic (1.58e-2)	unprognostic (6.53e-2)	unprognostic (1.91e-2)	unprognostic (3.79e-3)	unprognostic (2.08e-1)	unprognostic (1.76e-1)	unprognostic (8.01e-2)	unprognostic (5.46e-2)	13.1	12.1	20.1	16.5	20.4	27.8	14.2	29.9	21.5	12.4	12.3	9.5	12.5	9.3	15.3	17	11.8	11.5	12	13.6	13.2	12.2	13.7	12.8	15.9	13.3	9.9	17.8	16.8	13.2	28.9	24.8	13.7	15.3	14.5	11	10.7	11.6	16.6	12.9	15.6	10.5	13	10.9	12.3	12	24.9	12.2	13.5	16.6	7.5	12.1	18.6	18.1	2.6	1.9	7.5	2.4	7	5.6	1.1	5.4	4.6	6.8	8.1	8.3	10.7	10.9	6.1	6.5	4.9	7.1	5	5.9	9.3	4.7	6.2	3	6	4.8	9	8.6	4.9	6	4.5	4.6	7	9.8	6.1	7.1	5.4	5.2	10.8	5.7	9.5	16.7	8.7	2.9	13	10.3	6.3	2.9	8.5	5.8	7.6	4.8	10.4	7.9	6.6	7	4.3	6.3	4	6.7	8.4	5.3	4.1	11.5	4.9	19.4	11	14.8	8.7	9.9	5.7	3.3	2	7.5	3.1	1.7	2.1	2.6	3	2.4	1.6	2.6	5.6	2.8	4.1	7	2.4	1.9	2.7	1.1	20.1	20.4	29.9	21.5	13.2	12.2	9.9	17.8	15.3	12.2
BRSK1	KIAA1811	ENSG00000160469	BR serine/threonine kinase 1	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 65.0	Cell line enhanced	Detected in many		SCLC-21H: 25.9;SH-SY5Y: 23.2;WM-115: 21.1	Cancer enhanced	Detected in all		glioma: 12.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA021212, HPA061719"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA021212: AB_1845455, HPA061719: "	unprognostic (1.42e-3)	unprognostic (2.92e-2)	unprognostic (1.20e-1)	unprognostic (6.69e-3)	unprognostic (2.71e-1)	unprognostic (4.21e-2)	unprognostic (3.06e-6)	unprognostic (4.24e-1)	unprognostic (2.06e-2)	unprognostic (3.04e-1)	prognostic favourable (1.02e-4)	unprognostic (3.00e-1)	prognostic unfavourable (7.98e-6)	unprognostic (1.16e-1)	unprognostic (6.61e-3)	unprognostic (1.34e-1)	unprognostic (2.09e-1)	1.4	9.8	28.6	3.2	23.6	1	1.6	26.7	65	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3	2.3	3.9	6.5	33.4	20	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0	3	0	1.6	3.2	0.7	0	0.3	0	0.9	0.1	0.8	0.2	0.3	1.2	15.3	8	0	0.6	0.1	2.4	3.4	3.3	4.8	5.9	2.7	3.1	1.7	2.7	0.1	3.2	0.1	3.1	14.4	12.6	2	1.6	0.6	3.3	0.6	5.9	2.1	0.3	3.3	0	0.1	2.8	18.8	2.9	0.8	3.6	0.7	11.1	1	8.3	3.8	0.5	0.2	0	25.9	23.2	0	0.4	5.6	1.3	1.7	0	6.3	6.7	3.5	4.6	15.6	11.4	7	6.5	1.4	21.1	0	0.9	0	0.1	0.4	0.8	0	0	0	0.1	0	0	0.2	0	0.1	0	0.3	0	0.2	28.6	23.6	26.7	40.2	33.4	20	20.4	14.8	13.3	7.2
BRSK2	"C11orf7, PEN11B, STK29"	ENSG00000174672	BR serine/threonine kinase 2	Q8IWQ3	11	1389899-1462689	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	brain: 34.9;pancreas: 78.8	Cell line enhanced	Detected in some		AF22: 8.9;AN3-CA: 9.7;CACO-2: 7.7;HAP1: 7.2;NTERA-2: 15.0;SCLC-21H: 35.0	Cancer enhanced	Detected in many		glioma: 3.7	Low region specificity	Detected in all			Cell type enriched	Detected in single	13	NK-cell: 1.3	Lineage enriched	Detected in single	13	NK-cells: 1.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA073690			Approved	Golgi apparatus				Golgi apparatus		HPA073690: 	unprognostic (5.47e-2)	unprognostic (4.11e-2)	unprognostic (1.26e-1)	unprognostic (2.85e-2)	unprognostic (1.18e-1)	unprognostic (1.40e-2)	unprognostic (1.05e-2)	unprognostic (3.63e-1)	unprognostic (6.42e-2)	unprognostic (3.86e-2)	unprognostic (2.22e-2)	unprognostic (2.31e-1)	unprognostic (3.17e-7)	unprognostic (3.24e-2)	unprognostic (1.57e-1)	unprognostic (1.49e-3)	unprognostic (1.86e-1)	1.5	3.5	13.6	1.5	12.8	1.3	1.3	30.8	34.9	1.3	1.5	10	0	1.7	1.4	1.3	1.3	1.4	1.9	1.5	15.6	10.6	1.4	1.3	1.4	1.3	8.3	17.2	1.4	78.8	1.6	4.6	1.8	9.5	1.6	1.4	2.2	1.6	1.4	1.5	1.5	1.9	1.4	6.5	1.3	1.9	5.5	9.2	0	1.9	0	1.3	1.3	0.2	0	0	0	0	1.3	0	0	0	3.9	8.9	9.7	0.1	0.3	0	0.1	0.1	0.7	0.3	7.7	0.5	0	1.3	0.1	0	7.2	0	0.6	0.9	3.8	0	0	0.1	0.4	0	0.3	0.1	0	0	0.9	0	0.1	0	0.1	0.9	0	0	15	1.2	0	0	0	0.1	0.1	35	5.2	1.7	0.1	2.4	0.2	0.4	0.2	0.8	0	0	0	0.2	0	0	0.1	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	13.6	12.8	30.8	23.3	15.6	10.6	8.3	17.2	9.5	9.2
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	Bruton tyrosine kinase	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 77.5;lymphoid tissue: 37.0	Cell line enhanced	Detected in some		Daudi: 28.8;HEL: 40.0;HMC-1: 144.1;U-937: 20.9	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		basophil: 77.5	Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		610000	610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	unprognostic (3.19e-2)	unprognostic (2.51e-3)	unprognostic (1.06e-2)	unprognostic (3.66e-2)	unprognostic (5.69e-2)	unprognostic (3.76e-3)	unprognostic (6.55e-2)	unprognostic (3.58e-3)	unprognostic (6.02e-2)	unprognostic (3.12e-1)	unprognostic (1.02e-1)	unprognostic (1.41e-1)	unprognostic (2.08e-3)	unprognostic (7.80e-2)	unprognostic (1.29e-2)	unprognostic (1.56e-2)	unprognostic (8.14e-2)	7.3	2.4	3.3	23.5	5.6	14	2.6	0.8	3.6	2.3	3	4.7	0.3	2.2	1.9	2.6	2.4	2	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1	1	2.5	12.9	3.3	10.8	37	3.1	1.3	6.3	4	1.7	1.8	36.7	5.8	2	13.7	13.2	77.5	20.7	0	0	6.1	0	0	0	0	0	0	0	0	0	0	0	0	0	28.8	0	0	0	0	0	0	0	0	40	0	0	0	16	144.1	0	0	0	0	0	8.4	0.3	0	0	0	11.2	0.2	0	12.1	0	1.8	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0.3	0.1	13.7	0	20.9	0	77.5	11.3	19.3	0	18.1	0	13.7	0	0	13.2	13.7	0	0	4.5	0	20.7	6	0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	BUB1 mitotic checkpoint serine/threonine kinase	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	lymphoid tissue: 56.5;testis: 30.9	Cell line enhanced	Detected in many		HEL: 67.2	Low cancer specificity	Detected in all			Low region specificity	Detected in some			Cell type enhanced	Detected in many		T-reg: 6.1	Low lineage specificity	Detected in many			Not detected	Not detected							HPA006123			Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	HPA006123: AB_1845498	unprognostic (7.74e-2)	unprognostic (3.45e-2)	unprognostic (9.72e-3)	prognostic unfavourable (3.65e-4)	unprognostic (1.61e-1)	unprognostic (5.62e-3)	prognostic unfavourable (1.03e-5)	prognostic unfavourable (3.94e-4)	unprognostic (1.26e-3)	unprognostic (1.15e-1)	prognostic unfavourable (2.37e-5)	unprognostic (1.76e-1)	unprognostic (0.00e+0)	unprognostic (2.45e-2)	unprognostic (3.64e-1)	unprognostic (5.01e-2)	unprognostic (1.28e-1)	1.1	0.9	0.5	15.8	1	8.9	0.6	0.3	1	1.2	2.8	0.4	0	2.4	0.7	2.3	5.8	0.5	1	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1	0.7	0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2	1.8	2.4	3	0.2	1.4	6.1	1.1	29.9	8.8	23.1	14.5	1	1.7	12.3	15.6	10.3	27.2	20.5	18.4	17.2	20.3	9.7	9	13.1	29.5	11.3	33.8	16.1	14.4	67.2	9.4	14.7	0.2	19.3	19	0.4	0.7	20.9	10.4	15.8	29.4	42.4	22.2	9.8	32.3	16.2	22.3	16.6	21.5	19.8	31	5.5	9.5	15.5	6.7	11.1	9.4	8.4	7.4	16.4	6.5	12.4	20.2	9.3	21.6	22.2	20.8	25	8.3	15	21.7	3	0	0.7	0.6	0.2	0.9	1.8	2.5	1	0.8	1.4	1.6	1.5	0	1.4	0.1	2.4	6.1	1.1	0.5	1	0.3	1	0.5	0.5	0.6	0.2	0.5	0.1
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	BUB1 mitotic checkpoint serine/threonine kinase B	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 49.5;testis: 25.6	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Not detected	Not detected			Cell type enhanced	Detected in some		naive B-cell: 2.8;plasmacytoid DC: 2.8	Low lineage specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in some			HPA008419			Supported	Cytosol				Cytosol		HPA008419: AB_1078308	unprognostic (4.40e-2)	unprognostic (2.23e-1)	unprognostic (4.65e-2)	unprognostic (2.44e-3)	unprognostic (9.66e-2)	unprognostic (3.52e-2)	prognostic unfavourable (7.43e-6)	prognostic unfavourable (3.56e-4)	unprognostic (3.69e-3)	unprognostic (2.32e-1)	prognostic unfavourable (1.79e-4)	unprognostic (1.76e-2)	unprognostic (0.00e+0)	unprognostic (3.75e-2)	unprognostic (4.66e-2)	unprognostic (2.20e-1)	unprognostic (3.94e-2)	1	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2	2.8	2.8	0	0.2	0.7	0.7	0.5	21.6	11	35.1	13.9	0.8	2.5	11.3	20.5	11.5	22	19.1	16	8.3	19.6	11.5	7.4	24.4	33.1	11.1	24	16.8	17.8	28.6	28.4	14.9	0	25.7	15.7	0.5	0.6	13.4	12.7	15.9	24.6	20.9	21.9	7.3	20.2	15.7	23.7	12.5	21.7	28.8	14.8	6.7	11	22.9	14.1	12.7	12.1	4.5	14.1	13.4	9.2	16.9	17.9	16.8	18.2	10.9	18.5	32	9	29	21.9	0	0	0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0	0.7	0.1	2.8	0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1
CAMK1	CaMKI	ENSG00000134072	Calcium/calmodulin dependent protein kinase I	Q14012	3	9757342-9769992	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		adrenal gland: 60.5;blood: 59.4	Cell line enriched	Detected in many	4	HMC-1: 92.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	6	eosinophil: 59.4	Lineage enriched	Detected in many	6	granulocytes: 59.4	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB031904, HPA051409"	Approved		Approved	Cytosol		550000	550000	Cytosol		"CAB031904: AB_630964, HPA051409: "	unprognostic (4.43e-2)	unprognostic (3.05e-1)	unprognostic (1.68e-1)	unprognostic (1.29e-1)	unprognostic (1.11e-1)	unprognostic (3.06e-2)	prognostic unfavourable (7.52e-4)	unprognostic (5.53e-2)	unprognostic (3.32e-1)	unprognostic (9.74e-2)	unprognostic (1.37e-3)	unprognostic (2.17e-1)	unprognostic (1.14e-3)	unprognostic (7.76e-2)	unprognostic (1.72e-1)	unprognostic (3.67e-2)	unprognostic (3.01e-1)	27.1	60.5	28	11.7	26	3.5	34.1	12.4	31.2	9.5	10.7	4.4	5.8	6.8	12.6	10.5	7.1	12.6	8.9	10.2	21.4	14	13.1	20.7	9.2	10.4	10.3	19.9	21.5	4.5	7.4	7.9	5.1	10.1	18.6	8.1	6.8	5.1	15.1	4.7	3.3	8.3	18.4	7.2	7.1	8.1	13.4	5.6	0.6	7	3.7	10.4	9.5	10.3	0	3.2	59.4	9.2	0.7	0.4	0.9	0.1	3.6	2.9	0	15.1	5.6	7.3	8.6	4.8	9.9	9.4	5.3	0.6	0.2	2	5.8	0.6	0	1.1	6.2	0.1	21.1	11.6	6.9	7.4	8.4	1	92	5.9	0.9	13.9	1.5	8.3	1.5	0.2	3.7	2.2	0	8.5	2	5.7	0	0.1	0.2	5.9	0.6	0.9	3.7	1.5	0.1	0.8	0.9	14.9	4.3	4.5	5.6	6.4	10.8	0	0	0.2	9.6	3.3	0.6	3.3	4.8	59.4	0	9.2	0	0	0.1	0	3.2	0	0	0	0.2	0.7	9.2	0.1	0.4	0.9	28	26	12.4	31.2	21.4	14	10.3	19.9	10.1	5.6
CAMK1D	CKLiK	ENSG00000183049	Calcium/calmodulin dependent protein kinase ID	Q8IU85	10	12349482-12835545	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HDLM-2: 46.7;U-266/70: 21.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		eosinophil: 31.8	Lineage enriched	Detected in all	4	granulocytes: 31.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007266	Approved		Approved	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA007266: AB_1078389	unprognostic (1.06e-1)	unprognostic (2.19e-2)	unprognostic (2.77e-1)	unprognostic (3.65e-3)	unprognostic (4.23e-1)	unprognostic (2.32e-2)	unprognostic (6.90e-3)	prognostic favourable (1.67e-4)	unprognostic (1.06e-1)	unprognostic (1.49e-2)	unprognostic (2.95e-1)	unprognostic (7.40e-2)	unprognostic (1.35e-2)	unprognostic (6.55e-2)	unprognostic (1.65e-1)	unprognostic (4.66e-2)	unprognostic (2.56e-3)	5.1	5.3	20.9	10.5	22.1	6.6	4	23.4	33.5	8.3	11.5	4.6	10	3.8	3.3	3.3	8.7	4.3	6.8	13.8	18.6	7.2	2.2	11.5	7.6	9.3	5.8	17.8	2.6	17	1.3	2.5	3.2	5	4.9	12.9	11.9	4.5	15.4	1.7	18.5	5.5	5.6	4.9	10.5	3.4	6.2	6.8	20.8	13.6	2.9	12.5	8.1	7	7.1	4.2	31.8	3.7	1.4	2.3	1.3	0.1	2.5	2.9	0.1	1.8	0.6	0.2	0.4	0.9	0.6	0.9	3.5	2	1.4	0.3	0.2	1.3	3.5	0.5	0.5	46.7	1.8	5.6	8.3	0.2	0.5	0.1	5.1	0.1	2.3	1.2	0.1	0.3	0.1	0.2	0.7	2.9	10.9	2.2	1.9	1.1	8.3	1.6	2.6	0.1	2.7	4.5	2	5.5	2	0	1.5	1.3	0.1	2.4	3.6	7.7	1.6	21.5	6.7	4.7	3.6	3.6	0	8.3	2.2	31.8	1.8	3.1	1.9	5.6	1.6	2.3	4.2	7.1	1.9	1.3	13.9	1.4	3.7	1.4	0.5	1.3	20.9	22.1	23.4	33.5	18.6	7.2	5.8	17.8	5	6.8
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	Calcium/calmodulin dependent protein kinase IG	Q96NX5	1	209583717-209613938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 34.4;ovary: 29.2	Cell line enhanced	Detected in some		BJ: 2.0;hTEC/SVTERT24-B: 12.1;NTERA-2: 1.9;SK-MEL-30: 3.6;U-138 MG: 2.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all														unprognostic (5.17e-2)	unprognostic (9.64e-2)	unprognostic (1.73e-1)	unprognostic (1.49e-3)	unprognostic (2.56e-2)	unprognostic (1.93e-1)	unprognostic (6.79e-2)	unprognostic (3.98e-1)	unprognostic (3.59e-3)	unprognostic (8.55e-3)	unprognostic (3.17e-2)	unprognostic (1.14e-2)	unprognostic (4.25e-2)	unprognostic (1.75e-1)	unprognostic (2.27e-1)	unprognostic (9.10e-2)	unprognostic (3.43e-2)	0.7	3.5	7.5	0.9	34.4	1	0.7	1.3	27.8	1.1	0.8	0.7	1.2	0.8	1.8	6.1	0.6	0.9	1.5	0.6	10.9	9.2	6.9	0.9	1.2	0.8	3.6	17.7	29.2	1.3	0.6	2	2.8	3.9	4.6	0.8	0.6	0.6	7.4	0.6	0.6	0.8	2.3	0.9	6.1	0.7	1.4	2.7	0	0.7	0	0.8	1.1	0.4	0	0	0	0.1	0	0	0	0	0	0.4	0	0.2	0	0	2	0.3	0.8	0.3	0	0.2	0	0	0.8	0.2	0	0	1.3	0.6	0	0	0.1	0	0.7	0	0	0	0.1	12.1	0	0.1	0	0.1	0	0	0	0	1.9	0.2	0	0	0	0	0	0	0.1	0	0	3.6	0	0	0.2	2.1	0.2	0	0.1	0	0.2	0	0.8	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.5	34.4	1.3	27.8	10.9	9.2	3.6	17.7	3.9	2.7
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	Calcium/calmodulin dependent protein kinase II alpha	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	21	brain: 105.7;skeletal muscle: 50.1	Cell line enhanced	Detected in some		HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0	Cancer enriched	Detected in single	13	glioma: 6.0	Group enriched	Detected in all	6	amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in all	4	amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1	Low region specificity	Detected in all			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		21000	21000	Plasma membrane	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: "	unprognostic (7.20e-3)	unprognostic (6.47e-3)	unprognostic (6.16e-3)	unprognostic (4.85e-2)	unprognostic (4.25e-2)	unprognostic (1.06e-3)	unprognostic (1.13e-1)	unprognostic (6.19e-3)	unprognostic (3.07e-1)	unprognostic (1.05e-1)	unprognostic (4.49e-2)	unprognostic (1.41e-2)	unprognostic (2.00e-8)	unprognostic (2.71e-4)	unprognostic (1.68e-1)	unprognostic (1.70e-2)	unprognostic (1.36e-3)	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0	1.2	0	1.1	1.4	0.1	0.1	0	0.2	0	0	0	0	0	0.6	0.5	0	0	0.6	0	0.5	1.3	0.8	0.7	0	0.1	0	0.2	0.6	2.6	0	0	0.1	0	0.1	0	0	0.4	0.1	0	0.2	0.5	0.2	1.7	0	0	0	0.7	0.2	0	0	0	0.2	0	0	0.5	0.2	0	0	9.5	0	0.1	0.2	0.2	0	0.1	0	0	0.3	0	0.1	0.2	0.1	0	8	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	Calcium/calmodulin dependent protein kinase II beta	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7	Cell line enriched	Detected in some	8	SCLC-21H: 41.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		680000	680000	Plasma membrane	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: "	unprognostic (1.88e-3)	unprognostic (4.49e-2)	unprognostic (3.55e-3)	unprognostic (1.36e-2)	unprognostic (5.25e-2)	unprognostic (2.90e-2)	unprognostic (8.78e-2)	unprognostic (1.09e-1)	unprognostic (1.44e-1)	unprognostic (2.71e-1)	unprognostic (1.17e-2)	unprognostic (1.60e-2)	unprognostic (5.23e-7)	unprognostic (7.04e-2)	unprognostic (2.34e-1)	unprognostic (3.15e-2)	unprognostic (3.95e-2)	1.4	8.1	20.6	1.4	46.7	1.2	2	60.1	81.9	1.2	1.4	4	0.7	1.7	1.3	18.8	2	1.8	1.2	39.2	36.5	18	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0	7.7	2.4	2	1.1	0	1.3	1	3.2	1.2	3.2	1.2	0.8	0	0.3	0.2	0.3	0	0.2	0.2	0.1	0	0.1	0	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.7	0	1	2.4	0	0.1	0.1	0	0	0.5	0	0	0	0.3	0	0	0.4	0	5.2	0	0.2	0.1	2.3	0.1	0.9	0.1	0	0	41	2.2	0.2	0	0	1.9	0.1	0.2	0.2	0.3	0.2	0	0.5	0.4	0.1	0.1	0	0.2	3.2	0.7	1	0.8	0.9	1.2	1.1	1	0.5	0.5	1.3	1.2	1.1	2	3.2	1.2	1	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18	10.3	21.3	13.4	4.8
CAMK2D	CAMKD	ENSG00000145349	Calcium/calmodulin dependent protein kinase II delta	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		ASC TERT1: 66.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		140000	140000	Plasma membrane	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: , HPA051785: , HPA053973: "	unprognostic (2.14e-2)	unprognostic (3.17e-1)	unprognostic (2.13e-1)	unprognostic (7.49e-2)	unprognostic (2.19e-1)	unprognostic (5.09e-1)	unprognostic (4.26e-2)	unprognostic (1.17e-1)	unprognostic (2.26e-1)	unprognostic (2.62e-1)	unprognostic (7.81e-2)	unprognostic (7.91e-3)	unprognostic (2.62e-2)	unprognostic (1.46e-1)	unprognostic (9.68e-2)	unprognostic (1.87e-1)	unprognostic (1.90e-2)	22.8	12.9	47.7	18.3	13	2.8	23.5	50.2	30.6	11	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14	23.8	12.9	7.4	33.7	7	9.3	12.5	16.3	19	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1	14.3	15.8	5.3	34.6	66.2	5.6	33.5	22.4	13.2	11.4	9.6	4	20.5	4.9	23.3	0.5	9.8	5.2	13.5	7.8	2.5	0	5.2	11	17.5	0	0	42.3	7.2	10.2	25.3	11.7	0.8	9.2	24.8	3.8	2	0.8	2.2	5.3	4	18.5	0.1	13.5	9.7	4.3	4.3	4.5	6.8	4.5	0.1	5.5	7	34.9	8.2	14.8	6.6	7.1	3.6	17.6	18	1.2	16.4	0	8.8	0	5.1	5.1	9.7	8	5	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0	9.3	5.2	47.7	13	50.2	25.6	17.9	21.4	14	23.8	12.5	8.5
CAMK2G	CAMKG	ENSG00000148660	Calcium/calmodulin dependent protein kinase II gamma	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 73.0	Cell line enhanced	Detected in all		PC-3: 45.4;SK-BR-3: 57.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Lineage enriched	Detected in all	4	granulocytes: 39.8	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		170000	170000	Plasma membrane	"Cell Junctions, Cytosol"	"HPA040656: , HPA051783: , HPA051785: , HPA053973: "	unprognostic (8.63e-3)	unprognostic (2.01e-1)	unprognostic (1.05e-1)	unprognostic (3.46e-3)	unprognostic (4.27e-2)	unprognostic (1.82e-2)	unprognostic (2.19e-2)	unprognostic (2.36e-1)	unprognostic (2.48e-1)	unprognostic (6.25e-2)	unprognostic (2.92e-2)	unprognostic (1.08e-1)	unprognostic (1.73e-2)	unprognostic (2.48e-1)	unprognostic (8.28e-2)	unprognostic (9.64e-2)	unprognostic (4.62e-2)	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8	6	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73	9.1	18.1	29.6	29.8	11	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5	10.9	7.9	7.1	13.6	5.2	8.6	8.4	7.5	12.9	10.4	8.5	12.2	11.8	8.1	7.9	9.7	17	5.6	6.4	8.3	7.3	6.7	5.5	6.1	5.5	2.6	7.5	9.3	4.5	5.8	10.3	7.2	8.8	6	12.1	5.7	7.6	12.5	11.2	5.2	45.4	11.4	7.5	4.3	5.4	15.9	3.7	8.6	4.3	57.2	3.7	10.7	4.7	10.8	7.7	12.4	4.2	10.1	3.7	4.4	7.5	8.3	21.5	2.7	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8	7.1	3.9	8.1	7.9	36.4	9.8	4	2.4	8.1	5	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4
CAMK4	CaMK-GR	ENSG00000152495	Calcium/calmodulin dependent protein kinase IV	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 48.9;lymphoid tissue: 71.7	Cell line enhanced	Detected in many		HDLM-2: 41.2;MOLT-4: 12.6;SH-SY5Y: 16.1	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Group enriched	Detected in many	4	MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3	Lineage enriched	Detected in single	26	T-cells: 19.8	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	unprognostic (2.99e-5)	unprognostic (7.19e-2)	unprognostic (3.43e-3)	unprognostic (5.11e-2)	unprognostic (4.75e-3)	unprognostic (3.48e-2)	unprognostic (7.66e-4)	unprognostic (7.22e-3)	unprognostic (2.49e-1)	unprognostic (2.92e-1)	unprognostic (1.09e-1)	unprognostic (1.46e-1)	unprognostic (2.23e-5)	unprognostic (2.42e-2)	unprognostic (3.01e-2)	unprognostic (1.66e-1)	unprognostic (9.99e-3)	1.1	6.5	9.5	6.4	34.2	4.6	1	48.9	16.5	1.8	2.3	1	0	2.4	1.3	0.8	1.4	0.9	2.7	0.9	5.9	3.2	1.4	2.5	1.9	12	2.3	6.8	1.4	0.9	0.3	1.3	0.6	3.4	5.8	2.5	0.1	1.7	2.6	0.8	0.9	3.8	1.5	2	4.2	2.6	13.8	6.6	71.7	1	0	8.1	2.8	1.1	0.7	0	0.4	0	0.6	19.8	3.4	0	0	1.4	1	0.3	1.1	0	0.3	3.2	3.8	3.7	0	0	0	2	0.1	0.1	3.1	0.3	2.8	41.2	2.6	0.6	1.3	0	0.1	0.2	0.1	0.1	0	8	0.8	0.6	0	1.5	0.2	0	12.6	0	1.9	0.1	1.9	2.4	0.1	1.4	0	9.1	16.1	0.5	0	2.7	0	0.2	0	7.8	4.6	0	6.9	1.3	0.1	0	3.8	0	3	0	0	0	2.8	0	14.1	0.7	10.3	7.8	0	0.2	19.8	10.9	0.4	0.6	0	0	11.3	3.4	9.5	34.2	48.9	15.1	5.9	3.2	2.3	6.8	3.4	6.6
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	Calcium/calmodulin dependent protein kinase kinase 1	Q8N5S9	17	3860315-3894891	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 38.9;salivary gland: 27.1	Cell line enhanced	Detected in many		HeLa: 17.8;U-87 MG: 20.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB009111, HPA028062"	Approved		Supported	Cytosol				Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	unprognostic (1.39e-2)	unprognostic (2.13e-1)	unprognostic (8.66e-3)	unprognostic (4.40e-3)	unprognostic (2.94e-3)	unprognostic (4.79e-2)	unprognostic (1.98e-1)	unprognostic (4.47e-3)	unprognostic (8.23e-2)	unprognostic (1.03e-2)	prognostic favourable (2.65e-4)	unprognostic (1.98e-1)	unprognostic (1.59e-1)	unprognostic (7.19e-2)	unprognostic (8.70e-2)	unprognostic (8.36e-2)	unprognostic (3.10e-1)	4.3	10.2	15.3	5.1	21.4	3.7	4.7	23.2	38.9	4.1	3.2	2.2	4	3.1	7.5	5.2	4.2	3.7	3.8	5.7	13.8	6.8	1.5	1	4	2.5	5.5	16	6	7.5	5	10.1	2.3	11.2	3.3	3.1	2.5	27.1	11.2	2.2	7.8	3.7	6.2	2.2	4.3	2.9	6.1	5	1.7	7.2	2.3	2.5	5.6	4.9	0.1	1.6	5.6	4.1	0	1	1.1	4.8	8.4	0.9	4.2	3	5.4	0.3	3.4	3.7	3.2	1.5	3	1.5	2.9	3.6	6.4	14.5	2.3	4.1	2	0.1	7.7	3.3	17.8	1.1	3.1	0.5	2.6	4.1	3.5	6.1	2.1	1.4	2.6	0.1	1.6	1.3	4	1.9	0.9	7.9	2.1	3.7	3.4	3.5	3.1	4.9	2.7	1.3	10	2.2	3.8	1.1	2	5.6	7.6	7.1	2.7	0.4	0.2	0.1	20.5	2.8	0.7	0	1.8	3.6	0.6	3.9	1	0	0.6	0.5	1.6	0.1	0.6	0.3	5.6	0	4.1	0.8	0	1.1	15.3	21.4	23.2	38.9	13.8	6.8	5.5	16	11.2	5
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	Calcium/calmodulin dependent protein kinase kinase 2	Q96RR4	12	121237691-121298308	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	brain: 125.5	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Region enhanced	Detected in all		cerebellum: 125.5	Group enriched	Detected in many	5	classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5	Group enriched	Detected in all	5	dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol				Cytosol		"HPA017389: AB_1845956, HPA063713: "	unprognostic (5.08e-2)	unprognostic (1.81e-1)	unprognostic (1.38e-1)	unprognostic (3.08e-1)	unprognostic (1.88e-1)	unprognostic (1.12e-1)	unprognostic (2.62e-3)	unprognostic (2.80e-2)	unprognostic (1.93e-1)	unprognostic (7.76e-2)	unprognostic (5.01e-2)	unprognostic (1.70e-1)	unprognostic (1.75e-1)	unprognostic (4.13e-1)	unprognostic (3.34e-2)	unprognostic (1.67e-1)	unprognostic (1.38e-1)	11.7	6.5	19.7	7.8	30.2	13.8	8.8	125.5	45.5	9	9.5	7.1	2.6	12.8	8.6	5.3	8.3	11.8	6.3	6.9	11.2	5.1	7.1	8.9	9.6	6.9	6.2	17.3	10.5	5.8	6.4	4.1	7.5	9.1	12.2	9.7	6.2	7.5	13.2	5.1	9.1	13.2	10.3	6.2	14.1	7.6	3.6	5.8	5.2	6.1	4.5	7.2	7.2	7.4	2.2	7.2	26.1	19.4	3.6	2.2	6.3	12.3	9.3	6.9	13.4	20.8	19.4	10.6	10.2	10.9	8.4	7.7	9.7	5.3	19.1	8.6	20.7	10.2	8.5	11	6.6	13.1	16.7	9.5	6.2	9.5	14.1	21.6	9.1	12.5	16.4	7.9	18	19.6	11	10.4	8.1	12	23.9	17.8	5	10.5	15.6	8	16.9	8.1	13.8	26.6	10.6	13.4	7.2	8.5	17.9	26.4	14.3	6.9	5.6	5.8	5.6	39.7	23.6	14.5	12.9	15.1	6.8	0.7	14.2	26.1	2.1	19.4	2.2	2.2	1.7	1.9	7.2	1.2	1.5	1.7	17.2	3.6	16.5	1.6	1.3	6.3	19.7	30.2	125.5	45.5	11.2	5.1	6.2	17.3	9.1	5.8
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	CaM kinase like vesicle associated	Q8NCB2	3	49857988-49870222	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	36	brain: 77.2	Cell line enhanced	Detected in some		AF22: 5.2;HAP1: 6.9;NTERA-2: 24.6;RPMI-8226: 4.7;SCLC-21H: 8.4;SH-SY5Y: 5.4	Group enriched	Detected in some	11	glioma: 4.0;testis cancer: 5.2	Low region specificity	Detected in many			Cell type enriched	Detected in single	12	neutrophil: 1.2	Lineage enriched	Detected in single	12	granulocytes: 1.2	Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	Cytokinetic bridge	"CAB034931: AB_2068550, HPA007656: AB_1078391"	unprognostic (9.47e-4)	unprognostic (5.65e-3)	unprognostic (1.42e-1)	unprognostic (2.70e-7)	unprognostic (2.76e-1)	unprognostic (7.95e-4)		unprognostic (3.09e-2)	unprognostic (2.61e-1)	unprognostic (1.48e-1)	unprognostic (4.30e-3)	unprognostic (1.72e-1)	unprognostic (8.11e-2)	unprognostic (1.00e-3)	unprognostic (7.61e-2)	unprognostic (9.51e-2)	unprognostic (1.67e-3)	1.2	2.1	20.7	1.2	77.2	1.2	1.2	0.5	62.8	1.2	1.2	1.7	0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	33.4	11.7	1.2	1.2	1.2	1.2	3.3	23.5	1.2	1.2	1.2	1.8	1.2	2.1	1.2	1.2	0	1.2	1.2	1.2	1.3	1.2	1.2	1.9	1.2	1.3	2.1	6	0	1.2	0	1.2	1.2	0	0	0	1.2	0	0	0	0	0	0.2	5.2	0.5	0	0	0	0	0	0	0	2.8	0	0	0	0	0	6.9	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.1	0.7	0.1	24.6	0.1	0.7	0	4.7	0	0	8.4	5.4	0	0	0	0	1	0	0	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	20.7	77.2	0.5	34	33.4	11.7	3.3	23.5	2.1	6
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	Calcium/calmodulin dependent serine protein kinase	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in some	5	basophil: 26.3	Lineage enriched	Detected in many	11	granulocytes: 26.3	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB001949, HPA023857"	Enhanced		Approved	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	unprognostic (6.30e-2)	unprognostic (3.78e-2)	unprognostic (1.48e-1)	unprognostic (2.48e-3)	unprognostic (1.56e-1)	unprognostic (1.29e-1)	unprognostic (1.42e-3)	unprognostic (3.58e-1)	unprognostic (1.02e-1)	unprognostic (5.85e-3)	prognostic unfavourable (6.11e-5)	unprognostic (1.13e-1)	unprognostic (1.05e-1)	unprognostic (8.72e-2)	unprognostic (1.15e-2)	unprognostic (2.13e-2)	unprognostic (2.85e-2)	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20	7.1	27.1	12.2	13.7	17.2	9.9	16	7	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.8	13.9	13.3	7.9	9	7.4	4.3	9.5	7.9	5.6	5.1	29.9	17.7	0.1	4.9	11.8	21.8	14.7	9.7	9.4	9.6	8.2	0	12.5	10.6	9.3	1.7	1.4	8.4	26.7	10.6	13.6	4.5	0.8	8.5	12.1	12.7	3.1	0.7	12.2	9.1	5.1	32.8	5.2	12.6	23.7	12.2	6.5	17.9	7.1	5.4	7.7	0.3	5.3	10.5	10.6	8.9	5.2	3.3	2	3.6	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	CDC42 binding protein kinase alpha	Q5VT25	1	226989865-227318474	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 2.0	Low lineage specificity	Detected in single			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB070414, HPA071252"	Approved		Approved	Intermediate filaments				Intermediate filaments		"CAB070414: AB_11156796, HPA071252: "	unprognostic (3.67e-3)	unprognostic (1.45e-1)	unprognostic (1.10e-1)	unprognostic (2.78e-2)	unprognostic (3.04e-1)	unprognostic (5.90e-2)	unprognostic (7.89e-2)	unprognostic (2.27e-1)	unprognostic (1.46e-1)	unprognostic (3.93e-1)	unprognostic (4.88e-2)	unprognostic (2.87e-2)	unprognostic (7.73e-3)	unprognostic (1.35e-1)	unprognostic (1.70e-1)	unprognostic (9.79e-2)	unprognostic (1.21e-2)	17.2	15.2	19.1	8.6	21.1	3.9	14	29.2	20.4	21.1	19.3	16.4	13.1	16.9	15.8	9.9	12.3	12.9	16.6	14.1	21.7	17.7	20.8	17	11.7	3.5	20	16.3	17.4	15.1	29.3	29.6	14.8	19.3	21.1	12.4	11	8.4	18.5	11.9	7.6	17.2	27.6	16.6	8.8	25.2	26.7	19.9	0.7	9.8	7.3	2.5	23.4	23.1	0.1	0.7	2	0.1	0	0.1	0	9.3	8.9	9.5	4.4	9.5	11.8	3.3	10.7	15.2	7.4	7.8	7.2	21.3	0	11.6	17.8	4.3	6.9	6	9.1	0	5.6	7.2	10.5	2.8	10.8	5.8	3.2	8.2	7.7	12	12.1	24.8	18.4	0	12.1	2.5	0.1	1	7.7	8.5	0	16	0	12	18.1	6.8	10	18.2	7.6	10.7	9.9	0.3	24.9	13.7	7.1	15.5	14.2	0	0	0	18.1	0	18.2	2	0.1	0	0	0	0	0.1	0.1	0	0	0	0	0.1	0	0	0	0.7	0	0	19.1	21.1	29.2	20.4	21.7	17.7	20	16.3	19.3	19.9
CDC42BPB	"KIAA1124, MRCKB"	ENSG00000198752	CDC42 binding protein kinase beta	Q9Y5S2	14	102932379-103057462	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		intermediate monocyte: 2.0	Low lineage specificity	Detected in single			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA022821	Approved					12000	12000			HPA022821: AB_1846376	unprognostic (6.73e-2)	unprognostic (2.19e-2)	unprognostic (6.99e-2)	unprognostic (5.67e-2)	unprognostic (1.41e-2)	unprognostic (2.19e-1)	unprognostic (2.90e-2)	prognostic unfavourable (2.38e-4)	unprognostic (2.71e-1)	unprognostic (1.24e-1)	unprognostic (3.46e-2)	unprognostic (2.28e-1)	prognostic favourable (8.67e-10)	unprognostic (2.11e-1)	unprognostic (1.86e-1)	unprognostic (8.59e-2)	unprognostic (7.56e-2)	32.2	22.7	33.1	14.8	33.2	3.1	19.8	30.3	42.1	26.7	21.8	42.3	21.5	26	27	18.7	28.3	26	28.1	30.7	31.4	25.5	23.7	20.1	26.4	7.9	31.2	28.4	29.7	28.8	32.5	25.9	25.6	27	25.1	18.2	23.7	23	28.8	17	23.8	29.6	28.7	24.3	18.3	25.5	21.8	31	2.1	26.3	15.9	12.4	25.2	32.6	0.9	0.2	0	2	0	0.4	0.1	13.1	26.4	17	12.4	18.9	21.7	17.1	15.1	16	16	14.8	9	15.5	0	16.6	29.4	16.8	17.5	18	17.1	16	7.9	7.2	21.3	9	20.6	0	7.8	18.7	18.7	16.4	15.8	31.1	5.8	3.7	15.4	27.6	0.1	1.6	8.1	21.8	0	14.3	0.3	20.5	25.9	12.4	13.5	26.8	10.1	11.3	15.6	4.6	39.5	15.4	10.4	34	14	4.9	5.2	3.8	17.3	1.6	14.9	0	1.4	0	0	2	0	0.9	0.4	0	0.2	0.5	0	0	0	0	0.5	0	0.1	0.1	33.1	33.2	30.3	42.1	31.4	25.5	31.2	28.4	27	31
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	CDC42 binding protein kinase gamma	Q6DT37	11	64823387-64844569	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 19.1;HaCaT: 14.3;MCF7: 19.3;RT4: 11.7;SK-BR-3: 11.9;T-47d: 11.6	Low cancer specificity	Detected in many			Region enriched	Detected in some	9	cerebellum: 19.4	Cell type enhanced	Detected in single		MAIT T-cell: 1.0	Low lineage specificity	Detected in single			Region enriched	Detected in single	4	cerebellum: 5.9	Low region specificity	Detected in single			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol				Cytosol		"HPA027382: AB_1846378, HPA061836: "	unprognostic (3.26e-2)	unprognostic (1.58e-1)	unprognostic (6.00e-2)	unprognostic (2.60e-1)	unprognostic (1.21e-1)	unprognostic (2.50e-1)	unprognostic (4.68e-1)	unprognostic (5.27e-2)	unprognostic (3.91e-2)	unprognostic (3.65e-2)	unprognostic (1.26e-1)	unprognostic (1.81e-1)	prognostic favourable (5.99e-13)	unprognostic (2.60e-2)	unprognostic (1.55e-1)	unprognostic (2.14e-2)	unprognostic (3.99e-3)	0.5	2.7	0.8	2.1	0.5	1.1	3.5	19.4	0.8	2.9	9.1	0.8	6.3	8.2	1	8	14.3	2.9	10.5	0.5	0.7	0	3.5	0.5	4.2	0.7	0.5	0.5	1.5	7.9	7	6.5	13	2	4.4	3.4	1	14.3	7.6	0.5	22.4	19.7	1.6	0.8	0.8	8.5	2.5	0.7	1.8	3.9	8.1	7.7	5.4	6.3	0.4	0	0	0	0.2	1	0.1	5.5	0.8	0.5	0	0	0	19.1	0	0	0	0	7.4	4.7	0.1	2.8	0	14.3	0.8	5.6	0	0.2	2.2	0.4	3.1	2.3	0	0.1	1.4	0	7	0	0.1	0	3.7	0	0	19.3	0.1	1	1.7	0.8	0.8	0.3	2.6	3.4	11.7	10.2	0.5	1.8	11.9	0.3	11.6	0.2	0	0	2	0	0	1.3	1.3	1.4	0	0.2	0	0	0	0	0.1	0	1	0.2	0.3	0.1	0	0.4	0.2	0	0	0.2	0	0	0.4	0.1	0.8	0.5	19.4	0.8	0.7	0	0.5	0.5	2	0.7
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	Cell division cycle 7	O00311	1	91500893-91525764	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"				Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: "	unprognostic (6.84e-2)	unprognostic (6.01e-2)	unprognostic (4.64e-2)	unprognostic (7.02e-3)	unprognostic (5.57e-2)	unprognostic (3.57e-3)	prognostic unfavourable (3.15e-6)	unprognostic (6.52e-2)	unprognostic (2.23e-2)	unprognostic (1.36e-3)	unprognostic (2.04e-2)	unprognostic (1.75e-2)	prognostic unfavourable (1.89e-15)	unprognostic (9.44e-3)	unprognostic (2.49e-2)	unprognostic (1.09e-1)	unprognostic (5.39e-2)	2.5	3.7	5.7	7.6	8.9	15.4	4.3	19.4	10.3	2.5	4.2	1.4	0.9	4.2	2.8	2.6	4.7	1.7	2.6	1.9	6.8	5.2	3.6	2.3	5.1	11.7	4	4.7	3.7	2.4	2.2	12.3	7.9	5.2	2.7	6.8	2.3	2.5	2.3	1	6.8	4.9	3.3	5.9	15.1	2.6	21.2	4.7	18.7	2.5	4.5	12	4.2	3	1.6	3.5	0.1	1.6	2.4	6.5	2.1	14	4.2	27.1	7.7	0.6	3.6	8.6	5.3	4.2	10.5	11.5	8.7	5	9.7	7.5	3.3	6.1	17.8	6	14.6	16.1	15.3	14.8	12	4.1	1	16.1	5.4	1.9	1.8	9.6	5.5	4	19.5	14.2	7.2	5.1	13.7	14.4	22.5	9.9	17.1	22.5	6.2	4.6	10.6	21.6	8.5	16.9	4.7	9.4	4.4	7.9	3.3	12	10.6	9.2	8	5.2	6.6	26.1	4.3	15.6	4.4	0	1.6	0	5.9	1.2	5.2	1.5	4.5	5.6	3.5	1.6	2.5	5.1	0.1	2.4	0.3	2.1	6.5	2.1	5.7	8.9	19.4	10.3	6.8	5.2	4	4.7	5.2	4.7
CDK1	"CDC2, CDC28A"	ENSG00000170312	Cyclin dependent kinase 1	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	lymphoid tissue: 88.4	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		NK-cell: 6.1;T-reg: 5.7	Group enriched	Detected in many	5	dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7	Low region specificity	Detected in single							"HPA003387, CAB003799"	Enhanced		Supported	"Nucleoplasm,Cytosol"				Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	unprognostic (6.34e-2)	prognostic favourable (8.81e-4)	unprognostic (1.90e-1)	unprognostic (6.82e-2)	unprognostic (6.67e-2)	unprognostic (3.83e-2)	prognostic unfavourable (1.10e-6)	prognostic unfavourable (7.88e-4)	unprognostic (1.30e-2)	unprognostic (1.30e-1)	prognostic unfavourable (4.15e-6)	unprognostic (1.80e-2)	prognostic unfavourable (0.00e+0)	unprognostic (2.27e-1)	unprognostic (2.75e-1)	unprognostic (2.13e-1)	unprognostic (1.60e-1)	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1	0.5	4.4	13.3	1.2	1.5	8.3	1	3.8	2.9	1	4.9	8.3	2.7	2.5	8.3	5	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0	0.2	6.1	5.7	1.8	48.2	18.4	48.9	19.3	3.2	4.9	20.1	36.5	26.6	44.5	42.9	43	42.7	44.2	14.2	10	30	33.2	21.2	46.4	31.4	24.2	23.2	18.1	24.9	0.5	35.5	24	0.9	2.1	28.8	28.1	26.7	35.3	54.5	49.5	12.8	44.6	25.5	21.5	38.7	38.8	45.5	21.7	17	16	22.9	20.1	24.5	37.3	18.9	40.2	21.8	11	19	40.6	20	49.8	21.4	34.3	39.9	16.4	39.8	23.6	0	0	0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2
CDK10	PISSLRE	ENSG00000185324	Cyclin dependent kinase 10	Q15131	16	89680737-89696364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Cilium biogenesis/degradation	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"				Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: , HPA059634: , HPA067060: "	unprognostic (7.89e-2)	unprognostic (8.08e-2)	unprognostic (3.74e-3)	unprognostic (9.87e-2)	unprognostic (1.76e-1)	unprognostic (3.44e-2)	unprognostic (4.53e-1)	unprognostic (9.06e-2)	unprognostic (2.99e-1)	unprognostic (2.13e-1)	prognostic favourable (2.69e-4)	unprognostic (2.58e-2)	unprognostic (2.93e-1)	unprognostic (3.32e-2)	unprognostic (1.79e-1)	unprognostic (6.88e-2)	prognostic favourable (3.63e-4)	12.3	19.9	16.8	16.4	23.8	17.3	10.1	14.8	21.9	11.1	18.3	8.1	16.4	23.4	12.1	21.7	14.4	14.4	19.4	8.7	15.3	12.6	22.2	33.9	11.8	14	13.3	19.4	11.3	22.2	21.6	27.7	13.6	15.8	13.6	12.6	8.1	17.2	8.9	17.5	14.1	20.7	9	10.7	15.9	19	8.7	13.6	8	27.1	10.1	12.1	10.8	14.5	7.8	14.5	3.4	15.3	15.2	13.3	8.8	14.5	9.5	7.7	3.1	3.2	6.1	8	12	6.8	8.6	2.9	7.3	11.1	12.9	6.2	10.4	10.2	3.3	16.8	5.4	2.8	8	5.1	10.6	0.8	13.2	8.2	9.3	7.4	5.6	5.4	8.2	15	13.3	1.7	9.8	19	9.9	23.5	15.6	7.2	14.4	10.4	18.1	15.4	11.6	7.5	16.3	15.1	7	3.5	16.5	13	13.2	5.9	15.1	6.1	8.2	6.6	3.6	4	8.9	14.2	8.3	3.2	11.7	3.4	12.9	15.3	10.9	6.8	11.4	8.9	14.5	7.8	13.3	10.9	1.5	15.2	11.2	10	8.8	8.8	16.8	23.8	14.8	21.9	15.3	12.6	13.3	19.4	15.8	13.6
CDK11A	"CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE"	ENSG00000008128	Cyclin dependent kinase 11A	Q9UQ88	1	1702730-1724324	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 33.5	Low lineage specificity	Detected in all											"CAB010467, HPA025061, HPA073626"	Supported		Supported	"Nuclear speckles,Cytosol"				Nuclear speckles	Cytosol	"CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: "	unprognostic (6.25e-2)	unprognostic (8.32e-2)	unprognostic (1.47e-2)	unprognostic (2.74e-1)	unprognostic (9.32e-3)	unprognostic (3.54e-2)	unprognostic (2.25e-3)	unprognostic (7.97e-2)	prognostic unfavourable (5.06e-4)	unprognostic (1.28e-1)	unprognostic (5.58e-3)	unprognostic (3.07e-2)	prognostic unfavourable (1.15e-6)	unprognostic (1.97e-1)	unprognostic (5.98e-2)	unprognostic (1.54e-1)	unprognostic (3.70e-2)	14.3	14.9	17.2	23.7	26.9	39.7	13	35.2	32.7	12.5	16.4	14.3	6.1	29.2	16.5	8.5	12.1	12.6	10.2	10.2	19.4	8.4	11.7	12.5	19	20.3	22.6	9	16.2	12.9	12.2	27.5	12.9	17.1	14.4	14.6	11.6	12.7	10.3	21.5	15.1	34.9	13.1	26	24.2	15.7	16.4	25.1	14.9	14.6	7.6	22.4	13.5	15.2	7.4	11.8	33.5	6.3	4.4	5.5	1.4	16.1	9.7	7	6.4	9.2	7.4	6.9	15.9	7.1	7.9	9.2	12.2	14.8	17.2	9.7	4.6	12	6.5	8.2	6.3	13.1	10.4	15.3	18.3	10.9	6.1	17.1	22.1	8.5	5.6	6.9	4.5	13.6	17.9	14.4	6.6	9.1	7.9	13.4	9.7	8.3	14.5	10.7	8.3	6.4	7.3	7.8	11.3	13.9	16.4	19.1	11	7.1	13.8	12.5	12.1	5.6	8.8	20.1	14.6	21.6	4.2	13.9	3.9	16.7	6.3	7.7	5.5	3.4	4.2	6.2	4.7	4.2	2	7.4	4.7	4	33.5	4.4	3.7	11.8	4.5	1.4	17.2	26.9	35.2	32.7	19.4	8.4	22.6	9	17.1	25.1
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	Cyclin dependent kinase 12	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		SK-BR-3: 85.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	unprognostic (2.02e-1)	unprognostic (1.80e-1)	unprognostic (2.61e-2)	unprognostic (7.56e-2)	unprognostic (1.05e-1)	unprognostic (3.19e-1)	unprognostic (2.56e-3)	unprognostic (2.37e-2)	unprognostic (3.86e-2)	unprognostic (3.00e-3)	unprognostic (6.87e-3)	unprognostic (1.86e-1)	unprognostic (3.06e-2)	unprognostic (9.10e-2)	unprognostic (1.24e-1)	unprognostic (2.22e-2)	unprognostic (5.32e-1)	16	13.1	12.4	17.4	9.2	32.4	14	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12	16.9	12.2	12.5	11	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17	16.5	11	10.6	16.3	11.8	18.9	8.3	29	15	5.4	17.3	16.3	20.5	5.1	4	10.4	2.9	6.6	4	0.9	8.7	10.8	6.5	6.1	4.8	5.4	6.1	7.9	6.7	10.9	8.1	13.3	5.4	12.4	7	8.3	14.2	13	10	10.5	8.1	11.2	13.4	7.4	10.3	4.7	18.3	9.4	5.8	6.9	13.2	10.5	6.6	22.7	8.2	6.2	4.1	14.9	4.7	6.8	4.9	9.9	14.1	7	4.1	10.5	7	4.5	10.1	85.6	6.9	11	7.9	7.1	9.9	7.9	6.9	10.2	6.7	4.8	17.5	7	7.8	6.4	10.4	2.9	4.1	4	2.2	3	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4	2	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	Cyclin dependent kinase 13	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059241	Uncertain		Supported	Nuclear speckles				Nuclear speckles		HPA059241: 	unprognostic (1.99e-1)	unprognostic (1.22e-2)	unprognostic (2.67e-1)	unprognostic (2.72e-1)	unprognostic (1.83e-1)	unprognostic (1.02e-1)	unprognostic (4.18e-3)	unprognostic (3.42e-2)	unprognostic (8.09e-2)	unprognostic (1.13e-2)	unprognostic (3.77e-2)	unprognostic (8.13e-2)	unprognostic (8.20e-2)	unprognostic (1.21e-1)	unprognostic (3.33e-2)	unprognostic (3.53e-1)	unprognostic (3.53e-2)	16.9	15.3	16	29	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14	3.9	7.9	3.4	5	5	1.4	15.6	9.3	16.3	15.5	14.7	14.4	11.2	12.5	13.6	11.5	14.4	9.7	10.8	28.4	7.3	13.1	19.1	13.3	11	17	13.9	9.8	12.6	11.4	8.8	14.1	19.2	13.8	8.5	14.8	13.1	17.6	13.5	21.3	19.7	11.9	8	15.2	13.6	23.5	10.9	16.9	10.8	11.4	10.8	15.8	11.6	16.8	15.9	34.4	11.3	14.1	23.9	16	15.9	15.2	10.2	17	16.2	13.7	23.4	11.6	17.4	20.2	7.9	2.7	4.4	5	2.2	3.4	7.6	4.8	3.7	1.5	14	4.9	4.9	7.6	5	3.4	3.9	4.3	1.4	16	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12	15.7
CDK14	"PFTAIRE1, PFTK1"	ENSG00000058091	Cyclin dependent kinase 14	O94921	7	90466424-91210590	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		Karpas-707: 30.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	7	basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6	Group enriched	Detected in many	9	B-cells: 9.8;granulocytes: 7.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015267	Approved		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA015267: AB_1855249	prognostic favourable (5.86e-4)	unprognostic (3.96e-1)	unprognostic (1.91e-2)	unprognostic (2.09e-3)	unprognostic (1.18e-1)	unprognostic (3.45e-1)	unprognostic (1.72e-1)	unprognostic (4.48e-2)	unprognostic (3.60e-2)	unprognostic (3.09e-2)	unprognostic (2.77e-3)	unprognostic (2.91e-2)	unprognostic (2.57e-2)	prognostic unfavourable (7.79e-4)	unprognostic (2.46e-1)	unprognostic (2.86e-1)	unprognostic (4.39e-3)	8.2	4.7	19.8	7.1	19.4	6.1	8.3	28.6	34.9	10.6	5.2	3.7	0.6	2.7	8.6	3.2	3.1	12	11.9	11.5	25.8	15.5	19.8	12.7	9.2	10.9	17.3	17.4	14.9	14.2	3.8	14.2	5.9	22.8	11.3	3.4	4.3	7.7	7	5.4	2.7	3.8	7.4	7	7.5	7.4	7.2	4.5	0.9	13.1	1.6	11.9	6.9	6.7	9.8	0.9	7.5	0.7	0.1	0.2	0.6	7	0	14.1	1.8	13.2	13.4	3.2	5.9	5.6	3.6	3.9	0.1	3.4	25	0.7	5.8	2.1	0.7	8.3	7	0	3.3	0	4.7	0.1	6.1	7.1	0.1	9.5	2.1	10.8	3.9	4.6	0.1	30.8	7.3	0	0	2.7	8.9	3.8	19.2	19.4	19	1.9	1.9	3.1	9.1	15	0	0.3	1.9	3.6	11.3	15.7	20.1	13.1	9	17.4	13.3	17.9	5.9	9.4	15.3	7.5	0.3	0.5	0	0.7	0	9.8	0	0	0.9	5.3	0	0	5.6	0.1	0.5	0.1	0.2	0.6	19.8	19.4	28.6	34.9	25.8	15.5	17.3	17.4	22.8	4.5
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	Cyclin dependent kinase 15	Q96Q40	2	201790461-201895550	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 20.2;ovary: 9.8	Cell line enhanced	Detected in some		BJ hTERT+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HBF TERT88: 18.2;HMC-1: 34.4;LHCN-M2: 10.2	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	52	basophil: 3.5;eosinophil: 6.9	Lineage enriched	Detected in single	69	granulocytes: 6.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Golgi apparatus	HPA015786: AB_1844780	unprognostic (2.51e-1)	unprognostic (2.73e-1)	unprognostic (2.84e-2)	unprognostic (1.30e-2)	unprognostic (1.42e-1)	unprognostic (2.94e-1)	unprognostic (4.79e-2)	unprognostic (1.07e-1)	unprognostic (1.52e-1)	unprognostic (1.52e-2)	unprognostic (1.64e-2)	unprognostic (1.80e-2)	unprognostic (7.38e-2)	unprognostic (9.99e-5)	unprognostic (6.31e-2)	unprognostic (1.48e-2)	unprognostic (1.05e-2)	1.3	0.2	0.1	5.2	0.1	0	3.7	0.3	0.1	3.4	2.3	0.1	0.1	0.3	4.1	20.2	1.1	1	4.2	0.3	0.1	0	0.4	0.1	3.3	0.1	0.1	0.1	9.8	0.2	0	0.5	0.1	0.1	2	0.7	1.4	0.6	0.3	0.7	1.1	3	3.9	0.1	0.1	1.1	2.5	0.1	0.1	0.2	1.2	1.2	1.6	1	0	0	6.9	0	0	0	0	0.1	0	0	0	0.9	1.7	0	3.1	14.6	5.5	11.9	0	1.5	0	0	1.3	0	0	0	18.2	0	0	1	0	0	0.2	0	34.4	2	0	1.5	0.7	0	0	0	10.2	0	0	0.3	0	0	0	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0.6	0.2	1.3	0	0	0	0	0.1	0	0	3.5	0	6.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	Cyclin dependent kinase 16	Q00536	X	47217860-47229997	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 91.2	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA000974, HPA001366, CAB016535"	Approved		Uncertain	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane, Microtubules, Cytosol"		"CAB016535: AB_785112, HPA000974: , HPA001366: AB_1079584"	unprognostic (2.37e-3)	unprognostic (6.93e-2)	unprognostic (2.96e-2)	unprognostic (1.16e-3)	unprognostic (8.80e-2)	unprognostic (2.92e-2)	prognostic unfavourable (2.02e-6)	unprognostic (2.85e-1)	unprognostic (5.59e-2)	unprognostic (7.62e-3)	unprognostic (1.20e-1)	unprognostic (1.09e-1)	unprognostic (1.46e-1)	unprognostic (1.59e-2)	unprognostic (1.83e-1)	unprognostic (3.89e-3)	unprognostic (2.55e-1)	22	20.1	32.3	13.9	25	26.6	17.6	51.5	49	17.2	19.3	15.5	17	16.4	14.8	12.8	23.8	18.8	14.1	47.3	29.2	18	19.9	12.7	14	10.8	22	21.1	16.7	18.6	22.8	14.9	18.6	28.5	12.7	14.7	13.7	20.1	16.1	91.2	17	15.3	18.2	14.8	12	14.7	28.7	12.1	10.4	20.9	36.3	12.6	12.9	12.1	8.5	13.5	8.5	10.7	6.3	7.7	5.7	41.2	31.7	30.4	44.9	22.3	19.2	30.4	19.6	24.2	29.9	22.3	35.6	20	9.9	12.5	35.2	23.4	32.3	41.8	20.2	11.9	51.3	10.8	44.5	27.7	29	11.3	25.2	23.9	26.8	42.4	51.2	26.7	16	16.9	26.1	35.9	9.8	26	23.8	34.2	10.5	24.1	17.4	22.5	32.7	25.7	19.4	53.3	41.3	20.2	36.8	13.9	26.8	20	32.8	30.5	23.4	13.3	13	9.7	17.6	52.7	22.4	3.1	8.8	8.5	4.8	10.7	6.2	3.8	6.2	7.7	11.6	8.5	5.6	5.8	4.2	6.3	9.6	13.5	6	5.7	32.3	25	51.5	49	29.2	18	22	21.1	28.5	12.1
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	Cyclin dependent kinase 17	Q00537	12	96278261-96400560	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		HUVEC TERT2: 43.7;TIME: 52.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015325	Approved		Approved	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA015325: AB_1855090	unprognostic (4.35e-1)	unprognostic (2.79e-1)	unprognostic (2.70e-1)	unprognostic (3.56e-1)	unprognostic (1.50e-1)	unprognostic (4.96e-3)	unprognostic (5.22e-3)	unprognostic (1.23e-1)	unprognostic (3.23e-2)	unprognostic (2.75e-2)	unprognostic (2.44e-1)	unprognostic (5.96e-2)	prognostic unfavourable (1.09e-6)	unprognostic (4.97e-3)	unprognostic (1.72e-1)	unprognostic (2.92e-2)	unprognostic (1.70e-2)	16.3	9.1	20.6	13.9	47	31.5	14.7	17.8	35.7	11.8	12.9	23.6	3.4	9.2	20.7	7.5	11.7	10.9	12.9	9.4	25.3	17.3	9.2	12.4	15.9	15.2	23.8	21	12.9	8	9.9	7.3	24.3	14.8	11.4	9.8	5.7	7.5	9.3	7.3	9.1	9.3	23.4	19.6	15.8	7.9	19.9	28	29.6	9.4	6.1	16.6	11	10.7	9.6	5.3	29.1	4.7	16.5	14.8	8.6	4.8	4.1	10.8	2.9	5.3	14	7.7	10.9	15.4	9.6	9.1	2.4	2.8	7.2	7.6	7.9	4.4	6.4	6.7	13.2	7.6	4.9	10.4	2.8	3.4	11.5	5.5	6	10.2	7	14.2	25.7	43.7	7.6	5.9	21.7	3	5.2	8.7	4.7	7.2	9.1	5.8	6.2	11.4	4.1	5.6	3.8	6.4	6	7.9	4.6	5	52.4	8.6	3.3	4.6	5.9	8.3	6.3	7.8	3.2	2.4	6.3	29.1	3.4	8.9	12.7	4.7	13.7	9.6	10.4	14.4	5.3	8.8	14.8	12.6	12.8	16.5	4.6	3.9	8.1	8.6	20.6	47	17.8	24.6	25.3	17.3	23.8	21	14.8	28
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	Cyclin dependent kinase 18	Q07002	1	205504595-205532793	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 98.7;heart muscle: 58.9	Cell line enhanced	Detected in many		HBEC3-KT: 20.9;HeLa: 18.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		intermediate monocyte: 2.1	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA045429	Approved		Approved	Actin filaments				Actin filaments		HPA045429: AB_10961257	unprognostic (7.95e-2)	unprognostic (3.42e-1)	unprognostic (1.51e-1)	unprognostic (1.33e-1)	unprognostic (4.38e-2)	unprognostic (1.30e-1)	unprognostic (7.06e-3)	unprognostic (2.93e-1)	unprognostic (2.95e-1)	unprognostic (1.13e-1)	unprognostic (8.89e-2)	unprognostic (2.81e-1)	prognostic unfavourable (5.07e-6)	unprognostic (6.07e-2)	unprognostic (1.45e-1)	unprognostic (6.12e-2)	prognostic favourable (2.81e-5)	2.6	4.3	13.6	2.7	31.8	1	2.4	4.2	25	7.6	6.9	38.1	20.2	17.3	3.4	4	2.7	5.7	6.4	58.9	22.1	16.2	13.7	4.7	6.5	1.9	47.8	16.7	7.5	10.7	3.7	4	9.6	22.1	3.1	6.1	5.3	16.5	23.5	3.9	1.6	15.1	4.8	98.7	3.5	9.1	0.9	36.4	0.4	4.8	1.4	2.5	3.7	4.7	0.1	1.4	0	2.1	0.6	0.9	0.6	12.2	0.8	0.1	0.6	0	0	13.2	0.2	2.5	0.6	3.2	5.5	9.2	7.3	1.8	0.1	11	2.7	20.9	0.5	2	2.4	1.7	18.4	5.6	2.3	0	0	1.4	1.1	0	0.4	0	0.1	8.8	0.1	9.9	0.7	0.3	10.4	0.4	0.9	0	9.1	2	7.8	4.3	1.7	3.7	1.8	8.1	8.2	3.5	0	0	5	0.1	0	2.5	1.2	1.5	0.1	5.2	2.1	0	0.8	0	0.1	2.1	0.9	0	0.2	0	1.4	0.1	0.3	0	0	0.6	0	0	0	0.6	13.6	31.8	4.2	19.7	22.1	16.2	47.8	16.7	22.1	36.4
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	Cyclin dependent kinase 19	Q9BWU1	6	110609978-110815958	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 31.1	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 8.5	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007053	Approved		Approved	"Nucleoplasm,Vesicles"				"Nucleoplasm, Vesicles"		HPA007053: AB_1846369	unprognostic (1.66e-2)	unprognostic (1.84e-1)	unprognostic (3.63e-1)	unprognostic (3.00e-3)	unprognostic (1.62e-1)	unprognostic (2.66e-3)	prognostic unfavourable (3.56e-4)	unprognostic (1.47e-2)	unprognostic (2.96e-2)	unprognostic (2.00e-3)	unprognostic (3.94e-1)	unprognostic (4.04e-1)	prognostic unfavourable (4.72e-5)	unprognostic (1.75e-1)	unprognostic (9.78e-2)	unprognostic (6.51e-2)	unprognostic (9.50e-3)	5.3	3.3	18.1	6.1	29.4	9.7	6	13.8	21.3	6.6	6.3	31.1	2.4	4.8	9.6	3.7	7.8	5.3	7.8	4.1	20.8	10.1	6.3	4.6	6.2	8	22.1	12.9	9.7	3.1	8	4.1	10.5	14.4	25.8	6.1	3.4	4.5	5.9	3.2	7.9	5.9	7.1	20.8	7	6.5	16.4	26.3	6.1	5.8	1.3	8.4	5.9	6.4	1.3	1.8	8.5	2.2	1.3	0.8	0.6	3.6	3.8	13.4	16.2	7.3	10.5	7	11.6	12.4	4.4	5.8	4.8	4	9.1	4.2	8.2	2.1	5.1	2.5	10.1	11.3	3	15.6	5.7	5.6	4.4	6.3	11.7	7.2	5.5	6	9.3	4.3	4.7	12.8	9.4	5.8	8.4	9.4	1.3	2.6	9.1	6.9	3.5	5.1	6.6	6.9	12.8	8.9	7.2	10.4	2.4	23.2	4.8	9.2	4.9	18.6	7.1	1.4	1.8	7.9	9.7	8.5	9.5	3.3	2.2	1.5	0.8	1.2	0.8	1.1	0.7	0.7	1.8	1.3	0.5	0.7	8.5	1.3	0.7	0.9	0.8	0.6	18.1	29.4	13.8	21.3	20.8	10.1	22.1	12.9	14.4	26.3
CDK2		ENSG00000123374	Cyclin dependent kinase 2	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		SK-MEL-30: 105.5	Cancer enhanced	Detected in all		melanoma: 88.3	Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in many			"CAB013115, HPA066915"	Enhanced		Enhanced	"Nucleoplasm,Centrosome,Cytosol"				Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: "	unprognostic (2.36e-2)	unprognostic (2.60e-1)	unprognostic (3.71e-2)	unprognostic (1.83e-2)	unprognostic (1.75e-1)	prognostic unfavourable (9.94e-4)	prognostic unfavourable (8.61e-5)	unprognostic (3.48e-2)	unprognostic (1.31e-1)	unprognostic (4.67e-2)	unprognostic (5.38e-3)	unprognostic (4.69e-3)	prognostic unfavourable (1.46e-10)	unprognostic (1.05e-1)	unprognostic (1.76e-1)	unprognostic (6.16e-2)	unprognostic (6.75e-2)	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6	2	14.2	8.3	5.2	4.2	49	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.5	8.9	19.6	10.9	4	5.2	36.2	20.6	10.8	25.6	24	18.7	15.9	15.7	15.5	7.6	10.6	14.9	9	26.1	18.5	14.6	18.1	14.8	7.1	1.3	14.3	13.1	2.7	2.3	17.3	6	12.9	17.2	14.3	17.8	12.7	29.6	12.1	7.8	13.3	29	18.9	11.8	7.4	16.2	8.1	10.5	23.5	8.6	105.5	18.6	10.5	7.2	17.7	17.2	13.6	15	8.2	9.4	19.6	10	10.5	15.2	5.2	3.6	3.1	7	3.9	7	9.3	3.2	5	2.7	6.1	3	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6	2	7.3	5.1
CDK20	"CCRK, p42"	ENSG00000156345	Cyclin dependent kinase 20	Q8IZL9	9	87966441-87974753	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		SCLC-21H: 14.4;THP-1: 21.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		NK-cell: 7.2	Group enriched	Detected in many	7	NK-cells: 7.2;T-cells: 5.0	Low region specificity	Detected in all							"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	unprognostic (4.60e-2)	unprognostic (6.48e-2)	unprognostic (1.69e-2)	prognostic favourable (2.59e-4)	unprognostic (2.32e-1)	unprognostic (4.33e-3)	unprognostic (2.81e-4)	unprognostic (6.33e-2)	unprognostic (1.45e-1)	unprognostic (1.34e-1)	unprognostic (2.83e-3)	unprognostic (4.04e-2)	prognostic favourable (2.12e-5)	unprognostic (8.24e-3)	unprognostic (5.77e-2)	unprognostic (3.83e-2)	unprognostic (1.42e-2)	2.6	16.2	10.8	2.4	13	1.6	4.1	8.7	17.1	8.7	5	6.1	5.1	5.3	7.2	6	2.8	19.5	5.6	3	8.6	10.7	8.2	3.2	4	2	5.8	14.3	9.5	4.8	7.6	10.8	3.1	9.3	6.1	3.4	7.7	3.6	8.6	2.1	3.6	7.6	5.5	3.1	1.6	3.7	17.7	5.2	0.8	6.8	1.2	1.1	6.3	3	0.1	0.8	0.4	0.8	7.2	5	1.3	2.3	3	2.4	7.6	1.7	2.4	1	2.1	4.2	5.8	5.4	0.7	3.5	0	3.3	3.5	3.1	0	2.1	2.4	5.9	2.4	0	1.9	0	7.4	2.8	3.3	1.9	4.4	9.2	3.8	0	0.3	0	1.7	7	1.9	0.8	1.9	1.1	0	0	0.1	7.4	2	14.4	4	2.5	3	3.6	3.3	21.6	0	2.6	1	0.5	2.4	3.8	3.6	0	9.3	1.9	2.7	0	0.7	0.4	1.3	0.8	0.5	0	3	1.9	0.7	0.1	5	3.2	0.1	7.2	0.7	0.8	2.7	1.3	10.8	13	8.7	17.1	8.6	10.7	5.8	14.3	9.3	5.2
CDK3		ENSG00000250506	Cyclin dependent kinase 3	Q00526	17	76000906-76005999	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Low cell line specificity	Detected in all			Low cancer specificity	Detected in some							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all							Low region specificity	Detected in many			HPA007420	Uncertain		Approved	Cytosol				Cytosol		HPA007420: AB_1078490	unprognostic (6.77e-2)	unprognostic (1.26e-1)	unprognostic (3.69e-2)	unprognostic (1.87e-3)	unprognostic (6.41e-2)	unprognostic (1.10e-3)	unprognostic (1.61e-2)	unprognostic (1.56e-1)	unprognostic (8.12e-3)	unprognostic (1.34e-1)	unprognostic (9.80e-5)	unprognostic (1.19e-2)	unprognostic (6.75e-7)	unprognostic (4.25e-2)	unprognostic (1.63e-2)	unprognostic (4.68e-1)	unprognostic (4.47e-4)	4.1	3.7	2.7	4.7	2.4	5.5	4.7	4.2	2.4	4.9	4.8			6.5	5.6	5.7	4	5	4.8	2.6	2.8	3	5.9	13	5.3	5.5	3		6.7	5.9	4.2	8.3	5		10.3	5.3		5.2	4.5	0.9	14.7	9.1	4.1	3.9	8.8	5.2	5.6			8.2		5.4	3.8	5.1	1.2	1.8	1.5	1.5	1.7	2.7	1.6	4.2	7.7	11.5	6	6.8	8	23.9	5.2	3.4	5.9	5.5	6	8.8	6.3	4.6	4.5	9.7	9.2	3.9	3.8	3.2	14.8	13.2	15.3	6	5.6	4.6	13.5	7.2	8.5	5.2	4.2	6.4	5.8	4.5	3.7	10.7	5.3	20.4	5.7	8.4	9.9	5	5.9	5.4	14	8.3	22.4	3.5	11.3	2.5	15.5	9.3	5.4	15.9	9.4	6.7	5.5	9.5	7.1	5.9	4.8	4.7	3.9	0	1.5	0	2.1	1	0.2	1.2	1.6	1.2	1.8	0.3	2.7	0.5	1.5	1.7	0.6	1.6	2.7	1.6										
CDK4	PSK-J3	ENSG00000135446	Cyclin dependent kinase 4	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Group enriched	Detected in all	10	HBEC3-KT: 125.1;LHCN-M2: 138.1;RH-30: 434.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: "	unprognostic (8.88e-2)	unprognostic (2.53e-1)	unprognostic (5.27e-2)	unprognostic (9.01e-2)	unprognostic (2.21e-1)	unprognostic (1.10e-1)	prognostic unfavourable (2.09e-7)	unprognostic (7.39e-2)	unprognostic (3.23e-3)	unprognostic (2.93e-2)	unprognostic (3.19e-2)	unprognostic (9.10e-2)	prognostic unfavourable (3.15e-5)	unprognostic (3.32e-1)	unprognostic (1.67e-1)	unprognostic (3.64e-1)	unprognostic (1.57e-2)	32.2	43.1	13.8	22.2	15.7	24	45	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31	32.3	27.4	14.5	12.1	24	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25	16	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.3	10.8	14.3	12.7	13.1	11.5	9.5	5.4	17.6	23.8	19.8	15.4	8.9	13.6	9.7	8.4	7.2	19.7	125.1	18.1	6.7	9.1	12.7	7.3	10.8	15.4	14.4	8.8	11.3	9.2	14.6	16.8	15.3	13.5	11.7	138.1	13.5	13.7	11.7	16.8	11	12.4	434.6	12.6	7.4	14.7	12.9	12.1	9.5	7.2	14.4	9.6	17.5	6.9	11.2	10.5	12.6	10.9	5.8	9.5	20.9	10.3	13.3	13.4	1.7	14.3	2.6	26.2	19.9	27	29.6	23.1	23.7	21	28.1	32.1	28.5	1.2	15.8	12	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16	17.5
CDK5	PSSALRE	ENSG00000164885	Cyclin dependent kinase 5	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 36.1	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				Plasma membrane	Nucleoplasm	"CAB008909: , HPA064535: "	unprognostic (1.21e-1)	unprognostic (3.23e-2)	unprognostic (4.22e-2)	unprognostic (1.43e-1)	unprognostic (1.10e-1)	unprognostic (3.48e-1)	unprognostic (5.67e-3)	unprognostic (1.05e-2)	unprognostic (1.22e-1)	unprognostic (5.78e-3)	unprognostic (6.25e-3)	unprognostic (3.35e-1)	unprognostic (4.47e-2)	unprognostic (1.46e-2)	unprognostic (1.77e-1)	unprognostic (2.88e-1)	unprognostic (1.11e-1)	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5	6.2	5.8	25	19.7	9	7.7	5.3	6	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6	6.3	5.7	6.5	6.2	6	8.6	5.2	5.7	3.1	7.7	6.8	6	3.6	6.9	6.7	3.1	6.6	21.5	9	21.7	9.5	14.9	10.6	11.6	14	13.1	21.3	14.5	10.7	6.5	7.7	12.8	15.2	12.6	9.9	10.9	11.5	27.7	9.5	8.3	21	11.8	7	9.1	12.5	12.6	12.3	9.8	9.6	10.2	23.7	11.5	8.8	12.5	3.9	10.2	12.8	8.4	15.2	22.6	27.4	20.8	14.4	22.1	13.4	5.4	12.8	13.2	8.8	8.3	35.7	11.1	13.7	14.6	6.4	9	8.6	15	3.9	11.2	14.4	19.6	21.4	4.5	23.6	14.7	26.8	7.8	19	9	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25	19.7	15.4	15.4	20.8	7.7
CDK6	PLSTIRE	ENSG00000105810	Cyclin dependent kinase 6	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 74.6	Cell line enhanced	Detected in many		MOLT-4: 91.7;REH: 44.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all							Low region specificity	Detected in all			"HPA002637, CAB004363"	Enhanced		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	unprognostic (1.29e-1)	unprognostic (5.98e-3)	unprognostic (9.07e-2)	unprognostic (2.78e-3)	unprognostic (2.56e-2)	unprognostic (3.24e-2)	unprognostic (3.39e-1)	unprognostic (2.42e-3)	unprognostic (7.19e-2)	unprognostic (7.78e-3)	prognostic unfavourable (3.86e-6)	unprognostic (4.06e-2)	unprognostic (4.09e-3)	unprognostic (1.09e-1)	unprognostic (7.88e-2)	unprognostic (1.93e-1)	prognostic unfavourable (2.33e-5)	6.6	11.3	6	9.1	7.5	22.5	5.9	2.4	6	7.8	10	9.6	5.7	7.5	6	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7	5.2	5	10	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8	74.6	4.3	9.2	10.3	6.7	9	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6	2.8	7.8	5	2.3	2.6	1.6	6.3	3.9	3.1	3	7.7	4.7	4.7	3.6	4.2	3.8	4.3	9	7.4	10.3	3	11.8	5.4	7.4	1.4	7.3	0.5	2.5	4.9	4.2	20	1.2	11.2	13	5.6	1.2	91.7	0.7	2.4	2.6	44.8	27.6	7.9	4.3	0.1	4.1	26.8	0.7	2.1	3.7	0.1	12	4.6	10.3	16.1	4	12.6	7	0.1	6.3	1.5	25	13.6	4.9	1.9	6.5	5.2	3.9	5.9	2	5.5	5.6	4	3.6	7.1	4	1.1	3.9	4.8	5.6	2.8	2.3	6	7.5	2.4	6	6.9	4.2	7	5.2	7.5	8
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	Cyclin dependent kinase 7	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004364, HPA007932"	Enhanced									"CAB004364: AB_627243, HPA007932: AB_1078492"	unprognostic (3.12e-2)	unprognostic (1.23e-1)	unprognostic (4.87e-2)	unprognostic (4.53e-2)	unprognostic (3.29e-2)	unprognostic (4.64e-2)	unprognostic (2.49e-3)	unprognostic (1.64e-2)	unprognostic (7.77e-3)	unprognostic (1.81e-2)	prognostic unfavourable (3.09e-4)	unprognostic (3.40e-2)	prognostic unfavourable (9.42e-7)	unprognostic (2.61e-1)	unprognostic (2.38e-1)	unprognostic (3.86e-2)	unprognostic (1.55e-2)	7.9	12.9	10.9	6.2	15.2	44.1	14	10.8	14.7	9.4	12.7	6	6.3	15.8	9.4	8.6	23.4	18.5	16.5	8.1	11.5	9.3	13.8	10.6	10.1	8.8	7.6	9.7	7.7	9.1	3.3	16.2	22.9	11.2	11.2	14.8	6.6	13.2	6.5	15.9	15.4	9.8	12.1	9.2	7.9	13.9	29	7.8	12.1	20	15.6	15.5	10.7	11.7	15.6	15	22.4	11.3	12.4	15.3	7.8	3.7	7.8	1.8	0.5	2.4	11.6	14.7	6.5	7.7	10.8	17.5	16.7	1.9	2.8	10.2	1.7	2.5	1.4	2.8	5.9	1.3	7	0.4	8.2	7.9	0.4	6.7	3.2	14.3	13.9	9	2.8	13.6	10.4	4.5	4.9	0.7	4.1	14.8	1.7	7.5	6.7	0.4	1.1	1.6	1	0.6	6.5	1.5	5.8	3.4	11.6	0.6	2.6	0.1	3.2	0.9	5.1	4.8	8.4	3.7	0.8	4	0.8	7.3	10.9	22.4	8.6	11.3	14.8	12.4	12.9	15.3	15	15.6	11.1	13.2	10	12.4	8	11.2	12.8	7.8	10.9	15.2	10.8	12.7	11.5	9.3	7.6	9.7	11.2	7.8
CDK8	K35	ENSG00000132964	Cyclin dependent kinase 8	P49336	13	26254104-26405238	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044721			Approved	Nucleoplasm				Nucleoplasm		HPA044721: 	unprognostic (3.28e-3)	unprognostic (2.25e-3)	unprognostic (2.08e-1)	unprognostic (3.88e-3)	unprognostic (2.30e-2)	unprognostic (1.05e-2)	unprognostic (6.42e-3)	unprognostic (1.85e-2)	unprognostic (5.00e-2)	unprognostic (8.57e-2)	unprognostic (2.52e-1)	unprognostic (3.18e-3)	unprognostic (2.12e-1)	prognostic favourable (9.23e-4)	unprognostic (1.43e-2)	unprognostic (1.88e-1)	unprognostic (6.37e-2)	7.6	8.8	10.1	10.4	8.5	5.2	5.6	26.9	11.3	5.9	24	6	13.8	13.8	11.2	6.5	10	7	11.2	7.6	8.3	7.3	9.4	10.4	6.7	5.2	7.8	7.9	6.1	12.7	8.4	10.2	10.6	8.2	7.8	11.2	4.6	9	19.2	9.7	6.1	15	12.7	6	6.4	11.7	16.3	9.9	12.8	6.4	6.9	7.2	15.5	11	1.9	1.7	3.4	1.6	1	2.1	1.3	6.8	5.6	11.4	11.6	6	7.5	7	13.2	9.1	9.8	7.1	16.3	9.6	7.3	5.8	6.8	8.4	13.1	8.9	12.4	16.8	7.2	13.8	4.6	5.6	4.2	21.6	7.9	5.4	8.5	7.4	12.4	7.1	21.4	0	8.8	7.3	16.5	10.2	9.1	7	10.4	11.3	5	5.7	6.4	9.7	5.7	5.6	10.7	9.7	3.8	9.9	7.3	6.3	8	11.5	7.1	5.6	9.9	13.4	3.9	9.1	7.4	0.4	0.9	3.4	1.1	1.6	1.9	1	1.5	2.1	1.7	1.9	2.1	1.7	0	1	1.2	1	0.6	1.3	10.1	8.5	26.9	11.3	8.3	7.3	7.8	7.9	8.2	9.9
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	Cyclin dependent kinase 9	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	Cytoplasmic bodies	"CAB004216: AB_627245, HPA006738: AB_1078493"	unprognostic (3.60e-1)	unprognostic (1.71e-1)	unprognostic (5.44e-3)	unprognostic (1.04e-3)	unprognostic (1.93e-1)	unprognostic (3.97e-2)	unprognostic (2.07e-1)	unprognostic (5.84e-2)	unprognostic (2.66e-1)	unprognostic (8.36e-2)	unprognostic (1.24e-3)	unprognostic (3.11e-2)	prognostic unfavourable (8.92e-4)	unprognostic (1.37e-1)	unprognostic (1.00e-1)	unprognostic (3.52e-2)	unprognostic (8.78e-3)	26.2	27	22.8	18.9	22.4	33.9	17.4	31	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21	17.9	29	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17	17.6	6	8.9	5.1	6.4	18.6	9.9	2.9	8.8	16.1	10.1	11.1	11.5	9	13.2	9.1	13.4	9.5	8.6	11.9	10	15.5	10.7	10.3	17.9	6.6	14.9	3.6	13.9	8	14.5	17.4	9.8	16.8	14	23.3	15.8	18.2	10.1	11.4	19.6	12.5	20.9	8.5	23.3	15.3	21.1	22.3	17.2	44.3	8.6	22.3	13.8	9.9	10	11.9	13.7	14.5	8.2	18.2	13.3	22.4	11.4	12.9	9.8	8.8	38.1	29.2	13.9	10.7	9.6	10.4	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31	26.8	26.3	23.4	23.4	18.8	20.6	16.1
CDKL1	KKIALRE	ENSG00000100490	Cyclin dependent kinase like 1	Q00532	14	50329404-50416461	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		SK-BR-3: 16.5	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA059605, HPA065919"	Uncertain		Enhanced	"Nucleoplasm,Vesicles"				"Nucleoplasm, Vesicles"		"HPA059605: , HPA065919: "	unprognostic (4.12e-3)	unprognostic (3.22e-1)	unprognostic (4.54e-2)	unprognostic (8.04e-2)	unprognostic (1.64e-2)	unprognostic (1.02e-1)	unprognostic (3.23e-3)	unprognostic (9.36e-3)	unprognostic (2.63e-1)	unprognostic (9.99e-2)	unprognostic (1.20e-1)	unprognostic (9.36e-2)	unprognostic (5.53e-8)	unprognostic (1.21e-1)	unprognostic (7.96e-2)	unprognostic (9.39e-3)	unprognostic (3.31e-3)	7.1	2.1	7.5	1.8	5.1	0.9	3	2.7	20.2	14.1	5.9	1.6	2.5	8.4	12.1	2.3	2.6	16.4	2.6	2.9	7.1	2.4	18.8	1.1	4.3	3	2	12.3	10.5	2	1.4	1.4	4.9	2.9	4	5.7	1.6	2.5	8.4	1.7	3	3	7.7	3.1	3.7	2	1.9	1.4	1.3	5	6.1	2.1	7	5.6	5.7	1.3	6	2.5	3.8	6.7	2.6	6	4.8	0.6	2.4	6.5	7.8	0.3	2.1	3.8	2.2	2.5	1.9	5.7	0.4	2.6	4.6	4.2	0.9	0.6	2.5	6.6	2.3	6.4	2.1	1.7	7.3	5.8	3.5	1.7	3.5	4.5	10	8.4	2.6	2.6	1	0.3	1.9	3.1	0.7	2.3	0.7	2.8	1.8	6.9	2.3	1.1	1.3	2.4	16.5	0.6	0.2	4.9	2.6	5.7	2.9	5.6	4.7	0.8	0.4	0.4	0.9	6.1	6.9	6	2.5	4.4	6.3	2.3	6.2	4.6	4.4	6.7	1.3	5.7	3.4	3.7	1.4	3.8	0.3	1.2	4.1	2.6	7.5	5.1	2.7	20.2	7.1	2.4	2	12.3	2.9	1.4
CDKL2	"KKIAMRE, P56"	ENSG00000138769	Cyclin dependent kinase like 2	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 27.7	Cell line enhanced	Detected in some		A-431: 5.6;HEK 293: 3.7;HHSteC: 4.3;RPTEC TERT1: 8.1	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enhanced	Detected in some		memory CD8 T-cell: 1.6	Lineage enhanced	Detected in single		T-cells: 1.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040672			Approved	"Nucleoplasm,Centrosome"				"Nucleoplasm, Centrosome"		HPA040672: AB_10794744	unprognostic (2.07e-1)	unprognostic (9.96e-2)	unprognostic (6.91e-2)	unprognostic (3.80e-5)	unprognostic (3.43e-2)	unprognostic (2.71e-2)	unprognostic (1.59e-1)	unprognostic (8.14e-3)	unprognostic (1.58e-1)	unprognostic (1.62e-1)	unprognostic (5.85e-2)	unprognostic (1.27e-1)	prognostic favourable (6.88e-15)	unprognostic (5.91e-2)	unprognostic (1.70e-1)	unprognostic (1.64e-1)	unprognostic (7.52e-2)	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2	6.2	0	1	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7	3.8	1.6	5.7	8.9	0.7	12.5	2	2.4	3.4	1.2	2	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0	6.9	0	2	1.1	0.9	0.4	0	0.2	0	0	1.6	0.1	5.6	0.7	0.3	0	0.3	0.3	0	0.3	1.7	2.4	1.9	0.5	1.2	0.1	0.9	0.1	0.8	0	0.5	2.2	0.2	3.7	0	0.2	0	4.3	0	0.1	1.4	2.1	0.4	0.8	0.1	0	0.4	0.9	0.1	0	0	0.2	0.2	0	0	0	8.1	0.3	3	2.5	0	0	1.2	0	0	0	0	0.3	0	0	0.4	2.2	0	1.7	0	0	0	0	0	0.6	0	0	0.4	0.4	1.6	0	0	0.6	0.5	0.2	0	0	0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7	12.5	6.1
CDKL3	NKIAMRE	ENSG00000006837	Cyclin dependent kinase like 3	Q8IVW4	5	134286350-134371047	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 33.4	Low cell line specificity	Detected in many			Low cancer specificity	Detected in single			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in many			HPA027751			Uncertain	"Nucleoplasm,Vesicles"				"Nucleoplasm, Vesicles"		HPA027751: AB_10601256	unprognostic (4.70e-2)	unprognostic (2.15e-2)	unprognostic (2.35e-1)	unprognostic (1.48e-1)	unprognostic (1.43e-1)	unprognostic (3.98e-2)	unprognostic (3.43e-3)	unprognostic (5.93e-2)	unprognostic (2.12e-3)	unprognostic (1.49e-1)	unprognostic (8.47e-4)	unprognostic (2.82e-1)	unprognostic (9.85e-4)	unprognostic (8.33e-2)	unprognostic (4.88e-2)	unprognostic (7.10e-3)	unprognostic (3.43e-3)	2.5	2.7	7	2.2	7.1	1.6	2.5	7	8.5	2.6	2.4	5.9	5.5	2.3	3.9	5.3	2.6	3.7	2.6	6.6	6.1	6.5	4.5	2.8	2.2	2.5	8	4.3	3	2.4	3.2	6.5	2.2	8.6	2.8	2.6	3.9	2	3.2	7.5	2.7	2.5	4.6	8.4	2.7	2.2	33.4	9.3	1.3	3.9	2.1	3	2.8	2.2	1.5	2.7	1	1.1	1.4	4	1.3	1	2.2	3.3	2.2	5.6	4.8	1.4	3	2.7	1.4	3.3	2	1.5	2.8	1.9	1.9	0.9	2.7	1.9	2.7	3	2.1	1.5	2.4	3.4	3.4	0.6	1	2.2	4.9	4.1	1.3	1.3	1.5	1.2	3.6	1.1	2.1	8.3	2.2	1	3.6	1.4	0.8	1.8	1	5	1.5	2.2	0.6	3.6	1.9	1.7	1	2.7	0.6	3.6	1	3.4	4.5	5.4	4.1	2.2	2.1	0	0.9	1	0.9	1.1	4	1.5	1.4	2.5	2.7	1	3.8	3.8	0.2	1.4	0.4	1.6	2.3	1.3	7	7.1	7	8.5	6.1	6.5	8	4.3	8.6	9.3
CDKL4		ENSG00000205111	Cyclin dependent kinase like 4	Q5MAI5	2	39175646-39229588	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 3.2;testis: 7.9	Cell line enhanced	Detected in some		HAP1: 1.8;HL-60: 4.9;RT4: 3.3;SH-SY5Y: 6.6	Not detected	Not detected							Group enriched	Detected in some	11	memory B-cell: 1.6;T-reg: 3.2	Group enriched	Detected in many	25	B-cells: 1.6;T-cells: 3.2	Low region specificity	Detected in many							HPA067895	Uncertain									HPA067895: 	unprognostic (3.57e-2)	unprognostic (3.92e-2)	unprognostic (1.14e-1)	unprognostic (1.98e-2)	unprognostic (3.29e-1)	unprognostic (7.46e-3)	unprognostic (3.26e-2)	unprognostic (4.26e-1)	unprognostic (3.82e-2)	unprognostic (6.13e-3)	unprognostic (1.77e-2)	unprognostic (8.43e-2)	unprognostic (8.45e-4)	unprognostic (8.59e-2)	unprognostic (4.95e-1)	unprognostic (3.08e-1)	unprognostic (3.26e-2)	0.3	1.1	0.3	0	0.6	0	0.3	0.1	0.7	0.2	0			0	0.2	0	0	1	0.1	0.1	0.5	0.9	0.2	0	0.4	0.1	0.2		0.3	0.3	0	1.6	1.2		0.4	0		0	0.1	0.1	0.2	0.1	0	0.1	0.2	0.3	7.9			0.3		0.1	0.1	0	1.6	0	0	0	0	3.2	0	0.1	0	0.5	0.4	0	0.1	0.1	0.3	0.2	0	0	0.2	0.1	0.1	0.1	0.3	0	1.8	0	0	0.1	0	0.1	0.3	0.7	0.3	4.9	1.1	0.3	0	0.1	0	0.1	0	0.3	0.3	0	0	0	0.5	0.1	0	0	0	0.2	3.3	0.6	6.6	0	0	0	0	0.1	0	1.5	0	0	0.2	0.1	0	0	0.4	0	0.1	0	0	0	0	0	0	1.6	0.2	0	0	0	0	0	0	0	0	0	3.2	0										
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	Cyclin dependent kinase like 5	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 28.0	Cell line enhanced	Detected in many		A549: 12.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	5	basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7	Lineage enriched	Detected in many	8	granulocytes: 7.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA002847, CAB011577"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	unprognostic (7.01e-2)	unprognostic (4.86e-2)	unprognostic (1.41e-1)	unprognostic (1.25e-4)	unprognostic (1.17e-1)	unprognostic (1.61e-2)	unprognostic (1.72e-2)	unprognostic (1.67e-1)	unprognostic (2.07e-1)	unprognostic (9.63e-3)	unprognostic (2.05e-3)	unprognostic (1.66e-1)	prognostic favourable (5.54e-4)	unprognostic (7.67e-3)	unprognostic (1.29e-1)	unprognostic (2.67e-3)	unprognostic (1.99e-1)	3.3	3.2	8	1.8	24.7	3.2	4.3	3.9	28	5.4	2.7	7.7	1.8	1.5	4.5	2.8	5.2	2.8	3.1	5	8	3.7	6.3	2.2	6.9	1.4	3.5	13.2	6.7	4.5	6.2	5	5.4	5.9	6.7	2.2	2	3.9	4.4	3	3.5	1.9	4	5.7	2.3	4.9	14	5.7	1.6	5.1	0.8	2.1	5.6	4.6	0.7	1	7.7	1	0.5	0.6	0.2	1.7	12.3	3.5	3.1	3.3	4.5	2.5	2	3.8	2.8	3.2	4	2.3	1.9	0.4	1.3	0.5	4	3	5.9	0.5	2.6	0	7.1	3.1	1.6	0.1	0.8	2.6	3.1	6.8	7.1	1.3	0.1	1.9	4.2	1.7	0.8	0.8	7.1	3	0.7	3.8	0.1	2.4	8.9	0.7	4.4	4.5	1.1	2.2	1.6	0.7	7.3	4.3	1.9	7.9	1.5	0.3	0.1	0.3	2.4	0.5	4.2	7.7	1	2.1	0.6	0.6	0.3	0.2	0.4	0.3	0.3	0.7	0.6	0.6	4.7	0.5	0.6	1	0.2	0.2	8	24.7	3.9	28	8	3.7	3.5	13.2	5.9	5.7
CHEK1	CHK1	ENSG00000149554	Checkpoint kinase 1	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		ductus deferens: 80.0;seminal vesicle: 66.8	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		T-reg: 11.7	Lineage enriched	Detected in many	6	T-cells: 11.7	Low region specificity	Detected in single							HPA044364			Supported	"Nucleoplasm,Vesicles"				Nucleoplasm	Vesicles	HPA044364: 	unprognostic (6.74e-2)	unprognostic (3.63e-1)	prognostic favourable (3.62e-4)	unprognostic (5.54e-2)	unprognostic (2.17e-1)	unprognostic (1.03e-1)	prognostic unfavourable (3.70e-6)	unprognostic (3.95e-3)	unprognostic (1.26e-3)	unprognostic (2.54e-2)	prognostic unfavourable (3.10e-6)	unprognostic (1.75e-1)	prognostic unfavourable (1.04e-8)	unprognostic (2.89e-2)	unprognostic (2.64e-1)	unprognostic (8.16e-2)	unprognostic (1.33e-1)	3	2.5	2.5	9	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80	5	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2	1.8	9.6	3	1.2	3.8	4	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1	12.7	10.4	23.4	14.2	4.8	10.3	10.2	17.9	8.6	11.5	12.4	25.4	28.3	33.4	18.5	7	15.4	14.3	9.4	14.2	20.9	6.6	61.9	8.7	13	1.5	31.6	11.8	5.3	2	14.5	10.3	13.6	31.3	29.4	15.1	6.6	46.9	15.5	23.7	9.4	28.6	21.9	17.5	10.6	17	14.8	15.7	14.7	10.2	4.3	27.5	10.3	9.1	16.6	14.1	8	16.4	6.6	11.8	47.6	6.1	23.8	19.4	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2	0.4	1.2	0.4	1.8	11.7	1	2.5	2.8	1.1	2.2	2.4	2.4	3	1.2	1.5	1.5
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	Checkpoint kinase 2	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Golgi apparatus	"CAB002030: AB_563660, HPA001878: AB_1078514"	unprognostic (1.54e-1)	unprognostic (2.20e-1)	unprognostic (5.83e-2)	unprognostic (2.93e-2)	unprognostic (2.42e-1)	unprognostic (3.83e-2)	unprognostic (1.49e-3)	unprognostic (5.08e-3)	unprognostic (3.33e-3)	unprognostic (9.62e-3)	unprognostic (1.28e-2)	unprognostic (3.13e-1)	prognostic unfavourable (7.80e-9)	unprognostic (2.38e-2)	unprognostic (1.78e-1)	unprognostic (7.27e-2)	unprognostic (6.79e-3)	5.6	8.3	2.5	13	7	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10	4.3	6	6	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7	5.8	2.2	6.3	8.5	5.4	5	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.7	4.7	13.5	16.7	3.8	19.2	8.7	7.3	8.6	9.7	14.2	12	10.1	17.4	6.2	5.1	14.2	20.5	13.4	11.3	12.4	15.7	22.9	9	19.8	3.8	14.5	16.8	8.1	6.2	12.4	11	10.7	13.8	15.2	9	20.7	11.6	23.3	19	12	25.3	9.2	20.3	6	6.1	7.9	4.5	8.1	14.5	8	9.9	13.4	3.7	7.8	9.3	6.8	3.8	9.2	16.2	34	7.4	15.2	9.9	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7	2.8	3.7	2.5	7	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	Conserved helix-loop-helix ubiquitous kinase	O15111	10	100188298-100229619	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001402, CAB004240, CAB018564"	Approved		Supported	"Nucleoplasm,Vesicles,Cytosol"				Nucleoplasm	"Vesicles, Cytosol"	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	unprognostic (8.61e-3)	unprognostic (1.70e-1)	unprognostic (3.74e-2)	unprognostic (3.01e-1)	unprognostic (3.02e-2)	unprognostic (5.93e-2)	unprognostic (4.02e-2)	unprognostic (2.09e-1)	unprognostic (8.58e-2)	unprognostic (8.39e-2)	unprognostic (6.73e-2)	unprognostic (1.49e-1)	prognostic favourable (1.27e-4)	unprognostic (2.48e-2)	unprognostic (1.95e-1)	unprognostic (1.88e-3)	unprognostic (2.22e-1)	16.6	16.6	14	14.3	18.9	21.3	14.2	16	15.8	11.8	15	13	13.9	16.1	14.7	12.4	13.5	12	11.7	14.5	13.3	17.6	27.2	35.8	14	20.8	17.9	6.9	11.4	14.5	19.6	18.2	14.2	16.4	12.9	17.6	9.5	13.9	12.5	23.6	11	20.6	16.1	18.6	18.7	15.1	12.5	15.6	22.5	14.5	11.7	15.5	13.8	13.6	3.7	3.4	7.2	4.8	4	4.3	1.4	15.6	13.2	13.6	20.2	13.1	11.8	10.5	19.9	19.6	18.6	22.8	14.8	9.3	21.2	11.8	13.5	15.5	22.6	10.6	21	22.5	19.5	14.1	10.5	16.3	11.2	26	20.7	9.4	11.3	21.5	21	13.2	15.9	17.6	20.3	9.5	20.5	16.1	8.8	9.7	13.4	15.1	9.7	11.8	10.1	8.1	12.1	10.8	8.4	17.3	16.7	15.9	13.9	11.7	13.2	12.7	22.6	20.8	18.7	20.7	12.8	21.2	9.2	2.6	3	5.1	2.4	4.8	4	3.7	3	4.3	3.4	2.1	3.3	4.2	7.2	4	3.2	2.1	2.8	1.4	14	18.9	16	15.8	13.3	17.6	17.9	6.9	16.4	15.6
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	Citron rho-interacting serine/threonine kinase	O14578	12	119685790-119877291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary microcephaly"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 15.3;brain: 35.0	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		T-reg: 1.2	Low lineage specificity	Detected in single			Low region specificity	Detected in many							"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol				Cytosol		"HPA019082: AB_1846803, HPA048812: , HPA075506: "	unprognostic (5.64e-2)	unprognostic (5.00e-2)	unprognostic (8.16e-2)	unprognostic (5.12e-3)	unprognostic (1.25e-1)	unprognostic (3.55e-2)	unprognostic (3.61e-6)	unprognostic (6.02e-2)	unprognostic (7.78e-2)	unprognostic (4.42e-1)	unprognostic (1.37e-3)	unprognostic (4.88e-2)	unprognostic (2.55e-3)	unprognostic (8.56e-2)	unprognostic (1.50e-1)	unprognostic (1.70e-1)	unprognostic (3.30e-1)	1.4	4.4	14.7	3.3	14	15.3	1.6	12.7	35	1.6	4.6	2.9	0	4	1.3	1.5	3.2	0.9	1.6	1	9.8	5.7	5.7	1.4	3	3.4	3.2	21.9	0.7	0.7	1.2	2.9	2.6	7.4	1	5.3	0.6	1.3	1	1.3	5.1	3.5	2.6	5	5.6	3.5	8.3	9.5	5.9	1.5	0.1	4.9	1.7	1.7	0.4	0	0	0.1	0	1.2	0.8	15	13.5	11.9	11.2	1.1	3.3	7	11.5	9.6	12.1	9.1	8.6	6.2	10.8	6.2	8.9	9.4	8.1	6.7	16.7	7.7	5.9	13.7	8.7	5.3	0.1	7.2	12.6	0.7	0.7	14.4	8.9	9.2	8.7	9.2	11.3	7.5	13	11	6.4	9.1	11.9	21.6	3.6	2.4	6.6	8.5	4.7	19.1	3.7	9.1	13.5	5.2	7	15.1	13.9	10.3	12.5	6.3	7	7.4	10	7.9	23.3	0	0	0	0.4	0.1	0	0.4	0.3	0	0	0.3	0	0	0	0	0	0	1.2	0.8	14.7	14	12.7	35	9.8	5.7	3.2	21.9	7.4	9.5
CLK1		ENSG00000013441	CDC like kinase 1	P49759	2	200853009-200864744	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: "	unprognostic (9.79e-2)	unprognostic (2.05e-1)	unprognostic (2.15e-2)	unprognostic (1.63e-1)	unprognostic (9.19e-2)	unprognostic (4.50e-3)	unprognostic (1.52e-1)	unprognostic (2.77e-3)	unprognostic (1.78e-2)	unprognostic (2.09e-2)	unprognostic (1.09e-2)	unprognostic (5.63e-3)	unprognostic (2.03e-3)	unprognostic (9.66e-2)	unprognostic (2.30e-1)	unprognostic (1.18e-1)	prognostic favourable (2.28e-4)	26.3	55.1	27.8	30.5	43.4	97.6	40.2	40.1	40.7	42.2	23	19.9	39.1	12.9	29.1	34.5	26.3	19.1	35.8	26.7	31	21.9	21.8	35.3	28.2	30.1	56	23.1	48.1	20.9	36.6	41.5	40	34.4	34.3	16.5	13.7	25.6	37.1	27.3	32.1	14.9	36.8	55.2	32.4	15.1	12.4	52.6	25	30.4	20.2	25.6	51.2	71.8	13.2	9.8	26.2	6.2	6.5	14.4	7.4	8.1	6.1	10.3	3.1	11.7	12.9	8.1	8.8	12.6	9	12	11.4	5.3	2.8	6	5.5	8.8	13	4.1	18.5	12.4	11.4	8.3	15.5	14.1	7	8.7	14.2	5.9	18.6	11.3	19.9	5.2	10	36.8	12.8	5.5	10.2	26.4	6.5	14	10.4	12.2	14.6	6.2	5.3	10.4	8.2	7.7	2.9	12.8	2.4	6	8	10.1	6.9	9.7	9.7	21.7	9	6.5	6.5	7.1	6.8	26.2	6.2	13.3	13.6	4.4	13.1	13.2	12.8	12.1	4.1	10.1	14.4	11.4	12.7	6.5	4.2	9.8	13	7.4	27.8	43.4	40.1	40.7	31	21.9	56	23.1	34.4	52.6
CLK2	clk2	ENSG00000176444	CDC like kinase 2	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nuclear bodies	"HPA055366: , HPA059507: "	unprognostic (2.00e-2)	unprognostic (1.35e-2)	prognostic unfavourable (3.77e-4)	unprognostic (2.84e-2)	unprognostic (3.16e-1)	unprognostic (1.75e-1)	prognostic unfavourable (2.82e-4)	unprognostic (2.38e-1)	unprognostic (2.36e-1)	unprognostic (1.36e-2)	unprognostic (7.66e-2)	unprognostic (3.84e-2)	prognostic unfavourable (2.95e-9)	unprognostic (1.70e-1)	unprognostic (1.40e-1)	unprognostic (1.11e-1)	prognostic favourable (5.43e-4)	15.3	16.6	14.6	15	19	12.9	17.1	33.1	20.2	22.3	18	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17	13.5	27	13.7	13.7	20.3	18.1	22.9	8	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	6	5.2	18.9	5.8	9.5	5.1	16.1	5.4	6.6	4.2	4.2	5.5	4.3	13.1	7.5	3.7	8.7	9.4	7	4	9.5	7.4	10.4	5.4	7	8.2	12.9	10.5	4.1	6.4	6.1	12.3	7.3	14.6	9.1	6.3	10.4	8.8	7.7	12.3	7.4	9.8	11.4	14.1	10.6	13.5	9	12.8	2	6.5	5	9.9	15.9	4.8	2.6	6.9	4.7	4.5	17.4	14.8	11.9	5.1	9.3	2.9	4.8	1.7	3.4	2	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3
CLK3	clk3	ENSG00000179335	CDC like kinase 3	P49761	15	74598500-74645414	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046817	Approved		Supported	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"		HPA046817: AB_10964124	unprognostic (4.10e-2)	unprognostic (8.43e-2)	prognostic unfavourable (2.05e-6)	unprognostic (1.91e-3)	unprognostic (7.91e-2)	unprognostic (5.76e-2)	unprognostic (1.46e-1)	unprognostic (1.30e-2)	unprognostic (1.95e-1)	unprognostic (2.54e-1)	unprognostic (8.14e-3)	prognostic unfavourable (5.92e-4)	unprognostic (1.35e-2)	unprognostic (2.24e-1)	unprognostic (9.73e-2)	unprognostic (2.48e-1)	unprognostic (2.25e-2)	20.9	17.2	15.7	24.7	22.5	62.7	31.1	23.4	18.8	24.9	24.6	23.1	16.4	18.6	24.1	17.7	25.3	17.3	21.2	16.4	17.8	13.5	17.2	16	19.6	21.9	29.3	14.5	23.7	21.8	19	19.9	27.9	16.7	20.6	14.4	19.9	24.8	20.9	28.4	24.1	20.7	19.8	19.2	23.8	19.6	31.5	23.3	28.8	21	12	23.7	23.2	19.8	38.9	36	60.7	46	43.6	43.4	39.7	22.3	14.2	18.8	10.5	24.2	18.5	14.8	15.3	24.2	21.9	26.9	19.2	14.8	20.4	11.3	13.6	15.8	35	14.7	14.3	28.9	19.1	25	21.1	13.3	38.5	6.7	19.4	23.2	29.3	28.7	24	23.9	12.1	14.9	12.7	15.8	19.8	22.7	12	10	16.1	9	13.3	17	16.2	10.6	12.4	12.2	13.6	13.5	12.9	13.5	11	13	10	8.1	20	24.4	19.6	16.7	11.4	33	16.3	32.9	34.4	45	38.5	37.4	37.4	37.7	41.1	39.7	31.9	38.9	42.1	40.1	60.7	43.6	46	36	43.4	39.7	15.7	22.5	23.4	18.8	17.8	13.5	29.3	14.5	16.7	23.3
CLK4		ENSG00000113240	CDC like kinase 4	Q9HAZ1	5	178602664-178630615	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043746	Approved		Approved	Actin filaments				Actin filaments		HPA043746: 	unprognostic (9.46e-2)	unprognostic (2.24e-2)	unprognostic (1.48e-1)	unprognostic (3.44e-2)	unprognostic (1.59e-1)	unprognostic (7.16e-3)	unprognostic (2.67e-1)	unprognostic (2.04e-2)	unprognostic (4.37e-2)	unprognostic (5.92e-2)	unprognostic (2.90e-3)	unprognostic (9.62e-3)	unprognostic (1.13e-2)	unprognostic (1.26e-1)	unprognostic (3.38e-1)	unprognostic (1.20e-1)	unprognostic (1.14e-3)	12.2	16.4	17	17.4	18.4	11.4	17.3	53.8	24.1	17.9	12.2	11.9	18.3	12.4	17	16.4	10.5	11	13.1	11.4	15.9	9.5	11.8	16	10.9	20.3	21.2	12.7	17.4	16.2	15.4	20.2	13.9	16.3	16.7	8.9	10.8	14.4	17	20.6	19.5	11.3	11.3	25.8	17	11	15.7	22	15	15.8	9.7	12.7	11.4	18	13.2	7.8	16.1	6.1	7.7	13.8	5.2	6.8	6.3	5.9	8.5	17.6	14.8	9.7	6.7	7.6	4	7.4	6.7	5.5	3.9	5.4	2.8	9.1	7.5	5.4	6.6	14.1	5.9	1.5	11.9	8.2	6.6	3.1	5	6.7	7.9	6.4	8.7	2.7	3.5	11.7	5.1	2.8	4	11.4	3	3.9	4	5.2	5.7	4	2.1	6.6	4.4	7.5	4.1	6.9	4.3	6.6	5.6	8.2	3	4.2	7.1	7.7	2.9	3	5.9	7.6	4.2	6.5	6.1	12	10	4.1	13.2	13.2	10.3	8.9	5.9	10.4	13.8	10.6	16.1	7.7	4.4	7.8	9.5	5.2	17	18.4	53.8	24.1	15.9	9.5	21.2	12.7	16.3	22
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	Coenzyme Q8A	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Ubiquinone biosynthesis	"Kinase, Transferase"	"Disease mutation, Neurodegeneration, Primary mitochondrial disease"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	skeletal muscle: 216.5	Cell line enhanced	Detected in many		HEK 293: 33.0;RPMI-8226: 30.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA061662			Supported	Mitochondria				Mitochondria		HPA061662: 	unprognostic (6.37e-3)	unprognostic (2.09e-2)	unprognostic (2.29e-1)	unprognostic (9.06e-2)	unprognostic (8.94e-2)	unprognostic (2.49e-1)	unprognostic (4.42e-2)	unprognostic (3.50e-3)	unprognostic (1.81e-1)	unprognostic (4.02e-1)	unprognostic (4.15e-3)	unprognostic (8.67e-2)	unprognostic (2.40e-2)	unprognostic (9.24e-2)	unprognostic (2.82e-1)	unprognostic (8.88e-2)	unprognostic (2.62e-1)	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5	6.1	41	2.7	1.8	3.8	17.7	2.7	4.1	5	2.4	7.2	20.3	1.6	1.6	2	3.8	6.5	2	1.9	7.2	5	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.2	5.8	1.5	4.5	4.7	3.1	23.6	1.5	1.3	2.2	2.9	9.2	5.2	9.5	7.3	1	3.7	2.9	3.3	0.5	9.9	33	6.6	4.8	15.1	1	10	4.1	5.9	5.1	1.7	2.3	1	11.4	7.8	0.3	4.3	5.8	14.7	6.4	12	5.7	7.1	30.2	0.7	2.4	24.3	9.9	3	11.8	8.5	6.2	13.6	1.2	2.5	2.3	3.5	5.5	17.6	15.4	5	2.3	11.4	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5	2.4	3.8	4.7
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	Coenzyme Q8B	Q96D53	19	40691529-40718207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	unprognostic (7.57e-2)	unprognostic (9.48e-2)	unprognostic (1.61e-1)	unprognostic (2.36e-2)	unprognostic (2.33e-2)	unprognostic (1.19e-1)	unprognostic (1.79e-1)	unprognostic (4.63e-2)	unprognostic (1.85e-1)	unprognostic (2.27e-1)	unprognostic (2.82e-2)	unprognostic (1.48e-1)	unprognostic (2.93e-2)	unprognostic (6.18e-2)	unprognostic (1.46e-1)	unprognostic (7.17e-2)	unprognostic (2.65e-2)	13.6	17.8	21.1	13.1	16.4	11.5	10	24.1	19.2	13.6	13.6	18.6	14.8	17.9	15	13.2	16.6	26.5	16.7	14.7	15.7	10.7	11.8	15.6	12.1	12.2	15.5	12.1	16.3	19.4	12.6	32.7	7.9	13.2	15.1	5.7	12.3	16.8	17.6	10.3	12.9	18.6	16.2	15.6	12.1	17.5	12.5	16.7	16.8	15.5	6.9	13.2	14.8	11.8	12.9	15	17.7	15.6	9.7	13.1	10.5	8.2	33.7	6.9	13.3	6.2	6	6.4	7.7	8.3	5.8	6.2	10.5	15	11	14.9	4.4	7.1	4.8	8.6	2.1	13.2	10	10.6	20.5	5.8	10.7	3.6	16.5	7.9	9.2	4.2	5.1	6.5	5.6	6	4	5	4.7	4.4	5.3	3.5	7.9	9.7	8.3	10.1	13.9	12.4	10.1	10.3	15.8	16.7	14.2	13.8	6.1	5	17	3.6	4.5	6.7	5.4	5.6	18.9	4.2	6.9	15.8	15.6	14.6	11.6	15.4	13.1	12.9	9	12.4	15	11.7	8.9	9.1	17.7	9.7	13.7	8.7	8.8	10.5	21.1	16.4	24.1	19.2	15.7	10.7	15.5	12.1	13.2	16.7
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	Colony stimulating factor 1 receptor	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 82.5;lymphoid tissue: 82.6	Group enriched	Detected in some	5	BEWO: 50.6;SK-BR-3: 19.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		intermediate monocyte: 60.7;non-classical monocyte: 82.5	Lineage enriched	Detected in many	4	monocytes: 82.5	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	Intracellular and membrane	1500000000	1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	unprognostic (3.82e-2)	unprognostic (1.31e-1)	unprognostic (1.86e-3)	unprognostic (9.83e-2)	unprognostic (1.20e-1)	unprognostic (7.33e-2)	unprognostic (1.03e-1)	unprognostic (1.45e-1)	unprognostic (9.37e-2)	unprognostic (1.11e-2)	unprognostic (2.49e-1)	unprognostic (1.65e-1)	prognostic unfavourable (1.08e-4)	unprognostic (3.67e-2)	prognostic unfavourable (4.92e-4)	unprognostic (1.72e-2)	unprognostic (4.61e-2)	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8	8.7	3	5.8	14.5	16.2	25.8	82.6	9	4.9	23	3.1	4.2	2.9	8.2	16.4	4.7	0	19.1	2.9	82.5	0	0.1	13.9	1.7	0	0	0	0.8	0.2	50.6	0.1	0	0	0	1.5	0	2.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.4	1.1	0	0	0	0	0	0	0	2	0	0	0	0.7	0.2	0	0	0	0.1	0	19.3	0	0	7.2	0	0.3	0	0	1.3	0	0.1	0	2.6	0.9	0	0.4	18.1	0.5	0.1	60.7	0	0	0	0	19.1	0	0	0	2.9	0	82.5	1.4	0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6	17.1	23
CSK		ENSG00000103653	C-terminal Src kinase	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 67.2	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Approved	"Vesicles,Cytosol"		1500000	1500000	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	unprognostic (1.05e-1)	prognostic favourable (5.14e-5)	unprognostic (2.59e-3)	prognostic favourable (8.22e-4)	unprognostic (4.15e-2)	unprognostic (4.11e-2)	unprognostic (1.87e-1)	unprognostic (2.96e-1)	unprognostic (2.20e-1)	unprognostic (1.31e-1)	unprognostic (4.12e-2)	unprognostic (4.61e-2)	prognostic unfavourable (1.74e-4)	prognostic favourable (1.07e-4)	unprognostic (1.44e-1)	unprognostic (1.01e-1)	unprognostic (6.29e-2)	9.3	8	9.5	39.3	11	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14	9.8	8.5	8	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.7	18	8.8	14.5	8.4	6.5	7.6	8.6	8.2	16.3	11.6	16.4	11.8	57.1	11.4	7.7	13.3	18.5	17.3	4.6	27.6	22.8	48.3	6.6	16.5	11.7	25.2	61.6	9.2	8.5	11.6	10.4	12.3	13.9	19.9	9.7	21.5	18.1	14.9	10.9	12.9	20.1	7.6	41.6	7.5	28.4	14.7	10.2	11.1	23.4	14.8	16.1	37.2	10.6	19.8	10.4	15.5	14.8	10.7	21.5	58.3	10.2	48.2	13.3	20.7	19.7	49.6	23.4	42.4	20	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	Casein kinase 1 alpha 1	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB016680, HPA051334"	Uncertain		Supported	Cytosol				Cytosol		"CAB016680: AB_1614518, HPA051334: "	unprognostic (4.27e-3)	unprognostic (5.85e-3)	prognostic favourable (1.15e-4)	unprognostic (7.39e-2)	unprognostic (2.66e-1)	unprognostic (3.14e-1)	unprognostic (1.27e-2)	unprognostic (5.56e-2)	unprognostic (4.38e-1)	unprognostic (8.31e-2)	prognostic unfavourable (5.79e-4)	unprognostic (5.47e-2)	unprognostic (1.56e-1)	unprognostic (7.92e-2)	unprognostic (4.41e-2)	unprognostic (6.28e-3)	unprognostic (6.92e-2)	33.5	35.8	26	26.9	35.2	71	40.2	32	39.3	33.8	38.2	28.2	40.5	23.2	41	29.4	66.1	31.8	36	45.7	24.4	26.1	24	30.1	37.5	27.3	28	29.8	31.7	23.9	46.9	30.9	28.7	38	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32	53.1	41.1	45	40	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.1	24.1	40.7	38.5	42	51.5	43.5	51.6	49.1	40.2	42.4	47	49	19.3	57.1	54.8	37	28.7	69.5	61.6	27.9	17.3	26.1	28	21.6	37.8	40.8	42	42.1	72.1	45.2	72.8	46.3	22	29.1	45.3	22.6	37.5	16.5	21.4	58.8	28	32.2	21.9	28	63	31.4	28.2	38.3	51.4	62.8	48.2	35.6	45.9	47.4	24.9	31.4	49.1	27	34.5	29.7	44.2	29.7	57.2	47.4	36.6	35.4	29	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34	31.1	34.2	39.6	24.2	41.9	40.8	26	35.2	32	39.3	24.4	26.1	28	29.8	38	24.1
CSNK1A1L	MGC33182	ENSG00000180138	Casein kinase 1 alpha 1 like	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	Wnt signaling pathway	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	blood: 10.5;testis: 9.0	Not detected	Not detected			Not detected	Not detected							Cell type enriched	Detected in single	40	neutrophil: 10.5	Lineage enriched	Detected in single	42	granulocytes: 10.5									HPA051334			Uncertain	Cytosol				Cytosol		HPA051334: 	unprognostic (1.23e-2)		unprognostic (1.59e-1)	unprognostic (3.19e-2)	unprognostic (3.54e-2)	unprognostic (2.40e-2)		unprognostic (5.40e-2)	unprognostic (8.90e-2)	unprognostic (3.47e-1)	unprognostic (1.47e-3)	unprognostic (4.50e-1)	unprognostic (2.02e-1)	unprognostic (2.28e-3)	unprognostic (3.45e-1)	unprognostic (2.38e-1)		0	0	0	0.3	0	1.4	0	0	0.1	0	0			0	0	0	0	0	0	0	0	0	0	0	0.1	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0.3	0	9			0		0	0	0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0	0	0.4	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0.3	0	0	0.3	0	0	0	0	0	0	0	0.4	0	0.1	0.1	0	0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2										
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	Casein kinase 1 delta	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoli fibrillar center	Nucleoplasm	CAB015410: AB_831049	unprognostic (1.07e-2)	unprognostic (1.27e-1)	unprognostic (2.31e-1)	prognostic unfavourable (7.04e-4)	unprognostic (2.38e-2)	unprognostic (3.43e-2)	prognostic unfavourable (2.38e-6)	unprognostic (8.05e-2)	unprognostic (1.09e-1)	unprognostic (5.00e-2)	prognostic favourable (9.62e-5)	unprognostic (2.23e-3)	prognostic unfavourable (8.34e-4)	unprognostic (3.54e-1)	unprognostic (2.52e-1)	unprognostic (5.52e-3)	unprognostic (4.74e-2)	30.1	36.3	30.8	25.9	30.8	21	26.3	36.3	42.8	30.9	33	27.7	32.9	32.6	37.9	29.8	31.3	38	34.9	28.5	26.2	26.9	32	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.3	25.4	14.5	19.9	19.1	20.4	29.1	31.4	19.8	22.5	21.1	20.8	18.4	19.5	24.8	22.3	20.7	13.6	31.8	18.2	16.5	32.9	24.2	20.2	22.3	55.5	19.9	18.5	30.9	22.6	15.3	22.8	32.8	27.2	10.4	21.2	24.9	25.5	20.8	15.5	40	22	17.9	17.3	23.7	33.5	17.9	32.3	37.5	31.3	35.1	22.4	26.1	34.5	32.4	29.1	28.1	23.8	22.7	11	20.9	26	17.1	23.5	4.7	11	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	Casein kinase 1 epsilon	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Biological rhythms	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		plasmacytoid DC: 15.7	Low lineage specificity	Detected in all											"CAB009626, HPA026288"	Approved		Approved	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	unprognostic (2.32e-1)	unprognostic (8.41e-2)	unprognostic (5.14e-2)	unprognostic (5.01e-3)	unprognostic (1.95e-2)	unprognostic (4.50e-3)	prognostic unfavourable (8.20e-5)	unprognostic (2.08e-3)	unprognostic (3.69e-1)	unprognostic (1.22e-1)	unprognostic (9.63e-2)	unprognostic (4.16e-3)	prognostic unfavourable (4.67e-6)	unprognostic (1.91e-1)	unprognostic (1.66e-1)	unprognostic (2.58e-1)	unprognostic (3.25e-3)	28.5	22.9	30.7	18.3	32.5	21.4	28.6	40.1	42.6	26.4	21.5	32.3	15.7	19	37.3	27.3	23.4	28	22.1	28.8	31.7	22.3	17.3	11.8	28.4	17.3	28.6	30.1	38.1	25.4	56.2	29.2	33.1	28.7	26.2	17.4	30.5	23.9	23.1	26.3	35.3	17.1	24	23.2	20.9	21.8	13	33.9	13.3	21.4	14.2	17.4	25.5	28.8	3.7	15.7	4.8	1.8	5.9	4	1.2	23.3	11.4	31	29.7	15.5	23.8	23.3	30.5	39.1	27.8	27	14.6	18.3	17.6	13.3	28.8	20	23.5	42.2	20.2	28.1	51.1	5.6	37.7	11.2	32	12.3	15	22.7	35.8	42.3	57.3	29.5	12.4	36.4	26.8	15.6	17.1	15.1	22.7	16.5	32	22.2	27.6	25.5	19.6	45.9	18	26	27	30.5	13.8	17.9	33.5	25.2	27.5	14.5	24.3	16.3	23.3	24.8	37.4	13.9	42.2	3.8	1.8	3.4	3.4	0.8	4	2.5	3.8	3.4	1.8	3.7	2.1	3.1	4.8	5.9	0.6	15.7	1.7	1.2	30.7	32.5	40.1	38.8	31.7	22.3	28.6	30.1	28.7	33.9
CSNK1G1	CK1gamma1	ENSG00000169118	Casein kinase 1 gamma 1	Q9HCP0	15	64165517-64356259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Wnt signaling pathway	"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA018209			Supported	Cytosol				Cytosol		HPA018209: AB_1847278	unprognostic (9.10e-2)	unprognostic (8.09e-2)	unprognostic (1.20e-1)	unprognostic (2.65e-2)	unprognostic (1.20e-1)	unprognostic (1.64e-1)	unprognostic (7.90e-3)	unprognostic (3.07e-1)	unprognostic (1.61e-2)	unprognostic (2.02e-1)	unprognostic (8.63e-2)	unprognostic (3.75e-2)	unprognostic (7.51e-2)	unprognostic (8.16e-3)	unprognostic (1.31e-1)	unprognostic (2.59e-2)	unprognostic (2.41e-1)	7.2	7.8	10.2	11.9	15.1	11.6	8.7	12.2	10.6	8.7	7.4	7.6	11.6	7	11.1	9.9	15.7	10.8	7.8	5.6	8.9	7.6	8.6	6	8.4	9.6	6.6	4.7	8.5	8.8	10.4	16.1	7.2	7.2	6.8	7.9	10.1	8.2	14.5	6.5	10.4	6.8	11.1	5.3	8.2	6.8	41.3	7.3	11.8	11.5	5.6	11.2	8.3	10.6	4.1	4.1	8.8	5.1	5.3	8	2.4	5.1	10.7	7.8	10.1	6.7	9.1	7.1	6.3	6.5	10.7	9.7	8.5	10	8	3.4	9.9	11.7	20.3	12.7	12.6	15.2	5.2	7.4	8.6	5.7	7.7	13.8	8.9	8.1	16.9	10.9	15.7	11.7	9	8.4	9.6	7	7	4.3	7.2	5.6	11.8	9.7	6.4	8.6	20.4	12.5	7.6	8.3	5	7.3	8.7	5.4	12.6	9.8	11.7	7.7	7.7	9.7	18.6	6.8	9.1	10.2	6	0.9	3.6	5.6	5.7	5.1	8	3.6	5.1	4.1	2.7	4.1	5.1	4.7	8.8	5.3	4.3	4.1	3.9	2.4	10.2	15.1	12.2	10.6	8.9	7.6	6.6	4.7	7.2	7.3
CSNK1G2	CK1g2	ENSG00000133275	Casein kinase 1 gamma 2	P78368	19	1941149-1981338	"Enzymes, Predicted intracellular proteins"	Wnt signaling pathway	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA034868, HPA056572"	Uncertain		Approved	Vesicles				Vesicles		"HPA034868: AB_10671235, HPA056572: "	unprognostic (2.00e-1)	unprognostic (2.15e-1)	unprognostic (1.83e-1)	unprognostic (2.42e-3)	unprognostic (6.51e-3)	unprognostic (2.27e-3)	unprognostic (1.14e-3)	unprognostic (2.00e-1)	unprognostic (9.42e-2)	unprognostic (5.78e-2)	unprognostic (4.83e-3)	unprognostic (4.09e-3)	unprognostic (7.95e-2)	unprognostic (4.65e-3)	unprognostic (5.09e-1)	unprognostic (2.01e-1)	unprognostic (1.63e-2)	18.7	22.2	24.8	34.9	19.5	38.1	16.7	30.8	28.9	14.1	19	18.2	18.9	27	16.5	19	22.1	16.9	20.4	16	23.3	18.3	19.3	17.9	21.8	35.1	17.3	21.2	18.6	27	11.4	24.4	16.7	18.7	18.7	8.7	19.7	26.6	16	29	23.3	22.1	15.1	12.7	39.1	24.1	58.5	17.4	20.6	16.5	18.1	32.2	17.1	17.1	4	5.9	11.2	14.1	3.5	4.9	2.3	23.2	12.5	17.5	27.4	6.1	11.6	14.6	14.4	9.6	11	13.6	10.3	12.8	14.7	12.2	9.2	16.8	9.4	17.6	4.9	13.3	20.4	10.4	20.5	17.4	9.9	16.5	26.3	11.4	11.6	11.5	7.4	13.1	21.6	50.5	7.2	13.6	32.8	21.7	31.7	14.1	28.5	11.1	23.8	8.3	24.6	28.2	23.2	11	18.1	16	11.5	27.2	15.6	14	11	29.2	16.8	32.6	17.3	18	14.1	15.7	14.6	2.8	4	5	4.9	6.2	3.5	3.9	3.6	4.2	3.9	4	2.9	4.1	11.2	3.5	14.1	5.9	2.5	2.3	24.8	19.5	30.8	28.9	23.3	18.3	17.3	21.2	18.7	17.4
CSNK1G3		ENSG00000151292	Casein kinase 1 gamma 3	Q9Y6M4	5	123512099-123617045	"Enzymes, Predicted intracellular proteins"	Wnt signaling pathway	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027010	Approved									HPA027010: AB_10602803	unprognostic (1.28e-1)	unprognostic (1.88e-1)	prognostic favourable (9.90e-5)	unprognostic (1.60e-2)	unprognostic (1.23e-1)	unprognostic (3.07e-1)	unprognostic (3.12e-3)	unprognostic (1.68e-1)	unprognostic (1.06e-1)	unprognostic (1.18e-3)	unprognostic (9.92e-3)	unprognostic (4.92e-1)	unprognostic (1.05e-2)	unprognostic (3.44e-1)	unprognostic (2.52e-1)	unprognostic (1.97e-3)	unprognostic (4.38e-1)	20.7	15	15.5	21.7	22.7	11.1	37.7	23.7	31.7	18.8	24	8.6	11.2	23.5	19.4	18.4	18.8	14.6	17.7	14	22.2	18	16.2	27.7	29	21.8	13.3	17.7	18.7	15.8	18.6	18.1	16.2	16.6	13.2	27.4	9.1	15.3	14.1	15.6	13.4	24.9	18.6	16.1	16.5	18.2	16.4	11.4	17.2	16.2	16.5	17.4	21.9	18.2	13.6	5.3	11.3	5.9	12.7	9.5	5.1	12.9	12.5	18.8	17.8	19.2	21.5	9.3	14.1	16.9	15.7	23.5	11.2	20.8	0	18.4	16.9	9.5	15.1	27.9	27.1	19.6	10.3	9.2	14.5	11.8	17.1	4.8	9.5	18.2	18.2	17.6	33.5	17	5.1	10.6	13.2	9	6.4	5.9	10.6	8.6	7.3	19.9	12.4	11.7	14.3	16.4	11.9	15.7	10.4	22.9	13.6	13.5	15.6	23.1	17.5	14	15.5	11.9	13	11.7	13.8	13.9	14.9	11.3	5.8	2.5	7.1	5.6	9.5	13.6	5.9	6.2	5.3	12.9	6.1	6.4	4.6	12.7	5.9	4.7	7.3	5.1	15.5	22.7	23.7	31.7	22.2	18	13.3	17.7	16.6	11.4
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	Casein kinase 2 alpha 1	P68400	20	472498-543835	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all											"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: , HPA061698: "	unprognostic (1.19e-1)	unprognostic (1.44e-1)	unprognostic (5.44e-2)	unprognostic (8.28e-3)	unprognostic (3.62e-2)	unprognostic (2.04e-2)	prognostic unfavourable (4.11e-6)	unprognostic (4.08e-2)	unprognostic (3.89e-1)	unprognostic (6.88e-2)	unprognostic (1.94e-2)	unprognostic (1.16e-1)	unprognostic (8.58e-2)	unprognostic (1.50e-1)	unprognostic (4.47e-1)	unprognostic (9.53e-2)	unprognostic (7.37e-2)	21.5	26.7	23.2	20.6	31.3	16.7	24.1	26.3	32.8	22.2	26.1	28.2	19.5	21.9	24.3	15.7	31.9	23.3	17.7	29.2	21.8	21.9	24.5	23.1	18.6	21.9	21.3	22.6	24.9	27.5	27.7	24.6	23.1	29.4	20.7	24.2	19.6	23.8	22.4	58.8	27	22.5	23.3	21.3	21.8	26.5	51.6	23.2	30.3	22.4	22.4	25.7	26.2	22.8	19.8	25.4	23.3	27.3	18.7	19.4	15.7	43.6	39	35.9	22.1	13.8	24	23.3	25.6	25.9	29.7	33.1	39.2	28.6	39	16.4	21	33.9	39.5	38.3	42.4	13.6	14.3	52.7	10.4	37.9	23.6	45.8	11.7	22	40.6	27.3	76.2	32	51.7	25.6	27.1	14.4	55	16.3	51.5	26.8	32.7	31.5	31.7	25.6	27.6	37.7	30	21.9	42.2	38.9	28.1	18	30.1	31.6	27.1	20.4	37.9	26.6	62.8	38.4	15.8	27.5	31.8	23.3	19.7	22.2	16.1	27.3	19.4	19.8	15.7	15.5	25.4	18.9	16	15	12.1	18.7	25.2	21.1	16.4	15.7	23.2	31.3	26.3	32.8	21.8	21.9	21.3	22.6	29.4	23.2
CSNK2A2	"CK2alpha', CSNK2A1"	ENSG00000070770	Casein kinase 2 alpha 2	P19784	16	58157907-58197920	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all														unprognostic (9.49e-2)	unprognostic (1.87e-1)	unprognostic (5.45e-2)	unprognostic (1.23e-1)	unprognostic (2.08e-1)	prognostic unfavourable (1.40e-5)	prognostic unfavourable (1.80e-4)	unprognostic (6.84e-3)	unprognostic (2.93e-3)	unprognostic (2.40e-1)	unprognostic (3.03e-2)	unprognostic (1.63e-1)	unprognostic (5.89e-2)	unprognostic (2.06e-3)	unprognostic (7.07e-2)	unprognostic (3.23e-1)	unprognostic (3.14e-2)	22.8	14.5	15.2	15.2	14.2	14.8	33.5	11.1	17	20.4	22.2	12.6	15.1	11.7	19	21.4	20.2	15.8	18.7	19.7	12.8	11.5	16.2	21.1	20	28.7	10.8	13.9	23.9	28.1	34.3	14.4	29.1	11.6	22	15	12.9	15.6	15.2	25.4	50.5	18	18.8	11.2	26.6	21.1	69.1	10.2	44.3	25.9	12	18.5	28.9	33.8	8.9	8	8.7	14.1	12.8	14.5	11.7	18.5	20.8	16.1	19.2	22.8	32.3	28.5	14.4	22.1	28.6	18.1	39	15.8	33.8	20.2	20.1	21.8	29	25.9	36.4	11.1	15.8	18.6	14	34.8	35.1	29.9	19.1	31.6	38.8	21.6	38.6	29.9	37.3	9.9	17.3	12.9	29.5	24.8	25.9	24.2	40.2	32.9	17.8	21.2	20.6	13.7	15.5	34.4	16.1	27.4	10.1	25.1	24.5	19.6	23.3	15.4	19.1	22.6	18.6	48	17.4	20.7	18.2	8.7	14.1	7.4	11.9	12.4	13.5	8.9	14.2	11.6	8	7.8	14.3	14.5	0.7	12.8	10.8	7.6	10.7	11.7	15.2	14.2	11.1	17	12.8	11.5	10.8	13.9	11.6	10.2
CSNK2A3	CSNK2A1P	ENSG00000254598	Casein kinase 2 alpha 3	Q8NEV1	11	11351942-11353357	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 5.5	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many											"HPA059206, HPA061698"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA059206: , HPA061698: "	unprognostic (3.10e-2)	unprognostic (3.39e-1)	unprognostic (4.65e-2)	unprognostic (1.55e-3)	unprognostic (1.82e-2)	unprognostic (1.60e-1)	unprognostic (6.25e-4)	unprognostic (4.36e-2)	unprognostic (5.42e-2)	unprognostic (1.88e-1)	unprognostic (5.46e-3)	unprognostic (1.07e-1)	unprognostic (1.50e-1)	unprognostic (1.31e-1)	unprognostic (1.32e-1)	unprognostic (1.42e-1)	unprognostic (3.38e-2)	4.6	1.6	1.3	2.8	1.3	0.6	1.9	1.6	5.5	2.8	3.8	0.5	2.1	3.4	1.8	3.8	3.4	1.1	1.6	2.3	1.5	1.2	5.4	3	3.7	1	1.1	0.7	2	1.4	0.6	1.7	2.9	2	2.2	0.7	2.1	1.7	3.6	5.3	1.9	2.9	2.9	1.2	0.9	1.3	3.5	0.3	3.6	1.6	1.8	2.7	1.8	1.3	0.7	0.9	1.1	0.6	0.8	1	1.2	5.5	1.1	0.2	2.1	0	0	0.7	0.5	0.3	0.3	0.3	0	0.3	0	0.4	0	1.8	0.9	0.8	0	0.2	0.3	0	0.2	0.5	0	0.2	0.3	0.6	0.4	0	0.6	0	0.4	0.8	0.7	0.6	1.3	0.7	1.7	3	0.9	0.2	1	0.6	1	0.4	1.2	1.6	3.1	0.6	1.2	0.4	0.7	0.9	1.1	0.4	0.6	0.4	0.9	0.8	2.6	0.2	2.5	0.7	0.5	1.1	0.6	0.6	0.9	0.7	0.4	0.7	0.9	0.7	1	0.3	0.1	0.8	0.6	0.7	0.7	1.2	1.3	1.3	1.6	5.5	1.5	1.2	1.1	0.7	2	0.3
DAPK1	"DAPK, ROCO3"	ENSG00000196730	Death associated protein kinase 1	P53355	9	87497228-87708633	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		placenta: 94.7	Cell line enhanced	Detected in many		HMC-1: 38.7;HUVEC TERT2: 21.9;RPTEC TERT1: 20.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	4	classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3	Group enriched	Detected in many	55	dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9	Low region specificity	Detected in many			Low region specificity	Detected in all			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome				Centrosome		"CAB037302: AB_1078622, HPA040472: , HPA048436: "	unprognostic (2.55e-1)	unprognostic (1.47e-1)	prognostic unfavourable (2.48e-5)	unprognostic (2.77e-1)	unprognostic (1.74e-1)	unprognostic (3.47e-2)	unprognostic (1.74e-1)	unprognostic (1.75e-1)	unprognostic (1.88e-2)	unprognostic (5.77e-3)	unprognostic (2.19e-2)	unprognostic (2.77e-3)	unprognostic (8.31e-3)	unprognostic (8.76e-2)	unprognostic (2.40e-1)	unprognostic (1.68e-1)	unprognostic (1.09e-3)	14.6	4.9	10.4	8.8	25.5	3.8	4.1	2.9	17.6	8.1	16.6	6.5	8.1	7.8	8.7	16.1	4.5	12.2	21.6	4.1	12.4	8.1	14.7	21.3	28.6	8.5	4.6	10.4	32.7	21.2	4.8	16.6	94.7	6.6	5.1	7.5	5.9	9.3	7.3	1.5	3.7	11	8.1	4.8	16.4	15	6.3	7.3	34.5	7.2	1.5	5.2	13.2	10.5	0.1	5.3	6.9	11.9	0.1	0.1	2.1	0	18.2	8.8	6.1	0.2	0.1	14	1.2	1.7	7.2	8.1	2.6	0.1	0.1	1.8	0.3	17	5.4	0.4	3.1	0.1	4.4	8.8	2.5	8.9	7.8	0	38.7	0.5	2.9	1.3	0.5	21.9	6.6	3.7	6	0.5	2.6	0	9.9	0	0.7	7.8	0	20	18.2	4	4.5	0	1.8	7.7	0	5.8	0.1	0	0.1	0	0	14.6	3	0	0.1	2.4	1.2	1.3	5.3	6.9	0	11.9	0	0.1	0	0	4	0	0	0.1	1.6	0.1	11.7	5.3	0	2.1	10.4	25.5	2.9	17.6	12.4	8.1	4.6	10.4	6.6	7.3
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	Death associated protein kinase 2	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 51.8;skeletal muscle: 46.1	Cell line enhanced	Detected in many		ASC diff: 10.0;HaCaT: 8.3;HMC-1: 17.0;MCF7: 8.6	Cancer enriched	Detected in many	15	thyroid cancer: 30.3	Low region specificity	Detected in all			Group enriched	Detected in some	13	basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4	Lineage enriched	Detected in many	23	granulocytes: 51.8	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA071581			Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		HPA071581: 	unprognostic (3.20e-2)	unprognostic (4.07e-2)	unprognostic (4.23e-2)	unprognostic (1.95e-3)	unprognostic (2.88e-2)	unprognostic (1.30e-2)	unprognostic (2.32e-1)	prognostic favourable (5.63e-4)	unprognostic (1.04e-1)	unprognostic (3.18e-1)	unprognostic (9.21e-2)	unprognostic (8.51e-2)	unprognostic (4.77e-7)	unprognostic (5.98e-2)	unprognostic (1.45e-1)	unprognostic (3.20e-3)	unprognostic (9.07e-2)	8.2	1.6	2.6	6.8	5	10.3	5.2	1.4	3.9	3.6	16.6	12	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2	2.2	1.4	14	2.5	6.8	3	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0	0.7	0.6	0.3	2.8	2	5.6	1.4	10	0.4	0.1	1.9	6	1	1.1	0.8	1.4	0.2	0.6	6	8.3	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17	1	7.2	0.3	0.2	0.6	0.4	0.1	0.7	8.6	0	0.3	0.6	2	2.6	0	0.3	0	2.8	0.4	0.3	0.4	1.1	0	4.8	0.4	0.4	0.8	1	1.3	1.6	0.6	0.2	0	0	2.7	0.2	19.1	0	51.8	0.6	0	0.2	0.3	0.1	0.5	0	0.1	0	0.4	16.4	0.7	0	2.2	0	0.3	2.6	5	1.4	3.9	3.6	2	6.8	3	4.7	6.5
DAPK3	"ZIP, ZIPK"	ENSG00000167657	Death associated protein kinase 3	O43293	19	3958453-3971123	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Translation regulation"	"Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	Tumor suppressor	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA028569, HPA064809"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA028569: AB_10794319, HPA064809: "	unprognostic (5.72e-2)	unprognostic (3.28e-2)	unprognostic (3.34e-3)	prognostic favourable (2.01e-5)	unprognostic (1.83e-1)	unprognostic (2.37e-1)	unprognostic (7.72e-3)	unprognostic (2.16e-1)	unprognostic (2.46e-2)	unprognostic (4.95e-2)	unprognostic (1.84e-3)	unprognostic (7.64e-2)	prognostic unfavourable (6.49e-4)	unprognostic (9.92e-2)	unprognostic (1.41e-1)	unprognostic (5.48e-2)	unprognostic (2.14e-1)	18.8	10.2	12.6	16.6	16.4	10	17.2	14.5	29.5	22.5	30.1	13.6	11.5	18.5	33.1	11.5	20.2	18.5	21.9	49.2	12.4	11	10.9	11	24.5	11.6	11.9	16.8	18.8	21.7	11.1	14.6	26	19.7	21.3	6.9	18.2	15.3	25.8	45.2	17.8	17	38.8	10.6	14.7	23.3	15.7	12.7	11.8	11.4	11.6	12.9	26.7	17.8	15	14.7	23.9	15.6	17.3	19.5	11	25.5	20.3	12.7	16	9.5	10.8	19.6	35.3	28.5	28.9	19.1	37.4	7.7	14.2	17.3	30.9	20.4	12.4	20	10.5	20.7	20.6	5.7	24.9	21.4	30.3	13.7	21.5	24.5	25	26.1	15.1	23.9	18	24.7	17.5	16.6	13.5	10.3	19.7	16.3	17	18.8	13.2	17.4	20.1	20.1	14	23.7	28.7	20.2	20.6	10.8	44.6	37.1	16.8	33.2	44	27.6	22.6	16.4	29.6	14.4	19.8	22.1	14.2	23.9	19.5	15.6	14	13.5	14.8	17.9	12.6	15	11.3	10.8	23.9	17.3	10.6	14.7	17.6	11	12.6	16.4	14.5	29.5	12.4	11	11.9	16.8	19.7	12.7
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	Doublecortin like kinase 1	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 76.5	Cell line enhanced	Detected in some		ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4	Cancer enhanced	Detected in many		glioma: 12.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	"Nucleoplasm,Cytosol"		11000	11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: , HPA015655: "	unprognostic (2.29e-1)	unprognostic (2.56e-1)	unprognostic (7.45e-2)	unprognostic (1.30e-2)	unprognostic (1.99e-1)	unprognostic (2.35e-2)	unprognostic (1.48e-1)	unprognostic (3.30e-2)	unprognostic (1.66e-1)	unprognostic (1.74e-1)	unprognostic (7.72e-2)	unprognostic (2.85e-1)	prognostic unfavourable (4.42e-4)	unprognostic (1.93e-3)	unprognostic (1.29e-1)	unprognostic (1.34e-1)	unprognostic (1.14e-4)	13.9	3.3	14.3	4.2	25	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17	10.4	4.6	2.5	2.2	8.5	0	2.1	1.4	2.9	5	3.5	0	0	0	0	0	0	0	0	0.2	3.9	0	17.3	16.4	0	0.1	0.2	0.1	0.1	0	0	0	0	13.3	0	10.3	0.2	0	0	0.6	0	0.4	0	0.6	0	0	15.1	7.5	0.3	0.2	0.1	0	0	0.2	0	0	0	21.4	0.2	0	1.2	0	0.6	0	4.3	2.6	0	0	1.3	0	0	0	0	3.5	4.4	0.7	0.1	0	0	1.4	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.3	25	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	Doublecortin like kinase 2	Q8N568	4	150078274-150257457	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 60.5	Cell line enhanced	Detected in many		AF22: 18.2;BJ hTERT+: 19.0;fHDF/TERT166: 8.3	Cancer enriched	Detected in many	17	glioma: 53.3	Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive B-cell: 2.5;plasmacytoid DC: 1.5	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015770	Enhanced									HPA015770: AB_1847509	unprognostic (7.37e-2)	unprognostic (1.56e-3)	unprognostic (9.30e-2)	unprognostic (1.49e-2)	unprognostic (4.06e-1)	unprognostic (6.24e-3)	unprognostic (1.90e-1)	unprognostic (7.38e-3)	unprognostic (2.18e-1)	prognostic favourable (3.25e-4)	prognostic favourable (2.48e-4)	unprognostic (6.87e-2)	unprognostic (3.93e-3)	unprognostic (3.74e-3)	unprognostic (4.53e-2)	unprognostic (1.48e-1)	unprognostic (1.45e-2)	2.9	3.9	23.3	2.1	23.5	1.6	2	9.3	60.5	3.1	2.8	16.5	0.8	2.8	4.3	3.5	3	2.8	4	14.4	23.5	17.5	2.9	1.8	2.7	1.6	14.9	14.5	4.3	3.5	1.4	4.7	2.9	20.2	3.9	3.5	2.1	2	3.6	2.3	2.1	2.7	6.4	23.4	2.1	2.2	4.2	15.9	0	4.1	0	1.5	3.3	2	2.5	1.5	0	0.5	0	0	0	0.8	3.2	18.2	2.8	0	0.9	0.3	8.2	19	2.7	0.6	0.1	0	0	0.3	8.3	0	2.6	0	3.4	3.7	1.6	0	4.7	0	3.9	0.5	0.5	0.5	0	1.6	0.2	0.9	0	0	1.9	0.1	0.3	0	0.3	1	0	2.1	0.7	0	0.8	7	6.6	3.4	2.5	0.8	0	0	1.6	2.5	1	1.6	0.9	0.8	0	0	2.4	0.1	0.8	0	0	0	0	0	0	0.8	0	0	0.3	2.5	0	0	0	0	0.5	1.5	0	0	23.3	23.5	9.3	19.3	23.5	17.5	14.9	14.5	20.2	15.9
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	Doublecortin like kinase 3	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 10.0;testis: 8.0	Cell line enhanced	Detected in some		NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 2.6;U-2 OS: 1.8;U-2197: 2.5	Cancer enhanced	Detected in single		testis cancer: 1.2	Region enhanced	Detected in many		basal ganglia: 10.0	Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA040685	Approved									HPA040685: 	unprognostic (9.09e-3)	unprognostic (1.41e-3)	unprognostic (2.75e-1)	unprognostic (2.66e-2)	unprognostic (2.41e-1)	unprognostic (1.80e-1)	unprognostic (1.40e-2)	unprognostic (1.08e-2)	unprognostic (1.96e-2)	unprognostic (1.86e-2)	unprognostic (2.05e-1)	unprognostic (7.07e-2)	unprognostic (6.11e-5)	unprognostic (7.94e-3)	unprognostic (5.80e-2)	unprognostic (3.25e-3)	unprognostic (1.36e-2)	1.1	0.4	2.6	1.4	10	0.3	0.1	0.1	2.3	0.5	0.2	0.3	0	0.5	0.3	0.1	0.1	0.2	0.6	0.9	1.4	0.9	0	0.1	0.3	0.2	0.6	0	0	0.2	0.4	1.8	1.1	0.4	0.3	0.3	1.3	1.7	0.2	2.7	0.4	0.4	0.9	0.7	0.1	0	8	3.2	0	0.9	0	0.3	0.5	0	0	0	0	0.1	0	0.2	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.8	0	3.3	0	0	0	0	0	0.2	3.2	2.6	0.1	0.3	0	0	0.4	0.3	0	1.8	2.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	2.6	10	0.1	2.3	1.4	0.9	0.6	0	0.4	3.2
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	Discoidin domain receptor tyrosine kinase 1	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HaCaT: 31.2;HBEC3-KT: 24.0;RT4: 31.9;T-47d: 35.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	Intracellular and membrane	2100000	2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	unprognostic (2.11e-2)	unprognostic (9.31e-2)	unprognostic (1.01e-1)	unprognostic (1.09e-1)	unprognostic (2.07e-1)	unprognostic (7.75e-3)	unprognostic (6.43e-2)	unprognostic (1.92e-1)	unprognostic (1.73e-1)	unprognostic (1.42e-1)	unprognostic (1.50e-1)	unprognostic (4.41e-2)	prognostic favourable (3.31e-10)	unprognostic (1.42e-1)	unprognostic (2.53e-1)	unprognostic (5.49e-3)	unprognostic (4.09e-2)	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0	0.2	0	1.8	0.9	19.3	6.4	9.1	1.9	0.6	0.8	5.6	0.5	0.1	0.2	0	8.6	10.3	0.1	10.8	1.7	31.2	1.9	24	0.1	10.7	3.4	0	5.8	2.2	1.8	0	0.4	1.2	12.4	0.1	0.2	0.7	5.6	0.2	1.3	12.2	0.6	0	1.5	1.3	1.3	6.8	0.7	4.6	31.9	1.6	0.8	1.8	14.4	7	35.8	0.2	1.4	4.5	4.2	0.4	4.5	0.2	0	0.8	2.9	0	3.9	0	0.2	0	1.1	0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0	0	0	0.4	0	0.9	23.5	36.2	6.8	25	27.8	20.8	55.7	19.8	34.7	37
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	Discoidin domain receptor tyrosine kinase 2	Q16832	1	162631373-162787400	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		ASC diff: 60.6;ASC TERT1: 59.9;BJ hTERT+: 44.3;fHDF/TERT166: 31.7;HSkMC: 42.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 1.1;MAIT T-cell: 1.3	Lineage enriched	Detected in single	5	T-cells: 1.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA070112			Supported	"Plasma membrane,Actin filaments"		850000	850000	"Plasma membrane, Actin filaments"		HPA070112: 	unprognostic (4.12e-2)	unprognostic (2.73e-1)	unprognostic (6.97e-3)	unprognostic (4.52e-2)	unprognostic (1.17e-1)	unprognostic (8.16e-2)	unprognostic (1.81e-1)	unprognostic (1.19e-1)	unprognostic (6.62e-2)	unprognostic (2.24e-2)	unprognostic (1.00e-1)	unprognostic (1.15e-1)	prognostic unfavourable (1.73e-7)	unprognostic (1.56e-3)	unprognostic (8.26e-3)	unprognostic (7.57e-2)	unprognostic (4.10e-3)	42.1	43.5	4.7	10.9	6.9	0.2	15.6	7.9	7.1	30.3	30.4	9	18.6	3.3	24.2	17.7	25	13.4	16.6	15.4	7.9	4.7	4	3.3	8.9	5.1	12.9	3.4	26.4	2.2	2.1	4	6.6	12.7	21.8	9.1	30.7	6.4	19.3	5.2	6.1	10.1	34.3	19.7	3.4	14.1	8.3	7.5	0	8.6	12.8	4.1	29	18.3	0.1	0.2	0	0	0.2	1.3	0	0.1	0	0	16	60.6	59.9	0.2	23.6	44.3	10.3	14.9	0	0	0	0	31.7	0	0	0.1	14.1	12.7	0.1	0	0	0	26.3	0	0	42.5	0.1	18.2	0.4	11.8	0.1	5	9.4	0	0	0	0.1	0.1	0	6.7	0.1	0	0	0	9.7	0	0	0.8	0	0	0.6	16.5	3.6	8.3	3.2	0.7	1.3	0	14.9	0	16.7	0	0	0	1.1	0	1.3	0	0.8	0.1	0	0.1	0	0	0	0.2	0	0.2	0	0	4.7	6.9	7.9	7.1	7.9	4.7	12.9	3.4	12.7	7.5
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	DM1 protein kinase	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 79.6	Cell line enhanced	Detected in many		RH-30: 44.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 2.2	Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA007164, HPA008905"	Enhanced		Approved	"Vesicles,Cytosol"				Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	unprognostic (7.44e-2)	unprognostic (2.66e-1)	unprognostic (1.76e-3)	unprognostic (2.61e-3)	unprognostic (1.29e-1)	unprognostic (5.46e-2)	unprognostic (8.67e-2)	unprognostic (1.50e-1)	unprognostic (1.31e-1)	unprognostic (1.67e-1)	prognostic favourable (9.39e-5)	unprognostic (1.93e-1)	unprognostic (1.60e-2)	unprognostic (1.19e-1)	unprognostic (1.18e-1)	unprognostic (3.03e-2)	unprognostic (4.24e-3)	9	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15	31.2	13.7	20.3	56.7	5	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12	5.9	4	1.1	6.1	36.6	5	44.9	8.2	1.5	0	0	0.8	0.3	2.2	0	7.2	10.1	12	7.4	8.1	11.3	7.2	16.2	12	6.5	6.3	1.2	3.9	2.3	2.4	18.5	10.6	3.4	1.6	2.4	11.3	10.6	0.9	12.6	1.7	7.9	0.1	4.1	16.5	5.7	5.6	2.7	3	7.1	5.8	9.4	8	1.1	2.7	7.1	2.2	3.7	44.2	3.7	3.5	8.3	6.5	10.3	8.8	18.5	5.2	15.2	3.5	9.1	7.6	7.5	7.2	11.8	11.2	9.6	2.3	6.9	1	10.6	0	0	0	2.2	0.8	0.5	0.3	0.7	0.2	0	1.5	0.4	0.1	0	0.3	0	0	0	0	5.1	6.3	8.8	6.2	5	5.3	4.8	6.5	5.6	4
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5"	ENSG00000133059	Dual serine/threonine and tyrosine protein kinase	Q6XUX3	1	205142505-205211566	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044140	Uncertain		Uncertain	"Nuclear speckles,Intermediate filaments"				"Nuclear speckles, Intermediate filaments"		HPA044140: AB_10965031	unprognostic (1.42e-2)	unprognostic (1.07e-2)	unprognostic (7.92e-2)	unprognostic (1.02e-3)	unprognostic (1.39e-1)	unprognostic (2.66e-1)	unprognostic (1.43e-2)	unprognostic (9.01e-2)	unprognostic (1.81e-1)	unprognostic (1.06e-1)	unprognostic (2.25e-3)	unprognostic (1.20e-1)	unprognostic (3.26e-2)	unprognostic (7.80e-2)	unprognostic (1.93e-1)	unprognostic (1.55e-1)	prognostic unfavourable (8.73e-5)	6.4	9.2	13.8	4.4	13.3	19.6	8.2	20.4	16.4	8.4	6.5	6.8	4.2	3.3	10.5	7.4	6.7	9.2	5.4	5.7	10.7	9	9.3	2.5	7.3	5.4	8.1	11.8	14	5.9	22	11	7.1	12.2	7.2	4.6	9.2	6.2	8.8	14.6	14	4.8	8.8	11	7	5.3	11.5	9.2	7.1	8.4	3.6	5.3	7.6	6.4	3.5	3.1	9.8	3.5	4.8	5.1	1.6	6.8	4.5	4.8	5.8	7	11.9	3.4	8.6	8.6	9	6.2	2	3.8	5.1	2.6	14.5	4.9	5.2	5.5	9.2	2.4	5.7	9.2	5.9	2.1	6.3	2.6	4.9	7	8.4	9.2	8.8	6.6	11.9	3.4	7.1	4.7	2	2.3	5.2	5.4	1.8	8.7	4.4	6	4.3	2.7	5.2	7.3	7.6	24.1	5.6	3.4	6.5	5.6	5.7	8.5	5.7	3.5	2.5	3	6.6	3.6	20.1	9.8	3.5	6	4.6	2.5	4.3	2.7	3.4	3.8	3.1	3.5	5.1	3.7	5.1	4.8	1.8	2.3	2	1.6	13.8	13.3	20.4	16.4	10.7	9	8.1	11.8	12.2	9.2
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	Dual specificity tyrosine phosphorylation regulated kinase 1A	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Host-virus interaction	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				Cytosol	Nucleoli fibrillar center	"HPA015323: AB_1847922, HPA015810: AB_1847921"	unprognostic (2.71e-1)	unprognostic (3.35e-2)	unprognostic (1.27e-1)	unprognostic (5.62e-2)	unprognostic (4.17e-2)	unprognostic (1.41e-1)	unprognostic (1.67e-1)	unprognostic (9.28e-2)	unprognostic (1.02e-1)	unprognostic (1.51e-1)	unprognostic (9.95e-2)	unprognostic (7.39e-2)	unprognostic (9.09e-2)	unprognostic (1.07e-1)	unprognostic (2.92e-2)	unprognostic (3.14e-1)	unprognostic (1.40e-2)	20	18.5	19.2	23.4	20	49.7	19.9	31.6	24.6	23.7	23	16.3	17.6	15.4	24.4	18.7	16.8	19.4	19	23.2	18.8	17.9	16.9	16.1	24.8	27.3	15.5	17.8	25.7	17.8	31	25.1	25	14	17.6	18.1	18.5	18.7	22.7	39.8	20.1	18.7	22.7	13.8	24.1	18.5	23.5	16.3	60.9	22.7	17.4	22.1	22.7	29.3	3	3.3	6	2.5	1.3	3.8	0.8	10.2	8	16.3	11.5	7.8	8.5	14.5	9.1	11.7	9.3	9.8	11.4	9	13.8	6.2	16	7	11.9	8.9	10.9	21.1	5.1	40.8	13.3	6.9	11.7	16.1	15	8.6	10.6	12	18.5	9.6	15.4	32	9.6	10.3	21.1	11	17.3	4.8	27.4	9	12.7	9.7	13.4	16.9	9.4	20.8	14.3	14.3	13.4	15	12.3	12.7	3.8	7.9	7.6	21.8	16.9	19.8	10.1	18.2	13.8	5.5	1.5	2	3.4	2.1	2.1	2.8	3.6	2.6	1.8	3	3.8	3.7	6	1.3	2.5	3.3	3.1	0.8	19.2	20	31.6	24.6	18.8	17.9	15.5	17.8	14	16.3
DYRK1B	MIRK	ENSG00000105204	Dual specificity tyrosine phosphorylation regulated kinase 1B	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 89.1	Cell line enhanced	Detected in many		SCLC-21H: 12.1;SH-SY5Y: 13.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA028522, HPA028786"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA028522: , HPA028786: AB_10670831"	unprognostic (2.22e-2)	unprognostic (9.86e-2)	unprognostic (4.55e-2)	unprognostic (3.45e-3)	unprognostic (1.96e-1)	unprognostic (1.13e-2)	unprognostic (2.25e-1)	unprognostic (2.39e-1)	unprognostic (6.02e-2)	unprognostic (3.67e-2)	unprognostic (8.93e-2)	unprognostic (4.22e-2)	prognostic favourable (8.83e-4)	unprognostic (9.73e-2)	unprognostic (1.12e-1)	unprognostic (2.53e-2)	unprognostic (3.88e-2)	4.8	7.9	7.4	3.7	10.2	5	4	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8	4.6	9	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7	2.6	0.4	8.6	8.3	5.9	4.7	4.5	0.7	2.7	1.7	2.5	2.2	0.8	3.3	1.3	10.6	3.2	2.9	1.2	1.9	2.2	4.9	7.2	0.6	5.3	0.8	4	0.3	1.8	6	1.2	0.8	2.8	0.6	1.3	1.9	0.4	4.2	1.9	0.7	2	1.9	0.9	0.1	0.6	5.4	2.1	12.1	13.7	4.2	4.2	0.2	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7	4.7	4	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6
DYRK2		ENSG00000127334	Dual specificity tyrosine phosphorylation regulated kinase 2	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA027230, HPA056902"	Approved		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: "	unprognostic (5.86e-3)	unprognostic (4.18e-1)	unprognostic (4.08e-3)	unprognostic (2.56e-3)	unprognostic (1.18e-2)	unprognostic (1.69e-1)	unprognostic (3.37e-3)	unprognostic (7.83e-2)	unprognostic (2.83e-2)	unprognostic (1.22e-1)	unprognostic (1.04e-1)	unprognostic (3.47e-1)	unprognostic (2.12e-2)	unprognostic (2.03e-2)	unprognostic (1.38e-1)	unprognostic (1.57e-1)	unprognostic (1.35e-1)	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4	3.3	7.6	8.5	3.6	4.4	13	5	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26	11.2	5.3	10.3	14	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.5	7.7	11.5	8.3	5.8	7.9	9.2	13.8	9	6.8	3.9	10.1	7.5	25.4	17.1	20	15.9	9.2	5.4	7.3	10.9	12	4.1	5.1	3.8	2.2	9.2	8.9	6.5	7.8	18.2	14.6	3.8	5	13.3	8.6	7.8	7.9	4.5	10	12.4	21.1	11.4	11.2	7.9	17.1	15.2	18	5.8	7.8	8	5.3	7.8	5.6	10.8	10.2	7.4	10.9	6.3	1	14.1	10.4	6.3	11.1	3.2	0.5	5.9	5.2	1.3	4	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4	3.3	5	3.9
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	Dual specificity tyrosine phosphorylation regulated kinase 3	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 38.2	Cell line enhanced	Detected in many		hTERT-HME1: 35.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in single	15	plasmacytoid DC: 6.1	Lineage enriched	Detected in single	15	dendritic cells: 6.1	Low region specificity	Detected in all			Low region specificity	Detected in some			HPA075041			Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	HPA075041: 	unprognostic (6.51e-2)	unprognostic (1.24e-2)	unprognostic (3.36e-2)	unprognostic (2.03e-1)	unprognostic (2.81e-2)	unprognostic (1.23e-1)	unprognostic (1.20e-4)	unprognostic (2.69e-1)	unprognostic (3.91e-1)	unprognostic (2.71e-1)	unprognostic (2.79e-3)	unprognostic (2.52e-1)	prognostic unfavourable (9.41e-7)	unprognostic (2.38e-1)	unprognostic (2.04e-1)	unprognostic (1.99e-2)	unprognostic (7.62e-3)	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6	3.4	3.4	7.4	5	1.6	2.6	2	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3	2.1	2	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3	1.7	5.4	7.6	0	6.1	0	0.1	0	0.3	0	2.5	3.4	0.8	4.8	8.6	7.7	0.1	8.1	17.9	7.4	9.6	0.2	1.2	3.7	1.2	9.5	0.7	4.2	6.5	7.9	0	2.8	5.4	4.4	0.8	13.7	3.7	3.5	5.4	4.2	12.8	35.2	5.7	10.3	0.7	11.4	0.9	8.1	2.1	6.8	6.4	20.2	2.6	0	2.3	0.1	4.9	3.6	7.3	0.3	9.9	0.9	0.9	4.3	15.5	5.9	7.5	6.7	2.9	1	4.4	9.2	4.1	1.4	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	6.1	0	0	4.2	3.5	1.3	2.7	6	3.4	2.6	2	4.6	3.1
DYRK4		ENSG00000010219	Dual specificity tyrosine phosphorylation regulated kinase 4	Q9NR20	12	4562204-4615302	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in all	9	testis: 85.9	Cell line enhanced	Detected in many		HHSteC: 16.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in all			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles				Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	unprognostic (2.50e-1)	unprognostic (1.55e-1)	unprognostic (1.22e-1)	unprognostic (3.56e-3)	unprognostic (2.62e-1)	unprognostic (4.07e-3)	unprognostic (2.03e-2)	unprognostic (4.69e-2)	unprognostic (1.29e-1)	unprognostic (7.13e-2)	unprognostic (1.22e-2)	unprognostic (2.46e-1)	prognostic unfavourable (6.52e-6)	unprognostic (1.86e-1)	unprognostic (9.71e-2)	unprognostic (1.04e-1)	unprognostic (3.98e-2)	1.6	2.1	2.3	2.1	1.8	1.6	2.8	1.9	2.3	2.6	2.1	2.2	2.3	1.7	2.5	9.1	1.6	2	1.7	1.7	1.8	1.8	1.9	2	2.2	2.5	1.9	2.5	2.2	2.3	2.9	2.7	2.9	2.3	2.3	2.7	2.4	2.3	3.4	1.6	1.9	2.4	2.1	2.7	4.3	1.7	85.9	2.1	1.6	4.3	1.6	2	2.4	1.6	7.6	2.7	1.3	5.2	1.1	1.6	1.6	1.9	3	3.9	4.2	5.9	7.2	4.6	2.3	4.7	5.3	5.8	0.6	3.1	5.8	0.3	6.6	4	2.9	4.3	4.2	4.4	6.6	4	0.8	3.3	16.6	3.5	3.2	4.9	9.3	3.7	12.3	7.5	1.6	6.6	4.8	4	3.2	8.6	5.2	1.8	0.7	2.8	2.5	6.5	1.9	0	1.5	0.4	2.3	3.3	1.8	3.1	0.5	6.3	4.9	0.6	2.9	1.9	2.3	3.4	3.3	5.4	3.2	0.6	2.8	1.3	1	2.2	1.1	7.6	1.5	1.6	2.7	5.8	1.6	1.6	0.1	1.1	5.2	1.4	1.1	1.6	2.3	1.8	1.9	2.3	1.8	1.8	1.9	2.5	2.3	2.1
EEF2K	eEF-2K	ENSG00000103319	Eukaryotic elongation factor 2 kinase	O00418	16	22206282-22288732	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HaCaT: 3.9;HMC-1: 4.7;NB-4: 4.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB007818, HPA056061"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB007818: AB_598150, HPA056061: "	unprognostic (4.79e-2)	unprognostic (6.10e-1)	unprognostic (3.89e-2)	unprognostic (3.49e-1)	unprognostic (1.94e-2)	unprognostic (5.09e-3)	unprognostic (1.40e-1)	unprognostic (2.24e-2)	unprognostic (1.74e-1)	unprognostic (8.50e-2)	unprognostic (2.01e-2)	unprognostic (9.07e-3)	prognostic unfavourable (2.38e-4)	unprognostic (2.86e-1)	unprognostic (1.11e-1)	unprognostic (1.24e-1)	unprognostic (1.80e-1)	16.8	5.5	5.3	8.6	3.7	7.6	12.4	17.5	4.8	14.3	10.7	1.3	9.4	5.6	13.2	8.3	6.1	8.2	12.5	9	3.2	3.3	3.7	5.5	9.2	6.7	2.4	4.9	6.4	8.1	3.3	3	6.4	4.9	12.5	4.6	4.4	12.4	20.5	16.2	37.5	5.1	15.5	1.6	6.1	6.4	4.6	3.1	4	4.4	11.5	6.7	13.3	14.2	0.7	2.3	2.2	0.9	1.3	1.6	0.1	0.1	0	0	0	1	1.3	1	0	0	0.2	0	0.7	0	0.9	0.4	0	3.9	0.6	0	0	0.3	0	1.6	0.7	2.7	0	3.7	4.7	0	1	0.2	0.3	0.2	0.5	3.3	0	0	0.2	4	0.4	0	1	2.6	0.7	1.1	0	1	1.5	0	0	0.4	0.5	1.2	1.3	2.4	0.9	3.6	0.1	0.7	0.3	1.1	2.7	2.7	0.4	1.5	0.8	0.6	0.5	0.9	0.7	0.4	0.3	0.2	0.2	0.7	0.7	0.3	2.2	1.3	0.5	2.3	1.6	0.1	5.3	3.7	17.5	4.8	3.2	3.3	2.4	4.9	4.9	3.1
EGFR	"ERBB, ERBB1"	ENSG00000146648	Epidermal growth factor receptor	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Host-virus interaction	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 102.3	Cell line enriched	Detected in many	12	A-431: 337.7	Cancer enhanced	Detected in all		glioma: 136.0	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in many			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	Secreted to blood	93000000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	unprognostic (2.62e-2)	unprognostic (9.56e-3)	unprognostic (1.59e-1)	unprognostic (7.51e-2)	unprognostic (1.08e-1)	unprognostic (1.27e-2)	unprognostic (6.11e-2)	unprognostic (4.88e-2)	unprognostic (2.85e-2)	unprognostic (3.30e-3)	unprognostic (1.78e-3)	unprognostic (1.04e-1)	unprognostic (1.93e-3)	unprognostic (6.98e-3)	unprognostic (1.72e-1)	unprognostic (6.62e-2)	prognostic unfavourable (2.04e-5)	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8	10.2	28.5	0	0	0	0	0	0	0	337.7	4.3	1.1	1.5	6.9	4.3	1.1	3.3	4.5	2	1.6	0.8	3.7	0.2	0.8	2.8	13.5	0	14.9	2.5	0.1	0.2	0	1.8	0.2	1.8	0	0	2.1	13.7	5.2	27.9	0.2	0	0	4.4	0.2	0	0	0.3	2.2	0	0.6	0	2.5	3.6	0	1.3	2.8	3.4	0.6	0.3	0.7	1	1.9	0.5	14.6	3.1	0	0.3	0.1	2.5	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9
EIF2AK1	"HRI, KIAA1369"	ENSG00000086232	Eukaryotic translation initiation factor 2 alpha kinase 1	Q9BQI3	7	6022244-6059230	"Enzymes, Predicted intracellular proteins"		"Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA016496, CAB022082, HPA061675"	Approved		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"CAB022082: , HPA016496: AB_1848057, HPA061675: "	unprognostic (7.15e-3)	unprognostic (2.00e-2)	unprognostic (1.45e-1)	unprognostic (2.91e-1)	unprognostic (6.70e-2)	unprognostic (9.69e-3)	prognostic unfavourable (6.99e-4)	unprognostic (2.36e-1)	unprognostic (2.54e-1)	unprognostic (1.07e-2)	unprognostic (1.48e-1)	unprognostic (8.96e-2)	unprognostic (2.53e-1)	unprognostic (1.99e-1)	unprognostic (5.45e-2)	unprognostic (9.02e-2)	unprognostic (1.06e-2)	21	38.2	31.7	25.4	32.7	62.8	26.9	23.9	41.1	22.8	34.5	31	20.8	26.5	22.6	28.6	28.4	23.4	21.5	40	29.9	30	32	46.3	22.1	23.3	33.3	30.3	23	32.4	61.9	25.4	43.9	33.4	26.4	34.9	23.4	46.4	26.3	31.6	28.9	29.9	17.8	35.6	25.4	34.7	16.3	22.6	37.1	29	17.4	29.6	22.4	20.1	11.7	7.5	17.4	7.4	10.4	10.6	4.8	41.1	25.9	20.8	31.6	20	18	27.4	21.2	19.4	19	24.1	23.7	27.8	32.2	23.3	23.3	29.1	27	19.3	24.5	19.9	41.5	33.2	28.2	35.7	16.4	28.2	30.3	14.5	24.4	17.9	19.3	20.1	53.1	31.2	17.8	41.1	15.4	36	26.1	29.3	34	21.9	37.8	24.1	20.1	25.9	46.6	40.8	54.5	18.1	41	34.6	19.2	10.9	40.7	19.2	22.4	31.7	31.6	32.8	22	37.2	31.6	10.6	7.4	17.4	9.5	5.9	6.4	11.7	7.4	10.6	7.5	7.7	8.6	7.7	4.1	10.4	6.5	6.6	8.8	4.8	31.7	32.7	23.9	41.1	29.9	30	33.3	30.3	33.4	22.6
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	Eukaryotic translation initiation factor 2 alpha kinase 2	P19525	2	37099210-37157065	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol				Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: "	unprognostic (1.70e-2)	unprognostic (2.26e-1)	unprognostic (1.62e-1)	prognostic unfavourable (3.77e-4)	unprognostic (1.66e-1)	unprognostic (1.04e-1)	unprognostic (1.77e-3)	unprognostic (8.42e-2)	unprognostic (8.02e-2)	unprognostic (4.67e-2)	prognostic unfavourable (2.08e-4)	unprognostic (1.19e-1)	unprognostic (3.15e-3)	unprognostic (3.33e-1)	unprognostic (1.74e-1)	unprognostic (4.65e-2)	unprognostic (5.32e-2)	25.5	14.2	15.9	16.3	15.5	36.4	13.9	16.4	19	14.7	13.7	9.9	9.3	14.5	17.2	21.5	12.1	12.8	15.4	10.7	13.7	19.2	12.2	11.5	13.7	10.7	14.3	15	18.7	11.7	19.2	21.1	18.2	17.3	15	12.8	10.2	23	17.8	7.1	6.7	15.2	16.2	14	15.5	14.3	5.1	12.8	14.1	13.6	8.1	10.6	14.8	15.5	8.8	6.9	27.6	10.8	8.6	9.9	3.3	24.9	12.8	7.9	10	8.7	11.9	15.6	13.2	19	41.8	40.3	14.6	14.9	13.3	17.2	14.4	14.8	13.6	13.4	18.8	29.3	7.2	14.6	9.8	9.5	8.6	14	0.1	9.7	5.3	16.7	12.2	10.3	10.1	13.4	9.4	11.1	17.9	7.2	8.2	9.2	18.1	19.4	6.6	7.8	9.6	8.9	9.4	16.1	11.7	25.4	6	4	13.4	17	18	7.2	21.2	9.9	16.3	0.2	8.1	9.5	14.8	17.1	8.2	11.1	8.9	10.6	9	8.8	7.5	8.1	6.9	7	6.1	7.5	27.6	8.6	10.8	4.7	9.9	3.3	15.9	15.5	16.4	19	13.7	19.2	14.3	15	17.3	12.8
EIF2AK3	"PEK, PERK"	ENSG00000172071	Eukaryotic translation initiation factor 2 alpha kinase 3	Q9NZJ5	2	88556741-88627576	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		Daudi: 37.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB009204, HPA015737"	Approved									"CAB009204: AB_2230863, HPA015737: AB_1848062"	unprognostic (7.25e-3)	unprognostic (5.35e-2)	unprognostic (3.03e-3)	unprognostic (9.32e-2)	unprognostic (9.39e-3)	unprognostic (3.25e-2)	unprognostic (2.27e-2)	unprognostic (3.46e-3)	unprognostic (9.84e-2)	unprognostic (3.50e-1)	unprognostic (1.89e-1)	unprognostic (2.31e-1)	unprognostic (2.06e-1)	unprognostic (2.92e-1)	unprognostic (9.80e-2)	unprognostic (3.60e-3)	unprognostic (2.90e-3)	12.7	10.3	7.2	12.3	7.6	18.6	10.7	8.8	6.6	15.8	10.7	6.1	20.9	7.3	9.6	12.4	9.5	8.9	8.5	11.1	5.7	5.5	11.5	15.9	10.4	9.3	7.9	5	8.8	36.7	18.5	18.4	14.4	8.3	11.4	12.6	7.3	28	20.9	12.7	8.9	10.8	7	7.5	11.1	19	4.6	7.3	8.7	15.7	6.3	17.3	21.5	19.2	6.6	2.6	1.5	0.7	1.6	2.4	0.6	4.8	3.2	7.1	4.6	13	9.1	11.3	7	9	5	7.4	7.2	3.5	37.3	4.2	4.7	4.4	5.1	3.9	7.3	13.1	3.3	4	3.3	7.4	8.1	4.9	9.5	3.4	6.3	4.6	10	5.3	2.3	13.4	3.8	5.4	4.6	4	5.2	3.7	18.1	9.8	6.7	6.2	9.2	5.5	7.5	4.1	10.7	7	3.9	2.9	4.2	4.3	4.6	9.7	4.3	25.2	12.6	26.4	6.1	4.5	5.7	1.1	0.7	1.5	1.7	0.6	1.9	4.7	1.7	2.4	0.9	6.6	1.5	1.1	0.2	1.6	0.2	2.6	1.4	0.6	7.2	7.6	8.8	6.6	5.7	5.5	7.9	5	8.3	7.3
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	Eukaryotic translation initiation factor 2 alpha kinase 4	Q9P2K8	15	39934146-40035591	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		plasmacytoid DC: 32.9	Group enriched	Detected in all	4	dendritic cells: 32.9;monocytes: 9.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA011811	Approved		Approved	Cytosol				Cytosol		HPA011811: 	unprognostic (3.10e-1)	unprognostic (4.78e-3)	unprognostic (5.97e-2)	unprognostic (7.18e-2)	unprognostic (1.05e-2)	unprognostic (3.32e-2)	unprognostic (1.18e-1)	unprognostic (3.18e-1)	unprognostic (1.36e-1)	unprognostic (1.21e-1)	unprognostic (1.38e-2)	unprognostic (7.27e-2)	unprognostic (2.38e-1)	unprognostic (1.27e-2)	unprognostic (6.47e-2)	unprognostic (2.31e-2)	unprognostic (5.11e-3)	20.7	16.5	20.2	19.4	27.3	20.2	36	22.4	27.3	16.8	16.3	13.6	17.1	12.2	35.7	17.9	17.8	18.1	19.4	18.2	19.5	20.5	15.4	22.7	22.5	16.6	18.6	14.2	20.1	21.5	20.3	34.7	20.5	17.6	22	14.6	17.9	16.7	20.3	20.4	20.7	12.2	24.3	14.6	16.1	16.4	11.5	15.1	17.7	24.1	10.6	15.9	27	14.4	5	32.9	4.2	9.3	3.8	4.5	2.4	13.8	6.6	11.9	17.9	19.6	33	11.3	19.5	22.4	16	15.8	9.5	6	7.3	10.2	26.5	14.8	15.9	23.6	22.4	34.8	7.9	15.7	12.3	11.4	16.8	9.4	10.9	26	16.2	15.2	27.5	22.3	11.6	7	31.5	4.6	7.8	13	7.3	14.9	9.5	16.5	12.1	19.9	9.4	6.2	9.6	13.9	8.5	12.1	11.9	16.3	23.6	21.4	16.2	10.7	12.6	9.7	17.4	2.3	15	13	29.8	4.2	5.8	4	3.6	6.7	3.1	3.5	4	4.1	8.4	5	4.5	4.2	1.7	3.8	9.3	32.9	2.7	2.4	20.2	27.3	22.4	27.3	19.5	20.5	18.6	14.2	17.6	15.1
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	EPH receptor A1	P21709	7	143390289-143408892	"Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		parathyroid gland: 104.4	Cell line enhanced	Detected in some		CACO-2: 10.3;HaCaT: 9.6;HBEC3-KT: 7.8;MCF7: 8.5;NTERA-2: 32.1	Low cancer specificity	Detected in many			Region enhanced	Detected in single		pons and medulla: 1.1	Group enriched	Detected in some	6	memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1	Lineage enriched	Detected in single	9	T-cells: 6.9	Not detected	Not detected							CAB026144	Uncertain					24000000	24000000			CAB026144: 	unprognostic (1.54e-2)	unprognostic (3.04e-2)	unprognostic (2.07e-1)	unprognostic (4.58e-3)	unprognostic (5.82e-3)	unprognostic (2.45e-2)	unprognostic (9.56e-2)	unprognostic (1.81e-2)	unprognostic (5.09e-1)	unprognostic (7.59e-3)	unprognostic (6.54e-2)	unprognostic (3.24e-3)	prognostic favourable (1.14e-6)	unprognostic (3.73e-2)	unprognostic (3.28e-2)	unprognostic (1.91e-1)	unprognostic (1.21e-1)	0.4	0.4	0	2	0.1	0.5	1.2	0.9	0.3	5.7	7.9	0	3.3	3.3	0.9	1.4	29.3	1.6	7.9	0.4	0	0	2.8	10.6	2.9	5.8	0	0	1.2	2.9	104.4	1.3	5.5	1.1	2.1	0.9	1.3	5.8	3.9	0.3	9.5	12.3	0.4	0.2	0.5	1.8	0.8	0	5.1	6	16.4	17.2	1.6	11.8	0	0.7	0.2	0.1	0.2	6.9	1.6	4.9	0	0	0	0	0	4.7	0	0	0	0	10.3	4.1	0	0	0	9.6	0	7.8	0	0	0	1	0	0.9	0	0.4	0	0	2.6	0	0	0	0	0	0	8.5	0	1	32.1	0	0	0	0	0.6	3.9	0.1	0	0	4.8	0	2.2	0.2	0	0	0	0	0	0	0	0	0	2.2	0	0	0.1	0.1	0.1	0	0.1	0	3.4	0.9	0.4	0	6.9	5.1	0.2	0.2	0	0.7	0.2	1.6	0	0.1	0.9	0.1	0	0	0	0	1.1	0
EPHA10	"FLJ16103, FLJ33655"	ENSG00000183317	EPH receptor A10	Q5JZY3	1	37713880-37765133	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 15.6;intestine: 12.6;testis: 24.8	Cell line enhanced	Detected in some		BEWO: 5.1;HDLM-2: 19.2;SCLC-21H: 8.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single											HPA027497	Uncertain				Intracellular and membrane					HPA027497: AB_10601158	unprognostic (9.27e-2)	unprognostic (1.21e-1)	unprognostic (2.94e-2)	unprognostic (1.24e-6)	unprognostic (1.06e-1)	unprognostic (1.11e-2)	unprognostic (5.39e-2)	unprognostic (1.25e-1)	unprognostic (2.55e-2)	unprognostic (1.40e-1)	unprognostic (7.06e-3)	unprognostic (1.50e-1)	unprognostic (8.81e-5)	unprognostic (2.55e-2)	unprognostic (2.97e-2)	unprognostic (2.67e-1)	unprognostic (3.04e-2)	0.4	1.1	5.8	1.7	15.6	0.7	1.9	1.3	10.5	0.6	12.6	3.6	0.2	5.8	0.5	6.8	0.8	1.8	2.1	0.4	4.6	7.4	0.5	0.4	0.5	0.6	3.5	5	0.4	5.1	1.1	10.8	0.4	6.4	1.4	10.3	1.6	2.4	0.7	0.4	0.6	7.3	1	2.3	0.5	5.3	24.8	2.1	0	1	0	0.5	0.6	0.3	0.4	0.3	1.5	0.3	0.8	0.7	0.1	1.5	1	0	0	0	0	5.1	0	0	0	0	1.6	2.8	0	0.4	0	0.1	0.1	0	0	19.2	0.8	0	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0.7	0	1	0	0.2	0.7	0.6	0	0	0.4	0.3	1.7	8.9	0.4	1.1	0	0	2.8	0.1	0	0	1	0.1	0	1.7	1.2	0	0	0	0	1.4	0.2	0.1	0.7	0.1	0.4	0.4	0.3	0.3	0.1	0.4	0.6	0.7	1.5	0.8	0.3	0.3	0.2	0.1	5.8	15.6	1.3	10.5	4.6	7.4	3.5	5	6.4	2.1
EPHA2	ECK	ENSG00000142627	EPH receptor A2	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 51.2	Cell line enhanced	Detected in many		CAPAN-2: 41.9;EFO-21: 40.4;PC-3: 48.0;U-251 MG: 49.2;WM-115: 53.9	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enriched	Detected in single	115	plasmacytoid DC: 11.4	Lineage enriched	Detected in single	115	dendritic cells: 11.4					Low region specificity	Detected in all			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	CAB010464: AB_631436	unprognostic (9.41e-2)	unprognostic (1.67e-1)	unprognostic (4.13e-2)	unprognostic (1.67e-2)	unprognostic (6.22e-2)	unprognostic (9.12e-2)	unprognostic (5.24e-2)	unprognostic (1.29e-3)	unprognostic (2.52e-2)	unprognostic (7.05e-3)	unprognostic (1.52e-3)	unprognostic (2.77e-1)	unprognostic (2.65e-2)	unprognostic (2.08e-1)	unprognostic (1.73e-1)	unprognostic (4.77e-3)	unprognostic (4.40e-2)	6.7	3.4	1.3	3.1	2.6	0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31	2.8	3.4	12.7	13.1	2.7	3	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0	11.4	0	0	0	0	0	15.4	31.3	8.7	4.2	0.6	0.7	5.1	9.3	13.3	17	10.8	13	41.9	0	40.4	5.3	6.3	2	21.6	5.9	0	1.4	0	9.1	8.3	11.1	0	0	1	8.1	9.2	20.5	18.1	0	0	10.7	4.9	0	0	4.2	48	0	7.9	0	18	8	0	1.3	18.2	4.4	1.2	0.6	0.1	22.3	6.1	16.3	0.4	49.2	0	0.1	0.1	4.7	0	53.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.4	0	0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	EPH receptor A3	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Cell adhesion	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		prostate: 39.0	Cell line enriched	Detected in some	6	AF22: 65.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in many			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	Intracellular and membrane			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	unprognostic (1.48e-3)	unprognostic (2.30e-2)	unprognostic (4.95e-2)	unprognostic (1.90e-1)	unprognostic (2.96e-2)	unprognostic (1.47e-2)	unprognostic (2.03e-1)	unprognostic (9.10e-3)	unprognostic (1.24e-3)	unprognostic (7.43e-2)	unprognostic (1.83e-1)	unprognostic (2.23e-1)	prognostic unfavourable (3.28e-7)	unprognostic (3.63e-2)	unprognostic (1.88e-2)	unprognostic (4.05e-2)	unprognostic (1.20e-2)	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10	2.2	2.5	1.5	4.4	2.7	3	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2	0	16.3	6	3	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0	0	0	65.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	3.7	0	0.2	0	0.8	0	0	4	0	0	0.5	0	0	0	0.2	0	0.8	0	0.1	0.8	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.1	0	0	11.5	0	0	0	0.5	0	0.5	0.2	0.1	0.2	0	0.1	0	0	0	0.2	0	0.3	0	0	0.5	0.3	0.1	0.1	0	0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2
EPHA4	"Hek8, TYRO1"	ENSG00000116106	EPH receptor A4	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.6	Cell line enhanced	Detected in many		AF22: 35.0;ASC diff: 15.5;CACO-2: 25.6;U-2197: 17.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	8	basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1	Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in all			CAB028368	Enhanced					8400000	8400000			CAB028368: AB_2099353	unprognostic (1.28e-1)	unprognostic (5.87e-2)	unprognostic (2.28e-1)	unprognostic (2.46e-2)	unprognostic (5.99e-2)	unprognostic (1.33e-1)	unprognostic (7.05e-4)	unprognostic (1.80e-2)	unprognostic (2.40e-1)	prognostic unfavourable (9.56e-4)	unprognostic (1.12e-1)	unprognostic (2.85e-2)	prognostic favourable (5.67e-4)	unprognostic (3.12e-2)	unprognostic (1.96e-1)	unprognostic (2.36e-1)	unprognostic (8.66e-2)	7.1	1.8	8.1	1.9	18.3	3.5	5.2	14.7	29.6	4.9	5.9	3.1	3.2	1.1	6.5	3.1	5	6.6	3.3	16.7	19.9	4.4	5.2	0.9	3.7	2.5	2.4	16.4	11.7	1.2	2	1.2	1.7	4.9	5.9	4.7	0.8	3.7	6.7	3.1	12.8	4.1	8.2	2.1	3.3	4	11.4	2.6	0.5	9.8	3.7	3.2	4.6	4.9	2.5	0.2	3	0	6	5	0.7	1.1	1	35	0	15.5	9.6	0	8.3	3.6	7.5	2.8	25.6	0.4	0	0	11.6	3	5.4	0	3.2	4.1	3	0	0.3	0	0.4	0	0.6	3.8	1.9	2.3	0	7.1	0	0	1.9	4.1	0.1	0	2.5	0.7	0	3.8	0	11.7	1.8	6.2	0	2.7	0.5	0.6	1.3	0	0	0.8	1.4	17.1	0.4	0	0	0	3.1	0	1.5	3	0	0	3.4	0	3.4	2.5	5	3.3	0	1.8	1.9	0.3	0.2	6	0	0.2	2.1	0.7	8.1	18.3	14.7	29.6	19.9	4.4	2.4	16.4	4.9	2.6
EPHA5	"CEK7, EHK1, Hek7, TYRO4"	ENSG00000145242	EPH receptor A5	P54756	4	65319563-65670495	"Enzymes, Predicted membrane proteins"	Neurogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.5	Cell line enhanced	Detected in some		PC-3: 7.0;TIME: 9.4;U-138 MG: 19.7;U-2197: 12.0;U-251 MG: 15.2	Cancer enhanced	Detected in some		glioma: 0.8	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all														unprognostic (1.02e-2)	unprognostic (4.22e-2)	unprognostic (2.38e-1)	unprognostic (4.89e-4)	unprognostic (7.43e-4)	unprognostic (1.60e-1)		unprognostic (6.68e-3)	unprognostic (2.49e-1)	unprognostic (1.12e-1)	unprognostic (1.03e-2)	unprognostic (9.25e-2)		unprognostic (5.88e-3)	unprognostic (2.55e-2)	unprognostic (5.97e-4)	unprognostic (3.81e-3)	0.9	2.7	17.6	1	9	0.8	0.8	1.9	25.5	5.9	1.2	1.5	1.8	0.9	1.9	0.9	1.1	1	0.9	2.7	17.3	6.8	0.9	0.8	1.1	0.9	5.4	13.2	6.2	0.8	0.8	6.5	2.7	10.2	4.2	1.1	2.6	1.2	4.1	0.8	1.2	0.9	1.4	17.7	1.5	1.1	2.2	0.7	0	3	0	0.8	1	1.7	0	0	0	0	0	0	0	0	0.5	0.6	0	0.6	0.3	0	0.3	0.9	0.5	0.1	0	0	0	0	0	0	0	0	0.2	0	3.3	0	3.8	0	0	0	0	0	0	0.1	0	0.2	0	1.1	1.9	0	0	0	0	7	0	2.2	0.4	0	0	0.8	0	0	0	3.2	0	0	9.4	19.7	2.5	12	15.2	0	0	0	2	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.6	9	1.9	24.7	17.3	6.8	5.4	13.2	10.2	0.7
EPHA6	FLJ35246	ENSG00000080224	EPH receptor A6	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 27.9;ovary: 13.2;testis: 15.5	Group enriched	Detected in some	6	HEK 293: 8.0;U-266/70: 24.3	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA007397: AB_2667821, HPA058047: "	unprognostic (9.87e-2)	unprognostic (1.67e-2)	unprognostic (3.42e-4)	unprognostic (7.21e-5)	unprognostic (8.51e-2)	unprognostic (1.32e-1)		unprognostic (1.82e-2)	unprognostic (3.14e-1)	unprognostic (1.87e-1)	unprognostic (1.34e-1)	unprognostic (2.22e-1)	unprognostic (1.71e-4)	unprognostic (1.93e-3)	unprognostic (1.76e-1)	unprognostic (1.48e-2)	unprognostic (7.14e-3)	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0	4.3	0	0.5	2.1	1.7	0	0	0.2	0	0	0	0	0	0.2	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	8	0	2	0	0	1.9	0	0	0.3	0	0.8	0	0	0.1	0	0	0	0	0.2	2	0	0	0	0	0	0.7	0.9	0	0	0	0.5	0	0.1	0	2.1	0	0.8	24.3	0	0	0	0	1.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8
EPHA7	Hek11	ENSG00000135333	EPH receptor A7	Q15375	6	93240020-93419547	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	parathyroid gland: 110.4	Group enriched	Detected in some	4	AF22: 8.7;HEK 293: 25.0;RH-30: 23.8;THP-1: 20.3	Cancer enhanced	Detected in many		renal cancer: 6.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB010496	Approved				Intracellular and membrane	340000	340000			CAB010496: AB_2099673	unprognostic (3.34e-1)	unprognostic (7.82e-2)	unprognostic (1.41e-1)	unprognostic (9.32e-2)	unprognostic (1.19e-1)	unprognostic (3.56e-2)		unprognostic (1.62e-2)	unprognostic (4.07e-1)	unprognostic (4.16e-2)	unprognostic (3.19e-2)	unprognostic (5.69e-2)	unprognostic (1.69e-1)	unprognostic (1.74e-2)	unprognostic (1.35e-1)	unprognostic (1.56e-2)	unprognostic (4.82e-2)	1.3	1.3	6	1.7	24.6	1.2	2.2	21.6	8.6	2.4	24.6	0	0.1	2.5	2	7.5	14.7	1.7	3.1	4.2	13.8	2.9	6.9	1.3	1.5	1.3	2.4	5.8	3	1.3	110.4	5.6	1.6	6.7	17.9	3.6	0.4	8.2	1.9	1.3	1.4	6.5	20.2	4.8	4.7	14.9	2.1	4.4	0	1.3	0	1.3	9.7	5.9	0	0	0	0	0	0	0.2	0	0.5	8.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	25	0	2.4	0	0	0	0	0.3	0	3.6	0	0	0	0	3.9	0	0	0	0.5	0.6	4.4	23.8	0	0	0	0.8	0	0	0	0	0	20.3	0	0.3	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	6	24.6	21.6	8.6	13.8	2.9	2.4	5.8	6.7	4.4
EPHA8	"EEK, Hek3"	ENSG00000070886	EPH receptor A8	P29322	1	22563564-22603594	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5	Cell line enriched	Detected in some	12	SCLC-21H: 36.4	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Region enriched	Detected in many	5	cerebellum: 25.0	"CAB009660, HPA031433"	Uncertain				Intracellular and membrane					"CAB009660: AB_2099696, HPA031433: AB_10601371"	unprognostic (8.58e-2)	unprognostic (8.59e-2)	unprognostic (3.72e-1)	unprognostic (1.15e-2)	unprognostic (4.69e-4)	unprognostic (3.58e-1)		unprognostic (7.14e-2)	unprognostic (1.52e-1)	unprognostic (4.75e-2)	unprognostic (9.80e-2)	unprognostic (2.10e-1)	unprognostic (9.84e-14)	unprognostic (2.14e-3)	unprognostic (1.69e-1)	unprognostic (2.76e-1)	unprognostic (8.68e-2)	0.2	9.4	1.6	0.2	3.1	0.2	0.1	1.8	3.9	0.2	0.2	2.2	0	1.7	0.1	0.3	0.2	0.1	0.2	0.2	2	2.6	0.1	0.1	0.2	0.2	2.1	4.1	0.1	8.3	0.2	1.7	0.1	5.3	0.2	0.2	1.6	0.8	0.2	0.3	0.4	0.2	0.1	1.3	10.3	0.2	3.5	0.6	0	0.2	0	0.1	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	36.4	2.9	0	0	0	0.9	0	0	0	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	1.6	3.1	1.8	3.9	2	2.6	2.1	4.1	5.3	0.6
EPHB1	"EPHT2, Hek6"	ENSG00000154928	EPH receptor B1	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 74.7	Group enriched	Detected in some	4	HDLM-2: 33.9;HMC-1: 20.1;RPTEC TERT1: 9.2	Cancer enriched	Detected in many	6	glioma: 7.0	Region enhanced	Detected in all		cerebellum: 74.7	Group enriched	Detected in some	33	neutrophil: 15.9;plasmacytoid DC: 15.4	Group enriched	Detected in many	33	dendritic cells: 15.4;granulocytes: 15.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Plasma membrane, Cytosol"		HPA067740: 	unprognostic (1.99e-1)	unprognostic (3.45e-1)	unprognostic (2.52e-1)	unprognostic (1.41e-6)	unprognostic (6.52e-2)	unprognostic (1.31e-1)	unprognostic (1.07e-1)	unprognostic (8.15e-2)	unprognostic (9.88e-2)	unprognostic (1.55e-1)	unprognostic (1.11e-1)	unprognostic (1.75e-1)	unprognostic (1.04e-1)	unprognostic (4.82e-2)	unprognostic (1.78e-1)	unprognostic (1.37e-3)	unprognostic (4.88e-4)	2	1.5	9	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1	3.3	2.8	7	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6	1.7	1.7	6	3.4	1.3	16.7	6	0	11.6	2.9	3.3	4.5	2.6	0	15.4	15.9	0	0	0.4	0.1	0	0	4.7	0	0.1	0	0.1	3.5	0	0.2	0	0	0	0.6	1	1.8	0	3.1	0	0.6	33.9	0.4	2.5	0	0	0	0	20.1	0	0	0	0	0.1	0.1	0.1	2.5	0.1	0.1	0.1	1.3	0	0	0.5	0.1	9.2	0	0.6	0.1	0	0	0	0.1	0.4	0.2	0.6	2	0.3	4.2	0.1	0.2	0.2	0.1	0	0.1	0	0	0.2	0	0	0.4	0	0	0	0	0	0	0	15.9	0	0	15.4	0	0.1	9	16.6	74.7	19	9.4	5.3	2.8	7	7.1	6
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	EPH receptor B2	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 25.0	Cell line enhanced	Detected in many		HBEC3-KT: 22.8;HUVEC TERT2: 31.1;TIME: 30.7;U-251 MG: 26.8	Cancer enhanced	Detected in many		colorectal cancer: 23.7	Low region specificity	Detected in all			Cell type enhanced	Detected in some		classical monocyte: 2.5;intermediate monocyte: 2.1	Low lineage specificity	Detected in single			Low region specificity	Detected in all			Low region specificity	Detected in many			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	Intracellular and membrane	290000	290000	Plasma membrane	Nucleoplasm	"CAB013647: , HPA071200: "	unprognostic (2.47e-2)	unprognostic (2.43e-2)	prognostic favourable (4.98e-4)	prognostic unfavourable (1.05e-5)	unprognostic (3.99e-2)	unprognostic (8.91e-3)	unprognostic (1.23e-1)	unprognostic (2.33e-3)	unprognostic (1.56e-1)	unprognostic (7.73e-2)	unprognostic (1.23e-2)	unprognostic (2.15e-2)	unprognostic (2.16e-4)	unprognostic (1.45e-1)	unprognostic (8.07e-2)	unprognostic (2.58e-1)	unprognostic (3.46e-2)	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12	8.2	3.3	25	2.2	6.6	4	0.7	1.8	22.6	4	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	16.7	7.1	6.8	10.9	0.6	0.6	0	3.9	0.2	11.8	2.5	2.4	6.7	0.2	8.4	1.7	15.8	4.6	22.8	3.1	0	1.6	0	0.7	0	7.1	0	1.7	2.3	7.3	21.1	0.1	31.1	0.6	0	2.3	2.5	0.3	0.1	1.6	4.6	2	7	0.3	5.8	1.6	7.4	7.8	6.8	0.2	0.1	0.4	0.2	30.7	4.7	12.4	11.9	26.8	0	0.1	0	8.8	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0	0	0	0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3
EPHB3	"ETK2, Hek2, Tyro6"	ENSG00000182580	EPH receptor B3	P54753	3	184561784-184582409	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Angiogenesis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pancreas: 49.3	Cell line enhanced	Detected in many		BEWO: 17.2;HaCaT: 23.6;SK-BR-3: 18.3;T-47d: 12.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	5	classical monocyte: 1.1;myeloid DC: 3.1	Group enriched	Detected in many	5	dendritic cells: 3.1;monocytes: 1.1	Low region specificity	Detected in many			Low region specificity	Detected in many			"HPA007698, HPA008184, CAB034350"	Enhanced					20000	20000			"CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206"	unprognostic (2.94e-2)	unprognostic (5.88e-2)	unprognostic (2.17e-2)	unprognostic (7.80e-2)	unprognostic (1.52e-1)	unprognostic (9.19e-2)	unprognostic (8.35e-2)	unprognostic (1.94e-1)	unprognostic (5.51e-2)	unprognostic (1.76e-1)	unprognostic (7.42e-2)	unprognostic (3.31e-1)	prognostic unfavourable (7.88e-5)	unprognostic (8.83e-3)	unprognostic (3.03e-2)	unprognostic (9.59e-3)	unprognostic (2.10e-3)	1.4	0.9	4.5	5	2.6	0.5	9	9.7	5.7	22.7	8.8	2.3	1.7	5.7	10	1.9	19.9	3	9.7	1.6	4.7	1.8	1.7	1	4.7	1	3.3	3.7	9	49.3	1.1	1.7	6.3	7.2	7.7	9.7	3.8	27.7	3.5	0.7	32.3	5.6	3.5	1.3	1.2	16	1.1	4	0.2	1	15.7	8.4	4	13.6	0	3.1	0.3	1.1	0	0.4	0.4	3.8	1.3	8.9	0.9	2.7	0.2	17.2	0.6	1.1	1.3	0.7	1.2	0.1	0	1.7	3.6	23.6	3.2	1.2	0.3	0.1	0.7	0	0.2	0	0.2	0	0.2	0.7	7.7	1.1	0.1	0	0	0	0.6	10.1	0	3.8	0.9	1.5	0.9	5.4	0	0	3.4	1.1	1.3	0.7	18.3	0.8	12.1	0.1	0	2.2	3.2	1.1	1.4	0	0	0.1	0.2	0	8.4	0	1.1	0	0	0	0	0	0.3	0	3.1	0	0.1	0.4	0.3	0	0	0	0	0.4	4.5	2.6	9.7	5.7	4.7	1.8	3.3	3.7	7.2	4
EPHB4	"HTK, Tyro11"	ENSG00000196411	EPH receptor B4	P54760	7	100802565-100827521	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in some		classical monocyte: 3.6;neutrophil: 7.4	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB013537	Uncertain					1000000	1000000			CAB013537: 	prognostic unfavourable (8.56e-4)	unprognostic (1.05e-2)	prognostic unfavourable (4.33e-4)	unprognostic (1.33e-1)	unprognostic (5.23e-2)	unprognostic (3.43e-2)	unprognostic (1.46e-1)	unprognostic (1.01e-1)	unprognostic (2.73e-1)	unprognostic (1.84e-1)	unprognostic (8.16e-3)	unprognostic (1.43e-1)	unprognostic (9.51e-3)	unprognostic (6.63e-2)	unprognostic (3.13e-1)	unprognostic (2.07e-2)	prognostic unfavourable (8.84e-4)	14	20.7	1.8	4.2	2.9	2.2	17.1	1.9	3	29.1	9.5	2.9	14.6	4.1	28.8	10.3	11	13.1	35	19	3.4	1.1	16.8	29.8	16.5	12	2.2	0.9	24.6	11.6	5.6	3.1	35.5	3.2	13.7	5.4	11.6	10.8	14.7	5.1	14.2	7	12.4	2.2	50.5	8.6	12.2	2.1	2.3	10.2	13.1	7	7.7	21.5	0	1.6	7.4	3.6	0	0	1.2	12.5	11.1	11.1	32.2	7.1	4.6	32.9	4.9	10.7	7.7	10.1	9.1	9.6	1.6	22.4	5	13.1	4.8	12.9	4.1	2	8.9	0.4	6.4	14.1	4.1	0.2	0.3	5.4	19.5	4.9	11.4	28.7	23.6	0.6	6.2	21.8	0.2	4.9	19	16.7	17	5.5	2.9	9.8	6.6	0	9.6	7.5	3.5	7.3	8.9	2.2	24.1	9.6	15.3	17.7	7.2	0.1	0.2	0.5	1.4	4.1	17.4	0	3.6	0	0	0.9	0	0	0	0	1.6	0	0	0	7.4	0	0.2	0.3	0	1.2	1.8	2.9	1.9	3	3.4	1.1	2.2	0.9	3.2	2.1
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	Erb-b2 receptor tyrosine kinase 2	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enriched	Detected in many	27	SK-BR-3: 263.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		gdT-cell: 8.8	Lineage enriched	Detected in many	4	T-cells: 8.8	Low region specificity	Detected in many			Low region specificity	Detected in all			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Supported	"Plasma membrane,Cytosol"		430000	430000	Plasma membrane	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: , HPA001060: , HPA001338: , HPA001383: AB_1078500"	unprognostic (1.97e-1)	unprognostic (6.60e-3)	unprognostic (6.21e-2)	prognostic unfavourable (8.99e-8)	unprognostic (2.96e-2)	unprognostic (1.40e-2)	unprognostic (1.97e-2)	unprognostic (9.04e-2)	unprognostic (1.79e-2)	unprognostic (1.20e-3)	prognostic unfavourable (9.17e-4)	unprognostic (3.92e-1)	prognostic favourable (2.41e-14)	unprognostic (9.29e-2)	unprognostic (1.40e-1)	unprognostic (3.75e-2)	unprognostic (1.96e-1)	5.8	2.4	5.2	10.4	7	0.1	20.1	4.2	7	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	3.1	3.8	4.2	2.7	5.1	3.6	5.7	2.2	3.7	4.9	4.2	2.8	8.6	0.2	4.6	5.1	9.8	0.2	5.1	2.3	0.4	3.2	0.1	3	4.5	3	0	0	3.5	4.8	3	1.8	2	0.4	0.1	3.6	4.8	0.5	0.2	7.6	0.9	0.3	1.7	0.4	5	9.8	0.8	0.2	4.2	263.9	1.3	7.4	0.1	0.2	2.5	3.3	3.2	1.4	0.4	0.2	0.2	0.2	0	8.2	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7	4.2	7	6.3	3.1	5.1	5.6	7.5	3.7
ERBB3	"HER3, LCCS2"	ENSG00000065361	Erb-b2 receptor tyrosine kinase 3	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 31.1;MCF7: 20.3;RT4: 24.3;SK-BR-3: 28.6;SK-MEL-30: 38.1;T-47d: 31.7;WM-115: 40.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 5.3	Lineage enriched	Detected in many	4	granulocytes: 5.3	Low region specificity	Detected in many							"CAB025331, HPA045396"	Uncertain		Approved	"Plasma membrane,Actin filaments"	Secreted - unknown location	420000	420000	Actin filaments	Plasma membrane	"CAB025331: , HPA045396: "	unprognostic (2.97e-1)	unprognostic (2.71e-2)	unprognostic (1.91e-1)	unprognostic (8.97e-2)	unprognostic (1.63e-1)	unprognostic (1.07e-3)	unprognostic (2.31e-3)	unprognostic (2.66e-2)	unprognostic (9.89e-2)	unprognostic (4.30e-2)	unprognostic (4.76e-3)	unprognostic (5.77e-2)	unprognostic (1.06e-2)	unprognostic (4.56e-2)	unprognostic (1.57e-1)	unprognostic (6.72e-3)	unprognostic (2.07e-2)	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2	16.7	6.8	40.5	40.3	12	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.1	0.6	0.8	0.3	0	0	16.5	0.8	1.9	1.1	1.1	5.5	18.3	0	0.2	0.2	8.6	1.2	1.9	0.6	0.2	0.8	0	0.3	31.1	0	0	0.1	0.4	2.5	0.2	0	0	0.7	0.3	0.1	20.3	0.1	0.3	2.8	0.4	0.1	1.9	0.5	2.1	24.3	0.9	0.3	0.7	28.6	38.1	31.7	0.1	0	0.1	1.1	0.6	0.1	0.3	0.1	0.1	0.1	0	40.5	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2	16.7	18.6	9	23.5	9.3	14.9	23.8
ERBB4	"ALS19, HER4"	ENSG00000178568	Erb-b2 receptor tyrosine kinase 4	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 24.5	Cell line enhanced	Detected in some		AF22: 9.4;EFO-21: 7.0;HEK 293: 5.2;RPTEC TERT1: 7.7;SCLC-21H: 4.3;T-47d: 6.9	Cancer enhanced	Detected in many		breast cancer: 4.1	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB000276, HPA012016, CAB025522"	Enhanced					140000	140000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	unprognostic (1.48e-1)	unprognostic (3.28e-1)	unprognostic (4.31e-3)	unprognostic (1.76e-3)	unprognostic (3.59e-1)	unprognostic (2.75e-1)	unprognostic (2.88e-1)	unprognostic (9.56e-2)	unprognostic (2.07e-1)	unprognostic (4.67e-3)	unprognostic (1.07e-1)	unprognostic (3.61e-1)	unprognostic (7.14e-3)	unprognostic (1.49e-3)	unprognostic (1.41e-1)	unprognostic (1.14e-1)	unprognostic (4.11e-2)	1.6	1.9	15.1	1.2	15	1	13.4	18.6	14.1	7.8	1.1	7.6	8.8	1.1	1.5	1.2	1.3	24.5	1.2	7	14.3	6.5	11.9	1.1	2.9	1.2	7.8	10.7	1.3	2.4	10.8	5.1	1.3	8.8	1.7	1.1	2	9.7	18.1	3.8	1.8	1.2	1.1	7.3	1.2	1.5	7.6	12	0	4.5	1.1	1.2	1.4	0.7	0	0	0	0	0	0.2	0	0	0	9.4	0.2	0	0	0	0	0.3	0.5	0.1	0	0	0	7	1	0.4	0.2	0	0	0.1	5.2	0	1.7	0	0	0.1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0.5	0	7.7	0.4	4.3	0.2	0	0.1	0.1	6.9	0	0	0.1	0.1	0	0	0.1	0.1	0	0	0	0.7	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	15	18.6	14.1	14.3	6.5	7.8	10.7	8.8	12
ERN1	"IRE1, IRE1P"	ENSG00000178607	Endoplasmic reticulum to nucleus signaling 1	O75460	17	64039142-64130819	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		Karpas-707: 40.4;RPMI-8226: 18.1;U-266/70: 38.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 12.9;MAIT T-cell: 12.2	Low lineage specificity	Detected in many			Low region specificity	Detected in some			Low region specificity	Detected in all			"CAB009495, HPA027730"	Supported									"CAB009495: AB_2098712, HPA027730: AB_10602494"	unprognostic (2.52e-1)	unprognostic (1.16e-2)	unprognostic (1.89e-1)	unprognostic (4.05e-3)	unprognostic (3.63e-2)	unprognostic (2.81e-2)	unprognostic (9.14e-2)	unprognostic (2.72e-2)	unprognostic (4.55e-1)	unprognostic (6.17e-2)	unprognostic (2.95e-1)	unprognostic (1.33e-1)	prognostic unfavourable (1.68e-4)	unprognostic (4.65e-1)	unprognostic (1.89e-1)	unprognostic (1.36e-2)	unprognostic (3.11e-2)	5.5	24.9	2.2	10.6	1.6	8	7.7	2.3	1.8	15.8	10	3.5	36.1	5.1	11.9	15	7.4	7.9	10.6	4.1	1.9	1.7	6.4	21.5	12.3	12.6	2.1	1.6	14.7	44.1	2.9	32.8	10.1	1.8	6.6	3.9	5	23.2	34.9	4.2	6.6	11.5	4.1	2.2	9.9	8.8	2.8	1.6	11.6	7.5	5.9	16.7	10	7.7	0.1	5.7	12.9	0.7	3	12.2	1	2.2	1.7	0.9	2.3	2.2	1.8	4.4	1.9	4.2	1.3	1.1	1.2	1.2	2.8	1.3	1.4	1.4	1.2	1.8	3.2	0.8	1	2.6	0.9	1.8	13.5	1.2	0.9	2	5.1	3.6	11.5	2.4	1.8	40.4	1.1	1.5	1.8	0.5	0.3	1.6	1.9	1.9	18.1	1.1	2.9	3.2	1.9	1.8	3	4.4	1.6	2.6	2.3	1.1	2.6	2.5	1.1	38.1	10	2.2	2.1	1.3	1.8	12.9	0.7	0.2	4.6	0.4	12.2	0.1	3	3.2	0.3	0.1	0.7	1.3	3.3	3	0.2	5.7	0.7	1	2.2	1.6	2.3	1.8	1.9	1.7	2.1	1.6	1.8	1.6
ERN2	IRE1b	ENSG00000134398	Endoplasmic reticulum to nucleus signaling 2	Q76MJ5	16	23690326-23713500	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 64.5;stomach 1: 30.0	Cell line enriched	Detected in some	7	CAPAN-2: 12.2	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 3.6	Low lineage specificity	Detected in many			Region enhanced	Detected in single		hypothalamus: 0.7	Low region specificity	Detected in all			HPA076875	Approved				Intracellular and membrane					HPA076875: 	unprognostic (1.06e-1)	unprognostic (5.20e-2)	unprognostic (3.45e-1)	unprognostic (2.98e-2)	unprognostic (3.83e-2)	unprognostic (1.13e-2)	unprognostic (7.67e-4)	unprognostic (1.31e-1)	unprognostic (1.16e-1)	unprognostic (4.93e-2)	unprognostic (7.34e-2)	unprognostic (1.19e-1)	unprognostic (1.14e-9)	unprognostic (1.48e-1)	unprognostic (2.14e-1)	unprognostic (1.06e-1)	unprognostic (3.13e-3)	0.1	0.3	0.1	8.1	0.2	0	0.1	0.1	0.2	11.4	17.3	0.2	0.1	7	1.1	0.1	0.9	0.1	64.5	0.1	0.1	0	0.2	0.1	1	0.5	0.1	0.1	0.1	0.5	0	0.8	0.1	0.1	2.6	12.6	0.2	14	0.1	0.1	0.1	11.8	0.9	0.1	0.1	30	0.1	0.1	0.2	0.1	2.2	7.6	6.3	3.9	0.9	0.6	3.6	0.4	1.5	0.4	0.1	0	0	0	0.2	0.1	0	0.4	0	0	0	0	0.2	12.2	0.1	0.1	0	0.4	0	0	0	0	0	0	0.3	1.8	0	0	0.1	0.4	0	0	0.1	0	0	0.2	0	0	0	0.1	0.2	0.1	0.2	0	0.1	0	0.2	0.1	0.1	0	0	0	0	0	0.1	0	0	0.1	0	0.2	0.1	0	0.1	0	0	3.6	0.4	0.5	0.3	0.3	0.2	0.3	0.3	0.3	0.1	0.9	0.3	0.4	2.1	1.5	0.2	0.6	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1
FASTK	FAST	ENSG00000164896	Fas activated serine/threonine kinase	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 89.5	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA031621, CAB032539"	Approved		Approved	"Nuclear speckles,Mitochondria"				Mitochondria	Nuclear speckles	"CAB032539: AB_2101115, HPA031621: AB_10611966"	unprognostic (7.67e-2)	unprognostic (6.41e-3)	prognostic unfavourable (4.73e-4)	unprognostic (2.60e-1)	unprognostic (1.75e-3)	unprognostic (2.03e-3)	unprognostic (1.14e-3)	unprognostic (1.01e-1)	unprognostic (1.24e-1)	unprognostic (4.66e-2)	prognostic favourable (3.99e-4)	unprognostic (3.49e-2)	unprognostic (2.79e-2)	unprognostic (4.12e-2)	unprognostic (1.05e-1)	unprognostic (1.09e-1)	unprognostic (8.17e-2)	13.8	16.8	18.8	15.7	19	6.4	10.2	19	26.4	18	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12	15	14.4	20.7	20.2	21.8	18.5	12	16.8	10.6	14	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26	19.7	22.3	13.1	19	14.5	15.7	18.4	5.9	14.1	22	9.9	9.8	12.7	17.3	10.8	13	12.7	13.7	3.7	17.3	17.1	10.3	5.6	15.2	2.9	10.8	10.1	4.6	4.6	10.8	27.9	3.2	10.4	13	22.3	12.5	9.2	12.7	6.7	7.9	12.5	31.7	7.7	9.2	9.9	21.7	5.1	7.1	11.8	14.7	10.9	7	7.3	16.7	26	16.9	14	12.6	10.4	13.8	3	12.9	11.2	21.2	12.9	2.4	27.5	7.2	15.8	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19	16.3	4.8	13.1	20.8	26	18.7	14.5	18.8	19	19	26.4	17.6	12.9	12	15	12	10.9
FER	"PPP1R74, TYK3"	ENSG00000151422	FER tyrosine kinase	P16591	5	108747822-109196841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enriched	Detected in many	5	RPMI-8226: 44.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all							"HPA007641, CAB022464"	Approved		Supported	Cytosol				Cytosol		"CAB022464: , HPA007641: AB_1078845"	unprognostic (1.72e-1)	unprognostic (1.66e-2)	unprognostic (1.74e-1)	unprognostic (2.46e-3)	unprognostic (4.72e-2)	unprognostic (5.65e-2)	unprognostic (6.81e-2)	unprognostic (7.39e-2)	unprognostic (1.05e-1)	unprognostic (8.36e-3)	unprognostic (7.36e-2)	unprognostic (8.05e-2)	prognostic favourable (5.55e-4)	unprognostic (3.83e-3)	unprognostic (3.22e-1)	unprognostic (1.03e-1)	unprognostic (3.99e-3)	13.4	5.7	5.5	6.1	13.4	1.8	5.2	6	5	9.7	6.7	1.4	16.8	2.5	6.5	19.3	8.2	4.6	5.3	4.6	4.8	4.8	7.2	3.6	12.2	1.9	4.9	2.2	7.2	3	18.5	15.9	5.7	3.1	6.8	3.6	5	4.5	21.9	5	6.6	3.5	7.2	6.2	8.1	4.1	15.9	2.6	3.9	10.2	12.8	2.8	7.7	9	10.5	5.4	8	5.1	1.2	2.8	1.1	4.6	1.6	5.7	9	3.4	5.2	3.6	5.6	5.5	3.3	3.9	9.5	2.9	7.5	3.5	6.7	3.3	3.1	7	7.5	3.1	4.2	4.9	7.2	3.4	2.3	2.7	4.2	3.1	3.9	7.9	9	4.9	6.1	5.6	4.2	1.3	2.1	0.8	0.8	3.3	1.7	5.5	44.2	3.2	1.6	1.9	2.8	9.2	0.5	6	2.2	1.2	7.2	6.4	4.9	3.2	4.4	4.8	7.1	2.9	4	0.8	3	8	5.1	5.4	1.7	3.1	2.8	10.5	1	1.8	2.8	3.8	1.6	2	0.4	1.2	2.4	5.4	2.1	1.1	5.5	13.4	6	4.2	4.8	4.8	4.9	2.2	3.1	2.6
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 60.8;lymphoid tissue: 49.7	Cell line enhanced	Detected in many		HEL: 20.9;HL-60: 18.6;HMC-1: 39.8;NB-4: 24.4;THP-1: 36.6;U-937: 15.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		eosinophil: 60.8	Group enriched	Detected in many	4	dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA001376	Approved		Approved	"Nucleoplasm,Vesicles,Cytosol"				"Nucleoplasm, Cytosol"	Vesicles	HPA001376: AB_1078847	unprognostic (1.07e-2)	unprognostic (2.54e-2)	prognostic unfavourable (5.78e-4)	unprognostic (2.31e-2)	unprognostic (4.05e-3)	unprognostic (7.33e-2)	unprognostic (1.74e-1)	unprognostic (2.22e-1)	unprognostic (1.58e-3)	unprognostic (1.35e-1)	unprognostic (4.66e-2)	unprognostic (5.15e-3)	unprognostic (1.78e-3)	unprognostic (2.53e-3)	unprognostic (6.08e-2)	unprognostic (1.18e-1)	unprognostic (1.40e-1)	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.5	1	3.1	6	0.9	0	1.7	1	0.8	0	2.2	0.1	2	0.5	0.6	0.1	0.5	1.1	0.3	20.9	0	3.7	2	18.6	39.8	3	0	2.6	0	10.5	0.6	0	0	6.8	0.5	24.4	1	0	2.7	0	0	0	0	0.1	0	0	0.9	0.8	0	36.6	8.3	0	3.6	0.1	0	0	2.6	0.8	0.1	15.8	0.8	10.4	30.5	60.8	0.1	17.6	0	1.1	0	0	32.6	0.9	0	0	20	9.3	7.3	12.9	0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	Fibroblast growth factor receptor 1	P11362	8	38411138-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		AN3-CA: 109.2;BJ hTERT+: 49.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB033614, HPA056402"	Approved					120000000	120000000			"CAB033614: AB_783377, HPA056402: "	unprognostic (9.53e-2)	unprognostic (7.33e-2)	unprognostic (2.44e-1)	unprognostic (1.35e-2)	unprognostic (4.23e-3)	unprognostic (7.02e-2)	unprognostic (6.59e-2)	unprognostic (2.77e-1)	unprognostic (1.81e-1)	unprognostic (3.99e-2)	unprognostic (7.97e-3)	unprognostic (4.59e-2)	unprognostic (7.69e-2)	unprognostic (6.87e-3)	unprognostic (5.60e-2)	unprognostic (4.59e-3)	unprognostic (1.05e-3)	41.1	8.6	12.5	14.5	12.2	7.2	39.5	45	10.5	36	31.5	10.1	11.6	5.5	29.3	20.6	22.9	29.4	32.4	31.7	12.8	10.1	11.8	5.4	18.6	9.7	11.4	14.3	42	51.2	11.5	22.3	28.4	20	28.2	10.8	35.8	14	31.6	12	12.9	14.4	52.4	15.6	4.5	16.4	16.4	8.5	11.3	12.6	13	9.8	39.6	41.2	1.6	0.7	1.8	1.1	0.8	5.7	0.7	2.4	9.3	40.3	109.2	25.1	17.9	26.6	24.8	49.8	17.3	18	6	1.4	0.3	6.9	23.8	0	19.1	1.2	20	6.5	4.2	0	1.5	5.9	14.1	5.8	0.1	16.2	0.1	14	2.8	16.6	2.2	0.1	8.1	2.8	17	1.9	28.4	3.9	15.7	4.2	0	8.4	0	1.6	3.6	4.4	0.2	1	2.2	1.1	10.4	11.3	6.2	31.2	5.9	0.4	0.7	0	13.4	0.3	5.9	1.4	1.1	0.4	5.7	0.3	3.9	0.7	2.7	3.7	0.1	1.6	1.5	4.1	1.8	0.8	0.5	0.7	2.2	0.7	12.5	12.2	45	10.5	12.8	10.1	11.4	14.3	20	8.5
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	Fibroblast growth factor receptor 2	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 74.8	Cell line enhanced	Detected in some		AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	15	basophil: 10.8;eosinophil: 4.6	Lineage enriched	Detected in single	35	granulocytes: 10.8	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	Secreted - unknown location	500000	500000	Cell Junctions	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	unprognostic (5.53e-2)	prognostic favourable (8.79e-4)	unprognostic (1.08e-1)	unprognostic (5.23e-2)	unprognostic (1.73e-1)	prognostic favourable (9.32e-4)	unprognostic (1.53e-1)	unprognostic (4.96e-3)	unprognostic (1.74e-1)	unprognostic (1.56e-1)	unprognostic (1.07e-1)	unprognostic (3.74e-2)	unprognostic (1.01e-1)	unprognostic (6.11e-2)	unprognostic (2.54e-1)	unprognostic (6.93e-2)	unprognostic (2.25e-1)	2.1	8.8	16.4	3	30.3	0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0	2.2	0.1	9	57.8	0	0	19.4	0.1	0	0	0	15.1	0.3	0	4.1	0.9	17.4	18.7	4	0	0	4	0	0	0.3	0.4	0	3.8	0	8.4	0	0.2	0	0	0	0	3.5	0	0	18.5	0	0	0	2.2	5.6	4.9	0.1	0.1	0.1	10.6	0	15.5	0	0	0.1	2.8	0	0.2	0	0	0	0.1	0	0.1	10.8	0.1	4.6	0.1	0	0	0	0.3	0	0	0.1	0	0.1	0.5	0.1	0	0.1	0	0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	Fibroblast growth factor receptor 3	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	skin 1: 131.7	Cell line enhanced	Detected in many		CACO-2: 19.1;HaCaT: 14.9;Hep G2: 32.1;NTERA-2: 15.6;RT4: 19.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004231, HPA067204"	Enhanced		Supported	Endoplasmic reticulum	Intracellular and membrane	670000	670000	Endoplasmic reticulum		"CAB004231: AB_627596, HPA067204: "	unprognostic (1.34e-1)	unprognostic (5.29e-3)	unprognostic (1.49e-1)	prognostic unfavourable (3.77e-4)	unprognostic (5.90e-2)	unprognostic (1.24e-3)	unprognostic (7.22e-2)	unprognostic (2.54e-1)	unprognostic (1.99e-1)	unprognostic (2.17e-1)	unprognostic (1.38e-1)	unprognostic (2.88e-2)	unprognostic (1.30e-1)	unprognostic (9.11e-3)	unprognostic (1.98e-1)	unprognostic (4.74e-2)	unprognostic (1.97e-1)	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2	5	2	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23	1.2	3	5.6	15.1	3.7	3.8	1.7	3.8	9	1.7	131.7	7.4	1.3	9	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0	0	1.5	9	2.6	0	0.1	9.2	1	0.1	0.4	0.2	19.1	0.4	0	7.6	0.3	14.9	2.6	0.1	0.1	0.1	9.6	5.9	1.5	32.1	0	0	0.1	0	5	0.1	0	0	6.4	0	0	9.5	0.3	0.2	15.6	0	0.5	0.5	0.1	1.3	19.1	2.6	0.7	0.8	1.6	0	8.9	1.1	0.4	0	0.9	0.2	0.6	0	0	0	0.1	0.7	0.5	0	0.1	0	0	0	0.3	0	0	0	0	0.1	0	0.1	0.1	0.2	0	0.6	0.1	0	24.7	30.3	10.2	22	21.6	11.7	17.6	21.5	15.1	10.6
FGFR4	"CD334, JTK2"	ENSG00000160867	Fibroblast growth factor receptor 4	P22455	5	177086886-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 33.6;kidney: 37.7;liver: 45.3	Group enriched	Detected in many	4	CACO-2: 42.0;Hep G2: 42.0;RH-30: 67.6	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in some		neutrophil: 3.0	Low lineage specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				Intracellular and membrane	4300000	4300000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	unprognostic (1.96e-1)	unprognostic (2.10e-2)	unprognostic (1.12e-1)	unprognostic (9.06e-3)	unprognostic (2.87e-1)	unprognostic (1.95e-2)	unprognostic (7.85e-3)	unprognostic (9.19e-2)	unprognostic (4.25e-1)	unprognostic (4.46e-2)	unprognostic (1.16e-1)	unprognostic (3.48e-2)	unprognostic (1.78e-1)	unprognostic (1.71e-3)	unprognostic (2.41e-1)	unprognostic (5.75e-2)	unprognostic (4.68e-2)	0.5	5.7	0.7	14.3	0.6	0.1	1.6	2.6	0.5	2.8	10.4	0.9	0.7	13.5	0.9	4.8	1.6	1.7	33.6	0.7	0.8	0.3	37.7	45.3	25.3	2.5	0.7	1	13.6	26	0	0.7	1.3	0.8	4	3.7	2	1.6	0.3	4.3	0.5	17.3	1.6	0.8	11.2	5.4	2.9	0.4	0.3	0.8	2.3	0.7	1.9	3.6	1.1	0.9	3	1.1	0.4	0.4	0	0.7	11.8	0.2	2.9	0	0	5.8	0	0	0	0	42	1.6	1.2	5.5	0	0.6	2.3	0.4	0	0.7	2.8	0.1	0.6	42	1.3	0.1	1	0.2	0	2.1	0	0	3.9	0.1	0.9	9.6	0	0.8	7.1	1	1.9	67.6	7.1	5.7	0.1	0.4	0.7	0.4	3	1.4	2.9	0.6	0.2	0	5.7	0	0.1	0.4	0.4	0.7	0	0.2	0.5	1.5	1.1	0.4	0.4	0.3	0.3	1.1	0.4	0	0.1	0.6	0.4	0.4	3	0.4	0.3	0.9	0.2	0	0.7	0.6	2.6	0.5	0.8	0.3	0.7	1	0.8	0.4
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3	Group enriched	Detected in some	4	Daudi: 29.4;U-266/70: 54.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in many			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				Plasma membrane	Aggresome	HPA002024: AB_1078503	unprognostic (2.66e-2)	unprognostic (1.51e-2)	unprognostic (6.32e-2)	unprognostic (9.74e-3)	unprognostic (6.66e-3)	unprognostic (6.71e-2)	unprognostic (5.77e-2)	unprognostic (1.25e-1)	unprognostic (1.81e-2)	unprognostic (7.45e-2)	unprognostic (2.79e-2)	unprognostic (1.10e-1)	unprognostic (1.94e-2)	unprognostic (6.26e-2)	unprognostic (3.93e-2)	unprognostic (2.30e-1)	unprognostic (8.12e-3)	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68	36.3	29.6	55	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	29.4	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0.5	10.4	0.1	0	0	0	0	0	0.1	0	0	1.2	1.7	0	0	0	0	0	0	0.6	0	0	0	0	0	0	3.5	0	0	0	0	0	54.6	0.7	2.2	0	6.7	0	3.1	52.4	32.3	29.6	68	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
FLT1	"FLT, VEGFR1"	ENSG00000102755	Fms related tyrosine kinase 1	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	8	placenta: 155.3	Cell line enhanced	Detected in some		BJ: 17.0;BJ hTERT+: 13.5;HMC-1: 84.6;HUVEC TERT2: 15.3;WM-115: 30.3	Cancer enhanced	Detected in all		renal cancer: 28.7	Low region specificity	Detected in all			Group enriched	Detected in some	4	memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1	Group enriched	Detected in many	5	B-cells: 3.7;granulocytes: 2.1	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	Secreted to blood	54000	54000	"Plasma membrane, Actin filaments"		"CAB068189: , CAB068190: , HPA011740: AB_1858737, HPA014290: AB_1858738"	unprognostic (3.33e-2)	unprognostic (3.52e-3)	unprognostic (1.13e-3)	unprognostic (5.02e-2)	unprognostic (3.65e-1)	unprognostic (5.03e-2)	unprognostic (8.25e-2)	unprognostic (2.27e-3)	unprognostic (9.91e-2)	unprognostic (6.61e-2)	unprognostic (2.33e-1)	unprognostic (1.57e-1)	prognostic unfavourable (2.19e-4)	unprognostic (4.20e-2)	unprognostic (6.00e-2)	unprognostic (1.57e-1)	unprognostic (6.32e-2)	18.9	4	9.9	4	14.3	1.2	13.5	8	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3	5	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0	0	0	0.1	0.1	0.2	0	17	13.5	6.2	3.6	0	0	0	0	2.2	0	1.6	0	11	0	0.4	0	0	0	0	0	84.6	0.1	0	0	0.2	15.3	0.4	0	0	0	1	0.8	9	0	0.6	0	0	0	0	1.9	0.1	0	0	0	0	0	1.4	0	0.2	0	0	0.5	0.2	0	0.1	0	30.3	0.2	0.1	0.1	0.1	0.1	0	1.1	0.1	0.1	0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8	15.9	11.4	7.3	10.3	3.2	13.8	10.2
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	Fms related tyrosine kinase 3	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	Host-virus interaction	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 29.9;brain: 19.3;lymphoid tissue: 15.0	Group enriched	Detected in some	11	REH: 27.8;THP-1: 17.1	Cancer enhanced	Detected in some		breast cancer: 1.8	Region enhanced	Detected in many		cerebellum: 19.3	Group enriched	Detected in some	11	myeloid DC: 29.9;plasmacytoid DC: 12.1	Lineage enriched	Detected in many	16	dendritic cells: 29.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA047539			Approved	Endoplasmic reticulum		180000	180000	Endoplasmic reticulum		HPA047539: 	unprognostic (2.19e-3)	unprognostic (3.16e-3)	unprognostic (6.54e-3)	unprognostic (9.96e-2)	unprognostic (3.88e-1)	unprognostic (3.96e-7)	unprognostic (7.99e-3)	unprognostic (1.65e-2)	unprognostic (5.37e-2)	unprognostic (1.01e-2)	unprognostic (1.96e-1)	unprognostic (1.03e-1)	unprognostic (4.56e-2)	unprognostic (3.65e-1)	unprognostic (3.91e-2)	unprognostic (2.51e-1)	unprognostic (2.22e-1)	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15	1.8	1.1	0.5	5.7	0	0.4	0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3	1.3	4.4	8.8	0.9	1.2	0	8.2	0.6	0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	2	0.5	0	27.8	0	0	0	0	0.4	0	0	0	0	0	17.1	0	0	0	0	0	0	0	0	0	0	0	1	1.8	1.4	0	0.3	0	0.1	0	0	29.9	0	0	0	0	0.8	0	12.1	0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0
FLT4	"PCL, VEGFR3"	ENSG00000037280	Fms related tyrosine kinase 4	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 56.3	Cell line enhanced	Detected in some		AN3-CA: 8.3;BEWO: 10.2;HEK 293: 12.6;HL-60: 7.4;HUVEC TERT2: 8.1;T-47d: 12.0;TIME: 12.7	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enriched	Detected in some	5	MAIT T-cell: 7.7	Lineage enriched	Detected in single	35	T-cells: 7.7	Low region specificity	Detected in many			Not detected	Not detected			"CAB000099, HPA046519, HPA067906"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	Secreted to blood	270000000	270000000	Plasma membrane	"Nucleoplasm, Cell Junctions"	"CAB000099: , HPA046519: , HPA067906: "	unprognostic (7.35e-2)	unprognostic (1.63e-1)	unprognostic (9.45e-3)	unprognostic (3.81e-1)	unprognostic (9.26e-2)	unprognostic (3.20e-3)	unprognostic (1.13e-2)	unprognostic (1.80e-2)	unprognostic (2.19e-1)	unprognostic (1.70e-1)	unprognostic (2.13e-2)	unprognostic (3.69e-1)	unprognostic (1.88e-2)	unprognostic (9.41e-3)	unprognostic (1.83e-1)	unprognostic (8.26e-2)	unprognostic (1.32e-1)	14.8	7.1	1.6	4.9	6	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2	0.3	19.4	4.4	2.3	6.1	14.7	0	0.1	0.2	0	0	7.7	0.2	0.1	2	2.7	8.3	0	0	10.2	0.2	0.1	0	0	0.3	0.3	0.2	0.8	0.1	0.3	2.8	0.1	0.2	0.1	12.6	1	0.4	0.4	0.1	7.4	0.2	0.2	0	0.1	0.3	8.1	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.5	6.5	0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0	12	0.2	12.7	0.1	5.9	0.2	0.1	0.2	0.1	0	0	0.2	0.1	0.1	0	0	0.9	0	7.7	0	0.4	1.6	0	0	0	0.2	0.2	0	0	0.1	0	0.2	1.6	6	1.3	2.7	1.7	0.9	2	0.8	2.1	2
FRK	"GTK, PTK5, RAK"	ENSG00000111816	Fyn related Src family tyrosine kinase	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 41.4	Cell line enhanced	Detected in many		RT4: 10.1	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in all			"CAB025217, HPA030479"	Approved		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"CAB025217: , HPA030479: "	unprognostic (7.70e-3)	unprognostic (1.99e-2)	unprognostic (1.11e-1)	unprognostic (4.68e-3)	unprognostic (1.96e-1)	unprognostic (3.49e-2)	unprognostic (2.09e-1)	unprognostic (1.58e-1)	unprognostic (4.23e-2)	unprognostic (5.82e-3)	unprognostic (1.45e-1)	unprognostic (7.54e-2)	prognostic favourable (9.66e-7)	unprognostic (1.52e-2)	unprognostic (1.34e-1)	unprognostic (2.02e-2)	unprognostic (1.10e-1)	1.5	2.2	0.8	3	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2	41.4	2.5	2.4	1	5.5	1.8	0.5	1.2	1	5.2	7.4	5	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	3.2	5.3	0.8	1.3	0.4	0.4	1	0.8	0.2	0.1	0.1	4.1	5.1	1.3	4.9	0.8	7.7	0.4	1.5	0.2	4.4	0.5	1.8	4.6	3.5	0.3	1.2	1.1	0.3	2.2	0.5	0.6	0.3	0.9	3.3	1.3	1.8	1	0.8	1.4	0.9	1.5	4.6	1.6	6.5	10.1	1.1	1.2	1.1	6.8	0.7	2.1	1	1.3	1.5	1.6	1.2	0.8	5	3.5	2.3	1.5	0.8	1	3.2	1	1	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		U-2197: 103.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	17	NK-cells: 15.3;T-cells: 43.2	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		2000000	2000000	Plasma membrane	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: "	unprognostic (8.62e-3)	unprognostic (8.25e-2)	unprognostic (2.11e-1)	unprognostic (2.00e-2)	unprognostic (1.51e-1)	unprognostic (2.43e-2)	prognostic favourable (1.84e-4)	unprognostic (4.60e-2)	unprognostic (2.89e-2)	unprognostic (2.92e-1)	prognostic favourable (4.78e-4)	unprognostic (1.43e-1)	prognostic unfavourable (1.43e-4)	unprognostic (6.95e-2)	unprognostic (3.10e-1)	unprognostic (6.62e-3)	unprognostic (2.40e-1)	29.1	7.2	49.2	29	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32	19.4	21.2	39.4	34	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15	12.5	17.7	25.6	9.6	10	11	6.4	8.4	7	16.5	19	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.2	34.2	5.7	26.2	16.1	0.6	5.4	17.1	4.6	8.3	0.2	0.3	3.8	3.5	10.4	0.2	4.8	7.5	9.1	0.1	12.6	10.5	2.5	0.5	15.5	3.5	3.6	15.4	11.3	17.4	14.9	18.8	0.8	26.8	16.4	0.2	16.7	3.2	4.9	3.4	5.3	4.6	0.2	0	1.7	24	9.7	1	0.4	22.8	0.2	10.6	11.9	14	2.6	103.1	3.4	3.8	3.5	5.9	26.4	8.2	24.3	0.2	1.5	0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7	18.7	0.7	15.3	0.9	1	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34	35.7	23.1	25.6	31.3
GAK	DNAJC26	ENSG00000178950	Cyclin G associated kinase	O14976	4	849276-932373	"Enzymes, Predicted intracellular proteins"	Cell cycle	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"				Golgi apparatus	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	unprognostic (1.55e-1)	unprognostic (1.66e-1)	unprognostic (2.46e-1)	unprognostic (3.24e-3)	unprognostic (1.07e-1)	unprognostic (3.50e-3)	unprognostic (1.68e-1)	unprognostic (7.07e-2)	unprognostic (1.39e-2)	unprognostic (3.34e-1)	unprognostic (3.03e-2)	unprognostic (3.33e-3)	prognostic favourable (1.70e-6)	unprognostic (1.09e-3)	unprognostic (1.79e-1)	unprognostic (6.26e-2)	prognostic favourable (7.41e-4)	16.5	18.9	16.8	42.2	22.7	29.9	16.7	32.4	27.7	18	32.5	19.7	18.6	48.2	22.4	18.6	23.7	20.5	26.8	11.4	16.2	13.9	25	22.1	22.2	22.4	17.6	19.4	21.1	33	19.5	18.9	16.6	17.9	20.3	15.2	16.9	70.8	20.6	26.2	25.6	41.1	15.2	14.3	30.9	39.2	28.6	18.5	23.6	19.7	19.2	22.3	18.9	18.9	4.7	7.1	10.8	19.3	4	8.5	6.9	15.7	12.7	7.8	13.2	7.8	6.7	20.1	15	9	10.3	8.6	16	22.6	13.5	10.2	9	13.8	8	12.4	4.9	13.7	14.1	15.6	12.8	12	14.7	15.8	24.5	9.7	10.7	10.4	5.1	11.2	16.8	17.1	6.9	15.2	26.8	40.9	13.9	23.3	22.2	9	12	8.3	12.9	13.4	14.5	8.7	11.1	10.4	17.8	13.6	18.4	14.4	8.4	14.6	20	27.8	18.6	15	16.2	19.4	13.1	2.6	9	10.8	8.5	8.9	7.4	4.7	5.6	5.7	6	4	3.2	4.7	6.7	4	19.3	7.1	5	6.9	16.8	22.7	32.4	27.7	16.2	13.9	17.6	19.4	17.9	18.5
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	G protein-coupled receptor kinase 1	Q15835	13	113667155-113737735	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	retina: 51.5	Cell line enhanced	Detected in single		SCLC-21H: 1.2	Cancer enhanced	Detected in single		thyroid cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			"HPA035200, HPA059376"	Enhanced									"HPA035200: AB_2674515, HPA059376: AB_2683996"	unprognostic (7.93e-2)	unprognostic (2.50e-1)	unprognostic (1.87e-1)	unprognostic (1.24e-5)	unprognostic (1.76e-3)	unprognostic (1.53e-1)		unprognostic (3.59e-2)		unprognostic (2.21e-2)	unprognostic (1.84e-3)	unprognostic (2.00e-2)	unprognostic (4.02e-2)	unprognostic (6.91e-2)	unprognostic (6.18e-2)	unprognostic (6.11e-2)		0	0	0	0	0.2	0	0	0.1	0.2	0	0	0	0	0.3	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	51.5	0	0	0	0	0	0	0	0	0	0.3	0	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0	0	1.2	0.9	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0.1	0.1	0	0	0	0
GRK2	"ADRBK1, BARK1"	ENSG00000173020	G protein-coupled receptor kinase 2	P25098	11	67266410-67286556	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 78.2	Cell line enhanced	Detected in all		NB-4: 55.2;REH: 73.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB005021, CAB037248, HPA048330"	Approved		Approved	Vesicles				Vesicles		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: "	unprognostic (5.58e-2)	unprognostic (1.75e-1)	unprognostic (2.01e-2)	unprognostic (5.33e-2)	unprognostic (1.38e-1)	unprognostic (1.29e-3)	unprognostic (3.31e-2)	unprognostic (6.17e-2)	unprognostic (1.11e-1)	unprognostic (6.35e-2)	unprognostic (2.22e-1)	unprognostic (2.55e-2)	prognostic unfavourable (1.25e-4)	unprognostic (3.66e-1)	unprognostic (2.40e-1)	unprognostic (4.04e-2)	unprognostic (5.19e-3)	13.1	10.7	24.5	35.8	17	78.2	17	32.9	35.3	12.8	17.2	12.2	12.6	17.5	11.4	9.9	20.2	12.6	17.6	13.6	21.9	17.4	13	14.1	19.1	42.8	13.4	19	9.8	10.4	9.7	12.2	12.7	15.7	17.8	16.2	9.3	17.4	20.8	20.8	23.5	26.3	12.2	12.5	59.6	17.4	6.8	11.1	35.9	10.1	13.6	37.5	17.1	15.5	4.1	6	21	18.3	3.8	5.3	7.4	7.5	5.3	5.2	8.8	4.2	3.8	5.2	4.5	4.3	6.2	5.1	11.8	12.5	38.8	7.3	4.2	10.2	7.6	6.1	3.2	47.2	4.7	22	6.1	5.3	5.2	46.1	44.2	3.4	7.1	4.9	6.6	7.9	7.9	19.9	5.3	14	25.6	55.2	6.5	8	73.3	10.3	11.5	6.3	9.9	10.5	5.7	6.7	9.8	16	9.1	50.2	4.3	4.9	6.5	6.2	5	12.7	11.6	34.8	6.4	27.3	4.5	6.9	10.3	10.5	5.3	15.9	4	3.8	4	4.3	6	4.1	3.2	3.1	21	3.8	18.3	5.3	2.6	7.4	24.5	17	32.9	35.3	21.9	17.4	13.4	19	15.7	11.1
GRK3	"ADRBK2, BARK2"	ENSG00000100077	G protein-coupled receptor kinase 3	P35626	22	25564849-25729294	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 28.0	Cell line enhanced	Detected in many		HDLM-2: 22.6;SH-SY5Y: 20.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	9	classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Plasma membrane	HPA000804: AB_1078281	unprognostic (1.02e-1)	unprognostic (4.38e-2)	unprognostic (5.68e-3)	unprognostic (4.33e-2)	unprognostic (2.09e-1)	unprognostic (3.67e-2)	unprognostic (3.29e-1)	unprognostic (1.78e-2)	unprognostic (1.97e-1)	unprognostic (3.54e-1)	unprognostic (1.95e-3)	unprognostic (5.79e-2)	unprognostic (1.01e-3)	unprognostic (1.74e-1)	unprognostic (2.87e-3)	unprognostic (1.89e-2)	prognostic favourable (1.29e-4)	28	6	11.9	12.4	10.8	7	11.3	7.9	18.9	4.7	4	3.1	0.7	3	5.7	3.1	2.7	9.1	5	4.6	15.7	8.3	3	3.4	9.4	14.1	9.7	9.8	4.1	8.4	4.4	8.2	4.5	9.6	8.2	4.3	4.8	3.7	1.9	1.4	4.1	6.1	6.2	4.9	23.2	4	14.8	2.7	11.6	4.5	1.3	15.2	6.7	2.5	6.2	3.7	5.6	8	0	0.4	1.6	0	2.1	6.5	2.1	4.5	0.6	9.4	0.7	2	2	3.5	3.4	3.7	11.8	0.2	0.1	0.1	6.4	4.8	6.1	22.6	4.2	5.4	0.7	7.4	0.2	17.5	9.2	1.1	3.3	1.4	2.5	0.3	0.5	0	2.4	2.9	12.5	1.2	4.6	0	5.6	10.3	2	0	3.5	15.1	20.5	1.1	0	4.9	1.8	7	0.2	0	13.3	0.1	2.5	1.4	4.6	9.2	8.7	6.2	2	0.6	4.8	5.6	0	8	0.3	4.9	0	0.3	3.7	6.2	0.1	0.2	0.3	0	7.4	3.2	0.4	1.6	11.9	10.8	7.9	18.9	15.7	8.3	9.7	9.8	9.6	2.7
GRK4	"GPRK2L, GPRK4"	ENSG00000125388	G protein-coupled receptor kinase 4	P32298	4	2963608-3040747	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 41.2	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA028737, HPA057023"	Approved		Supported	Vesicles				Vesicles		"HPA028737: , HPA057023: "	unprognostic (1.86e-2)	unprognostic (2.88e-1)	unprognostic (1.03e-1)	unprognostic (9.51e-3)	unprognostic (3.65e-1)	unprognostic (1.84e-1)	unprognostic (1.21e-1)	unprognostic (2.39e-1)	unprognostic (1.79e-1)	unprognostic (1.87e-1)	unprognostic (3.90e-4)	unprognostic (3.20e-1)	unprognostic (1.01e-2)	unprognostic (4.74e-2)	unprognostic (2.17e-1)	unprognostic (1.17e-1)	unprognostic (1.89e-1)	3.4	3.6	5.4	1.6	5.1	1.7	4.8	12.5	5.9	3	2.1	4.2	1	1.5	2.7	3.1	2.4	2	3	5.6	5.2	4.8	2.8	2.3	2.4	1.6	5.3	5.3	3.4	7.9	3.9	6.2	2.2	5.9	2.4	2	3.1	4	2.9	5	2.9	1.7	2.8	5.4	1.9	2.5	41.2	3.7	1.6	4.1	1.6	1.7	2.5	3.3	1.2	2.5	4.5	2	1.6	1.7	1	2.4	0.9	3	8.5	7.3	7	1.8	4.8	2.1	2.7	2.4	2.4	0.8	5.5	2.1	7.6	0.8	3.9	4	2.4	3.8	3.9	6	3.4	2.8	4.3	2.4	2.2	4.7	6.2	4.8	2.3	5.1	5.6	7.2	6.4	2.8	5.1	5.1	2.3	6.7	6.5	3.8	2.2	2.6	3.1	17.3	5.3	2.9	1.3	4.3	6.5	3.7	5.9	7.4	1.9	5	4.2	7.4	4.2	4.2	3.7	5.3	2.5	4.5	1.1	2.1	1.1	2	1.4	1.1	0.7	0.7	0.3	1.2	1.7	1.6	4	1.6	0.7	2.5	0.4	1	5.4	5.1	12.5	5.9	5.2	4.8	5.3	5.3	5.9	3.7
GRK5	GPRK5	ENSG00000198873	G protein-coupled receptor kinase 5	P34947	10	119207589-119459742	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		BJ hTERT+: 36.5;HUVEC TERT2: 28.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"				"Nuclear membrane, Nuclear speckles"	Plasma membrane	"CAB025579: , HPA046838: "	unprognostic (1.09e-1)	unprognostic (3.47e-1)	unprognostic (1.19e-1)	unprognostic (6.02e-2)	unprognostic (6.56e-2)	unprognostic (3.74e-2)	unprognostic (4.62e-2)	unprognostic (3.69e-1)	unprognostic (4.11e-1)	unprognostic (1.06e-1)	unprognostic (3.70e-1)	unprognostic (2.32e-1)	prognostic unfavourable (2.38e-7)	unprognostic (1.10e-1)	unprognostic (3.27e-2)	unprognostic (1.55e-2)	unprognostic (1.90e-2)	15.9	8.3	3.4	16.8	7.8	2.7	10.2	6.5	5	12.5	18.8	3.9	4.5	12.4	13.4	12.2	8.1	7.7	19.5	45.4	4.2	4.2	4.3	5.7	27.6	8.8	3.7	2.5	16.5	3.5	26.2	6.3	24	4.5	7.5	6.4	5.6	5	6.7	12.8	4.7	10.4	10.8	4.8	17	13.9	3.5	4.7	9.8	8.9	10.7	8.6	9.5	13.6	9.3	2.2	6.5	3.7	0.2	11.3	4.2	4	2.3	6	6.1	13.8	13.3	1.8	7.8	36.5	4.9	2.7	1.9	5.9	4.3	1.8	12.2	1	2.6	8.6	3.2	17.1	2.1	0.7	5	7.7	9.5	0.2	2.2	1.8	1.3	9.8	1.4	28.8	0.4	4.2	1.7	0.6	4	3.9	0.9	6	1.4	0.8	1	0.8	1.6	2	5.5	2.7	1.2	7.5	0.1	1	8.7	2.6	1.9	15.8	3	0.9	4.6	2.6	5.5	4.8	2.5	0.9	3.7	6.5	5.3	3.2	0.4	9.3	7.7	3.8	2.2	9.1	11.3	5	5	0.2	0.9	0	9.2	4.2	3.4	7.8	6.5	5	4.2	4.2	3.7	2.5	4.5	4.7
GRK6	GPRK6	ENSG00000198055	G protein-coupled receptor kinase 6	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	Wnt signaling pathway	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 68.1	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in many			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		7500	7500	Mitochondria		"HPA015327: AB_1850334, HPA018903: AB_1850335"	unprognostic (1.06e-1)	unprognostic (3.39e-2)	unprognostic (4.46e-2)	unprognostic (3.87e-2)	unprognostic (2.35e-3)	unprognostic (1.53e-1)	prognostic unfavourable (5.66e-6)	unprognostic (2.63e-1)	unprognostic (6.45e-2)	unprognostic (8.96e-2)	prognostic favourable (1.22e-4)	unprognostic (1.74e-2)	unprognostic (1.99e-2)	unprognostic (1.83e-3)	unprognostic (1.15e-1)	unprognostic (4.00e-2)	unprognostic (3.47e-1)	6.8	5.5	7.8	26.8	7.3	68.1	10.2	7.7	10.9	5.9	9.2	6.6	5	10.9	8	6	11	6.6	9.3	6.2	8	7.3	5.7	6.6	11.1	37.6	7.1	10.7	6.1	12.1	3.5	5.6	4.9	6.7	8.1	5.5	5	10.8	5.2	7.4	7.7	14.5	7.8	5.4	34.3	9.1	10.5	5.1	32.3	5.3	6.4	26.5	11.4	6.5	9.2	5.7	32.1	22.6	17.4	11.7	9.1	12.1	13.2	4.8	21.1	1.4	2.4	20.7	8.9	4.7	11.3	11.2	30.8	10.4	14.4	13.7	4.7	8.9	7.5	20.4	4.4	39.6	23.4	12.8	10.8	10.4	7.8	17.2	16.3	3.8	5.1	11.2	6.6	6.3	13.3	52.2	3.4	34.7	17.7	18	8.3	14.6	17	7.8	20.8	3.3	9.9	11.2	15.2	7.4	13.1	17.2	10.3	19	8	9.1	13.8	9.7	22.3	15.1	18.2	11.7	6.2	28.2	8.9	4.5	9.5	32.1	11.7	16.5	8.4	9.2	9.8	10.7	5.5	9.2	10.4	9	23.2	17.4	22.6	5.7	11.7	9.1	7.8	7.3	7.7	10.9	8	7.3	7.1	10.7	6.7	5.1
GRK7	GPRK7	ENSG00000114124	G protein-coupled receptor kinase 7	Q8WTQ7	3	141778148-141818490	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 2.4	Cell line enhanced	Detected in some		BEWO: 4.0;HeLa: 1.4;U-937: 1.7	Not detected	Not detected							Cell type enhanced	Detected in single		neutrophil: 2.4	Low lineage specificity	Detected in single							Not detected	Not detected														unprognostic (1.11e-1)	unprognostic (1.70e-2)	unprognostic (3.35e-3)	unprognostic (1.22e-2)	unprognostic (1.13e-1)	unprognostic (1.60e-1)	unprognostic (1.39e-2)	unprognostic (5.08e-2)	unprognostic (1.21e-1)	unprognostic (1.31e-2)	unprognostic (3.46e-2)	unprognostic (1.20e-1)	unprognostic (2.53e-8)	unprognostic (3.08e-1)	unprognostic (1.99e-1)	unprognostic (3.11e-1)	unprognostic (2.91e-1)	0.2	0.5	0.3	0.5	0.4	1.5	0.2	0.9	0.3	0.2	0.1			0.4	0.3	0	0.3	0.3	0	0.2	0.3	0.3	0.2	0	0.2	0.2	0.2		0.6	0.3	0.7	0.2	0.2		0.3	0		0.4	0.2	1.6	1.5	0.4	0	0.2	0.4	0.1	1			0.1		0.3	0.1	0.3	0.7	0.2	2.4	0.4	0.5	0.6	0.1	0	0.1	0.1	0.6	0.4	0	4	0.1	0	0	0.1	0.2	0.6	0.2	0.2	0.1	0.1	0.1	0	0.1	0.4	0.5	0.2	1.4	0.2	0	0.4	0.3	0.1	1.1	0	0.1	0	0.2	0.2	0	0.2	0.2	0.7	0.4	0.2	0.2	0.1	0.2	0	0.5	0.3	0.4	0.2	0	0	0.5	0.2	0.2	0.2	0.1	0	0	0.2	0	0.2	0.1	1.7	0.2	0.2	0.4	0.3	0.4	0.2	0.6	0.6	0.5	0.3	0.1	0.7	0.5	0.5	2.4	0.5	0.3	0.2	0.2	0.1										
GSK3A		ENSG00000105723	Glycogen synthase kinase 3 alpha	P49840	19	42230186-42242625	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Cancer-related genes, Diabetes mellitus"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004422, HPA028423"	Approved		Approved	Cytosol				Cytosol		"CAB004422: AB_627680, HPA028423: AB_10612116"	unprognostic (5.46e-2)	unprognostic (1.50e-1)	unprognostic (1.45e-1)	prognostic unfavourable (4.02e-4)	unprognostic (1.35e-1)	unprognostic (3.96e-2)	prognostic unfavourable (1.13e-4)	unprognostic (3.80e-3)	unprognostic (2.27e-1)	unprognostic (2.87e-1)	unprognostic (4.99e-2)	unprognostic (3.36e-1)	unprognostic (2.69e-1)	unprognostic (2.77e-2)	unprognostic (4.49e-2)	unprognostic (7.22e-2)	unprognostic (8.22e-3)	15.3	19.8	31	16.8	38	14.4	12	31.4	62.2	15.9	16.8	24.3	11.4	28.6	16.9	18	17.3	16.7	11.8	21.3	31.3	23.6	17.5	13.1	14.2	15	21.8	26.3	20	19.3	16.1	14.2	14.7	31.7	15.8	16.1	15.5	18.1	20.3	41	25.1	27	18.5	18	14.5	14.7	19.1	17.7	16.6	15.8	11.9	15.8	15.8	15.5	1.6	2.2	4	1.9	1.7	2	1	23.6	42	24.1	22.3	14.4	12.9	10.2	16.7	15.9	22.1	20	15.7	15.1	17.1	17.2	13.1	10.9	19.8	19.4	15.5	13.8	31.8	17.8	13.5	15.5	19	20.2	21.8	12.6	20.6	18.1	20.7	20	29.9	25.6	18.9	28.7	26.2	17.9	17.8	17.4	23.9	14	13.2	20.4	24.8	28.1	28.4	22.9	30	15.2	17.3	26.8	17.7	22.8	17.1	13.2	29.5	26.2	30	13.4	26.5	20.4	25	2.5	1.5	1.6	2	1.9	1.4	1.2	1.2	1.3	1.4	1.6	0.7	1.5	4	1.7	1.1	2.2	1	1	31	38	31.4	62.2	31.3	23.6	21.8	26.3	31.7	17.7
GSK3B		ENSG00000082701	Glycogen synthase kinase 3 beta	P49841	3	119821323-120094417	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		81000	81000	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	unprognostic (1.09e-2)	unprognostic (2.62e-1)	unprognostic (1.40e-1)	unprognostic (2.17e-3)	unprognostic (1.15e-1)	unprognostic (4.86e-2)	prognostic unfavourable (8.20e-5)	unprognostic (3.39e-2)	unprognostic (1.11e-1)	unprognostic (1.67e-2)	unprognostic (1.05e-3)	unprognostic (6.79e-2)	prognostic favourable (1.52e-4)	unprognostic (2.39e-1)	unprognostic (2.58e-1)	unprognostic (1.28e-2)	unprognostic (1.16e-1)	17.6	17.6	17.4	13.8	21.3	25	13.7	32.7	28.3	15.8	16	15.6	7.1	15.5	14.5	12.6	20.3	12.4	14.4	20.8	17.1	22.4	15.7	21.7	17.1	17.5	17	22.6	14	14.9	25	19.2	24.1	18.1	13.9	17.9	14.9	18.5	11.7	23.9	21.6	18.2	17.1	13.4	26.3	13.3	30.8	14.4	46.5	17.4	8.4	14.1	14.2	15.7	1.7	2	10.6	3.1	1.4	3	1	28.3	13.7	23	13.3	15.3	15.6	22.3	16	30.8	15.4	14.1	14.8	11.6	11.5	9.8	22.8	19.4	10.8	31.1	23.9	7.8	3	16.8	10.3	11	17.5	17.2	22.5	15.7	20.9	16.4	33.5	16.9	7.1	22.4	20.1	15.3	18.3	4.8	12.5	14.2	7.3	19.6	11.1	11.2	20.3	17.3	10.7	18.8	13.7	18.5	17	11.6	21.6	22.1	24.9	6.9	9.5	14.9	13.7	22.2	13.7	11.5	17.6	4.3	2.9	7.5	2.4	2.6	2.1	1.1	2	3	2	1.7	2	1.5	10.6	1.4	3.1	1.6	1.3	1	17.4	21.3	32.7	28.3	17.1	22.4	17	22.6	18.1	14.4
GUCY2C	"GUC2C, STAR"	ENSG00000070019	Guanylate cyclase 2C	P25092	12	14612632-14696585	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	cGMP biosynthesis	"Lyase, Receptor"	"Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	intestine: 85.1	Cell line enhanced	Detected in some		AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.1;CAPAN-2: 4.5;SiHa: 4.2	Group enriched	Detected in many	5	colorectal cancer: 23.9;stomach cancer: 9.1	Not detected	Not detected			Cell type enhanced	Detected in some		memory B-cell: 4.3	Low lineage specificity	Detected in many			Low region specificity	Detected in some			Low region specificity	Detected in all			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA037655: AB_10672388, HPA073759: "	unprognostic (1.08e-1)	unprognostic (2.12e-1)	unprognostic (3.58e-2)	unprognostic (2.11e-2)	unprognostic (1.60e-2)	unprognostic (5.67e-3)	prognostic unfavourable (1.37e-5)	unprognostic (9.14e-2)	unprognostic (1.49e-2)	unprognostic (2.95e-1)	unprognostic (1.58e-1)	unprognostic (5.40e-2)	unprognostic (2.35e-4)	unprognostic (8.02e-2)	unprognostic (1.64e-1)	unprognostic (1.33e-1)	unprognostic (1.98e-1)	0.2	0.1	0.2	3.4	0.2	0	0.2	0.2	0.2	0.2	38.8	0.2	0.2	28	0.3	0.2	0.4	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0	0.2	0.2	0.2	0.2	17.5	0.2	0.5	0.2	0.2	1	85.1	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	4.3	0.7	2.7	1.7	0	0	0.6	1.1	0.1	0	3.7	0	0	2.2	0.1	0	0	0	3.1	4.5	0.7	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.4	0	0	0.7	0	0.4	0.4	0	0	0	0.5	0.1	0.6	0	0.5	4.2	0.3	0	0.3	0.1	0	0	0	0.9	0.1	1.3	0.8	1.3	0	0	0.1	0	1.7	0	0	0.5	0	4.3	0	0	0.7	2.3	0	0	2.7	0	0	0.7	0	0.6	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002594-8020339	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase	"Cone-rod dystrophy, Disease mutation, Leber congenital amaurosis"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	blood: 10.6;retina: 33.3	Cell line enriched	Detected in single	7	HMC-1: 5.3	Low cancer specificity	Detected in single			Not detected	Not detected			Cell type enriched	Detected in single	31	plasmacytoid DC: 10.6	Lineage enriched	Detected in single	53	dendritic cells: 10.6	Not detected	Not detected			Not detected	Not detected														unprognostic (3.57e-4)	unprognostic (5.05e-1)	unprognostic (1.49e-1)	unprognostic (9.75e-5)	unprognostic (5.94e-2)	unprognostic (1.86e-1)	unprognostic (4.44e-2)	unprognostic (3.81e-2)	unprognostic (2.92e-1)	unprognostic (2.26e-1)	unprognostic (7.54e-2)	unprognostic (4.44e-1)	unprognostic (7.59e-5)	unprognostic (1.05e-1)	unprognostic (3.46e-1)	unprognostic (3.08e-1)	unprognostic (1.07e-1)	0.1	0	0.1	0.3	0.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	1.3	0.3	0.1	0.2	0.1	0	0.1	0.1	0.1	0.4	0	33.3	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.6	0.1	5	0.1	0.2	0.1	0.1	0.9	0.1	0.2	0	10.6	0.1	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.2	0.1	0	0.1	0	0	0	0	0.7	0	0	0	0.1	0	5.3	0.6	0.2	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	10.6	0	0	0.1	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.1	0.1
GUCY2F	"CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2"	ENSG00000101890	"Guanylate cyclase 2F, retinal"	P51841	X	109372906-109482072	"Enzymes, Plasma proteins, Predicted membrane proteins"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	retina: 23.1	Group enriched	Detected in some	5	THP-1: 4.4;U-266/70: 1.6;U-937: 1.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																	unprognostic (1.91e-1)	unprognostic (4.45e-2)									unprognostic (2.96e-1)	unprognostic (2.23e-1)			0	0.1	0	0	0.1	0	0	0	0.2	1.6	0	0	0	0	0.4	0	0	2.3	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.4	0	0	0	0	23.1	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0.3	0	0.1	0	0	0	0	0	0.2	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	4.4	0	0	0	0	0.1	1.6	0	0.1	0	1.5	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0
HASPIN	GSG2	ENSG00000177602	Histone H3 associated protein kinase	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	Cell cycle	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in many			"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA027422: AB_10601812, HPA030698: "	unprognostic (1.15e-2)	unprognostic (2.78e-2)	unprognostic (7.06e-2)	unprognostic (2.14e-2)	unprognostic (8.05e-2)	unprognostic (2.81e-1)	unprognostic (1.01e-4)	unprognostic (1.57e-2)	unprognostic (6.60e-2)	unprognostic (1.77e-1)	unprognostic (2.75e-3)	unprognostic (3.82e-3)	unprognostic (0.00e+0)	unprognostic (5.65e-3)	unprognostic (3.09e-2)	unprognostic (1.31e-1)	unprognostic (1.73e-1)	1.2	0.3	0.3	11.8	0.6	7.5	1.8	0.5	0.3	0.5	1.5	0.2	0	2.2	0.3	0.4	2.8	0.6	1.3	0.6	0.2	0.2	0.8	0.4	2.6	5.8	0.4	0	0.4	0.5	0	0.3	1.3	0.2	0.7	1.5	0.2	1	0	1.2	0.9	3.6	0.4	1.2	4.9	1.7	26.7	0.3	26.7	0.7	1.7	7.3	0.8	1	2.8	1.5	2.1	0.6	0	1.2	0.4	7.5	8.2	7.6	8.6	0.5	1	6.4	6.9	5.3	13.7	13.5	6.4	3.1	18.5	4	3.8	12.3	13.7	6.7	13.1	0.1	11.5	9.2	6.7	3.8	0.3	5.3	9.5	0.6	0.5	10.3	6.4	6.2	8.1	16.3	6.9	3.9	10.7	3.1	6.7	5.7	11.1	9.6	5	2	5.3	3.1	4.5	6.1	4.2	2.4	4.2	5	3.2	6.1	7	6.8	12.1	3.1	3.5	9	3.6	7.7	7.3	0.4	0.6	2.1	0.2	0.5	0.2	0.7	0.8	0	1.1	2.8	1.2	0.2	0.2	0	0	1.5	0.1	0.4	0.3	0.6	0.5	0.3	0.2	0.2	0.4	0	0.2	0.3
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 107.1;lymphoid tissue: 72.6	Group enriched	Detected in some	8	THP-1: 22.6;U-937: 64.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	15	classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1	Group enriched	Detected in many	15	dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1	Low region specificity	Detected in many			Low region specificity	Detected in all			"CAB005195, HPA063768"	Approved		Approved	"Nucleoplasm,Plasma membrane"				Plasma membrane	Nucleoplasm	"CAB005195: AB_631619, HPA063768: "	unprognostic (6.22e-2)	unprognostic (6.16e-3)	unprognostic (2.26e-2)	unprognostic (7.98e-2)	unprognostic (8.83e-2)	unprognostic (5.50e-2)	unprognostic (4.09e-2)	unprognostic (1.72e-2)	unprognostic (4.34e-2)	unprognostic (1.59e-1)	unprognostic (4.08e-2)	unprognostic (1.21e-1)	prognostic unfavourable (1.66e-4)	unprognostic (4.92e-2)	unprognostic (4.42e-2)	unprognostic (6.95e-2)	unprognostic (1.12e-1)	12.3	5.8	5.9	40.8	13.1	20.8	4	1.8	5.3	3	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6	3.7	4	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73	107.1	1.1	0.1	40.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.3	0	0	0.4	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	5.5	0	0	0	1.5	0.1	0	0.1	0	0.2	0	0	0.1	0	0.1	0	0.1	0	22.6	0	0	0.1	0	0	0.6	0.1	3.3	0	64.8	0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0	73	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6	3.7	11.2	1.2	8	8.2
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	Homeodomain interacting protein kinase 1	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 90.1	Cell line enhanced	Detected in all		MCF7: 61.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016664	Approved		Approved	"Nucleoplasm,Centrosome,Cytosol"				"Nucleoplasm, Centrosome, Cytosol"		HPA016664: AB_1850725	unprognostic (2.98e-1)	unprognostic (3.94e-2)	unprognostic (4.89e-3)	unprognostic (2.52e-2)	unprognostic (6.47e-2)	unprognostic (9.84e-3)	unprognostic (4.64e-3)	unprognostic (7.22e-2)	unprognostic (7.52e-2)	unprognostic (1.45e-2)	unprognostic (1.26e-1)	unprognostic (1.15e-1)	unprognostic (8.63e-2)	unprognostic (1.84e-1)	unprognostic (2.64e-1)	unprognostic (1.94e-2)	unprognostic (1.99e-2)	15.1	16.8	21.2	14.7	23	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6	2.3	8.1	6.6	9.2	7	10.8	5.7	6.2	5.6	6.8	8	7.7	7.6	3.1	10.9	7.7	8.9	5.5	11.8	6.6	11.6	7.9	6	15.9	8.3	8	9	12.7	19.7	6.1	9.6	10.2	10.5	11.8	10.8	11.8	11.5	61.5	16.6	7.2	9.4	5.9	10.1	27	3.8	7.2	7	4.1	5.4	10.2	11	7.2	6.4	18.3	11.5	7.9	10.7	12.8	8.5	7.4	5.8	9.5	8.8	10.3	17.9	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5	6	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23	38.1	20.4	22.9	17.2	15	16.4	21.3	21.3
HIPK2		ENSG00000064393	Homeodomain interacting protein kinase 2	Q9H2X6	7	139561570-139777778	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 66.1	Cell line enhanced	Detected in many		HDLM-2: 42.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	6	basophil: 17.8	Lineage enriched	Detected in many	6	granulocytes: 17.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007611	Supported		Supported	Nucleoplasm				Nucleoplasm		HPA007611: AB_1850730	unprognostic (1.35e-3)	unprognostic (1.49e-2)	unprognostic (1.65e-1)	unprognostic (7.65e-2)	unprognostic (5.50e-2)	unprognostic (9.44e-2)	unprognostic (2.76e-1)	unprognostic (4.66e-2)	unprognostic (1.44e-1)	unprognostic (2.76e-2)	unprognostic (3.42e-3)	unprognostic (4.58e-2)	prognostic favourable (9.99e-4)	unprognostic (1.38e-1)	unprognostic (7.82e-2)	unprognostic (3.93e-3)	unprognostic (1.03e-2)	19.6	9.8	58.8	7.4	53.6	14.4	12.6	8.5	39.8	5.5	7.4	54.5	5.2	8.2	4.7	5.2	10.2	9.9	5.5	30.5	60	39.9	28.2	17.5	8.6	5.3	66.1	16.4	6.6	12.3	17.2	7.6	10.8	26.4	10.7	5.8	9.4	11.5	7.1	21.6	3.2	6.2	4.8	56.2	7.3	15.4	2.6	38.6	1.7	10.4	2.8	4.9	6.8	7.4	0.6	0.5	17.8	2.9	0.2	1.4	0.5	4.1	18.2	8.4	5.2	20.7	14.8	1	2.2	2.2	2.5	2.6	1.3	2.2	0	5.3	4.2	0.2	3.8	5.9	6.4	42	1.6	18.7	3	6.5	11.6	5.1	5.1	22.6	3.9	11.7	17.6	6.3	10.8	5.2	19.5	3.1	6.4	3.7	2.1	12.5	7.7	4.6	0.5	11.6	0.7	5.1	4.7	5.1	0.1	2.6	2.9	2.1	21.2	8.9	4.3	10.3	11.1	25.4	15.1	3.7	18.3	2.7	4.8	17.8	1.1	2.7	0.2	0.9	0.3	0.6	0.5	0.1	0.5	0.3	1.4	0.4	1.5	0.2	2.9	0.2	0	0.5	58.8	53.6	8.5	25.2	60	39.9	66.1	16.4	26.4	38.6
HIPK3	"DYRK6, FIST3, PKY, YAK1"	ENSG00000110422	Homeodomain interacting protein kinase 3	Q9H422	11	33256672-33357023	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA028069	Approved		Supported	"Nuclear bodies,Cytosol"				Cytosol	Nuclear bodies	HPA028069: AB_10601815	unprognostic (2.41e-3)	unprognostic (1.02e-1)	unprognostic (4.61e-1)	unprognostic (5.74e-2)	unprognostic (2.09e-1)	unprognostic (1.78e-2)	unprognostic (1.63e-1)	unprognostic (7.29e-2)	unprognostic (1.61e-1)	unprognostic (2.78e-1)	unprognostic (2.18e-1)	unprognostic (2.68e-1)	unprognostic (3.29e-3)	unprognostic (7.89e-3)	unprognostic (1.80e-1)	unprognostic (1.87e-1)	unprognostic (2.48e-2)	46.3	13.4	12.7	15.9	15.9	12.7	49.2	11.7	13.7	23.6	24.8	11.9	15.9	9.9	28.3	22.8	22.9	24.1	18.8	69	13.4	11.8	23.4	21.1	20.2	20.9	15.5	8.2	23.6	15.4	49.7	21.2	20.5	15.2	23.2	12.8	15.6	18.8	18.1	45.9	18.7	25	32.9	15.9	20.1	20.5	14.7	14.2	15.2	37.9	26	14.4	33.6	34.6	3.1	11.3	17.6	10.1	3.3	4.4	3.7	9.4	9	6.8	7.7	31.6	20	6.8	10	11.6	8.1	6.9	9.9	6.9	10.2	8.5	12.2	12.1	5.1	11.2	11.5	14.8	8	10.3	10.2	7.5	13.1	11	6.5	18.7	22	3.1	9.2	9.9	3.2	20.5	13.1	4.9	9.1	7.7	1.7	5.5	12.3	24.2	10.2	13.4	14.8	1	5.7	13.6	15.6	9.3	17.5	20.4	12.7	12.8	8.8	14.7	7.1	11.3	17.7	10.8	6.2	11.7	11.9	6.6	10.1	4.8	3.5	7.6	4.4	2.4	3.2	3.7	11.3	3.1	2.9	3.5	17.6	3.3	8.6	1.4	3.2	3.7	12.7	15.9	11.7	13.7	13.4	11.8	15.5	8.2	15.2	14.2
HIPK4	FLJ32818	ENSG00000160396	Homeodomain interacting protein kinase 4	Q8NE63	19	40379271-40390187	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	testis: 34.7	Cell line enhanced	Detected in some		A549: 3.0;AN3-CA: 2.3	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		NK-cell: 1.1	Low lineage specificity	Detected in single			Not detected	Not detected			Low region specificity	Detected in all			HPA027733	Uncertain									HPA027733: AB_1850734	unprognostic (2.07e-2)	unprognostic (6.25e-2)	unprognostic (2.58e-2)	unprognostic (5.53e-3)	unprognostic (4.00e-2)	unprognostic (1.36e-1)	unprognostic (3.69e-2)	unprognostic (2.52e-3)	unprognostic (1.08e-1)	unprognostic (7.48e-3)	unprognostic (8.85e-2)	unprognostic (9.09e-2)	unprognostic (3.06e-2)	unprognostic (8.71e-3)	unprognostic (3.64e-2)	unprognostic (2.03e-2)	unprognostic (4.63e-2)	0.3	0.1	2.3	0.3	7.4	0.2	0.3	1.2	5.7	0.3	0.3	0.3	0.3	0.2	0.4	0.3	0.5	0.2	0.3	0.8	2.9	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.3	0.4	0.3	1.4	0.2	0.3	0.3	0.3	0.3	0.1	34.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0.7	0	0.4	1.1	0.3	0.1	0.1	3	0.2	2.3	0.1	0.3	0	0.7	1.1	0.8	0.4	0	0	0	0.2	0.5	0	0.2	0	0.1	0.4	0.3	0	0.1	0	0	0	0.3	0.5	1.2	0.3	0.3	0.1	0.3	0	0.2	0.7	0.1	0.1	0.1	0.4	0.1	0.3	0.3	0	0.4	0	0.3	0.4	0.1	0	0.4	0.1	0.6	1.3	1.2	1.1	0	0.7	0.5	0	0	0	0	0	0.4	0	0	0	0	0	0	0.3	0.7	0	0	0	0	1.1	0	0	0	0.1	2.3	7.4	1.2	3.5	2.9	0.3	0.3	0.3	0.3	0.3
HUNK		ENSG00000142149	Hormonally up-regulated Neu-associated kinase	P57058	21	31873315-32044633	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 10.4;BEWO: 12.9;RH-30: 14.2;SCLC-21H: 11.6;SiHa: 10.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in many			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA027295: , HPA027372: "	unprognostic (9.09e-3)	unprognostic (7.29e-2)	unprognostic (1.42e-1)	unprognostic (5.95e-3)	unprognostic (1.99e-1)	unprognostic (2.12e-4)	unprognostic (4.00e-2)	unprognostic (6.90e-2)	unprognostic (5.07e-1)	unprognostic (2.27e-1)	unprognostic (9.09e-2)	unprognostic (1.13e-1)	prognostic favourable (7.48e-5)	unprognostic (8.84e-2)	unprognostic (2.22e-1)	unprognostic (1.39e-1)	unprognostic (6.69e-2)	1.7	1.9	2.7	2.9	3.5	0.5	2.1	3.2	6.4	1.1	5.9	0.2	12.6	2.4	9	3.4	1.1	3.3	1	1.7	3.7	3.2	6	1.3	1.7	0.7	1.2	2.1	1.8	15.7	0.2	4.7	7.6	1.4	4	6.5	9.1	1.5	11.1	0.6	5	4.4	4.1	0.9	0.4	2.1	1.8	0.2	0.4	1.1	2.2	1	3.8	7.7	1	0.7	1.7	0.5	0.5	0.5	0.1	0	3	10.4	0.1	0	0	12.9	1	0	0.2	0	4.1	0.1	0	0.4	4.8	0	6.2	0	0	0	3.1	0	2.7	2	0	0	0.1	0	0	0	0	0	0	0	0	0.8	0.2	0.9	7.9	0.1	0.1	14.2	0	1.1	0	11.6	7.7	10.2	0.8	0.4	4.2	1.1	0	0	7.4	0	0	0.1	0	1.4	0	0	4.9	0.8	0.5	0.5	0.5	0.3	0.3	0.5	0.5	0.3	0.2	1	0.5	0.5	1.7	0.5	0.3	0.7	0.4	0.1	2.7	3.5	3.2	6.4	3.7	3.2	1.2	2.1	1.4	0.2
ICK	"KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	Intestinal cell kinase	Q9UPZ9	6	53001279-53061802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Cilium biogenesis/degradation	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA000791, HPA001113"	Approved		Approved	Nucleoli fibrillar center				Nucleoli fibrillar center		"HPA000791: , HPA001113: AB_1851385"	unprognostic (1.75e-2)	unprognostic (1.02e-1)	unprognostic (5.47e-2)	unprognostic (2.95e-1)	unprognostic (2.32e-1)	unprognostic (1.00e-2)	unprognostic (1.44e-1)	unprognostic (1.82e-2)	unprognostic (1.17e-3)	unprognostic (5.11e-2)	unprognostic (1.18e-1)	unprognostic (8.28e-2)	unprognostic (8.12e-3)	unprognostic (1.21e-1)	unprognostic (1.39e-1)	unprognostic (1.07e-1)	unprognostic (2.26e-1)	9.8	28.2	10.1	6.5	10.7	2.8	13.4	14.3	12.7	11.5	12.3	20.1	6.6	11.3	10.6	6.8	10.4	9.2	8.3	9.6	10.8	7.7	5.4	9.6	8.2	5.5	13.3	8.1	11.8	8.2	9	5.3	44.3	12.3	12.2	13	9.7	20.7	12.7	5.9	10.1	14.2	13.7	16.8	6.2	15	5.6	12.6	14.8	7.6	7	7.9	10.6	9.1	4.5	4.1	6.2	3.1	3.2	5	2.1	5.2	2	10.3	7	6.4	10.1	11.9	4.7	8.6	7.6	8.7	2.8	1.7	3.8	2.8	14.3	3.5	12.2	4.9	10.1	13.2	4.8	2.9	2.4	15	3.2	3.5	3.8	9	5.3	3.2	3.7	7.1	5.4	15.8	17.3	4.5	3.7	4.3	3.9	4.3	5.9	4.5	5.1	3.1	3.8	16.6	7.4	4.6	11.4	6.5	6.6	7.4	5.8	12.2	5.7	4.5	11.6	4.4	3.1	1.5	2.5	3.4	5.9	6.2	3.1	5.6	5	2.3	4.8	3.7	3.6	4.1	2.9	4.5	4.2	3.6	1.7	3.2	2.5	4.1	4.8	2.1	10.1	10.7	14.3	12.7	10.8	7.7	13.3	8.1	12.3	12.6
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	Insulin like growth factor 1 receptor	P08069	15	98648971-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 7.7	Group enriched	Detected in many	5	granulocytes: 7.7;T-cells: 2.9	Low region specificity	Detected in all							"CAB010268, HPA045563"	Approved		Approved	Vesicles		36000	36000	Vesicles		"CAB010268: AB_671792, HPA045563: "	unprognostic (1.30e-3)	unprognostic (5.81e-3)	unprognostic (1.53e-1)	unprognostic (3.34e-2)	unprognostic (2.65e-1)	unprognostic (2.05e-2)	unprognostic (1.29e-2)	unprognostic (6.87e-2)	unprognostic (2.64e-2)	unprognostic (2.87e-2)	unprognostic (8.56e-2)	unprognostic (1.62e-1)	prognostic favourable (3.75e-7)	unprognostic (1.57e-1)	unprognostic (3.59e-1)	unprognostic (1.41e-1)	unprognostic (1.06e-1)	8.4	12.7	11.5	5.9	13.5	16.3	18.5	23	15.7	15.3	13.4	10.4	22.7	4.2	15.3	16.3	9.2	18.9	7.7	11.6	11.7	7.3	17	2	11	4.9	8	11.8	23.2	22.5	4.7	13.8	17.5	9.5	21.7	7.2	16.7	12.5	23.2	9.1	13	7.5	18.1	8	7.3	10.7	12	11.5	10.7	16.1	7	5.6	12.8	21.6	1	0.4	7.7	0.6	1	2.9	0.7	3.3	16.5	11.6	0.2	5.8	4.2	7.7	3.7	7.4	1.2	1.1	7.1	8.8	0.8	10.7	7.2	15.8	5.1	15	1	0	5.2	12.5	18.5	14.2	5.1	6.6	1.3	6.6	7.1	2.1	10.2	4.1	0.6	2.9	5.7	23.4	2.5	4.4	10.8	0.9	4	9	3	3.5	20.3	3.9	17.3	26.7	1.5	14.4	8.1	3.1	11.3	1.1	15	3	5.8	1	4.4	2.7	2.2	4.9	2.8	4	0.6	1.8	0.9	0.6	0.6	0.4	0.8	0.3	0.4	1	2.9	1	7.7	1	0.5	0.3	0	0.7	11.5	13.5	23	15.7	11.7	7.3	8	11.8	9.5	11.5
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	Inhibitor of nuclear factor kappa B kinase subunit beta	O14920	8	42271302-42332653	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Host-virus interaction	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001249, CAB004447"	Enhanced		Approved	Cytosol				Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	unprognostic (1.04e-1)	unprognostic (2.30e-2)	unprognostic (1.31e-1)	unprognostic (1.73e-3)	unprognostic (1.26e-1)	unprognostic (1.27e-3)	unprognostic (1.95e-1)	unprognostic (1.25e-3)	unprognostic (1.75e-1)	unprognostic (1.55e-1)	unprognostic (3.27e-1)	unprognostic (1.73e-1)	unprognostic (1.20e-2)	unprognostic (1.89e-2)	unprognostic (9.20e-2)	unprognostic (3.02e-1)	prognostic favourable (1.46e-6)	9.1	10.8	10.9	17	16.7	9.3	10	26.1	16.9	10.3	10.3	12.4	11.4	4.7	15.3	13.2	17.9	16.4	14.9	7.9	13.1	6.9	12.4	9.9	14.9	12.2	20.3	7.9	9.6	13.3	18	13.6	11.2	11.9	14	10.9	10.5	11.4	9.7	17.6	22.2	9.8	16.4	10.5	18.7	10.8	8.3	18.6	12.9	14.3	8.4	17.1	18.1	12.8	12.6	14.8	14.1	9.6	11.9	11.2	5.8	3.6	13.1	3.7	6.4	14.5	12.6	4.8	3.2	11.5	9.7	8.5	3	6.8	7.2	5.6	8.9	4.2	5.1	13	12.5	7	5.8	10.1	6.1	2.3	11.1	1.9	10.6	8.4	9.9	9.3	14.4	14.3	8.5	3.5	21.2	4.2	7	3.2	3.6	4.1	7.2	6.4	4.2	10.9	3.3	1.1	2.1	2.1	3.6	5.3	4.8	8.5	7.4	6.8	3.6	5.3	2.3	2.1	2.2	5.1	8.1	4.8	7.7	14.1	9.6	10.4	10.1	7.6	10.3	9.4	10.5	11.2	8.9	12.6	10.2	10.4	11.4	11.9	9	14.8	9.9	5.8	10.9	16.7	26.1	16.9	13.1	6.9	20.3	7.9	11.9	18.6
IKBKE	"IKK-i, IKKE, KIAA0151"	ENSG00000263528	Inhibitor of nuclear factor kappa B kinase subunit epsilon	Q14164	1	206470476-206496889	"Enzymes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 24.8;lymphoid tissue: 19.5	Cell line enhanced	Detected in many		NB-4: 25.1	Low cancer specificity	Detected in all							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA015788, CAB025983"	Approved		Supported	Cytosol				Cytosol		"CAB025983: , HPA015788: AB_1851566"	unprognostic (6.43e-2)	unprognostic (3.04e-1)	unprognostic (1.48e-1)	unprognostic (5.76e-2)	unprognostic (7.78e-3)	unprognostic (7.37e-3)	unprognostic (1.99e-3)	unprognostic (2.82e-1)	unprognostic (5.09e-3)	unprognostic (1.30e-1)	unprognostic (1.50e-1)	unprognostic (1.27e-1)	prognostic unfavourable (5.34e-7)	unprognostic (1.48e-2)	unprognostic (5.77e-2)	unprognostic (2.84e-3)	unprognostic (2.84e-2)	2.1	0.9	1	17.3	3.4	4.3	1.4	1.1	1.7	2.2	4.8	1.5	1.7	3.9	2	3.9	6.1	1.2	3.6	1.1	2.9		1.5	0.6	3.7	13.6	2.1	0.7	1	1.5	0	0.8	2.5	1.9	1.8	4.3	1.5	8.3	2.9	0.1	8.9	4.2	1	2.9	12.8	4	0	2.4	18.8	2.6	4.4	19.5	4.4	0.4	12.9	4.6	4.2	15.9	10.8	24.8	12.3	8.8	7	1.9	0.2	3.5	5	2	3.6	11.3	4.9	5.5	5.5	14.4	17.5	9.7	7.2	12	0	9.1	1	2.8	1.7	2.4	4.2	3.8	4.6	14.9	8	6.5	1.6	4	0.8	7.1	1.1	5.4	5.1	1.8	9.5	25.1	2.8	5.4	5.1	2.1	14	5.8	15.1	0	0	1.5	12	2.2	7.2	10.6	13.7	4.9	3	3.5	4	1.8	0.8	11.4	9.2	12.5	2	4.2	15.9	0.3	10.5	11.2	7.5	12.9	16.7	15.2	4.6	7.4	13.3	13.6	1.1	10.8	6.4	1.5	24.8	12.3										
ILK		ENSG00000166333	Integrin linked kinase	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Focal adhesion sites"		130000000	130000000	"Cell Junctions, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: "	unprognostic (1.78e-1)	unprognostic (2.26e-2)	unprognostic (5.26e-2)	unprognostic (2.12e-2)	unprognostic (7.57e-2)	unprognostic (1.01e-1)	unprognostic (6.19e-3)	unprognostic (5.25e-3)	unprognostic (1.49e-2)	unprognostic (9.65e-2)	unprognostic (2.64e-1)	unprognostic (8.12e-2)	prognostic favourable (2.44e-4)	unprognostic (4.01e-3)	unprognostic (9.27e-2)	unprognostic (2.42e-1)	unprognostic (6.36e-3)	20.9	17.6	11	22.3	11.9	7.5	37	9.4	14.6	40.2	75.1	14.7	41.9	13.5	75.4	25.2	35.7	33.2	41.1	35.1	11.1	9.2	21.6	15.1	21.9	18.9	11.5	14	24.2	22.3	20.4	10.9	22.2	11.5	39.9	24.6	19.3	19.4	89.9	18.5	12.4	22.2	103.5	10.6	20.2	33.2	14.2	11	8.2	17.5	14.1	13.6	60.8	25.9	19.5	45.9	76.5	49.4	45.3	25.8	63.7	23.8	18.4	29.1	10	44.9	31.9	13.2	35.1	69.4	41.6	50.8	19.2	28.1	9	9.3	57.4	19.2	16.2	29.7	41.8	15.7	14.8	12.9	17.6	14.9	30.1	10.3	14.8	30.6	14	28.1	21.5	39.6	11.8	10.7	54.2	17.9	9.1	17.7	18.3	21.6	9.6	15.2	9.5	30.5	19.1	5	11.4	16.6	23	19.3	16	11.8	45.8	52.2	23.6	21.6	17	7.8	4.8	12.6	38.7	15.6	24.3	48.3	49.4	76.5	25.8	47.9	25.1	19.5	23.3	24.4	45.9	17.1	14.7	18.5	31.7	45.3	44.4	18.5	25.7	63.7	11	11.9	9.4	14.6	11.1	9.2	11.5	14	11.5	11
INSR	CD220	ENSG00000171105	Insulin receptor	P06213	19	7112255-7294034	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Carbohydrate metabolism	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		pancreas: 64.5	Cell line enhanced	Detected in many		Karpas-707: 30.6;U-266/70: 22.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	7	dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		72000	72000	Vesicles	Plasma membrane	"HPA036302: , HPA036303: "	unprognostic (4.64e-2)	unprognostic (2.42e-1)	unprognostic (9.65e-3)	unprognostic (9.70e-2)	unprognostic (1.44e-1)	unprognostic (1.15e-2)	unprognostic (2.58e-1)	unprognostic (5.09e-2)	unprognostic (1.97e-1)	unprognostic (3.05e-1)	unprognostic (9.29e-2)	unprognostic (1.86e-1)	unprognostic (6.33e-2)	unprognostic (3.45e-3)	unprognostic (2.43e-1)	unprognostic (2.75e-1)	unprognostic (8.82e-2)	13.9	14.7	7.1	3.5	8.2	4.5	12	12	8.2	10.3	15.2	11.7	10.6	8.4	15.5	6.1	4.7	13.1	7.7	17.7	6.4	5.8	18.7	32.5	5.3	2.2	10.1	4.9	28.3	64.5	11.6	11.6	26.2	8	10.5	8.9	11	12	10.6	15.1	7.3	16	10.6	6.8	47.3	8.7	6.9	9.7	2.2	17.1	5	3.2	11.3	16	1.1	8.8	5.1	10.5	0.8	0.7	1.3	3.7	2.1	1.9	2.9	10.6	3.7	6.4	2.1	1.9	1.2	1.2	5.3	4.3	4.7	5.3	3.8	1	4.6	0.9	0.7	0	3.7	0	1.5	11.5	4.6	2.2	3.8	5.7	2.4	0.1	2.8	2.1	5.7	30.6	0.9	1.7	1.6	3.8	1.8	3.3	16.3	1.1	4.1	0.1	15.5	3.7	2.8	3.8	2	2.1	0.9	10.8	2	2.2	1.4	4.7	2.8	22.6	12.3	10.9	2.6	3.8	0	2	8.2	5.1	0.2	7.8	0.3	0.8	0.3	0.1	8.8	1.1	0.7	0.1	1.7	0.8	10.5	7.4	0	1.3	7.1	8.2	12	8.2	6.4	5.8	10.1	4.9	8	9.7
INSRR	IRR	ENSG00000027644	Insulin receptor related receptor	P14616	1	156840063-156859018	"Enzymes, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 5.5;brain: 5.9;kidney: 8.3	Group enriched	Detected in some	7	SCLC-21H: 5.4;SH-SY5Y: 18.6	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in single			Not detected	Not detected			HPA025285	Uncertain									HPA025285: AB_1851814	unprognostic (1.19e-1)	unprognostic (7.69e-2)	unprognostic (2.42e-2)	unprognostic (6.76e-4)	unprognostic (1.51e-1)	unprognostic (9.07e-3)	unprognostic (5.57e-2)	unprognostic (1.75e-1)	unprognostic (6.17e-2)	unprognostic (5.57e-2)	unprognostic (2.20e-2)	unprognostic (7.00e-2)	unprognostic (4.22e-5)	unprognostic (2.82e-1)	unprognostic (9.55e-2)	unprognostic (2.75e-3)	unprognostic (3.66e-2)	0.9	5.5	0	0.3	5.9	0.1	0.8	1.9	1.4	1.9	0.1	0	0	0.1	2.7	0.1	0.1	0.6	0.3	1.9	0.5	1.3	8.3	0.1	0.1	0.4	0.8	0.6	0.3	0.9	0.1	1.7	0.4	5.6	2.7	0.1	2.1	0.6	0.5	0.4	0.1	0.2	0.3	0	0.2	3	4.2	0.4	0.3	0.3	0	0.8	0.2	0.5	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.1	0	0	0	0	0.4	0.9	0	0	0	0	0.1	1.7	0	0	0	0	0	0	0.1	0	0	0	0	5.4	18.6	0	0	0	0	0	0	0	0	0.2	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	5.9	1.9	1.4	0.5	1.3	0.8	0.6	5.6	0.4
IRAK1	"IRAK, pelle"	ENSG00000184216	Interleukin 1 receptor associated kinase 1	P51617	X	154010500-154019980	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004461, HPA054476"	Supported		Supported	"Nucleoplasm,Cytosol"				Cytosol	Nucleoplasm	"CAB004461: AB_2249106, HPA054476: "	unprognostic (4.46e-3)	unprognostic (9.32e-2)	unprognostic (1.71e-2)	unprognostic (5.04e-3)	unprognostic (7.09e-3)	unprognostic (4.43e-3)	prognostic unfavourable (3.03e-4)	unprognostic (7.89e-3)	unprognostic (3.36e-2)	unprognostic (3.69e-2)	unprognostic (1.95e-1)	unprognostic (6.64e-2)	prognostic unfavourable (2.06e-4)	unprognostic (2.76e-3)	unprognostic (2.36e-1)	unprognostic (2.21e-3)	unprognostic (3.04e-1)	22.3	23.7	12.1	25	11.4	48.3	38.5	7.7	14.8	11.1	24.8	10.8	13.4	29.9	13.2	12.4	25.5	12.2	23.1	14.1	9.9	12.3	23.7	46.9	18.5	37.5	12.6	7.9	15.1	34.6	8.1	15.2	14.3	11.9	18	11	10.1	31.9	15.9	32.6	15.9	34.6	11.5	12.7	34	19.3	14.3	9.8	17	12.6	20.4	26.7	17.2	15.3	10	13	6.7	10.6	6.3	6.7	3.4	76.3	29.7	4.2	34.3	8.4	6.7	18.3	11.4	10.8	17.6	16.4	23.5	34	32.6	64.3	12.2	20.9	9.7	18.6	6.9	25.6	29	11.9	26.7	14	19.4	28.1	20.5	9.3	16.4	16.8	18.6	10.5	20.9	37.8	12.3	28.1	11.5	25.1	10.4	59.3	30	21.3	54.8	11.7	14.5	23.6	17	13.6	15.2	22.5	5.9	29.9	14.3	21.4	33.9	48.9	70.7	47.6	30.4	59.8	31.3	33.8	22.2	1.3	8.7	6.7	6.7	10.6	5.9	7.5	5.3	5.3	5.4	10	3.1	6.1	5.9	6.3	8.1	13	2.5	3.4	12.1	11.4	7.7	14.8	9.9	12.3	12.6	7.9	11.9	9.8
IRAK2		ENSG00000134070	Interleukin 1 receptor associated kinase 2	O43187	3	10164865-10243743	"Enzymes, Predicted intracellular proteins"				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 28.7	Cell line enhanced	Detected in many		BEWO: 17.7;BJ hTERT+: 18.4;CAPAN-2: 18.7;RT4: 25.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles				Vesicles		"CAB013483: , HPA050520: "	unprognostic (1.31e-1)	unprognostic (2.04e-2)	unprognostic (1.46e-2)	unprognostic (4.61e-3)	unprognostic (8.71e-2)	unprognostic (9.55e-2)	prognostic unfavourable (8.35e-4)	unprognostic (1.89e-2)	unprognostic (8.01e-2)	unprognostic (1.24e-1)	prognostic unfavourable (2.26e-4)	unprognostic (2.24e-1)	unprognostic (3.10e-2)	unprognostic (7.22e-2)	unprognostic (4.38e-2)	unprognostic (3.91e-2)	prognostic favourable (6.60e-5)	12.1	5.8	3.6	8.6	5.9	28.7	5.4	4.5	7	3.3	4	12.2	2.3	3.3	3.5	2.6	8.4	2.4	6.8	2.7	3.6	5.2	4.3	15.4	12.7	5.3	10.4	3.7	1.9	3.2	2.4	1.8	3.5	7.8	6.4	3.1	2.1	4.8	3.4	19.6	6.2	6.7	3.4	6.1	5.9	5.2	1.7	8.6	3.9	4.1	2.7	16.7	14.3	7.2	5	1.3	2.5	1.2	8.4	7.9	2.5	1.4	4	0.1	0.5	4.4	3.7	17.7	1.5	18.4	2.5	2.4	1.9	18.7	0	0.5	2.2	0.4	0.4	4.7	3.4	1.1	1.3	0.4	0.9	5.1	2.1	0	0.6	2.2	0.8	9.2	12.1	5.1	0.9	5.7	3	0	0	0.9	0.1	3.9	0.8	0	0.3	5.5	25.5	0.2	0.1	1.7	0.1	0.2	0.4	0.8	5.3	5.7	0.5	3.5	3.6	1.9	5.6	1	12.3	2.4	1	0.2	1.2	0.1	7.5	0.7	7.9	5	2.2	4.1	1.3	4.5	1.6	3.9	2.5	8.4	0.2	0.1	0.9	2.5	3.6	5.9	4.5	7	3.6	5.2	10.4	3.7	7.8	8.6
IRAK3	IRAK-M	ENSG00000090376	Interleukin 1 receptor associated kinase 3	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Asthma	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 58.0	Cell line enhanced	Detected in some		ASC diff: 14.7;ASC TERT1: 12.2;HEL: 12.6;HL-60: 16.7;NB-4: 13.3;THP-1: 20.2;U-937: 14.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in many	5	basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6	Group enriched	Detected in many	12	dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA043097	Approved		Approved	Vesicles	Intracellular and membrane			Vesicles		HPA043097: AB_10795612	unprognostic (7.12e-2)	unprognostic (1.06e-1)	unprognostic (2.90e-1)	unprognostic (1.28e-1)	unprognostic (1.90e-1)	unprognostic (7.56e-3)	unprognostic (1.49e-1)	unprognostic (2.46e-1)	unprognostic (7.82e-2)	unprognostic (1.33e-1)	unprognostic (2.95e-2)	unprognostic (8.52e-2)	prognostic unfavourable (6.23e-4)	unprognostic (5.58e-2)	unprognostic (4.64e-2)	unprognostic (3.41e-2)	unprognostic (3.23e-2)	21.8	3.7	2.1	10.6	3.6	58	13.4	1	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7	7.6	16	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7	3	5.5	6	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0	0	0.2	0	14.7	12.2	0	1.6	0	0.9	1.3	0	1.2	0	0.8	3	0	1.8	0	0.7	0	0	12.6	0.7	0	7.7	16.7	2.3	7.7	0	0.7	0	4.3	0	0	0.5	0	0	13.3	0.7	0	0	3.6	0	0.1	1.8	0.1	0	6.5	0	0.7	0	20.2	4.6	0	0	0	0	0.5	0.1	1.2	0	14.7	0	5.6	13.1	2.2	0	13.2	0	0	0	0	6.2	0.4	0	0	7.2	0.9	20.6	0	0.3	3.6	2.1	3.6	1	2.4	2.9	2.1	4.6	0.3	3.7	2.8
IRAK4	NY-REN-64	ENSG00000198001	Interleukin 1 receptor associated kinase 4	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		U-937: 32.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB016685, CAB022077"	Uncertain		Approved	"Nucleoli,Microtubules,Cytosol"				Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	unprognostic (2.76e-2)	unprognostic (5.63e-2)	unprognostic (1.47e-2)	prognostic favourable (3.46e-5)	unprognostic (6.15e-2)	unprognostic (3.50e-3)	unprognostic (1.44e-2)	unprognostic (8.49e-2)	unprognostic (6.44e-3)	unprognostic (7.50e-2)	unprognostic (4.00e-3)	unprognostic (6.29e-2)	unprognostic (4.52e-2)	unprognostic (2.95e-1)	unprognostic (2.31e-1)	unprognostic (1.84e-1)	prognostic favourable (4.42e-5)	18	9.4	5.1	15	10.4	10.3	11.3	3.7	6	10.3	12.2	9.1	12.5	10.2	13	14.1	15	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12	24	13.2	3.9	9.3	20.1	9.1	16.1	14	9.8	10.5	10	11.9	11.9	15.1	4.1	15.2	15	11.8	13	25	12.3	7.1	11.7	30.3	17	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6	8.8	7.7	4.7	5.3	3.9	2.8	3.7	10.1	17	4	7.5	5.3	6	5.5	3.3	5.1	9.1	7.4	6.2	4.4	3.1	4.8	8.6	13	2.9	8.7	3	2.1	5.8	12	10.7	9	7.8	7.6	4.4	8.8	8	6.8	16.4	2.9	10.4	6.8	1	4.6	6.9	3.4	4.8	4.6	5.1	2	1.9	3.6	4.7	3.6	5.9	10.7	7.8	7.4	1.4	9	5.1	8.4	10.8	7.9	7.6	32.4	4	16.9	4.6	9.4	7.4	5.4	7.7	4	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6	5.8	7.5	4.7	5.1	10.4	3.7	6	6.7	5.2	13.2	3.9	9.8	11.7
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	IL2 inducible T cell kinase	Q08881	5	157142933-157255191	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	blood: 28.0;lymphoid tissue: 60.5	Cell line enriched	Detected in some	5	MOLT-4: 21.7	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Group enriched	Detected in many	28	gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1	Group enriched	Detected in many	29	NK-cells: 9.2;T-cells: 28.0	Low region specificity	Detected in some			Low region specificity	Detected in single														unprognostic (2.08e-3)	unprognostic (6.57e-4)	unprognostic (5.06e-3)	unprognostic (4.96e-5)	unprognostic (1.52e-2)	unprognostic (1.12e-4)	unprognostic (8.45e-4)	unprognostic (1.56e-2)	unprognostic (1.87e-2)	unprognostic (5.99e-3)	unprognostic (1.76e-1)	unprognostic (2.52e-1)	unprognostic (4.52e-6)	unprognostic (3.64e-1)	unprognostic (4.42e-2)	unprognostic (1.46e-1)	unprognostic (3.26e-2)	2.3	0.7	0.5	12.2	0.6	2.5	1.3	1.9	0.5	1.4	3.3	0	0	0.5	1.2	1.1	1.8	1.4	4.3	0.9	0.5	0.5	1.4	1.2	6.6	60.5	0.9	0	0.7	0.7	0	0.9	0.1	0.3	1.1	1.3	1.5	3.5	1.1	0.5	1	8.9	0.4	1.2	10.7	2.3	1.4	0	60.3	1.6	2.7	24.3	4.1	1.3	0	0	0.4	0.6	9.2	28	13.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	3.6	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	21.7	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	13.8	0	9.1	0	19.5	18.9	0	0	28	22.8	0.4	9.2	0.6	0	23.1	13.6	0.5	0.6	1.9	0.5	0.5	0.5	0.9	0	0.3	0
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	Janus kinase 1	P23458	1	64833229-64966504	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		ASC diff: 69.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB013088	Approved									CAB013088: 	prognostic favourable (9.63e-4)	unprognostic (1.24e-1)	prognostic favourable (2.81e-4)	unprognostic (5.10e-2)	unprognostic (1.16e-1)	unprognostic (4.21e-2)	unprognostic (1.53e-1)	unprognostic (7.00e-3)	unprognostic (8.40e-2)	unprognostic (7.88e-3)	unprognostic (1.66e-2)	unprognostic (8.84e-2)	prognostic favourable (2.67e-4)	unprognostic (2.35e-1)	unprognostic (2.04e-1)	unprognostic (7.30e-2)	unprognostic (3.51e-1)	46.7	20.4	15.5	31.1	16.5	21.2	56.6	24.3	20.4	27.3	27.1	16.3	16.5	13.8	28.2	22	27	20.7	27.7	27.3	15.3	16.5	31.4	38.3	36.5	61.4	15.6	14.1	33.3	29.1	28.3	39.8	22.9	25.1	26	22.2	18.1	19.8	21.3	45.1	29.7	29.3	30.7	16.3	52.7	20.9	17.3	15	62.7	29	17.9	42.5	37.2	29.3	20.2	15.4	34.9	17.1	68.1	27.5	25.8	10.9	14.4	6	0.6	69.4	39.3	7.8	17.2	25.4	14.3	16.9	4.7	6.1	16.7	13.4	30.5	6.2	4	13.3	20.4	22.1	6.4	22.7	7.5	10.2	25.6	8.7	15.8	34.5	18.5	21.6	22.6	44.6	8.2	17.9	15.8	6.3	4.7	5.8	4.1	8.6	6.8	17.3	6.1	36.9	19.4	4.2	12.7	23.6	11.1	10.1	23.5	5.4	40.4	17.2	7.7	38.9	9.1	11.2	5.1	13.3	16	11.5	7.7	31.2	10.9	31.5	22.8	15.2	27.5	20.2	22	25.7	15.4	16.1	24.3	20.7	34.9	68.1	17.1	10.5	26.5	25.8	15.5	16.5	24.3	20.4	15.3	16.5	15.6	14.1	25.1	15
JAK2	JTK10	ENSG00000096968	Janus kinase 2	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Group enriched	Detected in many	5	ASC diff: 18.9;HDLM-2: 26.7;HEL: 54.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 40.8	Lineage enriched	Detected in all	4	granulocytes: 40.8	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: , HPA043870: "	unprognostic (2.24e-3)	unprognostic (2.76e-2)	unprognostic (1.50e-2)	unprognostic (7.67e-2)	unprognostic (5.50e-2)	unprognostic (3.09e-2)	unprognostic (1.48e-1)	unprognostic (7.36e-2)	unprognostic (1.09e-1)	unprognostic (5.49e-3)	unprognostic (1.58e-1)	unprognostic (1.72e-2)	unprognostic (3.85e-1)	unprognostic (4.53e-2)	unprognostic (3.43e-2)	unprognostic (1.96e-1)	unprognostic (7.37e-3)	19.8	8.8	11.5	19	10.5	19	17.7	14.7	14.4	17.8	10.6	7	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7	10.5	15.9	6.7	10.1	7.5	12	10	12	7.4	9.4	7.2	7.4	14.4	19	12.3	10.4	11.7	21.5	14.1	10.1	9	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.4	1.4	2.5	18.9	4.9	0.4	3.4	2.9	2.6	1.7	0.1	0.8	0.1	0.8	2	0.8	1.5	2.1	1.9	26.7	0.5	54.8	2.9	0.7	3.9	3.7	2.8	4	0.9	1.1	1.8	2.4	3.9	6.4	4.7	0.9	0.9	5.2	1.3	1.7	1.9	2.7	0.7	2	1.3	1.6	0.9	1	1.5	1	0.7	6.5	5	4	1.3	4.1	2.4	1.2	2.2	0.5	5.2	1.8	2	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7	10.5	10	9
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	Janus kinase 3	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	lymphoid tissue: 68.3	Cell line enhanced	Detected in some		HDLM-2: 20.1;HEL: 9.0;HMC-1: 9.2;Karpas-707: 23.5;U-266/70: 9.1;U-266/84: 13.5;U-937: 13.7	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		HPA070314: 	unprognostic (5.59e-3)	prognostic favourable (6.42e-5)	unprognostic (5.71e-2)	unprognostic (2.34e-1)	unprognostic (6.13e-3)	unprognostic (1.11e-3)	unprognostic (4.21e-2)	unprognostic (2.60e-1)	unprognostic (2.38e-2)	unprognostic (2.36e-1)	unprognostic (3.58e-2)	unprognostic (1.94e-1)	prognostic unfavourable (2.89e-14)	unprognostic (2.28e-1)	unprognostic (2.21e-2)	unprognostic (4.43e-2)	unprognostic (7.61e-2)	6.8	1.7	4	24.5	8.5	12	2.7	2.4	3.1	1.9	2.3	1	0	2.2	1.7	2	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2	8.4	68.3	7.5	0	11	2	0.4	2.3	4.1	5.3	3	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15	6.8	0.1	0.3	0.3	1	0.4	1.4	0.2	0.5	0	0	0.1	0	0.9	0.4	1.9	0.4	0.1	0	0.2	0	20.1	0	9	0	0.8	0.7	0	9.2	5	0.2	0	0	0.2	0	23.5	0	0.4	3.6	0	0.1	0.7	4.6	0	0.4	0.5	0	0	0.3	0.1	0.2	0	2	1.3	0.4	0	0.4	0	0	9.1	13.5	2.5	0.1	13.7	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15	13.1	4.5	7.4	14.9	13	16.9	8.4	8.8	3.7	11.8	6.8	4	8.5	2.4	3.1	2.7	2.8	7.5	0	5.3	5.8
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	Kalirin RhoGEF kinase	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 35.2;retina: 31.2	Cell line enhanced	Detected in many		CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 4.3	Lineage enriched	Detected in single	5	T-cells: 4.3	Low region specificity	Detected in many							"HPA011913, CAB026456"	Approved		Approved	"Nucleoplasm,Cytosol"		110000	110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	unprognostic (2.54e-2)	unprognostic (3.43e-1)	unprognostic (2.08e-1)	unprognostic (3.12e-4)	unprognostic (2.54e-1)	unprognostic (1.74e-1)	unprognostic (1.52e-1)	unprognostic (1.53e-1)	unprognostic (3.41e-2)	unprognostic (8.58e-2)	unprognostic (1.65e-1)	unprognostic (1.04e-1)	unprognostic (2.26e-3)	unprognostic (5.58e-2)	unprognostic (2.67e-1)	unprognostic (3.70e-2)	unprognostic (2.81e-3)	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8	11.5	2.2	2.4	0	5.3	6.7	3.1	2.9	4.1	0.1	0	0.9	0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.6	1.4	0.8	1.4	0.6	32.1	2.5	0.1	0.4	3.6	0.2	0.8	0	1.1	0	0.3	19.6	0.3	4.9	0	0	0	0.2	0	0.3	0	1.6	4.5	0.1	0.4	2.3	0	0	2	3.1	1	1.6	0	0.1	0.3	1.2	9.2	0.4	0.3	0.3	0.7	0.1	8.1	4.1	1.6	0.6	0.6	0	0.3	0	0.5	0	1.8	0.1	0	0	0.1	0	0	0.1	1.8	0.3	0	0	2.4	0.7	0.9	0.1	0	0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	Kinase insert domain receptor	P35968	4	55078259-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Group enriched	Detected in some	9	HUVEC TERT2: 31.8;TIME: 35.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all			CAB004028	Enhanced		Supported	Plasma membrane	Intracellular and membrane	7400000	7400000	Plasma membrane		CAB004028: AB_2212507	unprognostic (1.61e-1)	unprognostic (2.03e-1)	unprognostic (9.65e-2)	unprognostic (1.97e-1)	unprognostic (9.63e-2)	unprognostic (1.22e-2)	unprognostic (1.78e-3)	unprognostic (2.59e-2)	unprognostic (1.19e-2)	unprognostic (1.10e-1)	unprognostic (8.79e-3)	unprognostic (1.34e-1)	prognostic unfavourable (7.26e-4)	unprognostic (4.00e-2)	unprognostic (2.30e-1)	unprognostic (3.22e-1)	unprognostic (1.86e-1)	19.7	6.2	1.8	4.4	3.1	0.4	20.5	1.1	2.2	11.4	6	1.8	11.5	2.3	28.8	10.2	5.2	9.5	6.2	12.1	2.3	1.7	7.8	10.4	13.2	14.1	3.1	2.9	6	8.1	8	6.8	34.5	3.9	9.5	1.4	27.6	7.1	10.3	5.3	3	3.8	7.7	2.6	4.4	4.2	5.3	1.2	0.5	20	5.3	3	4.4	12	0.1	0.1	0.7	0	0.2	0.2	0.1	0	0	1.7	0	0.2	0.3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	2.9	0	0	3.7	0	0	0.3	0	0	0.2	31.8	0	0	0.2	0	0	0	0.8	1.1	0	0	0	0	0	0	0	0	0	0	0	0	35.9	0	0	0	0.5	0	0	0	0.4	0	0.1	0.1	0	0.7	0.1	0	0	0	0.2	0	0	0.1	0	0.1	0	0.2	0	0.1	0	0.1	1.8	3.1	1.1	2.2	2.3	1.7	3.1	2.9	3.9	1.2
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	KIT proto-oncogene receptor tyrosine kinase	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		breast: 65.5	Group enriched	Detected in some	13	HEL: 47.7;HMC-1: 100.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	6	basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7	Group enriched	Detected in many	6	granulocytes: 12.7;NK-cells: 9.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	Plasma membrane		48000000	48000000	Plasma membrane		"CAB003288: AB_2335702, CAB068253: , CAB072867: , HPA004471: AB_1078431, HPA073252: "	unprognostic (1.55e-2)	unprognostic (1.91e-1)	unprognostic (4.04e-2)	unprognostic (8.19e-2)	unprognostic (3.96e-2)	unprognostic (2.18e-2)	unprognostic (2.33e-2)	unprognostic (1.97e-2)	unprognostic (3.60e-2)	unprognostic (1.64e-1)	unprognostic (2.20e-1)	unprognostic (1.92e-2)	prognostic favourable (5.63e-4)	unprognostic (1.34e-3)	unprognostic (1.87e-1)	unprognostic (1.29e-2)	unprognostic (2.30e-1)	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36	4.4	9.4	1.1	13.8	3.8	3.6	6	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0	1.8	12.7	0.9	9.7	1.9	0.1	0	0	0.7	0	0.1	0	0	0.6	0.9	2.5	3.2	0	0	0	0	1.4	0	0.5	0	2.1	0	1.1	47.7	0	0	0	0	100.2	0	0	0	0	5.6	0.6	0.1	0	0	0.2	0.4	1.3	0	0.1	0	0	0	4.7	1.2	0.4	0	0	0	0	0.5	0	0.1	0	1	0	0	0	0	0.1	0.1	0.1	12.7	0	10	0.1	0	1.9	0	0.3	0.7	1.8	0	0	0	0.8	9.7	0.9	0	0	0.1	9.5	11.8	18.3	12	36	4.4	3.6	6	5.7	4.5
KSR1	"KSR, RSU2"	ENSG00000141068	Kinase suppressor of ras 1	Q8IVT5	17	27456470-27626438	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		pancreas: 57.7	Cell line enhanced	Detected in many		HDLM-2: 87.7;HEL: 31.5;HMC-1: 21.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		eosinophil: 7.0	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB009623, HPA011215"	Uncertain									"CAB009623: AB_2265455, HPA011215: AB_1852649"	unprognostic (2.03e-2)	unprognostic (2.74e-1)	unprognostic (2.60e-1)	unprognostic (3.48e-3)	unprognostic (2.90e-1)	unprognostic (6.98e-2)	unprognostic (1.92e-5)	unprognostic (8.36e-3)	unprognostic (1.32e-1)	unprognostic (3.15e-2)	unprognostic (1.12e-3)	unprognostic (1.65e-1)	prognostic unfavourable (6.54e-4)	unprognostic (1.00e-1)	unprognostic (7.55e-2)	unprognostic (1.74e-2)	unprognostic (9.61e-2)	10.5	9.3	15.3	12.5	16	9.5	7.7	20.5	18.5	15.5	6.1	20.5	7	5.4	17.9	7	15.5	9.3	21.2	7	17.5	7	12.4	3.8	12.4	8.6	18.3	12.5	14.4	57.7	7.3	8.9	29.4	16.2	7.9	5.9	19.8	4.7	13.4	17.5	13.8	7.6	13.7	12	12.2	5.1	11.5	19.9	5.2	16.3	3.3	9.4	8.9	13.5	0.9	1.1	7	4.1	1.5	1.1	0.7	1	4.1	2.5	1.3	2.2	1.5	15.1	0.9	2	1.4	1.7	12.4	0.1	1	2.2	1.8	0.6	2.5	0.5	0.8	87.7	2.8	31.5	4	5.1	3.8	0.4	21.7	1.9	0.9	4.1	0.1	8	16.4	0.1	0.8	0.9	0.4	1.2	1.9	0.7	2	14.3	0.7	5.9	0.7	4	2.6	5.1	1.2	1.3	0.1	1.6	7.4	0.4	1.9	1.2	0.6	0.1	0	0	0.4	1.8	2.4	0	1.9	7	0.7	4.1	0.7	0.9	0.3	0.4	1.1	0.4	0.2	0.2	2.2	1.5	2	0.1	1.1	0.7	15.3	16	20.5	18.5	17.5	7	18.3	12.5	16.2	19.9
KSR2	FLJ25965	ENSG00000171435	Kinase suppressor of ras 2	Q6VAB6	12	117453012-117968983	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 27.4;pituitary gland: 24.6	Group enriched	Detected in some	5	HUVEC TERT2: 7.2;SCLC-21H: 5.3;TIME: 10.8	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA035536	Enhanced									HPA035536: AB_10673485	unprognostic (1.74e-2)	unprognostic (4.21e-2)	unprognostic (2.38e-1)	unprognostic (2.29e-2)	unprognostic (9.11e-2)	unprognostic (8.42e-2)	unprognostic (6.91e-3)	unprognostic (1.10e-2)	unprognostic (5.78e-2)	unprognostic (5.80e-2)	unprognostic (2.05e-4)	unprognostic (1.19e-1)	unprognostic (9.28e-3)	unprognostic (5.02e-2)	unprognostic (5.68e-2)	unprognostic (8.14e-3)	unprognostic (5.74e-2)	0.9	5	13.2	1.1	13.8	1.1	1.7	27.4	17.2	1	1.9	1.3	2.2	1	0.8	2.6	0.9	1.7	1	0.8	12.9	4.8	3.5	0.8	1.2	1.6	2.2	10.8	0.8	3	0.9	24.6	0.9	7.7	1.3	2.3	0.2	1.2	3.4	0.9	1	1	0.9	2.9	1	1.7	3.2	3	0	3.8	0	1.5	2.3	0.5	0.1	0.2	0.8	0.1	0.2	0.1	0	0.1	0.7	0	0	0	0	0.2	0	0	0	0	0.1	0.1	0.1	1.1	0	0.2	0	0	0	0.5	0.6	0	0	0	0	0	0	0	0	0	0	7.2	0	0	0	1.5	0.1	0	0.5	1.2	0	0	0.1	0.7	1.4	5.3	0.1	0	0	0	1.1	0	10.8	0	0.8	0	0.2	0.9	1.5	0	0.4	0	0.1	0.5	0.1	0.1	0.1	0	0	0.1	0	0	0	0.1	0	0.1	0.8	0.2	0.1	0.2	0	0	13.2	13.8	27.4	17.2	12.9	4.8	2.2	10.8	7.7	3
LATS1	WARTS	ENSG00000131023	Large tumor suppressor kinase 1	O95835	6	149658153-149718256	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Tumor suppressor	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031804	Approved		Approved	"Nucleoplasm,Vesicles"				Vesicles	Nucleoplasm	HPA031804: AB_10601688	unprognostic (4.02e-3)	unprognostic (3.80e-3)	unprognostic (1.28e-2)	unprognostic (1.00e-1)	unprognostic (4.40e-2)	unprognostic (2.09e-1)	unprognostic (6.15e-3)	unprognostic (1.29e-2)	unprognostic (9.67e-2)	unprognostic (1.02e-2)	unprognostic (1.74e-1)	unprognostic (1.52e-1)	unprognostic (5.62e-2)	unprognostic (1.92e-1)	unprognostic (8.43e-2)	unprognostic (2.63e-1)	unprognostic (2.65e-1)	15.4	12.9	17.6	12.5	17.6	19.4	14.7	38.4	16.9	15.9	13.6	17.4	9.5	10.1	17.7	11.8	12.2	14.6	11.1	11.7	15.1	8.8	11.5	11.1	12.7	12.6	18.2	8.8	23.6	12.2	22.3	21.8	17.2	15.5	16.3	12.5	14.1	13.8	11.9	12.4	12.8	14.7	15.8	13	13.5	11.6	10.6	19.6	20.5	12.9	6.5	12.8	14.7	14.7	7.4	4.6	9.5	11.4	4.2	8.9	2.9	6.1	4.8	10.2	14.4	9.6	12.6	7.8	8.1	8.2	8.8	8.8	7.8	5.3	9.9	8.3	11.3	8.6	13.3	8.7	13.9	9.1	10.6	20	6.1	7	8.9	18.7	14.6	8.4	14	9.9	17	10.9	24.6	10.2	8.6	7.3	9.7	7.7	6	4.7	9.5	12.2	4.6	8.1	8.7	6.8	10.9	11.4	8.3	6	8.6	16.2	13.4	7	11	8.3	13	8.5	9.3	11.4	6.4	10.6	10.3	9.5	4.2	6.6	8.9	7.7	8	5.8	7	7.4	4.6	7.4	6	7.8	2.9	4.2	11.4	4.1	6.7	2.9	17.6	17.6	38.4	16.9	15.1	8.8	18.2	8.8	15.5	19.6
LATS2		ENSG00000150457	Large tumor suppressor kinase 2	Q9NRM7	13	20973032-21061547	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Tumor suppressor	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many							Low region specificity	Detected in all			"HPA039191, HPA049037"	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA039191: , HPA049037: "	unprognostic (2.77e-1)	prognostic unfavourable (3.26e-4)	unprognostic (6.22e-3)	unprognostic (3.38e-2)	unprognostic (2.51e-2)	unprognostic (1.84e-2)	unprognostic (1.88e-1)	unprognostic (2.16e-3)	unprognostic (4.48e-1)	unprognostic (6.57e-3)	unprognostic (8.03e-2)	unprognostic (4.92e-2)	unprognostic (7.85e-2)	unprognostic (1.66e-2)	unprognostic (1.25e-1)	unprognostic (7.97e-2)	unprognostic (1.11e-2)	22.9	13	3	8.6	5.7	12.8	33	7.9	3.7	16.6	14	6.8	9.3	2.9	21.2	12.7	15.1	11	20.6	14.1	5.4	2.6	12.4	11	19.8	10.9	5.2	2.4	17.4	10.2	5	3.5	18.3	6.3	13.7	4.5	16.7	8	11.1	23	9.3	7.4	34.6	7.5	15.2	10.4	27.8	5.2	1.4	17.2	13.8	7	20.3	28	0.1	1.5	3.3	1.9	1.3	3.1	0.5	3.3	3.7	8.3	5	9.8	12.9	7.6	11.2	11.7	11.8	10.1	10.6	5.1	0	5.5	17.1	4.9	4.9	5.1	17.5	1.9	1.2	6.2	4.7	7.9	15.3	1.6	2.2	19.1	9.4	7.7	5.2	16.4	1.1	0.2	14.8	5.8	0.1	5.8	2	1.8	1.4	14.8	0	8.4	1.6	0.1	0	8.8	5.8	11.6	5	3.2	20.6	12.5	8.4	9.1	7.1	1.5	0.8	0	3	1.9	9.5	0.4	1.9	1.8	1.6	1.5	3.1	0.1	0.2	0.5	1.5	0	0.1	0.3	3.3	1.3	0.6	0.1	0	0.5	3	5.7	7.9	3.7	5.4	2.6	5.2	2.4	6.3	5.2
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	Host-virus interaction	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	blood: 112.2;lymphoid tissue: 153.0	Group enriched	Detected in some	6	MOLT-4: 98.9;U-698: 57.0	Low cancer specificity	Detected in many			Not detected	Not detected			Group enriched	Detected in many	14	gdT-cell: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2	Group enriched	Detected in many	13	NK-cells: 42.8;T-cells: 112.2	Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA003494, CAB003816"	Enhanced		Approved	Golgi apparatus				Golgi apparatus		"CAB003816: AB_562158, HPA003494: AB_1852751"	unprognostic (6.38e-3)	unprognostic (5.45e-3)	unprognostic (8.39e-2)	prognostic favourable (2.96e-6)	unprognostic (2.20e-2)	prognostic favourable (2.91e-4)	unprognostic (4.78e-3)	unprognostic (1.33e-2)	prognostic favourable (5.65e-5)	unprognostic (3.07e-2)	unprognostic (3.80e-2)	unprognostic (2.83e-1)	prognostic unfavourable (2.60e-5)	unprognostic (8.15e-2)	unprognostic (4.05e-2)	unprognostic (7.39e-2)	unprognostic (1.17e-2)	2.6	0.7	0.4	28.2	0.5	3.8	1.3	0.3	0.5	1.7	3.9	0.5	0.9	2.2	1.1	4.5	2.3	1.6	3.8	1	0.4	0.4	3	2.3	6.6	34.9	0.9	0.5	1.2	0.8	0	0.8	0.7	0.6	2.2	1.9	1.3	8.4	1.3	0.9	1	16.5	0.7	1	28.9	3.5	0.7	0.5	153	2.9	1.5	27.1	5.8	2.1	6.1	0.5	2.5	0.3	42.8	112.2	109.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	12	0.6	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	98.9	0	1.1	0	3.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0.1	0	57	0	0	0	0.6	0.3	0.4	83.4	0.3	77.5	4	86.1	90.2	0.3	6.1	97	91.3	2.5	42.8	0.3	0.5	112.2	109.3	0.4	0.5	0.3	0.5	0.4	0.4	0.9	0.5	0.6	0.5
LIMK1	LIMK	ENSG00000106683	LIM domain kinase 1	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 45.2	Cell line enhanced	Detected in all		U-87 MG: 51.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA028064, HPA028516"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA028064: AB_10600111, HPA028516: AB_10601751"	unprognostic (1.45e-2)	unprognostic (2.75e-1)	prognostic unfavourable (4.95e-5)	unprognostic (2.77e-2)	unprognostic (1.40e-3)	unprognostic (3.35e-2)	prognostic unfavourable (7.79e-6)	unprognostic (1.90e-2)	unprognostic (2.16e-1)	unprognostic (1.18e-1)	unprognostic (3.32e-2)	unprognostic (3.16e-2)	prognostic unfavourable (6.63e-8)	unprognostic (4.14e-2)	unprognostic (7.00e-2)	unprognostic (3.84e-2)	unprognostic (5.79e-2)	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22	33.4	22.2	12.1	8.1	4	7.2	8	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.2	13.5	10.3	17.1	13.6	18.5	7.5	10.7	10.3	8.7	9.7	7.8	17	10.7	4.8	13.1	10.4	3.8	6.6	3.3	18.5	6.7	7.9	4.6	8.9	15.6	6	29	18.2	5.9	7	3.7	12.9	5.3	3.4	10.8	15.1	5.1	10.8	19.5	8.4	7.5	16	6.7	9.6	3.7	4.1	9.4	6.9	16.5	8.6	5.2	5.4	15.3	13.9	12.9	35.7	17.1	3.9	4.3	19.5	51.4	4.4	9.4	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5
LIMK2		ENSG00000182541	LIM domain kinase 2	P53671	22	31212239-31280080	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		BEWO: 37.8;hTCEpi: 70.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	5	eosinophil: 14.7;neutrophil: 37.2	Lineage enriched	Detected in all	7	granulocytes: 37.2	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA008183, CAB019313, HPA053882"	Approved		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		"CAB019313: , HPA008183: AB_1079252, HPA053882: "	unprognostic (1.79e-1)	unprognostic (1.95e-1)	unprognostic (1.04e-2)	unprognostic (2.59e-2)	unprognostic (1.39e-1)	unprognostic (2.42e-2)	unprognostic (4.02e-2)	unprognostic (5.99e-2)	unprognostic (1.21e-1)	unprognostic (2.95e-1)	unprognostic (3.96e-1)	unprognostic (1.43e-1)	prognostic unfavourable (4.57e-6)	unprognostic (4.48e-2)	unprognostic (1.48e-2)	unprognostic (5.72e-2)	unprognostic (1.37e-1)	9.4	6.6	23.5	23.6	26.2	29.4	17	9.9	16.8	11	20.9	15.6	10.7	13.1	12.9	8.7	33.7	22.1	28.7	6	15.4	10.7	15.4	19.9	21.6	18.1	20.8	7.2	11.4	19.9	20	12.8	64.3	23.3	17.1	22.1	10.1	25.7	16.2	9.7	36.7	13.3	10.1	28.3	17.4	18.5	16.8	17.9	12.4	25.8	15.6	15.3	13.1	20	1	1.6	37.2	1.9	2.4	5.6	1.6	7	1.1	4.9	2.7	2.1	2.5	37.8	4.7	2.2	4.7	4	6.1	3.3	6.9	8.4	7	14.4	5.7	24.6	3	5	6.2	5	5.6	6.5	3.2	9.2	9.2	4	70.1	3.8	11.5	12	2.8	5	6.4	5.5	5.6	3.2	4.6	1.8	7.5	8.3	3.8	5.5	16.8	6.3	5.7	3.5	22.7	9.4	18.9	3.7	7.2	4.2	6.6	2.3	4.3	2.8	4.1	6	2.7	4.4	1.8	2.1	1.9	14.7	1.3	1.3	2.4	0.8	2.3	1.7	0.7	1	2.3	1.8	37.2	2.4	0.5	1.6	5.6	1.6	23.5	26.2	9.9	16.8	15.4	10.7	20.8	7.2	23.3	17.9
LMTK2	"AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100"	ENSG00000164715	Lemur tyrosine kinase 2	Q8IWU2	7	98106885-98209633	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 4.8	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA010657, HPA041836"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol"				"Nuclear speckles, Centriolar satellite"	"Plasma membrane, Cytosol"	"HPA010657: AB_1079259, HPA041836: "	unprognostic (7.36e-2)	unprognostic (3.16e-1)	unprognostic (1.59e-1)	unprognostic (2.60e-3)	unprognostic (2.47e-2)	unprognostic (2.45e-1)	unprognostic (2.35e-2)	unprognostic (1.23e-1)	unprognostic (4.96e-1)	prognostic unfavourable (8.03e-4)	unprognostic (1.23e-1)	unprognostic (4.65e-1)	prognostic favourable (1.12e-7)	unprognostic (1.88e-1)	unprognostic (3.92e-1)	unprognostic (2.16e-2)	unprognostic (6.38e-3)	5.1	10.3	13.7	5.6	21.3	17.3	5.6	16.6	34.3	7.3	13.8	6.1	5.6	12.6	6.1	6.3	12.7	6.4	7.9	16.9	11	10.1	10.1	8.5	10	5.1	7.5	18.9	8	21	22.2	10	4.8	13.2	7.9	11.8	5.4	10.5	6.5	17.5	11.5	13.8	5.7	5.5	6.8	9.4	8	6.9	7.2	8.7	5.7	7.4	8.3	8.1	0.6	0.7	4.8	0.9	0.3	1.6	0.5	9.9	11.7	9.1	9.3	4.9	3.9	8.5	4.1	4.5	4.1	4.9	9.2	9.1	5.2	11.9	5.3	10.9	10.5	6.3	6.4	7.4	7.4	3.5	10.5	9.2	6	6.3	6.4	2.7	8.8	8.4	11.4	6.1	9.2	11.1	3.7	13.5	6.6	3.8	11.1	5.7	7.3	6.2	10.3	6.8	17.5	6.5	13.1	8.3	15.2	6	4.2	2.6	7.4	8.5	14	16.9	9.4	4.9	8.6	10.5	5.7	5	10.1	1.2	0.6	0.5	0.8	0.3	0.5	0.6	0.9	0.9	0.3	0.6	1.1	1.6	4.8	0.3	0.9	0.7	0.8	0.5	13.7	21.3	16.6	34.3	11	10.1	7.5	18.9	13.2	6.9
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	Lemur tyrosine kinase 3	Q96Q04	19	48485271-48513189	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 38.1	Cell line enhanced	Detected in many		HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA040203, HPA077070"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Cell Junctions	"HPA040203: AB_10671690, HPA077070: "	unprognostic (2.41e-1)	unprognostic (1.48e-1)	unprognostic (5.37e-2)	unprognostic (5.45e-2)	unprognostic (2.95e-1)	unprognostic (1.71e-2)	unprognostic (5.67e-2)	unprognostic (2.46e-1)	unprognostic (2.09e-1)	unprognostic (2.51e-3)	unprognostic (5.71e-2)	unprognostic (1.47e-1)	prognostic favourable (3.18e-8)	unprognostic (1.38e-1)	unprognostic (3.22e-2)	unprognostic (3.24e-1)	unprognostic (6.11e-2)	1.3	4.4	19.8	2.3	28.6	2	2	20	38.1	2	1.5	6	0.2	6.2	1.4	1.5	2.3	1.6	1.9	1.7	17.2	11.1	2.5	1.3	3.2	2.2	6.5	23.8	1.3	2.1	8.5	6.1	2.1	12.5	3.5	1.2	1.6	5.2	3.1	1.2	2.4	4	1.2	6.6	1.8	2.9	1.5	10.3	0	2.3	0	2.2	1.6	1.2	0	0	0	0.2	0	0.4	0.1	4.5	3	0.3	0	0	0	4.4	0	0.2	0	0.1	2.2	3.6	1.6	1.2	0	2.1	0.3	1.6	0	0	1.2	0.2	0.3	0.7	0	0	8.4	0.2	0.9	0	0	0.1	1.4	2.8	0	3	0.6	0.8	1.1	0.9	3.8	0	1.3	1.1	0.7	0.7	2.8	0.1	10	0	3.8	0.2	0.1	0	0.8	0.1	0	9.3	7.5	0.4	0.2	3.8	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0.2	0	0	0.1	19.8	28.6	20	38.1	17.2	11.1	6.5	23.8	12.5	10.3
LRRK1	"FLJ23119, KIAA1790, RIPK6, Roco1"	ENSG00000154237	Leucine rich repeat kinase 1	Q38SD2	15	100919215-101078254	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 26.3	Cell line enhanced	Detected in many		Daudi: 23.1;Karpas-707: 17.0;U-266/84: 15.4;U-698: 15.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		eosinophil: 3.2;plasmacytoid DC: 3.3	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in many			HPA010537	Uncertain		Supported	"Mitochondria,Cytosol"				"Mitochondria, Cytosol"		HPA010537: AB_1079283	unprognostic (3.74e-2)	unprognostic (1.41e-1)	unprognostic (2.82e-1)	unprognostic (3.72e-1)	unprognostic (6.68e-2)	unprognostic (6.35e-2)	unprognostic (1.94e-1)	unprognostic (4.75e-2)	unprognostic (3.43e-2)	unprognostic (3.34e-2)	unprognostic (2.95e-2)	unprognostic (8.50e-2)	prognostic unfavourable (5.71e-5)	unprognostic (2.92e-2)	unprognostic (1.82e-2)	unprognostic (3.13e-1)	unprognostic (5.25e-2)	6.1	1.9	4.5	26.3	3.9	6.5	5	2.1	8.1	6.4	8	5.9	2.2	2.9	7.9	6	5.4	7.1	4.2	3.4	4	1.5	2.7	1	4.7	15	4.5	4	6.3	5.3	2.8	2.3	4.4	2.5	7.1	6.5	2.8	7.7	6.8	1.6	7.3	8.5	5.7	3.7	11.1	3.9	5.1	3.4	1.2	3.5	2.1	17.4	7.5	6.7	2.3	3.3	3.2	1.1	0	0	0.1	0.8	4.7	0	0	7.3	7.5	0	2.8	2.1	2.6	1.8	0.8	2.1	23.1	1	7.7	4.7	0.6	0.5	1.3	0.4	1.1	7	1	0	0.5	3.7	5.4	5.9	1	1.7	1.5	4.7	1.1	17	0.5	0	0	2.3	0.2	2	1.6	0.4	6.3	0	0	0	1.6	1.8	2.7	5.3	0.3	4.5	5.4	0	0.8	1	0	8.7	15.4	15	0.3	0.5	4.3	0	0.7	3.2	0	0.3	0	2.3	0	0	0.9	1.5	0	0	0.8	0	1.1	3.3	0	0.1	4.5	3.9	2.1	8.1	4	1.5	4.5	4	2.5	3.4
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	Leucine rich repeat kinase 2	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	blood: 40.4;lung: 50.4	Cell line enhanced	Detected in some		A549: 9.7;ASC TERT1: 10.0;BJ hTERT+: 5.6;RPTEC TERT1: 10.7	Group enriched	Detected in many	7	lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7	Low region specificity	Detected in all			Cell type enriched	Detected in many	7	neutrophil: 40.4	Lineage enriched	Detected in many	7	granulocytes: 40.4	Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA014293, CAB037160"	Approved		Approved	"Nucleoplasm,Vesicles"				"Nucleoplasm, Vesicles"		"CAB037160: AB_1840989, HPA014293: AB_1853353"	unprognostic (2.67e-1)	unprognostic (1.75e-1)	unprognostic (6.45e-3)	unprognostic (1.06e-1)	unprognostic (3.00e-2)	unprognostic (6.10e-3)	unprognostic (2.71e-1)	unprognostic (3.14e-1)	unprognostic (2.25e-1)	unprognostic (9.07e-2)	unprognostic (2.76e-1)	unprognostic (1.23e-1)	prognostic favourable (3.02e-6)	unprognostic (2.55e-2)	unprognostic (3.43e-2)	unprognostic (2.01e-3)	unprognostic (5.21e-3)	3.7	3.4	2.3	7	3.9	8.6	3	1.7	5	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1	1.9	3.6	1.6	3.3	4.2	2	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0	0	0.8	0	9.7	0.1	0	3.9	10	0.1	2.1	5.6	0.4	0.3	0	0	0	0	1.9	0	0.3	0	0.4	0	0.7	0.3	0.2	0	0.7	0.5	0.1	2.5	0.7	0	0.2	0.6	0	0	0.7	0	0	1.2	0.2	0.1	0	0	0	10.7	0	0.1	0.6	0	0.2	2.7	2.8	2.2	1.4	1.1	1.1	1.2	0.7	0	0	0	2.3	0	0.5	0	5.8	1.2	0	3.1	0	0.9	0	0	1.5	0.9	0	0	40.4	0	3	0.2	0	0.8	2.3	3.9	1.7	5	1.8	1.4	2.2	3.6	1.9	2.4
LTK	TYK1	ENSG00000062524	Leukocyte receptor tyrosine kinase	P29376	15	41503638-41513887	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Systemic lupus erythematosus	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		lung: 15.1	Cell line enhanced	Detected in some		HEL: 5.3;NB-4: 10.3;RH-30: 5.0;THP-1: 15.8	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Group enriched	Detected in some	5	MAIT T-cell: 8.3;plasmacytoid DC: 7.0	Group enriched	Detected in many	10	dendritic cells: 7.0;T-cells: 8.3	Low region specificity	Detected in many							HPA059545	Uncertain		Approved	Vesicles				Vesicles		HPA059545: 	unprognostic (9.47e-4)	unprognostic (5.52e-4)	unprognostic (1.51e-1)	unprognostic (2.49e-1)	unprognostic (4.12e-1)	unprognostic (5.65e-3)	unprognostic (1.74e-2)	unprognostic (7.22e-2)	unprognostic (2.89e-2)	unprognostic (2.81e-3)	unprognostic (9.36e-3)	unprognostic (5.36e-2)	unprognostic (4.68e-2)	unprognostic (5.78e-2)	unprognostic (1.52e-1)	unprognostic (1.10e-1)	unprognostic (1.90e-1)	1	0.5	0.5	5.1	1.6	3.1	0.5	2	3.2	0.6	8.2	0.5	1.9	10.6	1.3	1.1	1.2	0.3	2	2.2	0.5	0.1	3.5	4.3	15.1	0.6	0.5	0.5	1	0.5	1	0.7	8.9	0.5	0.7	4.8	4.3	11.7	0.5	2	0.9	10.7	0.5	0.5	5.5	8.3	2.4	0.8	0.5	0.7	0.5	2.2	0.6	0.7	0.7	7	0	0	0	8.3	0.2	0	0	0	0	0.1	0.3	0.6	0.1	0.6	0.9	1.3	2.4	0	0	0.1	0.7	0	2.9	0	0.4	0.2	1.4	5.3	0	0	2.3	0	0	0.4	0.4	0	0.1	0	2	0	2	0	0	10.3	0.4	0.2	0.2	5	0.1	0	0	0.5	3.3	0.1	0.2	0	0.2	15.8	0	0	0.2	0.2	0	0.4	0.2	0.2	0	0.5	0.9	0	0	0	0.6	0	8.3	0.7	0.5	1.4	0.1	0.1	0	0.1	0	0	0	7	0	0.2	0.5	1.6	2	3.2	0.5	0.1	0.5	0.5	0.5	0.8
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 70.9	Cell line enhanced	Detected in many		HEL: 56.8;HMC-1: 57.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 36.8	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		11000000	11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	unprognostic (7.87e-2)	unprognostic (4.89e-2)	unprognostic (9.04e-2)	unprognostic (3.74e-1)	unprognostic (8.12e-2)	unprognostic (2.17e-1)	unprognostic (5.70e-2)	unprognostic (1.11e-1)	unprognostic (2.79e-1)	unprognostic (8.80e-2)	unprognostic (3.68e-2)	unprognostic (7.15e-2)	prognostic unfavourable (3.43e-4)	unprognostic (2.13e-1)	unprognostic (2.72e-3)	unprognostic (1.21e-1)	unprognostic (7.39e-2)	8.8	6.8	4.5	34	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.6	7.5	1.7	0.3	0.1	0	13.7	9.7	14.2	6.1	4.3	5.2	4.4	12.2	4.3	3.8	5.9	7.1	7.2	5.2	19.8	7.1	56.8	2.3	1.8	1.9	5.7	57.7	0.3	2.5	0.1	4.4	8.2	30	26.5	0.9	0.7	0	6	10.9	0.8	0.9	2.8	1.5	3.9	6	1.1	22	4.8	0	2	1.1	13.4	9.6	0	2.8	0	4.4	8.9	3.2	27.6	0.6	11.3	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1
MAK	"dJ417M14.2, RP62"	ENSG00000111837	Male germ cell associated kinase	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Retinitis pigmentosa"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		retina: 38.1;testis: 19.3	Cell line enhanced	Detected in some		HDLM-2: 4.7	Low cancer specificity	Detected in some			Region enriched	Detected in many	7	pons and medulla: 10.6	Cell type enriched	Detected in single	13	neutrophil: 11.7	Lineage enriched	Detected in single	14	granulocytes: 11.7	Not detected	Not detected			Low region specificity	Detected in single														unprognostic (1.23e-3)	unprognostic (8.77e-3)	unprognostic (2.44e-1)	unprognostic (3.81e-2)	unprognostic (6.62e-2)	unprognostic (1.35e-3)	unprognostic (1.97e-2)	unprognostic (2.53e-1)	unprognostic (3.21e-2)	unprognostic (2.42e-2)	unprognostic (1.13e-3)	unprognostic (6.73e-2)	unprognostic (6.59e-5)	unprognostic (1.55e-1)	unprognostic (8.40e-2)	unprognostic (7.71e-3)	unprognostic (4.59e-2)	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3	0.9	1.8	1.8	0.1	0	1.7	0	0.2	1	1	1.3	1.7	0.9	0.7	0	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0	3.2	2.9	0.1	0	0.2	0.3	0	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	Mitogen-activated protein kinase kinase 1	Q02750	15	66386817-66492312	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		62000	62000	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	unprognostic (4.05e-2)	unprognostic (1.23e-2)	unprognostic (2.07e-1)	unprognostic (4.92e-2)	prognostic unfavourable (1.95e-4)	unprognostic (1.81e-3)	unprognostic (5.78e-2)	unprognostic (9.91e-3)	unprognostic (1.11e-1)	unprognostic (1.77e-1)	unprognostic (1.45e-1)	unprognostic (7.62e-3)	unprognostic (1.20e-1)	unprognostic (2.71e-1)	unprognostic (1.96e-1)	unprognostic (1.15e-1)	unprognostic (9.40e-3)	28.6	16.9	33.9	19.1	54.1	29	23.6	32.5	48.4	12.5	12.1	8.4	10.2	10	11.8	16.5	22	10.6	14.4	19.1	49.2	26.4	15.3	53.1	16.4	23.3	17.6	31.2	13.5	11.7	23.4	12	15.4	17.2	14.4	12.9	9.1	13.2	12.4	39.5	12.3	10.9	16.9	17.4	14.5	10.8	7.8	12.6	12.6	12.3	9.7	27.9	13.6	18.7	4.6	16.2	5.5	8.2	8.4	7.9	2.7	33.1	15.6	31.5	13.1	19	14.3	18.2	24.1	20.6	26.2	23.4	23.5	27.3	30.5	29.9	19.8	29.6	29.4	35.2	30.8	24.5	17.5	9.8	16.4	12.7	15.4	12.9	14.6	11	21.8	18.9	28.1	20.4	17.3	39	38.1	12.8	10.3	16.8	16.1	13.7	11.7	19.5	27.1	25.4	14.3	19.4	10.8	19.5	15.3	20.2	13.8	11	28.1	34.1	20.9	24	35.7	24.2	43	19.4	36	22.8	15.9	3.2	8.2	5.5	7.4	8.2	6.7	3	6.6	6.9	8.3	4.6	7.9	4.9	3.9	8.4	7.3	16.2	4.9	2.7	33.9	54.1	32.5	46.9	49.2	26.4	17.6	31.2	17.2	12.6
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	Mitogen-activated protein kinase kinase 2	P36507	19	4090321-4124129	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all											"CAB003835, HPA051993"	Supported		Supported	Cytosol				Cytosol		"CAB003835: AB_562312, HPA051993: "	unprognostic (4.39e-1)	prognostic favourable (3.72e-4)	unprognostic (4.24e-1)	unprognostic (1.26e-3)	unprognostic (2.58e-1)	prognostic favourable (7.98e-4)	unprognostic (2.08e-3)	unprognostic (2.11e-1)	unprognostic (2.65e-1)	unprognostic (1.06e-1)	unprognostic (7.45e-3)	unprognostic (4.95e-2)	unprognostic (1.32e-1)	prognostic favourable (5.43e-5)	unprognostic (2.91e-2)	unprognostic (2.25e-1)	unprognostic (4.90e-2)	23.9	33	35.6	27.6	36.1	46.7	30.2	31.2	43.4	22.6	38.8	24.6	27	70.9	21.8	23.2	32.8	21.7	27.9	41.4	33.1	31	22.7	42	24.1	44.5	34.4	29.2	30.8	46	18.9	29.7	21.3	26.1	25.7	24.3	21.7	41.5	24	134.9	27.4	56.7	19	25.2	25.9	28.3	42	20.9	44.1	26.2	42.2	29.1	20	26.9	11.4	10.7	28.3	10.6	11.3	12.1	4.5	36.2	40	21.9	30.7	30.3	36.6	21.9	23.9	32	32.7	29.7	34.6	19.7	31	22.6	27.2	26.2	17.1	25.5	25.4	26.3	20.8	11.3	21.8	38.2	46.5	20.8	23.9	40.4	24.9	22.9	30.6	28.9	21.6	61.3	27.5	45.4	41.1	29.2	25.1	29.1	31.5	14.4	35.4	28.5	23.3	29.7	29.6	21.9	30.4	74.5	23.4	35.7	25.5	26.9	23.3	68.6	36.8	61.7	37.3	21.7	41.7	37.5	45.9	15.2	9.1	28.3	11.9	10.6	9.7	8.9	9.7	12.1	10.7	11.4	8.9	11.6	14.4	11.3	8.7	6	9.2	4.5	35.6	36.1	31.2	43.4	33.1	31	34.4	29.2	26.1	20.9
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	Mitogen-activated protein kinase kinase 3	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB018548	Approved		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		CAB018548: AB_631927	unprognostic (2.31e-1)	unprognostic (6.39e-2)	unprognostic (4.63e-2)	unprognostic (3.68e-1)	unprognostic (3.54e-3)	unprognostic (1.60e-1)	unprognostic (2.97e-2)	unprognostic (1.35e-2)	unprognostic (5.25e-3)	unprognostic (1.88e-2)	unprognostic (3.16e-2)	unprognostic (2.18e-2)	unprognostic (1.33e-1)	unprognostic (6.48e-2)	unprognostic (1.22e-2)	unprognostic (2.92e-1)	unprognostic (1.77e-1)	16.1	12.1	5.5	14.8	7.3	66.9	29	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45	21.4	16	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10	21.6	22	2.9	13.3	17.8	11.4	11.1	33.6	36.5	26.8	24.7	24.3	14	19.6	13.7	52.5	21.5	9.3	29.8	19.1	20.3	17	11.4	12.6	22	5.5	14.9	23.4	8.8	8.5	36.5	11	12	2.2	9.8	22.3	21.5	7.4	14.2	8.4	12.6	15.5	18.9	14.5	15.1	22.9	8	2.8	12.4	13.4	23.3	6.7	5.1	10.9	25.5	20.8	27.2	21.6	12.3	6.2	25.2	24.6	12.9	13.1	14.5	16	25.2	14.6	24	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	Mitogen-activated protein kinase kinase 4	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 13.2	Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Cell Junctions	"CAB007751: , HPA060074: "	unprognostic (1.55e-1)	unprognostic (1.85e-1)	unprognostic (4.47e-2)	unprognostic (1.02e-2)	unprognostic (1.04e-1)	unprognostic (2.70e-1)	unprognostic (2.89e-1)	unprognostic (2.16e-1)	unprognostic (1.93e-3)	unprognostic (2.53e-1)	unprognostic (2.76e-3)	unprognostic (4.82e-2)	unprognostic (5.32e-3)	unprognostic (3.13e-1)	unprognostic (2.30e-1)	unprognostic (7.00e-2)	unprognostic (1.79e-1)	10.7	13.2	23.7	9.4	21	3.1	14.4	25	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	17.9	15.5	20.4	10.5	11.3	14.7	13	12.3	16.2	14	13.4	9.2	6.2	7.5	10	19.1	12.1	17.7	17.1	21.1	13.2	20.8	8.3	9.1	17.3	13.3	7.9	12.6	12.1	17	16.4	17.2	12.7	8.8	4.4	17.6	6.7	9.6	7.4	11.9	7.6	11.8	22.9	5.1	19.2	11.6	4.1	12.1	14.2	7.6	11.8	9.6	5.8	11.6	6.9	10.7	9.5	14.5	8.7	9.7	5.9	13	6.3	10	0.6	2.7	2	3	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21	25	42.7	31.7	29.3	24.5	27.1	23.4	9.8
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	Mitogen-activated protein kinase kinase 5	Q13163	15	67542709-67807123	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB022094, HPA027347, HPA027755"	Supported		Approved	"Nucleoli,Microtubules"				"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	unprognostic (4.54e-2)	unprognostic (1.87e-2)	unprognostic (4.16e-2)	unprognostic (9.06e-2)	unprognostic (1.77e-3)	unprognostic (1.06e-1)	unprognostic (1.96e-1)	unprognostic (3.73e-1)	unprognostic (2.41e-2)	unprognostic (2.83e-1)	unprognostic (1.47e-2)	unprognostic (5.41e-2)	prognostic favourable (8.03e-5)	unprognostic (1.68e-1)	unprognostic (2.74e-1)	unprognostic (3.99e-2)	unprognostic (2.73e-2)	18.6	22.2	20.3	13.8	30.9	14.6	23.7	25	25.4	17	19.3	17.2	19.9	14.7	17.4	11.3	13.5	16.2	14.4	18.8	17.1	16.4	14.2	15.5	13.5	27.9	12.6	11.5	29	21	34.1	14.4	17.7	22.2	15.9	14.8	15.6	15.7	18.5	28.5	18.7	15	19.4	17.2	13	15.4	20.3	16.2	40.2	16.9	9.2	11.9	17	17.9	6.6	10.2	10.3	7.3	11.7	11.2	5.5	5.5	14.6	8.8	10.3	13	22.8	6.9	5.5	11.2	10.4	11.4	5.8	9.9	9.1	11.7	9.2	8.3	14.9	8.8	8.6	13.1	14.9	12.3	10.9	6.3	16.4	7.4	7.7	15.6	11.7	7.5	17.1	13.7	10.8	15.2	8.6	7.1	12.1	8.8	12.3	7.1	12	10.2	15.1	6.3	10.1	5.5	8.6	6.2	9.2	22	11.5	14.6	11.4	10.7	7.1	7.4	7.4	21.5	25.3	10.6	14.4	17	7.7	10.3	7.3	6.6	7.7	5.6	11.2	6.6	7.3	9	10.2	6.2	10.4	9.5	1.7	11.7	6.2	3.9	7.4	5.5	20.3	30.9	25	25.4	17.1	16.4	12.6	11.5	22.2	16.2
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	Mitogen-activated protein kinase kinase 6	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 31.9;skeletal muscle: 55.6	Cell line enhanced	Detected in many		A549: 23.9;HUVEC TERT2: 17.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	7	classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9	Group enriched	Detected in all	9	dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB007744, HPA031134"	Enhanced		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	prognostic favourable (2.27e-6)	unprognostic (2.24e-1)	unprognostic (8.46e-2)	unprognostic (4.10e-2)	unprognostic (3.75e-2)	unprognostic (1.23e-1)	unprognostic (7.61e-3)	unprognostic (9.52e-2)	unprognostic (3.67e-1)	unprognostic (4.09e-3)	prognostic favourable (7.52e-4)	unprognostic (3.61e-2)	unprognostic (2.29e-2)	unprognostic (7.48e-2)	unprognostic (9.43e-2)	unprognostic (1.39e-1)	unprognostic (2.03e-2)	4.5	2	3.2	8.6	5.9	10.1	14	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0	3.2	1.1	5.3	2.8	22.8	5.3	4	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	23.9	10.8	13	4.7	2.5	1.6	0.1	3.5	1	1.5	0.7	1.1	0.6	8.8	0.5	1.2	3.7	0.5	0.3	0.8	1.9	0.1	6.7	6.7	4.6	1	0.9	11.9	0.3	0.3	0	17.2	0	1.7	0	0.1	12.5	0.4	7.6	4.4	4.5	1.1	0.3	4.8	3.3	4.8	7.3	1	0.9	2.2	3.3	1.3	3	1.3	1.5	1.1	0.4	1.2	1.3	0.3	1	1.5	1	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	Mitogen-activated protein kinase kinase 7	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all							Low region specificity	Detected in all			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Golgi apparatus	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: "	unprognostic (1.77e-1)	unprognostic (5.04e-2)	unprognostic (1.06e-2)	unprognostic (2.16e-1)	unprognostic (4.24e-2)	prognostic favourable (8.54e-5)	unprognostic (1.80e-3)	unprognostic (2.55e-1)	unprognostic (2.69e-2)	unprognostic (1.69e-2)	unprognostic (1.27e-3)	unprognostic (1.56e-1)	unprognostic (3.54e-2)	unprognostic (3.71e-2)	unprognostic (6.05e-2)	unprognostic (1.73e-2)	prognostic favourable (1.56e-4)	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17	16.4	16.2	14.4	7.9	14.2	23	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3	2.6	4.8	2.7	3.3	2.5	1	12.7	7.3	6.4	10.4	5.1	5	11.9	8.4	4.1	5.7	6	10.5	7.8	15.2	13.6	4.4	11.7	5.5	6.4	2.2	12.1	27.4	10.7	9.7	7.8	6.6	9.9	13.6	5.7	8.4	4.5	5.2	5.2	15.6	20	3.3	6.7	14.2	24.2	11.2	16.5	14.1	6.9	15.4	5.1	10.7	11.7	11.8	5.7	10.1	11.7	10.8	11.4	7.7	17.5	10	12.3	11.3	29	13.4	14.3	8.7	14.7	7	0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2	1.3	3	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	Mitogen-activated protein kinase kinase kinase 1	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		SH-SY5Y: 27.0;THP-1: 25.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Region enriched	Detected in many	6	olfactory region: 22.5	Low region specificity	Detected in all			"CAB004500, HPA046509"	Approved		Approved	Cytosol				Cytosol		"CAB004500: AB_627926, HPA046509: "	unprognostic (1.77e-1)	unprognostic (1.71e-2)	unprognostic (4.09e-1)	unprognostic (2.18e-1)	unprognostic (3.48e-2)	unprognostic (5.39e-3)	unprognostic (5.20e-3)	unprognostic (2.52e-2)	unprognostic (1.35e-1)	unprognostic (1.41e-1)	unprognostic (1.05e-2)	unprognostic (6.73e-2)	unprognostic (1.97e-3)	unprognostic (2.18e-2)	unprognostic (1.58e-1)	unprognostic (9.92e-3)	unprognostic (1.11e-1)	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.4	3.9	6.2	4.1	1	0.8	10.4	1.2	1.7	3.9	5.5	18.4	4.9	5.8	0.4	1.5	3.4	5.1	2.3	5.4	2	2.2	3.2	1.7	8.6	2.5	5.1	9	1	2.5	1.2	1.9	1.7	2.8	10.5	1	2.8	3.5	6.9	2.8	0.5	5.6	4.4	19.9	6.8	6.8	2.6	27	3.8	4.8	11	13.2	25.2	4.9	0.3	3.3	1.4	2.3	7.7	3.9	11.1	0.6	3	6.6	6.7	4.5	1	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8	4.5	3.7	3.2	6.4	3.1	4.5	5.1
MAP3K10	"MEKK10, MLK2, MST"	ENSG00000130758	Mitogen-activated protein kinase kinase kinase 10	Q02779	19	40191744-40215575	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 32.0	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007039	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Actin filaments, Cytosol"		HPA007039: AB_1079357	unprognostic (2.09e-1)	unprognostic (3.77e-2)	unprognostic (1.42e-3)	unprognostic (2.03e-2)	unprognostic (2.04e-1)	prognostic favourable (8.69e-4)	unprognostic (4.50e-3)	unprognostic (1.80e-1)	unprognostic (3.94e-2)	unprognostic (6.13e-2)	unprognostic (1.34e-3)	unprognostic (4.62e-3)	unprognostic (6.88e-2)	unprognostic (1.53e-2)	unprognostic (1.51e-2)	unprognostic (4.77e-3)	prognostic favourable (2.13e-4)	7.7	7	29.6	4.7	22.8	3.7	2.2	14.3	32	3.3	3.4	5.3	1.8	4.4	4.5	1.8	3.7	3.1	4	8.2	28.2	11.2	4.7	2.1	4.2	4.6	11.5	9.4	4.3	8.1	4.7	5.2	3.7	9	4.6	2	2.4	6.9	4.8	22.9	5.6	5	4	5.3	6.7	6.2	6.6	7.1	2.3	3.3	2.6	2.4	3.8	5.4	0.8	0	0	0.2	0	0.9	0	6.2	7.5	2.3	5.5	2.2	1.3	6.5	4.4	2.2	2	2.1	1.7	1.8	5.7	4.6	1.5	2	0.9	2.2	0.3	10.9	7.1	1.5	3.2	1.7	4.2	1.2	3.7	1.2	5.4	2.2	1.5	1.9	5.4	9.8	0.6	3.7	4.7	2.3	2.8	4.9	5.9	2.5	3.4	1.8	4	7.8	11.3	5.1	1.8	10.3	2.5	2.3	3.1	5.3	5.1	7.8	8.4	13	7.5	2.5	6.2	2.4	7.7	0	0.1	0	0.4	0.2	0	0.8	0.2	0.9	0	0.1	0.1	0.5	0	0	0.1	0	0	0	29.6	22.8	14.3	28.7	28.2	11.2	11.5	9.4	9	7.1
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	Mitogen-activated protein kinase kinase kinase 11	Q16584	11	65597755-65615382	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		vagina: 75.8	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		CAB010165: AB_631936	unprognostic (8.36e-2)	unprognostic (1.17e-2)	unprognostic (1.06e-1)	unprognostic (9.99e-2)	unprognostic (3.40e-1)	unprognostic (1.87e-1)	unprognostic (7.56e-3)	unprognostic (3.10e-2)	unprognostic (4.50e-2)	unprognostic (4.30e-1)	unprognostic (4.69e-2)	unprognostic (2.77e-2)	unprognostic (3.13e-2)	unprognostic (2.01e-2)	unprognostic (7.62e-2)	unprognostic (1.95e-1)	unprognostic (8.27e-3)	23.2	10.8	11.4	23.7	21.2	14.2	27.4	7.9	13.8	8.6	15.8	29.8	6.1	31.9	11	8.1	14.7	11.6	12	11.6	13.3	8.1	16.1	31.2	21.1	14.4	30.9	8.2	8.4	12.5	8.3	10.3	14.7	16.7	13.4	8.2	15.4	13.5	9.5	11.9	13.7	31.9	8.6	17.7	28.8	16.9	8.6	19	8.9	13.6	7.6	12.7	8.9	75.8	2.3	7.6	13.8	12	1.8	3.5	5.6	16.5	14.6	7.9	8.4	2.5	3.2	8.1	6.4	4.5	7.7	5.3	14.6	16	6.2	23.7	5	14.4	4.7	6.9	2.8	13.6	6	17.5	10	17.4	7	10	26.5	5	6.7	5.7	5.2	21.5	7.5	12.5	4	20.4	11.7	18.9	8.6	18.7	19.5	5.1	12.6	7.2	14.3	7.1	8	7.5	21.8	37.5	17.4	16.3	23.9	11.8	12.8	17.2	11.3	8	9	5.5	13.8	11.6	27.3	4.3	7.7	9.2	2.4	12	2.4	2	2.6	3.5	7.6	2.3	2	1.5	13.8	1.8	11.7	2.3	1.4	5.6	11.4	21.2	7.9	13.8	13.3	8.1	30.9	8.2	16.7	19
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	Mitogen-activated protein kinase kinase kinase 12	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 40.3	Cell line enhanced	Detected in many		ASC diff: 28.4;HHSteC: 27.1;HSkMC: 27.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	4	granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"HPA039936: AB_10795239, HPA071996: "	unprognostic (4.01e-1)	unprognostic (3.30e-1)	unprognostic (8.89e-3)	unprognostic (6.40e-3)	unprognostic (1.10e-1)	unprognostic (2.22e-1)	unprognostic (6.97e-2)	unprognostic (3.61e-2)	unprognostic (2.39e-1)	unprognostic (2.70e-1)	prognostic favourable (1.51e-4)	unprognostic (8.50e-3)	prognostic unfavourable (5.43e-10)	unprognostic (1.65e-2)	unprognostic (2.44e-1)	unprognostic (1.32e-1)	unprognostic (1.18e-1)	8	8.7	12.3	5.8	16	3	5.1	40.3	20.6	14.1	6.1	7	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.5	4.7	7.3	28.4	15.2	0.6	5.1	9.6	5.6	5.6	0.1	0.9	1.7	2.9	5.4	0	2.1	3.4	2.2	2.5	2.6	1.8	3.8	0	27.1	0	1.9	27	2.4	7.6	4	8.7	0	8.1	5.3	3.3	1.8	0.4	1.6	2.8	2.6	3.2	0.4	2.8	0	4.7	6.4	2.7	3.5	7.2	2.4	4.7	6.4	5.4	5.8	2.4	1.3	3.3	3.7	0	8.7	3.3	5.2	0	1.7	0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4
MAP3K13	"LZK, MEKK13"	ENSG00000073803	Mitogen-activated protein kinase kinase kinase 13	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				Centriolar satellite	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	unprognostic (8.95e-2)	unprognostic (6.72e-3)	unprognostic (9.46e-2)	prognostic unfavourable (1.28e-5)	unprognostic (5.16e-2)	unprognostic (2.81e-1)	unprognostic (2.61e-1)	unprognostic (1.23e-2)	unprognostic (9.04e-2)	prognostic favourable (1.11e-4)	prognostic unfavourable (7.27e-5)	unprognostic (2.70e-3)	unprognostic (1.54e-2)	unprognostic (2.94e-2)	unprognostic (2.82e-1)	unprognostic (6.64e-2)	unprognostic (9.31e-3)	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.6	6.7	4.6	10.9	13.2	11.2	11	0.2	23	12.2	16.7	0.3	15.5	19.4	32.4	15	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	12.1	0.3	23.7	9.7	9.1	1.8	7.2	13	13.7	0.2	13.5	16	19.2	7.6	18.6	12.4	11.3	17.1	23.2	25.8	8.6	8	9	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8
MAP3K14	"FTDCR1B, HS, HSNIK, NIK"	ENSG00000006062	Mitogen-activated protein kinase kinase kinase 14	Q99558	17	45263121-45317040	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		A549: 22.0;HDLM-2: 22.6;U-251 MG: 22.1	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA027269, HPA027270"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA027269: AB_10600302, HPA027270: AB_10600884"	unprognostic (1.05e-2)	prognostic favourable (5.27e-5)	unprognostic (2.71e-2)	unprognostic (9.42e-2)	unprognostic (5.31e-2)	unprognostic (2.61e-3)	unprognostic (2.70e-2)	unprognostic (1.72e-1)	unprognostic (3.40e-1)	unprognostic (3.45e-1)	unprognostic (1.07e-2)	unprognostic (1.78e-1)	prognostic unfavourable (2.78e-4)	unprognostic (8.82e-2)	unprognostic (3.49e-2)	unprognostic (1.03e-2)	unprognostic (2.28e-1)	3.7	3.4	3	14.7	4	3.4	2.7	4.9	3.6	5	7.3	4.5	3.5	6	5.5	3.3	6.8	4.2	6.2	4.5	3		4.4	5.1	4.9	12	3	0.6	3.5	5.7	3.5	7.7	1.5	4.6	5.2	3.5	4.3	7.5	4.8	14.5	6.1	9.6	5.2	4.1	8.4	4	4.5	4.5	7.1	2.2	6.9	18	4.9	2.8	9.5	4.8	7.7	3.6	5.6	5.2	2.3	9.4	22	2.2	3.9	1.5	3.7	5.6	2.6	1.8	8.3	5.1	3.4	11.6	4.2	13.3	2.7	6.6	1	3.5	4.3	22.6	1.7	0.9	6	1.5	4	0.7	4.4	5.8	2.2	4.1	2.2	1.6	1.8	18	4.2	3.4	3.9	1.5	1.2	3.1	5.2	6.7	9.5	6	1.9	2.3	1.9	4	2.7	2.8	1.7	0.4	3.5	3.8	5.9	3.2	22.1	17.2	6.4	2.2	2.1	2.4	5.1	1.5	3.4	1.6	3.5	3.6	2	7.6	2.4	2.5	2.3	9.5	2.6	2.5	7.7	5.6	2.2	4.8	5.2	2.3										
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	Mitogen-activated protein kinase kinase kinase 15	Q6ZN16	X	19360056-19515261	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 17.3;brain: 13.2	Cell line enhanced	Detected in some		A549: 3.4;HAP1: 8.6;HEK 293: 7.2;HEL: 2.9;REH: 4.4	Low cancer specificity	Detected in single			Region enriched	Detected in some	6	pons and medulla: 13.2	Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			HPA004006			Approved	Vesicles				Vesicles		HPA004006: AB_1079358	unprognostic (2.87e-1)	unprognostic (7.09e-2)	unprognostic (3.21e-2)	unprognostic (6.56e-8)	unprognostic (3.47e-2)	unprognostic (1.42e-2)	unprognostic (2.19e-3)	unprognostic (2.35e-2)	unprognostic (1.46e-1)	unprognostic (4.87e-2)	unprognostic (1.30e-2)	unprognostic (8.95e-2)	unprognostic (2.77e-3)	unprognostic (4.00e-1)	unprognostic (2.37e-1)	unprognostic (3.98e-2)	unprognostic (8.20e-2)	0.1	17.3	0.5	0.4	0.3	0.5	0.1	2.3	0.1	0.1	0.1	5	0	0	0.1	0	0.1	0.1	0	0.1	0.4	0.5	3.6	0.1	0.5	0	0.1	0	1.3	4.1	0.4	5.7	0	13.2	0.1	0	4.1	0.1	0	0.1	0.1	0.1	0	0.1	2.6	0.1	2.1	0	0	0.1	0	0	0.1	0.1	0	0	0.2	0	0	0	0	0	3.4	0.1	0.3	0	0	0.3	0	0	0	0	0.4	0	0	0.4	0	0	8.6	0	0	1.4	7.2	2.9	0	0.8	0	0	0.3	0	0	0	0	0	0.5	0	0	0.2	0	2.2	2.2	0.9	4.4	0	0	0.5	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.5	0.3	2.3	0.1	0.4	0.5	0.1	0	13.2	0
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	Mitogen-activated protein kinase kinase kinase 19	Q56UN5	2	134964491-135047468	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 18.3;fallopian tube: 23.9	Group enriched	Detected in some	5	RPMI-8226: 4.0;U-266/70: 2.3	Cancer enhanced	Detected in some		endometrial cancer: 0.8	Region enhanced	Detected in many		pons and medulla: 18.3	Cell type enriched	Detected in single	6	plasmacytoid DC: 1.5	Lineage enriched	Detected in single	6	dendritic cells: 1.5	Low region specificity	Detected in all			Region enhanced	Detected in many		midbrain: 20.2	HPA011388			Uncertain	Cytosol				Cytosol		HPA011388: AB_1848822	unprognostic (7.12e-3)	unprognostic (6.55e-3)	unprognostic (6.96e-2)	unprognostic (3.90e-3)	unprognostic (3.63e-1)	unprognostic (2.21e-1)	unprognostic (1.96e-1)	unprognostic (9.38e-2)	unprognostic (1.09e-1)	unprognostic (4.33e-1)	unprognostic (2.02e-2)	unprognostic (1.32e-1)	unprognostic (4.04e-6)	unprognostic (1.50e-1)	unprognostic (4.13e-2)	unprognostic (1.54e-1)	unprognostic (2.83e-4)	0.1	0.2	1.7	0.2	6.2	0.1	0.1	0	0.5	1.1	0.2	7.3	0	0.2	1	6.7	0.2	23.9	0.1	0.1	2.9	3.8	0.2	0.2	5.6	0.2	0.5	1.5	7.3	0.1	0.1	1	0.1	18.3	0.3	0.2	0	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	7.6	3.1	0	0.1	0	0.1	0.1	0	0	1.5	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0.6	0	4	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	2.3	0.6	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0.2	0	1.7	6.2	0	0.5	2.9	3.8	0.5	1.5	18.3	3.1
MAP3K2	"MEKK2, MEKK2B"	ENSG00000169967	Mitogen-activated protein kinase kinase kinase 2	Q9Y2U5	2	127298730-127388465	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 13.6	Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021540	Approved		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA021540: 	unprognostic (5.81e-2)	unprognostic (2.76e-1)	unprognostic (1.58e-1)	unprognostic (9.46e-2)	unprognostic (1.02e-1)	unprognostic (5.76e-2)	unprognostic (7.19e-2)	unprognostic (4.50e-1)	unprognostic (1.27e-1)	unprognostic (4.00e-1)	unprognostic (1.25e-1)	unprognostic (1.39e-1)	unprognostic (4.97e-3)	unprognostic (7.56e-2)	unprognostic (8.93e-2)	unprognostic (8.88e-2)	unprognostic (2.11e-1)	18.5	14.5	13.7	20.1	14.5	41	22.6	20.1	16.3	16.6	19.6	12.7	18.9	18.8	19.8	18	13.4	15.9	18.6	13.3	12.5	10.2	15.5	27.6	20	28.5	17.9	13	20.3	15.4	23.8	21.2	13.9	12.3	13.6	13.1	12.2	18.1	25.5	24.5	19.4	22.5	18.1	14.9	17	18	14.9	14.3	25.8	22.5	13.7	16.8	17.1	20.3	3.1	5.1	13.6	2.9	2.3	2.1	1.1	16.3	7	5.6	5.6	7.8	10.4	9.3	10.2	11.1	10.1	8.2	8.3	7.3	10.8	17.6	14.5	13.9	8.9	6.8	11.3	27	6.9	10	12.6	7.3	9.1	10	21.7	9.3	7.6	12.2	15	4.6	4.7	21.6	9.9	5.9	11.7	7.1	5.7	9.1	7.7	10.5	8	4.1	15.3	11.1	5.9	14.8	9.1	9.2	5.9	7.7	10.6	19.8	18.6	9.1	13.8	22.4	16.1	11.1	9.5	6.6	8.5	4	2.9	2	1.7	1.8	2.1	3.1	1.6	1.7	2.4	2.6	1.9	2	13.6	2.3	2.2	5.1	1.4	1.1	13.7	14.5	20.1	16.3	12.5	10.2	17.9	13	12.3	14.3
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	Mitogen-activated protein kinase kinase kinase 20	Q9NYL2	2	173075435-173268010	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Cell cycle	"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		skeletal muscle: 96.1	Cell line enhanced	Detected in many		U-138 MG: 47.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		myeloid DC: 13.7	Group enriched	Detected in many	5	dendritic cells: 13.7;monocytes: 8.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA017205	Approved		Supported	Cytosol				Cytosol		HPA017205: AB_1858933	unprognostic (2.90e-2)	unprognostic (9.99e-3)	unprognostic (4.63e-3)	unprognostic (1.98e-1)	unprognostic (7.63e-2)	unprognostic (5.02e-2)	unprognostic (2.34e-2)	unprognostic (3.89e-3)	unprognostic (2.83e-2)	unprognostic (9.27e-2)	unprognostic (4.54e-2)	unprognostic (1.74e-1)	prognostic unfavourable (3.41e-6)	unprognostic (2.34e-1)	unprognostic (1.86e-1)	unprognostic (2.23e-1)	unprognostic (1.19e-2)	21.7	5	2.9	7.4	3.3	0.8	9.2	2.8	3.1	25.7	24.8	2.1	10.7	3.1	30.2	15.4	26.2	13.1	14.9	52.5	3.5	3	2.4	8.5	7.5	2.5	4.5	3	21.7	4.4	22.6	3.1	6.9	4.2	25.6	5.4	11.5	6.7	15.8	96.1	5.8	8	68.4	4.7	3.7	15.8	6.6	3.5	2.8	6.7	38	4.9	46.7	24	2.1	13.7	2.3	8	0.4	1.6	2.7	8.7	7.3	5.8	7.6	16.9	25.2	3.6	31.6	24.7	14.8	15.9	5	5.8	6.7	8.3	31.6	5.9	8.6	16.7	33.3	13.1	5.8	11	8.3	1	6.7	9.8	11.6	20.2	7.2	27.8	43.9	9.7	4.9	1.3	9.7	3.7	6.1	4.9	3.2	4.2	9.1	11.9	0	3.6	5	3.4	3.3	12.2	3	5.1	3.4	5.3	9.7	47.2	19.4	14	7.1	0	0	1.4	33.9	2.7	4.9	0.1	8	0	0.9	7.5	0.9	1.5	0.8	1.6	13.7	2.1	0	0.8	2.3	0.4	6.6	0.3	0.7	2.7	2.9	3.3	2.8	3.1	3.5	3	4.5	3	4.2	3.5
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	Mitogen-activated protein kinase kinase kinase 21	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pancreas: 28.9	Cell line enhanced	Detected in many		HEK 293: 18.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	6	NK-cell: 5.0	Lineage enriched	Detected in single	6	NK-cells: 5.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		HPA007636: AB_1079392	unprognostic (3.29e-2)	unprognostic (5.10e-2)	unprognostic (2.00e-1)	unprognostic (2.42e-3)	unprognostic (4.30e-2)	unprognostic (1.23e-1)	unprognostic (1.82e-2)	unprognostic (1.84e-1)	unprognostic (1.51e-1)	unprognostic (1.25e-1)	unprognostic (2.09e-1)	unprognostic (8.21e-2)	unprognostic (3.76e-2)	unprognostic (2.23e-1)	unprognostic (1.71e-1)	unprognostic (9.22e-2)	unprognostic (4.84e-2)	0.6	3.2	2	3.4	2.2	1.3	2.2	10	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1	1.2	1.3	6	1	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5	0.2	0.1	7.3	12.5	0.2	0	0	0	6.3	0.2	0	0.3	0.5	6.9	6.4	0.7	5.2	0.1	3.9	9.4	3.8	0.8	13.6	18	0.1	7	0	0.4	11.9	2.9	0.1	5.1	0.2	7.3	0.4	0.1	2.4	0	1.6	3.8	4.3	8.9	5.5	0	0	13.1	8.6	3.1	9.2	2.5	4.3	0.2	0	3.7	3.8	0	0	1.2	0	7.3	2.2	2.8	0	1.2	3.3	0.3	0	0.3	0	0	0.1	0	0.3	0.2	0.1	0.8	0.5	0	0	0.1	5	0	0.2	0.2	0.1	2	2.2	10	3.3	1.3	2.1	0.9	1.7	1.2	0.6
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	Mitogen-activated protein kinase kinase kinase 3	Q99759	17	63622415-63696303	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"CAB007764: AB_562314, HPA035410: , HPA035411: "	unprognostic (9.65e-3)	unprognostic (1.33e-1)	unprognostic (5.14e-2)	prognostic unfavourable (1.13e-4)	unprognostic (1.16e-1)	unprognostic (4.12e-2)	unprognostic (1.03e-2)	unprognostic (1.33e-1)	unprognostic (1.36e-1)	unprognostic (9.37e-2)	unprognostic (1.46e-3)	unprognostic (5.51e-2)	unprognostic (2.35e-1)	unprognostic (2.79e-2)	unprognostic (4.68e-2)	unprognostic (1.09e-1)	unprognostic (3.08e-2)	23.9	11.8	10.5	20.5	15	24.8	19.1	26.8	14.9	22.2	21.8	15	14	8	24.5	13.2	16.6	18.3	20.6	37.4	11.3	8.4	17.1	12.4	23.1	21.4	14.4	9.6	21.6	11.4	16.9	12.3	21	11.9	18.4	8.3	21.7	12.8	18.5	19.6	15.4	14.7	20.4	13.2	30.4	16.4	26.5	12.3	12.9	15.5	12.8	15.4	19	26.8	1.9	3.5	18.3	8.5	1.1	2.6	2.3	10.1	7.6	9.7	9.4	18.6	15	4.4	10	11	12.5	10.1	3.5	2.1	10.9	7.1	19.6	3.8	6.3	7.1	7.9	9.5	13.9	8.9	10.3	4.9	9.7	6.8	9.5	10.7	4.9	15.5	8.2	30.3	5.4	14.5	9.9	7.1	12.2	7.1	6	8.1	6.5	24.8	7.1	4.5	4.6	5	11.9	6.8	8.2	8.3	8.2	6.8	27.2	32	8.5	17.3	12.1	14.4	14.6	4	6.9	5.5	8.3	8.8	8.5	10.4	2.2	8.3	2.3	1.5	2.6	2.1	3.5	1.9	2.5	2.5	18.3	1.1	8.2	1.3	1.9	2.3	10.5	15	26.8	14.9	11.3	8.4	14.4	9.6	11.9	12.3
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	Mitogen-activated protein kinase kinase kinase 4	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007625	Uncertain		Approved	Cytosol				Cytosol		HPA007625: AB_1853770	unprognostic (3.05e-3)	unprognostic (2.19e-2)	unprognostic (1.36e-1)	unprognostic (1.44e-1)	unprognostic (2.06e-1)	unprognostic (7.65e-2)	unprognostic (1.35e-3)	unprognostic (6.38e-2)	unprognostic (2.09e-1)	unprognostic (3.81e-3)	unprognostic (2.09e-2)	unprognostic (2.61e-1)	unprognostic (1.16e-2)	unprognostic (5.86e-2)	unprognostic (3.45e-1)	unprognostic (1.93e-1)	unprognostic (6.84e-2)	12	8	13.1	17.7	12.6	9.1	14.6	23.1	14	16.4	13.9	9.3	12.2	9.5	22.2	11.9	21.4	14.1	11.4	12.4	11.9	7.8	9.4	8.2	15.9	14.4	12.8	8.9	17.4	12.1	15.8	16.2	12.4	9.2	14.2	9.8	9.4	15	15.4	24.4	15.1	13.3	13.9	7.7	10.6	11.1	13.5	12.4	16.2	10.6	13	16.8	15.8	23.9	8.8	5.4	17.5	3.8	3.5	8.9	2.2	4.6	5.3	10.1	8.6	6.3	7.4	6.5	5.3	4.7	6.1	6.5	7.5	3.4	9.6	3.8	13.5	11.7	10.3	10.6	7.5	7	8.4	12.5	4.9	7.4	4.8	13	6.1	4.6	12.3	6.4	5.8	7.9	31.6	11.1	6.5	4.8	8.7	6.6	6.1	8.2	9.6	9.3	7.6	5.6	3.4	5.8	5.2	9.9	10.6	0.9	4.3	15.9	7.4	7.5	9.6	6.9	25	6.5	5.2	8.8	8.8	13.4	7.8	17.5	3.8	2.3	5	3	8.9	6.2	7.1	4.5	4.3	8.8	5	4.9	0.2	3.5	1.7	5.4	4.8	2.2	13.1	12.6	23.1	14	11.9	7.8	12.8	8.9	9.2	12.4
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	Mitogen-activated protein kinase kinase kinase 5	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		adrenal gland: 55.6	Cell line enhanced	Detected in many		BJ hTERT+: 22.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB007824, HPA063245"	Supported		Supported	Cytosol				Cytosol		"CAB007824: AB_598175, HPA063245: "	unprognostic (1.37e-1)	unprognostic (3.21e-2)	unprognostic (2.85e-2)	unprognostic (1.38e-1)	unprognostic (3.19e-1)	prognostic favourable (6.08e-4)	unprognostic (8.76e-2)	unprognostic (1.41e-2)	unprognostic (2.84e-1)	unprognostic (1.90e-2)	prognostic unfavourable (5.91e-4)	unprognostic (3.97e-1)	unprognostic (3.75e-2)	unprognostic (1.37e-1)	unprognostic (2.72e-1)	unprognostic (2.72e-2)	unprognostic (6.59e-3)	7.7	55.6	13	7.5	17.6	7.6	5.5	12.9	12.7	4	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2	10	3.4	9	10.8	18.9	2.5	2.5	8.5	3	4.1	7	1.4	2.8	1.7	0	0	4.1	11.1	1	4.1	22.3	2.1	2	0.1	2.9	1.7	6.1	5.7	4	7.1	2.1	5.6	2.3	5.6	14.7	3.9	0	19.8	6.8	0	14.6	2.8	3.3	9.6	7.1	3.6	16.5	15	5.5	0.1	5.8	0.7	2.4	3.8	4.7	6.7	8.6	18.3	5.2	3.4	3.4	3.3	0.9	0.7	6.1	6.2	3.6	1.1	0.2	3.8	13.5	8.9	0	2.8	9.6	3.1	5.7	3	3.3	2.7	2.3	4.9	2	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7	1.4	13	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	Mitogen-activated protein kinase kinase kinase 6	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skin 1: 63.9	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in some			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	HPA051192: 	unprognostic (1.19e-2)	unprognostic (2.77e-3)	unprognostic (2.62e-2)	unprognostic (1.97e-2)	prognostic unfavourable (2.13e-4)	prognostic favourable (7.26e-4)	prognostic unfavourable (8.76e-4)	unprognostic (9.10e-2)	unprognostic (2.79e-1)	unprognostic (6.91e-2)	unprognostic (6.56e-2)	unprognostic (1.25e-1)	unprognostic (4.65e-3)	unprognostic (4.95e-2)	unprognostic (2.79e-1)	unprognostic (7.07e-3)	unprognostic (1.50e-1)	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16	11.7	8.7	9	6.7	7	0.6	12	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.4	6.9	6.2	6.9	8.7	15.3	1.6	9.3	5.4	7	5.3	2	10	0.1	8.3	14.1	11.8	2.1	6.5	3.5	6.2	5.1	0.5	16	3.1	2.7	0.5	0.6	12.2	15.9	7.3	2.6	4.7	2.3	4.1	11.1	18.4	0.3	8.4	1.9	5.7	2.7	4.1	1.7	10.5	7.8	2.3	3.4	9.8	8.6	7.3	4.6	6.4	9.8	17.6	7.4	19.7	4.8	3.3	4.1	0.1	15.6	6.1	5.1	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	Mitogen-activated protein kinase kinase kinase 7	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	unprognostic (1.48e-1)	unprognostic (3.45e-2)	unprognostic (1.35e-1)	unprognostic (6.48e-2)	unprognostic (1.44e-1)	unprognostic (1.84e-1)	prognostic unfavourable (3.51e-4)	unprognostic (9.77e-2)	unprognostic (6.51e-2)	unprognostic (1.98e-2)	unprognostic (1.44e-1)	unprognostic (2.79e-1)	unprognostic (2.56e-3)	unprognostic (4.76e-2)	unprognostic (1.95e-1)	unprognostic (2.08e-1)	unprognostic (1.17e-1)	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20	22.2	22.9	16.4	25	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17	23.3	24.3	18.7	14.7	19.4	23	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.7	6.9	20.1	17.2	14.7	19.7	14.2	15.6	18.1	14.1	17.8	8.8	7.5	17.3	10	16.9	8.3	12.6	12.2	24	8.8	13.4	15.4	9.5	11.7	15.4	17.1	11.9	16.2	14.9	13.7	16.9	13.2	30.8	14.2	20.1	9.5	7.9	14.5	16.5	8.7	13.7	36.1	8.4	11.8	8.7	10.2	14.5	10.9	7.6	11.8	7.5	30.5	12.6	11.5	7.3	10.5	14.5	12.7	11.3	7.5	17.6	18.8	16.8	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	Mitogen-activated protein kinase kinase kinase 8	P41279	10	30433937-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 104.6	Cell line enhanced	Detected in many		HMC-1: 24.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"CAB005120, HPA017962"	Supported		Supported	Cytosol				Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	unprognostic (1.91e-2)	unprognostic (2.94e-1)	unprognostic (3.07e-1)	unprognostic (9.29e-2)	unprognostic (6.73e-2)	unprognostic (1.00e-2)	unprognostic (1.44e-1)	unprognostic (3.36e-2)	unprognostic (1.41e-2)	unprognostic (8.04e-3)	unprognostic (8.23e-2)	unprognostic (2.96e-1)	prognostic unfavourable (8.76e-7)	unprognostic (1.88e-1)	unprognostic (1.49e-1)	unprognostic (1.63e-2)	unprognostic (5.98e-3)	28	7.6	3.6	15.6	4.1	104.6	26.1	1.5	2.6	8.2	8.4	2.7	11.3	3.4	11.5	16.5	13.8	19.5	15.3	20.1	4.3	2.9	6.3	7.6	29	33.7	4.3	2	9.8	3.6	2.8	4.1	27.5	8.3	7.9	6.8	9.4	6.1	18.4	8.6	15.3	9.6	23.4	9.7	25.6	10.7	6.7	3.6	2.4	7	13.2	17.2	13.2	15.6	19.6	13.8	23.7	16.8	12.4	7.8	4	7.9	7.1	1.9	4.1	10.3	8.7	9.1	2	11.9	4.4	5.3	4.9	18.5	5.2	5.1	4.2	14.9	4.5	1.9	1.6	12	2.3	9.7	12.1	15.7	8.7	3	24	10.8	1.1	4.4	0.8	1.9	4.3	7.8	0.7	4.5	0.1	11.6	0.7	2.5	0.6	1.6	3	4.4	16.1	0.2	0.8	7.1	6.1	0.9	2	6.4	0.1	2.7	2.3	9.7	0.3	11.9	11.1	1.5	3.9	13.2	0.1	17.9	7	23.7	7.8	12	4.3	9.6	1.7	4.9	6.6	19.6	0.1	3	16.7	12.4	16.8	13.8	0.4	4	3.6	4.1	1.5	2.6	4.3	2.9	4.3	2	8.3	3.6
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	Mitogen-activated protein kinase kinase kinase 9	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 20.1	Cell line enhanced	Detected in many		A-431: 17.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000942	Approved		Approved	"Nucleoplasm,Nucleoli"	Intracellular and membrane			"Nucleoplasm, Nucleoli"		HPA000942: AB_1079360	unprognostic (1.20e-1)	unprognostic (3.75e-1)	unprognostic (4.01e-2)	unprognostic (1.43e-2)	unprognostic (3.16e-3)	unprognostic (2.45e-2)	unprognostic (3.75e-5)	unprognostic (2.58e-1)	unprognostic (4.20e-2)	unprognostic (4.38e-2)	unprognostic (1.53e-2)	unprognostic (2.48e-2)	unprognostic (4.23e-6)	unprognostic (5.71e-3)	unprognostic (6.86e-3)	unprognostic (1.79e-1)	unprognostic (2.35e-1)	0.5	2.2	5.8	2	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	17.7	8.2	1.6	2	0	0	5.5	0.3	0.2	1.7	1.5	5.9	6.8	3.6	2.4	0.1	8.4	5.2	10	1.8	2.4	1.5	0.2	2.9	3.9	0.2	0.4	0.8	0.1	5.5	1.2	10.4	0	1.3	0.8	0.4	7.1	2.8	0.4	3.5	3.8	1	3.1	0.7	3.9	8.2	11.3	2.4	5.1	6.1	1	5.5	0.6	0	0	7.2	0	2.8	1.9	4.3	1.9	2.7	0.3	1	0.5	0.2	0.8	0.6	0.1	0.1	1	0.6	1	0	2.3	1	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8
MAP4K1	HPK1	ENSG00000104814	Mitogen-activated protein kinase kinase kinase kinase 1	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2	Cell line enhanced	Detected in some		Daudi: 20.5;HDLM-2: 20.3;Karpas-707: 21.1;REH: 11.2;RPMI-8226: 12.7;U-266/70: 16.6;U-266/84: 16.3;U-698: 25.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA007419, CAB007754"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	unprognostic (1.99e-3)	prognostic favourable (6.17e-5)	unprognostic (9.50e-3)	unprognostic (3.27e-1)	unprognostic (6.03e-2)	prognostic favourable (3.26e-4)	unprognostic (4.88e-3)	unprognostic (5.32e-3)	unprognostic (2.79e-1)	unprognostic (2.51e-1)	unprognostic (3.92e-2)	unprognostic (2.55e-1)	prognostic unfavourable (7.99e-10)	unprognostic (1.72e-1)	unprognostic (1.83e-1)	unprognostic (3.18e-2)	unprognostic (1.50e-2)	1.6	0.9	1.2	31.4	2.3	6.3	1.1	1	1.2	1	3.1	1.7	0.1	2.1	0.9	1.4	2.6	1.2	2.9	0.9	1.1	1.4	2.2	1.6	3.9	23	2.3	0.7	0.8	1.2	0.2	1.2	1.4	2.1	1.6	1.9	2	4.4	0.8	0.5	1.2	16.9	0.7	3.4	34.4	2.3	0.9	1.3	19.1	1.9	1.4	39.2	3.1	1.3	16.2	15.9	1.3	6.2	3.7	14.6	7.3	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	20.5	0.3	0	0	0	0	0	20.3	0.1	4.3	0	0	0	1.4	0.2	0	0	0	0	0	0.1	21.1	0	0.1	4.9	5.1	0.6	0	11.2	0	12.7	0	0	0.2	0	0	0.1	0	0.1	4.6	0	0	0.1	0	0	16.6	16.3	25.8	0	5.8	0	1.3	3.2	1.2	13.4	6.2	12.4	16.2	11.2	14	15.9	10.7	6.2	8.7	0.3	3.7	3.4	14	14.6	7.3	1.2	2.3	1	1.2	1.1	1.4	2.3	0.7	2.1	1.3
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	Mitogen-activated protein kinase kinase kinase kinase 2	Q12851	11	64784914-64803241	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007330	Enhanced		Approved	Vesicles				Vesicles		HPA007330: AB_1079361	unprognostic (1.66e-1)	unprognostic (2.83e-1)	unprognostic (3.07e-3)	unprognostic (4.37e-3)	unprognostic (2.67e-1)	unprognostic (9.23e-2)	prognostic unfavourable (3.10e-5)	unprognostic (4.51e-2)	unprognostic (3.65e-1)	unprognostic (5.28e-2)	unprognostic (1.24e-2)	unprognostic (1.41e-1)	unprognostic (2.47e-2)	unprognostic (2.97e-1)	unprognostic (1.57e-2)	unprognostic (1.82e-1)	unprognostic (1.95e-2)	6.9	6.2	9.4	15.2	10	19.1	5.8	12.1	15.6	5.2	5.8	10.1	6.9	4.9	6.2	4	4.3	4.4	6.3	5.5	9.4	9.2	6.2	3.1	12	22.3	8.3	7.3	4.2	7.2	5.2	8	12.3	12.5	6.1	4.7	6.7	9	8.9	3.4	5	9.9	5.6	6.7	22.6	7.1	5.5	6.6	11.5	8.7	3.9	18.8	6.1	5.1	10.8	5	8.2	14.8	2.3	9.6	7.1	6.1	5.5	3.6	6.6	3.3	2	8.6	4.6	4.3	5.6	3.9	2.4	2.9	10.7	8.6	5.2	1.8	4.4	4.5	3.3	13.9	2.1	18.8	7.7	5.1	4	9.9	7.1	2	2.3	4.3	2.8	13.6	1.6	1	1.7	7.6	5.8	9.9	2.4	7.5	12.2	0.4	12.3	3.1	3.1	4.4	6.3	4	5.2	4.1	10.5	15.2	10.5	4.7	10.5	4.3	1.9	1.2	2.4	11.6	4.1	15	3.4	2.2	4.2	5.6	5.2	12.2	5.3	10.8	7	4.7	4.4	7.6	8.6	6.3	8.2	2.3	14.8	5	9.6	7.1	9.4	10	12.1	15.6	9.4	9.2	8.3	7.3	12.5	6.6
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	Mitogen-activated protein kinase kinase kinase kinase 3	Q8IVH8	2	39249266-39437312	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		AF22: 40.8;RT4: 37.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"				Centriolar satellite	Nucleoplasm	HPA030380: AB_10601132	unprognostic (4.82e-2)	unprognostic (7.22e-2)	unprognostic (5.87e-3)	unprognostic (7.34e-3)	unprognostic (6.77e-2)	unprognostic (2.57e-1)	unprognostic (1.05e-2)	unprognostic (6.73e-2)	unprognostic (1.66e-1)	unprognostic (6.73e-2)	unprognostic (4.33e-3)	unprognostic (4.26e-2)	unprognostic (2.12e-1)	unprognostic (3.08e-2)	unprognostic (3.30e-1)	unprognostic (2.43e-1)	unprognostic (5.08e-2)	19.7	18.9	17.6	15.4	17.6	9.6	17.8	37.1	19.6	19.2	16.9	14.6	9.8	13.7	23.5	14.8	11.1	15.3	18.7	19.5	15.4	12.5	26.2	15.4	15.6	5.8	15.4	13.4	24.6	14	25.7	24.6	30.8	14.4	18.6	14.1	17.9	13.3	15.7	33	17.8	17.2	18.6	15.3	11.5	26.1	21	16.5	9.4	25.9	11.3	7.5	18.8	32.6	0.7	0.5	2.5	1.9	1	1.3	0.4	9.7	6.1	40.8	6.4	6.6	13.4	11.2	8.7	11.1	8.6	7.4	5.1	4.9	2.1	9.8	5.9	5.3	15.3	7.7	13.2	2.4	6.3	3.5	4.3	11.9	17.3	1.5	5.8	11.9	7.7	11.2	12.1	7.4	4.5	4	11.5	5.3	3.4	2.3	12.3	9.3	3.7	13.3	1.6	11.4	37.8	7.3	8.3	5.1	8.2	22.6	5.5	2.2	6	6.7	8	6	4.7	6.1	3.4	0.7	8.3	2.5	7.8	2.5	0.7	0	1.2	1.1	0.1	0.1	1.2	0.9	0.1	0.7	1.1	1.3	0	1	1.9	0.5	0.6	0.4	17.6	17.6	37.1	19.6	15.4	12.5	15.4	13.4	14.4	16.5
MAP4K4	"FLH21957, HGK, NIK"	ENSG00000071054	Mitogen-activated protein kinase kinase kinase kinase 4	O95819	2	101696850-101894689	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 81.2	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008476	Uncertain									HPA008476: AB_1079362	unprognostic (6.40e-2)	unprognostic (1.09e-2)	unprognostic (4.01e-1)	unprognostic (1.89e-1)	unprognostic (1.88e-1)	unprognostic (1.87e-2)	unprognostic (2.83e-2)	prognostic unfavourable (1.57e-4)	unprognostic (4.29e-2)	unprognostic (9.79e-2)	unprognostic (2.22e-3)	unprognostic (8.65e-2)	prognostic unfavourable (3.62e-6)	unprognostic (6.67e-3)	unprognostic (8.98e-2)	unprognostic (3.15e-1)	unprognostic (7.14e-3)	27	5	68.3	21.1	56.3	32.1	35.2	14.5	50.4	13.2	7.8	47.5	2.1	5.4	14.6	6.7	18.5	8.6	18	22.2	70.5	40.5	6.3	16.8	13.2	25.8	65.3	21.5	12.6	8.3	9.5	4.3	25.1	40.2	7.6	9.6	6.1	7.7	5.7	16.1	8.7	6.5	14.8	81.2	11.7	11	20.3	49.1	13.2	8.3	6.6	29.6	13.5	16.3	4.6	6.3	14.4	3.4	1.1	3.7	1.5	18.8	14.3	30.7	14.6	29.1	52.3	38.6	24	19.8	21.5	17.8	23.7	25.1	27.5	20.9	35.9	7.8	9.7	21.1	21.5	36.8	6.6	20.6	10.8	61.8	24.6	9.8	0.9	46.9	9.7	53	23.7	55.8	13.3	0	56.4	10.3	22.7	6.1	15.6	22.8	27.5	21	0.1	14.3	6.6	12	20	16.5	0	17.9	3.9	17.8	70.1	42.7	18.3	12.3	28.5	0	0	16.7	27.5	12.5	31.2	6.9	3.3	0	2.4	3.4	1.8	3.5	3.3	1.7	1.1	4.6	2.5	2.7	14.4	1.1	3	6.3	3.7	1.5	68.3	56.3	14.5	38.9	70.5	40.5	65.3	21.5	40.2	49.1
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	Mitogen-activated protein kinase 1	P28482	22	21754500-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 80.3	Cell line enhanced	Detected in all		K-562: 79.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA003995, CAB004229, HPA005700, HPA030069"	Approved					250000	250000			"CAB004229: AB_627547, HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	unprognostic (9.41e-3)	unprognostic (2.68e-1)	unprognostic (2.50e-3)	unprognostic (4.17e-1)	unprognostic (4.44e-3)	unprognostic (1.72e-1)	prognostic unfavourable (4.95e-4)	unprognostic (2.29e-1)	unprognostic (1.67e-1)	unprognostic (1.58e-1)	unprognostic (8.43e-3)	unprognostic (1.04e-1)	unprognostic (1.35e-2)	unprognostic (2.08e-1)	unprognostic (1.94e-1)	unprognostic (1.41e-1)	unprognostic (6.49e-2)	16.1	21.1	32.9	18.3	80.3	20.2	13.6	31	54.5	18.6	18.5	23.2	9.6	13.7	17.4	10.6	25.7	16.9	14.9	22.8	32.4	23.4	21.7	16.4	19.9	16.6	18.4	23.6	16	19.8	27.4	10.9	17.2	27.6	16.4	19.9	14.2	15.8	17.8	28.2	17.5	15.1	22.8	20.4	19.8	17.2	24.2	21.5	19.5	23	11.1	21.4	17.7	15.3	2.5	3.2	13.5	4.9	7	13.7	2.5	19.3	12.2	15.7	9	18.7	18.9	6	21.4	20	19.2	18.6	9.7	10.3	10.7	10.6	28.6	18.4	18.5	17.1	25.1	43.1	17.3	19.4	11.5	11.4	15.4	27.3	20.1	14	13.7	23.2	21.5	26.2	79.5	12.2	23.4	7.9	17.6	6	5.9	12.1	19.4	39	2.9	11	15.9	12.9	7.1	23.1	14	12.5	10.5	9.2	22.9	16.1	21	18.4	13.6	11.7	14.3	16.7	15.2	13.3	17.4	1	4	5.8	13.7	4.6	3.9	2	2.9	4.9	3.2	2.5	2.8	5.1	13.5	7	4.9	3.2	2.7	2.5	32.9	80.3	31	54.5	32.4	23.4	18.4	23.6	27.6	21.5
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	Mitogen-activated protein kinase 10	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Biological rhythms	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 58.3	Cell line enriched	Detected in many	6	AF22: 58.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022625	Approved									CAB022625: 	unprognostic (2.46e-2)	unprognostic (4.36e-2)	unprognostic (1.13e-1)	unprognostic (4.05e-2)	unprognostic (5.17e-2)	unprognostic (2.03e-1)	unprognostic (4.59e-2)	unprognostic (4.82e-2)	unprognostic (3.81e-2)	unprognostic (4.45e-2)	unprognostic (1.18e-3)	unprognostic (3.02e-2)	prognostic favourable (3.11e-4)	unprognostic (1.92e-2)	unprognostic (1.44e-1)	unprognostic (6.22e-3)	prognostic favourable (5.57e-4)	17.2	11.9	31.6	3.7	34.5	9.7	6.2	26.1	58.3	11.4	4	12.6	8.1	3.2	11	14.2	7.4	11.9	10.4	5.1	36	28.6	15	2.7	6.5	3.9	31.5	36.4	11.3	5.6	10.9	31.5	3.4	37.9	16.6	4.3	5.4	3.4	18.9	2	3.5	3.9	11.4	23.1	5.3	4.3	18.2	15.8	0	15.3	0.4	3.6	11.1	10.2	3.7	3	6.9	1.8	3.3	3.6	2.3	1	1.9	58.9	1.8	1.6	1.3	2.2	1.2	1.1	1	0.4	1.1	1.7	2.6	2	0.7	3.6	0.6	1.5	1.7	3.7	1.6	2.1	2.3	1.9	1.4	0.9	1.2	1.6	0.7	1.4	1.9	1.2	1.9	9.7	0.6	1.5	1.7	1.1	3.4	1.2	1.8	1.5	0.9	4.2	6.2	3.6	3.2	1.2	4.8	0.8	3.5	1.2	2.7	2.6	2.6	1.1	1	3.2	1.9	1.6	3.7	1.3	1.4	6.9	1.8	3.3	2.3	1.6	2.4	3.7	1.9	2.5	1.6	3.3	2.7	3.6	6.2	3.3	1.5	3	2.7	2.3	31.6	34.5	26.1	58.3	36	28.6	31.5	36.4	37.9	15.8
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	Mitogen-activated protein kinase 11	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in single		memory B-cell: 1.1	Low lineage specificity	Detected in single			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB012961, HPA045069"	Approved		Approved	Mitochondria				Mitochondria		"CAB012961: AB_2533144, HPA045069: "	unprognostic (1.11e-1)	unprognostic (1.28e-1)	unprognostic (1.49e-2)	unprognostic (1.92e-1)	unprognostic (1.18e-2)	unprognostic (1.64e-3)	unprognostic (1.02e-1)	unprognostic (5.84e-2)	unprognostic (5.89e-2)	unprognostic (2.46e-1)	unprognostic (4.96e-3)	unprognostic (2.18e-1)	prognostic unfavourable (6.02e-6)	unprognostic (9.84e-2)	unprognostic (4.25e-2)	unprognostic (9.16e-2)	unprognostic (2.10e-2)	20.4	5.7	14.2	7.5	17.3	0.8	8.2	22	23.7	6.6	2.7	2.8	1	1.9	8.2	6.2	5.3	7	8.8	8.8	11.7	9.1	5	1.5	8.5	8.5	7.2	19.9	5.3	3.1	6.4	10.9	8.4	6.6	7.2	2.7	4.1	5.7	8	5	6.4	2.6	9.8	5.5	7.3	4.6	3.1	4.1	0.9	4.5	5.3	6.1	6	4.4	1.1	0	0	0.3	0	0.9	0	1.7	4.2	4.6	17.3	6.1	9.2	0.1	6.4	4.6	4.3	1.7	1.6	3.2	0	5.8	6	4.2	3	2.6	0.3	8.9	2.1	6.1	5.5	0.4	7	1.5	9.5	12.8	7.6	1.2	0.5	9.4	4.9	16.7	4.2	7.4	0.3	5.6	0.4	4.8	16.7	0.1	5.9	6.5	0	4.3	11.5	5.5	2.3	4.6	7.6	4.8	14.7	12.9	10.8	0.9	2.4	0.7	1.9	7.1	6.5	1.7	10.8	0	0	0	0	0.3	0	1.1	0.4	0.2	0	0.5	0	0.6	0	0	0	0	0.9	0	14.2	17.3	22	23.7	11.7	9.1	7.2	19.9	6.6	4.1
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	Mitogen-activated protein kinase 12	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	10	skeletal muscle: 104.2	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	31	NK-cell: 3.0	Lineage enriched	Detected in single	31	NK-cells: 3.0	Region enhanced	Detected in many		cerebellum: 35.4	Low region specificity	Detected in all			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"				Nuclear speckles	Cytosol	"CAB025483: , HPA054562: "	unprognostic (3.68e-2)	unprognostic (1.72e-1)	unprognostic (4.53e-3)	unprognostic (1.54e-1)	unprognostic (3.22e-2)	unprognostic (6.35e-3)	unprognostic (3.90e-3)	unprognostic (3.16e-2)	unprognostic (6.02e-2)	unprognostic (5.70e-2)	unprognostic (3.48e-2)	unprognostic (1.07e-1)	prognostic unfavourable (5.00e-6)	unprognostic (2.57e-1)	unprognostic (8.88e-2)	unprognostic (1.11e-2)	unprognostic (4.28e-3)	3	1.6	4.5	2.1	4.5	1	1.8	9	7	2.1	1.4	2.1	1.6	2	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1	2.1	2	3.5	5.7	3	1.4	1.2	7	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0	1.3	10.8	1.1	2.4	1.9	0	0	0	0	3	0	0	10.3	6.4	2.4	7.4	5.6	6.2	3.5	7.9	6.9	13.3	8.5	9.2	3.2	19.4	10.8	8.7	6.9	11	1.6	2.5	5.6	15.4	12.7	19.3	11.4	17.9	11.9	25.2	13.4	2.9	3	0	15	11.2	18.1	6.1	5.7	0	15.9	7.5	10.4	18.1	6.7	19.7	7.9	1.4	8.5	2.9	6.1	0.2	9.8	3.3	13.8	7.8	13.7	12.4	2.9	4.9	4.2	3.2	10.4	3.5	11.2	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	4.5	4.5	9	7	3.9	3.6	3.5	5.7	2.6	2.4
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	Mitogen-activated protein kinase 13	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		HBEC3-KT: 45.7;RPMI-8226: 27.6;RT4: 28.6	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Group enriched	Detected in many	4	B-cells: 16.5;T-cells: 27.8	Region enhanced	Detected in some		cerebellum: 6.5	Region enriched	Detected in some	15	cerebellum: 59.9	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cytosol"				Nucleoli	"Nucleoplasm, Cytosol"	"CAB025854: , HPA007667: AB_1079867"	unprognostic (6.36e-2)	unprognostic (6.88e-2)	unprognostic (2.93e-1)	unprognostic (6.64e-3)	unprognostic (1.13e-2)	unprognostic (4.80e-2)	unprognostic (4.30e-3)	unprognostic (5.28e-2)	unprognostic (1.77e-1)	unprognostic (2.14e-2)	unprognostic (1.57e-1)	unprognostic (7.21e-2)	prognostic favourable (9.00e-4)	unprognostic (3.12e-2)	unprognostic (1.70e-1)	unprognostic (2.21e-2)	unprognostic (1.41e-1)	6.5	22	2.2	5.4	4	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5	13.8	16	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.3	0.1	0.3	0.2	1.1	5.6	2.7	1.5	0.2	0.2	0.5	16.2	19.1	4.6	1.2	1.5	15.1	0	45.7	0.4	11.8	5.1	0.1	0.5	16	1.9	0.1	1.2	4.8	16.2	2.9	0.6	3	0.3	5.2	0.5	10.2	0.1	1.2	0.1	0.3	11.4	0.2	27.6	8.8	28.6	19.3	0.3	1.7	0.3	0.1	21.7	2.5	4	1.4	0.2	0.5	0.3	0.3	6.9	1.4	0	0.5	0.1	5.2	0.3	4.5	16.2	0	10.5	10.8	11.6	13	0.1	16.5	10.6	11.9	3.9	2.8	0	0	27.8	6.7	2.2	4	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	Mitogen-activated protein kinase 14	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in all	5	basophil: 32.1;neutrophil: 12.3	Lineage enriched	Detected in all	7	granulocytes: 32.1	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		7100000	7100000	Nuclear speckles	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	unprognostic (6.76e-3)	unprognostic (6.28e-2)	unprognostic (6.30e-3)	unprognostic (3.30e-3)	unprognostic (6.98e-2)	unprognostic (4.04e-2)	unprognostic (8.10e-2)	unprognostic (1.93e-1)	unprognostic (2.20e-3)	unprognostic (8.39e-2)	unprognostic (6.27e-2)	unprognostic (1.10e-1)	unprognostic (1.47e-2)	unprognostic (3.66e-3)	unprognostic (6.66e-2)	unprognostic (3.25e-1)	unprognostic (1.58e-1)	21.5	20.6	11.7	18.4	15.5	49.9	20.7	26.5	18.1	22	20.5	12.5	11.9	16.9	38.8	12.1	24	18.9	16	16.4	9.3	9.5	16	29.8	21.5	29	12	11.3	17.7	18.5	15	27.2	27.3	10.2	23.4	18.3	17	16.7	16.5	21.2	25.6	22.5	26	10.6	35.5	18.2	11.1	10.3	34.1	20.9	17.6	20.8	25	30	2.3	4	32.1	4.9	3	2.8	2.1	18.3	10.1	10.9	17.5	24.8	24.8	24	19.2	25	22.8	23.8	24.7	9.5	14.9	19.1	21.1	13.2	18	16.6	23.9	16.8	14.3	34.4	14.4	20.6	13.7	21.6	20.8	17.4	16.2	16.4	16.3	25.8	19	18.7	15.5	8.7	22.2	26	6.7	10.1	26.4	17.7	13.8	16.1	25.3	8.2	7	17.3	13	20.1	15.3	40.4	18.1	20.5	11.9	12.9	17.6	9.2	21	14.9	9.3	42.8	16.8	32.1	4.9	3	2.4	3.5	2.8	1.5	2.2	2.6	4	2.3	2.5	2.4	12.3	3	4.7	1.9	2.6	2.1	11.7	15.5	26.5	18.1	9.3	9.5	12	11.3	10.2	10.3
MAPK15	"ERK7, ERK8"	ENSG00000181085	Mitogen-activated protein kinase 15	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 26.9;epididymis: 27.6;fallopian tube: 29.5	Cell line enhanced	Detected in some		CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 26.9	Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in some			Low region specificity	Detected in all			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	Cell Junctions	HPA002704: AB_1079307	unprognostic (9.11e-2)	unprognostic (1.38e-1)	unprognostic (8.04e-3)	unprognostic (2.94e-1)	unprognostic (2.54e-2)	unprognostic (1.14e-2)	unprognostic (1.22e-1)	unprognostic (6.09e-2)	unprognostic (2.59e-2)	unprognostic (1.48e-1)	unprognostic (3.88e-1)	unprognostic (9.51e-2)	unprognostic (2.64e-2)	unprognostic (1.54e-2)	unprognostic (5.78e-1)	unprognostic (6.35e-2)	unprognostic (1.62e-2)	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0	0	0	0	0	0	0.4	0.4	1.7	0	0	0	0.6	1.3	0	0	0	0.2	7.1	0	1.3	0	5.3	0	0.2	0	1.1	1.6	0	14	0	0.1	0	0.1	0	0	0	0	0	2.7	0	0	13.6	0	0	2	1.1	0	2.9	0.3	0.9	1.3	3.9	3.9	0	2.8	0	12.2	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4
MAPK3	"ERK1, p44erk1, p44mapk, PRKM3"	ENSG00000102882	Mitogen-activated protein kinase 3	P27361	16	30114105-30123506	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	6	eosinophil: 25.1;neutrophil: 11.3	Lineage enriched	Detected in many	8	granulocytes: 25.1	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB002683, HPA003995, HPA005700, HPA030069"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	unprognostic (5.03e-2)	unprognostic (4.62e-2)	unprognostic (3.46e-2)	unprognostic (1.60e-1)	unprognostic (4.70e-3)	unprognostic (2.75e-1)	prognostic unfavourable (1.11e-4)	unprognostic (2.09e-2)	unprognostic (3.59e-2)	unprognostic (1.12e-1)	unprognostic (1.55e-1)	unprognostic (3.51e-2)	unprognostic (8.78e-2)	unprognostic (1.45e-1)	unprognostic (3.01e-2)	unprognostic (2.38e-1)	unprognostic (1.19e-2)	24.9	18.5	63.3	15.3	43.2	15.6	21.1	24.8	52	21.3	45.1	30.4	6.3	39.7	24.2	11.4	44.1	28.7	25.6	21.2	37.1	34	13.4	8.8	23.3	13.1	33.8	27.4	32.7	13	26.1	15.2	27.6	27.6	20.1	36.7	26.2	17.1	18.3	13.9	18.7	49.2	24	27.8	15.9	33.7	11.6	19.5	8.4	20.5	18.7	26	18.2	22.2	1.4	1.5	25.1	2.7	0.8	3.1	1.4	13.7	7.5	16.1	9.1	40.5	53.8	9	10.3	25.6	16.4	19.6	9	27.8	13.9	10.2	28.8	5.1	13.5	12.1	16	26.3	15.7	4.3	8.3	15	40.7	3.1	11.9	33.1	7	18.7	8.4	41.6	5.8	17.9	21.6	36.3	14.3	5	4.3	6.6	17	9.6	31.2	14.9	8.7	14.2	10.1	5.9	20.8	6	13.6	7.6	29.4	10.8	9.3	12.3	3.5	20.3	9.3	7.1	21.6	6.7	7.6	2.4	2.7	25.1	0.9	1.9	1.4	1.3	2.1	1.6	1.4	1.4	1.5	1.6	11.3	0.8	1	1.5	3.1	1.4	63.3	43.2	24.8	52	37.1	34	33.8	27.4	27.6	19.5
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	Mitogen-activated protein kinase 4	P31152	18	50560078-50731824	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Cell cycle	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5	Cell line enhanced	Detected in some		HAP1: 3.0;HeLa: 4.4;NTERA-2: 3.0;SCLC-21H: 15.4;SH-SY5Y: 3.7	Group enriched	Detected in many	5	glioma: 15.2;melanoma: 3.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"				"Nucleoplasm, Golgi apparatus"	Midbody	HPA007461: AB_1079308	unprognostic (4.12e-2)	unprognostic (3.24e-2)	unprognostic (3.60e-1)	unprognostic (1.42e-3)	unprognostic (5.17e-2)	unprognostic (1.84e-2)	unprognostic (6.32e-2)	unprognostic (2.08e-2)	unprognostic (8.24e-2)	unprognostic (1.61e-1)	unprognostic (4.38e-3)	unprognostic (2.16e-1)	unprognostic (3.44e-7)	unprognostic (1.96e-4)	unprognostic (5.99e-4)	unprognostic (2.31e-2)	unprognostic (1.82e-1)	1.9	26.4	16.9	1.1	33.4	0.9	1.8	15.9	23.9	1.4	2.6	9.5	3.8	1.6	1.8	4.5	3.5	1.5	3	16.9	13	14.3	4.5	7	3.5	0.9	17.1	9.1	4.2	2.5	43.5	8.3	3.7	20.5	5.3	1.8	4.1	1.8	12.4	1.7	1	1.9	5.2	11.8	1.1	1.3	3.5	12.4	1.7	7.8	0	0.9	2.2	0.8	0	0	0	0.3	0	0	0	0	0	1.3	0.8	0	0	2	0	0	0	0	0	0	0	0	0	0	3	0	0	0	1.5	1.4	4.4	0	0	0	0	0	0.3	0	0	0	0.3	0	0	0.9	0.1	0	3	0	0	0	0	0.1	0.1	15.4	3.7	0	1.1	2.5	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.9	33.4	15.9	14.5	13	14.3	17.1	9.1	20.5	12.4
MAPK6	"ERK3, HsT17250, p97MAPK, PRKM6"	ENSG00000069956	Mitogen-activated protein kinase 6	Q16659	15	51952106-52067372	"Enzymes, Predicted intracellular proteins"	Cell cycle	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all							"CAB005184, HPA030262"	Approved	Supported	Enhanced	Cytosol				Cytosol		"CAB005184: AB_2140298, HPA030262: AB_10601868"	unprognostic (6.61e-2)	unprognostic (1.75e-2)	unprognostic (5.05e-2)	unprognostic (3.40e-3)	unprognostic (2.72e-1)	unprognostic (5.52e-2)	unprognostic (6.13e-2)	unprognostic (2.32e-3)	unprognostic (3.99e-2)	unprognostic (8.54e-2)	unprognostic (3.68e-2)	unprognostic (3.90e-2)	unprognostic (3.27e-3)	unprognostic (2.03e-1)	unprognostic (1.72e-1)	unprognostic (3.07e-2)	unprognostic (2.31e-2)	11.8	7.4	14.4	10.9	23.2	25.6	13.7	33	24.5	16.3	18.7	12.5	9.3	16.3	15.9	13.3	32.3	8.2	17	9.1	13.3	15.9	14.4	32.6	12.6	9.4	13.1	16.8	11.5	8.5	12.2	15.3	13.9	23.8	10.5	18.1	9.5	17.9	11.4	27.1	24	26.2	17.8	14.2	9.2	15.7	25.7	13	11.7	13.4	22.7	12.4	18.9	22.4	4.9	4.2	3	4.5	6.5	7.9	3.6	8.7	11.8	23.3	8.9	7.2	11.9	17	12.5	12.6	11.6	13.7	14.1	5.3	12.6	8.8	16	12.4	17.9	23.9	15.9	7.7	5.6	18.8	7	22.3	17.4	14	40.2	12.7	43.9	14	36.4	10.9	24.3	21.5	14.7	19.7	9.8	11	8.2	5.7	8.6	15	20.2	11.1	36.9	11.4	10.8	10.1	8.2	18.3	7.5	20.9	10.8	13.9	15	9	16.7	11.2	32.9	15.6	17.2	20.6	17	3	4.5	1.2	3.8	4.3	4.7	4.9	5.6	4.3	4.2	2.6	5.4	3.8	0.6	6.5	2.8	1.9	7.9	3.6	14.4	23.2	33	24.3	13.3	15.9	13.1	16.8	23.8	13
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	Mitogen-activated protein kinase 7	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		ASC diff: 27.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB018561, HPA031031"	Uncertain		Enhanced	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: "	unprognostic (1.63e-1)	unprognostic (2.75e-2)	unprognostic (1.72e-1)	unprognostic (2.90e-2)	unprognostic (4.38e-2)	unprognostic (1.20e-3)	prognostic unfavourable (1.86e-4)	unprognostic (5.67e-3)	unprognostic (1.62e-2)	unprognostic (1.16e-1)	unprognostic (1.83e-2)	unprognostic (4.75e-2)	unprognostic (1.23e-2)	unprognostic (1.90e-1)	unprognostic (5.71e-1)	unprognostic (1.55e-1)	unprognostic (3.78e-2)	11.5	15	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3	4.1	6.5	5.4	4.2	27.1	11.3	6.3	5.6	5.2	7.8	7.2	7.5	0.7	2.5	4.6	9.7	4.6	6.3	5.1	4.9	4.3	4.8	1.2	4.7	3.3	11.7	1.1	4.2	11.9	3.6	11.8	4.2	5.7	2.2	0.9	7.7	2.7	8.3	4.4	6.2	4.3	4.5	7.9	1.7	2.6	2.3	2.4	7.2	5.7	0.5	2.9	3.5	1.4	3.2	8.4	6.2	9.2	3.8	1.6	2.4	0.6	9.7	1	5	1	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1	3	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5
MAPK8	"JNK, JNK1, PRKM8, SAPK1"	ENSG00000107643	Mitogen-activated protein kinase 8	P45983	10	48306639-48439360	"Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	Biological rhythms	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004463, CAB069396"	Approved									"CAB004463: AB_675868, CAB069396: AB_1619977"	unprognostic (7.49e-2)	unprognostic (1.47e-1)	unprognostic (2.74e-2)	unprognostic (1.46e-1)	unprognostic (3.07e-2)	unprognostic (1.60e-2)	prognostic unfavourable (8.66e-4)	unprognostic (4.23e-2)	unprognostic (5.98e-2)	unprognostic (4.31e-3)	unprognostic (2.33e-1)	unprognostic (6.06e-2)	prognostic favourable (8.66e-4)	unprognostic (1.58e-1)	unprognostic (9.95e-2)	unprognostic (1.85e-2)	unprognostic (1.01e-3)	13.4	11.7	15.3	11.5	18.5	13.3	22.1	33.6	35.2	15.2	13.9	12.9	19.5	16.7	17.1	10.8	16.1	12.4	15.1	11.2	20	18	20.1	23.6	11.7	12	15.9	16.7	18.9	15.3	12.7	23.7	12.2	23.6	13	14.3	12.4	17.2	15.9	18.9	10.8	17.7	14.6	13.7	9.6	12.2	23.4	12.2	20.5	22.3	9	13.8	11.8	13	4.5	4.3	5.2	4.3	4.7	5.7	3.5	15.7	4.3	14.3	8.1	5.5	6.5	11.1	23.8	16.3	14.3	11.7	4.9	16.4	5.7	6.5	13.3	9.7	5	9.2	18.7	34.1	8.2	8.2	5	6.7	9.1	14	9.6	5.5	10.6	10.6	21.1	13.1	13.1	10.6	9.3	4.6	17.1	7.4	8.9	3.1	11.2	14.7	5.7	8.7	6.1	24.1	19.1	9.3	7.8	10.7	8.5	6.7	11.2	10.7	25.6	8.1	17.9	3.3	8.1	11.6	7.4	14.9	6.1	0	3.3	3	4.1	2.8	4.7	4.5	5.7	5	3.3	2.9	5.6	3.9	5.2	4.7	4.3	4.3	2.9	3.5	15.3	18.5	33.6	35.2	20	18	15.9	16.7	23.6	12.2
MAPK9	"JNK2, p54a, PRKM9, SAPK"	ENSG00000050748	Mitogen-activated protein kinase 9	P45984	5	180233143-180292099	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	Biological rhythms	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 48.7	Cell line enhanced	Detected in all		HDLM-2: 68.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	basophil: 13.2	Lineage enriched	Detected in all	4	granulocytes: 13.2	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB008910	Approved									CAB008910: 	unprognostic (5.04e-3)	unprognostic (2.06e-2)	prognostic favourable (1.11e-4)	unprognostic (8.53e-2)	unprognostic (1.75e-1)	unprognostic (5.06e-3)	unprognostic (6.83e-3)	unprognostic (3.16e-1)	unprognostic (4.93e-2)	unprognostic (3.76e-1)	unprognostic (5.97e-2)	unprognostic (1.36e-1)	unprognostic (1.50e-1)	unprognostic (2.13e-1)	unprognostic (2.29e-1)	unprognostic (9.38e-3)	unprognostic (2.40e-1)	10.3	12.4	22.9	9.6	31.8	10.3	11.4	48.7	41.4	10.8	12.4	10.6	4.7	10.1	8.7	9.5	8.7	8.8	7.8	14	24.3	25	12.2	9.7	10.8	10	22	21	8.5	25.9	16.3	8.8	10.9	29.4	11.7	15.3	7	9.9	13.1	20.5	6.3	10.4	11.4	16.8	8.6	12.3	9.4	10.3	7.1	15.4	5.1	11.3	9.9	7.3	1.4	1.4	13.2	2.4	1.3	3.1	0.3	17	14.1	12.5	15.6	12.4	13.9	26.9	16.4	14.6	13.9	13.9	18.5	12.2	18.3	28.4	17.4	13.1	12.8	27.6	16.3	68.7	12.4	7.6	15.7	13.1	9.4	15.7	13.3	10.2	12.4	13.4	13	16.4	8.4	13.3	18.8	22.4	15.6	6.6	8.7	8.4	15.2	21.3	8.7	10.5	16.4	14.4	10.2	19.3	18.8	13.1	19.1	13.7	11.7	16.6	16.8	23.4	24.5	9.6	11.3	12.5	17.6	14.7	11	13.2	0.6	2.5	2	1.3	2	1	1.5	1.8	1	1.4	1	1.2	0.9	1.3	2.4	1.4	3.1	0.3	22.9	31.8	48.7	41.4	24.3	25	22	21	29.4	10.3
MAPKAPK2		ENSG00000162889	Mitogen-activated protein kinase-activated protein kinase 2	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	DNA damage	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	6	plasmacytoid DC: 18.7	Lineage enriched	Detected in all	6	dendritic cells: 18.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	"Nucleoplasm,Centrosome"				Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: , HPA063708: , HPA064435: "	unprognostic (7.93e-2)	unprognostic (1.83e-1)	unprognostic (5.27e-2)	unprognostic (5.12e-2)	unprognostic (1.80e-1)	unprognostic (1.32e-2)	prognostic unfavourable (1.93e-4)	unprognostic (9.85e-2)	unprognostic (1.68e-1)	unprognostic (2.00e-1)	unprognostic (1.01e-2)	unprognostic (1.35e-1)	prognostic unfavourable (4.58e-6)	unprognostic (2.12e-1)	unprognostic (1.37e-1)	unprognostic (6.96e-2)	unprognostic (3.29e-2)	23	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20	18.5	23.5	17.3	26	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	20.9	8.3	11.5	12.9	34	20	14.3	14.6	33.1	22.3	21.1	15.8	10.2	10.1	10.2	29.4	15.9	8.6	15.5	16.1	11.7	6.5	16.9	10.3	10.2	26.3	24.9	56.6	27.5	19.9	21.4	23.7	18.2	19.4	45.9	18	26	10	18	13.3	11.6	25.8	24.1	3.2	16.8	12.8	9.2	11.9	17.2	29.1	20.2	14.1	24.2	17.3	20.1	17	23.3	19.8	59.8	53.1	8.2	22.8	15.2	6.6	1.1	0.7	1.4	1.6	1.1	1.5	1	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	Mitogen-activated protein kinase-activated protein kinase 3	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 86.7;skeletal muscle: 70.1	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in all	4	classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9	Group enriched	Detected in all	5	dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058275			Supported	Nucleoplasm				Nucleoplasm		HPA058275: 	unprognostic (6.46e-3)	unprognostic (1.84e-1)	prognostic favourable (8.08e-5)	unprognostic (1.17e-1)	unprognostic (1.93e-1)	unprognostic (9.96e-2)	unprognostic (8.77e-3)	unprognostic (7.68e-3)	unprognostic (1.11e-1)	unprognostic (5.87e-2)	unprognostic (2.19e-3)	unprognostic (1.01e-1)	prognostic favourable (1.90e-8)	unprognostic (2.15e-2)	unprognostic (1.22e-1)	unprognostic (1.86e-1)	unprognostic (1.69e-1)	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11	15.1	7.2	4.1	8.7	24.2	11.2	9	9	6	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12	5.2	5.9	12.5	9	4	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3	27.1	23	61.4	7.3	6.4	19.5	23	7.1	3	8.5	4.6	11.5	6.7	5.6	8	8.7	7.4	11.1	21.5	9.3	5.7	18.7	8.2	20.5	22.1	7.8	20.4	4.9	48.7	10.2	10.1	9.1	35	25.9	9.1	13.8	20.2	27.5	7.6	13.6	6.1	18.2	9.4	14.9	35.3	11.2	29.5	6.6	7.2	13.9	40.3	13.2	5.6	4	5	14.2	6.4	8.9	21.7	5.5	6.8	15.7	35.3	13.8	4.1	7.6	7.7	36.4	55.1	2.8	6.4	30.2	23	5.5	50	5.4	3	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6	5.2
MAPKAPK5	PRAK	ENSG00000089022	Mitogen-activated protein kinase-activated protein kinase 5	Q8IW41	12	111841978-111902238	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Tumor suppressor	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all							Low region specificity	Detected in all			"CAB004546, HPA015515"	Supported		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		"CAB004546: AB_627910, HPA015515: AB_1853569"	unprognostic (6.45e-2)	unprognostic (7.29e-2)	unprognostic (1.27e-3)	unprognostic (1.09e-2)	unprognostic (5.52e-2)	unprognostic (3.76e-2)	prognostic unfavourable (2.98e-8)	unprognostic (1.88e-1)	unprognostic (3.09e-2)	unprognostic (1.22e-1)	unprognostic (1.75e-1)	unprognostic (1.25e-2)	unprognostic (3.20e-1)	unprognostic (6.03e-2)	unprognostic (3.39e-2)	unprognostic (9.41e-2)	unprognostic (3.25e-2)	20.7	26.2	21.4	17.5	26.4	24.1	21.7	23.7	28.3	17.3	28.8	26.1	21.9	26.3	25.8	22.8	20.8	17.5	22.7	20.7	17.7	15.2	21.7	21.5	18.9	19.4	22.3	20.4	21.3	24.5	19.8	20.4	21	17.3	18.7	32.9	23.6	23.3	20.5	33.2	23	28.4	21.1	18	18.4	19.8	16.7	22	19.3	20.5	15.1	19.3	19.9	16.5	4.9	4.1	3.2	11.4	3.9	6.8	2.5	15.1	20.2	19.5	16.4	14.1	14.3	29.7	15.2	18.4	23.4	16.2	26	12.5	22.9	11.3	17.9	15.2	25.6	15.9	22	15.2	14	20.4	14	20.8	17.1	25.6	14.5	15.1	22.9	22.3	26.6	17.1	28.1	9.1	17	17	25.4	40.5	27.7	14.2	25.2	14.2	22	18.6	22	24.1	20.4	17.3	29.5	21.1	23.8	29.3	14.9	13.3	13.4	13.6	19	18.6	22.7	27.1	16.2	18.7	18.8	1.3	4.8	3.2	6.5	3.5	3.5	4.9	4.3	4.7	3.3	4	6.8	5.1	2.5	3.9	11.4	4.1	6.6	2.5	21.4	26.4	23.7	28.3	17.7	15.2	22.3	20.4	17.3	22
MARK1	"MARK, PAR-1C"	ENSG00000116141	Microtubule affinity regulating kinase 1	Q9P0L2	1	220528183-220664461	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Wnt signaling pathway	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		HAP1: 9.4;RT4: 35.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007421, HPA008061"	Uncertain									"HPA007421: AB_1079311, HPA008061: AB_1079310"	unprognostic (1.51e-1)	unprognostic (6.27e-2)	unprognostic (6.72e-2)	unprognostic (3.63e-2)	unprognostic (2.23e-1)	unprognostic (1.01e-1)	unprognostic (1.54e-2)	unprognostic (3.48e-1)	prognostic unfavourable (2.63e-4)	unprognostic (4.59e-2)	prognostic favourable (2.23e-5)	unprognostic (6.62e-2)	unprognostic (4.27e-2)	unprognostic (9.56e-3)	unprognostic (3.35e-2)	unprognostic (1.72e-1)	unprognostic (3.74e-2)	14.3	5.6	11.4	4.6	13.5	0.9	9	15.2	22.7	9.8	6.7	4.7	6.4	2.1	7.8	26.6	9.4	5.9	5	19.1	10	12.5	4.7	1.5	4.8	2.3	10.3	12.4	3.7	3	5.8	12.1	3.9	13.2	7.2	4.1	6.2	5	11.3	4.2	3.5	3.4	10.1	7.1	3.2	4.3	16	4.6	0.4	8.4	5.3	5.7	8.8	14.9	0.8	0	0	0	0	0.3	0.1	0.7	0	4.5	1.2	0	0	1.8	1.5	2.2	1.5	2.3	0	0	0	0	0	2.3	9.4	6.1	1.1	0	6.9	0	2.4	0	0	0.7	0.9	0.7	5.2	0	2.9	0.2	0	0	0	0	0	0	8.7	2.2	0	7	0	0	35.3	6.5	5.8	0.3	0.3	0.4	0.7	0	0	0	3.5	4.8	6.1	0	0	0	1.4	0	3.3	0	0	0	0	0	0	0.8	0.3	0	0	0.1	0	0	0	0	0	0	0	0.1	11.4	13.5	15.2	17.5	10	12.5	10.3	12.4	13.2	4.6
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	Microtubule affinity regulating kinase 2	Q7KZI7	11	63838928-63911019	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"				Plasma membrane	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: "	unprognostic (1.33e-2)	unprognostic (2.45e-2)	unprognostic (1.64e-1)	prognostic unfavourable (3.21e-4)	unprognostic (7.13e-2)	unprognostic (3.82e-2)	prognostic unfavourable (1.30e-4)	unprognostic (2.73e-3)	unprognostic (4.41e-1)	unprognostic (5.79e-2)	unprognostic (3.94e-3)	unprognostic (3.77e-1)	unprognostic (5.20e-3)	unprognostic (5.15e-3)	unprognostic (6.78e-2)	unprognostic (1.03e-1)	unprognostic (2.40e-1)	9.7	11.6	16.5	16.3	21.4	18.5	13.8	24.7	26.1	15.2	20.5	20	11.1	21.3	13.6	7.5	48.4	13.6	14.4	14.7	17	10.1	11.9	12.4	15.4	16.3	18.1	13.7	11	17.3	21.8	22.4	21.1	15	14.9	19.8	10.6	20.7	14.3	15.7	35.8	26.9	13.3	13.3	21.6	16.8	9.8	18.7	22.9	15.9	13.6	23.5	14.8	21.3	2.9	1.9	9.8	1.9	3.3	4.5	1.2	22.4	15	12.3	12.9	6.7	8.9	17.1	9.1	8.8	13.2	10.2	16.1	23.7	16.6	16.2	9.5	29	11.8	14.3	11.5	11.4	9.3	18.2	11.8	10.4	7.6	19.8	24.1	4.9	19.5	12.1	10.5	10.8	15.5	19.1	8.7	27.6	20.7	14.1	14	10.9	17.1	9.1	18.3	9.8	18.6	17	11.4	15.8	40.4	10.6	29.4	11.8	10.3	14	8.8	18	10.1	11.6	12	16.2	9.5	10.4	11.1	2.7	1.7	4.4	2.9	1.5	4.5	2.3	3.2	3.1	1.9	2.9	2.6	2.4	9.8	3.3	1.9	1.7	1.5	1.2	16.5	21.4	24.7	26.1	17	10.1	18.1	13.7	15	18.7
MARK3	"CTAK1, KP78, PAR-1A"	ENSG00000075413	Microtubule affinity regulating kinase 3	P27448	14	103385392-103503831	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	14	eosinophil: 42.2	Lineage enriched	Detected in many	23	granulocytes: 42.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024652	Approved									HPA024652: AB_1853582	unprognostic (6.86e-2)	unprognostic (2.93e-1)	unprognostic (7.70e-2)	unprognostic (3.48e-2)	unprognostic (8.41e-2)	unprognostic (1.50e-1)	unprognostic (2.31e-3)	unprognostic (2.21e-1)	prognostic unfavourable (1.14e-4)	unprognostic (2.29e-3)	unprognostic (3.66e-2)	unprognostic (1.55e-2)	unprognostic (1.13e-1)	unprognostic (4.71e-2)	unprognostic (1.34e-1)	unprognostic (1.33e-2)	unprognostic (1.60e-1)	20.8	31.9	24.6	20.9	29.5	62.7	19.7	59.1	30.2	25.3	20.8	33.2	19.9	17.4	28.5	28.4	24.4	23.1	22.2	33.6	24.9	22.4	20.3	20.1	25.9	20.8	29.6	23.3	24.6	30.7	28.1	30.9	20.5	27.4	19.3	20	23.6	18.3	23.1	40.9	19.9	19.2	26.8	20.9	26.8	26.9	24.1	30.3	29.1	25.8	23.1	23	20.8	29	1.2	1.2	42.2	1.1	0.8	1.8	0.4	13.2	16.1	23.5	17.7	28.2	22.1	20.3	23.6	24.9	28.6	27.5	12.6	20.9	15.8	15	22.1	25	25.6	25.4	36.4	18.4	11.3	20.4	17.1	15.8	53.2	23.3	13.6	25.6	23.6	23.1	47.4	26.4	21	37	21.4	35.6	15.9	20.7	17.2	24.3	20.9	24	12.7	25.3	28.3	20.7	20.6	25	17.2	22.9	23.4	20	22.8	15.4	10.9	28.6	21	24	30.4	19	18.7	18.7	20.7	0.4	1.1	42.2	1.1	0.8	0.9	1.2	1.6	1.8	1.1	0.9	1.8	1.4	3.1	0.8	0.7	1.2	1.6	0.4	24.6	29.5	59.1	30.2	24.9	22.4	29.6	23.3	27.4	30.3
MARK4	"FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D"	ENSG00000007047	Microtubule affinity regulating kinase 4	Q96L34	19	45079288-45305283	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039186	Approved		Supported	Cytosol				Cytosol		HPA039186: AB_10796223	unprognostic (1.64e-1)	unprognostic (1.95e-1)	unprognostic (1.57e-3)	prognostic unfavourable (8.31e-8)	unprognostic (2.02e-1)	prognostic unfavourable (3.05e-5)	unprognostic (1.90e-1)	unprognostic (2.16e-2)	unprognostic (6.26e-2)	unprognostic (5.64e-3)	unprognostic (1.24e-3)	unprognostic (7.50e-2)	unprognostic (3.80e-2)	unprognostic (6.89e-2)	unprognostic (7.23e-2)	unprognostic (4.65e-2)	unprognostic (3.02e-2)	11.8	13	19.4	10.3	26	8.4	15.2	21.9	28.6	11.4	10.2	9	12.9	6.6	14	17.5	13.5	12.9	13.4	14.7	22.2	15.7	8.7	13.5	11.7	10.5	14.3	21.6	21	16.8	13.7	12.9	12.1	15	12.2	6.3	14.1	12.1	14.2	40.7	20.6	7.5	14.1	10.8	12.4	10.3	32.1	12.3	11.2	10.5	11.5	9.4	13.7	17.9	1	2.8	3.5	2.9	1.8	4.3	1.2	8.8	3.8	15	10.9	10.7	17.1	4.2	6.6	10.3	9.8	9.2	2.3	5.1	4.3	5.6	12	6	10.6	9.6	5.5	7.8	8.7	8.5	4.6	8.2	19.7	2.1	7.4	21.2	13.7	8.2	9.5	13.1	10.8	10.7	10.6	7.4	7.5	6.7	6.4	3.3	29.3	4.9	2.8	9.3	7.2	28.1	12.4	9.7	8.6	5	4.1	12.4	10.6	8.8	6.7	6	4.2	12	9.5	4.8	9.4	4	7	3.5	2.9	0.7	3.4	2.2	0.7	0.9	1.2	4.3	0.8	1	2.3	2.6	2.9	1.8	2	2.8	2.4	1.2	19.4	26	21.9	22.7	22.2	15.7	14.3	21.6	15	12.3
MAST1	"KIAA0973, SAST"	ENSG00000105613	Microtubule associated serine/threonine kinase 1	Q9Y2H9	19	12833951-12874951	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 51.0	Cell line enhanced	Detected in many		AN3-CA: 14.8;SCLC-21H: 26.2;SH-SY5Y: 13.0;U-266/70: 10.7	Cancer enhanced	Detected in many		glioma: 3.5	Low region specificity	Detected in all			Group enriched	Detected in some	6	MAIT T-cell: 3.6;T-reg: 2.0	Lineage enriched	Detected in single	8	T-cells: 3.6	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA028181, HPA073106"	Enhanced		Approved	Vesicles				Vesicles		"HPA028181: AB_10603872, HPA073106: "	unprognostic (6.32e-2)	unprognostic (3.66e-2)	unprognostic (3.93e-2)	unprognostic (2.83e-5)	unprognostic (1.72e-1)	unprognostic (4.19e-2)	unprognostic (2.38e-1)	unprognostic (8.72e-2)	unprognostic (1.04e-1)	unprognostic (3.64e-1)	unprognostic (8.89e-3)	unprognostic (3.43e-2)	unprognostic (3.84e-3)	unprognostic (1.19e-1)	unprognostic (7.04e-2)	unprognostic (2.49e-2)	unprognostic (1.96e-1)	1.2	5.2	20.4	1.7	13.6	1.6	1.5	51	40.1	1.1	1.5	1.4	0	1.7	1.3	1.2	1.3	1.2	1.6	1.3	16.1	16.3	1.2	1.3	1.2	1.3	8.8	19.5	1.5	1.6	1.2	10.4	1.2	19.9	1.2	1.3	1.6	1.3	1.2	1.2	4.1	1.6	1.3	4.2	1.2	1.5	3.9	2.7	0	1.2	0	1.3	1.2	0.2	0.4	0	0	0.2	0	3.6	0.1	2.2	1	0.9	14.8	0	0	1.2	0.1	0.1	0.2	0.6	0.5	0.9	3.6	1.6	0	0	4.3	0	0	2.5	2.9	0.3	3.6	1.6	0	0.7	0.7	0.3	0	0.5	0.5	0	3.1	1.9	0	0.5	1.5	0.4	4.4	4.5	9.8	2.9	5.1	0.2	0.1	26.2	13	0.5	0.9	2.6	2.4	1.3	0	1.8	2.8	2	0.4	10.7	8.5	2.1	3.3	2	0.1	0	0.2	0	0	0.2	3.6	0.1	0	0.2	0	0.4	0	0.4	0	0	0.1	0	2	0.1	20.4	13.6	51	34.3	16.1	16.3	8.8	19.5	19.9	2.7
MAST2	"KIAA0807, MAST205"	ENSG00000086015	Microtubule associated serine/threonine kinase 2	Q6P0Q8	1	45786987-46036124	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 83.3	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		non-classical monocyte: 4.3	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA039722, HPA040155"	Approved		Approved	Cytosol				Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	unprognostic (7.80e-2)	unprognostic (3.02e-2)	unprognostic (5.77e-2)	unprognostic (1.52e-1)	unprognostic (3.82e-1)	unprognostic (3.17e-2)	prognostic unfavourable (4.31e-8)	unprognostic (8.86e-2)	unprognostic (2.34e-2)	unprognostic (1.98e-1)	unprognostic (1.60e-1)	unprognostic (1.75e-1)	prognostic unfavourable (6.85e-13)	unprognostic (4.82e-3)	unprognostic (2.43e-1)	unprognostic (9.73e-2)	unprognostic (4.90e-1)	8.9	4.3	7	9.9	8.1	3.7	7.1	7.1	11.8	13.6	15.2	8.4	6.6	11.2	16.7	7.7	8.8	9.5	9.9	25.5	5	7.6	4.8	6.1	5.9	4.4	8.9	7.3	19.8	3.6	9.1	10.5	5.5	10.1	13.9	13.9	7.2	8.3	8.6	83.3	5.5	21.3	14.9	5.8	2.5	9	24.8	4.8	3.5	5.7	27.4	7.5	16.3	10.6	0.5	1.9	1.4	4.3	1.4	1.4	0.5	15.2	12.4	12.5	9.6	16.4	23.6	13.9	16.3	11.8	15.1	16.9	14.2	5	23.9	7.7	19.9	7.6	15.1	9.3	16	11.5	8.1	10.8	14	13	14.3	5.8	13.9	18.1	12.1	25.3	20.3	14.1	8.3	7.3	18	10.4	8.4	6	10.3	14.2	12.4	21	4.5	7.8	8.3	17.5	10.4	19.2	25.1	8.2	11.4	5.7	13.7	29.3	18.9	15.3	16.1	10	8.9	8.7	19.6	7.9	12.1	0	1.1	1.4	1.4	0.6	1.4	0.2	0.7	1.4	1.9	0.5	0.5	1	0	1.4	4.3	0.1	0	0.5	7	8.1	7.1	11.8	5	7.6	8.9	7.3	10.1	4.8
MAST3	KIAA0561	ENSG00000099308	Microtubule associated serine/threonine kinase 3	O60307	19	18097793-18151692	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 72.5	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA035061, HPA035062"	Uncertain		Approved	Nuclear speckles				Nuclear speckles		"HPA035061: AB_10670585, HPA035062: AB_10671508"	unprognostic (5.94e-3)	unprognostic (4.75e-2)	unprognostic (1.70e-1)	unprognostic (1.02e-1)	unprognostic (3.38e-1)	prognostic favourable (2.97e-4)	unprognostic (1.93e-1)	unprognostic (4.63e-2)	unprognostic (1.43e-1)	unprognostic (3.21e-1)	prognostic favourable (7.01e-4)	unprognostic (2.58e-1)	unprognostic (1.64e-3)	unprognostic (1.02e-2)	unprognostic (3.61e-1)	unprognostic (1.58e-3)	unprognostic (1.26e-3)	4.6	3.5	20.7	8.3	36.1	12.3	1.8	1.1	72.5	3.8	5.3	19	0.2	9.1	3.6	4.9	2.2	4.9	3.1	2.1	19.7	9.3	3.6	6.4	4.6	9.9	13	33.6	4.6	14.3	7.1	7.7	2.6	13	2.7	4.4	0.7	4.6	4.2	2.6	6.9	8.8	3	7.9	11.4	3.9	2.1	12.5	1.8	2.4	0.3	9.4	3.3	2.4	4.4	10.3	23.2	9.7	5.8	8.4	3.1	3.3	4.9	2.3	10	6.8	5.5	5.4	3.4	2.2	2.4	3.4	4.9	4.6	8.6	5.1	3.4	1.8	3.3	1.9	1.7	7.3	4.1	3.9	5.2	7.8	5.7	2.1	13.2	6.2	5.7	3.6	1.4	1	4	5.7	2.7	5.9	4.4	6.9	2.4	6.1	11.9	1.9	6.3	1.8	1.5	3.7	6.1	4.7	2.8	2	3.1	4.9	3.9	3.1	3.3	12.9	1.4	6.2	8.3	7.9	6.7	11.1	2.8	0.1	4.5	9.4	8.4	5.6	6.2	4.1	4.7	3.3	2.1	4.4	3.7	6.4	23.2	5.8	9.7	10.3	5	3.1	20.7	36.1	1.1	72.5	19.7	9.3	13	33.6	13	12.5
MAST4	KIAA0303	ENSG00000069020	Microtubule associated serine/threonine kinase family member 4	O15021	5	66596361-67169595	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HBEC3-KT: 17.5;HDLM-2: 22.2;HEL: 18.4;RT4: 22.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 12.1	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000544	Approved		Approved	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA000544: AB_1079315	unprognostic (1.77e-2)	unprognostic (6.24e-2)	unprognostic (1.80e-1)	unprognostic (4.99e-3)	unprognostic (2.83e-2)	prognostic favourable (5.18e-5)	unprognostic (9.01e-2)	unprognostic (1.00e-1)	unprognostic (2.79e-2)	unprognostic (9.47e-2)	unprognostic (5.03e-2)	unprognostic (3.01e-2)	unprognostic (1.01e-2)	unprognostic (1.37e-2)	unprognostic (2.63e-1)	unprognostic (2.63e-1)	unprognostic (3.08e-2)	16.2	12.9	10.2	6.9	11.8	2.5	12.6	6.2	19.4	13.9	6.9	6.3	6.3	6.3	14.4	8.9	31.2	11.6	9.7	24.5	9.9	8.1	14.2	9.5	13.1	5	6.5	9.2	20.2	5.9	35.6	16.7	18.4	11.1	10.1	5.3	5.7	13.7	8.7	12.7	16.9	6.8	11.4	5.6	6	8.2	10.7	5	37.5	8.1	21.8	20.6	13.6	22.3	3.4	1.1	12.1	0.9	2.4	7.5	1.4	7.4	4.1	2	0.1	6.8	6.1	4.9	1.7	2.6	0.6	0.5	3.8	2	0.5	3.5	1.4	6.7	6.3	17.5	0.7	22.2	2	18.4	2.3	1.6	0.5	0	6.5	10.1	9.7	3.8	7.7	13.9	1.7	2.1	4.7	6.5	2.6	0.1	1.3	3.3	0.6	1.8	0.4	1.6	22.5	3	2.4	2.2	0.9	0.1	1.5	0.1	13.2	1.6	2.2	2.4	2.8	5.4	2.4	0.1	4.2	0	1.3	12.1	0.4	0.8	1.2	0.5	2.9	3.4	4.7	1.2	0.4	2.1	5	2.1	4.1	2.4	0.9	1.1	7.5	1.4	10.2	11.8	6.2	19.4	9.9	8.1	6.5	9.2	11.1	5
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	Microtubule associated serine/threonine kinase like	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027175: AB_1853591, HPA054273: "	unprognostic (4.10e-2)	unprognostic (6.89e-2)	unprognostic (1.22e-2)	unprognostic (3.14e-3)	unprognostic (3.67e-1)	unprognostic (1.97e-2)	prognostic unfavourable (2.52e-6)	unprognostic (2.19e-2)	unprognostic (4.00e-2)	unprognostic (4.05e-2)	prognostic unfavourable (4.81e-5)	unprognostic (3.78e-2)	prognostic unfavourable (1.71e-6)	unprognostic (1.55e-3)	unprognostic (2.27e-1)	unprognostic (2.66e-1)	unprognostic (1.79e-1)	9.1	7	3.6	8.9	6.1	21.1	8.3	4	7.5	7.4	7.6	3.8	5.7	5.7	6	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8	4.7	4	10.1	10	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4	1.8	11.7	9.5	18.1	6.7	2.8	4.1	10.7	17.6	7.4	29.2	36	11.4	11.8	9.4	6.7	7.4	11.4	11.5	6.9	20.8	8	11.1	11.1	6.6	6.6	1.6	4.2	8.4	2.4	3.1	17.6	3.5	6.3	8.4	21.3	17.7	7.8	13.7	4.7	13.4	3.9	8.8	30.2	7.7	7.2	4.4	8.1	11.6	11.1	7.4	7.8	7.5	9	5.4	7.3	15.3	18.6	15.4	2.6	4.1	13.9	8	12.9	6	0.1	4.4	3.8	2	4.3	3	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4	1.8	3.6	6.1	4	7.5	6.8	4.5	5.4	5.7	6.7	2.3
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	Megakaryocyte-associated tyrosine kinase	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 29.3;bone marrow: 19.1;brain: 27.4	Cell line enhanced	Detected in some		HL-60: 40.7;HMC-1: 12.5;K-562: 18.1;MCF7: 13.2;NB-4: 28.4;SCLC-21H: 12.4;THP-1: 10.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		gdT-cell: 19.4;NK-cell: 29.3	Group enriched	Detected in many	54	NK-cells: 29.3;T-cells: 19.4	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"				Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	prognostic favourable (5.27e-4)	unprognostic (1.28e-2)	unprognostic (1.84e-1)	unprognostic (3.54e-2)	unprognostic (3.36e-1)	unprognostic (3.39e-2)	unprognostic (9.50e-2)	unprognostic (1.23e-1)	unprognostic (7.91e-2)	unprognostic (3.19e-3)	unprognostic (2.07e-2)	unprognostic (4.51e-2)	unprognostic (1.16e-2)	unprognostic (7.59e-2)	unprognostic (1.66e-1)	unprognostic (2.26e-1)	unprognostic (2.33e-2)	11.2	1.6	22.1	6.8	18.1	19.1	2.2	1.5	27.4	1.5	2.3	1.7	0	7	1.2	0.4	1.1	4.7	5.1	1.7	25.1	10	1.1	2.8	7.3	9.6	7	11	1	1.6	0.1	1.4	1.4	6.1	1.2	1.4	0.6	3.8	1	0.8	1.6	6.7	1.1	2.8	14.8	4.1	2.1	1.3	3.5	0.9	0	4.5	2.4	0.7	0.4	0.3	0.4	0	29.3	19.4	2.7	0	0.1	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0.6	0	4.1	5.4	0.1	0	0	7	4.5	0.5	1.1	0	40.7	12.5	0	0	0	0	0	18.1	0	0	13.2	0.1	28.4	3.3	0.1	0	0	0	0	0	12.4	0	0	0	0	0	10.7	1.3	0	0.2	0.6	0	0	0	0	0	0	0	0	0	0	19.4	0	13.2	0	2.5	12.2	0.3	0.4	1.2	7.1	0.4	29.3	0	0.1	0.1	2.7	22.1	18.1	1.5	27.4	25.1	10	7	11	6.1	1.3
MELK	KIAA0175	ENSG00000165304	Maternal embryonic leucine zipper kinase	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 42.4	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Not detected	Not detected			Cell type enriched	Detected in some	5	T-reg: 4.8	Lineage enriched	Detected in many	5	T-cells: 4.8	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA017214	Uncertain									HPA017214: AB_1853798	unprognostic (5.03e-2)	unprognostic (9.57e-2)	unprognostic (2.27e-2)	unprognostic (3.42e-3)	unprognostic (2.16e-1)	unprognostic (1.23e-1)	prognostic unfavourable (2.91e-7)	prognostic unfavourable (3.99e-4)	unprognostic (1.26e-2)	unprognostic (1.60e-2)	prognostic unfavourable (4.58e-4)	unprognostic (4.69e-2)	prognostic unfavourable (0.00e+0)	unprognostic (8.86e-3)	unprognostic (1.37e-1)	unprognostic (2.40e-1)	unprognostic (1.35e-1)	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2	8.3	0.4	0.1	0.7	0.8	0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1	0.1	0.4	4.8	0.5	35.4	18.2	24.6	14.5	3.4	5.9	14.3	26.3	18.6	36.9	45.6	14	14	11.9	8.5	12.9	12.2	21.4	16.5	40.8	32.3	8.5	9.3	21.7	13.9	1.3	14.4	11.8	2.1	3	28.5	16.2	18.6	11.9	19	30.2	11.8	17.9	6.8	19.6	14.3	16.6	16.6	7.6	11.3	12	16.7	12.4	14	13.5	8.5	11.3	6.9	9.1	19.9	25.2	16.8	23.9	3.7	13.5	17.8	12.6	10.7	27	0	0	1	0.2	0	0	0.1	0.8	1	0	0	0	0.6	0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	10	intermediate monocyte: 10.3;non-classical monocyte: 6.4	Lineage enriched	Detected in single	48	monocytes: 10.3	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA036196, HPA075622"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		29000000	29000000	Plasma membrane	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: "	unprognostic (2.17e-2)	unprognostic (8.10e-2)	unprognostic (4.85e-2)	unprognostic (2.68e-1)	unprognostic (2.44e-1)	unprognostic (1.77e-1)	unprognostic (1.07e-1)	prognostic favourable (4.74e-4)	unprognostic (6.84e-2)	unprognostic (1.25e-1)	unprognostic (6.22e-2)	unprognostic (3.72e-1)	prognostic favourable (4.43e-5)	unprognostic (5.13e-2)	unprognostic (2.11e-1)	unprognostic (5.86e-2)	unprognostic (2.05e-2)	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2	8.4	14.1	26.6	0	0.2	0.1	10.3	0	0	0.3	0.5	0.9	4.3	9.7	0.2	0.1	6.9	0	0.1	0.5	1	20.8	1.3	0.1	4.6	0	0.1	5.7	0	0.8	0.8	3	3.7	0	21.6	0.1	0.1	0.8	0.2	0	5	0.3	21.5	1.1	2	1.6	0.9	0	4.9	2.7	3.4	1.4	1.2	1.6	10.9	12.9	0.1	4.1	0.1	0.3	1.7	0	0.2	3.2	0.6	2	0	0	1.7	2.5	0	0	0.8	0	0	0.8	0	0	10.3	0	0	0	0	0.2	0	0	0	0.1	0	6.4	0.1	0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		A-431: 45.4;CAPAN-2: 49.6;EFO-21: 43.3	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in many	5	amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1	Low region specificity	Detected in many			"CAB005282, CAB018577, HPA055607"	Approved		Supported	"Plasma membrane,Cytosol"	Secreted to blood	70000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: "	unprognostic (1.60e-2)	unprognostic (7.71e-2)	unprognostic (2.53e-2)	unprognostic (1.58e-1)	unprognostic (3.57e-3)	prognostic unfavourable (6.75e-4)	unprognostic (1.68e-1)	unprognostic (3.22e-2)	unprognostic (3.81e-2)	unprognostic (2.52e-2)	prognostic unfavourable (1.21e-7)	unprognostic (1.86e-1)	unprognostic (1.25e-1)	unprognostic (5.53e-2)	unprognostic (8.88e-2)	unprognostic (2.01e-2)	unprognostic (2.20e-1)	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2	9.3	0.7	8.1	24.4	2.6	8	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7	2.1	10.1	15	0.2	0.3	1.2	0.2	0.3	0.4	0	45.4	26.1	0	0.1	2	2	1.8	26	10.6	14	11.8	5.4	49.6	2	43.3	16.3	12	4.5	24.7	28.7	0.1	5.6	0	27.1	4.7	0.3	0	0	2.6	9.8	9.1	30.1	9.6	0.9	0.2	25.9	1	0	0	3.9	26.7	0	22	0	24.6	5.2	3.8	0	10.7	3.4	10.1	0	0.2	17.7	20.9	7.4	11	20.1	0.5	4	0.2	23	0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4
MINK1	"B55, MAP4K6, MINK, YSK2, ZC3"	ENSG00000141503	Misshapen like kinase 1	Q8N4C8	17	4833388-4898061	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA056296	Approved									HPA056296: 	unprognostic (2.80e-1)	unprognostic (3.83e-2)	unprognostic (1.85e-1)	unprognostic (6.62e-2)	unprognostic (2.88e-1)	unprognostic (3.26e-3)	prognostic unfavourable (3.00e-4)	unprognostic (4.64e-3)	unprognostic (3.21e-1)	unprognostic (2.78e-2)	prognostic favourable (2.77e-4)	prognostic unfavourable (9.27e-4)	unprognostic (8.44e-3)	unprognostic (2.49e-2)	unprognostic (1.37e-1)	unprognostic (2.47e-2)	unprognostic (1.62e-1)	12.7	14.8	31.4	18.2	46.8	14.9	14.2	30.8	43.5	15.2	26	32.6	8.8	33.1	12.4	7.7	40	14.3	15.6	9	28.4	12.8	13.8	10	23.3	17.1	28.6	27.3	27.5	21.5	16.5	15.4	17.4	29	14.3	20.7	14.5	21.1	11.3	8.3	47.3	31.1	11.4	24.8	20	22.3	14.5	30.9	9	12.7	14.6	16.8	14.9	24.1	2.6	1.2	6.4	1.6	0.3	3	2.3	18.4	33.9	7.9	12.8	12.6	9.2	22.8	14.8	13.5	11.8	10	12.8	12.9	13.2	17.1	15.5	37.6	5.9	26.6	5.8	18.9	16.5	9.4	21.5	10	8.3	3.5	18.5	9.8	20	11.1	10.3	12.7	10.1	11.5	8.7	11	5.6	8	6.2	11	7	6.5	8	18.1	19	8.3	6.6	15.3	12.8	9.6	11.5	4.9	18.4	12.6	5.7	21.3	14	6.6	5.3	2.7	11.3	7.6	8.5	0	1.6	6.4	2.7	1.6	3	2.6	2.8	2.1	1.2	1.5	2	0.8	1.3	0.3	0.8	0.8	2.8	2.3	31.4	46.8	30.8	43.5	28.4	12.8	28.6	27.3	29	30.9
MKNK1	MNK1	ENSG00000079277	MAP kinase interacting serine/threonine kinase 1	Q9BUB5	1	46557408-46616843	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Translation regulation	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		pancreas: 72.3	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: "	unprognostic (4.05e-3)	prognostic favourable (7.05e-4)	unprognostic (5.28e-2)	unprognostic (3.47e-2)	unprognostic (1.64e-1)	unprognostic (7.38e-2)	prognostic unfavourable (1.24e-5)	unprognostic (3.50e-2)	unprognostic (1.77e-1)	unprognostic (2.60e-1)	unprognostic (1.50e-1)	unprognostic (2.14e-2)	prognostic unfavourable (1.51e-5)	unprognostic (7.02e-2)	unprognostic (3.19e-2)	unprognostic (4.67e-1)	unprognostic (5.67e-3)	17.6	12	10.7	16.2	10.5	16.8	12.1	13.7	12.3	9.2	12.6	11	9.6	9.7	11.9	13.3	12.2	11.1	11.4	12.3	10.8	7	9.4	10.8	16.1	16.3	9.9	9.8	10.7	72.3	8.6	11.3	15.4	11	9.9	13.3	11.9	10.6	7.7	12.8	10.2	12.7	13.3	8.1	25.6	11.7	7.6	8.7	12.5	8.8	15.8	10.9	10.9	14.5	4.9	6	33.3	12.1	5	22	6.1	19.3	13.1	8.7	9.6	7.8	11.6	11.6	9.8	9.8	11.9	16.2	15.1	8	12.8	12.1	9.8	23.5	14.5	16	12.7	21.9	12.9	27	15	12.9	12.2	14.4	22	15.2	11.1	15.5	8.5	13.9	14.1	9.4	6.4	12.7	10.3	12.9	5.9	15.6	9.5	18.2	12.8	12.7	20.3	6.1	5.5	18.9	17.1	15.8	11.5	16.1	11.2	4.3	0.9	13.5	10.9	8	13.3	10.9	8.4	18.6	7.9	3.9	12.1	14.3	7.5	11.5	22	4.6	6.6	6.8	6	4.9	4.8	7	33.3	5	8.1	4.4	4.4	6.1	10.7	10.5	13.7	12.3	10.8	7	9.9	9.8	11	8.7
MKNK2	"GPRK7, MNK2"	ENSG00000099875	MAP kinase interacting serine/threonine kinase 2	Q9HBH9	19	2037465-2051244	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 207.5	Cell line enhanced	Detected in all		HHSteC: 78.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA021875, CAB037253, HPA070499"	Supported		Supported	Nuclear bodies				Nuclear bodies		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: "	unprognostic (8.76e-2)	unprognostic (1.71e-1)	unprognostic (1.64e-1)	prognostic favourable (4.86e-5)	unprognostic (3.08e-1)	unprognostic (1.59e-2)	unprognostic (6.42e-3)	unprognostic (1.35e-1)	unprognostic (4.32e-2)	unprognostic (7.52e-2)	unprognostic (1.08e-1)	unprognostic (6.56e-2)	unprognostic (4.07e-2)	prognostic favourable (4.01e-4)	unprognostic (1.63e-1)	unprognostic (1.60e-1)	unprognostic (1.59e-1)	30.3	15.6	7.6	24.2	8.5	31.9	31.1	16.6	9.7	12.5	22.7	6.5	21.4	13.1	9.3	18.4	42.1	11	21.7	33.3	7.5	5.7	10.3	22	24.5	16.9	10.3	3.3	13.8	53.1	8.3	13.4	16.7	9.2	18.8	8.4	14.2	35.2	32.5	207.5	19.3	15.1	13	7	27.8	16.7	9.1	9.1	16	32.3	47.1	32.8	21.2	63.6	10.7	5.9	26.9	8	6.1	7.5	2.2	13.1	14.8	6.3	13.8	46.9	17	14.2	7.8	5.6	5.6	5.7	9.5	23.1	18.6	10.8	15.7	16.3	7.9	22.8	2.5	25.3	7.4	7.5	12.5	10.1	78.8	14.7	13.6	18.1	55.5	10.6	22.6	13.2	12.9	33.3	3.8	7.7	8.8	12.3	16.5	16.2	16.9	1.8	23.5	9.9	8.6	8.7	10.4	18.3	27.1	33.4	11.2	18.3	19.8	2	8	8.2	9.3	54.3	21	18.2	16.5	11.1	3.7	2.7	6.1	5.7	5.6	6.3	5.1	10.7	5.8	6.2	4.8	10.2	3.7	4.5	26.9	6.1	8	5.9	7.5	2.2	7.6	8.5	16.6	9.7	7.5	5.7	10.3	3.3	9.2	9.1
MLKL	FLJ34389	ENSG00000168404	Mixed lineage kinase domain like pseudokinase	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	Necrosis			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		vagina: 50.4	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in all														unprognostic (7.53e-2)	unprognostic (1.74e-2)	unprognostic (2.57e-1)	prognostic favourable (2.16e-4)	unprognostic (1.23e-1)	unprognostic (3.07e-1)	unprognostic (5.69e-2)	unprognostic (3.67e-3)	unprognostic (1.90e-1)	unprognostic (6.64e-3)	unprognostic (1.37e-1)	unprognostic (2.74e-1)	unprognostic (1.60e-3)	unprognostic (5.30e-2)	unprognostic (1.26e-2)	unprognostic (1.06e-1)	unprognostic (1.53e-3)	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10	6	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.1	0.1	0.1	3.1	6.7	0.1	8.4	7.3	8	11.8	7	13.1	0.1	9.7	7.1	10.5	2.2	12.2	3	4.1	0.3	9.1	9	7.9	2.3	5.9	9.5	4.4	1.2	8.5	3	19.2	1.3	1.3	6.2	10.8	3.4	11.9	1	14.9	6.6	0.9	11.7	11.3	4.8	0.5	0.4	6.7	4.4	3.7	3.2	6.3	20.9	4	2.4	3.6	5.7	5.6	19.1	1.6	7.2	21	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	MOK protein kinase	Q9UQ07	14	102224500-102305200	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in all		testis: 45.0	Cell line enhanced	Detected in many		HBF TERT88: 28.0;hTEC/SVTERT24-B: 71.2;NB-4: 88.6;U-138 MG: 37.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in many		NK-cell: 10.6	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027292			Supported	Endoplasmic reticulum				Endoplasmic reticulum		HPA027292: AB_10600989	unprognostic (8.16e-2)	unprognostic (1.82e-1)	unprognostic (6.68e-2)	unprognostic (6.05e-3)	unprognostic (1.34e-2)	unprognostic (1.81e-2)	unprognostic (4.43e-2)	unprognostic (3.49e-4)	unprognostic (2.19e-1)	unprognostic (2.03e-2)	unprognostic (2.93e-1)	unprognostic (3.01e-3)	unprognostic (5.97e-2)	unprognostic (1.81e-1)	unprognostic (2.17e-1)	unprognostic (1.26e-2)	unprognostic (2.48e-1)	5.9	6.8	12.9	2.7	17.3	3.7	7.8	9.7	15.9	7.6	3.6	8.7	6.2	4.7	7.6	10.2	3.9	26.4	6.4	8.3	13.5	10.2	7.7	3.6	6.1	2.5	6	13.7	12.4	8.6	9.4	22.1	3.6	16.6	5.1	3	15.2	6.1	5.4	1.9	8.6	4.1	5.9	6.2	3.8	11.7	45	6.2	0.4	11.7	2.3	2.2	6.2	3.9	0.7	3.9	0.9	1.1	10.6	2.4	1.3	3.3	3	0.4	1.7	0.7	2.5	0.7	6.8	2	9.9	11.9	0.2	8.3	2.5	0.5	1.3	0.7	0.6	3.5	28	2.8	2.5	0.6	0.3	2.2	3	0.2	3.3	2.1	0.9	71.2	6.6	0.3	0.6	0.1	6.4	2.2	0.2	88.6	0.1	7.2	0.4	0.1	0	4	0.1	1.1	0.7	1.2	0.4	19.2	2	0.2	0.2	37.6	1.9	1.4	2.1	0.2	0.4	0.2	7.5	0.2	17	0	1.1	0	0.7	0.7	1.2	0	0.5	1.9	3.9	0.7	1.1	2.4	0.9	10.6	0.1	0	0	1.3	12.9	17.3	9.7	15.9	13.5	10.2	6	13.7	16.6	6.2
MOS		ENSG00000172680	"MOS proto-oncogene, serine/threonine kinase"	P00540	8	56112942-56113982	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	5	testis: 3.5	Not detected	Not detected			Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all																												unprognostic (3.28e-1)			0	0	0.6	0	0.5	0	0	0	0.3	0	0			0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0.2		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	3.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0										
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	Macrophage stimulating 1 receptor	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 27.7;intestine: 34.3;skin 1: 28.7	Cell line enhanced	Detected in some		CAPAN-2: 35.3;HaCaT: 19.5;HBEC3-KT: 21.2;hTCEpi: 29.8;RT4: 22.8	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in single		MAIT T-cell: 2.1	Lineage enhanced	Detected in single		T-cells: 2.1	Low region specificity	Detected in single			Not detected	Not detected			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol				Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	unprognostic (3.84e-3)	unprognostic (3.86e-1)	unprognostic (1.92e-1)	unprognostic (7.33e-3)	unprognostic (3.82e-2)	unprognostic (2.32e-1)	unprognostic (8.07e-3)	unprognostic (1.54e-2)	unprognostic (4.12e-2)	unprognostic (2.15e-1)	unprognostic (1.24e-3)	unprognostic (2.28e-1)	unprognostic (8.08e-3)	unprognostic (2.38e-1)	unprognostic (2.18e-1)	unprognostic (8.00e-3)	prognostic favourable (2.33e-5)	1.7	0.1	0.4	7.5	0.6	0	2.4	0.5	0.7	1.8	20.5	0.7	2	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5	1.1	0.4	0.6	0.5	4.1	0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6	4.5	4.3	3.5	0.2	0	0	0	0.6	2.1	0	12.7	4.9	0	0.2	0	0	0.8	0.1	0	0	0	1.2	35.3	0.5	3.1	0.2	19.5	0	21.2	0	0.3	0.3	0	8.4	0.3	0.3	0	0.4	0.1	29.8	0.1	4.2	0	0.2	0.1	0	1.7	0	0	0.1	10.3	0.8	0	0.3	13	22.8	0.3	0	3.6	8.2	0	6.5	0.3	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	2.1	0	0.1	0	0	0.2	0	0	0	0.6	0	0	0.9	0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	Mechanistic target of rapamycin kinase	P42345	1	11106535-11262507	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Biological rhythms	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB069425, HPA071227"	Approved		Approved	"Vesicles,Cytosol"				"Vesicles, Cytosol"		"CAB069425: , HPA071227: "	unprognostic (3.18e-1)	unprognostic (1.50e-1)	unprognostic (1.20e-1)	unprognostic (2.45e-3)	unprognostic (5.50e-2)	unprognostic (2.55e-2)	unprognostic (1.39e-1)	unprognostic (1.68e-1)	unprognostic (1.18e-1)	unprognostic (8.24e-3)	unprognostic (3.48e-2)	unprognostic (1.88e-1)	prognostic favourable (1.49e-5)	unprognostic (1.27e-1)	unprognostic (2.45e-1)	unprognostic (6.60e-2)	unprognostic (7.55e-2)	11.3	13.9	18.7	13	22.5	12.3	14.9	25.2	25.2	11.3	14.5	18.2	10.4	11.2	13.8	23.6	13.1	10.5	15.7	14.2	14.5	13.6	15.8	19.4	10.8	14.3	14	14.4	10.7	16.6	26.5	16	12.5	15.5	15.2	17.1	14.4	14.2	15.2	24.6	16.5	13.6	15.2	10.4	15.4	13.1	38.6	13.1	16.6	13.2	9.9	15.7	11.7	10.2	3.9	4	3	6.4	2.6	5.6	2.3	15.2	13.8	18.7	14.1	22.6	10.8	9.3	12.9	12.4	17.2	17	14.2	14.1	16.9	11.1	15.2	18.2	25.2	19.7	22.3	13.5	18.4	22.5	28.6	17.9	14.2	21.9	16.8	13.8	15	24.6	25	21.8	25.1	14.6	12	17.4	15.1	16.7	14.1	13.1	15.2	22	11.3	15.2	13.8	18.9	13.8	27.6	14.9	16.9	12.1	13	23.2	15.1	13.7	11.5	17.2	14.4	13.4	33.3	10.9	23.7	15.8	0.7	2.9	3	5.2	6.4	4.3	3.9	3	2.7	4	3.4	3.6	3.1	2	2.6	3.3	3.1	5.6	2.3	18.7	22.5	25.2	25.2	14.5	13.6	14	14.4	15.5	13.1
MUSK		ENSG00000030304	Muscle associated receptor tyrosine kinase	O15146	9	110668771-110801620	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease mutation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	7	skeletal muscle: 50.0	Group enriched	Detected in some	15	LHCN-M2: 19.3;RH-30: 19.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Region enhanced	Detected in some		basal ganglia: 4.5	Not detected	Not detected														unprognostic (6.12e-2)	unprognostic (9.01e-2)	unprognostic (5.39e-2)	unprognostic (3.66e-1)	unprognostic (3.14e-1)	unprognostic (1.20e-2)		unprognostic (1.50e-2)		unprognostic (2.46e-1)	unprognostic (3.13e-1)	unprognostic (7.58e-2)	unprognostic (6.03e-5)	unprognostic (4.58e-2)	unprognostic (1.62e-1)	unprognostic (9.67e-2)	unprognostic (5.11e-2)	7.5	0.3	0.6	5.8	0.7	0	0.2	0.1	0.2	0.3	6.8	0	0	2.3	0.2	4	3.8	0.1	2.1	3.2	0.9	0.7	0.2	0.5	4.2	0.9	0.2	0.1	0.3	0.3	0	0.2	0.6	0.3	1.9	5.3	0	0.4	0	50	0.3	5	3	0.3	0.2	2.6	5.9	0	0	0.3	1.4	3.9	3.6	2.9	0	0.2	0.6	0.3	0	0	0	0	0	0	0	0.3	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	1.2	0	0	0	0	0	0	19.3	0	0	0	0.4	0.2	0	19.6	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0.3	0	0.4	0	0	0	0	0	0	0.3	0.6	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.6	0.7	0.1	0.2	0.9	0.7	0.2	0.1	0.3	0
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	Myosin light chain kinase	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		smooth muscle: 191.1	Cell line enhanced	Detected in many		BJ: 36.5;BJ hTERT+: 55.2;fHDF/TERT166: 45.0;HBF TERT88: 29.0;RPTEC TERT1: 59.6	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Group enriched	Detected in some	10	basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7	Group enriched	Detected in many	13	dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3	Low region specificity	Detected in many			Low region specificity	Detected in many			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		3000000	3000000	Actin filaments	Plasma membrane	"CAB020789: , HPA031677: AB_10794617, HPA048055: "	unprognostic (2.80e-2)	unprognostic (5.05e-2)	unprognostic (5.55e-2)	unprognostic (2.85e-2)	unprognostic (1.69e-1)	unprognostic (1.41e-1)	unprognostic (4.86e-2)	unprognostic (8.55e-2)	unprognostic (1.20e-1)	unprognostic (1.40e-1)	unprognostic (8.21e-2)	unprognostic (1.58e-1)	prognostic unfavourable (2.04e-6)	unprognostic (5.26e-3)	unprognostic (9.60e-2)	unprognostic (3.00e-1)	prognostic unfavourable (4.46e-4)	14.9	4.9	4.5	19.8	10.9	0	14.4	0.8	5.8	77.1	107.3	22	93.2	9.4	111.2	48.3	96	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8	16	85.1	27.6	6	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0	0.2	17.3	2.5	7.7	2.1	1.3	2.1	0.4	0.9	36.5	55.2	23.6	17	1.6	1.4	0.1	8.2	45	0.9	0.9	0.3	29	0	0.1	20.3	0.2	5	11	0.1	1.9	6.8	0.7	4.6	6.9	1.8	0.2	0.1	17.5	0.3	0	0.5	2.2	1	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	0.2	0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0	0.2	0	0	2.8	0.1	0.2	0.1	4.5	0	0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16	13
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	Myosin light chain kinase 2	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	skeletal muscle: 176.1	Cell line enhanced	Detected in some		Karpas-707: 5.2;RH-30: 13.2;RPMI-8226: 10.7	Cancer enhanced	Detected in some		glioma: 1.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			"HPA059704, HPA059890"	Enhanced		Supported	Endoplasmic reticulum				Endoplasmic reticulum		"HPA059704: , HPA059890: "	unprognostic (1.74e-2)	unprognostic (1.87e-1)	unprognostic (8.84e-2)	unprognostic (5.27e-2)	prognostic favourable (4.00e-4)	unprognostic (5.58e-2)	unprognostic (1.38e-7)	unprognostic (2.29e-1)	unprognostic (2.60e-3)	unprognostic (1.99e-1)	unprognostic (1.20e-1)	unprognostic (4.73e-2)	unprognostic (7.25e-11)	unprognostic (2.01e-1)	unprognostic (3.15e-1)	unprognostic (2.60e-2)	unprognostic (2.70e-2)	1.4	0	0.1	0	0.1	0.1	0.1	0	0.1	0	0	0	0	0	0	1.9	1.4	0	0	0.3	0.1	0.1	0	0	0	0	0.1	0	0	4.4	0	0	0	0	0.2	0	0	1.4	0.3	176.1	0	0	0	0.1	0.1	0.1	0	0	0	1.1	18.2	1.4	0	0	0	0	0	0	0	0	0	0.4	0	0.8	0.8	0	0	0.5	0.1	0	0.4	0.1	0.3	0.3	0.6	0.4	0	0.1	0.1	0	0.2	0.2	0.2	0.7	0.3	0	0	0.6	0.1	0	0	0.4	0	1	0.2	5.2	0.1	0.8	0.7	0.4	0.6	0.4	0.7	13.2	10.7	0.1	0.1	0.7	0.6	3.4	0.1	0	0.1	0.1	2.6	0.2	1	0.6	2.9	0.1	0.9	0.2	0.2	3.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	Myosin light chain kinase 3	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1	Cell line enhanced	Detected in some		BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0	Not detected	Not detected			Region enhanced	Detected in many		pons and medulla: 6.6	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	7	cerebral cortex: 9.8;hippocampal formation: 5.7	Region enriched	Detected in some	5	hippocampal formation: 5.2	HPA073447	Enhanced		Approved	"Nucleoplasm,Vesicles"				Nucleoplasm	Vesicles	HPA073447: 	unprognostic (6.01e-4)	unprognostic (2.19e-1)	unprognostic (2.64e-1)	unprognostic (1.77e-2)	unprognostic (1.84e-1)	unprognostic (2.94e-3)	unprognostic (2.60e-1)	unprognostic (4.73e-2)	unprognostic (3.33e-2)	unprognostic (2.41e-2)	unprognostic (6.58e-3)	unprognostic (1.83e-1)	unprognostic (4.16e-2)	unprognostic (2.57e-2)	unprognostic (2.52e-1)	unprognostic (1.08e-2)	unprognostic (2.97e-1)	0	0.1	0.7	0	1.7	0.1	0	0.1	0.2	0.2	0	3.8	0	0	0.1	3.4	2	0.8	0.1	62.2	1.5	1.4	0.4	0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1	0	0	1.3	0	20.8	0	0	0	0.3	0	0	2.9	0.3	0	0.1	31.1	1.1	0.1	0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0	0.1	0.1	0.1	0	0	9.5	0	0	0	0	0.6	0.1	0.1	0.1	0	0	0	0	0	0	0	28.5	1.5	0.1	0.1	0.1	0.2	0	0	0	0	0	4.4	0.2	0	0	0	0.2	0	0	0.1	0.1	0	0	0	0.3	0.3	0	6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.4	0	0.3	0	0.1	0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3
MYLK4	SgK085	ENSG00000145949	Myosin light chain kinase family member 4	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	17	skeletal muscle: 23.6;tongue: 63.6	Cell line enriched	Detected in some	6	HEL: 12.4	Low cancer specificity	Detected in some			Low region specificity	Detected in single			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Not detected	Not detected			Low region specificity	Detected in all			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"				Golgi apparatus	"Nucleoli, Vesicles"	HPA015860: AB_2147922	unprognostic (1.75e-1)	unprognostic (2.04e-1)	unprognostic (1.87e-1)	unprognostic (5.22e-3)	unprognostic (1.85e-1)	unprognostic (2.99e-2)	unprognostic (7.48e-2)	unprognostic (2.80e-1)	unprognostic (5.32e-2)	unprognostic (2.25e-1)	unprognostic (2.02e-2)	unprognostic (2.91e-1)	unprognostic (2.74e-3)	unprognostic (1.43e-1)	unprognostic (2.65e-1)	unprognostic (1.19e-2)	unprognostic (4.63e-2)	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1	0.2	0.3	1	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.1	0.6	1.1	1	1.2	0.6	0.7	1.5	0.5	0.4	0.5	1	1	1.6	0.8	1.9	0.2	0.4	0.7	0.2	0.6	12.4	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.5	0.1	0.1	0.3	0.5	0.1	1.3	0.2	0	0.9	0	0	0.8	0.3	1	0.6	0.3	0.2	0.5	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.2	0.1	0.1	0.1	0.5	0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3
MYO3A	DFNB30	ENSG00000095777	Myosin IIIA	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 8.1;testis: 12.5	Cell line enhanced	Detected in some		AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.6;SCLC-21H: 2.4;U-2 OS: 4.3;U-698: 10.9	Low cancer specificity	Detected in many			Group enriched	Detected in many	4	basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4	Cell type enriched	Detected in single	12	naive B-cell: 1.1	Lineage enriched	Detected in single	12	B-cells: 1.1	Not detected	Not detected			Low region specificity	Detected in some			"HPA048951, HPA051893"	Approved		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"				"Actin filaments, Cytoplasmic bodies"	Plasma membrane	"HPA048951: , HPA051893: "	unprognostic (5.00e-3)	unprognostic (3.36e-2)	unprognostic (1.53e-1)	unprognostic (3.20e-3)	unprognostic (2.96e-1)	unprognostic (4.37e-2)		unprognostic (5.29e-2)	unprognostic (2.74e-1)	unprognostic (4.31e-2)	unprognostic (1.03e-1)	unprognostic (5.66e-3)	unprognostic (7.96e-3)	unprognostic (6.34e-2)	unprognostic (1.46e-2)	unprognostic (6.62e-2)	unprognostic (9.69e-2)	0.8	0.7	0.4	0.3	5	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1	0.3	0.2	0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1	0.4	0.3	0.9	12.5	0.8	0	1.3	1.4	0.9	0.5	0.9	1.1	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	2.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	1.6	0	0	1.2	0	0	0	2.4	0	0	0	0	0	0	0	0	4.3	0	0	0	0	10.9	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0.4	5	0.3	1.9	0.5	1.3	0.2	0	5.4	0.8
MYO3B		ENSG00000071909	Myosin IIIB	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6	Group enriched	Detected in some	10	HDLM-2: 11.0;HEL: 10.1;RT4: 11.5	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in some		gdT-cell: 1.4;naive CD8 T-cell: 1.1	Lineage enriched	Detected in single	5	T-cells: 1.4	Region enriched	Detected in single	5	basal ganglia: 4.7	Not detected	Not detected			HPA045483	Approved									HPA045483: 	unprognostic (1.65e-1)	unprognostic (7.87e-2)	unprognostic (1.96e-2)	unprognostic (1.43e-2)	unprognostic (1.67e-1)	unprognostic (7.15e-3)	unprognostic (5.07e-2)	unprognostic (2.61e-2)	unprognostic (5.84e-3)	unprognostic (2.12e-1)	unprognostic (7.99e-3)	unprognostic (2.59e-1)	unprognostic (4.25e-5)	unprognostic (2.34e-1)	unprognostic (8.12e-3)	unprognostic (1.18e-1)	unprognostic (1.07e-1)	0.2	0.2	0.3	0	0.3	0	0.2	0.2	0.3	0.6	0.2	0	4.6	0	0.3	20	0.3	0.5	0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1	0	0.3	0.3	0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0	0	2.2	0	0.8	4.4	0.3	0.1	0.3	0	0	0	1.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	11	0	10.1	0	0	0	0	0	0	0.2	0	0	0	0.5	0	0	0	0	0	0.7	0	0	0	0	1	11.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1.4	0	0	0	0	0.5	0.3	0.1	0	1.1	0	0	0	0	0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	NIMA related kinase 1	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	unprognostic (4.10e-2)	unprognostic (2.97e-1)	unprognostic (1.59e-2)	unprognostic (1.97e-1)	unprognostic (6.98e-2)	unprognostic (3.10e-1)	unprognostic (3.95e-1)	unprognostic (3.29e-1)	unprognostic (1.13e-1)	unprognostic (2.78e-1)	unprognostic (4.06e-3)	unprognostic (2.21e-1)	prognostic favourable (1.42e-4)	unprognostic (1.07e-1)	unprognostic (1.03e-1)	unprognostic (2.10e-2)	unprognostic (3.46e-1)	9.6	10.5	13.5	9.2	15.8	6	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.9	7.8	8.4	12.1	13.6	2.5	9	8.1	7.2	6.9	2.4	5.1	11.3	1.7	7.8	1.4	7.3	7.6	8.2	12.4	5	7.6	7.8	2.9	7.2	7.7	6.1	10.8	4.4	7.3	12.9	7	13.5	21.6	9.2	2.7	9.9	3.4	2.5	4.5	6.1	5.1	3.6	7.6	5	8.5	9.7	6.5	3.2	6	4	3.4	8.4	4.6	4.2	4.8	6	8.7	13.4	8.7	7.6	3.8	8	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16	14.8
NEK10	FLJ32685	ENSG00000163491	NIMA related kinase 10	Q6ZWH5	3	27110085-27369460	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 31.4	Cell line enhanced	Detected in many		BJ: 7.6;LHCN-M2: 10.5;U-2 OS: 8.9	Cancer enriched	Detected in single	5	breast cancer: 1.8	Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.9	Low lineage specificity	Detected in single			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA038941	Uncertain		Approved	"Nucleoplasm,Vesicles"				Vesicles	Nucleoplasm	HPA038941: AB_10673600	prognostic favourable (4.20e-4)	unprognostic (2.17e-1)	unprognostic (8.78e-2)	unprognostic (2.15e-2)	unprognostic (3.37e-2)	unprognostic (3.02e-1)	unprognostic (1.12e-1)	unprognostic (1.83e-1)	unprognostic (1.26e-1)	unprognostic (1.93e-2)	unprognostic (2.20e-3)	unprognostic (1.37e-1)	unprognostic (7.67e-2)	unprognostic (1.33e-2)	unprognostic (1.38e-2)	unprognostic (1.57e-3)	unprognostic (2.14e-1)	0.4	0.5	4.5	0.5	14.6	0.4	14.2	0.6	6.8	1.6	2	1.1	2	2.5	0.9	8.3	2	10.5	2.1	3.1	8.4	3.8	1.4	2.5	4.5	0.6	0.8	6.7	2.7	0.8	0.5	9	0.3	3.4	1.9	0.7	1.3	0.5	1.4	10.5	0.4	1	1.2	0.8	0.6	1.1	31.4	1.3	0.3	0.8	0.3	0.7	1.4	0.4	0.4	0.2	1.9	0.1	0.1	0.6	0.1	1	2	1	1.2	0.9	2	0.4	7.6	1.2	2.1	1.9	0	0.5	0.7	1.9	3.2	0.1	0.5	0.5	2.3	1.4	0.8	0.2	4.1	3.7	0.2	0.4	1	2.4	0.5	3.2	0.1	1.4	0.1	0.7	10.5	0.1	0.8	0.5	0.7	0.3	1	0.4	0.3	4	0.6	0.2	0.2	1.2	0.4	0.6	6.1	0.4	0.9	5.6	8.9	0.3	0.7	0.3	0.2	0.5	4.8	0.8	2.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.5	0.4	0	0.4	0.1	0.5	1.9	0.1	0	0.2	0	0.1	4.5	14.6	0.6	6.8	8.4	3.8	0.8	6.7	3.4	1.3
NEK11	FLJ23495	ENSG00000114670	NIMA related kinase 11	Q8NG66	3	131026850-131350465	"Enzymes, Predicted intracellular proteins"	Cell cycle	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 26.9	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA016908	Approved		Supported	Nucleoplasm				Nucleoplasm		HPA016908: AB_1854364	unprognostic (9.15e-3)	prognostic favourable (7.10e-4)	unprognostic (1.05e-1)	unprognostic (1.08e-1)	unprognostic (9.96e-2)	unprognostic (4.85e-3)	unprognostic (2.48e-5)	unprognostic (5.38e-2)	unprognostic (1.86e-1)	unprognostic (1.18e-1)	unprognostic (2.27e-1)	unprognostic (1.79e-1)	prognostic favourable (5.92e-6)	unprognostic (2.46e-2)	unprognostic (1.60e-1)	unprognostic (2.72e-2)	unprognostic (1.58e-1)	3.9	5.8	9.3	2.7	11.1	0.5	8.7	2.7	7.6	7.3	2.8	11.2	8.4	2	6.5	16	3.2	26.9	6	2.9	9.1	10	8.2	1.1	5.5	1.7	7.8	5.4	8.7	2.8	5	9.3	4.6	17.3	4	3.3	3	3.8	6.7	1.7	2.8	2.6	4.3	7.3	1.8	2.3	17.8	5.5	0.2	12.3	2.5	1.7	4.2	3	0.9	1	1.1	1.3	0.3	2.9	0.3	5.8	2.4	1.7	5.1	6.9	10.4	1	2.9	5.4	4.4	3.4	2.2	8.2	0.3	2.1	5.1	3.2	0.5	5	6.2	0.5	0.7	0.8	0.4	1	2.3	0.6	1.5	4.3	8.4	4.7	2.1	0.9	0.2	0.9	7.4	4.1	0.1	0.5	0.5	2.3	0	0.2	0.1	10.1	2.3	2.2	2.4	1.4	0.1	1.9	4.8	0.1	0.9	4.6	2.2	3.6	1.3	1.3	2.3	0.1	3.2	0.2	0.8	0	0.3	1.1	0.6	1.3	1.2	0.9	2.9	2.6	0.5	0.6	1	0.8	0.9	0.3	0.9	1	1.5	0.3	9.3	11.1	2.7	7.6	9.1	10	7.8	5.4	17.3	5.5
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	NIMA related kinase 2	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 14.0;testis: 41.0	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Region enhanced	Detected in some		cerebellum: 3.2	Low region specificity	Detected in all			"CAB017530, HPA064967"	Enhanced		Supported	"Nucleoplasm,Centrosome"				"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: "	unprognostic (1.28e-1)	unprognostic (2.33e-1)	unprognostic (1.02e-1)	unprognostic (8.51e-2)	unprognostic (1.83e-1)	unprognostic (1.35e-2)	prognostic unfavourable (9.47e-6)	prognostic unfavourable (9.11e-4)	unprognostic (1.95e-2)	unprognostic (2.00e-2)	unprognostic (1.09e-3)	unprognostic (8.49e-2)	unprognostic (0.00e+0)	unprognostic (8.21e-2)	unprognostic (4.11e-2)	unprognostic (1.25e-2)	unprognostic (2.71e-1)	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1	0.3	0.6	0.6	1	3.9	0.3	0.3	0.6	0.3	0	0.3	1.2	0.4	0.9	3.6	0.4	1	0.3	0.3	1.8	3	0.6	0.6	1.6	1.1	41	0.4	14	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.3	21.9	16.8	12	1	1.7	18.5	11.7	11	20.7	17.8	11.7	29.8	16.1	5.7	9	16.3	14.5	8.8	26.1	24.6	12.1	7.7	19.1	15.7	0.1	15.2	10.5	0.5	1	15.9	17.2	13.2	21.1	28.4	20.7	8.4	16.5	10.3	15.9	11.2	16.4	25.7	24.5	7.2	8.7	15.2	16.9	16.9	19	14.7	29.2	9.1	6.9	10.3	20.5	20.3	31.4	11.8	21.7	21.3	9	11.7	17.1	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1	0.3	0.3	0.3	0.4	0.4
NEK3	"HSPK36, MGC29949"	ENSG00000136098	NIMA related kinase 3	P51956	13	52132639-52159861	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA019062, HPA043230"	Enhanced		Approved	Microtubules				Microtubules		"HPA019062: , HPA043230: "	unprognostic (8.97e-2)	unprognostic (2.54e-2)	unprognostic (8.12e-2)	unprognostic (1.84e-1)	unprognostic (2.01e-2)	unprognostic (2.05e-1)	unprognostic (2.71e-1)	unprognostic (2.31e-1)	unprognostic (1.31e-1)	unprognostic (4.30e-3)	unprognostic (1.16e-3)	unprognostic (1.70e-2)	unprognostic (1.17e-3)	unprognostic (1.22e-2)	unprognostic (4.66e-2)	unprognostic (4.15e-2)	unprognostic (5.34e-2)	7.7	2.8	7.1	5.4	12.9	7.1	7.3	3.2	7.1	7	13.8	20.4	3.1	7.8	9.1	5.8	3.9	6	6.4	5	8.7	5.2	6.1	5.7	7.2	4.2	14	9.5	7.9	6.4	2.2	3.7	14.8	11.3	5.4	15	6.8	5.2	5	4.1	5.4	11.7	7.3	9.6	3.9	4.6	14.7	13.3	2.4	5	2.7	4.3	6.5	6	4.4	7.8	5.9	7.7	2	3.5	1.6	0.2	1.4	13.1	7.5	4.2	6.6	0.2	4.2	4.3	5.1	5.7	5	7.3	0	0.2	5.2	0.9	0.2	3.2	3.1	8.7	6.9	1	1.4	13.6	5.4	12.6	6.8	4.8	5.8	2.6	12.2	7.7	1.8	4.4	5.2	3.6	0.6	15.2	12.9	0.3	0.3	1.1	4.7	7.3	1.3	1.3	9.1	1.9	4	8.8	1.7	16.2	6.6	0.7	4.3	4	4.5	4.7	1.6	8.8	1.1	5	7.1	5.9	7.7	5.3	2.1	6.6	1.3	4.4	2.5	1.3	7.8	2.5	1.7	0.6	0.5	2	1.5	6.9	3.5	1.6	7.1	12.9	3.2	7.1	8.7	5.2	14	9.5	11.3	13.3
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	NIMA related kinase 4	P51957	3	52708449-52770949	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 47.7	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol				Cytosol		"HPA015750: AB_1854367, HPA058543: "	unprognostic (1.32e-1)	unprognostic (1.57e-1)	prognostic favourable (2.69e-5)	unprognostic (9.65e-3)	unprognostic (3.42e-1)	unprognostic (6.64e-2)	unprognostic (8.75e-3)	unprognostic (2.27e-1)	unprognostic (7.85e-2)	unprognostic (5.52e-2)	unprognostic (1.46e-1)	unprognostic (1.32e-1)	unprognostic (3.74e-3)	unprognostic (5.11e-2)	unprognostic (2.85e-1)	unprognostic (1.51e-2)	unprognostic (8.39e-2)	7.2	10.7	15.5	9.1	15.7	7.3	11	20.2	16.1	10.6	8.4	10.6	9.6	7.6	10.3	10.7	8.1	15.8	7.5	7.4	12.5	14.2	11.6	12.4	7.7	8.8	12.7	8.6	15.8	10.2	13.4	17.6	8.7	11.9	9.4	9.7	9.1	8.5	11.3	10.8	5.3	6.6	9.5	10.7	7.9	11	47.7	12.4	11.1	15.5	5	10.4	9.3	10.7	5.1	6.4	12.4	11.8	4.6	5.2	5.5	12.8	10	13.7	10.8	12.6	9.1	14.9	9.1	12.3	17.1	17.3	8.7	9.6	13.2	4.3	8.9	6	16.7	10.7	23	13.1	7	10.3	12.2	11.1	7.8	25.1	10.4	5.6	9.9	21.9	14.6	6.4	12.8	10.7	10.7	10.9	13.5	9.2	11.9	9.9	11.9	12	9.7	9.6	18.5	10.1	6.1	19.1	11.8	9	11	15.2	5.8	11.5	11.7	18.3	16.8	12	17.5	13	13.1	11.9	12.4	12.4	11.8	5.8	4.6	7.3	5.2	3.6	4	4.8	6.4	5.1	4.9	4.2	1.8	4.6	4.8	3.2	3.1	5.5	15.5	15.7	20.2	16.1	12.5	14.2	12.7	8.6	11.9	12.4
NEK5		ENSG00000197168	NIMA related kinase 5	Q6P3R8	13	52033611-52129078	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 11.8;fallopian tube: 12.7;testis: 15.7	Cell line enhanced	Detected in some		T-47d: 4.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		basophil: 2.5	Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			"HPA035565, HPA041399"	Enhanced									"HPA035565: AB_10672095, HPA041399: "	unprognostic (4.14e-2)	unprognostic (1.49e-1)	unprognostic (1.89e-1)	unprognostic (5.80e-3)	unprognostic (2.80e-2)	unprognostic (2.47e-1)	unprognostic (3.57e-2)	unprognostic (6.50e-2)	unprognostic (8.82e-2)	unprognostic (1.32e-1)	unprognostic (1.37e-2)	unprognostic (2.94e-1)	unprognostic (2.06e-3)	unprognostic (1.83e-3)	unprognostic (1.10e-1)	unprognostic (1.19e-3)	unprognostic (9.44e-3)	0.6	0.3	3.2	1.4	3.2	0.7	0.9	0.4	2.6	0.9	0.4	5.4	0.3	0.5	2.5	3	0.4	12.7	0.5	1.3	3.2	1.6	0.9	0.3	4.9	0.5	0.7	1.3	2.8	0.5	0.9	5.3	0.8	11.8	1.5	0.4	0.3	0.5	0.3	0.6	0.5	0.4	0.5	0.9	0.4	0.3	15.7	2.1	0	0.7	0	0.3	0.4	0.4	0.9	1.1	2.5	0.5	0.6	0.4	0	0.5	0.6	0.4	2.2	0.3	1.4	2.8	0	0	0	0.3	0.2	1.4	0.7	0.2	0	0.5	0.3	0.5	0.1	0.2	0.4	0.8	0.8	0.5	0.4	1.4	1.7	0.4	1.1	0.2	0.8	0.3	1.5	1	0	1.7	0.7	1.1	0.6	0.8	0.3	0.2	0	2.4	0.6	0.8	1.1	0.5	0	1.2	4.2	1.7	0.6	0.2	0.3	0.2	0.3	0.4	0.2	0.4	0.1	0.3	0.4	2.5	0.5	0.1	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.9	0.3	0.3	0.9	0.6	0.1	1.1	0.2	0	3.2	3.2	0.4	2.6	3.2	1.6	0.7	1.3	11.8	2.1
NEK6	SID6-1512	ENSG00000119408	NIMA related kinase 6	Q9HC98	9	124257606-124353307	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HMC-1: 65.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB045993: AB_2150651, HPA056828: "	unprognostic (6.27e-2)	unprognostic (1.02e-2)	unprognostic (4.15e-2)	unprognostic (1.65e-2)	unprognostic (5.22e-2)	unprognostic (2.47e-2)	unprognostic (3.13e-3)	unprognostic (2.13e-2)	unprognostic (2.38e-1)	unprognostic (3.30e-2)	unprognostic (1.38e-3)	unprognostic (6.53e-2)	unprognostic (5.03e-3)	unprognostic (1.97e-1)	prognostic unfavourable (7.66e-4)	unprognostic (5.27e-2)	unprognostic (4.77e-3)	14.8	5.3	26.1	22.2	29.1	12.8	18.8	7.2	21.2	20.5	15.6	13.4	4.3	12.5	9.2	7.5	6.8	8.5	18.4	7	17.1	16.6	12.9	51.9	17	18.1	19.4	13.3	11.2	20.5	1.6	6.4	21.4	14.7	14.8	16.6	18.5	16.9	13.2	5.5	5.1	18.2	23.4	13	11.3	19	5.8	12.9	4	6.3	1.9	22	17.7	10.1	21.9	11.5	29	18.8	8.3	3.8	7.6	7.7	12.7	12.3	4.8	23.4	30.4	15.3	9.7	15.6	15.1	12.6	12.1	14.5	9.4	15.6	18.8	1.5	6.3	28.3	10.3	10.3	5.6	25.9	10.7	21.1	27.9	4.6	65	40.6	4.6	14.3	14.9	16.4	4.6	0.4	27	8.1	0.2	5.1	3.1	11.6	10	9.2	4.8	16.2	2.8	5.5	1.9	3.2	6.1	13.8	13.1	19.1	32.1	11.1	11.2	7.6	6.6	2.1	2.6	5.4	13.9	10.6	14.7	10.2	18.8	29	3.8	12.3	2.4	21.9	2.3	3.2	11.5	9	0.4	1.6	23.4	8.3	14.7	10.6	2.8	7.6	26.1	29.1	7.2	21.2	17.1	16.6	19.4	13.3	14.7	12.9
NEK7		ENSG00000151414	NIMA related kinase 7	Q8TDX7	1	198156963-198322420	"Enzymes, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		BJ: 83.7;fHDF/TERT166: 113.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	unprognostic (2.08e-1)	unprognostic (2.98e-2)	unprognostic (1.65e-1)	unprognostic (5.38e-2)	unprognostic (4.26e-2)	unprognostic (3.00e-2)	unprognostic (2.14e-2)	unprognostic (5.47e-2)	unprognostic (4.77e-2)	unprognostic (3.21e-1)	unprognostic (1.46e-3)	unprognostic (2.82e-1)	unprognostic (1.13e-2)	unprognostic (1.26e-2)	unprognostic (1.74e-1)	unprognostic (2.05e-2)	unprognostic (1.56e-1)	31.7	31.4	24.9	15.2	23	5.6	23.7	7.8	15.6	19.3	20.6	25.5	13.7	11.3	24.5	11.4	18.7	12.8	15.1	74.7	23.9	20.4	16.1	16	22.3	14.9	26.8	13.4	17.2	11.1	14.6	17.6	40.5	18	20	13.2	11.8	13.5	21.3	29.9	10.6	15.8	30.9	34.9	16.4	11.7	9.5	22.6	18	14.9	12.8	12.5	27.4	20.7	1.6	2.1	6.1	2.2	3.8	14.7	1.4	7	1.8	2.2	0.9	5.9	6.8	2.6	83.7	35	34.1	16.2	3.4	7	2.5	6	113	4.3	3.4	4.5	34.5	7.9	4.9	3.4	8	1.4	7.1	5.8	7.1	4.2	3.9	22.4	6.7	6.4	2.7	6.3	15.6	2.2	5	3.4	1.2	1.4	2.6	5.6	4.4	5.8	3.6	1.4	2.6	13.9	8	9.3	5.9	5.3	14.2	9.6	8.1	27.4	8.7	4.4	4	1.7	4.2	5.3	7.4	1.9	2.2	3	3.2	1.9	14.7	1.3	3.6	4.6	2.1	1.6	2.9	3.6	6.1	3.8	1.7	1.4	6	1.4	24.9	23	7.8	15.6	23.9	20.4	26.8	13.4	18	22.6
NEK8	NPHP9	ENSG00000160602	NIMA related kinase 8	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease mutation, Nephronophthisis"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		plasmacytoid DC: 14.7	Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA040661, HPA040679"	Approved									"HPA040661: AB_10794065, HPA040679: AB_10796226"	unprognostic (2.63e-1)	unprognostic (4.57e-2)	prognostic unfavourable (6.98e-4)	unprognostic (6.25e-2)	unprognostic (2.23e-2)	unprognostic (5.93e-3)	unprognostic (6.48e-2)	prognostic favourable (4.52e-4)	unprognostic (7.85e-2)	unprognostic (1.37e-1)	unprognostic (1.51e-3)	unprognostic (1.55e-1)	unprognostic (4.87e-3)	unprognostic (4.61e-2)	unprognostic (3.58e-1)	unprognostic (1.75e-1)	unprognostic (4.67e-3)	3.5	4.6	2.9	11.9	4.5	2	4.3	1.7	4.9	5.3	4	4.7	1.4	4.2	2.1	5	4.8	5.9	4.4	1.6	2.9	1.9	10.4	6.9	5.7	7.8	2.3	2.1	4.4	6.4	8.5	9.7	8.7	5.6	5.6	3.2	5.2	5.3	4.1	0.9	4.4	6.5	1.7	3	8.4	4.9	4.9	1.4	4.8	10.7	3.5	15.6	4.5	3	4.7	14.7	3.2	1	1.3	1.1	0.8	2.1	3.5	3.7	2.9	2	2.2	11.4	1	2.2	1.4	1.8	5.4	5.1	13.2	3.7	2.8	3.9	5.4	4.9	1.4	3.5	6.6	2.9	5.6	10	3.5	1.8	3.9	5.1	1.9	2.6	6.1	0.9	4.3	1.3	1.5	4.7	1.8	3.4	3.4	1.1	4.9	2.4	5.8	7.3	5.8	6.7	1.6	3.1	6.5	1.6	9.7	2.4	0.9	1.3	2.4	1.7	1	1.5	1.7	8.9	2.1	1.6	3.2	3.2	0.9	1.2	0.8	0.4	0.9	3	0.7	0.7	0.1	4.7	0.8	1.1	0.5	1.3	1	14.7	0.5	0.8	2.9	4.5	1.7	4.9	2.9	1.9	2.3	2.1	5.6	1.4
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	NIMA related kinase 9	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001405	Approved		Approved	Mitochondria		190000	190000	Mitochondria		HPA001405: AB_1079467	unprognostic (1.00e-1)	unprognostic (5.37e-2)	unprognostic (9.97e-3)	unprognostic (2.64e-2)	unprognostic (3.86e-1)	unprognostic (2.77e-1)	unprognostic (1.12e-1)	unprognostic (5.60e-3)	unprognostic (2.81e-1)	unprognostic (1.15e-1)	prognostic favourable (5.63e-4)	unprognostic (8.58e-2)	unprognostic (1.36e-2)	unprognostic (4.54e-2)	unprognostic (9.22e-2)	unprognostic (2.61e-1)	unprognostic (1.57e-2)	17	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14	25	13.8	15.6	20	15.9	23.5	11.4	8.7	14	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17	14.1	14.4	23.6	18.7	6	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12	15.2	16.9	19.5	26.8	17.3	16.5	11.6	8.1	7.9	10.1	8.9	17.4	0.1	11.3	14	11.6	6.4	9	14.2	6.7	8.5	12	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	10.1	9.6	11.3	9.7	1.1	10.8	5.2	9	6.1	17.5	19.4	9	6.1	12.4	7.3	18.7	13.3	6.4	12.7	15.8	14.8	15.2	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9	8.7	8.3	7.5	5.4	5.8	4.2	5	5.9	2.8	4.8	3.9	6.4	6	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13	18.2
NIM1K	"MGC42105, NIM1"	ENSG00000177453	NIM1 serine/threonine protein kinase	Q8IY84	5	43192071-43280850	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in many	5	brain: 23.7;pituitary gland: 9.7	Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HDLM-2: 4.8;PC-3: 5.5;U-87 MG: 6.0	Cancer enriched	Detected in some	11	glioma: 6.2	Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 3.2	Group enriched	Detected in many	10	dendritic cells: 1.2;T-cells: 3.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007695	Uncertain		Approved	Cytosol				Cytosol		HPA007695: 	unprognostic (7.97e-2)	unprognostic (9.79e-2)	unprognostic (8.74e-2)	unprognostic (2.10e-1)	unprognostic (1.67e-1)	unprognostic (2.17e-1)	unprognostic (2.40e-1)	unprognostic (4.35e-2)	unprognostic (1.35e-1)	unprognostic (4.28e-2)	unprognostic (8.84e-4)	unprognostic (1.25e-1)	unprognostic (1.55e-5)	unprognostic (2.18e-1)	unprognostic (2.66e-1)	unprognostic (6.46e-3)	unprognostic (4.98e-3)	1.4	3.5	9.4	1.6	10.9	0.9	1.3	4.9	23.7	1.6	1.4	6.3	0	1.1	1.2	1.6	1.6	1.4	1.5	1.8	8.7	7.7	1.4	1.2	3.6	1.2	5.6	5.8	1.2	1.5	1.2	9.7	1.8	6.4	1.4	1.7	1.7	2.3	2.4	2	1.8	1.2	1.3	4.9	1	3	1.4	8.1	0	2.7	0	1	1.1	0.8	0.1	1.2	0	0	0.2	3.2	0	0.2	0.6	0.1	0.1	0.9	0.5	0	1	3.1	1.1	4.4	0.1	0	0.4	0.6	0.8	0.3	0.6	0	2.7	4.8	0.3	0.1	0.6	0.2	1.6	0.2	0.6	1.9	0.1	0.5	0	0	0.2	0.3	0.9	0.2	0.3	0.2	0	5.5	0.2	0.3	0.5	0.1	0.7	0.9	0.1	1.7	0.5	0.3	0.4	1.5	0	0.9	0.8	0.7	0.7	1.6	0.4	0.3	6	0.5	0.7	0	0	0	0	0	0	0.1	0.8	0	0.6	0	0	0	0	0.2	0	1.2	3.2	0	9.4	10.9	4.9	11.6	8.7	7.7	5.6	5.8	6.4	8.1
NLK		ENSG00000087095	Nemo like kinase	Q9UBE8	17	28041737-28196381	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in single	32	basophil: 17.6	Lineage enriched	Detected in single	32	granulocytes: 17.6	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA018192, HPA056511"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions"				Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: "	unprognostic (7.19e-2)	unprognostic (1.98e-1)	unprognostic (5.54e-2)	unprognostic (5.64e-3)	unprognostic (2.11e-1)	unprognostic (1.29e-1)	unprognostic (1.67e-2)	unprognostic (2.59e-3)	unprognostic (2.72e-2)	unprognostic (4.23e-3)	unprognostic (1.07e-2)	unprognostic (1.09e-2)	unprognostic (5.29e-2)	unprognostic (1.66e-1)	unprognostic (3.92e-1)	unprognostic (5.27e-2)	unprognostic (6.57e-2)	6.4	30.5	19.4	10.9	14.1	7.4	7.5	7.5	38.2	6.2	6.7	8.3	14.4	8.3	5.7	8.8	4.5	5.1	8.2	8.5	18.2	12	13	8.2	7.1	11.7	15.2	23.6	4.6	11.5	20.8	9.4	9.1	7	6.7	7.1	12.7	5.8	17.4	4.9	4.5	8.3	4.6	15.3	10.1	7	17.4	7.5	10.9	13.2	3.7	11	7.2	4.4	0.5	0.3	17.6	0.3	0.1	0.5	0.2	4.6	5.4	13	4.5	2.8	3.6	5.7	4.6	4.7	7.8	6	27	4.2	6.3	7.1	3.8	4.4	9.1	8.5	9	14.5	5.8	24.7	5	4.6	4.7	5.2	25.5	4.7	5.2	5.1	6.1	9.1	9.5	7.6	7.1	5.4	13.3	6	5	2.7	11.2	8.4	4.6	14.1	5.7	9.5	3.5	7.1	6.8	29	10.6	8.3	9.3	5.6	7.5	4.6	9.3	9	8.6	6.1	5.4	5.6	6.1	17.6	0.2	0.2	0.3	0.3	0.1	0.5	0.4	0.4	0.2	0.3	0.2	0.5	0.1	0.1	0.3	0.3	0.4	0.2	19.4	14.1	7.5	38.2	18.2	12	15.2	23.6	7	7.5
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	Natriuretic peptide receptor 1	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	cGMP biosynthesis	"Lyase, Receptor, Vasoactive"	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		breast: 98.4	Cell line enriched	Detected in some	6	ASC diff: 59.1	Cancer enhanced	Detected in all		ovarian cancer: 39.2	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Region enriched	Detected in many	5	olfactory region: 23.0	Region enhanced	Detected in many		olfactory region: 11.1	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	HPA031087: AB_10601975	unprognostic (2.54e-1)	unprognostic (3.03e-3)	unprognostic (6.31e-2)	prognostic unfavourable (3.97e-4)	unprognostic (1.55e-1)	unprognostic (6.60e-2)	unprognostic (1.54e-2)	unprognostic (2.03e-1)	unprognostic (2.46e-1)	unprognostic (3.27e-2)	prognostic favourable (2.49e-4)	unprognostic (1.27e-1)	unprognostic (6.69e-2)	unprognostic (1.16e-2)	unprognostic (1.09e-1)	unprognostic (4.06e-1)	unprognostic (1.74e-2)	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2	2	9	6.9	3.4	4.6	15.6	2.2	1.2	5	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0	0.5	0	0.3	0	0	0	0	0.4	0	0	59.1	0.2	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0.2	0	9.8	0	7.1	0	0	0.1	0	0.1	0	1.2	0	0	0	0	0	0	0.2	0	5.5	0	0	0.7	0	0	0	0.6	0	2	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0	2.5	0.2
NPR2	"AMDM, ANPb, ANPRB, GUCY2B, NPRB"	ENSG00000159899	Natriuretic peptide receptor 2	P20594	9	35792154-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease mutation, Dwarfism, FDA approved drug targets"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 32.7	Cell line enhanced	Detected in many		ASC diff: 27.2;ASC TERT1: 20.3;BJ hTERT+: 16.6;HSkMC: 20.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		plasmacytoid DC: 3.1	Group enriched	Detected in many	6	dendritic cells: 3.1;T-cells: 2.1	Low region specificity	Detected in all			Low region specificity	Detected in all														unprognostic (2.93e-2)	unprognostic (8.22e-3)	unprognostic (9.25e-3)	unprognostic (3.59e-2)	unprognostic (6.13e-2)	unprognostic (2.63e-2)	unprognostic (1.41e-1)	unprognostic (1.56e-1)	unprognostic (1.56e-1)	unprognostic (2.40e-1)	unprognostic (3.06e-1)	unprognostic (1.49e-1)	unprognostic (3.99e-2)	unprognostic (6.99e-3)	unprognostic (7.10e-2)	unprognostic (3.24e-1)	unprognostic (7.86e-2)	9	4.8	3.8	1.9	6.4	0	7.2	32.7	11.2	29.2	7.8	1.8	4.4	1.8	22.6	9.8	5.3	7.6	5.7	7.6	3.7	4.2	3.7	8.4	4.7	2.3	2.5	5.1	8	1.3	2.7	7.9	7.1	11.8	8.3	4	8.3	3.3	9.5	7.7	6.2	3.7	17.1	3.9	2.6	4.5	5.5	4	0.9	3.2	2.4	2	6.2	8.9	0.4	3.1	0	0	0.1	2.1	0.1	0	1.6	1.9	0	27.2	20.3	1.2	7.5	16.6	6.1	6.6	4	2.7	1.1	2	14.7	0.7	2.3	0.2	5.5	1.2	0.7	1	1.7	1.9	14.8	0.1	0	20.1	1.1	6.8	0.5	10	0.5	0.1	11.4	0.5	0.3	0.4	2.5	2.8	1.3	0.1	0.5	0.9	0.8	0.5	0.6	0.2	0	0.3	0.1	0	6.4	6.5	5	2.1	0.7	0.2	0.3	2.9	8.3	0.3	3.6	0	0	0	1.1	0	0	0.4	1.2	0.6	0	0	0.5	0.4	0	0.1	0	3.1	2.1	0.1	3.8	6.4	32.7	11.2	3.7	4.2	2.5	5.1	11.8	4
NRBP1	"BCON3, MADM, MUDPNP, NRBP"	ENSG00000115216	Nuclear receptor binding protein 1	Q9UHY1	2	27427790-27442259	"Enzymes, Predicted intracellular proteins"				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA029527, CAB033078"	Supported		Supported	Cytosol		38000	38000	Cytosol		"CAB033078: AB_2154375, HPA029527: AB_10601379"	unprognostic (4.95e-3)	unprognostic (1.29e-1)	unprognostic (1.09e-1)	unprognostic (1.38e-1)	unprognostic (3.62e-2)	unprognostic (3.95e-1)	prognostic unfavourable (2.22e-5)	unprognostic (7.36e-2)	unprognostic (1.44e-1)	unprognostic (6.11e-2)	unprognostic (3.13e-1)	unprognostic (2.60e-1)	prognostic unfavourable (5.84e-5)	unprognostic (1.26e-1)	unprognostic (2.69e-1)	unprognostic (2.75e-2)	unprognostic (3.48e-3)	30.8	27.6	20.9	30.8	25.9	49.8	29.1	31.6	38.4	36.3	35.2	21.3	27.5	27.3	40.6	34.2	52.2	28.7	29.9	27.7	18	26	24.6	38.8	27.1	25.6	21.5	26.2	36.6	28.2	23	27	58.7	33.9	30.3	25.4	30.6	31.6	34.7	62.2	36.6	31.5	40.7	18.3	29.1	28.9	46.9	20.6	24.4	25.4	39.4	37.6	34.2	37.7	20.6	29.1	57.9	37.2	27.5	33.7	32.9	30	30.2	25	33.1	38.7	38.7	30.4	28.6	36.1	41	31.9	30.5	12.3	8.7	21.5	45.5	20.8	24.8	25.8	26.5	17	15.4	17.3	12.3	40	32.5	9.7	23.3	31.6	32.5	41.8	28	45	9.7	13.8	35.9	45.3	12.7	23.3	31.4	19.1	9.9	53.4	9.7	29.1	20.9	6.7	19	33.9	24.5	17.8	13.4	10.8	35.5	36.2	36	21.6	23.1	29.2	29	10.4	28.3	16.9	18.1	53.6	28.5	57.9	33.2	37.2	29.2	20.6	28.6	29.9	29.1	18.1	26.3	27	38.2	27.5	33.3	18.6	33.7	32.9	20.9	25.9	31.6	38.4	18	26	21.5	26.2	33.9	20.6
NRBP2	DKFZp434P086	ENSG00000185189	Nuclear receptor binding protein 2	Q9NSY0	8	143833594-143840974	"Enzymes, Predicted intracellular proteins"	Neurogenesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 54.1	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in single		MAIT T-cell: 1.5	Low lineage specificity	Detected in single							Low region specificity	Detected in all			"CAB020944, HPA029051, HPA029052"	Approved		Approved	Cytosol				Cytosol		"CAB020944: , HPA029051: , HPA029052: AB_10602714"	unprognostic (1.84e-1)	unprognostic (4.66e-2)	unprognostic (2.54e-2)	unprognostic (1.53e-3)	unprognostic (1.01e-1)	unprognostic (2.00e-2)	unprognostic (4.03e-1)	unprognostic (2.86e-1)	unprognostic (3.97e-1)	unprognostic (1.08e-1)	unprognostic (2.24e-1)	unprognostic (2.47e-2)	prognostic unfavourable (2.01e-5)	unprognostic (3.86e-2)	unprognostic (3.98e-1)	unprognostic (4.56e-2)	unprognostic (2.04e-1)	18.5	10.7	21.6	6.8	21.1	1.9	10	17.5	32.6	7.6	13.3	47.5	8.7	8.8	11.2	10	9.9	14.6	11.3	15.2	23.5	14.9	14	18.9	14.9	4.9	30.9	23.6	10.7	10.4	8.4	8.8	6.1	30.2	17.8	6.9	10.1	22.1	15.5	7.6	23	9.3	12.3	54.1	7.5	10.1	6.1	27.5	1	9	3.6	3.8	8.2	7.8	0.5	0	0	0.4	0	1.5	0.3	5.8	7.3	6.7	8.2	10.4	16.1	1.5	12	5.2	4.3	6.4	1.7	5.5	0.6	3.2	14.3	9.5	3.9	4.2	1.7	7.1	2.9	1.1	19.4	3	10.7	0	2.8	20.6	9.9	2.2	2.2	6	3.7	7.8	9.2	2.5	0.5	0.3	2.5	4.1	2	6.2	2.7	5.9	2	2.4	4.9	15.3	7.8	6	11.2	0.4	13.9	2.6	7.9	12.4	3.8	4.3	0.2	0.1	13.8	2.4	3.5	0	0.4	0	0.2	0.2	1.5	0	0.2	0	0	0.5	0.1	0	0	0	0	0	0.1	0.3	21.6	21.1	17.5	21.4	23.5	14.9	30.9	23.6	30.2	27.5
NRK	DKFZp686A17109	ENSG00000123572	Nik related kinase	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ovary: 42.2;placenta: 64.8	Cell line enhanced	Detected in some		fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9	Cancer enriched	Detected in some	8	testis cancer: 6.1	Region enriched	Detected in single	10	cerebellum: 4.3	Not detected	Not detected			Not detected	Not detected			Region enriched	Detected in single	28	cerebellum: 16.0	Low region specificity	Detected in many			HPA017238	Uncertain		Approved	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA017238: AB_1854645	unprognostic (2.64e-4)	unprognostic (9.82e-2)	unprognostic (5.98e-3)	unprognostic (5.52e-2)		unprognostic (3.87e-2)	unprognostic (2.29e-2)	unprognostic (1.12e-1)	unprognostic (2.86e-2)	unprognostic (1.35e-2)	unprognostic (6.08e-2)	unprognostic (3.24e-2)	unprognostic (5.28e-3)	unprognostic (1.47e-3)	unprognostic (1.14e-1)	unprognostic (4.28e-2)	unprognostic (6.80e-3)	2.6	12.7	0.4	2.7	0.4	0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0	0.3	0	42.2	0.5	0	2.9	64.8	0.2	22	0.1	0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0	0	0.5	3.1	0.3	1.9	1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	32.4	0	0	0	0	0	0	0	0	0	1	0	0	6.2	0	0	0	1.9	0	0	0	0	0	0	1.2	0	0	7.3	0	19.9	0.4	0	0.1	0	1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0	0.2	0
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	Neurotrophic receptor tyrosine kinase 1	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	adrenal gland: 15.8;blood: 32.3;brain: 28.3	Cell line enriched	Detected in some	4	HMC-1: 41.1	Cancer enhanced	Detected in some		glioma: 1.3	Region enriched	Detected in many	5	pons and medulla: 28.3	Cell type enriched	Detected in single	127	basophil: 32.3	Lineage enriched	Detected in single	323	granulocytes: 32.3	Region enhanced	Detected in some		basal ganglia: 8.2	Low region specificity	Detected in all			"CAB004606, HPA035799, HPA076570"	Approved		Approved	"Vesicles,Cytosol"		140000	140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: , HPA076570: "	unprognostic (5.89e-3)	unprognostic (7.56e-2)	unprognostic (2.74e-2)	unprognostic (5.99e-3)	unprognostic (7.26e-2)	unprognostic (1.43e-3)	unprognostic (1.56e-1)	unprognostic (7.42e-3)	unprognostic (7.63e-2)	unprognostic (1.35e-1)	unprognostic (6.73e-2)	unprognostic (2.29e-2)	unprognostic (3.18e-11)	unprognostic (2.18e-3)	unprognostic (3.79e-2)	unprognostic (1.07e-1)	unprognostic (4.89e-1)	1	15.8	0.5	0.8	6	0.9	0.4	0	0.7	0.9	1.1	0.1	0	0.8	1.6	2	0.7	0.6	2.1	1.5	0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1	2.4	1.5	0.4	0.3	0	0.4	0.7	0.8	0	0	32.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	5.6	0	6.6	0	0	0	0	41.1	0	0	0	0	0	2.1	0.7	0	0	0	1.1	0	0.6	1.2	0	0.1	0	0	0.7	9.4	0	0	0	0	0	0.1	0	0.6	0	0	1.6	0.2	0	0	0	0	32.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	6	0	0.6	0	1.2	2.1	0.6	28.3	1.5
NTRK2	TRKB	ENSG00000148053	Neurotrophic receptor tyrosine kinase 2	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 133.8;thyroid gland: 63.4	Cell line enhanced	Detected in some		AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.6;SH-SY5Y: 13.3	Group enriched	Detected in many	5	glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4	Low region specificity	Detected in all			Cell type enhanced	Detected in single		T-reg: 1.4	Lineage enriched	Detected in single	14	T-cells: 1.4	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007637, CAB010346"	Enhanced		Approved	Cytosol		13000000	13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385"	unprognostic (2.75e-3)	unprognostic (3.48e-2)	unprognostic (1.82e-2)	unprognostic (3.26e-1)	unprognostic (9.26e-2)	unprognostic (2.56e-2)	unprognostic (1.29e-2)	unprognostic (9.16e-2)	unprognostic (6.13e-2)	unprognostic (1.05e-1)	unprognostic (4.25e-2)	unprognostic (2.18e-2)	unprognostic (2.66e-2)	unprognostic (1.20e-2)	unprognostic (1.21e-2)	unprognostic (1.31e-1)	unprognostic (1.39e-3)	19.8	2.7	66.1	2	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0	1.4	3	3.3	5.6	3.7	18.7	5.8	61	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3	2.1	34.1	3.8	3.1	2	8.6	11.9	2	7.2	1.6	3	22.1	6.5	1.4	2.4	34.1	0	63.4	2.6	3.4	3.5	3.8	0	0	0	0	0	1.4	0	0	0	10.4	0	0	0	0	0.8	0.1	0	0	0	1.6	0	0.2	0	3.7	0	0	0	0.2	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	11.6	0.8	0.9	13.3	0	0	0	0	0	0	0	0.2	0	0.5	0	0.1	0	0.4	0	3	0	0	0	0	0	0.6	0	0.6	0.1	0	0	0	0	0	0	0	0	1.4	0	66.1	56.7	15.1	45.6	61	30.7	32.4	41.4	34.1	34.1
NTRK3	TRKC	ENSG00000140538	Neurotrophic receptor tyrosine kinase 3	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 41.8	Cell line enriched	Detected in some	8	U-138 MG: 47.4	Cancer enhanced	Detected in some		glioma: 2.5	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli"		11000000	11000000	Nucleoli	Nuclear membrane	"CAB009233: AB_632555, HPA027484: , HPA048065: "	unprognostic (1.27e-3)	unprognostic (1.24e-2)	unprognostic (1.98e-2)	unprognostic (2.04e-2)	unprognostic (1.65e-1)	unprognostic (3.34e-1)	unprognostic (3.18e-2)	unprognostic (2.23e-2)	unprognostic (2.34e-1)	unprognostic (3.91e-1)	unprognostic (2.88e-1)	unprognostic (1.09e-1)	unprognostic (5.78e-3)	unprognostic (6.45e-3)	unprognostic (1.06e-2)	unprognostic (1.26e-2)	unprognostic (2.49e-3)	20.8	7.4	22	2.5	28.1	1.5	6.2	30.4	41.8	7	4	8.4	1.3	2	12.4	6.7	3.4	9.5	3.9	5.5	22	11.1	5.1	2	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3	13.8	13.7	0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0	0	5.9	1.2	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0.5	0	0.1	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	1.1	0	0	1.2	0	0	0	0.3	0	0	0	0	0	0	0	47.4	0.9	0	0.5	0	0	0	1.4	0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0	22	28.1	30.4	28.9	22	11.1	11.2	18.7	14.7	13.7
NUAK1	"ARK5, KIAA0537, NuaK1"	ENSG00000074590	NUAK family kinase 1	O60285	12	106063340-106140033	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.3;parathyroid gland: 18.6	Cell line enhanced	Detected in many		AF22: 23.0;EFO-21: 23.0;Karpas-707: 16.8;RH-30: 33.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3	Lineage enriched	Detected in single	14	T-cells: 1.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"				Nucleoli fibrillar center	"Nucleoplasm, Microtubules"	HPA057143: 	unprognostic (4.20e-2)	unprognostic (8.42e-2)	unprognostic (3.71e-2)	prognostic unfavourable (9.83e-4)	unprognostic (4.13e-2)	unprognostic (2.34e-1)	unprognostic (1.43e-1)	unprognostic (4.80e-2)	unprognostic (9.91e-2)	unprognostic (4.06e-3)	unprognostic (3.29e-1)	unprognostic (1.31e-1)	unprognostic (1.93e-3)	prognostic unfavourable (4.27e-4)	unprognostic (2.31e-1)	unprognostic (8.70e-2)	unprognostic (4.47e-2)	8.2	1.8	4.2	2	13	0	5.5	9.9	20.1	4.6	1.7	24.3	1.1	1	5.8	1.6	1.9	3.6	2.7	11.3	5.1	3.3	2.5	2.4	4.9	1.5	8.7	8.4	3.2	1.2	18.6	1.9	2.5	7.6	3.6	2.2	2.3	1.8	3.7	9.4	11.6	1.5	6.3	5.5	1.1	1.5	1.3	9.3	1.1	1.8	1.1	1.4	3.4	3.7	0	0	0	0	0	1.4	0	4.9	3.4	23	0.2	9.2	1	10.6	5.7	3.9	4.4	3.3	1.7	0.8	0	23	10.3	4.8	4.8	4.6	2	0	1.3	0	3.6	1.8	1.9	0	0	4.7	3.1	2.5	0.8	8.3	0	16.8	3.1	0.5	0.1	0.2	4.5	1.4	0	33	4	2.5	5.9	2.7	0.1	2.6	0.7	0.2	1.2	0.1	6.2	3.8	12.8	1.4	6.8	0	0	0.3	1.1	0	3.8	0	0	0	0.6	0	0	0	0.3	1.4	0	0	0	1.3	0	0	0	0	0	0	4.2	13	9.9	17.5	5.1	3.3	8.7	8.4	7.6	9.3
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	NUAK family kinase 2	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 42.4	Cell line enhanced	Detected in many		BEWO: 24.3;CACO-2: 12.9;RPMI-8226: 18.7;RPTEC TERT1: 22.2	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in all		neutrophil: 42.4	Group enriched	Detected in all	4	B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7	Not detected	Not detected			Low region specificity	Detected in some			HPA008958	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Cytosol"	Nucleoli fibrillar center	HPA008958: AB_1080040	unprognostic (2.24e-2)	unprognostic (6.33e-2)	unprognostic (1.17e-1)	prognostic unfavourable (3.01e-7)	unprognostic (8.24e-3)	unprognostic (1.58e-2)	unprognostic (3.00e-2)	unprognostic (1.08e-2)	unprognostic (1.74e-1)	unprognostic (9.19e-2)	prognostic favourable (7.94e-6)	unprognostic (3.71e-2)	unprognostic (3.17e-2)	unprognostic (4.90e-2)	unprognostic (5.80e-2)	unprognostic (4.54e-2)	unprognostic (1.61e-1)	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2	1.5	7.5	9.8	9.7	2	0.7	12.9	15.4	0.9	2.7	10.4	2	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.2	12.3	7.5	0.3	0.2	0.3	24.3	2.9	3	8.1	3.3	12.9	0.4	3.7	1.8	0.8	4.5	1.7	4.4	3.5	0	0.2	0	0.7	2.2	5.2	0	0	1.4	3.3	4.7	2.8	0.3	0.5	0.9	1.5	0.5	0	0	4.8	0.4	0	0.5	18.7	22.2	0	1.1	0.1	0.8	3.5	0.3	3.6	0	0.9	2.9	1.4	0.3	4.6	6.6	1	2.3	0.4	0	1.1	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1	5.5	1.5	2	2.4
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	skeletal muscle: 180.2;tongue: 48.4	Cell line enhanced	Detected in many		HeLa: 16.0	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in some		naive CD4 T-cell: 3.2	Low lineage specificity	Detected in many			Low region specificity	Detected in single							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	unprognostic (8.47e-3)	unprognostic (1.56e-1)	unprognostic (9.99e-2)	prognostic unfavourable (1.64e-4)	unprognostic (5.30e-3)	unprognostic (6.36e-2)	unprognostic (4.54e-3)	unprognostic (1.82e-1)	unprognostic (8.81e-2)	unprognostic (1.93e-2)	unprognostic (3.38e-1)	unprognostic (1.45e-1)	unprognostic (1.57e-3)	unprognostic (1.34e-1)	unprognostic (1.77e-1)	unprognostic (3.53e-1)	unprognostic (1.16e-2)	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1	0.6	21.2	0.5	0.7	1.6	0.5	1	1	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8	4.5	0.2	0.1	5.6	1.5	0.5	1	0.9	2	2.1	5.7	8.1	0.5	1	0.4	1.1	0.2	2.1	5.1	1.9	16	0	2	1.3	6.1	3	1	0.4	0.2	0.4	5.3	1.3	0.3	5	2	1.6	8.8	1.7	8.1	0.1	1.3	4.6	1.5	3	9	0.2	2.9	1.1	8	3.7	0.7	0	9.3	0.2	0.1	4.7	0.9	1.4	0	0.8	2.1	0.1	0.4	0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	Oxidative stress responsive 1	O95747	3	38165089-38255488	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		21000000	21000000	Cytosol		"CAB017181: , HPA008237: AB_1079540"	unprognostic (2.16e-1)	unprognostic (2.36e-2)	unprognostic (1.79e-2)	unprognostic (4.55e-3)	unprognostic (9.89e-2)	unprognostic (1.97e-2)	unprognostic (3.53e-3)	unprognostic (4.05e-2)	unprognostic (4.44e-1)	unprognostic (6.06e-2)	unprognostic (3.95e-3)	unprognostic (1.88e-2)	unprognostic (1.87e-3)	unprognostic (1.56e-1)	unprognostic (3.14e-2)	unprognostic (1.71e-1)	unprognostic (6.99e-3)	17.6	16.8	9.4	18.3	13.4	24.2	15.9	17.4	14.9	16.8	15.4	9.2	35.7	12.4	14.9	14.7	31.6	11.6	18.9	15.5	11.9	9	18.3	17.6	14.6	13.9	13.6	9.3	16.7	12.3	23.7	15.3	21.4	12.3	16.5	16.8	13	15.1	23.9	32.6	17.4	21.4	17	12.9	15.8	14	11.2	13.2	26.2	14.2	24.1	19.6	23.5	19.2	2.3	4.4	10.1	4.8	5	4.7	1.6	17.5	8	16.1	11.2	11.2	13	18.3	15.6	21.4	22.5	24.5	10.3	11.5	19.5	7.9	18.6	10.9	21.6	16	29.8	20.6	8.8	21.3	17.1	11.3	13.5	13.1	13	10.3	18.9	20.8	33.7	14	16.1	11.2	38.5	4.9	25.3	9.5	16.9	9.6	8.8	13.5	15	13.9	13.4	8.4	12.9	17	43.2	10.6	14.2	8.6	12.7	14.2	14.1	21.5	23	8.6	10.2	14.3	19.4	16.4	28.2	10.1	2.8	6.1	3.3	4.8	3.5	1.9	4	3.1	4.4	2.3	3	3.7	5.5	5	4.1	2.5	4.7	1.6	9.4	13.4	17.4	14.9	11.9	9	13.6	9.3	12.3	13.2
PAK1		ENSG00000149269	P21 (RAC1) activated kinase 1	Q13153	11	77321707-77474635	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 70.0;brain: 71.4	Cell line enhanced	Detected in many		U-266/70: 51.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	9	classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4	Group enriched	Detected in all	11	dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		200000	200000	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	unprognostic (1.15e-2)	unprognostic (3.23e-2)	prognostic favourable (5.87e-4)	unprognostic (1.30e-1)	prognostic unfavourable (1.15e-4)	unprognostic (6.62e-2)	unprognostic (8.19e-3)	unprognostic (4.84e-2)	unprognostic (1.05e-1)	unprognostic (1.22e-3)	unprognostic (1.86e-2)	unprognostic (2.76e-1)	unprognostic (1.02e-1)	unprognostic (6.91e-2)	unprognostic (1.57e-1)	unprognostic (4.00e-3)	unprognostic (1.52e-2)	5.4	6	30.5	13.8	39.5	22.9	7.8	49.1	71.4	9.8	18.2	8.4	2.3	18.2	9.1	13.3	9.9	9.8	13.2	5.3	19	16.9	11.3	6	6.9	7.5	12.8	40.6	10.4	9.2	11.8	10.8	11.9	39.2	12.2	20.2	5.4	10.4	8.8	34	6.7	18.9	11.6	7.8	11.7	17.1	11.1	6.6	7.6	17.7	3.9	9.4	10.5	10.4	2.7	42.3	70	30.4	4.3	2.4	12.2	11.8	8	17.4	7.8	7.1	11.9	13.9	13.6	9.7	12.9	15.2	11.4	15.9	10.6	5	11.7	6.1	12.1	14.4	20.4	12.2	9.8	11.2	5.4	0.7	4.7	18.9	16.6	8.8	8.7	15.1	22.5	3	7.4	18.7	23.4	0.8	12	8.7	25.7	6.9	18.5	22.5	0.4	3.3	9.9	7.5	7.4	7.3	3.1	5.7	13.9	8.6	0.2	8.6	14.9	45.9	11.3	51.4	26.4	7	7.2	12.6	9.3	0.3	29.3	45	1.9	28.7	1.5	2.7	1.4	1.8	42.3	1.9	1.3	2.4	70	4.3	30.4	3.6	1.1	12.2	30.5	39.5	49.1	71.4	19	16.9	12.8	40.6	39.2	6.6
PAK2	"PAK65, PAKgamma"	ENSG00000180370	P21 (RAC1) activated kinase 2	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB007794	Approved		Approved	"Nucleoplasm,Vesicles"		590000	590000	"Nucleoplasm, Vesicles"		CAB007794: AB_562363	unprognostic (1.03e-2)	unprognostic (6.34e-2)	unprognostic (2.52e-1)	unprognostic (2.50e-2)	unprognostic (1.32e-1)	unprognostic (1.80e-1)	unprognostic (5.18e-3)	unprognostic (1.85e-2)	unprognostic (7.97e-2)	unprognostic (1.09e-1)	prognostic unfavourable (3.36e-4)	prognostic unfavourable (9.58e-4)	unprognostic (1.30e-3)	unprognostic (4.57e-2)	unprognostic (1.25e-2)	unprognostic (1.70e-2)	unprognostic (3.39e-1)	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23	27.8	17.4	19	22.6	19.2	23.4	17.9	20.7	29	22.6	22	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13	27.6	22.8	17.7	23	12.9	19.6	21.2	34.2	16.3	25.2	23	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7	35.2	12.6	17.8	13	12.6	16.7	26.4	17.9	14.8	19.5	17.8	29.9	18.1	22.6	51.2	18.1	18.1	18.8	17	30.2	10.1	9.1	33.5	14.5	23.5	25.6	32.5	32.2	13.3	14	17.4	37.1	19.2	16.1	28.2	18.9	37.2	30.9	16.8	10.6	19	28.3	10.1	20.5	17	24.8	10.4	11.8	23.9	16.9	13.5	59.3	23.6	19.8	16.2	9	16.9	26.3	19.2	33.9	55.7	13.4	32.6	15.3	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7	22.4	23.5	17.4	20.7	22.6	22	26.8	13.5	22.8	24.8
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	P21 (RAC1) activated kinase 3	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 26.2;pancreas: 46.5;pituitary gland: 37.2	Cell line enhanced	Detected in some		EFO-21: 9.7;HAP1: 8.7;HDLM-2: 10.9;NTERA-2: 8.5;SCLC-21H: 11.1;SH-SY5Y: 6.9;U-2197: 6.7;U-251 MG: 11.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enriched	Detected in single	6	MAIT T-cell: 4.3	Lineage enriched	Detected in single	7	T-cells: 4.3	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA044791, HPA060219"	Approved		Approved	Cytosol				Cytosol		"HPA044791: , HPA060219: "	unprognostic (1.80e-2)	unprognostic (1.54e-1)	unprognostic (1.80e-2)	unprognostic (3.27e-4)	unprognostic (2.46e-1)	unprognostic (5.63e-3)	unprognostic (7.29e-2)	unprognostic (3.23e-2)	unprognostic (1.27e-2)	unprognostic (3.01e-1)	unprognostic (6.80e-3)	unprognostic (1.66e-1)	unprognostic (1.89e-4)	unprognostic (5.71e-3)	unprognostic (6.81e-2)	unprognostic (1.06e-1)	unprognostic (3.30e-2)	2	6.8	17.6	2.5	17.5	1	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3	7.1	2.4	2	1.4	6.1	5.8	2.9	3	3.6	1.9	0	7.7	0	1.7	2	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0	0	0.6	1.3	0	0	0	0	0.2	0.3	0.9	0	0	0	0	9.7	1	0	8.7	0.5	1.2	10.9	0.3	0	1	0	0	0	0.3	0.2	0	0.1	2	0	0	0.4	0	0	0.1	0.1	8.5	1.9	0.1	4	0	0.8	0	11.1	6.9	0	0.4	0	0	0	0	0.6	4.3	6.7	11.6	0	0.1	0.1	1.2	0	0.1	0.6	0.1	0.1	0.1	0	4.3	0	0.7	0.4	0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9
PAK4		ENSG00000130669	P21 (RAC1) activated kinase 4	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		A549: 44.6;MCF7: 49.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	unprognostic (1.71e-1)	unprognostic (2.84e-1)	unprognostic (5.86e-2)	unprognostic (2.84e-2)	unprognostic (1.93e-1)	unprognostic (8.51e-2)	unprognostic (3.56e-3)	unprognostic (1.13e-3)	unprognostic (3.90e-2)	unprognostic (4.04e-2)	unprognostic (7.29e-2)	prognostic unfavourable (9.85e-4)	prognostic favourable (5.29e-5)	unprognostic (2.39e-1)	unprognostic (7.05e-2)	unprognostic (2.02e-1)	unprognostic (4.85e-2)	6.8	11.1	11	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17	23	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.6	44.6	6.6	10.1	2.1	2.2	20.1	8.4	3.4	5.7	5.7	29.2	15	4	12.8	5.3	6.5	3.6	6.7	2.1	10.7	10.2	4.8	8.1	14.2	3.4	4.8	7	2.7	3	5.3	3.8	7.4	9.5	3.2	3.4	49.1	5.1	5.3	12.1	10.7	5.2	5.2	3	5.5	19.4	21.3	14.7	8.6	38.3	9.5	17	8	12.3	9.7	16.7	11.1	15	3.6	3.4	3.3	11.9	2.9	11.6	1	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3	1.9	11	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5
PAK5	"KIAA1264, PAK7"	ENSG00000101349	P21 (RAC1) activated kinase 5	Q9P286	20	9537389-9839041	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	brain: 30.3	Group enriched	Detected in some	9	SCLC-21H: 10.0;SH-SY5Y: 3.7	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA020444	Approved		Approved	Nucleoplasm				Nucleoplasm		HPA020444: AB_1854947	unprognostic (5.14e-5)			unprognostic (3.35e-1)	unprognostic (1.05e-1)	unprognostic (8.63e-2)		unprognostic (3.21e-1)		unprognostic (3.04e-1)	unprognostic (2.25e-4)	unprognostic (3.76e-1)	unprognostic (2.56e-2)	unprognostic (3.83e-1)	unprognostic (3.35e-2)	unprognostic (6.04e-2)	unprognostic (4.58e-1)	0.5	5.2	5.7	0.6	11.7	0.5	1.6	30.3	19.6	0.8	0.6	0.8	0	0.7	1	2.2	1	0.7	3.4	0.6	4	3.3	1	2.3	0.7	0.6	1.6	8.8	0.6	3.5	0.5	2	0.6	5.3	1.6	0.6	0.6	1.2	1.6	0.6	1.6	0.6	0.6	1.2	0.6	1.2	1	1.7	0	0.6	0	0.6	0.5	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.4	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	10	3.7	0	0	0	0	0.1	0	0	0.2	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0	0	0.6	0.2	0	0	0	0	0.2	0	5.7	11.7	30.3	13.6	4	3.3	1.6	8.8	5.3	1.7
PAK6	PAK5	ENSG00000137843	P21 (RAC1) activated kinase 6	Q9NQU5	15	40238759-40277487	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		skin 1: 22.2	Cell line enhanced	Detected in many		CACO-2: 14.5;HaCaT: 22.5;hTCEpi: 13.8;SK-BR-3: 7.6	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many											HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"				"Nucleoplasm, Nucleoli fibrillar center"	Cell Junctions	HPA031124: AB_10601044	unprognostic (1.85e-3)	unprognostic (2.15e-1)	unprognostic (3.33e-3)	unprognostic (7.79e-3)	unprognostic (7.08e-3)	unprognostic (9.57e-2)		unprognostic (2.71e-1)	unprognostic (7.73e-2)	unprognostic (1.34e-2)	unprognostic (7.13e-3)	unprognostic (4.04e-2)	unprognostic (8.87e-3)	unprognostic (1.72e-1)	unprognostic (1.79e-1)	unprognostic (7.37e-3)	unprognostic (3.34e-2)	0.3	5.3	14.7	0.8	18.4	0.8	2.3	11.3	20.1	3	1.3	1.6	2.5	1.4	1	1.1	15.8	4.3	1.4	7.9	11.6	5.2	3.4	0.4	2.6	1	3	10.9	0.6	7.4	12.9	6.4	8.1	2.1	3.6	1.2	0.3	3.4	7.5	3.5	22.2	1.4	0.8	1.2	1	3.6	12.8	2.2	0	7.4	8.5	5.1	3	5.1	1.4	0.7	2.9	0.7	2	5.5	1.2	2.6	0	0.2	0.1	0	0	4.3	0	0.1	0.6	0.4	14.5	2	0.1	2.3	0	22.5	3.2	4.8	0.2	0.1	0.7	0	1.9	0.1	0	0.1	0.3	0	13.8	0.2	3.2	0	1.1	0.2	0	3.1	0	0.3	0.4	2	0.2	0.1	1.8	1.1	5.9	5.2	1.3	1.8	7.6	0.2	0.8	7	0	0.2	0.4	0	0.1	0	0.2	0	0.5	0.3	0.1	2.1	0.7	2.9	5.5	0.3	2.1	1.4	0.5	4.2	0.7	0.5	0.3	1.2	1.3	2	0.2	0.5	0.1	1.2	14.7	18.4	11.3	20.1	11.6	5.2	3	10.9	2.1	2.2
PAN3		ENSG00000152520	PAN3 poly(A) specific ribonuclease subunit	Q58A45	13	28138506-28295335	"Enzymes, Predicted intracellular proteins"	mRNA processing			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA028817	Approved									HPA028817: AB_10602016	unprognostic (3.25e-2)	unprognostic (2.10e-1)	unprognostic (3.55e-2)	unprognostic (1.43e-1)	unprognostic (1.20e-1)	unprognostic (7.39e-2)	unprognostic (8.17e-2)	unprognostic (1.52e-1)	unprognostic (4.26e-3)	unprognostic (5.78e-2)	unprognostic (6.56e-2)	unprognostic (2.29e-2)	unprognostic (4.22e-2)	unprognostic (2.76e-2)	unprognostic (1.21e-1)	unprognostic (8.54e-2)	unprognostic (2.42e-2)	15.2	9	8.3	18.6	7.7	20	13.9	41.7	10.1	12.1	12.5	10.7	13	7	15.2	17.8	12.3	10.5	9	7.8	8.6	4.5	8.1	5.9	14.4	14.3	10.3	6.8	12.8	10.4	9.2	10.1	11.4	8.5	10.3	9.5	11	15.9	12.3	9.6	16	12.6	10.2	6.2	16	10.5	12.4	10.7	25.2	13.3	7.9	14.8	17.5	12.4	12.3	14.8	21.6	12.5	11.5	12.3	8.7	5.7	3.8	9.4	9.6	4.7	6.5	7.7	5.9	9.2	6.2	6	5.9	11.6	20	4.6	8.5	8.4	8.8	6.1	10.4	12.9	4.4	16.2	4.6	4.8	6.4	12.3	9.8	6.9	6.5	4.9	10.5	8.2	8.6	6	6.1	6.8	13.4	26.1	10	3.8	31.8	10.8	7	8.9	7.4	9.3	7.5	7	9.6	7.8	5.2	21.8	8.2	5.9	5.4	5.8	5.5	4.7	3.7	20.6	3.8	8.7	7.4	18.8	10.1	12.2	9.5	9.2	9.9	12.3	10.7	9.5	9.4	11.8	12.3	11.7	21.6	11.5	12.5	14.8	8	8.7	8.3	7.7	41.7	10.1	8.6	4.5	10.3	6.8	8.5	10.7
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	PAS domain containing serine/threonine kinase	Q96RG2	2	241106099-241150264	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 24.1;testis: 22.0	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Region enhanced	Detected in all		basal ganglia: 24.1	Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in some			Low region specificity	Detected in many			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol				Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	unprognostic (1.76e-2)	unprognostic (1.29e-2)	unprognostic (2.84e-1)	unprognostic (1.41e-2)	unprognostic (1.14e-1)	unprognostic (8.99e-6)	unprognostic (1.80e-2)	unprognostic (1.48e-1)	unprognostic (1.60e-3)	unprognostic (1.58e-2)	unprognostic (1.02e-2)	unprognostic (6.35e-2)	unprognostic (7.12e-2)	unprognostic (1.52e-3)	unprognostic (1.68e-1)	unprognostic (6.44e-2)	unprognostic (4.38e-3)	1.5	1.1	2.4	10.3	24.1	8.9	3.1	6.3	5.2	2.2	2.1	2.2	2.1	3.8	2.9	6.7	3.1	7.2	3.3	1.1	2.9	2.7	3.7	1.3	3	14.5	1.3	1.6	1.9	3.3	4.4	4.9	1.1	3.6	12.1	2.8	4.7	2.7	1.8	2	4.9	3.9	1.4	1.6	4.4	3.4	22	7.2	9	4.8	1.9	9.9	2.7	1.9	7.1	1.1	4.8	1	2.7	6	3	4.9	6.7	9.1	11.5	0.7	1.4	12.1	4.8	1.5	4.4	6.2	5.4	5	2.6	1	1.1	12.5	10.3	4.1	3.2	10.4	9.7	7.1	12.4	9.6	0.5	9.7	11.2	0.6	3.3	4.6	1.3	3.1	9.2	3.5	3.1	5.6	11.5	10.2	10.1	4.1	18.3	9.2	3.2	1.7	11.2	16.1	4.9	2.8	5.5	2.1	4.6	7	4.1	6.1	5.5	7.7	6.4	4.8	4.8	12.2	3.8	7.3	5.6	4.8	1	0.7	1.7	0.6	1.5	7.1	5.9	5.3	1.1	6.6	3.7	3.9	1.3	2.7	1	0.7	6	3	2.4	24.1	6.3	5.2	2.9	2.7	1.3	1.6	3.6	7.2
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	PDZ binding kinase	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	lymphoid tissue: 19.4;testis: 67.9	Cell line enhanced	Detected in many		A-431: 60.7	Low cancer specificity	Detected in all			Not detected	Not detected			Cell type enhanced	Detected in some		NK-cell: 2.1;T-reg: 1.6	Group enriched	Detected in many	10	NK-cells: 2.1;T-cells: 1.6	Low region specificity	Detected in single			Low region specificity	Detected in all			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol				Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	unprognostic (7.17e-2)	unprognostic (7.21e-3)	unprognostic (1.04e-3)	unprognostic (2.77e-2)	unprognostic (1.50e-1)	unprognostic (1.27e-1)	prognostic unfavourable (8.29e-5)	unprognostic (3.65e-3)	unprognostic (7.38e-2)	unprognostic (2.88e-3)	prognostic unfavourable (6.56e-4)	unprognostic (1.20e-1)	prognostic unfavourable (1.18e-12)	unprognostic (9.61e-2)	unprognostic (1.86e-1)	unprognostic (8.30e-2)	unprognostic (8.68e-2)	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0	0	0	2.1	1.6	0.5	60.7	19.8	19.5	12.3	1.9	3.4	8.2	27.9	13.3	28.8	24.3	6.9	11.3	32.4	9.9	10.7	16.1	18.7	9.4	31.6	7.9	10.2	7.8	14.1	10	0.1	5	11.6	0.9	7.7	13.3	7.1	14.5	11.4	21.8	33.9	6.9	19.2	5.9	3.5	17.2	12	27.2	8.7	10.8	9.4	7.7	12.1	10.4	12.2	15.6	12.9	7.7	8.4	18.9	45.6	23.9	29.6	3.1	8.6	15	11.5	8.9	40.8	0	0	0	0	0	0	0	0.8	1.3	0	0.1	0	0.1	0	2.1	0	0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	Platelet derived growth factor receptor alpha	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ovary: 81.5	Cell line enhanced	Detected in some		ASC diff: 81.0;ASC TERT1: 37.9;BJ hTERT+: 47.0;fHDF/TERT166: 32.7;HHSteC: 27.4;HSkMC: 68.9	Cancer enhanced	Detected in all		glioma: 30.8	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	Intracellular and membrane	150000	150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: "	unprognostic (1.67e-1)	unprognostic (9.35e-2)	unprognostic (4.59e-3)	unprognostic (1.60e-1)	unprognostic (8.92e-2)	prognostic favourable (9.33e-4)	unprognostic (1.24e-1)	unprognostic (2.00e-2)	unprognostic (1.46e-1)	unprognostic (2.18e-2)	unprognostic (2.18e-1)	unprognostic (7.01e-2)	prognostic unfavourable (9.79e-6)	unprognostic (9.58e-3)	unprognostic (9.87e-2)	unprognostic (2.16e-2)	unprognostic (1.72e-3)	35	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7	17.4	19.7	8.8	51.6	13.6	19	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0	0	0.2	0.1	81	37.9	0.1	4.2	47	0	0.1	11.2	0	0.1	0.1	32.7	0.1	3.2	0	0	0.4	0.1	0.1	0.1	0.2	27.4	0	0	68.9	0	5.3	0	0	0.1	0.1	0.1	0	0	0.2	0.6	0.1	0.1	0	0	0	0.3	0.1	6.6	0	0.1	0	0.1	0	0.1	14.8	0.5	16.2	0	0	0	0.1	0.4	0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4	7.2	9.3
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	Platelet derived growth factor receptor beta	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Group enriched	Detected in some	4	ASC diff: 169.0;ASC TERT1: 58.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 2.9;non-classical monocyte: 4.1	Group enriched	Detected in many	8	monocytes: 4.1;T-cells: 2.9	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		35000000	35000000	Vesicles	Golgi apparatus	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	unprognostic (4.75e-2)	unprognostic (2.48e-1)	unprognostic (5.21e-2)	unprognostic (3.60e-2)	unprognostic (3.27e-1)	unprognostic (5.61e-2)	unprognostic (1.02e-1)	unprognostic (3.36e-2)	unprognostic (2.12e-2)	unprognostic (2.57e-3)	unprognostic (6.72e-2)	unprognostic (1.25e-1)	prognostic unfavourable (5.87e-8)	unprognostic (3.13e-3)	unprognostic (1.25e-2)	unprognostic (5.47e-2)	prognostic unfavourable (8.11e-4)	61.8	10.4	8.3	11	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5	19.6	9.2	21.5	6.7	1.4	21.4	16	7.3	23.6	35.1	0.4	0.1	0	4.1	0	2.9	0.6	0	0	1	0	169	58.5	0.3	5.9	24.5	4.1	7	0.6	0	0	0.7	16.9	0	0	0	1.9	0	0	0	0.3	0.4	24	0	0	26.3	0	5.7	0	0	0	0.6	0.6	0	0	0	1.1	0	0.4	0.3	0	0	0	0	3.1	0	0	0	0	0	0	6.7	2.2	2.8	0.3	0	0	0	4.1	0	0.1	0	0	0	2.9	0.6	0	0.4	0.1	0.8	0.1	0.1	0	1.3	0	0	4.1	0	0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7
PDIK1L	CLIK1L	ENSG00000175087	PDLIM1 interacting kinase 1 like	Q8N165	1	26111165-26125543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA064157			Supported	Nucleoplasm				Nucleoplasm		HPA064157: 	unprognostic (1.09e-1)	unprognostic (1.81e-3)	unprognostic (2.99e-3)	unprognostic (2.52e-2)	unprognostic (2.54e-1)	unprognostic (1.34e-3)	unprognostic (3.93e-2)	unprognostic (1.72e-3)	unprognostic (7.29e-3)	unprognostic (1.08e-1)	unprognostic (2.42e-2)	unprognostic (3.59e-1)	unprognostic (1.34e-2)	unprognostic (4.24e-3)	unprognostic (2.94e-1)	unprognostic (4.47e-1)	unprognostic (1.78e-2)	7	6	8.6	6.2	12.3	19.9	11.5	17.8	15.9	8.6	8.9	7.1	7.6	9.5	7.8	6.4	11.4	7.5	5.8	4.8	8.5	10.6	8.5	11.3	6.7	8	9.3	9.9	10.2	15.3	10.7	9.9	5.6	11.5	6.8	10.6	6.1	10.2	8.9	7.7	9.4	9.7	6.5	8.3	8.3	10.2	7.8	9.3	19.1	22.2	6.7	8.8	8.8	8	6.7	9.3	11	6.1	5.6	10.4	5.2	5.5	2.1	5.8	7.3	2.2	3	1.9	1.4	2	3.7	2.4	1.4	7.9	11.6	4.2	2.1	4.1	7.8	2.9	3.6	4.1	5.2	10.3	3.3	1.5	3.4	10.8	6.2	1.6	4.2	3.3	6.7	3.3	12.2	11.6	1.2	3.1	15.7	4.8	2.6	3.1	8.4	5.3	13.9	2.5	4.3	9.3	7.9	5.6	7.1	7.2	4	3.7	3.1	4.1	3.6	5.2	4.5	17.3	17.1	8.8	4.3	13.4	3.8	11	5	4.2	6.7	4.6	6.2	6.7	9.4	7.4	9.3	5.6	10	8	0.5	5.6	6.1	3.5	10.4	5.2	8.6	12.3	17.8	15.9	8.5	10.6	9.3	9.9	11.5	9.3
PDK1		ENSG00000152256	Pyruvate dehydrogenase kinase 1	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		U-266/70: 31.3;U-87 MG: 32.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in all	5	B-cells: 5.9;granulocytes: 16.0;T-cells: 15.8	Low region specificity	Detected in all							"CAB017554, HPA027376, HPA059083"	Approved		Approved	"Nucleoli,Mitochondria"		22000	22000	"Nucleoli, Mitochondria"		"CAB017554: AB_2161138, HPA027376: AB_1855139, HPA059083: "	unprognostic (2.14e-1)	prognostic unfavourable (7.30e-5)	unprognostic (1.21e-1)	unprognostic (3.94e-2)	unprognostic (6.47e-2)	unprognostic (1.58e-1)	unprognostic (1.02e-2)	unprognostic (1.45e-1)	unprognostic (9.69e-3)	unprognostic (6.44e-2)	unprognostic (5.44e-3)	unprognostic (1.55e-1)	prognostic unfavourable (1.10e-8)	unprognostic (1.82e-1)	unprognostic (1.94e-1)	unprognostic (2.56e-2)	unprognostic (5.34e-2)	9.9	16.2	6.8	11	10.5	13.4	16.7	7.1	15.6	7.3	15.3	3.3	2.9	15.5	5.4	8	11.2	4.4	5.8	27.6	6.9	5.2	6.8	14.2	6.1	21.4	7.2	5.2	19.5	7.2	3.4	7.5	7.9	7.2	6.5	13.1	7.6	14.1	7.6	9.6	24.7	8.4	5.2	10.7	14.2	12.5	11	6.7	10.3	5.1	5	20.8	18	9.8	5.9	2.3	16	2.2	1.4	15.8	6.2	14.1	0.6	3.7	9.1	1.5	2.3	5.2	12.5	10.1	6.3	13.4	3.6	3	13.5	6.9	3.8	6.2	2.5	7.8	20.1	2.7	5	16.4	3.3	4.2	2.7	8.1	6.1	2.9	2.8	4.3	7.3	3.3	3.4	9.3	8.3	1.4	5.1	10.2	8.9	3.9	5.4	6	21.7	3.2	4.6	6.9	7.9	3.2	3.8	4.7	2.4	3.4	3.8	10	3.2	5.2	3.3	31.3	18.1	11.1	32	5.9	2	12.2	2.2	16	2.5	1.5	3	4.7	4.2	2.8	2.3	5.9	15.8	9.6	8.5	1.4	1.9	0.4	8	6.2	6.8	10.5	7.1	15.6	6.9	5.2	7.2	5.2	7.2	6.7
PDK2	PDHK2	ENSG00000005882	Pyruvate dehydrogenase kinase 2	Q15119	17	50094737-50112152	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 101.0	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008287	Supported		Supported	"Nucleoplasm,Mitochondria"				"Nucleoplasm, Mitochondria"		HPA008287: AB_1079589	unprognostic (2.74e-2)	prognostic favourable (5.87e-4)	unprognostic (1.16e-1)	unprognostic (2.43e-3)	unprognostic (1.22e-1)	unprognostic (9.63e-3)	unprognostic (9.80e-3)	unprognostic (8.39e-3)	unprognostic (3.19e-2)	unprognostic (1.25e-1)	unprognostic (1.17e-2)	unprognostic (2.21e-1)	prognostic favourable (9.59e-5)	unprognostic (3.81e-1)	unprognostic (2.54e-1)	unprognostic (5.33e-1)	unprognostic (1.55e-1)	20.6	26.1	17.2	5.2	27.5	3.2	10.8	53.7	34.4	10.1	16.1	16.1	10.1	15.5	13.1	69.8	12.5	14.4	11.5	51.7	18.2	13	33.7	27.8	9	5.7	14.6	20.9	27.7	24.1	16.9	7.5	8.6	14.2	12.7	12.4	19.5	14	16.5	101	10.6	16.5	15.1	9.9	7.8	13.6	7.2	11.4	6.2	15.6	31.4	7.4	13.8	9.4	11.3	20.1	8.9	12.9	16.5	17.4	12.2	6.4	9.4	11.3	10.1	11.9	9	1.2	7.1	10.5	10.6	10.3	0.9	7.1	8.2	11.9	19.8	3.1	7.5	2.8	10.5	16.5	10.4	7.3	9.2	6.9	6.4	0	8	18.9	11	6.9	0.5	9.2	2.9	8.2	6	8.3	6.1	0	2.4	9.1	9.2	25.2	11.1	5.8	5.5	7.5	11.4	10	3.2	4.7	18.5	7.3	4.7	12.5	10.3	8.5	5.1	16.2	15.3	4.4	18.3	2.6	8	8.9	12.9	6.8	14	9.8	11.1	11.1	12.5	14.8	14.2	11.3	14.6	15	2.2	16.5	10.5	20.1	17.4	12.2	17.2	27.5	53.7	34.4	18.2	13	14.6	20.9	14.2	11.4
PDK3		ENSG00000067992	Pyruvate dehydrogenase kinase 3	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA046583, HPA072492"	Approved		Supported	"Nucleoli,Mitochondria"				Mitochondria	Nucleoli	"HPA046583: , HPA072492: "	unprognostic (5.41e-3)	unprognostic (5.43e-3)	unprognostic (5.35e-3)	unprognostic (3.40e-1)	unprognostic (4.05e-3)	unprognostic (5.38e-2)	prognostic unfavourable (2.76e-4)	unprognostic (1.51e-1)	unprognostic (5.57e-2)	unprognostic (1.35e-1)	unprognostic (1.39e-2)	unprognostic (2.02e-1)	unprognostic (1.72e-1)	unprognostic (1.02e-1)	unprognostic (2.92e-1)	unprognostic (2.28e-2)	unprognostic (9.43e-3)	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11	6.7	9	4.6	3.9	6.5	0.1	0	4.1	2.7	2.4	3.7	6.5	0.4	11	9.1	1.8	0.7	2	11.3	6.9	9.9	7.8	5.4	4.9	5.3	2.6	1.3	4.1	4.8	0.7	3	0.9	0.9	5.5	0.9	13.9	0.5	16.9	7.8	5.4	7	5.4	4	7	13.4	3.2	17.6	2.5	3.2	14.7	6	4.5	8.2	1.6	0.1	2.6	3.8	4.8	3.2	8.9	6.8	11	7.1	6.4	5.3	9.4	8.9	21.3	7.6	10.9	11	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8
PDK4		ENSG00000004799	Pyruvate dehydrogenase kinase 4	Q16654	7	95583499-95596491	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 351.0;skeletal muscle: 497.0	Cell line enriched	Detected in some	7	ASC diff: 104.7	Cancer enhanced	Detected in all		renal cancer: 107.8	Low region specificity	Detected in all			Group enriched	Detected in many	11	classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6	Group enriched	Detected in many	11	dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA056731	Approved									HPA056731: 	unprognostic (3.18e-3)	unprognostic (1.98e-1)	unprognostic (1.52e-1)	unprognostic (1.34e-1)	unprognostic (5.15e-2)	unprognostic (1.32e-1)	unprognostic (1.00e-3)	unprognostic (3.47e-1)	unprognostic (6.38e-2)	unprognostic (2.24e-3)	unprognostic (1.87e-2)	unprognostic (8.75e-2)	unprognostic (2.41e-2)	prognostic unfavourable (1.80e-4)	unprognostic (9.15e-2)	unprognostic (4.20e-2)	unprognostic (1.12e-1)	90.7	41.9	6.9	5.9	14.6	0.4	49.1	2.5	9.1	12.3	30.9	9	150.6	13.6	10.7	13.7	29	14.7	15.6	351	9.2	3.7	27.7	39.5	14.1	6.1	18.2	2.4	46.6	102.9	0.8	8.1	19.4	26.1	29.3	8.4	4.4	8.4	150.6	497	10.2	46.2	20.7	13.9	19	21.2	10.8	17.4	1	13.4	12.3	2.5	23.8	46.4	0.7	7.1	15.6	26.1	1.4	0	4.7	0	7.8	0.3	2	104.7	0.1	0	0	0	0	0	0	2.6	0	1.1	0.3	0	0	0	0	0	0.2	0	14.3	0	1	0	0	1.1	0	0	0	0.5	0.3	0	0	0.1	0	0	0	0.4	0	0	0	5	0.5	0.1	0.5	0	0.6	1.6	0.2	0.2	0	0	0.1	0.4	0	0	0	0	0.3	0	0	0.1	14.2	15.6	0	26.1	0	0.1	0	0	7.1	0.7	0	0	1	1.4	15.6	0.2	0	4.7	6.9	14.6	2.5	9.1	9.2	3.7	18.2	2.4	26.1	17.4
PDPK1	PDK1	ENSG00000140992	3-phosphoinositide dependent protein kinase 1	O15530	16	2537964-2603188	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004272, HPA035199, HPA068961"	Supported		Approved	Vesicles				Vesicles		"CAB004272: AB_626657, HPA035199: , HPA068961: "	unprognostic (2.67e-2)	unprognostic (1.63e-1)	unprognostic (3.12e-3)	unprognostic (4.21e-2)	unprognostic (1.34e-1)	unprognostic (4.69e-3)	unprognostic (8.37e-2)	unprognostic (3.18e-2)	unprognostic (8.17e-2)	unprognostic (3.70e-2)	unprognostic (1.52e-2)	unprognostic (3.28e-2)	prognostic favourable (1.29e-14)	unprognostic (2.04e-2)	unprognostic (5.96e-2)	unprognostic (1.95e-1)	unprognostic (2.16e-1)	11.1	14.9	21	11.6	31.9	14.2	14.2	29.6	26.4	10.5	15.6	14.5	10.4	17.2	13	14	13.8	15.3	10.8	14.8	17.2	13.5	17.6	12.6	13.4	13.5	11.3	20.6	14.8	28.2	34.5	13.9	17.1	16.7	13.6	15.3	12.8	16.5	13.2	18.2	14.1	19.1	12.9	10.9	13.7	13.4	14.2	10.1	14.1	16.1	10.6	13.9	12.3	13.3	5.1	9.1	14.7	9.4	5.4	6	4.5	8.4	10.8	13.5	9	14	11.7	14.3	14	9.1	12.6	10.6	10.8	10.1	13.9	9.6	13.6	13.4	16.1	10.1	12	24.7	10.9	7.3	14.3	17.9	12.2	12.1	19.4	10.6	18.6	13.5	9.1	11.5	13.6	11.3	14.7	17.8	12.2	8.5	8.5	9.7	25	13.5	12.5	12.2	7.5	21.3	11	18.2	21	7.5	19.4	15.3	14.1	13.8	13.7	13.4	12.1	15.1	14.3	21.7	6.6	8.4	11.9	3.9	7.9	9	5.1	9.3	4.8	5.1	4.7	6	6.7	4.5	5.3	4.9	14.7	5.4	9.4	9.1	2.3	4.5	21	31.9	29.6	26.4	17.2	13.5	11.3	20.6	16.7	10.1
PEAK1	"KIAA2002, sgk269"	ENSG00000173517	Pseudopodium enriched atypical kinase 1	Q9H792	15	77100656-77420144	"Enzymes, Predicted intracellular proteins"				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		TIME: 25.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		NK-cell: 5.5	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026313, HPA026517"	Approved									"HPA026313: AB_1856801, HPA026517: AB_1856802"	unprognostic (1.15e-1)	unprognostic (2.89e-1)	unprognostic (1.05e-1)	unprognostic (4.20e-1)	unprognostic (6.26e-2)	unprognostic (8.82e-2)	unprognostic (6.63e-3)	unprognostic (1.90e-1)	unprognostic (2.42e-2)	unprognostic (6.00e-3)	unprognostic (1.06e-1)	unprognostic (9.75e-2)	unprognostic (2.25e-3)	unprognostic (5.73e-2)	unprognostic (2.09e-2)	unprognostic (3.33e-1)	unprognostic (5.65e-3)	21.5	6	14.3	8.7	13.2	9.7	12.4	8.4	14.1	15.1	9.3	12.3	6.2	7.2	16.1	8.7	6.6	7.5	12.2	18.5	12.3	7.5	6.6	4.9	20.5	7.5	13.8	8.8	9.8	5.8	7.6	4.2	19.5	9.8	8.4	10.2	13.7	7	9.5	8.8	8.4	9.1	14.8	10.1	41.8	6.7	11.5	15.9	2.7	8.3	9	5.7	10	12.2	0.9	0.6	1.1	0.6	5.5	1.4	0.4	2.5	3.8	9	2.1	17	18.4	3.1	14	9.7	7.4	7.5	3	2.3	2	2.5	20.1	1.2	7.2	2.2	8.5	2	3.7	3.6	5.7	1.8	6.2	2.1	1.9	14.1	2.2	14.4	2.4	20.8	4.7	2	7.9	1	1.2	2.3	4.1	1	2.5	5.4	1.4	2.2	4.6	2	2.4	5.4	1.1	9.4	0.8	1.5	25.4	15.9	7.6	6.6	5.9	3.1	4.4	2.8	2.7	5.1	8.5	0.4	0.6	1.1	0.7	0.2	1.4	0.9	0.2	0.2	0.3	0.8	0.3	0.3	0.6	5.5	0.2	0.6	0.2	0.4	14.3	13.2	8.4	14.1	12.3	7.5	13.8	8.8	9.8	15.9
PHKG1	PHKG	ENSG00000164776	Phosphorylase kinase catalytic subunit gamma 1	Q16816	7	56080283-56092996	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	skeletal muscle: 105.6;tongue: 32.9	Low cell line specificity	Detected in many			Cancer enriched	Detected in many	18	glioma: 23.6	Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 3.3	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012057	Enhanced									HPA012057: AB_1855305	unprognostic (2.00e-3)	unprognostic (1.09e-1)	unprognostic (7.09e-3)	unprognostic (5.87e-3)	unprognostic (2.19e-1)	unprognostic (1.54e-2)	unprognostic (1.31e-1)	unprognostic (6.69e-3)	unprognostic (2.10e-1)	unprognostic (1.99e-1)	unprognostic (9.14e-4)	unprognostic (1.92e-1)	unprognostic (7.97e-9)	unprognostic (6.61e-3)	unprognostic (2.34e-1)	unprognostic (1.12e-2)	unprognostic (3.85e-2)	2	1.5	4.9	0.8	6.1	1.1	1.5	6	5.8	0.7	2.6	6.5	0	1	0.9	1.5	3.2	0.9	1.1	11.8	4.1	2.9	0.6	0.7	0.9	0.8	3.5	3.9	1	0.8	1.2	0.6	0.6	6.8	1.4	0.8	0	1.6	0.8	105.6	1.6	0.9	1.1	3.6	0.8	0.8	0.7	4.8	0	0.6	32.9	1.2	1.8	0.3	1.3	0.6	3.3	0.7	0.3	1.9	0.2	2.9	2.1	0.5	1.7	3.1	5.3	1.4	0.3	0.6	1	0.8	0.7	1.3	0.8	0.5	1	1.5	1.2	0.2	0.8	0.8	2.1	0.8	2.9	0.7	0.8	1.5	3.2	3.3	2.2	1.6	0.7	0.3	2.2	3.9	0.1	1.3	2.2	5.5	1	1.3	1.2	0.3	1	0.6	1.9	1.5	1.6	0.3	2.1	0.1	1.1	1.9	0.8	0.5	1.7	4.4	1.1	1.8	0.7	2.2	1.2	1.4	1	0.4	0.5	0	0.8	0.2	1.9	0.3	1.2	0.3	0.2	1.3	0.6	0.6	3.3	0.3	0.7	0.6	0.5	0.2	4.9	6.1	6	5.8	4.1	2.9	3.5	3.9	6.8	4.8
PHKG2		ENSG00000156873	Phosphorylase kinase catalytic subunit gamma 2	P15735	16	30748270-30761176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Glycogen storage disease"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	blood: 44.5;testis: 95.4	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA065618, HPA068751"			Supported	Cytosol				Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	unprognostic (7.63e-3)	prognostic favourable (7.90e-4)	prognostic unfavourable (9.92e-4)	unprognostic (1.08e-1)	unprognostic (1.25e-1)	unprognostic (5.81e-2)	unprognostic (3.72e-2)	prognostic favourable (1.90e-4)	unprognostic (6.45e-2)	unprognostic (1.25e-2)	prognostic favourable (8.02e-4)	unprognostic (6.15e-2)	unprognostic (5.27e-2)	unprognostic (1.36e-2)	unprognostic (2.41e-1)	unprognostic (2.18e-2)	unprognostic (3.03e-2)	4.3	8.3	8.7	6.9	8	15.9	5.8	9.1	12	4.7	7.9	7.3	9	6.8	5.6	7.8	5.3	6.8	7.2	6.4	9	9.3	8.2	11	5.8	6.8	8.6	9.2	4.7	5.1	17.3	8.5	6.3	11.8	7.7	7.6	6.4	7	9.9	6.4	8.4	7.3	6.3	5.8	6.9	7.2	95.4	7.3	5.5	8.6	5.5	7.7	5.2	4.7	8.8	21.2	44.5	22.7	23.5	16.8	17.6	13.5	8.9	7.5	9.2	7.1	5.7	16.9	9.5	14.3	13	14.9	7.7	6.8	11.7	11.3	9.8	13	7.8	12.1	10.5	6.3	21.7	6.4	14.8	21.6	10.9	9.9	9.2	7.7	6.6	12.5	5.9	13.2	8.7	6.8	9.4	31.2	11.7	14.6	10.3	10.4	15.8	11.7	15.6	14.9	15.3	10.1	7	7.7	21.5	9.1	16.9	8.6	7.8	8	8.9	10	8.7	13.8	7.5	8	15.9	19.4	6.5	14	22.7	44.5	16.2	22.4	13.3	8.8	11.6	16.4	21.2	8.5	10.4	12.1	18.2	23.5	15.9	18.2	16.8	17.6	8.7	8	9.1	12	9	9.3	8.6	9.2	11.8	7.3
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA009985, CAB017804"	Approved		Approved	Cytosol				Cytosol		"CAB017804: , HPA009985: AB_1079610"	unprognostic (1.81e-1)	unprognostic (2.77e-1)	unprognostic (2.18e-1)	unprognostic (2.69e-3)	unprognostic (6.49e-3)	unprognostic (1.43e-1)	unprognostic (2.65e-2)	unprognostic (1.00e-2)	unprognostic (1.03e-1)	unprognostic (2.37e-1)	unprognostic (2.57e-3)	unprognostic (5.21e-2)	unprognostic (4.50e-2)	unprognostic (1.16e-2)	unprognostic (2.48e-1)	unprognostic (9.74e-2)	unprognostic (3.82e-2)	20.1	12.3	13.7	11.5	13.4	25.7	22.4	17.1	24.5	12.9	14	5.2	5.7	6.5	15.3	7.9	11.6	11.1	13.2	14.2	18.4	9.7	11.7	10.8	13.2	13.8	9.8	15.7	15.4	9.2	24.7	11.6	16.5	16.3	10.7	8.9	7.2	10.9	10.9	15.2	12	10.5	12.8	14.4	16.2	10.6	9.3	9.8	29.6	11	7.3	13.9	15.1	15.7	6.2	2.6	7.8	3.8	2.4	5	1.1	14.4	4.9	7.9	7.3	18.7	21.8	5.7	9.2	12.5	9.1	14.4	4.2	10.7	13.2	15.8	11	5.9	6.4	8	13.2	22	5.7	18.1	5.3	3.7	8.9	10.1	10.3	13.7	8.5	10	11.5	13	9	14.7	13	5.7	7.7	9.1	6.2	6.7	11.8	8	15.8	7.2	8.8	4.4	7.6	10	8.9	12	14.9	8.7	13.8	8.6	5.6	13.5	9.2	7.1	10.1	23.7	7.7	7.6	5	2.1	3.8	1.6	5	2.9	3.9	5.8	4.2	2.8	2.2	6.2	4.6	3.8	7.8	2.4	3	2.6	4.1	1.1	13.7	13.4	17.1	24.5	18.4	9.7	9.8	15.7	16.3	9.8
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8	Cell line enhanced	Detected in some		Daudi: 12.2;HMC-1: 15.2;Karpas-707: 12.6;MOLT-4: 23.0;U-266/70: 30.9;U-937: 21.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"				Plasma membrane	Cytosol	HPA069976: 	unprognostic (8.34e-2)	unprognostic (2.01e-2)	unprognostic (1.44e-2)	unprognostic (1.71e-2)	unprognostic (3.20e-2)	unprognostic (3.82e-3)	unprognostic (3.02e-1)	unprognostic (6.77e-2)	unprognostic (1.16e-1)	unprognostic (7.06e-3)	unprognostic (1.15e-1)	unprognostic (1.97e-1)	unprognostic (1.77e-2)	unprognostic (9.08e-2)	unprognostic (1.23e-1)	unprognostic (5.38e-1)	unprognostic (5.24e-2)	5	1.8	2.2	16	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0	2.8	1.7	2	2	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3	1	1.7	1.5	0.6	1.4	2	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	12.2	1.2	0	0	0	0	0	0.1	0	7.5	0	0	0	11.9	15.2	0	0	0	0	4.7	8.5	12.6	0	0	23	4.6	0	0	6.1	0	8.1	0	0	0	0	0	0	0	0	8.1	1.2	0	0.1	0	0	30.9	0	11.5	0	21.8	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3	1	2.5	3
PIK3R4	"p150, VPS15"	ENSG00000196455	Phosphoinositide-3-kinase regulatory subunit 4	Q99570	3	130678935-130746829	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA036032, HPA036033"	Approved		Approved	"Vesicles,Microtubules"				Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: "	unprognostic (7.50e-2)	unprognostic (3.90e-3)	unprognostic (1.68e-1)	unprognostic (4.05e-3)	unprognostic (2.88e-1)	unprognostic (1.28e-1)	unprognostic (1.34e-1)	unprognostic (1.21e-1)	unprognostic (1.11e-1)	unprognostic (2.67e-1)	unprognostic (1.02e-3)	unprognostic (7.26e-2)	prognostic favourable (4.40e-6)	unprognostic (8.25e-2)	unprognostic (3.72e-1)	unprognostic (2.27e-1)	unprognostic (1.05e-1)	15.5	16.2	11.6	11.6	15.9	10.6	14.9	14.7	17.2	16.5	13.1	14.9	9.5	10.3	18.8	12	12.9	15.6	12	12.2	9.7	10	14.9	28.2	13.7	12.4	12	11.4	17.8	12	40.7	20.6	14.4	17.3	14.1	11.6	14.1	14	15.4	14.8	16	13.4	14.6	12.1	18.5	13.3	14.9	11.8	29.7	18.1	10.2	13.6	16.5	13.9	8.4	9.6	12	8.5	11.5	13.7	7	14.1	9	13.2	9.5	19.6	15.6	9.2	10.5	12.7	14.6	16.9	11.6	12.1	16.7	13.3	10.6	20.2	21.7	16.4	23	10	8	13.6	10.3	8	9	20.6	6.8	10.8	11.8	15.5	9.9	13.4	15.7	8.5	12.8	12.4	16.8	6.3	16.6	8.8	11.8	15.4	15	9.6	11.6	12.2	8.9	15.1	9.6	10.6	13.2	9.1	10.6	11.2	9.8	12.6	8.4	9.9	9	22	12.3	7.9	10.4	12	7.2	9.2	9.4	8.4	13.7	8.4	8.6	6.9	9.6	5.7	10.1	9	6	11.5	8.5	3.4	9.3	7	11.6	15.9	14.7	17.2	9.7	10	12	11.4	17.3	11.8
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HEL: 34.8;HMC-1: 64.9;U-698: 116.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 64.6	Group enriched	Detected in all	5	granulocytes: 64.6;T-cells: 19.0	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA003941, CAB017040"	Uncertain		Supported	"Nucleoli,Cytosol"				Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	unprognostic (1.25e-2)	unprognostic (4.77e-1)	unprognostic (3.61e-2)	prognostic unfavourable (9.73e-4)	unprognostic (1.91e-2)	unprognostic (1.06e-1)	unprognostic (3.75e-1)	unprognostic (4.64e-2)	unprognostic (2.36e-1)	unprognostic (1.10e-1)	unprognostic (2.65e-2)	unprognostic (7.32e-2)	unprognostic (2.14e-3)	unprognostic (8.16e-3)	unprognostic (1.04e-1)	unprognostic (5.26e-3)	unprognostic (2.90e-1)	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20	9.6	2	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19	8.5	3	1.2	2	1.1	4.6	2.4	23.5	1	3.3	2.2	3.6	4.5	4.2	6	1.7	1.2	3.5	2	3.2	2	27.5	1.3	34.8	1.3	5.8	4.7	0.6	64.9	8.3	4	2	1.3	0.6	29.9	9.8	0.3	0.7	1.9	3.1	3.7	1.9	4.6	3.6	7.1	0.6	18.4	9.7	1.9	2.3	0.2	0.6	0.5	1	1.1	1.3	3.9	5.8	1.3	4.6	2.4	116.6	0.5	8.8	1.3	64.6	1.7	24.4	14.7	1.6	19	1.7	13.1	12.9	1.4	1.3	11.9	9	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 63.4;lymphoid tissue: 71.2	Group enriched	Detected in many	5	HDLM-2: 58.9;Karpas-707: 73.0;RPMI-8226: 71.9;U-266/70: 133.0;U-266/84: 117.5	Cancer enriched	Detected in all	6	testis cancer: 171.3	Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000285			Approved	Cytosol				Cytosol		HPA000285: AB_1079619	unprognostic (2.34e-3)	prognostic favourable (4.05e-5)	unprognostic (8.04e-2)	unprognostic (7.30e-2)	unprognostic (6.41e-3)	unprognostic (2.74e-3)	unprognostic (2.84e-1)	unprognostic (5.23e-2)	unprognostic (2.47e-2)	unprognostic (4.01e-2)	unprognostic (1.33e-3)	unprognostic (2.73e-1)	prognostic unfavourable (1.17e-11)	unprognostic (3.36e-2)	unprognostic (1.96e-2)	unprognostic (1.27e-1)	unprognostic (4.38e-2)	3.6	3.4	4.3	37.2	7.2	30.4	3.4	7.1	7.9	4.5	13.4	2.1	2.2	29.5	2.8	4.3	10	5.6	8.3	3.1	5.6	6.7	5.2	5.4	10.6	59.7	3.8	4.6	5.4	3	1	4.9	2.4	6.7	3.6	17.7	6.1	16.9	4.9	1.5	3	19.2	2.2	3.1	71.2	14.7	5.7	1.3	39.4	4.8	3.6	47.9	24.6	3.3	26	2.9	46.9	3	17	63.4	13.2	1.8	1.5	0.8	1.6	0.3	0.2	1.2	1.1	1.4	1.6	1.4	1.4	1.3	7.8	0.5	0.5	1.1	2.6	1	1.5	58.9	2.1	9.4	1.6	1.4	0.7	2.2	6.4	0.6	0.9	1.6	1	0.5	10	73	0.9	1.3	0.8	4.7	17.8	2.4	1	0.5	71.9	1.6	0.2	0.5	0.8	1.2	0.8	0.8	2	3.1	0.3	0.3	0.2	0.3	1.1	133	117.5	15	1.5	2	0.3	46.9	1.5	14.3	12.5	1.9	21.2	26	34.4	17.6	2.5	15.9	36.9	23	38.3	17	3	2.9	63.4	13.2	4.3	7.2	7.1	7.9	5.6	6.7	3.8	4.6	6.7	1.3
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960513-49964080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		Karpas-707: 45.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 16.9	Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA068758			Supported	Cytosol				Cytosol		HPA068758: 	unprognostic (3.67e-2)	unprognostic (7.69e-3)	unprognostic (1.07e-1)	unprognostic (1.11e-1)	unprognostic (3.67e-2)	unprognostic (5.83e-2)	unprognostic (1.48e-2)	unprognostic (1.13e-2)	unprognostic (2.71e-2)	prognostic unfavourable (9.68e-4)	unprognostic (2.00e-2)	unprognostic (1.00e-1)	prognostic favourable (8.09e-4)	unprognostic (5.59e-3)	unprognostic (1.71e-1)	unprognostic (3.92e-3)	unprognostic (7.27e-3)	32.5	15.5	6.8	19.9	16.7	62.4	50.5	7.6	11.9	16.4	22.6	11.3	20.9	15.9	14.4	17.6	25	15.9	37.8	23.6	7.5	7.9	29.1	25.7	38.3	29.4	21.1	4.9	13.9	36.4	4.8	14.9	31.4	15.1	28.4	7.6	9.7	27.6	22.7	39.9	31.3	20.9	12.2	10.1	25.4	33.6	13	13.5	9.7	19.1	19.9	19	25.6	18.3	6.1	5.7	16.9	4	1.2	4.5	1.9	7.2	4.8	3.2	6.1	2.5	1.9	18.5	4.6	7.4	5.4	3.9	8	6.2	12.9	5.8	1.2	6.2	6.2	3.4	1.9	9.7	25.7	5.3	11.5	9.6	12	11.5	10.3	3.6	11.5	3.3	5.7	17.6	7.3	45.7	1.6	16.2	5.8	20.6	6.8	7.7	27.2	5.4	15.3	2.9	5.5	11.6	8.1	8.9	40.6	28.4	5.3	15.3	4.6	3.4	14.8	5.6	7.4	23.5	14.9	11	8.6	6.5	9.2	0	3.1	0.1	1.9	3.2	2.3	3.4	4.4	3.8	2.5	6.1	4.1	1.7	16.9	1.2	4	5.7	4.5	1.9	6.8	16.7	7.6	11.9	7.5	7.9	21.1	4.9	15.1	13.5
PINK1	PARK6	ENSG00000158828	PTEN induced putative kinase 1	Q9BXM7	1	20633455-20651511	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 142.0	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 10.7	Group enriched	Detected in many	4	granulocytes: 10.7;monocytes: 4.4	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001931, CAB026191"	Uncertain									"CAB026191: , HPA001931: AB_1079620"	unprognostic (3.73e-3)	unprognostic (2.29e-2)	unprognostic (3.22e-1)	unprognostic (4.33e-2)	unprognostic (4.91e-2)	unprognostic (2.93e-2)	unprognostic (1.56e-2)	unprognostic (3.36e-2)	unprognostic (3.51e-2)	unprognostic (4.06e-3)	unprognostic (3.34e-2)	unprognostic (2.54e-1)	prognostic favourable (1.11e-16)	unprognostic (2.68e-1)	unprognostic (1.62e-1)	unprognostic (6.57e-2)	unprognostic (1.08e-1)	17.9	35.9	38.9	6.7	38	6	10.1	16.8	45	9.8	13	17.8	10	15.2	9.3	9.8	20.7	10.7	11.4	51.4	31	28.7	20.2	26.1	10	5.1	39.5	27.1	11.6	24.3	16.3	7.1	13.9	31	12.4	7.7	10.6	23.9	15.4	142	10.8	12.7	10.8	30.2	8.3	10.5	27.2	16.8	3.3	16	21.5	4.6	12.7	9.5	1.2	1.4	10.7	4.4	0.7	1.7	0.8	17.9	8.2	3.8	11	13.4	12.7	4	25.2	25.4	12.3	21.4	2.8	14.6	4.2	20	25.7	8.3	5.6	13.4	6.1	5	21.2	2.1	22.9	4.4	10.4	2.2	6.7	11.9	14.5	15.3	5.3	7.9	5.1	5.4	8.8	7.6	3.2	5.1	1.7	27	2.8	6.8	3.3	7.6	4.2	14.3	5.6	27.5	9.1	7.6	3	7.8	12	11.1	5.7	18.5	3.5	6.3	1.2	1.9	24.1	6.5	5.2	4.8	2.2	4.7	1.1	1.4	1.4	0.3	1	1.5	0.7	1.2	0.8	1.1	10.7	0.7	4.4	1.4	1.7	0.8	38.9	38	16.8	45	31	28.7	39.5	27.1	31	16.8
PKDCC	"SgK493, Vlk"	ENSG00000162878	"Protein kinase domain containing, cytoplasmic"	Q504Y2	2	42048020-42058528	"Enzymes, Predicted secreted proteins"	"Differentiation, Osteogenesis, Protein transport, Transport"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in some		AN3-CA: 30.5;ASC diff: 24.2;CACO-2: 36.1;HHSteC: 20.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026427, HPA026442, HPA026526"	Approved				Secreted to blood	10000	10000			"HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416"	unprognostic (6.77e-2)	unprognostic (3.35e-1)	unprognostic (1.04e-2)	unprognostic (3.59e-3)	unprognostic (8.31e-2)	unprognostic (1.11e-1)	unprognostic (2.18e-2)	unprognostic (5.79e-3)	unprognostic (1.04e-2)	unprognostic (1.32e-1)	unprognostic (3.20e-1)	unprognostic (6.09e-2)	unprognostic (2.14e-2)	unprognostic (9.08e-2)	unprognostic (2.62e-1)	unprognostic (4.73e-3)	unprognostic (2.58e-3)	21.4	5.7	1.9	8.4	1.8	0.8	18.9	0.3	4.7	20.8	13.7	1.7	6.3	9.3	17.6	16	9.2	10	29.6	17	2.3	0.7	4.7	3.5	8	3.7	3.7	0.3	43.6	3.3	0.9	3.2	3.2	2.6	13	5.2	17	38.6	5.6	40.2	1.7	7.7	26.2	2.3	4.6	4.8	14.1	2.3	4.2	3.1	13.1	2.1	22.8	23	0	0	0	0	0	0.9	0	0	1.9	5.4	30.5	24.2	0.3	1.9	0.1	0	0.4	0.6	36.1	0	0	0.1	0.6	0	0.5	0	0	2.9	1.2	0	1.3	9.5	20.8	0	0.4	2.1	0.1	0	0	0.2	0.4	0	0.1	0.1	0	0.1	8.9	0.6	0	10.5	0	0	0	1.1	1.9	0.5	0	0	0	0.2	0	0.2	1	0.6	0	0	0	0	0	0	0.1	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	1.8	0.3	4.7	2.3	0.7	3.7	0.3	2.6	2.3
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Cell cycle	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enriched	Detected in single	5	T-reg: 4.4	Lineage enriched	Detected in single	5	T-cells: 4.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				Golgi apparatus	"Nucleoplasm, Nucleoli"	HPA068860: 	unprognostic (7.82e-2)	unprognostic (8.70e-2)	unprognostic (5.93e-2)	unprognostic (2.04e-2)	unprognostic (4.54e-2)	unprognostic (1.44e-1)	prognostic unfavourable (8.33e-4)	prognostic unfavourable (3.37e-4)	unprognostic (4.52e-2)	unprognostic (2.15e-1)	unprognostic (1.61e-2)	unprognostic (7.95e-3)	unprognostic (0.00e+0)	unprognostic (1.09e-3)	unprognostic (9.13e-2)	unprognostic (1.96e-1)	unprognostic (5.91e-2)	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1	1.3	6.2	0.8	0.2	0.3	1.3	0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2	0.8	0.4	0.3	0.5	0.4	4.4	1	24.6	17.3	6.8	9.7	0.1	0.3	18.3	19.2	4.6	12.2	11.7	13.4	14.7	15.4	8.6	2.1	31.7	4.7	6.1	2.2	19.8	15.6	7.8	15.6	11.7	0	8.7	22.3	0.2	0.5	7.2	1.9	2.5	22.4	27.4	3.9	37	24.4	24.2	11.1	9.2	26.6	15.1	29.8	2.3	5.4	12.9	13.6	9.3	24.2	7.2	13.8	17.4	2.3	16.4	20.8	23.9	20	20.8	15.4	26.5	6.2	11.7	19	0	0.4	0.3	0.3	0.3	0	0.8	0.5	0.5	0.4	0	0	0	0.1	0.4	0.5	0.1	4.4	1	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	Protein kinase N1	Q16512	19	14433053-14471867	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA003982, CAB010278"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nuclear bodies	"Nucleoplasm, Cytosol"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	unprognostic (3.83e-2)	unprognostic (2.14e-1)	unprognostic (4.13e-2)	unprognostic (1.13e-2)	unprognostic (1.94e-1)	unprognostic (4.58e-1)	unprognostic (1.30e-2)	unprognostic (1.45e-1)	unprognostic (1.43e-1)	unprognostic (8.55e-3)	unprognostic (4.08e-3)	unprognostic (2.11e-1)	unprognostic (1.45e-2)	unprognostic (1.70e-1)	unprognostic (8.66e-2)	unprognostic (4.08e-1)	unprognostic (2.24e-2)	28.8	19.5	19.1	27.6	26.7	39.6	25.3	21.9	19.2	19.2	26	20.9	16.5	10	25.4	19.7	16.6	22.2	22.5	38.3	17.1	17.6	17.9	16.3	27.9	42.2	19.5	16.3	21.7	32.3	15.8	18.7	22.7	19.2	22.6	6.9	21.5	22.6	22.7	43.2	7.6	16.9	22.5	19.4	39.7	24.2	21.5	18.9	39.2	17.8	13.8	24	22.1	30.5	11.5	17	24.1	30.6	13.5	20.7	15.2	37.2	22.2	8.3	17.2	13.4	15.8	13.7	13.4	16.1	14.2	13.6	8.6	21.4	35.6	34.8	23	8.6	13.2	6	5.5	28.8	17.1	42.6	14.2	18.4	44.5	16.7	26.8	11.4	4.3	8.6	13.5	32.9	18.8	24.7	10.4	15.3	25.2	15.5	15	25.4	33.9	11.3	25.6	7	6.1	30.2	42.8	8.3	10.6	21.7	9.6	29.2	49.2	28.3	12.1	34.1	20.3	32.5	29.6	19.4	18.5	33.6	22.1	15.4	17.3	24.1	20.7	24.2	15.7	10.7	14	14.2	17	11.5	13.1	14.3	21.3	13.5	30.6	11.1	15.9	15.2	19.1	26.7	21.9	17.3	17.1	17.6	19.5	16.3	19.2	18.9
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	Protein kinase N2	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in all	5	neutrophil: 35.7	Lineage enriched	Detected in all	8	granulocytes: 35.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"				"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: , HPA057913: "	unprognostic (7.52e-2)	unprognostic (1.46e-1)	prognostic favourable (5.67e-4)	unprognostic (5.95e-2)	unprognostic (3.39e-2)	unprognostic (2.51e-2)	unprognostic (4.64e-3)	unprognostic (1.38e-1)	unprognostic (4.43e-2)	unprognostic (1.27e-2)	unprognostic (2.90e-3)	unprognostic (1.23e-1)	unprognostic (1.51e-2)	unprognostic (5.98e-2)	unprognostic (2.38e-1)	unprognostic (1.01e-2)	unprognostic (1.99e-1)	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49	17.5	12.5	18	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22	4	3.7	35.7	4.5	1.4	3	1	23.3	9.2	18.2	10.9	12.2	13.9	11.8	13.8	12.8	15.6	16.2	9.7	16.8	9.2	16.5	13.1	18.4	17.7	10.5	21.3	3.3	12.9	6.8	19	8.3	10.7	6.7	2	11.4	11	12.2	14.8	17.7	11.3	6.7	16.7	4.7	7.7	5.8	9.1	10.7	7.4	27.7	3.8	13.8	46	8.8	5.8	20.7	12	17.8	8.9	6.1	16.5	13.2	11.9	16.9	14.4	3.7	3.2	6.3	5.5	6.6	5	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4	3	2.6	35.7	1.4	3.2	3.7	1.8	1	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2
PKN3	"PKNbeta, UTDP4-1"	ENSG00000160447	Protein kinase N3	Q6P5Z2	9	128702523-128720918	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HeLa: 32.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA045390, HPA058305"	Uncertain		Approved	Vesicles				Vesicles		"HPA045390: , HPA058305: "	unprognostic (4.36e-2)	unprognostic (5.70e-2)	unprognostic (2.68e-2)	unprognostic (7.62e-2)	unprognostic (2.23e-1)	unprognostic (2.65e-2)	unprognostic (6.10e-2)	unprognostic (8.04e-2)	unprognostic (1.78e-1)	unprognostic (3.68e-1)	unprognostic (1.48e-1)	unprognostic (7.91e-2)	unprognostic (8.73e-3)	unprognostic (6.18e-3)	unprognostic (9.99e-2)	unprognostic (7.23e-2)	unprognostic (2.36e-1)	11.4	1.8	1.5	6.8	3.8	3.7	10.5	10.1	3.9	4.3	5.8	3.7	4.8	7.7	9.7	2.2	7.1	5.3	10.9	7.3	2.3	1.7	5	6.4	8.9	9.1	3.9	1.2	4	4.2	3.3	1.4	5.6	4.5	4.2	1.6	4.1	12.9	3.7	7.4	6.7	5.4	4.9	4.4	7.8	7.4	4.3	1.7	9.3	8.1	6.1	5.9	4.4	5	0.4	1	2.3	0.7	1	1.8	0.3	1.3	6.7	5.5	8.3	0	0.1	13.6	4.2	1.3	6.2	6.4	0	4.9	0	4.1	2.2	9.1	6.7	1	1.4	4.2	12.6	8	32.8	9.6	1	1	1.4	0.3	0.3	3.3	0.9	12.2	18.3	0.9	1.1	12.6	1.2	4.3	5.1	2	19.9	10.4	1.8	2.6	0.8	0.9	4.1	3.1	1.7	3.1	5.9	6.4	10.5	0	5.2	9.7	3.1	3	1.3	2.6	0.7	1	3.8	0	0.1	1.4	0.9	0.7	1.8	0.2	0.6	0.8	1	0.4	0.8	0.1	2.3	1	0.2	0.2	1	0.3	1.5	3.8	10.1	3.9	2.3	1.7	3.9	1.2	4.5	1.7
PLK1	PLK	ENSG00000166851	Polo like kinase 1	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 83.9;testis: 32.4	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enriched	Detected in some	5	T-reg: 9.0	Lineage enriched	Detected in many	5	T-cells: 9.0	Low region specificity	Detected in single			Low region specificity	Detected in many			"HPA051638, HPA053229"	Approved									"HPA051638: , HPA053229: "	unprognostic (7.21e-3)	unprognostic (1.77e-1)	unprognostic (1.98e-3)	unprognostic (4.97e-3)	unprognostic (9.56e-2)	unprognostic (5.12e-2)	prognostic unfavourable (2.70e-7)	prognostic unfavourable (2.28e-5)	unprognostic (2.55e-2)	unprognostic (1.89e-1)	prognostic unfavourable (4.12e-4)	unprognostic (1.24e-2)	prognostic unfavourable (0.00e+0)	unprognostic (1.33e-1)	unprognostic (8.10e-2)	unprognostic (1.19e-1)	unprognostic (1.26e-2)	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6	1.1	0.9	10.4	0.7	1.5	1	1	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9	2.3	43.1	45	37.2	20.2	1.1	2.6	20.9	24.7	16.3	38.7	28.9	39.3	28.5	21.6	12.9	16.6	24.8	50.7	20.3	46.6	30.7	28.6	27.4	35.5	53.7	0.3	31.6	30.1	1	1.1	27.4	28.3	28.3	42.6	29.8	29.8	39.4	29.7	31.6	42.5	22.9	46.5	25.3	34.3	11	9.4	21	14.6	28.2	19.8	12.8	25.2	19.5	14.3	18.4	23.6	18	42.1	21.2	33	37.4	15.6	27.5	30.1	0	0.1	0	0	0	0	1.9	1.4	0.5	0.5	0	0	0	0.7	1.3	0	0	9	2.3	1.1	1.5	2.1	1.1	1	0.8	0.8	0.6	0.7	0.5
PLK2	SNK	ENSG00000145632	Polo like kinase 2	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Tumor suppressor	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		RPTEC TERT1: 42.9;T-47d: 72.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		NK-cell: 10.4	Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in many			"CAB009624, HPA069329"	Approved		Approved	"Nucleoplasm,Mitochondria,Cytosol"				"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	unprognostic (4.82e-2)	unprognostic (1.08e-2)	unprognostic (2.38e-1)	unprognostic (6.51e-2)	prognostic unfavourable (7.75e-4)	unprognostic (1.22e-1)	unprognostic (2.55e-2)	unprognostic (1.03e-2)	unprognostic (2.44e-2)	unprognostic (1.06e-2)	unprognostic (1.01e-1)	unprognostic (3.11e-1)	prognostic unfavourable (2.08e-4)	unprognostic (6.56e-2)	unprognostic (1.43e-1)	unprognostic (3.46e-1)	unprognostic (1.95e-3)	11.4	3.7	19.6	4	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3	1.6	10.4	1.2	0.6	22.9	20.7	7.2	0.5	3.8	6.2	2.8	4.9	8.2	16.3	9.5	1.5	20.3	0	32.3	17.6	28.8	0.3	11.3	14.9	0	0.6	0	9.3	1.7	20.7	0.1	0.6	3.6	15.7	6.3	17.6	32.8	0	0.8	32.2	8.3	0	0	1.3	3.4	1.1	20	0	42.9	4.6	0.4	0.9	15.1	3	13.2	72.3	0.3	41.8	4.5	12.2	2	39.1	0	0	0	3.5	0	20	3	0.7	2.3	0.1	1.6	0	1.2	0.7	0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4
PLK3	"CNK, FNK, PRK"	ENSG00000173846	Polo like kinase 3	Q9H4B4	1	44800225-44805990	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA060318	Enhanced									HPA060318: 	unprognostic (1.06e-1)	unprognostic (8.71e-2)	unprognostic (3.69e-2)	unprognostic (3.51e-3)	unprognostic (3.09e-2)	unprognostic (4.72e-2)	unprognostic (1.02e-1)	unprognostic (1.59e-1)	unprognostic (5.12e-3)	unprognostic (6.78e-2)	unprognostic (7.67e-3)	unprognostic (2.79e-2)	prognostic unfavourable (1.75e-4)	unprognostic (2.04e-1)	unprognostic (1.43e-1)	unprognostic (5.06e-2)	unprognostic (1.35e-1)	14.8	7.6	4.4	16.3	18.8	8.6	10	2.4	6.4	8.6	5.3	13.9	3.2	4	9.9	5.8	23.9	8.5	21.6	6.8	10.5	6	6.7	9	14.9	10	9.9	2.5	7.8	10.7	15.6	9	29.6	14.8	6.4	4	7.6	8.2	6.8	7	16.6	7	6	15.2	9.1	6.1	4.5	5.6	4.6	8.4	25	18.2	9.9	9.5	1.3	4.2	2.8	5.1	0.6	11	3.5	4.1	2.7	4.2	1.9	3.1	10.2	7.8	9.8	13.8	3.7	3.8	1.6	5.9	5.1	4.1	8	3.8	2.3	13.4	2.1	8.2	0.7	5.6	1.5	3.6	15.3	1.8	7.2	7.9	8	11.1	10.9	11.7	2.9	2.1	8.4	2.7	3.7	1.6	2.8	3.3	4.4	2.8	7.3	13.3	1.6	3.2	2	2.6	4.6	10.8	0.4	1.8	14.9	2.3	5.7	4.5	5.7	5.9	2.7	1.3	4.9	2.9	4.5	0	2.9	0.8	1.7	5	2.1	1.3	9.9	4.2	4.2	1.1	11	4.9	2.8	0.6	5.1	1.8	10.5	3.5	4.4	18.8	2.4	6.4	10.5	6	9.9	2.5	14.8	5.6
PLK4	"Sak, STK18"	ENSG00000142731	Polo like kinase 4	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all							"HPA017327, HPA035026, HPA043198"	Approved		Supported	"Centrosome,Cytosol"				"Centrosome, Cytosol"		"HPA017327: , HPA035026: AB_10602080, HPA043198: "	unprognostic (2.44e-1)	unprognostic (4.24e-2)	prognostic favourable (7.46e-5)	unprognostic (2.18e-1)	unprognostic (3.79e-1)	unprognostic (9.20e-2)	unprognostic (1.06e-5)	prognostic unfavourable (5.13e-4)	unprognostic (1.44e-3)	unprognostic (5.66e-2)	prognostic unfavourable (5.14e-4)	unprognostic (1.27e-1)	unprognostic (2.22e-11)	unprognostic (2.29e-2)	unprognostic (3.58e-1)	unprognostic (4.75e-2)	unprognostic (7.93e-2)	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1	21.7	1	2.1	6	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4	0.8	11.6	5.5	20.7	10.6	0.7	2	9.4	11.4	8.1	15.2	15.8	7.7	12	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6	14.2	8.8	7.2	0.2	20	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21	12.8	8.1	30.8	9	9.6	6.3	16.1	14.5	5.4	5	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5	12	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0	1.4	0.3	0.4	4	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1
PLK5	"PLK5P, SgK384ps"	ENSG00000185988	Polo like kinase 5	Q496M5	19	1524074-1536046	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis"			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	6	brain: 50.1	Cell line enhanced	Detected in some		Daudi: 5.0	Low cancer specificity	Detected in single			Region enriched	Detected in all	6	cerebellum: 50.1	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many											HPA035024	Enhanced									HPA035024: 	unprognostic (4.32e-2)	unprognostic (1.22e-2)	unprognostic (1.35e-1)	unprognostic (7.69e-2)	unprognostic (1.11e-2)	unprognostic (1.33e-1)	unprognostic (2.69e-1)	unprognostic (8.38e-2)	unprognostic (4.06e-2)	unprognostic (1.74e-1)	unprognostic (3.36e-2)	unprognostic (9.94e-3)	unprognostic (2.18e-3)	unprognostic (3.21e-1)	unprognostic (7.49e-2)	unprognostic (3.54e-2)	unprognostic (4.01e-4)	0.4	0.7	8.3	0.4	4.8	1.7	0.8	50.1	7.9	5.9	0.4	1.6	0.3	0.5	6.4	6.2	1.6	2.7	0.4	0.3	3.2	1.7	0.3	0.3	0.3	0.4	1.1	1.9	0.8	0.6	0.5	0.5	0.3	2.9	0.9	0.4	8.4	0.6	3.2	0.5	1	0.7	2.8	0.8	0.4	0.2	7.4	1.8	0	0.4	0	0.3	0.2	2.9	1.2	1.2	4.4	0.9	1	1.1	0.1	0.2	0.9	0.8	1.2	0.4	0.9	1	0.2	0.5	0.5	0.4	0.5	1	5	0.3	0.5	1.2	0.8	0.5	0.2	0.5	0.6	1	1.3	0.8	0.1	0.2	1.1	1	0.3	0.8	0.2	0.3	0.8	1.7	0.8	1	0.4	1	1.4	0.9	1	0.3	0.4	0.6	0.1	0.5	0.7	0.7	0.4	0.3	1.5	0.7	0	0.9	1	1.2	0.2	1.5	0.4	0.6	0.4	0.7	0.5	1.6	0.9	2.2	0.8	0.5	0.5	0.7	0.8	0.5	0.2	1.2	1.1	0.6	4.4	1	0.6	1.2	1	0.1	8.3	4.8	50.1	7.9	3.2	1.7	1.1	1.9	2.9	1.8
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	Pregnancy up-regulated nonubiquitous CaM kinase	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 35.4;seminal vesicle: 38.5	Cell line enriched	Detected in some	8	AN3-CA: 26.5	Cancer enhanced	Detected in many		renal cancer: 15.3	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				Plasma membrane	"Golgi apparatus, Cytosol"	HPA007458: AB_1079644	unprognostic (1.56e-1)	unprognostic (2.56e-1)	unprognostic (1.16e-2)	unprognostic (5.95e-3)	unprognostic (1.83e-2)	unprognostic (3.98e-2)	unprognostic (2.15e-4)	unprognostic (1.72e-1)	unprognostic (1.08e-1)	unprognostic (1.46e-2)	unprognostic (3.60e-1)	unprognostic (1.27e-1)	prognostic unfavourable (1.04e-6)	unprognostic (2.86e-3)	unprognostic (1.43e-1)	unprognostic (2.66e-1)	unprognostic (6.26e-3)	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17	1	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0	0.5	0	0.7	10.4	1.4	0	0	0	0	0	0	0	0.3	0.1	0.3	26.5	0	0	2.8	0.3	0.3	0	0	0	0.1	0	0.8	0	0.3	0.4	0	0	0	3.2	0	0	0.4	0.1	0	0.1	0	0	0	0	0	0.3	0.2	0.1	0.5	0	0	0.7	0	0	0	0	0	0.1	0.2	3.1	0	0.1	2.1	0.2	0.3	0	0.2	1.1	0	0.2	0.2	0	0.2	0.4	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.4	35.4	3.7	23.2	19.5	17	6.1	15.5	3.8	1.7
POMK	"FLJ23356, SgK196"	ENSG00000185900	Protein-O-mannose kinase	Q9H5K3	8	43093506-43123434	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013321	Uncertain		Approved	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	HPA013321: AB_2668809	unprognostic (1.66e-2)	unprognostic (1.12e-2)	unprognostic (1.27e-1)	unprognostic (4.37e-2)	unprognostic (1.29e-1)	unprognostic (4.62e-2)	unprognostic (5.56e-2)	unprognostic (2.42e-1)	unprognostic (2.50e-1)	unprognostic (8.10e-2)	unprognostic (1.23e-3)	unprognostic (1.03e-1)	unprognostic (2.32e-1)	unprognostic (7.09e-2)	unprognostic (1.06e-1)	unprognostic (3.71e-3)	unprognostic (2.10e-2)	4.7	5.5	9.8	5.6	14.3	12.5	5.1	12.3	18.6	6.9	4.8	8.3	2.2	4.5	6.9	4.4	7.1	6.2	4.8	3.8	7.7	7	3.4	4.5	5.5	6	4.8	11.1	5.8	9.3	6.3	7.4	6.1	10.5	5.6	5.9	6.1	6.8	4	6.2	7.1	5.6	6.4	6.7	7.6	6.8	7.1	7.2	7.5	7.4	3.2	7.4	4.6	5	2.6	2.6	6.7	2.9	1	3.3	1.3	3.5	7.5	5.8	15.1	2.8	3.4	5.5	2.1	3.1	5.5	4	5.5	9.1	4.9	4.6	3.8	5.8	8.2	6.3	5.3	1.9	1.4	13.9	5.5	2.4	2	4.7	7.8	3.8	2.7	7.3	5.3	5.4	3.2	14.8	3.7	1.6	9.9	2	11.8	1	6.8	6.8	2.8	1.5	9.8	5.6	4.1	9.1	3.1	3	9.7	3.2	7.4	8.4	8.4	8.6	4.2	4.8	8.5	9.3	3.5	3.2	9.9	0.8	2.9	1.9	2.3	2.4	3.3	1.8	1.3	1.3	2.6	2.6	1.8	2.3	6.7	1	1.5	2.5	1.1	1.3	9.8	14.3	12.3	18.6	7.7	7	4.8	11.1	10.5	7.2
PRAG1	"DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223"	ENSG00000275342	"PEAK1 related, kinase-activating pseudokinase 1"	Q86YV5	8	8317736-8386498	"Enzymes, Predicted intracellular proteins"				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.4	Cell line enhanced	Detected in many		A549: 28.1;NTERA-2: 18.2	Low cancer specificity	Detected in all							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all							HPA012066	Uncertain									HPA012066: AB_1847706	unprognostic (7.04e-3)	unprognostic (7.90e-2)	unprognostic (2.32e-1)	unprognostic (2.95e-2)	unprognostic (1.60e-1)	unprognostic (2.92e-1)	unprognostic (1.05e-1)	unprognostic (4.78e-3)	unprognostic (2.64e-3)	unprognostic (5.19e-2)	unprognostic (4.95e-2)	unprognostic (1.78e-1)	prognostic favourable (4.81e-4)	unprognostic (5.27e-2)	unprognostic (1.23e-1)	unprognostic (5.04e-2)	unprognostic (5.22e-3)	7.6	0.2	6.4	8.8	4.9	0.1	5.4	30.4	7	2.4	5.7	1.8	3.2	9.8	0.8	1.7	2.6	5	4	1.8	2.1		1.3	0.9	4.3	9.1	0	1.4	1.7	1	2.2	0	5.4	1.2	1.5	3.4	0	1.7	5.7	5.6	2.8	9.4	0.9	1.4	5.7	3.9	0.7	1.2	1.8	15.4	4.7	6.2	1.5	0.2	3.1	4.6	2.2	1.6	1.3	3.9	0.4	3.4	28.1	3.2	0.4	0	0.2	8	7.1	1.5	2.8	1.2	13.9	8.2	5.6	4.9	3.4	12.2	0.5	8.6	0.6	0.2	0.9	0	3.4	7.8	3.1	0.8	8.9	0.7	5.6	0.4	1.3	5.8	0	0	2.1	4.7	0.7	2.6	18.2	7.2	3.6	3.4	1.3	4.1	9.8	1.6	1	2.7	7.9	2.8	6.1	3.5	7.7	0.3	7.5	0	1.7	0.4	0.6	7.7	1.8	1.9	4.2	0	0.5	2.2	1.2	0.1	0.9	3.1	1.5	0.4	0.7	2.6	3.9	3.2	0	1.3	1.6	4.6	0.2	0.4										
PRKAA1	AMPKa1	ENSG00000132356	Protein kinase AMP-activated catalytic subunit alpha 1	Q13131	5	40759379-40798374	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB005050, HPA035409, HPA064946"	Supported		Supported	Nuclear speckles				Nuclear speckles		"CAB005050: AB_562037, HPA035409: , HPA064946: "	unprognostic (2.07e-1)	unprognostic (1.41e-2)	unprognostic (2.51e-2)	unprognostic (3.57e-2)	unprognostic (3.97e-1)	unprognostic (1.05e-1)	unprognostic (3.51e-2)	unprognostic (7.53e-2)	unprognostic (1.66e-2)	unprognostic (2.88e-1)	unprognostic (3.34e-3)	unprognostic (2.63e-1)	unprognostic (2.82e-2)	unprognostic (1.35e-1)	unprognostic (1.60e-1)	unprognostic (1.27e-2)	unprognostic (1.10e-2)	40.6	15.7	9.4	15.9	16.1	29	26.2	14.3	17.7	30.2	24	19.9	18.9	21.7	23.5	20.9	22.5	20.4	21.3	15	10.5	11.7	35.9	40.7	24.8	16.7	12.2	8.5	28.8	20.6	25.3	20	16.8	35.7	26.1	22.3	20	23.2	17.9	18.5	16.6	32.6	20.7	14.1	25.1	22.1	29.3	11.4	21.4	28	20.5	22.9	32.5	17.9	8.4	6.5	15.9	8.9	10.8	12.6	6.5	11.3	11.8	9.5	12.6	23.5	24.5	9	19.3	19.8	14.5	13	11.1	14.7	6.7	9	19.8	9.2	8.7	17.6	27.5	19.6	7.9	13.3	27.3	8.8	19.4	12.6	14	22.6	8.6	19.4	20	21.4	6.2	19.4	21.6	5.4	11.6	9.9	4.1	14.3	9.8	20.3	9.8	22.3	19.3	8.2	8.3	33.9	22.6	11.5	11.9	10.5	22.9	26.2	14.2	15.1	15.7	7.7	6	8	16.4	27.4	13.9	14.1	6.6	12.7	10	8.1	12.6	8.4	9.4	9.4	6.5	7.7	11.5	10	15.9	10.8	8.9	2	11.3	6.5	9.4	16.1	14.3	17.7	10.5	11.7	12.2	8.5	35.7	11.4
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	Protein kinase AMP-activated catalytic subunit alpha 2	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 39.1;skeletal muscle: 40.2	Cell line enhanced	Detected in many		HEK 293: 8.5;RPTEC TERT1: 14.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.0	Lineage enriched	Detected in single	5	granulocytes: 1.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"				Nuclear speckles	Golgi apparatus	HPA044540: 	unprognostic (4.17e-3)	unprognostic (1.62e-2)	unprognostic (4.17e-1)	prognostic unfavourable (4.80e-4)	unprognostic (9.35e-2)	unprognostic (1.92e-3)	prognostic unfavourable (5.30e-4)	unprognostic (7.30e-2)	unprognostic (3.94e-1)	unprognostic (1.82e-1)	unprognostic (1.97e-1)	unprognostic (8.64e-2)	prognostic favourable (4.95e-5)	unprognostic (1.30e-2)	unprognostic (4.52e-2)	unprognostic (1.57e-2)	unprognostic (1.85e-1)	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5	4.6	2.2	6	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0	4	12.3	0.8	4.4	2.1	0.2	0	1	0.1	0.1	0.1	0	0	3.7	2	0	0.7	0.5	2.3	1.8	1.4	2.5	4.3	3.8	4.7	0	0.6	0.6	0	7.8	0	7.1	0	8.5	0	6.9	5.2	0	0	0.1	0.6	0	3.5	0.3	0.8	0	0	1	0.1	0	0	5.5	5.4	0	0	0	14	1.2	2	5.4	5.7	0.1	0	3.2	0	0	1.5	2.3	2.7	6.3	0	0	0	4.5	0	1.1	0.5	0	0.1	0.1	0.1	0	0.1	0	0	0	0.2	0	0.1	1	0.1	0	0	0	0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5	0.8
PRKACA	PKACa	ENSG00000072062	Protein kinase cAMP-activated catalytic subunit alpha	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010361, HPA071185"	Approved		Approved	Cytosol		1300000	1300000	Cytosol		"CAB010361: AB_2268772, HPA071185: "	unprognostic (1.08e-1)	prognostic favourable (6.28e-6)	unprognostic (2.09e-2)	prognostic unfavourable (6.26e-5)	unprognostic (1.38e-2)	unprognostic (2.95e-1)	unprognostic (1.64e-1)	unprognostic (9.36e-3)	unprognostic (7.01e-2)	unprognostic (3.41e-1)	prognostic favourable (6.47e-4)	unprognostic (2.86e-1)	unprognostic (1.17e-1)	unprognostic (4.68e-2)	unprognostic (1.87e-1)	unprognostic (3.66e-2)	unprognostic (6.14e-3)	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	25.7	15	34	40.5	30.1	32	6.1	27.4	25.4	39	35.8	18.2	9.2	11.1	22.2	43.4	16.9	23.9	26	37.1	20.3	12	20.5	28.3	17.6	25.8	12.6	21.7	30.4	12.5	31	10.8	32.8	19.2	29.2	39.8	38.2	28.4	9.5	12.2	33.4	25.7	31.4	25.7	19	16.3	26.8	17.1	24.8	15.2	11.3	21.7	12.2	25.4	46.1	12.9	61.6	25.6	20.2	20.7	16.4	30.9	19.2	17.2	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1
PRKACB	PKACb	ENSG00000142875	Protein kinase cAMP-activated catalytic subunit beta	P22694	1	84078062-84238498	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 85.5	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010363, HPA029754, HPA071185"	Approved		Approved	Cytosol		1500000	1500000	Cytosol		"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: "	unprognostic (9.38e-2)	unprognostic (1.18e-1)	unprognostic (6.37e-2)	unprognostic (1.39e-1)	unprognostic (1.58e-1)	unprognostic (1.98e-1)	prognostic unfavourable (9.49e-4)	unprognostic (1.28e-1)	unprognostic (3.28e-2)	unprognostic (1.92e-1)	unprognostic (2.31e-1)	unprognostic (4.62e-2)	prognostic favourable (1.89e-6)	unprognostic (1.22e-1)	unprognostic (3.28e-1)	unprognostic (1.12e-2)	unprognostic (2.48e-1)	7	21.5	40	10.5	57	6.2	8	54.7	85.5	9.4	23.6	16.9	3.9	4.8	8.7	17.6	8.1	5.2	11.5	10.1	43.1	52.1	10.6	9	6.9	16.2	38.3	33.5	8.3	11.9	12.2	18.3	5.1	35.5	13.8	22.6	4.9	32.9	12.7	3.2	2.6	6.3	12.6	47.7	14.6	14.2	3.6	25.9	25.5	11.1	1.8	15.3	13.5	4.6	13.5	7.1	17.1	5.4	25.9	27.6	22	3.1	6.2	9.9	11.9	11.5	10.1	4.6	15.4	11.7	7.8	7.4	0.1	2.8	16.3	10.6	12	2.1	4.6	5	8.4	15.9	2.5	35.9	8.5	1.2	11.3	14.2	0.8	6	2.2	7.6	4.3	36.1	1.1	9.4	12.8	0.5	18.4	7.5	9.8	4.4	14.3	15.5	9.9	19.1	11.1	3.2	12.7	8.5	3.3	9.4	3	3	32	10.9	8.5	11.1	11.6	7	8.4	16.5	5.2	15.1	13.6	17.1	2.7	5.8	23.3	3.6	18.7	13.5	17.3	20.6	7.1	10.2	26.4	27.6	1.5	25.9	5.4	4.1	15.9	22	40	57	54.7	58.2	43.1	52.1	38.3	33.5	35.5	25.9
PRKACG	PKACg	ENSG00000165059	Protein kinase cAMP-activated catalytic subunit gamma	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	31	testis: 27.4	Cell line enhanced	Detected in single		CACO-2: 1.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											"CAB004530, HPA071185"	Supported		Approved	Cytosol				Cytosol		"CAB004530: AB_628137, HPA071185: "					unprognostic (2.74e-1)									unprognostic (3.61e-2)	unprognostic (7.22e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27.4	0	0	0	0	0	0	0	0.3	0.1	0.7	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	0	0.5	0	0	0	0.1	0	0	0	0.7	0	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0
PRKCA	PKCA	ENSG00000154229	Protein kinase C alpha	P17252	17	66302636-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		U-87 MG: 53.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	17	dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		1900000	1900000	Cytosol	Plasma membrane	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	unprognostic (3.06e-1)	unprognostic (3.56e-2)	unprognostic (1.38e-2)	unprognostic (1.01e-1)	unprognostic (1.53e-1)	unprognostic (7.41e-3)	unprognostic (7.43e-2)	unprognostic (6.86e-3)	unprognostic (4.93e-2)	unprognostic (1.50e-1)	unprognostic (2.09e-1)	unprognostic (2.24e-2)	unprognostic (5.50e-2)	unprognostic (2.46e-1)	unprognostic (1.83e-1)	unprognostic (1.35e-3)	unprognostic (8.77e-2)	4	19.6	26.5	9	22.8	2.5	3	10.8	33.9	7	13.8	19	3.5	14.6	14.8	6.7	4.7	6.1	10.8	5.8	31.6	15.6	16.7	6.5	6	8.4	18.7	15.6	20.4	5.5	1.7	6	6.5	17.6	17.2	11.2	7	3.1	22.3	6.6	3.8	12.7	13.7	15	7.9	7.9	3.7	14.4	0.4	4.5	1.3	5.9	9.5	9.5	0	1.4	0.1	2.7	0.1	4	1	2.3	12.3	2.5	2.6	6.2	15.9	0.3	13.3	8.7	9.6	8.2	1.4	1.5	3.1	3.6	21.4	0.3	1.3	1.5	20.9	5.1	3	0	7.3	6.4	8.5	3.8	20.9	6.9	0.6	12	10.3	8.2	8	0	14.8	0.7	7.7	2.3	1	6.6	1.4	18.8	0	3.4	2	1.5	8.5	4.4	2.5	0.1	0.3	5.4	24.5	16.7	9.7	10.4	8.3	0	0	0.3	53	0	8.2	0.1	0.6	0	0.5	0.8	1.5	0	2.5	1.2	1.1	0	4	2.3	0	0.1	2.7	1.4	0.5	1	26.5	22.8	10.8	28.2	31.6	15.6	18.7	15.6	17.6	14.4
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	Protein kinase C beta	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 57.2;lymphoid tissue: 31.2	Cell line enhanced	Detected in some		HEL: 40.8;HMC-1: 40.9;K-562: 58.1;THP-1: 18.4;U-937: 16.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB003843, HPA048321, HPA054203"	Approved		Supported	"Nucleoplasm,Cytosol"		3400000	3400000	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: , HPA054203: "	unprognostic (1.53e-3)	unprognostic (4.53e-4)	unprognostic (2.52e-3)	unprognostic (3.07e-2)	unprognostic (1.72e-1)	unprognostic (7.13e-3)	unprognostic (2.06e-1)	unprognostic (1.67e-3)	unprognostic (3.19e-2)	unprognostic (1.79e-1)	unprognostic (7.38e-2)	unprognostic (1.06e-1)	unprognostic (3.17e-3)	unprognostic (2.08e-1)	unprognostic (2.12e-2)	unprognostic (3.28e-1)	unprognostic (4.95e-2)	4	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31	11	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19	7.5	0	0	0	0	0	0	0	0	0	0	0	0	0	7.7	0.2	0	0.1	0.1	0	0	0	0.8	40.8	1.9	0	0	5.9	40.9	0	0.1	0	0	0	58.1	0.1	0	0	12.9	12.9	0.3	0	12.3	0.1	2.3	0.1	3.6	7.1	0	0	0	0.6	0	18.4	0.2	0	0	0	0	1	0	0.3	0	16.4	0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11	20.4	8.3	6.4
PRKCD		ENSG00000163932	Protein kinase C delta	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		SK-BR-3: 63.3;THP-1: 45.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	6	basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5	Group enriched	Detected in all	7	dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9	Group enriched	Detected in many	5	basal ganglia: 124.2;thalamus: 366.1	Low region specificity	Detected in all			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		300000	300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	unprognostic (3.59e-1)	unprognostic (4.85e-2)	unprognostic (2.66e-2)	unprognostic (1.90e-1)	unprognostic (1.17e-1)	unprognostic (6.97e-2)	prognostic unfavourable (2.24e-4)	prognostic favourable (9.01e-4)	unprognostic (1.95e-2)	unprognostic (1.42e-1)	unprognostic (1.79e-1)	unprognostic (2.89e-1)	unprognostic (2.05e-1)	unprognostic (1.73e-1)	unprognostic (2.48e-2)	unprognostic (2.06e-3)	unprognostic (2.95e-3)	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.7	3	1.2	2	9	5.2	11.2	4.7	5.9	5.8	5.7	7.3	7.6	20	2.1	10.2	3.5	7.9	11.5	4.7	17.4	6	11.1	4.1	7.8	5.7	14.6	25.1	4.1	8.4	5.9	5.5	5	2.2	2.9	8.3	19.1	1.6	24.9	3.1	5.5	1.7	3	4.7	6.3	16.7	2	1.4	3.6	63.3	9.7	5.3	45.2	7.2	2.8	3.6	3.7	4.4	4.4	6.8	10.2	6.7	25.2	5.4	17.7	22.9	17	1.5	22.2	1	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8
PRKCE		ENSG00000171132	Protein kinase C epsilon	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 36.5	Cell line enhanced	Detected in many		REH: 19.1;TIME: 19.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		naive B-cell: 5.5	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB001948, HPA044496, HPA054252"	Enhanced	Supported	Approved	Vesicles				Vesicles		"CAB001948: , HPA044496: , HPA054252: "	unprognostic (1.10e-1)	unprognostic (1.78e-1)	unprognostic (2.27e-1)	prognostic unfavourable (2.42e-4)	unprognostic (9.61e-2)	unprognostic (5.70e-2)	unprognostic (1.51e-1)	prognostic favourable (9.62e-4)	unprognostic (3.05e-1)	unprognostic (6.72e-2)	unprognostic (7.49e-3)	unprognostic (9.99e-2)	prognostic favourable (2.63e-7)	unprognostic (1.21e-1)	unprognostic (7.11e-2)	unprognostic (6.43e-3)	unprognostic (2.23e-2)	5.5	7.4	15.3	7.2	14.2	9.3	8.1	28.8	36.5	6.6	5.5	3.8	5.9	3.6	5.6	4.6	4.7	7.6	4.7	7.7	22.5	10	12.8	15.5	17.5	6.9	6	15	4.1	4.2	16.3	6	10.4	9.1	3.6	4.7	3.7	3.6	8.6	7.2	3	3.7	6.2	4.4	4.9	4.4	7.2	3.7	1.5	6.5	1.2	5.4	5	6.5	5.5	2.2	1.7	1.4	0.9	1.3	0.6	5.3	2	2.8	2.8	4.3	5.1	2.3	3.8	6.8	3.2	3.4	0.5	5.3	8.1	3.6	3.9	1.3	1.8	2	4.5	4.8	3.4	0	1.4	1.1	4.9	0.6	2.9	4.5	2.2	4.7	3.4	11.6	1.1	1.9	3.6	2.7	2.6	0.3	1	1	19.1	13.5	8.6	2.9	3.7	2	4.3	1.7	5.7	12.3	4.6	1.9	19.2	6.2	6.5	4.5	3.7	0	0	6.8	5.1	4.5	6.2	0	1.2	1.7	1	0.4	1.1	3.6	0.7	0.7	2.2	5.5	1.3	0.4	0.4	0.9	1.4	0.9	0	0.6	15.3	14.2	28.8	33.2	22.5	10	6	15	9.1	3.7
PRKCG	"MGC57564, PKCC, PKCG, SCA14"	ENSG00000126583	Protein kinase C gamma	P05129	19	53879190-53907652	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Biological rhythms	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	brain: 49.9	Cell line enhanced	Detected in some		A549: 5.8;HAP1: 2.7;SH-SY5Y: 4.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all			"CAB013051, HPA047870, HPA054560"	Enhanced									"CAB013051: AB_2533015, HPA047870: , HPA054560: "	unprognostic (7.14e-2)	unprognostic (5.42e-2)	unprognostic (1.85e-1)	unprognostic (3.86e-2)	unprognostic (1.41e-1)	unprognostic (5.38e-2)	unprognostic (5.96e-2)	unprognostic (4.46e-2)	unprognostic (2.09e-1)	unprognostic (2.64e-2)	unprognostic (7.48e-3)	unprognostic (2.68e-1)	unprognostic (2.22e-7)	unprognostic (2.41e-2)	unprognostic (2.61e-1)	unprognostic (1.06e-1)	unprognostic (1.83e-1)	1	0.9	28	1.1	49.9	2.2	0.9	12.1	39.2	0.9	1.3	1.6	0	1.5	1	0.9	1	1.4	1	0.9	49.7	4.4	0.9	0.9	1	0.9	2.9	20.8	0.9	3.5	2.1	0.2	0.9	0.7	0.9	1.2	0	0.9	1	1	0.9	1.3	1.1	1.4	0.9	1.8	4.4	2.1	1.3	0.9	0	0.9	0.9	0	0	0	0	0.3	0	0.2	0	0.3	5.8	1.3	0	0	0.2	0.1	0.7	0.4	0.1	0	1.5	1.5	0.3	1.7	0	0.5	2.7	0	0	0	1.1	0	0.2	0	0.1	0	2.4	0	0	0.6	0	0	0	0.1	0	0.6	0.5	0.1	1	0.5	1	0.6	0.1	1.1	0	0	4	1.6	0.2	0	1.9	0	1	0	2	0	0	1.7	0.4	0.2	0	0	0.2	0	0.3	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	28	49.9	12.1	28.5	49.7	4.4	2.9	20.8	0.7	2.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	Protein kinase C eta	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		BEWO: 29.9;HUVEC TERT2: 39.2;MOLT-4: 26.0;RT4: 16.5;TIME: 25.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	12	gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6	Group enriched	Detected in many	14	NK-cells: 27.3;T-cells: 35.3	Group enriched	Detected in many	6	basal ganglia: 25.0;thalamus: 19.5	Low region specificity	Detected in many			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	Plasma membrane	"HPA026294: AB_10603988, HPA053709: "	unprognostic (1.42e-1)	unprognostic (3.89e-3)	unprognostic (1.78e-1)	unprognostic (1.96e-3)	unprognostic (1.04e-1)	prognostic favourable (8.55e-6)	unprognostic (1.14e-2)	unprognostic (2.97e-2)	unprognostic (4.14e-1)	unprognostic (1.94e-1)	unprognostic (7.96e-2)	unprognostic (1.60e-1)	unprognostic (1.52e-3)	unprognostic (1.13e-1)	unprognostic (4.14e-2)	unprognostic (6.98e-2)	unprognostic (4.73e-3)	17.5	5.4	5	21.6	22	11.2	14.7	2.8	6.1	13.6	10.3	6.2	6.9	5.1	19.1	7	20.1	8.6	12.7	10.1	6.8	4.4	8.1	5.5	24.1	27.6	5.9	2.5	7.1	5.9	8.8	15.5	22.7	7.2	9.8	5	9.1	24.7	10.8	9.1	15.9	16	10.5	5.7	25.9	6	4.3	6.4	54.6	15.1	10.6	34.6	13.2	14.4	0.4	2.2	1.5	0.7	27.3	35.3	17.9	6.2	2.2	0.3	1.7	1	0.2	29.9	0.1	0.5	0.3	0.3	0.6	3.7	0.1	4.5	0	4.4	0.2	4.8	0.5	0.7	2.8	0	0.7	0.2	0.4	0	0.9	0.8	5	0.2	3.4	39.2	0	0.1	2.2	11.5	26	0.2	0.5	3	2.2	1.1	0	0	16.5	1.1	1.9	0.7	5.8	3.6	5.7	0.5	25.7	0.7	5.2	0.7	0.3	0.5	0.1	0.2	1.1	0.3	1.2	0.1	0.7	0.5	30	0.4	23.9	0.4	23	35.3	2.2	0.3	28.5	27.6	1.5	27.3	0.2	0.7	18.6	17.9	5	22	2.8	6.1	6.8	4.4	5.9	2.5	7.2	6.4
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	Protein kinase C iota	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"				Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: "	unprognostic (2.26e-1)	unprognostic (6.75e-2)	unprognostic (4.57e-2)	prognostic unfavourable (3.93e-6)	unprognostic (1.59e-1)	unprognostic (1.84e-2)	prognostic unfavourable (3.02e-4)	unprognostic (2.52e-1)	unprognostic (7.10e-2)	unprognostic (1.73e-2)	prognostic unfavourable (1.22e-4)	unprognostic (5.32e-3)	prognostic favourable (3.10e-4)	unprognostic (1.16e-1)	unprognostic (2.65e-1)	unprognostic (1.06e-1)	unprognostic (9.73e-2)	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7	6	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11	16.3	12.2	7.3	25.8	12.6	12.7	11	11.6	12.5	6.8	6.1	30.2	15	5.3	12.6	23.1	8.4	9.9	16.3	13	1.9	1.8	1	1.3	5.8	4.8	1.4	35.9	9.1	9.2	9.8	8.2	11.4	14.9	9.2	13.7	12.3	13.3	13.3	17.6	11	30.5	13	16.9	17.3	18.1	21.1	8	10.7	10.2	11.6	7.4	13	9.2	4.6	10.2	12.7	10.4	16.5	9.5	11.2	9.1	12.3	12.4	13.3	3.6	19.3	10.2	9.6	14.2	18.2	19.3	11	14.6	11.9	20	26.3	9	28.9	6.3	10.1	12.8	9.9	11.9	15.2	15.7	15.1	15.7	9.2	7.2	5	0.1	1.3	1	2.6	1.2	4	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11	5.3
PRKCQ		ENSG00000065675	Protein kinase C theta	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4	Cell line enhanced	Detected in some		HEL: 30.9;MOLT-4: 23.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in many	10	gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7	Group enriched	Detected in many	11	NK-cells: 6.5;T-cells: 19.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA065279, HPA073098"			Enhanced	Centriolar satellite		200000	200000	Centriolar satellite		"HPA065279: , HPA073098: "	unprognostic (6.61e-3)	unprognostic (2.12e-1)	unprognostic (1.87e-1)	unprognostic (1.48e-1)	unprognostic (1.50e-1)	unprognostic (2.24e-1)	unprognostic (2.69e-3)	unprognostic (2.46e-1)	unprognostic (8.40e-2)	unprognostic (2.66e-1)	unprognostic (1.17e-1)	unprognostic (3.22e-1)	unprognostic (5.26e-2)	unprognostic (7.74e-2)	unprognostic (2.79e-1)	prognostic unfavourable (5.27e-4)	unprognostic (3.51e-2)	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4	4.6	0.9	3.3	6.6	4	2.2	1.1	7.7	0.3	1	0.4	2.7	1.4	1.3	5.4	2.8	1	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0	0.1	1.1	0.2	6.5	19.7	5.2	0	2.9	0	0	0	0	0.9	0	0	0.1	0.1	0.2	1.8	0.2	0	0	0	1.8	3.3	0	0	2.1	30.9	0	0.2	0.4	1.5	0.3	0.1	2	0.1	0.1	0.3	6.7	0	0	0	23.2	4.3	3.2	0	4.5	0.7	0	6.5	1.6	0.2	1.2	0	0	0	0	3.1	0	0	3.2	0	0	0	0	0	0	3.8	0	1.1	0.1	0.1	12.7	0.2	9.8	0	13.5	13.2	0.1	0	10.7	10	0.8	6.5	0	0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4	4	2.2	2.7	4.5
PRKCZ	PKC2	ENSG00000067606	Protein kinase C zeta	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Inflammatory response	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 43.6;placenta: 93.0	Cell line enhanced	Detected in many		BEWO: 23.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in some	6	eosinophil: 15.0	Lineage enriched	Detected in many	6	granulocytes: 15.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	Plasma membrane	HPA021851: AB_1855433	unprognostic (1.25e-2)	unprognostic (2.61e-1)	unprognostic (5.10e-2)	unprognostic (1.14e-2)	unprognostic (2.08e-1)	unprognostic (3.61e-2)	unprognostic (1.73e-2)	unprognostic (5.13e-2)	unprognostic (1.18e-1)	unprognostic (3.10e-1)	unprognostic (1.12e-1)	unprognostic (2.86e-1)	prognostic favourable (1.64e-9)	unprognostic (3.57e-2)	unprognostic (3.27e-2)	unprognostic (1.39e-1)	unprognostic (7.85e-2)	1.2	7.8	15.9	3	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5	12.2	23.6	1.9	8.5	9.8	12	93	27.3	5.8	7.5	2.6	7	3	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5	4	4.6	0.4	0.3	15	0.3	0.8	2.6	0.3	7.5	4.8	1.7	8.9	0	0	23.5	0.5	0.2	5.6	0.3	12.1	16.4	0	14.9	1.9	13.2	10.1	12.5	4	0.5	11.2	0	7.7	16.1	1.6	0	5.8	0.3	7.5	0	4.3	0	3.3	0.1	0.1	9.2	0.4	0	3.4	11.7	0	0	2.6	9.6	7.9	12.3	9.9	6.1	13.7	2.6	9.6	2	0	0	7.1	0.1	0	3.5	0.6	0.1	0.6	0.1	8.5	0.3	0	15	0.6	0.3	2.6	0.3	1	0.6	0	0.4	0.8	0.4	1.2	0.8	0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	Protein kinase D1	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		ASC diff: 17.8;fHDF/TERT166: 19.0;HSkMC: 17.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in single		plasmacytoid DC: 1.4	Low lineage specificity	Detected in single			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	Intracellular and membrane			Plasma membrane	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	unprognostic (5.35e-2)	unprognostic (3.20e-1)	unprognostic (2.27e-2)	unprognostic (6.70e-2)	unprognostic (2.37e-1)	unprognostic (1.92e-1)	unprognostic (1.08e-3)	unprognostic (8.88e-2)	unprognostic (2.37e-2)	unprognostic (5.29e-2)	unprognostic (7.08e-2)	unprognostic (1.56e-1)	prognostic favourable (2.44e-5)	unprognostic (9.45e-4)	unprognostic (1.99e-1)	prognostic unfavourable (2.91e-4)	unprognostic (3.89e-1)	7.4	10.6	8	5.3	9.7	0.7	19	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9	3.5	6.8	9	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0	0	0	0	0	0	2.7	3.6	4	17.8	16.7	0.1	12.1	9.3	12.4	6.7	0	0.5	0	1.2	19	0.1	5.9	1.4	6.8	0	4.1	0	0.1	0.4	9	0	0.1	17.7	0.6	0.8	1.4	2.5	1.2	0.4	11.6	1.3	0	0	2.5	6.2	0	7	3.2	13.2	5.6	3.6	7.1	2.1	0	4.7	0	0.1	6.3	11.7	4.8	1	3.5	0	0	0	3	0	13.4	0	0	0	0	0	0	0.7	0	0	0	0.5	0	0	0	0	0	1.4	0	0	8	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	Protein kinase D2	Q9BZL6	19	46674275-46717127	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		U-266/84: 56.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA021490, HPA056727"	Enhanced		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	unprognostic (3.01e-2)	unprognostic (1.22e-2)	unprognostic (1.23e-3)	unprognostic (7.06e-2)	unprognostic (8.91e-2)	unprognostic (1.99e-2)	unprognostic (8.79e-3)	unprognostic (2.61e-1)	unprognostic (6.22e-2)	unprognostic (4.21e-3)	unprognostic (8.89e-2)	unprognostic (2.74e-1)	unprognostic (3.45e-3)	unprognostic (1.04e-2)	unprognostic (7.19e-2)	unprognostic (4.34e-2)	prognostic favourable (9.15e-4)	17.1	7.6	7	25.8	6.5	18.1	18	2.5	6.8	16.8	13.7	5.8	18.7	13.7	14.8	16.5	23.4	15.6	17.4	7.4	6.3	3.1	13.2	9.1	21.3	24.8	7.5	2.7	17	12.5	10.3	17.2	20.1	6.6	14.8	7.7	11.9	15.6	21.5	7.5	26.8	19.8	11.7	6.8	34.8	15.2	6.6	7.2	41.5	18.7	10.5	33	17.4	37.5	6.6	0.4	7.3	1	2.9	6.1	1.9	8.6	13.4	5.3	6.5	4.4	3.6	6.8	4.5	7.1	9.4	10.3	7.4	8.5	10.1	7.9	6	12.9	4.7	12	2.9	8.6	7	10.6	4.2	3.9	5.8	7.7	15.7	4.3	5.8	5.4	4.6	16.5	6.8	14.6	3.9	9.1	14.8	25	4.5	6.8	9.7	2.5	16.3	5.8	12.9	3.4	10.8	8.4	7	1.8	5.6	3.1	7.8	4	8	3.4	3.6	14.3	56.9	5	4.2	6.4	4.2	0.9	1	3.4	5.6	0.9	4.9	6.1	5.7	6.1	0.4	6.6	5.1	4.9	7.3	2.9	0.7	0	4	1.9	7	6.5	2.5	6.8	6.3	3.1	7.5	2.7	6.6	7.2
PRKD3	"EPK2, PRKCN"	ENSG00000115825	Protein kinase D3	O94806	2	37250502-37324808	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029529	Uncertain		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA029529: AB_10602082	unprognostic (1.39e-1)	unprognostic (7.34e-2)	prognostic favourable (4.84e-4)	unprognostic (1.23e-2)	unprognostic (5.61e-2)	unprognostic (2.08e-1)	prognostic unfavourable (3.47e-4)	unprognostic (1.10e-1)	unprognostic (1.16e-1)	unprognostic (2.52e-2)	unprognostic (2.93e-1)	unprognostic (1.81e-1)	unprognostic (7.62e-3)	unprognostic (2.49e-2)	unprognostic (1.18e-1)	unprognostic (1.36e-1)	unprognostic (1.35e-1)	16.1	22.1	9.5	20.7	10.7	5.3	35.1	4.8	9.2	17.2	18	7.2	7.2	6	19.2	16	9.8	11.3	10	11.6	12.7	6.1	9.9	8.4	20.4	22.3	11.4	3.7	15	7.6	12.9	20.7	11.1	10.3	14.4	8.3	27.8	11.1	13.3	19.1	11.5	12.1	16.5	15.4	22	10.5	16.8	10.8	16.2	11.8	9.3	21.2	12.4	17.7	16.4	8.2	5.7	8.3	6.3	11.5	3.4	12.6	5.4	14.3	11.8	10.9	18.4	10.5	8.2	15.3	9.3	9.5	8.6	4.5	18.6	6.9	12.3	5	9.7	10.1	12.6	24	14.2	12.2	8.3	5.8	4.5	8.7	7.5	8.6	5.2	14.7	9.7	16.5	10.2	22.9	10.8	2.1	3.8	6.8	15.1	5.2	12.8	22.6	15.9	6.2	14.3	10.8	28	7.9	4.5	48.2	4.9	8	15.9	26.7	13.9	10.6	9.2	26.2	48.5	21.7	9.3	3.7	16	5.7	8.3	5.5	10.5	6.6	9.1	12.4	8.8	8.4	7.8	16.4	10.4	11.5	1.5	6.3	3.3	8.2	4.1	3.4	9.5	10.7	4.8	9.2	12.7	6.1	11.4	3.7	10.3	10.8
PRKDC	"DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic polypeptide"	P78527	8	47773108-47960183	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		1100000	1100000	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: "	unprognostic (3.14e-2)	unprognostic (3.02e-3)	unprognostic (1.56e-2)	prognostic unfavourable (1.03e-4)	unprognostic (8.95e-2)	unprognostic (1.34e-1)	unprognostic (7.70e-3)	unprognostic (5.74e-2)	unprognostic (1.12e-2)	unprognostic (1.60e-2)	unprognostic (7.76e-3)	unprognostic (7.77e-2)	unprognostic (2.84e-2)	unprognostic (2.32e-1)	unprognostic (2.20e-1)	unprognostic (6.76e-3)	unprognostic (2.15e-2)	21.3	20.5	16	22.3	22	27.4	30.2	16.5	23.1	19.6	20.6	17.3	18.1	12	26.2	14.5	27.4	24.4	13	21.1	20.8	15.2	16.7	18.4	17	33.6	16.6	18.2	24.6	23.8	33.4	29.4	20.5	17.3	17.9	20.3	17.8	17.9	17.8	34	23.9	18.4	27	20.3	24.4	19.1	20.5	15.9	44.4	20.8	15.9	27.9	21.3	19.1	17	13.9	7.1	11.5	11.5	11.3	2.3	32.4	27.8	27.1	25.7	16.9	17.9	11.5	13.8	13.6	19.5	19.2	18.1	10.7	31	12	16.9	18.5	35.8	18.9	30.6	6.8	22.2	60.9	25	22.2	7.3	23.1	12.7	12.9	6.2	30.7	32.2	20	40.5	13.1	21.4	15.2	32.6	19.1	29.8	8.4	16	21.3	10.9	9.8	28	13.6	17.3	42.6	13.9	13.4	19.9	16	23.2	25.5	21.7	20.1	27.7	11.5	14.6	44.6	14.4	26.3	20.6	6.7	8.1	3.5	8.7	6.3	10.9	12.6	10.8	8.8	5.9	17	11.3	10.3	7.1	11.5	11.5	13.9	7.4	2.3	16	22	16.5	23.1	20.8	15.2	16.6	18.2	17.3	15.9
PRKG1	"PGK, PKG, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase, cGMP-dependent, type I"	Q13976	10	50990891-52298350	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		AN3-CA: 11.3;BJ hTERT+: 15.5;fHDF/TERT166: 12.9;U-138 MG: 9.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	21	basophil: 8.0	Lineage enriched	Detected in single	24	granulocytes: 8.0	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007699, CAB009629"	Enhanced		Approved	"Vesicles,Cytosol"		33000	33000	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	unprognostic (3.94e-2)	unprognostic (2.60e-1)	unprognostic (1.44e-2)	unprognostic (5.36e-2)	unprognostic (1.25e-1)	unprognostic (1.86e-1)	unprognostic (5.54e-1)	unprognostic (2.23e-1)	unprognostic (4.94e-1)	unprognostic (2.05e-2)	unprognostic (1.22e-2)	unprognostic (3.40e-1)	unprognostic (9.26e-2)	unprognostic (5.50e-3)	unprognostic (4.24e-2)	unprognostic (1.11e-1)	unprognostic (3.78e-4)	8	10.9	5.2	6.6	7.3	0.8	6.9	2.8	5.4	19.2	14.4	2.1	6.8	2.9	22.8	10.7	6	9.9	12.6	14.8	7	4.9	4.4	2.1	19.5	2.6	3.1	4.8	8.9	2.6	13.7	8.4	11	4.6	9.5	6.2	6.2	6.4	9.4	24.9	2.8	5.3	28.2	2.7	2.7	5.9	5	3.1	0.2	9.2	12.7	1.2	13.4	15.8	0.1	0.1	8	0.1	0.3	0	0.1	0	0.1	1.4	11.3	5.4	5.2	0	4.9	15.5	1.6	2.3	0.1	0.7	0.2	0	12.9	0.1	0	0	1.4	0	4.2	0.8	0.3	0	4.7	0	0	6.6	0	4.1	0.1	0	0	0.1	4.3	0.1	0	0	3.2	1.9	0	3	0	0	0	0	5.7	0	0	0.1	0.1	0	0	9.5	1.7	4.8	2.9	1.2	0.5	0	8.4	0	2	8	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0.3	0.1	0.1	0	0.1	5.2	7.3	2.8	5.4	7	4.9	3.1	4.8	4.6	3.1
PRKG2	"cGKII, PRKGR2"	ENSG00000138669	"Protein kinase, cGMP-dependent, type II"	Q13237	4	81087370-81215117	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 34.3	Cell line enhanced	Detected in some		ASC diff: 5.1;ASC TERT1: 3.9;HEL: 20.3;hTCEpi: 4.0;SCLC-21H: 6.3	Cancer enhanced	Detected in some		melanoma: 4.1	Low region specificity	Detected in many			Cell type enhanced	Detected in some		basophil: 2.0;MAIT T-cell: 2.2	Group enriched	Detected in many	4	granulocytes: 2.0;T-cells: 2.2	Low region specificity	Detected in many							"HPA007386, CAB018739"	Approved									"CAB018739: AB_2284387, HPA007386: AB_1079678"	unprognostic (6.14e-2)	unprognostic (2.77e-1)	unprognostic (2.14e-1)	unprognostic (5.01e-4)	unprognostic (4.33e-2)	unprognostic (6.85e-2)	unprognostic (1.13e-1)	unprognostic (5.57e-2)	unprognostic (2.05e-1)	unprognostic (1.86e-1)	unprognostic (4.70e-2)	unprognostic (1.48e-1)	unprognostic (8.27e-2)	unprognostic (2.33e-1)	unprognostic (1.58e-1)	unprognostic (4.00e-3)	unprognostic (1.06e-1)	4.7	0.4	5.2	0.4	2.9	0.6	2.2	0.8	5.3	1.4	7.7	1.2	0.7	12.2	0.6	0.6	3.8	0.6	0.4	6.3	2.9	3.3	0.7	0.3	4.3	0.3	2.5	1.9	0.3	1.8	0	12.1	0.2	9.3	12.7	3.8	1.4	0.8	4.6	0.3	2.1	34.3	0.7	1.3	0.3	1.3	1.7	2.4	0	1.3	0	0.6	1.2	1.3	0.4	0	2	0	0.4	2.2	0.4	0.1	0.3	0.1	0	5.1	3.9	0	0.2	0	0	0	0.4	2.3	0	0.2	0.9	0.1	0.3	1.5	0	0.4	0	20.3	0.6	0	0	0	0	0.5	4	0	0	0	0	0.6	0	0	0	0.1	0.9	0.4	0	0	0.1	0	0.8	6.3	0	0	0.2	0	0.5	0	0	0	0.2	0	0	0	0	0.5	0	0	0	2	0	0	0.2	0	2.2	0.2	0.5	0.3	0	0.4	0.8	0.9	0	0.4	0	0	0	0.4	5.2	2.9	0.8	5.3	2.9	3.3	2.5	1.9	9.3	2.4
PRKX	PKX1	ENSG00000183943	"Protein kinase, X-linked"	P51817	X	3604370-3713608	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HMC-1: 38.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all							HPA015324	Supported		Supported	Nucleoplasm				Nucleoplasm		HPA015324: AB_1855715	unprognostic (1.07e-1)	unprognostic (1.23e-2)	unprognostic (1.57e-1)	unprognostic (3.63e-1)	unprognostic (2.45e-1)	unprognostic (3.33e-2)	unprognostic (1.47e-1)	unprognostic (1.33e-2)	unprognostic (4.14e-1)	unprognostic (1.68e-1)	unprognostic (2.68e-1)	unprognostic (2.92e-1)	unprognostic (1.07e-3)	unprognostic (2.15e-2)	unprognostic (9.91e-2)	unprognostic (2.52e-1)	unprognostic (1.70e-2)	4.3	1.3	12.3	7.5	15.8	5.4	11.2	4.4	12.3	6.9	5.2	5.4	11.5	4.1	7.3	8.4	13.6	16.5	3.9	4	14	7.4	14.2	2	8.4	9.5	27.9	5.6	4.8	4.1	3.2	2.3	6.6	22.7	3.7	5.2	3.1	6.5	5.3	1.6	9.9	6	3	17.6	10	3.1	6.1	22.7	6.1	28.8	3.2	8	3.7	11.2	2.5	2.8	12.2	4.1	3.3	3.8	1.7	4.5	4.2	11.6	8.6	2.2	3	10.6	2.7	1	1.3	1.8	6.2	3.1	0.4	2.7	2.1	3.1	10.8	8.1	2.3	5	7.5	5	3.2	0.1	2.3	6.4	38.9	2	8.7	1.4	5.4	13.1	5.8	6.5	4.4	3.9	7.3	5.8	7.7	4.8	13.7	11.1	8.5	10.7	3.8	7.8	5	2.8	1.8	2.7	1.4	5.1	7.1	1.2	2	1.9	1.8	0.1	0.3	5.8	0.7	5.8	3	12.2	3.1	1.8	3.5	3.3	3.8	2.5	3.7	3.3	2.3	2.4	3.1	3.3	0.8	3.3	4.1	2.8	2.5	1.7	12.3	15.8	4.4	12.3	14	7.4	27.9	5.6	22.7	22.7
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	Pre-mRNA processing factor 4B	Q13523	6	4021267-4064983	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA020638	Approved		Supported	Nuclear speckles				Nuclear speckles		HPA020638: AB_1855774	unprognostic (1.03e-1)	unprognostic (2.66e-1)	unprognostic (4.95e-2)	unprognostic (2.20e-1)	unprognostic (3.59e-3)	unprognostic (1.21e-2)	prognostic unfavourable (2.27e-4)	unprognostic (8.68e-3)	unprognostic (3.41e-2)	unprognostic (4.45e-3)	unprognostic (2.17e-1)	unprognostic (1.07e-1)	unprognostic (9.50e-3)	unprognostic (8.90e-2)	unprognostic (2.34e-1)	unprognostic (7.63e-3)	prognostic favourable (6.82e-5)	23.2	21.6	19.6	24	20.5	8.5	21.4	35.6	26.8	18.3	19.3	6	14.7	12	22.2	14.2	23.6	14.7	13.6	16.3	16.5	11.7	15	14.5	13	15.4	14.5	14.1	19.1	14.4	20.9	30.9	17.1	21	14.9	15.7	5.3	22.7	20.4	45.7	16.3	16.4	14.9	23.7	19	13.6	11.6	20.2	21.8	21.1	11.3	17.4	21.4	22.2	9.7	13.6	7.5	11.9	11.8	9.1	3.9	14.4	12.6	19.8	13.6	11.3	10.5	9.6	14.1	15.5	15.4	15.5	12	7.3	23.8	17.8	15.8	13	25	12.2	22.1	11.1	18.3	26.7	14.4	10.7	8.7	29.4	14.6	9.6	8.1	10.9	6.8	15.3	36.5	8.8	15	8.5	21.6	9.9	11.9	11.7	24.5	19.2	23	9.8	16.4	15.4	10.1	16.3	10.2	12.4	15.9	14.8	16.3	15.1	8.7	9.9	13.6	10	15.6	27.7	8.3	13.5	18.4	7.5	11.9	3.6	7.6	9.9	9.1	9.7	8.6	9	10.2	9.3	8	8	6.1	11.8	8.7	13.6	6.3	3.9	19.6	20.5	35.6	26.8	16.5	11.7	14.5	14.1	21	20.2
PSKH1		ENSG00000159792	Protein serine kinase H1	P11801	16	67893272-67929678	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA053927	Approved		Approved	Nucleoplasm				Nucleoplasm		HPA053927: AB_2682312	unprognostic (2.57e-2)	unprognostic (8.91e-3)	unprognostic (1.88e-1)	unprognostic (5.79e-2)	unprognostic (3.26e-1)	unprognostic (3.89e-1)	unprognostic (1.64e-1)	unprognostic (1.29e-2)	unprognostic (3.03e-1)	unprognostic (1.66e-2)	unprognostic (9.85e-3)	unprognostic (8.32e-2)	prognostic favourable (4.28e-10)	unprognostic (1.46e-1)	unprognostic (1.99e-1)	unprognostic (4.15e-2)	unprognostic (3.90e-3)	14.3	18.3	13.6	14	16.6	4.8	15.1	13.3	13.3	11	14.7	17.7	24	14	19.2	14.6	17.7	20.2	19.3	17.8	12.2	8.4	18.8	15.1	13.1	10.4	16.2	12.7	21.2	35.3	33.2	13	9.8	16.1	14.3	11.4	16.2	19	14.8	19.9	14	15.2	16.3	11.3	12.8	19.1	31.7	15	12.5	14.9	12.9	8.6	14.8	18.7	4	5.2	4.5	5.8	5.2	5.6	3.5	7.3	13.1	14.9	16.5	23.3	11.8	9.7	8.8	13.5	9.4	8.4	9.9	10.6	6.9	13.5	14.9	11.2	8.6	9.1	3.2	2.7	9.6	7.9	9.7	12.5	16	7.5	4.8	21.7	15.8	11.1	11.8	13.7	12	3	9.7	16.4	10.2	4.8	14.3	8.2	15.7	5.7	14.3	11.1	9.2	13	15.5	27.4	7.5	9	13.8	13.7	12	10.6	3.8	8.8	4.4	9.1	4.8	14.9	12.8	5.1	11.6	0	4.3	4.5	5.6	5.8	3.8	4	3.9	5.3	5.2	3.5	3.4	4.3	2.7	5.2	3.6	3.8	2.3	3.5	13.6	16.6	13.3	13.3	12.2	8.4	16.2	12.7	16.1	15
PSKH2		ENSG00000147613	Protein serine kinase H2	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	kidney: 1.9;placenta: 1.2;testis: 2.0	Cell line enriched	Detected in single	18	HEL: 13.9	Cancer enhanced	Detected in single		testis cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											"HPA015095, HPA056839"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															unprognostic (1.77e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	1.9	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	Protein tyrosine kinase 2	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		32000	32000	Focal adhesion sites	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	prognostic unfavourable (3.21e-4)	unprognostic (3.86e-2)	unprognostic (1.95e-1)	prognostic unfavourable (9.11e-4)	unprognostic (1.93e-1)	unprognostic (2.28e-1)	unprognostic (3.02e-2)	unprognostic (1.27e-1)	unprognostic (1.97e-1)	unprognostic (2.96e-2)	unprognostic (1.06e-2)	unprognostic (2.38e-1)	unprognostic (2.80e-2)	unprognostic (2.94e-2)	unprognostic (1.11e-1)	unprognostic (1.53e-1)	unprognostic (2.90e-2)	22.6	20.4	36	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20	43.5	23.9	22.3	17	21.5	13	41.4	31.4	19.4	18.2	33.1	13	42.1	30	19.2	20.7	11	21.9	25.5	17.9	13.5	16.3	21.9	38	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.6	23.4	32.5	11.7	13.7	14.7	21	14.5	20.2	13.6	13.4	10.2	12.2	8.9	33	18.6	17.4	19.1	33.3	20.6	0.1	8.9	19.7	12.9	14	18.7	0	9.4	10	16.4	17	24	40.1	19.8	0.2	18.2	25.5	0.2	0.2	12.6	26.2	13.1	17.8	0.4	28.7	33.5	12.9	16.1	22.7	7.3	14.7	17.2	0.3	24.2	13.4	25.3	15.8	16.3	0	0.1	0.9	17.4	0.1	18.1	1.8	3.9	0	0.3	1.6	0	6.8	0.8	0.1	5.3	8.6	5.7	2	1.7	5.2	0.9	7.2	0.2	4.1	36	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30	46.1
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	Protein tyrosine kinase 2 beta	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 46.7;brain: 65.2	Cell line enhanced	Detected in many		Daudi: 37.0;REH: 41.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Group enriched	Detected in many	4	amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5	Low region specificity	Detected in many			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		84000	84000	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	unprognostic (2.36e-2)	prognostic favourable (3.32e-4)	unprognostic (1.06e-1)	unprognostic (7.36e-3)	unprognostic (3.72e-2)	unprognostic (3.11e-2)	unprognostic (2.70e-2)	unprognostic (2.13e-2)	unprognostic (3.23e-1)	unprognostic (1.45e-1)	unprognostic (5.74e-2)	unprognostic (3.32e-1)	unprognostic (2.40e-3)	unprognostic (1.44e-1)	unprognostic (1.38e-1)	prognostic favourable (5.11e-4)	unprognostic (3.33e-3)	7.2	4.7	20.4	24.3	30	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7	6.8	5	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13	6	26.9	18.7	24	25.8	14.7	19	21.5	10.9	3	0.8	0.9	23.5	1.7	6.4	0.8	0.5	0.6	0.8	2.9	6.3	37	1.2	1.7	10.1	0.3	9.2	0.3	2.5	0.2	7.6	2.9	0.5	4.8	8.2	13.8	12.7	13.8	0.8	5.3	0.3	8.9	25.7	0.6	1.1	14	16.5	0.6	0.8	41	0.2	25.3	2.6	8.6	5.8	1	3.9	2.7	1.4	3.3	21.2	5.2	0.4	0.8	0.7	0.3	20.7	8.9	20	1.6	17.8	0.7	22.3	23.7	18	19	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24	14.7	25.8	6.2	9.5	21.5	20.4	30	65.2	48.3	30.5	7	4.3	25.4	3.9	3.7
PTK6	BRK	ENSG00000101213	Protein tyrosine kinase 6	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 44.0;intestine: 24.2;skin 1: 24.2	Cell line enhanced	Detected in some		A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	Nuclear bodies	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	unprognostic (2.32e-2)	unprognostic (1.36e-1)	unprognostic (1.05e-1)	unprognostic (2.42e-2)	unprognostic (1.41e-1)	unprognostic (1.35e-1)	unprognostic (1.04e-1)	unprognostic (2.29e-1)	unprognostic (3.03e-1)	unprognostic (3.72e-2)	prognostic unfavourable (1.96e-4)	unprognostic (1.28e-1)	prognostic unfavourable (1.26e-9)	unprognostic (4.19e-2)	unprognostic (1.74e-1)	unprognostic (1.73e-1)	unprognostic (4.24e-2)	0.7	0	0.4	5.3	0.4	0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44	0	11.7	0.4	0.4	0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15	1.3	4.5	1.2	2.4	0.3	1.9	0.9	11.3	1.3	0.1	0.1	0	0	0.1	0	0	0	0	0.2	21.8	0	3.9	0	17.7	0	0	0	2.8	0.2	0	4.5	0	0	0	3.6	0	24	0	0.1	0	0.1	1.3	0.1	6.3	0	0.1	0.1	8.2	0	0.6	0.2	0	13.8	0.2	1.2	1.3	4.3	0	13.3	0.8	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0	0.2	0.2	0.6	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0	0.4	0.4	0.4	0.4
PTK7	CCK4	ENSG00000112655	Protein tyrosine kinase 7 (inactive)	Q13308	6	43076268-43161719	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in some	9	plasmacytoid DC: 13.8	Lineage enriched	Detected in many	9	dendritic cells: 13.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003222	Approved				Secreted to blood	10000000	10000000			HPA003222: AB_1079713	unprognostic (1.80e-1)	unprognostic (7.49e-3)	unprognostic (6.22e-2)	unprognostic (2.03e-1)	unprognostic (1.65e-1)	unprognostic (1.15e-2)	unprognostic (5.85e-3)	unprognostic (9.81e-3)	unprognostic (1.47e-3)	unprognostic (7.15e-2)	unprognostic (5.11e-3)	unprognostic (8.17e-2)	unprognostic (3.37e-2)	unprognostic (1.73e-1)	unprognostic (3.61e-1)	unprognostic (9.12e-2)	unprognostic (5.70e-3)	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9	9	20.9	4.2	18.2	3.3	13.9	15	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0	13.8	0.3	0	0.7	1.5	0.8	2.1	0.6	21.1	35.1	22.7	23.3	30	22.6	36.5	19.8	25.4	19	7.6	0	17.9	26.3	24.5	9.4	21.5	12.6	0.1	11.7	2	4.3	25.5	34.5	0	0.1	33.3	19.5	26.1	8.3	2.5	1.3	0	9	1.6	7.6	3	9.8	1.7	7.7	30	0	15.3	10.5	12.1	23	3.6	0.3	11.7	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0	3.5	0.3	0	0	0.1	0	0.1	0	0	0.1	0.4	0	0.1	1.5	0.2	0.7	0	13.8	0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4
PXK	"FLJ20335, Slob"	ENSG00000168297	PX domain containing serine/threonine kinase like	Q7Z7A4	3	58332880-58426126	"Enzymes, Predicted intracellular proteins"		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 81.1	Cell line enhanced	Detected in many		U-937: 47.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024068	Approved		Supported	"Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	Centriolar satellite	HPA024068: AB_1855967	unprognostic (2.98e-2)	unprognostic (3.29e-1)	unprognostic (2.71e-3)	unprognostic (1.61e-1)	unprognostic (2.40e-1)	unprognostic (6.62e-3)	unprognostic (5.03e-3)	prognostic favourable (5.68e-4)	unprognostic (3.90e-1)	unprognostic (8.09e-2)	unprognostic (3.48e-2)	unprognostic (1.21e-1)	unprognostic (1.38e-3)	unprognostic (2.14e-1)	unprognostic (1.06e-1)	unprognostic (1.03e-1)	unprognostic (2.86e-2)	9.3	9.4	20.7	17	51.4	33.6	7.6	22.6	31.4	28.9	8.9	81.1	2.4	6.3	14.2	5.3	6.6	8	9.6	7.5	33.7	19.9	10.4	5.7	8.2	23.8	68.6	23.4	11.1	8.5	13.7	6.1	17.5	43.9	6	6.4	4.4	8.8	7.7	7.6	7.5	7.7	11.8	55.9	13.5	8.3	6.7	56.6	3.7	40.3	2.5	26.1	9.8	13.1	31.3	18.8	31.8	22.5	8.7	11.2	13.4	4.2	2.5	1.9	3.5	26.6	23.6	5.6	6.9	14.6	6.6	9.3	1.2	0.9	22.6	1.6	11.6	1.3	6	4.3	7	5.6	3.8	3.9	3	1.7	31	33.5	6.9	20.2	10.5	8.3	14.4	5.8	4.7	7.4	11.8	1.6	7.3	34.6	2.3	6.3	12.6	3.3	4	4.2	2.4	1.7	1.2	4.7	3.3	5.4	11.4	34.7	5.9	8.3	3.4	15.7	7.2	5.8	5.7	22.5	12	47.6	3.4	14.6	20.1	29.4	11.2	16.2	9.9	29	8.1	9.4	18.8	31.3	7.1	8.4	31.8	8.7	22.5	13.5	8.7	13.4	20.7	51.4	22.6	31.4	33.7	19.9	68.6	23.4	43.9	56.6
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664226	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 53.9	Lineage enriched	Detected in all	5	granulocytes: 53.9	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA002640, CAB019291"	Approved		Approved	Nuclear speckles				Nuclear speckles		"CAB019291: , HPA002640: AB_1856047"	unprognostic (6.33e-2)	unprognostic (1.29e-1)	unprognostic (5.92e-2)	unprognostic (2.17e-3)	unprognostic (6.51e-3)	unprognostic (7.66e-3)	unprognostic (2.66e-3)	unprognostic (1.53e-2)	unprognostic (2.72e-1)	unprognostic (7.66e-2)	unprognostic (2.92e-2)	unprognostic (1.29e-2)	unprognostic (2.79e-2)	unprognostic (1.79e-1)	unprognostic (1.27e-1)	unprognostic (2.64e-2)	unprognostic (2.36e-2)	19.5	15.6	15.1	14.7	17.1	32.2	17.5	35.2	18.9	19.9	20.3	21.1	19.6	18.4	24.9	15.7	24.6	18.6	20.2	39.3	15.3	11	21.7	36.2	19.7	15.7	16	13.4	24.9	31.3	30.7	16.9	24.8	14.3	18.8	19.2	25	18.3	18.4	79.7	23.9	29.6	23.7	13.8	22.1	23.7	16.7	17.8	27.7	26.9	27.9	26.1	20.5	20.4	6.6	9.3	53.9	9.9	8.5	8.6	7.7	15.1	17.4	26.6	20.5	23.1	18.7	53.5	23.1	39.2	30.6	34.8	13.6	12.5	15.9	11.1	35.8	9.7	28	20.5	31.9	27.7	21.9	21.4	21	12.6	23.4	20.8	20.3	17.2	20.7	31.5	25.6	21.9	15.5	41.8	29.5	25.9	26.7	15.3	27	23.7	21.6	23.4	20	18.3	22.9	8.3	17.5	18.9	18.3	12.3	30.4	27.5	15.7	21.1	20.1	17.6	25.7	32.6	51.8	34.2	18.2	24.3	22.4	11.3	9.7	18.4	7.4	9.9	7.5	6.6	7.3	7.2	9.3	6.3	7.5	7.6	53.9	8.5	9.6	4.2	8.6	7.7	15.1	17.1	35.2	18.9	15.3	11	16	13.4	14.3	17.8
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	Ret proto-oncogene	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Cell adhesion	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		parathyroid gland: 63.9	Cell line enhanced	Detected in some		MCF7: 17.6;NB-4: 11.6;SH-SY5Y: 89.7;THP-1: 26.8	Cancer enhanced	Detected in many		breast cancer: 11.0	Low region specificity	Detected in many			Cell type enhanced	Detected in some		non-classical monocyte: 6.7	Group enriched	Detected in many	13	dendritic cells: 2.1;monocytes: 6.7	Low region specificity	Detected in many			Region enriched	Detected in many	6	midbrain: 95.5	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		260000	260000	"Golgi apparatus, Cytosol"	Plasma membrane	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	unprognostic (7.94e-2)	unprognostic (3.68e-2)	unprognostic (4.49e-1)	prognostic unfavourable (5.02e-4)	unprognostic (1.15e-1)	unprognostic (9.13e-4)	unprognostic (1.27e-2)	unprognostic (3.62e-2)	unprognostic (2.86e-1)	unprognostic (2.01e-1)	unprognostic (1.54e-3)	unprognostic (4.43e-1)	unprognostic (9.35e-5)	unprognostic (1.64e-3)	unprognostic (8.28e-2)	unprognostic (3.67e-3)	unprognostic (2.02e-2)	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1	1.2	1.5	5.8	1	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2	0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0	6.7	0	0.3	0.4	0	0.1	0	0.5	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	2.3	0	0	0.1	0	0	0	0	0	0	17.6	0	11.6	2.1	0	0	0	0	0	0	1.3	89.7	0	0	0	1.2	26.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	1.8	0	0.2	0	0	0.9	0	0	0	0	0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9	1.5	5.8	17.5	1.2	16.8	0
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	RIO kinase 1	Q9BRS2	6	7389496-7418037	"Enzymes, Predicted intracellular proteins"	Ribosome biogenesis	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA017866, HPA051446"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA017866: , HPA051446: "	unprognostic (2.33e-2)	unprognostic (1.24e-1)	unprognostic (2.38e-1)	unprognostic (1.03e-2)	unprognostic (1.16e-1)	unprognostic (1.51e-1)	prognostic unfavourable (3.41e-5)	unprognostic (2.23e-1)	prognostic unfavourable (4.43e-4)	unprognostic (3.45e-2)	unprognostic (1.47e-1)	unprognostic (1.87e-1)	prognostic unfavourable (5.85e-5)	unprognostic (2.33e-1)	unprognostic (2.09e-1)	unprognostic (6.12e-3)	unprognostic (2.59e-2)	13.8	10.6	7.7	13.2	13	17.5	13.1	12.2	13.5	12.7	11.6	7.3	4	7.3	15.4	6	15.6	12.3	8.5	11.8	8	8.1	8.7	11.7	10.1	14.2	11.6	9.4	13.8	15.3	7.7	17.8	13.9	13.3	10.7	9.6	7.2	10.2	10.3	18.8	12.5	9.9	15.5	9.4	14.4	10.3	21.3	9.2	19.2	10.1	14.7	16.8	10.9	12.6	15.4	14.9	7.7	11.1	18.6	15	8.2	7.5	4.4	7.1	16.7	11.1	9.1	10.9	9.5	6.4	8.9	7.4	12.8	3.9	19.7	16.9	7.7	7.7	17.9	7.6	11.4	13	19.3	10.5	7.1	13.7	9.4	30.2	13.8	6.7	10.6	9.6	19.8	7.8	26.8	4.6	8.3	9.9	20.5	14.3	15.3	10.4	15.8	9.3	21.4	5	7.4	23.7	11.7	8	4.8	13.8	7.3	10	7.8	9.8	7.4	6.4	14.3	6.4	12.1	29.3	3	15.6	14.9	7.7	8.5	5.9	11.5	11.1	13.8	15.2	11.9	12.1	14.9	15.4	13.7	15	1.7	18.6	9.7	12.4	11.3	8.2	7.7	13	12.2	13.5	8	8.1	11.6	9.4	13.3	9.2
RIOK2	FLJ11159	ENSG00000058729	RIO kinase 2	Q9BVS4	5	97160867-97183260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all											HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	Plasma membrane	HPA005681: AB_1856286	unprognostic (6.36e-2)	unprognostic (1.21e-1)	unprognostic (1.13e-2)	unprognostic (8.04e-2)	unprognostic (1.38e-1)	unprognostic (4.51e-2)	unprognostic (2.71e-3)	unprognostic (3.08e-1)	unprognostic (3.90e-2)	unprognostic (1.11e-1)	unprognostic (8.76e-2)	unprognostic (6.63e-2)	unprognostic (1.26e-3)	unprognostic (3.60e-1)	unprognostic (9.98e-2)	unprognostic (1.43e-2)	unprognostic (1.39e-2)	22.2	20.1	14.8	17.1	17.5	24.4	19.7	26.3	18.6	19.1	17	8.9	14	17.3	17.5	17.1	17	15	10.7	19.6	15.7	13.4	21	23.6	13.3	17.6	20	11.1	20.7	21.5	15.1	37.5	15.8	19.7	19.5	17.3	10.3	18.7	16.6	24.9	13.3	20.2	16.3	20.7	22.5	16.4	14.8	18.6	25.8	21.7	20.7	17.4	20.7	21	15.2	17.8	9.4	18.7	17.8	24.1	13.5	8.8	10.4	9.7	18.8	12.8	14	15.5	22.3	13.8	15.8	21	14.2	15.6	19.6	25.4	10	10.5	16.5	13	21.7	13.8	9.1	9.8	20.1	19.8	11.5	18.6	13.8	9.2	10.2	19.3	19.6	12.8	14.8	12.7	18.1	14.8	21.7	22.2	11.5	11.2	24.5	18.9	28.8	12.4	8.1	12.1	9	13.5	14	15.3	14.7	17.7	13.7	20.3	14.1	16.1	24.2	12.5	16.2	44	12.1	19.1	18.4	7	16	9.4	16.3	18.7	22.3	15.2	20.7	17.8	17.8	11	22.5	24.1	3.2	17.8	13.4	17.8	18.5	13.5	14.8	17.5	26.3	18.6	15.7	13.4	20	11.1	19.7	18.6
RIOK3	SUDD	ENSG00000101782	RIO kinase 3	O14730	18	23452823-23486603	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	unprognostic (7.99e-2)	unprognostic (1.71e-2)	unprognostic (2.39e-1)	unprognostic (3.03e-2)	unprognostic (1.05e-1)	unprognostic (7.48e-2)	unprognostic (8.98e-3)	unprognostic (1.01e-1)	unprognostic (5.10e-2)	unprognostic (4.20e-1)	prognostic unfavourable (4.10e-4)	prognostic unfavourable (5.80e-4)	unprognostic (3.90e-2)	unprognostic (1.46e-1)	unprognostic (5.44e-2)	unprognostic (1.39e-1)	unprognostic (2.71e-2)	10.1	8.7	6.9	11.7	7.7	52.4	10.9	8.9	10.1	14.7	21.4	8.5	5.9	15.6	8.8	9.3	41	7.8	10.7	11.5	6.1	5.5	10.5	19.9	10.1	10.7	9.1	6.2	7.6	10.7	7.5	11.6	21.4	11.6	6.8	14.7	6	14.9	7	40	13.3	36.5	15.2	10.5	8.9	12.9	22.7	7.6	11.1	7.3	16	16.5	13.7	21.5	11.7	11	21.7	21.5	8.3	11.2	10	14.7	5.8	6	7.8	11	12.3	10.9	14.8	10.9	10.5	10.1	6.6	15.9	10.2	19.4	16.4	19.3	10.2	16.8	16.2	10.1	4.2	9.5	10.8	8.3	27.5	26.7	8.3	14.7	32	18.6	25.8	14.5	13.7	12.9	15.7	7.8	9.2	4.4	5.6	11.6	10.4	12.6	12.4	12	19.3	14	10.1	18.9	8.6	10.8	7.6	14.5	22.9	17.3	4.3	7.6	9.6	23.2	19.6	15.2	10.2	12.4	12.9	21.7	13.5	8	9.1	19.6	6.9	8.2	7.6	7.9	11	11.7	6.1	6.9	9.3	8.3	21.5	5.1	11.2	10	6.9	7.7	8.9	10.1	6.1	5.5	9.1	6.2	11.6	7.6
RIPK1	RIP	ENSG00000137275	Receptor interacting serine/threonine kinase 1	Q13546	6	3063991-3115187	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010302, HPA015257"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	unprognostic (1.24e-1)	unprognostic (6.83e-2)	unprognostic (1.87e-1)	unprognostic (7.75e-2)	unprognostic (6.08e-2)	unprognostic (1.01e-2)	unprognostic (1.26e-2)	unprognostic (1.96e-1)	unprognostic (9.46e-2)	unprognostic (1.46e-1)	unprognostic (5.00e-2)	unprognostic (3.29e-1)	unprognostic (9.65e-3)	unprognostic (3.44e-1)	unprognostic (9.01e-2)	unprognostic (1.38e-2)	prognostic favourable (6.71e-4)	24.5	12	6.9	15.7	12.4	10.5	28	11.9	11	16.4	18.9	9.6	22.9	14.5	16.8	17.7	17.1	13.5	17.9	12.3	7.5	6.8	18.5	36.7	16.7	19.8	11.8	6.6	13.2	19.9	14.4	17.9	24.4	10.2	17.8	16.6	10.9	21.1	18.7	11.4	18.9	24.8	21.3	6.9	19.4	15.8	9	9.4	18.6	18.5	15.2	19.2	15	20.4	4.1	3.2	6.6	3.9	6.6	7.6	2.1	9.5	6.9	10.4	10.7	22.2	14.2	5.7	15.1	20.5	16	18.4	9.3	6.6	9	14.6	21.6	11	12.9	12.4	17.5	18.6	7	11.5	4.5	6.7	12.5	10	14.8	19.2	11.1	14.8	10.7	13.8	13	5.2	15.4	12.4	6.9	10.9	6.5	8.6	8.4	7.7	10.1	14.3	19.2	9	8.8	9.9	6.3	16.7	11.4	7.1	16.7	17.5	9.4	6.6	11.1	8	10.3	9.6	7.3	5.5	19.4	1.1	3	6.4	6.1	3.7	4.9	2	4.9	7.6	3.2	4.1	4.1	5.4	6.6	6.6	3.9	2.9	5.7	2.1	6.9	12.4	11.9	11	7.5	6.8	11.8	6.6	10.2	9.4
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	Receptor interacting serine/threonine kinase 2	O43353	8	89757747-89791063	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		hTERT-HME1: 27.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol				Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	unprognostic (1.20e-1)	unprognostic (1.02e-2)	unprognostic (2.35e-1)	unprognostic (3.82e-2)	unprognostic (1.67e-1)	unprognostic (6.20e-2)	unprognostic (1.43e-3)	prognostic unfavourable (6.33e-5)	unprognostic (2.06e-1)	unprognostic (7.80e-2)	prognostic unfavourable (5.00e-6)	unprognostic (6.39e-2)	prognostic unfavourable (0.00e+0)	unprognostic (1.84e-2)	unprognostic (5.08e-2)	unprognostic (1.05e-2)	prognostic favourable (8.05e-4)	12	5.5	9.3	11.2	7.9	13.6	10	3	9.3	9.7	7.9	10.6	5.2	3.5	10.9	7.8	8.3	7	17.3	11.6	9.2	8.6	7.7	10.4	18.7	10.9	11.8	5.8	8.9	13.2	14.7	7.3	20.8	9.1	10.7	5.6	4.6	10.2	5.8	3.1	10.4	6.9	10.4	16.5	14.2	8.3	5.6	11.5	5.1	8.5	4.9	11.8	15	7.6	7.5	6.9	19.4	11.2	3.8	5.5	4.3	10.1	3.5	1.8	2.6	4.4	6.1	3.3	11.3	19.3	6	7.8	3.1	5.3	7.9	17.6	6.3	2.4	4.8	3.7	11.1	5.6	4.9	6.6	1.7	3.1	12.4	2.4	3.2	4.9	3	8.5	27.7	6.3	3.2	2.6	5.5	2.1	0	5	1	8.4	1.7	2.5	3.8	14	4.6	0.3	2	2.7	7.1	5.3	6.8	3	5.6	3.7	3.5	6.2	5.2	5.2	2.3	4.7	9	0.2	2.4	8.8	5.7	19.4	3.6	10.6	4.1	7.5	5.5	4.7	6.9	4.3	5.2	5.5	4.5	3.8	11.2	2.3	1.2	4.3	9.3	7.9	3	7.4	9.2	8.6	11.8	5.8	9.1	11.5
RIPK3	RIP3	ENSG00000129465	Receptor interacting serine/threonine kinase 3	Q9Y572	14	24336021-24340045	"Enzymes, Predicted intracellular proteins"	Necrosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 25.8	Cell line enhanced	Detected in some		BJ hTERT+: 4.2;CAPAN-2: 8.1;HDLM-2: 4.6;SK-BR-3: 13.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in single			Low region specificity	Detected in many														unprognostic (1.85e-2)	unprognostic (1.66e-1)	unprognostic (5.16e-3)	unprognostic (1.12e-2)	unprognostic (1.95e-1)	unprognostic (1.29e-1)	unprognostic (1.19e-1)	unprognostic (2.32e-1)	unprognostic (3.25e-1)	unprognostic (2.02e-1)	unprognostic (3.31e-2)	unprognostic (1.11e-1)	unprognostic (5.26e-3)	unprognostic (9.58e-2)	unprognostic (5.58e-2)	unprognostic (1.08e-1)	unprognostic (2.93e-2)	7.6	1.3	1.8	9.7	2.4	4.3	6	0.9	1.6	4.5	13.6	1.8	1.4	10.6	3.7	3.8	9.2	3.2	12.7	2.6	2.7	0.6	3.8	1.3	6.4	7.2	3.9	0.8	1.7	8.4	0.5	0.9	3.7	2.3	3.7	11.8	3.6	7.5	1.7	2.1	5.9	25.8	2.1	3.8	15.1	9.2	1.6	3.6	7.2	8.7	6.1	13.3	4.6	5.6	3.5	5.2	6.3	8.8	3.9	9.1	4.3	0	0	0	0	3.1	3.4	0	0.7	4.2	0	0	0.1	8.1	0.1	2.1	0.3	2	0	0.1	0	4.6	0	0	0.3	0	0	0	0	1	0	0	0	1.4	0	0.1	0	0	0	0.5	0	0	0	0	1.4	1.5	0	0	0	0.1	13.3	0	2.3	3.5	1.9	0	0	0	0	0	0.4	0	0	1.8	0	2.6	5.1	6.3	6.3	7.7	6.4	3.5	5.4	6.2	5.2	3.5	2.9	4	2.6	3.9	8.8	2.6	9.1	4.3	1.8	2.4	0.9	1.6	2.7	0.6	3.9	0.8	2.3	3.6
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	Receptor interacting serine/threonine kinase 4	P57078	21	41739369-41767106	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 42.1	Cell line enhanced	Detected in many		CAPAN-2: 16.3;HaCaT: 24.0;hTCEpi: 16.2;PC-3: 13.4;RPTEC TERT1: 14.5;RT4: 15.5	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Group enriched	Detected in some	9	naive CD4 T-cell: 1.5;neutrophil: 2.2	Group enriched	Detected in many	17	granulocytes: 2.2;T-cells: 1.5	Not detected	Not detected			Low region specificity	Detected in many			HPA030942	Enhanced									HPA030942: 	unprognostic (8.93e-2)	unprognostic (2.67e-1)	unprognostic (6.32e-3)	unprognostic (7.87e-2)	unprognostic (1.24e-1)	unprognostic (5.61e-2)	unprognostic (1.30e-1)	unprognostic (2.88e-2)	unprognostic (1.02e-1)	prognostic unfavourable (6.22e-5)	prognostic unfavourable (3.48e-4)	unprognostic (9.98e-2)	prognostic favourable (6.52e-4)	unprognostic (2.69e-1)	unprognostic (2.95e-3)	unprognostic (2.28e-1)	unprognostic (2.78e-2)	1	0.2	0.2	0.8	0.2	0.1	3.3	0.2	0.2	6.7	9.4	0.3	12	6.8	1.7	6.5	42.1	4.2	17.1	1.1	0.4	0.2	10.8	17.3	5.4	0.4	0.2	0.1	1.8	14.4	4.7	6.8	2.8	1.1	10.6	1.3	4.8	10.2	14.8	0.2	11.7	11.6	2	0.3	0.2	11.2	2.7	0	8.1	13.6	12.3	26.6	5.2	11	0	0	2.2	0.1	0	1.5	0.2	7	4.5	0	0	0	0	7.1	0	0	0.1	0.1	11.7	16.3	0	6.9	1.4	24	0.3	9.7	0	0	4.8	0	3.3	4.3	0	0	0	0	16.2	0.1	2.2	0	0	0	0	5.1	0.9	0	0.4	13.4	0	0	1.1	14.5	15.5	2.3	0.1	7.8	8	7.3	4.9	0	0	0.1	0.1	0	0.1	0	0	0	2.1	0	6	0	0.1	0	0	0	0	0	0.2	0	0	0	1.5	0.1	2.2	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	1.1	0
RNASEL	"PRCA1, RNS4"	ENSG00000135828	Ribonuclease L	Q05823	1	182573634-182589256	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Antiviral defense	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA002633, CAB010906"	Approved		Supported	Cytosol				Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	unprognostic (3.46e-2)	unprognostic (9.10e-2)	unprognostic (7.74e-2)	unprognostic (1.13e-1)	unprognostic (9.29e-2)	unprognostic (1.57e-1)	unprognostic (6.14e-2)	unprognostic (1.42e-1)	unprognostic (3.89e-2)	unprognostic (1.93e-2)	unprognostic (1.01e-1)	unprognostic (2.02e-1)	unprognostic (5.43e-2)	unprognostic (1.99e-1)	unprognostic (1.44e-1)	unprognostic (2.59e-1)	unprognostic (1.81e-1)	8.1	10.8	7.4	9.5	10.9	3.7	8.3	5.7	7.7	12.5	9.3	6.7	8.5	8	12.4	11.9	10	8.8	8	5.8	7	5.3	9.9	3.9	8.4	10.1	7.7	3.3	14	5.3	13.5	18	8.5	10.1	10.5	10.8	13.3	10.5	10.3	4.1	6.3	12.2	9.6	7.4	10.5	8.8	3.5	6.7	13.3	13.3	2.8	11	13.9	11	5	7.2	26.9	13.5	5	9.2	4.9	2.3	3.3	1.4	0.5	7.6	13.3	2.6	4.5	5.6	4.6	4.3	1.9	5.1	5.1	7.9	5.1	4.3	3.3	4.6	1.8	4	2.8	5.9	1.2	0.2	3.9	11	11.7	9.4	10.6	2.4	0.7	2	2.1	3.9	4	3.3	3.2	4.6	1.1	0.9	4.8	1.1	2.6	4.9	3.1	0.7	0.2	4	4.9	3.8	5	12.3	2.5	2.4	1.9	2.5	2.4	3.5	1.2	0.6	3.8	6.8	3.5	16.8	7.2	24.6	4.9	7.6	6.4	5	5.8	5.2	6	3.8	9.2	6.7	26.9	5	13.5	7.2	4.6	4.9	7.4	10.9	5.7	7.7	7	5.3	7.7	3.3	10.1	6.7
ROCK1	p160ROCK	ENSG00000067900	Rho associated coiled-coil containing protein kinase 1	Q13464	18	20946906-21111851	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004562, HPA007567, HPA045639"	Approved					240000	240000			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: "	unprognostic (7.86e-2)	unprognostic (2.86e-2)	unprognostic (1.22e-1)	unprognostic (6.63e-2)	unprognostic (9.90e-2)	unprognostic (1.17e-1)	unprognostic (6.74e-2)	unprognostic (1.00e-1)	unprognostic (1.63e-1)	unprognostic (8.89e-3)	prognostic unfavourable (9.93e-4)	unprognostic (3.85e-2)	unprognostic (8.93e-3)	unprognostic (3.04e-2)	unprognostic (5.47e-2)	unprognostic (3.19e-1)	unprognostic (1.28e-1)	19.3	9.7	9.7	16.3	9.7	40	15.1	18.3	11	13.9	12.6	7.1	14.4	10.1	16	14.9	13.3	14.4	11.7	11.9	10.3	5.6	10.5	9.2	17	20.5	10.1	6	13.7	9.5	11.2	12.2	11.5	10.3	14.2	9.4	9.5	9.4	9.8	7.9	8.5	11.6	27.7	10.7	17.3	12	6.6	12.4	24.8	10.9	9.6	11.2	17.9	21	5.4	5.3	17.9	5	2.6	5.1	2	6.4	4	4	3.9	7.6	8.2	6.6	9	4.4	4	4.4	6.7	2.8	8	6.5	10.6	5.3	3.6	5.2	8.1	11.3	4.2	6.4	7.4	2.9	3.9	17.5	10	5.9	4.8	6	4.9	6.1	3.6	8.3	4.7	4.1	8.2	3.8	3.4	6.8	11.7	4.7	3.1	3.9	6	4.7	3.7	7.2	4.9	3.6	4.8	6.7	10.1	8.1	6.7	7.3	7.3	11.4	5.1	9.2	6.1	7.5	5	2.8	5	6.3	5.1	3.1	4.1	3.7	3.8	3.9	4	5.4	3.7	3.6	17.9	2.6	3.6	5.3	3.2	2	9.7	9.7	18.3	11	10.3	5.6	10.1	6	10.3	12.4
ROCK2		ENSG00000134318	Rho associated coiled-coil containing protein kinase 2	O75116	2	11179761-11348330	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Biological rhythms	"Kinase, Serine/threonine-protein kinase, Transferase"	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		3700000	3700000	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	unprognostic (4.55e-2)	unprognostic (1.05e-2)	unprognostic (4.18e-3)	unprognostic (4.87e-2)	unprognostic (1.49e-1)	unprognostic (2.71e-1)	unprognostic (1.39e-2)	unprognostic (2.72e-1)	unprognostic (3.62e-2)	unprognostic (6.66e-2)	unprognostic (3.83e-2)	unprognostic (1.48e-1)	prognostic unfavourable (1.57e-5)	unprognostic (1.51e-1)	unprognostic (1.99e-1)	unprognostic (2.52e-2)	unprognostic (3.47e-2)	26.9	7.8	14.6	9.5	21.9	4.4	21.4	26.1	26.4	16.6	16.5	5.6	8.6	12.3	22.4	11	12.4	13.2	11.9	12.3	13.4	7.6	11.4	12.3	16.7	6.8	7.2	16.7	15.1	8.6	12.9	14.8	18.4	10.3	14.4	20.3	5.6	10.3	14.4	28	8.7	13.8	42.9	7.1	12.6	10.7	5.8	9.6	5.9	10.5	5.1	6.2	22.1	20.8	2.5	3	3.6	2.2	3.5	3.3	0.9	6.5	15.9	13.2	12.9	23.8	16.7	8.4	15.5	14.5	10.1	10.7	15	14.3	8.2	9.2	24.5	7.3	9.5	8.9	16	11.7	5.7	16.4	27.4	30	8.6	9.1	4.7	13	5.7	12.4	8.9	16.1	14.2	3.3	15	5.5	6.7	4.7	7.3	9.8	8.1	29	2.6	5.5	18.5	6.2	6.6	30.4	10.6	10.6	4.3	5.1	21.9	20.9	15.1	8.3	13.6	2.6	3.2	7.3	9	10.8	29.1	3.6	1.8	1.7	2.7	2.2	3.3	1.6	2.2	1.8	1.3	2.5	1.9	2.1	3	3.5	1.7	3	1.8	0.9	14.6	21.9	26.1	26.4	13.4	7.6	7.2	16.7	10.3	9.6
ROR1	NTRKR1	ENSG00000185483	Receptor tyrosine kinase like orphan receptor 1	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Wnt signaling pathway	"Kinase, Receptor, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		parathyroid gland: 31.2	Cell line enhanced	Detected in many		ASC diff: 19.4;ASC TERT1: 24.3;CACO-2: 16.6;HHSteC: 18.5;HSkMC: 19.9;NTERA-2: 20.2	Low cancer specificity	Detected in many			Region enriched	Detected in many	4	cerebellum: 13.0	Group enriched	Detected in some	5	NK-cell: 3.3;plasmacytoid DC: 1.1	Group enriched	Detected in many	5	dendritic cells: 1.1;NK-cells: 3.3	Low region specificity	Detected in many			Low region specificity	Detected in single			HPA057016			Approved	Microtubules	Intracellular and membrane	2800000	2800000	Microtubules		HPA057016: 	unprognostic (5.15e-2)	unprognostic (1.19e-2)	unprognostic (3.65e-2)	unprognostic (1.03e-2)	unprognostic (6.24e-2)	unprognostic (1.61e-1)	unprognostic (7.11e-3)	unprognostic (1.41e-1)	unprognostic (4.06e-1)	unprognostic (3.84e-1)	unprognostic (3.20e-2)	unprognostic (2.02e-2)	unprognostic (3.64e-3)	unprognostic (1.48e-2)	unprognostic (1.52e-1)	unprognostic (5.87e-2)	unprognostic (5.15e-2)	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13	2.8	16.7	8.8	2.2	4.4	2	14.2	5	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1	2.4	8.3	9.8	31.2	3.6	2.9	3	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0	7	5.5	2.8	0.3	19.4	24.3	1.9	1.3	3.8	0.7	2	16.6	2.2	0.1	3.2	3.2	1.5	0	1.3	0.5	0	1.7	0	0.7	0.2	18.5	0	0	19.9	5.1	10.2	12	0.3	0	0.1	5.1	0.1	0.1	0	20.2	2.8	0.1	0.1	4.3	4.1	0.1	1.6	6.5	0.4	0.1	2.9	0	0	3.8	1.5	2.9	10.8	2.8	0	0	0	0.2	0	0.4	0	0.1	0.1	0.1	0.1	0	0.4	0	0	0.2	0.2	0	0	0.1	3.3	0.1	1.1	0	0	1.3	2.7	13	2.8	1.3	1.1	1	2.4	3	0.9
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	Receptor tyrosine kinase like orphan receptor 2	Q01974	9	91563091-91950162	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Wnt signaling pathway	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Dwarfism"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 12.0;HHSteC: 31.7;HSkMC: 26.4;U-266/70: 18.3;U-266/84: 12.2	Low cancer specificity	Detected in many			Region enriched	Detected in some	6	pons and medulla: 6.6	Cell type enriched	Detected in single	6	MAIT T-cell: 3.9	Lineage enriched	Detected in single	6	T-cells: 3.9	Not detected	Not detected			Region enriched	Detected in single	9	cerebellum: 13.5	HPA021868	Uncertain									HPA021868: AB_1856406	unprognostic (9.38e-3)	unprognostic (4.69e-1)	unprognostic (2.26e-1)	unprognostic (8.48e-3)	unprognostic (1.23e-1)	unprognostic (2.38e-1)	unprognostic (2.06e-1)	unprognostic (1.31e-1)	unprognostic (8.03e-2)	unprognostic (2.03e-1)	unprognostic (5.76e-2)	unprognostic (2.66e-1)	prognostic unfavourable (9.86e-7)	unprognostic (2.16e-3)	unprognostic (9.13e-2)	prognostic unfavourable (4.28e-8)	unprognostic (1.25e-2)	4.4	4.3	0.7	5.3	1.1	0	3.6	0.2	0.8	23.4	20.7	2.9	11.1	1.9	29.1	9.1	8	8.1	18.7	8.5	1	0.9	2	0.5	4.2	0.7	0.3	0	19.1	3.1	20.3	1.3	7.1	6.6	20.3	2.1	11	1.2	13.1	1.1	2.9	6.2	30	0.3	4.7	10.5	5.2	0.3	2.6	7.9	1.9	3.3	23.7	18.1	0.6	0	0	0	0	3.9	0	0	0.1	12	0	2.6	0.2	3.4	0.2	3.1	2	3.8	0	0	0	0	0.6	0.1	2.5	0	0.8	0	2	0	9.2	0	31.7	0	0	26.4	0	2.7	0	0	6.6	0	0	0.2	0	1.7	1.9	0	0	0	0	0	0	0.4	3.5	0.2	0	0	7.1	0.1	0	0	2.4	1	0	18.3	12.2	0	0	0	0	0	0	0	0	0	3.9	0	0	0.6	0	0.6	0	0	0	0	0	0	0	0	0.7	1.1	0.2	0.8	1	0.9	0.3	0	6.6	0.3
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		epididymis: 38.6;lung: 20.2	Group enriched	Detected in some	5	HSkMC: 9.3;hTCEpi: 19.3;LHCN-M2: 13.4	Cancer enriched	Detected in some	13	lung cancer: 6.9	Group enriched	Detected in some	10	cerebral cortex: 7.4;olfactory region: 2.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles				Vesicles		"HPA049098: , HPA072424: "	unprognostic (8.18e-2)	unprognostic (4.64e-3)	unprognostic (1.60e-1)	unprognostic (2.37e-2)	unprognostic (7.57e-2)	unprognostic (2.05e-2)	unprognostic (1.57e-1)	unprognostic (1.79e-1)	unprognostic (2.79e-2)	unprognostic (1.00e-2)	unprognostic (2.42e-1)	unprognostic (5.20e-2)	unprognostic (1.56e-12)	unprognostic (1.09e-2)	unprognostic (2.81e-1)	unprognostic (1.91e-1)	unprognostic (2.12e-1)	0.3	0.2	0.2	0	0.4	0	0.2	0.2	7.4	0.2	0.4	0	7.9	0	0.2	38.6	0.2	0.2	0	0.2	0.2	0.2	0.4	0.2	20.2	0	0.2	2.5	0.2	0.2	0	0.3	0.7	0	0.2	0.3	0	0.2	2.3	0.2	0.7	0.3	0	0.2	0.2	0.3	0.7	0	0	0.2	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	1.9	0	0	0	0	9.3	19.3	0.2	1.7	0	0	0	13.4	0	0	0.1	0	0	0	0	0	0	0	0	0	2.5	0	0	0	1.8	0	2.3	1.5	0.1	1.8	0	0	0	1.7	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0	0
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	Ribosomal protein S6 kinase A1	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		intestine: 45.2	Cell line enhanced	Detected in many		HMC-1: 29.6;U-937: 31.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Region enriched	Detected in all	5	cerebellum: 60.4	Low region specificity	Detected in all			"CAB003852, HPA007981"	Enhanced		Supported	"Nucleoplasm,Cytosol"				Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	unprognostic (1.04e-3)	unprognostic (1.23e-1)	unprognostic (1.61e-3)	prognostic favourable (7.20e-7)	unprognostic (7.35e-2)	unprognostic (3.69e-1)	unprognostic (6.93e-3)	unprognostic (1.12e-2)	unprognostic (1.09e-1)	unprognostic (7.51e-3)	unprognostic (2.37e-2)	unprognostic (9.64e-2)	prognostic favourable (1.84e-4)	prognostic favourable (4.58e-4)	unprognostic (4.77e-2)	unprognostic (7.61e-2)	prognostic favourable (8.33e-4)	11	8.2	6.3	24.2	9.7	15.8	5	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6	8	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10	7.4	3.3	8.6	8.6	15.8	3.6	19	5.5	1.1	9	45.2	2.8	7.9	27	9.7	2.7	9	15.9	13.9	4.9	17.3	6.2	4.5	5	22	40.1	18	7.9	8.3	17.1	9.7	3.4	2.8	3.7	0.1	0	3.7	0.8	1.5	4.2	4	4	8.1	18.3	4.5	0.5	11.5	6.3	22.7	3	15.1	4.1	20.1	8.5	7	1.3	23.7	29.6	0.7	8.3	3.8	6.9	1.8	3.4	6.7	0.2	5.4	0.8	23.3	7.2	11	12.6	3.6	8	12	2.7	4.1	1.6	6.9	6.6	3.2	4.2	20.3	1.2	0.2	5.3	0.7	3.3	4.1	4.9	10	2.5	31.8	4	9.6	18	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22	5	3.9	5.5	34.5	7.9	17.3	8.6	6	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	Ribosomal protein S6 kinase A2	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Tumor suppressor	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		ASC diff: 53.2;ASC TERT1: 39.0;HHSteC: 39.5;HSkMC: 35.1;hTERT-HME1: 42.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in some	4	eosinophil: 17.5	Lineage enriched	Detected in many	4	granulocytes: 17.5	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: , HPA054237: "	unprognostic (8.71e-2)	unprognostic (3.14e-3)	unprognostic (7.29e-2)	unprognostic (1.72e-1)	unprognostic (3.80e-1)	unprognostic (2.45e-1)	unprognostic (6.44e-3)	unprognostic (8.63e-2)	unprognostic (1.40e-1)	prognostic unfavourable (8.63e-5)	unprognostic (8.68e-2)	unprognostic (4.11e-2)	prognostic favourable (2.86e-5)	unprognostic (3.12e-3)	unprognostic (1.51e-1)	unprognostic (1.56e-2)	unprognostic (2.01e-1)	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14	11.9	12.5	40.9	25	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18	12.1	22.7	10.6	7.4	11.1	9	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	2.1	0	4.3	6.2	53.2	39	0	4.6	8.9	2.5	3.6	0	1.3	0.2	1.5	16.1	1.9	2.2	9.9	2.3	0.9	0.5	0	9.4	0.1	39.5	0.1	1.7	35.1	7.1	13.7	42.4	13.9	0	0	10.4	0.4	0.2	0.4	1.1	2.5	0.7	2.2	6.2	2.7	2.3	2.4	16.8	1.6	4.3	5.8	0.1	3.3	5.1	9.1	0.9	25.1	1.3	1.2	1.8	0.6	6	0.2	8.6	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25	18.3	22.4	18.4	22.7	25.7
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	Ribosomal protein S6 kinase A3	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		Hep G2: 67.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA003221, CAB003853, CAB013520"	Approved		Approved	"Nucleoplasm,Nucleoli,Cytosol"				Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	unprognostic (1.87e-2)	unprognostic (1.03e-1)	unprognostic (1.80e-2)	unprognostic (4.26e-2)	unprognostic (3.53e-1)	unprognostic (1.11e-1)	unprognostic (1.15e-2)	unprognostic (1.61e-3)	unprognostic (1.02e-1)	unprognostic (1.57e-1)	unprognostic (5.04e-1)	unprognostic (1.07e-1)	unprognostic (1.04e-1)	unprognostic (4.49e-3)	unprognostic (3.91e-1)	unprognostic (1.09e-1)	unprognostic (2.22e-1)	19.7	12.5	9.9	23	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34	9.9	10	12.7	14	36.6	9.8	11	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15	18.2	20.3	19	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.6	22.2	8.4	4.3	8.2	14.5	2.5	11	16.8	8.2	11.3	25.1	16.4	8.3	3.8	11.5	9	9.6	9.3	15.3	7	7.6	9.8	14	67.5	8.4	19	10.2	9.2	7.5	12.9	16.3	29.8	6.4	23.9	8.6	6	12.3	5.8	6	13.4	6.6	17.8	9.6	7.1	10.6	3.9	3.8	14.8	4.5	16	0	5.7	16.6	9	6.3	28.5	6.2	19.1	11.6	9.3	17	9.5	21.2	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7	4.2	5	6	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10	10.2	9.7
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	Ribosomal protein S6 kinase A4	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	plasmacytoid DC: 12.6	Lineage enriched	Detected in many	4	dendritic cells: 12.6	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB008649, HPA023225"	Approved		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	unprognostic (2.30e-1)	unprognostic (7.05e-2)	unprognostic (2.03e-1)	unprognostic (4.07e-2)	unprognostic (2.40e-1)	unprognostic (7.47e-2)	prognostic unfavourable (8.17e-4)	prognostic unfavourable (9.27e-4)	unprognostic (2.45e-1)	unprognostic (9.03e-2)	unprognostic (1.41e-2)	unprognostic (3.06e-3)	unprognostic (1.98e-2)	unprognostic (3.93e-3)	unprognostic (5.25e-2)	unprognostic (1.09e-1)	unprognostic (2.85e-1)	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14	11	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3	0.3	1	2.1	27.7	15.5	2.2	5.7	5	4.7	32.1	14.7	7.8	11.6	5.8	15.4	14.6	2.8	17.3	8.5	25.7	2.7	12	5.7	8.7	5.2	6.5	13.3	7.8	5	6.6	12.2	4.7	11.3	9.8	8.1	7	2.6	4	5.9	25.4	5.9	10.3	2.5	32.9	11.7	9.3	9.3	8	12.9	3.3	2.6	15.3	9.4	12.9	11	8.2	13.9	15.8	19.9	28.6	13.2	4.8	3.7	2.9	10.5	7.6	8	1.1	3	1.4	0.9	2.4	1	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	Ribosomal protein S6 kinase A5	O75582	14	90847862-91060636	"Enzymes, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HMC-1: 29.5;SK-BR-3: 14.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: "	unprognostic (3.05e-2)	unprognostic (2.19e-3)	unprognostic (4.27e-4)	unprognostic (1.98e-3)	unprognostic (4.79e-2)	unprognostic (4.20e-4)	unprognostic (3.70e-2)	unprognostic (5.80e-4)	unprognostic (6.70e-2)	unprognostic (8.39e-2)	unprognostic (1.84e-1)	unprognostic (1.97e-1)	unprognostic (1.38e-4)	unprognostic (5.73e-3)	unprognostic (1.07e-1)	unprognostic (2.42e-1)	unprognostic (1.75e-1)	4.9	2.4	8.3	13	21.6	5.8	16.3	32.9	12.2	7	11	12	4.2	9.3	11.8	2.6	11.9	8.9	6.7	6.1	9	7.9	4.5	4.1	6.1	7.3	12.8	9.7	10.2	4.9	12	6.9	14.9	11	8	11.7	2.8	8.7	9.9	14.3	6.6	9.8	19.4	17.1	7.4	9.8	5.2	13.7	4.8	8.6	7.8	7.7	11.6	7.3	5.8	2.5	20	3.2	8.4	7.1	2.2	1.2	1.7	2	1.3	0	0.4	8.5	0.7	1.1	2.2	3.4	0.9	2.2	5.8	2.4	2.1	3.7	1.7	1.7	4.7	0.9	3.1	5.8	1.6	0.2	0	5.7	29.5	0.5	3.5	1.4	1.1	2.4	0.6	6.6	2.3	2.4	1.7	2.9	0.6	2.6	3.1	9.4	2.9	2.5	2.2	9.9	3.1	2.4	14.8	8.4	2.8	1.9	0.5	0.7	1.3	0.6	2.9	2.9	2.7	5	1.4	4.2	9.3	10.5	2.7	7.8	3.6	2.1	5.9	4.4	4.8	3.5	2.5	5.8	5.6	3	20	8.4	3.2	1	7.1	2.2	8.3	21.6	32.9	12.2	9	7.9	12.8	9.7	11	13.7
RPS6KA6	RSK4	ENSG00000072133	Ribosomal protein S6 kinase A6	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ductus deferens: 20.7	Cell line enhanced	Detected in many		NTERA-2: 10.8;PC-3: 11.7;RH-30: 14.4;SH-SY5Y: 11.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA002852, HPA003904"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitochondria"				"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	unprognostic (1.17e-1)	unprognostic (1.02e-2)	unprognostic (3.44e-1)	unprognostic (4.93e-4)	unprognostic (1.71e-1)	unprognostic (3.04e-3)	unprognostic (2.09e-2)	unprognostic (2.50e-1)	unprognostic (2.86e-1)	unprognostic (4.88e-2)	unprognostic (3.38e-3)	unprognostic (2.88e-1)	unprognostic (2.12e-9)	unprognostic (4.44e-3)	unprognostic (1.30e-2)	unprognostic (2.34e-2)	unprognostic (8.49e-3)	0.7	2.9	5.9	1	12.2	0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4	1.5	4	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3	15	1.4	2.3	2	1.7	1	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0	3.6	3.5	0	3.4	3.4	0	7.5	4	3.4	2.8	2.7	3	0	0	4.1	0.1	9	6	7.9	0	4.5	0	0.1	0	3	0	0	1.9	0	0	3.7	0.8	0	0.1	2.7	0	1.3	0.1	10.8	11.7	0	14.4	0	0.5	8.3	0	11.5	0	4.2	0	1.9	0	0	0.1	4.3	0	0	0.5	0	0	1	0	0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K1, STK14A"	ENSG00000108443	Ribosomal protein S6 kinase B1	P23443	17	59893046-59950564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enriched	Detected in all	5	MCF7: 74.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: "	unprognostic (2.25e-1)	unprognostic (4.52e-2)	unprognostic (1.91e-3)	unprognostic (1.35e-2)	unprognostic (9.81e-2)	unprognostic (1.13e-1)	unprognostic (3.72e-3)	unprognostic (1.70e-1)	unprognostic (5.86e-2)	unprognostic (1.66e-1)	unprognostic (3.67e-1)	unprognostic (1.76e-2)	prognostic unfavourable (5.09e-7)	unprognostic (3.45e-1)	unprognostic (2.09e-1)	unprognostic (3.98e-2)	unprognostic (1.52e-3)	18.4	18.3	16.6	23.2	19.5	20.5	18.4	25.7	24.2	18.1	18.2	13.1	18.4	13.1	19.6	16.5	25.4	14.5	14.9	14.2	15.7	12.6	13.5	20	14.8	17.3	20.3	17.5	21.6	22.3	24.5	18.9	20.3	17.6	16.7	15	10.1	17.3	21.5	50.3	15.8	14.1	19.3	19.8	17.6	17.5	10.7	20	17.8	16.8	18.4	22	18.5	20.8	8.9	12.8	25.9	11.1	9.4	13.5	8.3	10.6	10.4	8.9	8.4	6.1	9	6.7	9.9	9.2	8.7	9.7	8.5	5.3	12.9	12.3	8.2	5.5	11.7	8.9	14	7.1	13.1	8.8	6.8	9.7	9.1	13.6	8.9	9.1	6.8	10.1	7.5	11.3	11.7	8.3	6.4	74.4	16.1	5.8	6	8	9.5	15	12.1	7.2	7.9	6.5	7.8	8.3	4.8	5.2	9.5	7.5	9.7	8.5	14.1	6.9	13.1	15	12.7	14.5	6.4	8.4	6.7	25.9	10.1	9	11.4	10.2	13.5	8.9	10.5	13	12.8	8.6	12.3	12.9	10	9.4	11.1	8	9.5	8.3	16.6	19.5	25.7	24.2	15.7	12.6	20.3	17.5	17.6	20
RPS6KB2	"KLS, P70-BETA, p70S6Kb, STK14B"	ENSG00000175634	Ribosomal protein S6 kinase B2	Q9UBS0	11	67428460-67435408	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA010010, CAB019404"	Approved		Supported	Cytosol				Cytosol		"CAB019404: AB_331355, HPA010010: AB_1856469"	unprognostic (1.38e-1)	unprognostic (2.36e-3)	unprognostic (8.50e-2)	unprognostic (2.56e-2)	unprognostic (1.84e-1)	unprognostic (1.41e-1)	unprognostic (9.01e-3)	unprognostic (5.10e-2)	unprognostic (1.22e-1)	unprognostic (9.49e-3)	unprognostic (7.66e-2)	unprognostic (2.79e-2)	prognostic unfavourable (2.03e-7)	unprognostic (1.28e-2)	unprognostic (1.55e-1)	unprognostic (2.12e-1)	unprognostic (2.66e-1)	8.7	14.1	8.5	12.8	9.2	18	11.2	12.9	11.5	13.1	13	12.5	12.3	19.8	10.2	10.1	36.1	11	10.7	10.7	8.8	4.2	11.3	27.8	10.7	12	11.4	8.7	9.5	18.7	9.6	11.7	13.8	8.7	17.2	9.9	11.7	18.1	15.8	25	41.4	17.7	8.8	7.6	18.6	17.1	7.5	8.8	21.8	11.4	28.6	21.8	10.1	15.6	15.7	27.1	16.4	28.3	17.8	20.7	20.2	21.7	16.5	9	15.2	4.2	8.1	11.8	10.5	13.2	19.7	13.7	25.7	14.6	8	18.3	10.3	16.2	10.1	16	8	13.8	27	12.9	21	20.9	14.2	16.3	16	10.3	16.9	10.4	10.7	14.6	20.7	21.5	9.9	33.3	25.1	25.7	9.7	21.2	18.6	12.5	38	9.1	12.5	13.6	14.6	10.8	30.1	22.4	35.4	13.6	6.1	10.3	11	24.8	11.7	19.3	15.8	12.9	16.9	10.3	12.8	9.7	22.6	16.4	15.7	25.2	15.9	15.7	14.9	15.3	27.1	14.3	10.9	11.9	15.1	17.8	28.3	18.7	20.7	20.2	8.5	9.2	12.9	11.5	8.8	4.2	11.4	8.7	8.7	8.8
RPS6KC1	humS6PKh1	ENSG00000136643	Ribosomal protein S6 kinase C1	Q96S38	1	213051233-213274773	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026531, HPA031565"	Approved		Enhanced	"Endosomes,Lysosomes"				"Endosomes, Lysosomes"		"HPA026531: AB_10601497, HPA031565: "	unprognostic (3.90e-2)	unprognostic (5.90e-2)	unprognostic (3.22e-1)	unprognostic (4.88e-2)	unprognostic (2.42e-1)	unprognostic (9.81e-2)	unprognostic (1.32e-2)	unprognostic (1.64e-1)	unprognostic (4.10e-2)	unprognostic (3.34e-1)	unprognostic (4.18e-1)	unprognostic (5.11e-2)	prognostic unfavourable (2.70e-4)	unprognostic (8.10e-2)	unprognostic (5.48e-2)	unprognostic (2.98e-2)	unprognostic (4.44e-2)	12	14.1	15.6	10	19.4	6.4	17.1	13.5	19.4	14.1	13.1	12.6	8.8	9.2	15.9	8.4	10.3	11.8	11.6	9.4	17.3	15.6	9.8	10.8	13.6	7.5	17.8	16.8	14.4	13.5	19.9	16.7	12.3	15.3	17.6	10.1	7.3	8.9	17.7	14.1	6.7	8.7	18.5	22.3	11	12.5	26.5	13.2	6.8	10.4	6.1	7.8	14.6	16	2.5	8.7	13.7	6.8	4	3.3	2.2	7.4	6.4	10.6	11.4	10.6	15.7	9.3	9.8	14.4	15.2	17.5	5.2	8.3	4.7	6.6	14.7	6.1	12.8	8	11.6	9.9	4.7	12.7	7.6	7.2	9.8	8	15.1	10.3	6.9	13.3	7.3	12.6	16.3	7.3	15.5	4	3.3	2.6	15.3	7.3	4	10	4.6	7	7.5	6.2	16.1	10.6	8.4	14	12	3.4	11.7	10.4	9.6	11.9	6.4	4.3	8.3	3.6	4.4	3.1	10.6	13.7	4.6	3.3	2.8	6.8	2.3	2.5	2.3	2.4	8.7	1.9	1.5	3.3	0.5	4	6.3	1	1.6	2.2	15.6	19.4	13.5	19	17.3	15.6	17.8	16.8	15.3	13.2
RPS6KL1	MGC11287	ENSG00000198208	Ribosomal protein S6 kinase like 1	Q9Y6S9	14	74903954-74923396	"Enzymes, Predicted intracellular proteins"		"Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.1	Cell line enhanced	Detected in many		HMC-1: 12.8;SCLC-21H: 24.5;SK-BR-3: 14.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	4	memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4	Group enriched	Detected in many	26	B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA027451, HPA027794"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA027451: AB_10599304, HPA027794: AB_10602098"	unprognostic (2.71e-2)	unprognostic (9.33e-3)	unprognostic (3.36e-1)	unprognostic (1.13e-2)	unprognostic (1.08e-1)	unprognostic (1.63e-2)	unprognostic (1.44e-2)	unprognostic (7.49e-4)	unprognostic (2.06e-1)	unprognostic (1.54e-1)	unprognostic (4.09e-3)	unprognostic (2.91e-1)	unprognostic (1.11e-1)	unprognostic (1.33e-2)	unprognostic (1.14e-1)	unprognostic (7.03e-2)	unprognostic (7.52e-2)	4.2	7.5	14.7	2.3	13.6	4.2	5.7	18.2	29.1	2.1	4.8	9	2.2	3.8	5.1	8.8	5.3	2.5	3.7	10.2	14.3	13.7	2.3	2.1	2.5	2.5	11.1	15.3	1.5	6.7	4	10.6	1.4	8.4	2.8	5.6	5.9	3.2	5.4	12.7	1.2	2.8	6.9	8.8	1.7	2	11.4	6.8	0	3.8	1.2	2.5	1.9	0.8	2	5.4	0.1	0	0	2	0.1	2.3	0.3	0.9	3.7	0.1	0	4.4	0.4	0.2	1.8	0.5	5.5	1.6	0	3.4	0.7	0.3	1.8	0.3	2.3	0	0.8	1.9	0.7	4.1	4.6	2.2	12.8	0.3	3.2	2	0	5.8	2.6	0.7	0.1	7.5	0	0.7	0.8	3.6	1.8	0	7.1	1.8	0	24.5	3	0.2	14.1	2.3	1.3	1.5	3.9	0.1	0.2	3	0	9.9	5.2	5.2	1.3	0.2	0	0	0	0	0.6	0	0.2	2	0.4	0.1	0	0.4	1.9	2	0.1	0	0	5.4	0	0.1	14.7	13.6	18.2	18.2	14.3	13.7	11.1	15.3	8.4	6.8
SBK1	Sbk	ENSG00000188322	SH3 domain binding kinase 1	Q52WX2	16	28292519-28323849	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6	Cell line enhanced	Detected in some		AF22: 15.0;AN3-CA: 10.8;NTERA-2: 15.4;REH: 16.3;SCLC-21H: 23.8;SH-SY5Y: 22.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	8	gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4	Group enriched	Detected in many	10	NK-cells: 1.4;T-cells: 4.3	Region enriched	Detected in all	5	cerebellum: 306.7																unprognostic (5.15e-2)	prognostic favourable (6.88e-4)	unprognostic (2.08e-1)	unprognostic (6.22e-2)	unprognostic (1.81e-1)	unprognostic (1.71e-2)	unprognostic (5.71e-3)	unprognostic (3.66e-3)	unprognostic (1.17e-1)	unprognostic (1.62e-2)	unprognostic (2.87e-2)	unprognostic (6.38e-2)	unprognostic (1.19e-3)	unprognostic (3.99e-2)	unprognostic (3.50e-2)	unprognostic (7.91e-2)	unprognostic (5.03e-3)	0.9	2	8	1.8	7.3	2	1.7	31.1	17.5	1.7	1.2	1.5	0	1.1	1.9	1.3	1.5	1.6	1	1.8	9.9	5.6	1.6	0.9	1.8	2.7	6	4	1.1	2.7	4.2	4.1	0.8	8.3	2.6	1.2	1.4	3.8	1	39.6	1.4	1.1	0.9	3.1	2.8	1.6	2.3	3.1	22.1	2.6	0	1.7	1.2	0.3	0.2	0.2	0.2	0.1	1.4	4.3	0.4	0.1	0.2	15	10.8	0	0	2.3	0	0	0	0	0.1	0.7	0.3	0.1	0	0.3	4.5	0.1	0	1.5	0.5	0	0.1	0.4	0	0.1	0.3	0	0.1	0	0	0.1	0	0.9	0	1.8	6.9	0.1	15.4	0.1	16.3	0.8	0.1	0.1	0.9	23.8	22.4	0.3	1.4	0.2	1.7	0	0.4	0	2.3	0.2	0.1	0.2	0	0.2	0.1	0.2	0.8	0.2	0.1	0.1	4.3	0	1.4	0	1.2	2.4	0	0.2	1.4	3	0.1	1.4	0.1	0.2	1.4	0.4	8	7.3	31.1	17.5	9.9	5.6	6	4	8.3	3.1
SBK2	SGK069	ENSG00000187550	SH3 domain binding kinase family member 2	P0C263	19	55529733-55537089	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	27	heart muscle: 45.7;tongue: 20.8	Cell line enhanced	Detected in some		A549: 4.3;Hep G2: 3.1;MCF7: 4.4;NTERA-2: 8.7;RH-30: 8.1;U-2 OS: 4.8	Cancer enhanced	Detected in some		ovarian cancer: 1.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			HPA030631	Enhanced									HPA030631: AB_10602088	unprognostic (1.33e-1)			unprognostic (1.85e-3)	unprognostic (4.57e-1)	unprognostic (3.49e-1)				unprognostic (5.43e-3)	unprognostic (4.18e-3)		unprognostic (2.08e-1)	unprognostic (6.58e-2)	unprognostic (1.05e-1)			0.2	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0.3	0	0.1	45.7	0	0	0	0	0	0	0	0	0	0.5	0	0.3	0	0	0.1	0	0	0.6	0	1.2	0	0	0	0	0.3	0	0.8	0	0	0.7	20.8	0.8	0	0	0	0	0	0	0	0	0	0	4.3	0	0.1	0	0	0	0.7	0	0.4	1	0.4	0	0	0.3	0	0	0	0	0	0	0.3	0	0	3.1	0	0	0	0.3	0	0.4	0	0	0	0	0.3	4.4	0	0	8.7	0	0	8.1	0	0	0	0.6	0	0	0	0	0	0	0	0	4.8	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0
SBK3	SgK110	ENSG00000231274	SH3 domain binding kinase family member 3	P0C264	19	55540656-55545543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	heart muscle: 24.2	Cell line enhanced	Detected in some		A549: 9.2;CACO-2: 3.2;CAPAN-2: 5.4;NTERA-2: 2.5;RH-30: 4.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			HPA078322			Approved	Mitochondria				Mitochondria		HPA078322: 	unprognostic (2.15e-1)	unprognostic (1.99e-3)	unprognostic (2.71e-1)	unprognostic (1.39e-3)	unprognostic (7.52e-2)	unprognostic (2.83e-1)	unprognostic (5.47e-5)	unprognostic (4.64e-3)		unprognostic (7.24e-2)	unprognostic (1.65e-1)	unprognostic (3.38e-1)	unprognostic (3.08e-3)	unprognostic (1.21e-2)	unprognostic (4.92e-2)	unprognostic (2.41e-1)	unprognostic (1.79e-1)	2	0	0	0	0	0	0.2	0.1	0	0	0			0.2	0	0	1.7	0	0.1	24.2	0	0	0	0	0.1	0	0		0	0.2	0	0	0		0	0		0.1	0	1.9	0	0	0	0	0	0.2	0			0.1		0	0	0	0	0	0	0	0	0	0	0	9.2	0.8	0	0.1	0	0.2	0.2	0	0.1	0.3	3.2	5.4	0	0.2	0.2	0	0	0	0	0	0	0	0.9	1.8	0.4	0	0	0.1	0	0	0	0	2.1	0	0	1	0	0	2.5	0.6	0.2	4	0	0.1	0	0	0	0	0.2	0.1	0	0	0	0.2	1.2	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0										
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	SCY1 like pseudokinase 1	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all							HPA015015	Uncertain		Supported	Cytosol				Cytosol		HPA015015: AB_1856643	unprognostic (5.56e-2)	unprognostic (1.16e-1)	unprognostic (1.03e-1)	unprognostic (3.99e-1)	unprognostic (1.23e-2)	unprognostic (7.87e-2)	unprognostic (1.23e-2)	unprognostic (5.06e-2)	unprognostic (1.14e-1)	unprognostic (7.23e-2)	unprognostic (4.41e-1)	unprognostic (4.29e-1)	unprognostic (7.86e-3)	unprognostic (6.49e-3)	unprognostic (4.27e-1)	unprognostic (8.29e-2)	unprognostic (2.29e-3)	24.1	35.5	24.1	20.2	24.4	22.8	49.4	24.6	47.3	25	21.6	19	27.8	22.5	26.9	30	24.1	26.7	21.4	35.8	25.1	21.1	24.1	61.4	22.4	22.9	21.7	23.9	34.1	40.7	27	24.3	30.7	19.6	24.7	14.3	24.9	34	30.3	51.2	23.6	19.8	23	17.1	24.7	24.4	31.4	20.6	18	27.3	20.2	20.2	24.9	24.1	10.7	15.5	27.9	13.7	11.1	14.7	12.1	19.8	17.1	13.8	19.1	25.3	22.1	18.9	24.7	33.6	29.5	23.1	24.6	12	14.3	25.1	32	18.2	14.5	18.5	10.3	16.8	18.6	16.8	18.8	28.2	36	11	24.3	30.6	18.4	25.3	18.9	19.3	17.5	20.3	18.3	43.2	14.7	25.4	13.3	23.9	15	10.7	26.2	18.1	17.8	12.8	13.6	15.2	33.7	26.8	33.4	14	19	23.5	15.8	38	14.5	28.1	19.5	14.9	27.2	9.2	16.4	1.9	13.7	17.6	14.7	13.2	11.8	10	13.8	14.6	15.5	10.7	11.2	10.5	27.9	11.1	8.5	11.3	9.5	12.1	24.1	24.4	24.6	47.3	25.1	21.1	21.7	23.9	19.6	20.6
SCYL2	"CVAK104, KIAA1360"	ENSG00000136021	SCY1 like pseudokinase 2	Q6P3W7	12	100267140-100341724	"Enzymes, Predicted intracellular proteins"				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021050	Approved									HPA021050: AB_1846175	unprognostic (7.01e-3)	unprognostic (3.04e-2)	unprognostic (4.34e-3)	unprognostic (4.01e-2)	unprognostic (3.87e-2)	unprognostic (1.07e-1)	unprognostic (1.27e-2)	unprognostic (8.19e-2)	unprognostic (5.32e-2)	unprognostic (1.31e-1)	unprognostic (1.34e-2)	unprognostic (1.93e-2)	unprognostic (4.44e-1)	unprognostic (2.72e-1)	unprognostic (3.46e-1)	unprognostic (1.60e-1)	unprognostic (2.18e-1)	22.7	20.3	19.6	17.5	16.8	19.8	18.3	21	20.2	16.9	23.5	13.9	19.5	20.9	18.9	23.7	26.2	16.2	17.3	20.2	13.7	15.2	26.1	35.1	21.2	15.9	12.6	15.7	19	19.4	28.1	30.3	31.3	16.2	19.8	28.6	13.3	22	17.8	24.6	17.9	23.2	18.5	14.8	19	20.8	17.4	11.5	31.7	17.4	16.1	20.3	28	21.4	4.4	8.1	13.3	8.1	10.8	7.5	4.7	17.9	13.8	22.5	18.6	14.4	15.3	21.6	18.5	20.1	16.9	14.4	13.2	9.2	11.3	8.9	21.9	15.4	17.5	13	20.3	17.5	11.9	36	9.5	9.6	12.8	16.7	35.4	11.3	20.6	19	22.1	21.1	18.9	9.6	18	13.6	14	14.6	14.5	15.9	11.1	16.6	10.8	15.5	28.6	14.3	13.1	21.4	21.6	17.2	31.6	13.3	20.9	14.7	8.6	13.8	11.9	11.4	15.1	13.8	7.4	12	16.8	13.3	6.1	11.7	5.3	8.1	6.8	4.4	5.7	5	8.1	3.4	6.3	6.5	8.6	10.8	6.5	2.6	7.5	4.7	19.6	16.8	21	20.2	13.7	15.2	12.6	15.7	16.2	11.5
SCYL3	"PACE-1, PACE1"	ENSG00000000457	SCY1 like pseudokinase 3	Q8IZE3	1	169849631-169894267	"Enzymes, Predicted intracellular proteins"				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA005624	Approved		Uncertain	"Nuclear bodies,Microtubules"				Microtubules	Nuclear bodies	HPA005624: AB_1854916	unprognostic (2.35e-1)	unprognostic (1.25e-1)	unprognostic (7.53e-2)	unprognostic (8.36e-2)	unprognostic (7.13e-2)	unprognostic (2.72e-3)	unprognostic (1.31e-1)	unprognostic (2.12e-2)	unprognostic (2.85e-2)	unprognostic (7.17e-2)	unprognostic (8.80e-2)	unprognostic (9.88e-2)	unprognostic (1.20e-3)	unprognostic (3.54e-1)	unprognostic (1.75e-1)	unprognostic (4.60e-2)	prognostic favourable (8.85e-4)	10.8	11.4	8.5	15.4	10.6	5	15.8	10.5	11.9	12.1	14.6	11	14.6	10.7	12.6	14	14.4	10.6	11	7.8	7.3	6.5	12.1	18	11.8	13.7	9.3	7.8	13	12.8	22.7	14.4	15.8	9.5	13.2	13.9	12.3	15.5	13.8	14.6	14.1	14.9	13	7.3	12.6	11.3	9.1	8.9	17.2	13.3	9.5	16	16	12.7	8.3	13.6	12.3	4.3	11.8	10.5	5.9	3.9	5.1	8	5.5	10.3	7.5	9.2	6.2	8.1	7.3	6.9	4.7	7.7	8.2	4.6	6.4	9.3	4.7	5.5	6.5	15	4.4	5.6	5.7	3	7.3	8.1	7.4	7.2	5.5	5.1	7	6.8	9	10.9	6.9	3	6.6	6.3	6.4	2.5	6.1	4.4	9.7	7.7	7.2	6	8.7	4.9	16.4	9.7	9.1	7.6	5.1	5.2	3.5	6.2	5	14.6	12.9	9.8	4	6.1	5.7	12.3	3.7	9.7	8	3.9	10.5	8.3	10.4	8.7	6	7.3	9.2	7.5	8.2	11.8	4.3	13.6	9.5	5.9	8.5	10.6	10.5	11.9	7.3	6.5	9.3	7.8	9.5	8.9
SGK1	SGK	ENSG00000118515	Serum/glucocorticoid regulated kinase 1	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		parathyroid gland: 141.3	Cell line enhanced	Detected in many		HHSteC: 50.1;RPTEC TERT1: 76.9;SK-MEL-30: 49.8;TIME: 59.8;U-266/84: 54.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	4	classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2	Group enriched	Detected in many	7	granulocytes: 45.9;monocytes: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	Nuclear speckles				Nuclear speckles		"CAB022085: , CAB025148: , HPA051251: "	unprognostic (2.05e-2)	prognostic favourable (5.26e-4)	unprognostic (1.12e-1)	unprognostic (5.09e-3)	unprognostic (2.76e-1)	unprognostic (4.20e-2)	unprognostic (4.53e-2)	unprognostic (5.62e-2)	unprognostic (4.03e-1)	unprognostic (7.94e-2)	unprognostic (1.78e-1)	unprognostic (2.55e-1)	unprognostic (5.82e-3)	unprognostic (9.10e-2)	unprognostic (3.81e-2)	unprognostic (1.79e-1)	unprognostic (6.59e-2)	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0	8.6	2.1	0.9	12.3	25.7	16.1	13.2	1.9	1.7	2	1.8	12.7	0.4	1.1	1.9	11.9	0	0.5	0.1	30.7	1.4	50.1	0.1	1.1	12.9	12.4	15.8	20.6	27	3.9	31.4	5.7	0.1	0.1	0.4	0.7	1.3	0.3	1.4	0.2	76.9	0.2	0.3	3	38.7	0.1	49.8	0	0.3	59.8	4.7	2	28.9	2.7	5.9	54.8	6.3	4.4	1.9	6.3	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25	22.9	9.6	48.8	16.6	28.3	50.1
SGK2		ENSG00000101049	"SGK2, serine/threonine kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 33.1;kidney: 39.1;liver: 32.9	Group enriched	Detected in some	5	A549: 13.5;CAPAN-2: 10.6;EFO-21: 5.4;Hep G2: 13.7;RPTEC TERT1: 19.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008859: , HPA011387: AB_1856744"	unprognostic (1.82e-1)	unprognostic (1.84e-1)	unprognostic (4.53e-2)	unprognostic (2.86e-1)	unprognostic (6.27e-2)	unprognostic (2.98e-4)	unprognostic (2.05e-2)	unprognostic (1.35e-1)	unprognostic (4.30e-2)	unprognostic (2.60e-1)	unprognostic (1.05e-1)	unprognostic (5.72e-4)	unprognostic (4.15e-2)	unprognostic (1.38e-1)	unprognostic (2.56e-1)	unprognostic (3.11e-2)	prognostic favourable (5.65e-4)	11.4	0.7	2.8	4.3	9.9	0.2	3.1	1	10.2	1.4	21.3	33.1	0.9	17.8	1	19.7	0.7	1.6	7.9	0.7	4.3	2.5	39.1	32.9	0.6	0.5	6.9	5.1	3.2	14.1	0.5	1.7	0.5	13.7	1.4	23.4	0	0.9	1.8	0.4	3.2	20.7	1	14.2	0.7	11.9	1	6	0	1	0.2	0.2	3.1	1.6	0	0	0	0	0	0	0	0	13.5	0.2	0.1	0.2	0	0	0.1	0	0.1	0	0.6	10.6	0	5.4	0.1	0.1	0	0	0.1	0	0.2	0.1	0	13.7	0.3	0	0	0	0.4	0	0	0	0.1	0.1	0	0.1	0	0.2	0.1	0	0.1	0	0	19.4	2.2	0.1	0.5	0	0.9	0.1	0	0.1	0.3	0	0	0	0	0.5	0	0	0.1	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	9.9	1	10.2	4.3	2.5	6.9	5.1	13.7	6
SGK3	"SGK2, SGKL"	ENSG00000104205	Serum/glucocorticoid regulated kinase family member 3	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		T-47d: 23.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA006699, HPA027146"	Supported		Supported	"Nucleoplasm,Vesicles"				Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	prognostic favourable (5.52e-6)	prognostic favourable (8.28e-4)	unprognostic (8.52e-3)	unprognostic (1.10e-2)	unprognostic (3.75e-1)	unprognostic (1.37e-2)	unprognostic (2.32e-1)	unprognostic (1.69e-3)	unprognostic (9.51e-2)	unprognostic (8.86e-3)	prognostic favourable (9.65e-4)	unprognostic (1.94e-2)	unprognostic (8.95e-2)	unprognostic (4.55e-3)	unprognostic (1.77e-1)	unprognostic (1.01e-1)	unprognostic (5.29e-3)	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12	10	24	8.7	8.6	8	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7	7.7	6.1	12.4	10.8	6	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8	5.8	13.8	21.4	15.7	6.9	13.3	8	11.4	2.9	0.5	1.8	3.5	6.8	6.5	7.3	6.9	4	4.2	5.2	7.7	8.6	1.8	8	3.7	6	4.3	5	4.8	10.2	7.8	2.1	5.1	3.5	7	9.3	3.3	3.8	1.9	6.7	6.4	1.5	4.2	7.6	1.8	5.5	4.3	1.6	4	9.7	4.3	5.8	5.4	2.6	2.5	1.9	3.3	4.9	11	23.1	14	7.6	3.8	3.4	3.3	2.7	5.2	9.9	9.9	4.4	11.8	3.9	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9	6.9	2.5	6.9	4.4	7.7	5.3	8	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9
SIK1	"msk, SNF1LK"	ENSG00000142178	Salt inducible kinase 1	P57059	21	43414483-43427189	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Tumor suppressor"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in all		skin 1: 34.5	Cell line enhanced	Detected in many		HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 2.0;plasmacytoid DC: 1.6	Group enriched	Detected in many	10	B-cells: 2.0;dendritic cells: 1.6									"CAB023801, HPA038211, HPA078064"	Approved		Approved	"Nucleoplasm,Vesicles"				Nucleoplasm	Vesicles	"CAB023801: , HPA038211: , HPA078064: "	unprognostic (4.06e-2)	unprognostic (9.38e-2)	unprognostic (3.31e-3)	unprognostic (3.00e-1)	unprognostic (5.02e-2)	unprognostic (7.97e-3)	unprognostic (1.51e-1)	unprognostic (7.30e-3)	unprognostic (2.35e-3)	unprognostic (4.97e-2)	unprognostic (1.89e-2)	unprognostic (1.30e-1)	unprognostic (3.89e-1)	unprognostic (9.94e-3)	unprognostic (3.88e-2)	unprognostic (2.89e-1)	unprognostic (1.82e-1)	8.8	2.3	3	3.6	3	5.9	7.5	3	3	13.5	3	3	3	0	3	3	12.9	5.5	10.7	7.1	3	0.8	3	12.3	5.4	3	3	3	13.7	7.3	3.5	5.7	8.2	3	3.9	0.1	3	4.6	9.8	5	34.5	3	3.3	3	4	5.3	3	3	3	3.9	3	3	10.5	6.1	2	1.6	0	0.1	0	0.1	0.1	0.5	1.7	2	0	0.1	0.8	0.7	0.9	0.3	1.6	1.3	2.4	0	2.4	0.7	0.2	11.1	1.6	16.7	1	0.1	0.5	0.7	27.8	0.9	2.3	0.7	0.1	1	21.5	0.4	5.1	0.3	0.1	0.5	21.6	0.1	0.4	1.7	0.8	1.5	0	0.3	2.5	1.9	6.3	0	0	10.9	1.8	0.4	1.1	0.3	3.7	0.4	2	0.1	0	4.3	15.7	0.4	4.6	2	0.4	0	0.1	0	0.1	0	0.1	2	0	0.1	0.5	0.9	0	0	0	0	0	1.6	0	0.1	3	3	3	3	3	0.8	3	3	3	3
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	Salt inducible kinase 2	Q9H0K1	11	111602391-111730853	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		ASC diff: 34.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016026	Approved		Approved	Golgi apparatus				Golgi apparatus		HPA016026: AB_1857321	unprognostic (2.35e-1)	unprognostic (1.10e-1)	unprognostic (1.08e-1)	unprognostic (1.10e-2)	unprognostic (1.59e-2)	unprognostic (4.81e-2)	prognostic favourable (4.93e-4)	unprognostic (6.41e-2)	unprognostic (1.87e-1)	unprognostic (1.40e-2)	unprognostic (3.72e-3)	unprognostic (9.27e-2)	prognostic favourable (1.17e-9)	unprognostic (1.23e-1)	unprognostic (2.79e-1)	unprognostic (2.82e-3)	unprognostic (2.13e-2)	32.8	10.7	10.1	6.6	17.2	4	22.5	10.6	17.3	10	9.9	15.1	5.2	7.7	9.5	7	7.9	9.7	12.7	14.5	10.5	10.3	14.6	24.4	13.6	5.4	9.7	9.9	16.4	37.8	22	28.6	7.5	11.9	8.4	8.3	14.9	15.4	8.6	35.1	8.7	7.7	8.7	9.6	5.8	19.6	4.2	13	4.4	11.1	7.9	5.8	8.6	10	2.2	2.7	2.8	3.6	2.2	3.5	2.1	5.8	3.9	6.8	7.3	34	10.1	4	5.1	7.3	3.9	4.5	13.1	6.2	4.6	7.1	5.9	8.3	5.3	3.8	5.1	3.4	2.2	5	3.4	6.4	7.4	4.8	3.3	9.8	5.7	5.7	7.4	4.6	4.6	6.7	6.1	2.7	5	4.4	2.3	3.9	6.7	7.3	5.5	8.7	5.3	3.2	7.5	7.5	3.1	3	7.5	3.9	6.4	8.6	5.2	5.5	7	1.9	1.5	9.7	2.8	6.8	5.8	1.1	3.3	2.8	3.5	3.6	1.9	2	2.5	2.5	2.7	2.2	1.4	2	1.4	2.2	2.9	1.5	2.4	2.1	10.1	17.2	10.6	16.4	10.5	10.3	9.7	9.9	11.9	13
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	STE20 like kinase	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		17000	17000	"Plasma membrane, Cytosol"		HPA015757: AB_1857236	unprognostic (1.89e-1)	unprognostic (1.80e-1)	unprognostic (1.38e-1)	unprognostic (8.28e-2)	unprognostic (1.01e-1)	unprognostic (3.64e-1)	unprognostic (8.67e-2)	unprognostic (6.85e-2)	unprognostic (1.01e-1)	unprognostic (2.31e-1)	prognostic unfavourable (2.77e-5)	unprognostic (1.95e-1)	prognostic favourable (3.95e-5)	unprognostic (8.48e-2)	unprognostic (3.95e-1)	unprognostic (3.09e-2)	unprognostic (1.07e-1)	15.2	11.2	13.7	11	36.7	14.6	16.1	16.7	13.1	16.6	19	9.9	10.9	9.1	17	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13	12.1	15.7	10.2	12.8	12	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.2	12.4	14.9	10.6	16.1	22.5	6.3	13.3	17.7	9.9	9.3	7.9	22.9	11.3	8.3	13.7	23.2	7.8	16.8	14.5	9	10.8	11.5	10.2	6.6	12.1	13.7	10	11.5	22.1	13.4	39.2	17.8	14.3	7.8	13	7.4	9.6	7.6	3.7	8	9.4	18.3	5.8	13	24.5	3.5	6.1	11.5	11.2	11	5.8	9.9	26.9	7.3	7.6	13.4	15.5	9.5	11.6	7.2	10.8	18.4	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8
SMG1	"ATX, KIAA0421, LIP"	ENSG00000157106	"SMG1, nonsense mediated mRNA decay associated PI3K related kinase"	Q96Q15	16	18804853-18926454	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Nonsense-mediated mRNA decay"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA006870, HPA031623, HPA073972"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006870: AB_1079725, HPA031623: , HPA073972: "	unprognostic (6.34e-2)	unprognostic (5.88e-2)	unprognostic (5.98e-2)	unprognostic (2.66e-1)	unprognostic (2.44e-2)	unprognostic (1.35e-2)	unprognostic (1.03e-1)	unprognostic (2.28e-1)	unprognostic (1.22e-1)	unprognostic (2.42e-1)	unprognostic (8.32e-3)	unprognostic (7.28e-2)	unprognostic (1.05e-1)	unprognostic (2.61e-2)	unprognostic (1.15e-1)	unprognostic (3.17e-2)	unprognostic (2.45e-2)	4.7	3	2.1	4.5	3.5	11.7	6.2	13.2	3	4.4	4.5			3.1	5.4	5.1	5.5	4	3	4.5	2.3	2.2	4.6	5.4	4.1	6.2	2.3		6.3	4.5	7.2	3.9	3.1		4.2	5		4.7	3.3	21.1	14.4	5	3.9	3.4	4.5	4.3	4			6		5.8	5.2	4.9	7.1	4.6	19.1	5.6	2.3	6.1	1	23.2	15.6	14.7	10.4	16.9	17.9	10.9	10.9	10.7	11.9	13.3	13.7	8.6	32.1	15.7	15.1	13.3	16.9	9.5	19	20.6	10.6	14.6	13.7	17.5	13.7	19.6	11.6	10.5	16.1	24.5	29.6	16.6	22.4	17.9	13.1	12.4	13.5	11.8	15.7	9	15.7	19.8	11	10.2	18.3	13.4	10.2	16.9	11.5	11.9	9.2	12.5	21	17.9	12	11	16.1	9.2	11.9	21.2	11.9	15.3	10.6	19.1	2.5	3.4	6.1	2.8	2.9	3.7	4	4.3	2.5	7.1	5.4	4.7	7.6	2.3	5.6	4.6	3.7	1										
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	SNF related kinase	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		HUVEC TERT2: 50.8;TIME: 29.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	HPA042163: AB_10794645	prognostic favourable (9.28e-4)	unprognostic (8.46e-2)	unprognostic (2.79e-3)	unprognostic (6.41e-2)	unprognostic (1.14e-1)	unprognostic (1.16e-3)	unprognostic (2.00e-2)	unprognostic (1.08e-1)	unprognostic (2.63e-3)	unprognostic (4.25e-1)	unprognostic (2.32e-1)	unprognostic (4.68e-2)	prognostic favourable (9.41e-5)	unprognostic (9.21e-3)	unprognostic (2.04e-1)	unprognostic (7.06e-3)	unprognostic (7.38e-2)	31.5	8.8	9.8	13.1	14.4	41	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11	11	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3	20.9	5.5	8.1	10.7	6.5	3.2	2	3.7	3.5	11.1	4	3.5	3.5	5.9	3.8	3.8	2.7	4.7	5.1	2.8	4.4	2.1	4.3	7.5	4	5.9	3.5	5.9	3.7	3.1	5.8	6.6	6.6	4.4	5.2	4.3	7.4	50.8	2.6	6	3.5	1.7	6.6	5.8	4.1	9.1	4.6	2.7	5.4	9.9	5.6	2.6	5.5	3	3.3	4.2	2.2	8.4	29.5	3.4	3.4	3.9	4.1	9.7	6.9	4.4	2.4	7.9	4.8	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3	3.2	10.1	10.1	20.9	8.1	5	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11	11	11.4	10.6	22.5	7.2
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta"	ENSG00000072195	SPEG complex locus	Q15772	2	219434846-219498287	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		skeletal muscle: 88.7	Cell line enhanced	Detected in many		U-138 MG: 14.7;U-2 OS: 15.0;U-251 MG: 13.7;U-87 MG: 16.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all							HPA018904	Enhanced		Approved	Vesicles				Vesicles		HPA018904: AB_1844924	unprognostic (3.70e-1)	unprognostic (1.23e-2)	unprognostic (5.05e-3)	unprognostic (2.45e-4)	unprognostic (2.04e-2)	unprognostic (4.65e-3)	unprognostic (2.41e-2)	unprognostic (1.12e-1)	unprognostic (8.92e-3)	unprognostic (2.29e-2)	unprognostic (8.66e-4)	unprognostic (1.06e-1)	unprognostic (3.47e-9)	unprognostic (1.14e-1)	unprognostic (7.01e-2)	unprognostic (5.95e-4)	unprognostic (1.28e-3)	7.7	7.1	10.1	9.1	7.7	1.2	4.2	10.4	9.8	19.2	45.1	4.1	10.5	5.7	31.6	14.1	13.5	19	17.4	17.8	8.7	5.3	2	1.4	3	1.7	4	8	7	2.9	4.7	10.5	4.8	5.5	16.7	4.5	6.7	7.8	23	88.7	2.2	9.2	45.2	9.1	1.9	16.1	3	3.9	0	2	16.8	1.6	22.5	12.6	0	0.3	0	0	0	0.5	0.7	4	0.3	2.1	3.5	1.1	3.2	1.4	8.7	5.8	5.8	4.4	3.1	1.4	0	3.2	6.4	5.1	1.7	2	2.3	0.5	1.3	0.4	3.7	0.2	1.5	0	0.7	9.3	3.1	5.3	1.3	0	3	0	4.2	1.1	0.1	12.4	4.4	1.6	2.1	4.7	0.7	5.7	0	2.3	10.9	0.6	0	0.1	0.3	0.1	0.1	14.7	15	1.7	13.7	0.5	0	0.1	16.6	0.1	0.9	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0.1	0	0	0	0.3	0	0.7	10.1	7.7	10.4	9.8	8.7	5.3	4	8	5.5	3.9
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		A549: 35.5;HBEC3-KT: 33.0;PC-3: 32.1;RT4: 34.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		intermediate monocyte: 5.3;non-classical monocyte: 4.4	Group enriched	Detected in many	6	dendritic cells: 3.0;monocytes: 5.3	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004023, HPA030875"	Approved		Supported	"Plasma membrane,Cell Junctions,Cytosol"		20000000	20000000	"Plasma membrane, Cell Junctions"	Cytosol	"CAB004023: AB_2106059, HPA030875: "	unprognostic (5.58e-2)	unprognostic (9.83e-2)	unprognostic (3.56e-1)	unprognostic (4.54e-3)	unprognostic (1.52e-1)	unprognostic (1.54e-2)	prognostic unfavourable (4.90e-5)	unprognostic (3.89e-2)	unprognostic (7.04e-2)	unprognostic (8.13e-2)	unprognostic (1.54e-2)	prognostic unfavourable (1.63e-4)	prognostic unfavourable (1.22e-4)	unprognostic (2.33e-2)	unprognostic (4.72e-2)	unprognostic (3.65e-2)	prognostic favourable (5.22e-5)	6.9	17.5	12.8	11.1	12	5.4	9.9	6.4	16	16	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4	6.6	10.5	10.4	26.4	20	0.3	3	0.1	5.3	0.6	0.1	1.6	7.6	35.5	8.1	7.3	3.1	4.9	17	7.1	6.1	8.6	5.5	13.3	6.9	0.2	4.4	12.8	14	4.9	33	3.4	0	4.4	1.9	1.2	20.7	7.4	0.1	3	5.3	11.2	5.6	7.5	7.8	0.2	0	1.4	5.2	1.8	0.2	3.8	32.1	8.3	2.1	0.2	3.6	34	7.6	27.5	8	11.3	8.8	10.1	2.8	11.5	10.4	7	3.8	6.3	0.1	0.2	0.1	7.3	0	7.7	0	2.6	0	0	5.3	0	0.3	0	0.1	1.1	0.3	0	0	0.1	0.6	4.4	3	0.1	1.6	12.8	12	6.4	16	11.3	6.6	3.3	9.9	5.1	4.8
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites	Q9H3Y6	20	63540810-63547504	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		epididymis: 10.2	Cell line enhanced	Detected in some		CAPAN-2: 5.7;HaCaT: 2.6;MCF7: 4.9;RT4: 10.1;T-47d: 2.6	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enhanced	Detected in single		naive B-cell: 1.1	Lineage enriched	Detected in single	8	B-cells: 1.1	Low region specificity	Detected in some			Low region specificity	Detected in single			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"				Intermediate filaments	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: "	unprognostic (2.26e-2)	unprognostic (1.26e-2)	unprognostic (2.52e-3)	unprognostic (8.32e-2)	unprognostic (2.62e-1)	unprognostic (5.47e-3)	unprognostic (1.65e-1)	unprognostic (2.28e-1)	unprognostic (9.63e-2)	unprognostic (6.48e-3)	unprognostic (7.28e-3)	unprognostic (1.46e-1)	unprognostic (1.73e-3)	unprognostic (2.58e-3)	unprognostic (4.75e-2)	unprognostic (4.97e-2)	unprognostic (2.54e-3)	0.3	0	0.3	0.5	0.3	0	1.1	1.1	0.3	0.3	1.8	0.3	0.3	0.4	0.3	10.2	0.4	0	0.3	0.3	0.3	0	0.9	0.3	0.3	0.3	0.3	0.3	0.3	2.7	0	0.3	0.3	0.3	2.2	0	0.3	2.5	0.3	0.3	1.7	0.8	0.3	0.3	2.5	4.2	0.9	0.3	0.3	0.3	0.3	0.8	1.5	0.3	1.1	0	0	0	0	0.1	0.3	0.2	0	0	0.3	0	0	0.1	0.1	0	0	0	0.1	5.7	0.2	2.3	0	2.6	0	0	0	0.6	0.2	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	4.9	0	0.2	0	0.8	0	0.2	0	0	10.1	0.8	1	0.3	2.1	0.4	2.6	0	0	0	0.3	0.2	0	0	0.5	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	1.1	0.1	0	0	0	0	0	0	0.3	0.3	0.3	1.1	0.3	0.3	0	0.3	0.3	0.3	0.3
SRPK1	SFRSK1	ENSG00000096063	SRSF protein kinase 1	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	Plasma membrane	"HPA016431: AB_1857478, HPA056486: AB_2683148"	unprognostic (4.65e-3)	unprognostic (6.82e-3)	unprognostic (2.54e-3)	unprognostic (1.01e-3)	unprognostic (7.74e-2)	unprognostic (3.31e-2)	prognostic unfavourable (7.90e-6)	unprognostic (1.23e-2)	unprognostic (2.54e-3)	unprognostic (2.36e-2)	prognostic unfavourable (6.53e-5)	unprognostic (7.28e-2)	unprognostic (2.21e-3)	unprognostic (9.24e-2)	unprognostic (4.43e-1)	unprognostic (1.01e-1)	unprognostic (7.55e-3)	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8	8.3	9.5	26	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19	13.9	32.7	7.6	21	8.5	17	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5	6.7	2.9	29.3	11.1	16.4	24.5	9.2	12	20.8	18	17.4	16.9	18	31.3	9.9	39.2	15.3	11.1	15.1	32	21.5	30.3	26.7	23.1	20.6	13.1	27.1	8.2	30.4	10.1	7.7	11.7	19.4	25.4	21.1	43.6	16.6	14.1	10.4	31.3	23.7	13.4	12.2	22.1	19.7	24.2	16.9	49.3	35.1	12.9	18.5	17.6	12.5	9.9	20.3	15.2	15.9	12.4	10.7	22.6	9.8	21.6	36.8	6.3	35.4	14.1	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8	8.3	9.6	7.6
SRPK2	SFRSK2	ENSG00000135250	SRSF protein kinase 2	P78362	7	105110704-105399308	"Enzymes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 69.3	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 58.2	Lineage enriched	Detected in all	5	granulocytes: 58.2	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA015522, HPA020876"	Enhanced		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		"HPA015522: AB_1857479, HPA020876: AB_1857480"	unprognostic (9.75e-2)	unprognostic (1.68e-2)	unprognostic (1.12e-1)	unprognostic (4.64e-2)	unprognostic (3.54e-1)	unprognostic (1.30e-1)	unprognostic (5.14e-2)	unprognostic (1.54e-1)	unprognostic (2.28e-2)	unprognostic (1.92e-1)	unprognostic (2.19e-1)	unprognostic (2.31e-1)	unprognostic (5.38e-2)	unprognostic (7.95e-2)	unprognostic (4.72e-2)	unprognostic (2.87e-2)	unprognostic (3.44e-1)	9.9	12.1	24.8	10.1	27.6	7.1	13.3	28.4	47.1	12.7	9.4	21	7.8	8.2	13.2	11.9	11.9	10.9	11.6	10.4	26.4	28.6	10.3	10.1	9.2	11.5	27.2	30.2	13	10.5	11.9	15.3	12	27.3	14	10.9	7.9	10.1	11.1	7.9	16.9	8.2	13.3	23.1	12	11.3	69.3	32.3	22.1	11.3	4.7	14	13.6	9.7	12.2	7.3	58.2	8.1	10	11.9	6	13.1	8.7	13.9	27.6	14.9	16.9	7.8	12.8	15.1	12.9	15.1	6.8	11.2	8.3	16.4	16.6	7.9	14.1	13.6	16.5	14.4	12.5	11.8	8.2	5.9	17.3	11.2	17.7	11.7	25.3	10.9	20.6	22.1	11.6	34.2	14.2	24.8	41.5	8.5	11.5	9.6	13.5	15.4	18.2	18.6	20.4	20.5	14.2	14.6	22	13.5	8.2	7.8	14.5	23.8	17.4	22.6	12	37.6	37	20.5	9.3	11.6	17.7	11.2	8.1	26	11.9	5.5	7.1	12.2	9	8.9	7.3	11.6	8.5	9.7	58.2	10	6.2	6.4	10.1	6	24.8	27.6	28.4	38.7	26.4	28.6	27.2	30.2	27.3	32.3
SRPK3	"MSSK1, STK23"	ENSG00000184343	SRSF protein kinase 3	Q9UPE1	X	153776412-153785732	"Enzymes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	skeletal muscle: 73.4	Cell line enhanced	Detected in many		RH-30: 30.8;U-266/70: 12.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		plasmacytoid DC: 2.6	Low lineage specificity	Detected in single			Low region specificity	Detected in many			Low region specificity	Detected in all														unprognostic (1.79e-3)	unprognostic (6.21e-2)	unprognostic (1.79e-2)	unprognostic (7.24e-2)	unprognostic (1.44e-1)	unprognostic (2.51e-1)	unprognostic (1.97e-1)	unprognostic (4.47e-4)	unprognostic (2.83e-1)	unprognostic (1.71e-1)	unprognostic (4.10e-4)	unprognostic (8.70e-2)	unprognostic (5.38e-7)	unprognostic (1.97e-2)	unprognostic (1.97e-1)	unprognostic (3.83e-2)	unprognostic (1.07e-4)	1.6	1.8	1.3	0.9	1.8	0.8	0.3	7.7	1.5	0.9	4.5	1.1	0.2	1.3	2.5	3.3	2.6	0.7	1.7	16.7	2	1.8	0.2	0.2	0.4	0.8	2	0.7	0.7	0.7	1	5.8	0.3	1.1	2.8	0.8	0.9	2.9	0.5	73.4	2.3	1.3	4	2	0.8	1.3	0.5	0.9	0.3	0.6	18.3	1.6	2	0.8	0.4	2.6	0.9	0.3	0.1	0.6	0.3	3.2	4.3	0.7	2.2	0	0.1	1	0.4	0	0.2	0	3.6	0.6	3.2	0.4	0.3	0.9	0	0.1	0	2.8	3	1.7	2.7	0.5	0	0.8	5	2.7	0	0	0	0	2.1	3.8	0.8	6.9	0.6	4.7	0.8	1.2	1.5	30.8	0.9	0	1.4	5.2	2.5	0	2.3	1	2.9	3.7	0	1.2	2.8	2.3	0.4	12.8	2	2.2	0.6	6.1	1.6	0.8	0.3	0.2	0.5	0.1	0.6	0.2	0.1	0.1	0	0.4	0.1	0.1	0.9	0.1	0	2.6	0	0.3	1.3	1.8	7.7	1.5	2	1.8	2	0.7	1.1	0.9
STK10	"LOK, PRO2729"	ENSG00000072786	Serine/threonine kinase 10	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Cell cycle	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 40.9	Cell line enhanced	Detected in all		WM-115: 51.5	Low cancer specificity	Detected in all			Region enriched	Detected in all	5	cerebellum: 27.5	Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		24000	24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: "	unprognostic (1.17e-1)	unprognostic (5.43e-2)	prognostic favourable (2.76e-4)	unprognostic (2.88e-1)	unprognostic (6.96e-3)	unprognostic (1.02e-1)	unprognostic (5.25e-3)	unprognostic (3.07e-2)	unprognostic (1.07e-1)	unprognostic (1.03e-1)	unprognostic (2.65e-1)	unprognostic (3.43e-1)	prognostic unfavourable (1.63e-4)	unprognostic (1.09e-1)	unprognostic (1.01e-2)	unprognostic (3.10e-1)	unprognostic (1.84e-1)	15	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3	3.6	5	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11	9	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4	5.6	7.8	2.5	3.1	9	12.2	5.7	4.6	33	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5	10.3	22.3	30.8	7.4	18	15.6	7.7	7.2	4.5	6.7	5.2	6.5	11.5	10.1	8.4	7.3	6.8	3.7	10.2	9.3	5.4	12.4	9	2	12.3	4.8	12.2	3.3	11.2	3	2.1	7.5	11.3	13.3	6.4	2.6	9.9	8.3	6.3	1	13.1	5.1	12.4	8.1	25.5	1.8	5.7	13.4	3.5	6.2	3	9.8	3	3.7	5.8	8.1	27.6	2.9	24	8.7	8.2	4.1	5.7	5.4	11.1	16.3	5.9	10.8	17.5	51.5	7.1	10.8	10	18	21.4	13.3	5	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3	2.4	2.5	5.4	1.9	4.5	3.5
STK11	"LKB1, PJS"	ENSG00000118046	Serine/threonine kinase 11	Q15831	19	1177558-1228435	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 11.7	Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: "	unprognostic (8.60e-2)	unprognostic (1.68e-1)	unprognostic (5.00e-2)	prognostic favourable (3.69e-5)	unprognostic (2.04e-2)	prognostic favourable (1.96e-4)	unprognostic (9.11e-3)	unprognostic (3.19e-1)	unprognostic (9.08e-2)	unprognostic (1.26e-1)	unprognostic (1.95e-3)	unprognostic (7.70e-3)	unprognostic (3.54e-2)	unprognostic (3.16e-2)	unprognostic (1.60e-1)	unprognostic (3.31e-1)	unprognostic (3.12e-3)	13.4	13.7	13.5	11.8	12.4	19.3	16.7	17.8	16	12.2	16.1	8.3	19.8	18.1	10.8	8.7	15.1	10	11.8	15.3	12.6	9.8	10.7	22.1	9.4	12.5	9.7	10.4	11	16.8	10.7	11.6	12.2	9.9	12.2	5.3	11.9	16	12.2	49.2	16.8	18	7.7	7.6	16.9	15.5	59.8	7.5	11.8	12.4	14.5	19	11.4	9.8	2.7	1.9	11.7	6.3	1.9	1.8	0.5	21.1	10.2	7.8	14.7	7.4	6.7	16.5	10.3	10.8	9.7	10.4	8.3	14.8	13.9	11.5	10.8	13.7	7.6	15.9	3	25.9	18.7	14.2	0.6	10.5	15.9	14.2	23.8	12.2	11.6	7.5	11.1	9.7	26.5	19.1	5.5	15.8	13.7	14.4	14.9	12.6	21.7	8.3	15.5	8.8	15.5	18.1	13	0	7.7	11.1	12.1	23.4	13.1	10.1	11.4	19.7	16.4	37.6	15.8	10.4	10	19	10.3	2	4.2	4.5	0.6	6	0.4	2.7	1	1.8	1.9	1	1	0.9	11.7	1.9	6.3	1	0.7	0.5	13.5	12.4	17.8	16	12.6	9.8	9.7	10.4	9.9	7.5
STK16	"MPSK, PKL12"	ENSG00000115661	Serine/threonine kinase 16	O75716	2	219245455-219250337	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029450	Approved		Approved	Cytosol				Cytosol		HPA029450: AB_10603118	unprognostic (1.99e-1)	unprognostic (2.08e-1)	unprognostic (5.84e-2)	prognostic favourable (6.09e-4)	unprognostic (6.21e-2)	unprognostic (5.55e-2)	unprognostic (4.98e-3)	unprognostic (4.25e-1)	unprognostic (1.48e-1)	unprognostic (4.22e-2)	unprognostic (1.73e-2)	unprognostic (3.17e-1)	unprognostic (4.39e-3)	unprognostic (1.76e-1)	unprognostic (2.00e-1)	unprognostic (2.68e-1)	unprognostic (1.34e-1)	10.2	19	15.7	12.8	20.3	13.3	14.6	8.8	21	11.5	16.2	15.2	20.5	17.2	11.4	22.1	16	18.3	15.5	13	14.5	11.9	19.5	30.1	11.4	24.6	14.2	13.2	13.2	24.5	16.5	15.1	14	13.3	14.3	13.7	12.8	19	16.3	9.9	12.2	14.2	11.5	12.3	15.9	16.8	18.9	12.7	27.2	19.8	12.8	17	12.9	10.3	7.9	7.8	5.8	7.6	14.5	11.2	9.7	7.3	9.6	8.4	7.2	21.2	20.7	9.7	9.5	13.1	8.1	8.1	11.2	16.4	4.2	13.3	15.7	7.6	9.8	15.7	4.3	10.4	11.4	9.6	8.7	9.6	19.2	9.1	11.2	22	25.3	11.1	29.4	9.8	11.9	11.6	13.8	13.5	9.9	19.8	7.9	5.9	9.3	9.5	12.4	16.8	8.5	6.8	8.7	3.4	13.5	19.3	14.1	19.2	7.5	11	7.8	8.9	9	14.3	6.1	10.1	12.2	9.6	9.6	2	7.6	5.8	6	4.2	6.8	7.8	7.5	11.2	7.8	7.9	7.8	10	5.2	14.5	3.6	6.7	8.4	9.7	15.7	20.3	8.8	21	14.5	11.9	14.2	13.2	13.3	12.7
STK17A	DRAK1	ENSG00000164543	Serine/threonine kinase 17a	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 43.3	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many											"HPA018138, HPA037979"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"				Nuclear speckles	Plasma membrane	"HPA018138: , HPA037979: AB_10795247"	unprognostic (1.81e-3)	unprognostic (1.08e-2)	unprognostic (2.67e-1)	unprognostic (5.41e-2)	unprognostic (5.11e-2)	unprognostic (3.35e-2)	unprognostic (1.03e-2)	unprognostic (9.15e-3)	unprognostic (2.07e-1)	unprognostic (6.34e-2)	unprognostic (1.36e-2)	unprognostic (6.61e-2)	unprognostic (2.99e-3)	unprognostic (3.76e-2)	unprognostic (3.08e-1)	unprognostic (1.97e-3)	unprognostic (3.66e-1)	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11	9	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.5	5.7	5.2	3.5	6.5	8.6	2.1	16.5	17.8	9	9.2	4.9	3.3	7.3	26	13.7	9.4	3.9	21.9	12.6	18	4.4	6.5	4.3	6.1	4.8	11.2	4.4	7	25.8	11.9	10.9	16.8	7.6	25.2	10.3	2.1	18.2	5.2	8	18.7	6.3	3.3	14.5	15.7	3.4	2.8	6.3	7.4	3.4	4.8	4	5.7	16.8	19.6	7.5	11.6	18.4	15.3	7.6	10.6	19.9	9.9	31.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8
STK17B	DRAK2	ENSG00000081320	Serine/threonine kinase 17b	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2	Cell line enhanced	Detected in many		Daudi: 35.5;HMC-1: 36.0;Karpas-707: 33.4;U-698: 38.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Region enriched	Detected in many	6	cerebellum: 71.1	Low region specificity	Detected in all			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		HPA034858: AB_10670981	unprognostic (2.14e-1)	unprognostic (2.45e-3)	unprognostic (3.68e-2)	unprognostic (3.61e-2)	unprognostic (3.63e-2)	unprognostic (7.43e-3)	unprognostic (1.75e-1)	unprognostic (7.63e-2)	unprognostic (9.15e-2)	unprognostic (1.14e-1)	unprognostic (9.90e-2)	unprognostic (1.52e-1)	prognostic unfavourable (5.72e-8)	unprognostic (1.88e-1)	unprognostic (1.19e-2)	unprognostic (2.64e-2)	unprognostic (5.80e-2)	21	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6	4.6	1.4	72.2	7.5	7	56.2	11.3	6	16.9	13.6	62	27	10.3	28.4	19	3.1	2.2	3.3	1.2	14.7	5.6	3.7	7.6	11.4	8.3	8.7	6.6	1.1	35.5	7	4.3	2.2	1.4	3.2	10.2	6.2	3.8	3.3	2.8	0.6	4.4	13.4	36	7.1	3.2	10.3	5.4	3.4	2.6	33.4	20.6	1.7	17.4	30.4	1.9	5.1	2.9	20.3	10.7	4.9	7.5	1.2	1.3	1.9	1.9	1.6	1.3	7	4.1	8.1	4	5.8	4.2	13.7	22.2	38.7	6.1	4.6	3.6	35.9	19.7	40.2	12	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62	10.3	27	9.7	18.5	19	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	Serine/threonine kinase 24	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026435, HPA026502"	Enhanced		Supported	"Nucleoli,Cytosol"		2800000	2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	unprognostic (3.49e-2)	unprognostic (2.39e-2)	unprognostic (1.78e-1)	unprognostic (3.44e-2)	unprognostic (2.86e-1)	unprognostic (3.25e-2)	unprognostic (9.67e-3)	prognostic unfavourable (6.23e-6)	unprognostic (5.45e-2)	unprognostic (1.13e-1)	prognostic unfavourable (5.81e-4)	unprognostic (9.62e-2)	prognostic favourable (6.91e-5)	unprognostic (3.10e-2)	unprognostic (4.49e-2)	unprognostic (3.88e-2)	unprognostic (1.12e-2)	28.6	14.2	15	29.7	16.9	19.1	34.8	12.2	21	36.3	37.4	12.1	23	31.9	24.6	26.5	68.4	20.4	41.3	30	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36	11.2	20	18.5	30.8	18.4	28.4	16.9	23.8	23.7	23.2	32.9	49	25.7	8.6	21.1	32.7	18.5	37.2	22.7	64	9.5	27.4	14.4	18.8	43.5	27.6	19.5	11.9	59.5	18.6	54.8	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	8.5	26.1	12.3	13.9	22.8	32.6	11.7	16.8	10.7	17.2	22.8	20.8	26.9	27.4	15.1	11	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15	16.9	12.2	21	14.7	12.8	10.6	10.1	14.7	7.6
STK25	"SOK1, YSK1"	ENSG00000115694	Serine/threonine kinase 25	O00506	2	241492674-241509730	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	skeletal muscle: 164.2	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047147	Uncertain									HPA047147: AB_10966137	unprognostic (1.75e-1)	unprognostic (8.29e-2)	prognostic unfavourable (6.03e-4)	unprognostic (3.42e-2)	unprognostic (2.71e-1)	unprognostic (1.24e-1)	prognostic unfavourable (3.91e-8)	unprognostic (6.16e-2)	unprognostic (7.15e-3)	unprognostic (1.11e-1)	unprognostic (2.58e-3)	unprognostic (1.55e-1)	unprognostic (2.47e-2)	unprognostic (2.00e-1)	unprognostic (1.37e-1)	unprognostic (3.19e-1)	unprognostic (4.58e-1)	17.8	13.6	22.3	14.2	26	16.3	12.9	22.3	35.3	16.4	17.1	17	13	14.6	17.7	15.9	19.3	15.4	16.7	19	19.4	20	17.3	13.5	13.4	13.5	16.3	20.4	17.5	19.2	18.9	17.1	15.6	16.4	15.1	12.9	13.5	14.2	17.6	164.2	15.3	14.2	17.3	12.6	15.8	16.1	16.8	14.4	15.2	20	24.6	12.6	14.6	16.6	15	13.6	13.7	16.4	21.5	19.9	10.6	18.3	11.7	23.4	29	28.8	20.1	36	30.7	20.7	23.4	26.8	13	16.2	7	8.7	40.9	15.7	32.9	33.4	28.5	26.2	34.5	19.6	24.8	33.6	26.1	11.9	15.1	28.9	24	22.6	18.2	52.8	30.2	6.2	42.8	19.3	17.6	18.5	32.6	16.8	29.7	29.8	10.4	20.6	15.6	39.3	18	14.9	11.3	19.2	9	21.1	61.5	17.7	21.7	20.3	21.7	12.9	2.9	11.9	17.1	9.8	20	13.7	14.8	11.5	16.9	13.4	15.5	14.5	15.5	17.5	13.6	15	12	11.6	5.5	21.5	16.4	10.7	19.9	10.6	22.3	26	22.3	35.3	19.4	20	16.3	20.4	16.4	14.4
STK26	"MASK, MST4"	ENSG00000134602	Serine/threonine kinase 26	Q9P289	X	132023265-132075943	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		U-937: 40.3	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"				Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	HPA059921: 	unprognostic (6.53e-2)	unprognostic (7.83e-2)	unprognostic (1.77e-1)	unprognostic (1.02e-3)	unprognostic (4.42e-1)	unprognostic (1.03e-2)	prognostic unfavourable (6.82e-4)	unprognostic (1.18e-1)	unprognostic (1.93e-1)	unprognostic (1.31e-1)	unprognostic (1.42e-3)	unprognostic (2.49e-1)	prognostic unfavourable (6.87e-5)	unprognostic (4.76e-2)	unprognostic (1.83e-1)	unprognostic (1.77e-1)	unprognostic (2.88e-1)	5.4	1.4	1.1	13.5	5.1	25.9	3.3	3.8	1.1	18	6.4	0.3	34.8	3.7	42.3	29.6	11.7	6	5.2	1.9	1.2	2.3	3.5	3.2	6.7	12.8	1.2	0.3	4.7	4	10.2	5.8	50.7	1.2	11.5	4.8	2.2	6.3	22.4	1.2	5.1	6.1	19.1	1.5	8.5	4.7	5.2	0.8	44.7	2.3	6.8	10.2	18	6.6	8.4	6.2	26.4	11.6	22	13.3	10.2	9	3.1	0.3	0	1.5	1.4	20.7	0.3	1.1	0.1	0.1	8.3	8.2	12.3	5.6	2	10.3	23	14.4	0	10.6	18.8	17.7	7.8	7.8	1.4	37	1.4	2	8.6	0	9.8	4	7.8	11.6	3.4	7.9	38	34.4	18.4	1.2	27.5	11.4	15.8	9.3	14.5	7.7	8.5	5.4	4.9	0.2	6.3	9.8	0.1	3.7	4	11.2	13.2	8.9	14	13.7	3.4	40.3	1.8	26.4	5.1	16.6	13.3	6.7	13	8.4	9.1	11.3	6.2	7.3	11.8	12.2	10	22	11.6	2.3	4	10.2	1.1	5.1	3.8	1.1	1.2	2.3	1.2	0.3	1.2	0.8
STK3	"KRS1, MST2"	ENSG00000104375	Serine/threonine kinase 3	Q13188	8	98401403-98942827	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		A-431: 37.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in all	5	dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"				"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	unprognostic (7.88e-3)	unprognostic (1.96e-1)	unprognostic (6.57e-2)	prognostic unfavourable (1.53e-4)	unprognostic (2.95e-1)	unprognostic (1.12e-3)	unprognostic (9.68e-3)	prognostic unfavourable (4.25e-4)	unprognostic (6.71e-2)	unprognostic (9.83e-2)	prognostic unfavourable (9.21e-5)	unprognostic (9.16e-2)	unprognostic (1.03e-1)	unprognostic (2.27e-1)	unprognostic (1.29e-1)	unprognostic (5.86e-2)	unprognostic (9.72e-2)	16.5	16.6	6.5	8.1	12.4	2.5	20.5	2.6	10.6	17.2	13.1	10.5	14.2	4.6	22.2	13.1	9	16	12.6	10	7.4	4.1	14.7	12	16.2	10.8	12.8	3.6	22.8	10.7	15.1	18.9	53.1	9.9	15	6	8.2	10.8	16.4	11.6	10	10.8	23.5	12.9	8.2	9.5	10.1	11.4	3.4	10.6	7.9	5.9	16.4	24.3	1.9	8.3	9	8.7	1.8	1.8	2.9	37.6	7.1	7.5	9.9	24.4	12.2	7.5	13.1	11.8	12.3	10.7	5.2	16	0	11.4	13	15.3	5.2	11.3	19.9	9	6.7	10.1	3.5	3.5	8.3	3.3	8.8	8.1	19.5	6.3	17.2	5.2	4.2	5.5	8.9	4.7	8.4	4	2.2	2.8	7.4	6.5	3.2	14	4.7	1.9	4.4	8.3	9.6	8.1	7.9	5.5	3.9	8.3	5.3	12.5	7.2	4.4	6.5	2.7	7.4	4.2	13.1	2.1	8.6	4.5	1.3	8.7	1.4	1.9	0.8	1.8	8.3	1.3	1.1	0.7	9	1.8	5.4	3.4	0.1	2.9	6.5	12.4	2.6	10.6	7.4	4.1	12.8	3.6	9.9	11.4
STK31	"SgK396, TDRD8"	ENSG00000196335	Serine/threonine kinase 31	Q9BXU1	7	23710167-23832513	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	63	testis: 56.0	Cell line enriched	Detected in some	8	CACO-2: 19.7	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			HPA023194	Enhanced									HPA023194: AB_1857590	unprognostic (4.25e-2)	unprognostic (1.04e-1)	unprognostic (3.98e-2)	unprognostic (5.41e-2)	unprognostic (1.62e-1)	unprognostic (1.50e-2)	unprognostic (1.09e-2)	unprognostic (1.26e-1)	unprognostic (1.34e-1)	unprognostic (1.73e-1)	unprognostic (2.42e-3)	unprognostic (2.92e-1)	unprognostic (1.29e-6)	unprognostic (7.83e-2)	unprognostic (9.21e-3)	unprognostic (1.46e-1)	unprognostic (3.65e-1)	0.1	0	0.1	0.1	0.7	0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0	0.1	0.1	0.2	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	56	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0	0.5	0	0	0	0	19.7	2.4	0	2.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.1	0	0	0.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.7	0.8	0.1	0.2	0	0.1	0.1	0.1	0.1
STK32A	"MGC22688, YANK1"	ENSG00000169302	Serine/threonine kinase 32A	Q8WU08	5	147234963-147387852	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		adrenal gland: 19.7;brain: 21.1;retina: 31.9	Group enriched	Detected in some	5	RT4: 9.6;SK-MEL-30: 33.8	Cancer enhanced	Detected in many		melanoma: 11.9	Low region specificity	Detected in all			Cell type enriched	Detected in single	5	neutrophil: 1.2	Lineage enriched	Detected in single	10	granulocytes: 1.2	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA040236	Uncertain		Approved	Centrosome				Centrosome		HPA040236: AB_10795416	unprognostic (1.90e-1)	unprognostic (4.71e-4)	unprognostic (5.32e-2)	unprognostic (3.49e-2)	unprognostic (7.62e-2)	unprognostic (6.82e-2)	unprognostic (2.66e-2)	unprognostic (2.96e-3)	unprognostic (4.85e-2)	unprognostic (2.36e-2)	unprognostic (3.87e-1)	unprognostic (8.38e-2)	unprognostic (2.50e-3)	unprognostic (5.53e-5)	unprognostic (2.48e-1)	unprognostic (3.20e-2)	unprognostic (3.67e-3)	2.1	19.7	4.8	1.3	7.1	0.4	2.3	21.1	7.7	1.2	1.8	6.2	0.6	1.2	1.6	5.6	1	1.3	4.3	1.6	4.9	12.6	6.3	0.6	2.1	0.5	12.1	2.2	5.1	4.2	0.4	8.5	0.7	20.7	2.1	1.1	31.9	1.2	1.8	0.6	2.9	1.1	1.4	12.4	0.8	1.4	2.1	6.9	0	15.7	0.5	0.5	4.1	2.1	0.1	0	1.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0.3	0	0	0	0	0.1	0	0	2.6	0	0	0.4	0	0	0.1	0.1	0	0.1	0	0	4.1	0	0	0	0	0.3	0.7	0	0	0.1	3.7	9.6	0.9	0.4	0	0.1	33.8	0	0	0.1	0	0.6	0.4	0.3	1.1	0.2	0	1.1	0	0.1	0.2	0	0	0	0	0	0	0.1	0	0	0.1	0	0	1.2	0	0	0	0	0	4.8	7.1	21.1	2.3	4.9	12.6	12.1	2.2	20.7	6.9
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	Serine/threonine kinase 32B	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		kidney: 23.6;lymphoid tissue: 33.6	Cell line enhanced	Detected in some		HUVEC TERT2: 11.5;REH: 10.1;U-2197: 18.5;WM-115: 47.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	4	naive B-cell: 1.3;plasmacytoid DC: 3.5	Group enriched	Detected in many	4	B-cells: 1.3;dendritic cells: 3.5	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA058536			Approved	"Vesicles,Microtubules"				Microtubules	Vesicles	HPA058536: 	unprognostic (4.48e-2)	unprognostic (1.02e-1)	unprognostic (6.08e-2)	unprognostic (1.35e-1)	unprognostic (8.12e-3)	unprognostic (9.96e-2)	unprognostic (1.64e-4)	unprognostic (1.27e-1)	unprognostic (1.27e-1)	unprognostic (1.70e-1)	unprognostic (2.54e-1)	unprognostic (8.82e-2)	prognostic favourable (1.63e-8)	unprognostic (8.10e-3)	unprognostic (5.04e-2)	unprognostic (3.62e-2)	unprognostic (1.67e-3)	5.2	0.8	6	2.1	4.8	2.3	7.3	1	5.8	6	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3	2.9	1.9	2.1	3.6	1.6	7	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0	0.5	0	0	0	0	5.7	0.3	0	0.2	0.4	0	4	0.5	2.7	0.1	0	0	0	0.8	8.1	0	0.6	0	1	0	0	0	2.5	0	0	0	0	0	0	2.1	0.1	11.5	0	0	1.4	0	0	0.8	1.7	0	10.1	0	0	2.6	0	0.1	0	0	0	3.5	0	0	2.9	0	1.1	18.5	0	0.4	0	0	0	0	47	0	0.5	0	0	0	0	0	0	0	0.2	1.3	0	0	0	0	0	3.5	0	0	6	4.8	1	5.8	4.5	7.6	5.3	2.2	4.2	2.9
STK32C	"MGC23665, PKE, YANK3"	ENSG00000165752	Serine/threonine kinase 32C	Q86UX6	10	132207492-132331847	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA017894	Uncertain									HPA017894: AB_1857591	unprognostic (2.11e-1)	unprognostic (8.40e-2)	unprognostic (4.80e-3)	prognostic unfavourable (1.09e-4)	unprognostic (1.65e-2)	unprognostic (5.52e-2)	prognostic unfavourable (1.68e-6)	unprognostic (2.03e-1)	unprognostic (7.79e-2)	unprognostic (2.14e-1)	unprognostic (1.18e-2)	unprognostic (1.13e-1)	prognostic unfavourable (5.31e-6)	unprognostic (8.65e-2)	unprognostic (3.20e-1)	unprognostic (5.05e-2)	unprognostic (1.36e-1)	6.8	8.2	23.5	6.4	23.5	6.1	7.1	8.3	31.6	4.1	4.9	6.3	6	5	4.6	15.5	3.4	9.4	7.8	7	17.9	12.8	6.3	4.2	7.3	8.5	9.2	16.1	5.8	7	6.2	6.7	4.8	7.7	4.6	4.7	3.2	5.6	5.5	11.3	7.1	4.7	4.9	7.7	10.7	4.8	26.1	8.1	8.7	4.9	3	6.1	4.6	3.6	5.5	14.5	25	11.2	3.2	4.9	3.6	31.5	20.7	6.3	16	9	11.4	1.3	6.6	5.2	8.4	10.9	4.6	22.1	7	5	7.7	7.3	9.2	2.7	8.2	4.1	14.8	4	21.2	21.9	11.3	3.7	15.2	8.6	10.1	7.6	8.7	7.4	7.1	4.9	9	9.5	4.6	14	4.2	15.1	5.5	4	2.2	11	5.5	16.7	13.1	4.8	4.5	9.4	5.1	8.8	4.9	7	6.9	8.7	5.2	9.1	1.7	17.3	15.2	3.5	3.4	25	10.7	9.2	3.5	11.2	4.5	3.6	2.9	4	14.5	5.5	3.6	2.9	1.4	3.2	9.5	8.3	4.9	3.6	23.5	23.5	8.3	31.6	17.9	12.8	9.2	16.1	7.7	8.1
STK33		ENSG00000130413	Serine/threonine kinase 33	Q9BYT3	11	8391868-8594289	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 34.4	Cell line enhanced	Detected in many		Daudi: 14.1;HEK 293: 12.0;Karpas-707: 13.2;SCLC-21H: 14.8;U-251 MG: 14.9;U-266/84: 12.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	4	memory B-cell: 7.1;naive B-cell: 4.4	Lineage enriched	Detected in many	5	B-cells: 7.1	Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA015742, HPA056855"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cytosol"				Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: "	unprognostic (2.57e-2)	unprognostic (2.80e-1)	unprognostic (2.23e-3)	unprognostic (2.76e-3)	unprognostic (3.57e-1)	unprognostic (1.40e-1)	unprognostic (7.28e-2)	unprognostic (3.85e-4)	unprognostic (1.23e-1)	unprognostic (8.06e-2)	unprognostic (1.33e-3)	unprognostic (9.46e-2)	prognostic favourable (4.89e-6)	unprognostic (2.39e-2)	unprognostic (1.37e-1)	unprognostic (3.49e-2)	unprognostic (2.90e-2)	0.9	6.1	4.7	1.6	7.5	1.1	0.6	6.1	4.4	5.4	5.3	6.8	7.7	2.6	9.6	15.3	2.3	30.7	4.5	11.4	6.6	6.1	7.7	0.4	5.3	2.3	4.9	2.7	10.3	4.6	20.4	29.9	0.3	17.7	5.3	1.3	14.8	1.6	8.9	2.6	0.3	2.5	7	6.7	1.2	4.4	34.4	4.6	4.5	14.6	1.5	1.8	3.7	1.4	7.1	0.7	0	0	0.2	1.4	0.3	0	2	9.8	0	0	0	0	1.7	1.9	4.2	3.9	1.2	0	14.1	7.4	0.3	0	4.3	1.3	3.7	0	12	0	2.6	3.3	1.6	7.8	0	0.4	0	0.1	0	0.3	0	13.2	0.1	0	0.3	0	7	0	5.3	1.3	8.9	3.8	0	14.8	3.9	0	0	0.1	0	0.8	0	0	6.7	0.1	14.9	3.1	12.5	0.2	4.3	0	0	0	0	0	0.5	0	0	7.1	0	1.4	0	4.4	0	1.1	0	0.2	0	0.7	0.2	0.3	4.7	7.5	6.1	4.4	6.6	6.1	4.9	2.7	17.7	4.6
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	Serine/threonine kinase 35	Q8TDR2	20	2101611-2177038	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		retina: 27.8;testis: 37.6	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026452, HPA051673"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA026452: , HPA051673: "	unprognostic (2.25e-2)	unprognostic (2.97e-1)	unprognostic (2.87e-2)	unprognostic (1.30e-2)	unprognostic (3.25e-1)	unprognostic (2.28e-1)	prognostic unfavourable (9.46e-6)	unprognostic (6.53e-2)	unprognostic (1.82e-1)	unprognostic (3.05e-2)	unprognostic (1.37e-1)	unprognostic (2.07e-1)	unprognostic (4.39e-2)	unprognostic (1.74e-1)	unprognostic (4.67e-1)	unprognostic (1.40e-1)	unprognostic (4.99e-2)	5.3	6	10.3	3.6	14.3	4.3	5.1	6.1	13.7	3.7	4.3	3.1	2.5	4.2	4.5	3.5	8	5.1	4.3	5.2	5.9	4.8	4.4	5.7	4.2	3.3	4.4	7.6	3.9	5.9	5.3	6.5	3.5	4	3.8	5.2	27.8	6.1	4	3.5	6.3	4.6	4.9	4.5	4.1	4.1	37.6	4.4	1.7	5.4	6.1	4.5	4.1	3.7	1.8	2	3.2	1.4	0.8	2.7	1.2	14.8	12.6	9.9	16.9	4.5	6.2	12	6.1	7.5	8.2	8.5	16.6	11.6	10.2	5	7.6	22.5	11.6	14	9.4	4	5.5	9.7	4.4	17.9	5.8	8.7	4.5	5.4	12.3	13	11.3	7.7	9.4	8.5	5.3	6.6	10.9	12.4	18.3	8.6	9.5	8.8	6.4	7.4	14.9	16.3	7.9	10.8	19.5	9.7	9.6	8.7	6.5	14	9.6	7	9.6	7.5	9.6	7.1	7.5	9.5	6.1	0	1.2	0.7	1.9	1	2.5	1.7	2.7	1.3	2	1.8	2.6	2.2	3.2	0.8	1.4	1.7	1.3	1.2	10.3	14.3	6.1	13.7	5.9	4.8	4.4	7.6	4	4.4
STK36	"FU, KIAA1278"	ENSG00000163482	Serine/threonine kinase 36	Q9NRP7	2	218672026-218702716	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Cilium biogenesis/degradation	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 63.2	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA027409, HPA027453, HPA030058"	Approved		Supported	Cytosol				Cytosol		"HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225"	unprognostic (8.11e-2)	unprognostic (3.77e-1)	unprognostic (3.59e-2)	unprognostic (1.27e-1)	unprognostic (1.50e-1)	unprognostic (2.52e-2)	prognostic unfavourable (5.20e-4)	unprognostic (1.55e-1)	unprognostic (5.83e-3)	unprognostic (9.04e-2)	unprognostic (1.38e-2)	unprognostic (1.13e-2)	unprognostic (3.52e-3)	unprognostic (1.46e-1)	unprognostic (2.60e-2)	unprognostic (1.77e-1)	unprognostic (1.99e-3)	4.8	10	7.5	4.7	11.4	2	6.4	7.9	11.1	9.1	7.4	7	11.9	4.1	14.4	13.3	5	13.9	9.8	3.3	6.3	3.5	10.1	4.4	6.9	3.9	2.3	6.6	13.6	9.7	12.3	23.2	3.9	7.6	9.5	6.3	9.3	7.3	8.3	3.3	4.6	5.8	7.8	5.5	4.9	7.9	63.2	4.2	3.5	11.4	3.7	5	9.3	7.1	1.8	1.6	3.2	1.9	2.2	1.6	1.7	2.7	6.4	14	11.9	15.2	11.9	8.5	7.6	6.1	9.7	9.2	8.3	4.6	3.7	10.6	7.9	5.6	9.5	7.9	8.6	1.6	7.9	3.6	19.1	11.4	7.4	5	6.1	12.8	5.9	9.5	6.8	7.2	8.3	4.7	8	6.4	3	6.3	8.4	4.1	5.6	6	3.7	11.9	14	11.4	9.7	5.9	9.6	3.9	9.8	4.1	6.9	13.5	5	5.1	5.2	6	4.6	1.9	8.4	2.4	5.6	0	1.9	3.2	1.5	1.2	0.9	1.8	1.1	1.3	1.6	0.6	1.1	1.6	0.2	2.2	1.4	1.3	1	1.7	7.5	11.4	7.9	11.1	6.3	3.5	2.3	6.6	7.6	4.2
STK38	NDR	ENSG00000112079	Serine/threonine kinase 38	Q15208	6	36493892-36547470	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol				Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: "	unprognostic (3.58e-3)	unprognostic (1.80e-2)	unprognostic (3.07e-2)	unprognostic (6.76e-3)	unprognostic (8.25e-2)	unprognostic (1.47e-2)	unprognostic (2.88e-3)	unprognostic (2.08e-1)	prognostic unfavourable (9.44e-5)	unprognostic (3.78e-2)	unprognostic (2.18e-1)	unprognostic (3.21e-2)	unprognostic (1.98e-2)	unprognostic (3.80e-1)	unprognostic (2.59e-1)	unprognostic (1.69e-1)	unprognostic (3.13e-3)	19.1	8.4	12.4	39.8	10	19.4	32.8	18.8	12.7	16	26.3	7.8	14.9	17	18.8	16.4	28.1	14.6	18.3	15.3	12.1	7	15	17.3	21.7	45.9	11.9	6.4	12.3	9.5	7.8	11	15.4	9	17	27.1	11.3	24.8	18.7	14.9	21.8	29.1	28.1	13.1	25.1	16.4	24.4	11	34.3	10.6	13.4	28.5	22.4	19.8	10.6	13.1	33.2	30.5	25.8	27.6	22.4	17.6	13	13.8	14.8	27.9	21.3	12	19.7	16	20.5	20.7	10	12.1	23.7	15.3	29.3	18.9	11.4	8.2	24.3	9.7	9.8	17	16.9	9	13.8	6.4	9.4	14	21.6	15.9	10.2	12.8	13.8	13.9	29.2	10.6	10.3	16.7	5.7	11.6	40.2	16.7	6.3	19.4	22.2	16.1	7.6	24	11.1	13.8	11.8	16.9	12.3	16.7	14.8	13.3	12.7	11.7	20.7	16.7	3.8	25	16	33.2	19.8	15	27.6	22.6	21.5	10.6	22.9	24.1	13.1	8.1	20.5	22.3	27.1	25.8	30.5	6.6	21.4	22.4	12.4	10	18.8	12.7	12.1	7	11.9	6.4	9	11
STK38L	"KIAA0965, NDR2"	ENSG00000211455	Serine/threonine kinase 38 like	Q9Y2H1	12	27243968-27325959	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		HDLM-2: 56.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Group enriched	Detected in all	5	dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA038623, HPA051324"	Approved		Approved	Cytosol				Cytosol		"HPA038623: AB_10967059, HPA051324: "	unprognostic (2.14e-2)	unprognostic (1.01e-1)	unprognostic (9.94e-2)	unprognostic (2.43e-2)	unprognostic (2.02e-1)	unprognostic (1.76e-1)	unprognostic (3.33e-2)	unprognostic (4.68e-2)	unprognostic (5.56e-2)	unprognostic (1.56e-1)	prognostic unfavourable (5.82e-4)	unprognostic (1.16e-1)	unprognostic (3.41e-2)	unprognostic (1.09e-1)	unprognostic (1.95e-1)	unprognostic (5.05e-2)	unprognostic (1.05e-2)	21.2	8.4	11	14.6	10.9	10.9	27.2	9.6	14.6	13	26.3	5.7	9.7	8.4	23.9	18.2	16.8	14.8	18.2	30.2	10.9	7.8	8.9	8.5	10.8	7.8	11.1	11.8	9.6	8.9	30.2	15.2	10.6	11.9	15.3	15	6.8	14	10.9	9.1	10.8	14.6	52.3	17	7.6	15.6	7.5	10.1	10	8.8	10.5	9.8	21.9	22.7	4.5	19.3	32.2	13	4	4	5.3	4.1	5.7	14.9	6.6	6.8	4.7	11	2.7	3.9	1.7	2.4	7.2	3.1	9.7	6.4	2.3	7.8	6.7	4.6	2.7	56.9	5.5	6	6.9	3.6	5.7	14.7	7	5.6	4.8	6.3	8.1	13.7	7.3	7.7	3.4	3	9.7	16	17.6	8.7	3.6	17.3	7.5	2.5	8	2.4	7.9	12	7.4	4.6	3.6	5	5.4	5.9	5.2	8.4	7.3	2.8	2.7	10.2	2.9	6.9	2.4	6	13	22.9	4	11.1	2.8	4.5	3.1	3.9	19.3	3.4	3.8	3.1	32.2	4	8.1	8.2	4	5.3	11	10.9	9.6	14.6	10.9	7.8	11.1	11.8	11.9	10.1
STK39	"DCHT, SPAK"	ENSG00000198648	Serine/threonine kinase 39	Q9UEW8	2	167954020-168248141	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 35.5	Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB046022, HPA061803, HPA062802"	Enhanced		Supported	"Nucleoplasm,Vesicles,Cytosol"				Nucleoplasm	"Vesicles, Cytosol"	"CAB046022: AB_2196960, HPA061803: , HPA062802: "	prognostic favourable (3.96e-4)	unprognostic (2.97e-2)	unprognostic (4.40e-2)	unprognostic (4.22e-2)	unprognostic (4.36e-1)	unprognostic (6.14e-2)	prognostic unfavourable (5.67e-5)	unprognostic (3.04e-2)	unprognostic (8.86e-2)	unprognostic (9.43e-2)	unprognostic (3.20e-2)	unprognostic (1.38e-1)	unprognostic (2.06e-1)	unprognostic (9.45e-2)	unprognostic (8.61e-3)	unprognostic (1.14e-1)	unprognostic (6.20e-3)	6.2	2.1	8.4	4.6	11	1.3	3.5	9.3	14.1	4.3	9.1	8.3	1.7	10.5	2.3	4.7	14.1	1.9	5.9	7.6	9.8	7.4	2.9	0.8	2.4	7.3	12.3	9.7	3.2	9.9	5	8.2	1.2	14.2	9.9	11.7	7.1	22.8	3.8	2.2	3.4	6.1	4.3	19	2.5	11.2	35.5	5.5	7.2	2.2	1.8	8	5.6	5.3	0.7	1	0	0.7	1.9	3.4	0.5	6.6	4	15.2	4.8	9.4	13.8	1.5	16.7	12.3	11.2	10.4	0	21.6	18.3	4.6	10.8	17.3	9.7	12.2	14.1	5.8	6	7.6	4.4	13.5	17.4	10.2	0.8	9.5	17.3	13.3	13.9	7.6	0.1	0	23.4	3.8	17.7	3.6	10.5	8.5	25.4	6	1.5	8.4	16.5	22.5	9.5	5.8	0.8	6.8	3	7.5	7.1	13.6	4.2	9.6	10.9	0	0	14.7	10.3	9.1	9.1	0	0.7	0	2.5	0.4	1.3	0.7	1.9	3.4	1	0.7	0.4	2	0	1.9	0.3	0.3	3.3	0.5	8.4	11	9.3	14.1	9.8	7.4	12.3	9.7	14.2	5.5
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	Serine/threonine kinase 4	Q13043	20	44966474-45079959	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nuclear bodies	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	unprognostic (2.77e-1)	unprognostic (1.10e-1)	unprognostic (8.83e-2)	unprognostic (8.49e-3)	unprognostic (2.95e-2)	unprognostic (1.24e-1)	prognostic unfavourable (8.04e-4)	unprognostic (1.70e-1)	unprognostic (2.51e-1)	unprognostic (1.05e-1)	unprognostic (1.96e-1)	unprognostic (2.70e-2)	prognostic unfavourable (1.84e-5)	unprognostic (1.28e-1)	unprognostic (5.70e-2)	unprognostic (3.96e-1)	unprognostic (1.18e-2)	9.5	8.8	10.4	24.5	11.5	39.5	8.1	7.5	13.4	7.8	8.6	10.3	5.4	8.1	9.3	6.5	8.9	7.3	9.4	6.1	9.3	8.8	6.3	7.4	18.8	30.6	10.5	9.1	8.3	6.4	5.9	9.3	8.2	7.7	7.5	10.6	7.4	9.3	8.7	4.2	11.4	16.1	8.2	12	29.1	9.6	7.4	9.6	32.3	8	4.9	36.6	11.5	8.7	10.8	6.9	40.6	13.3	10.3	14.5	7.9	11.6	7.9	10.1	7.2	6.2	7.8	7	10.3	15.8	17.5	15.9	22.4	6.4	28.6	9	7.3	12.4	10.7	13.8	22.5	12.8	5.7	20.8	11.6	15.7	10.9	26.7	29.6	6.3	11.4	16.4	17.9	6.4	9.6	16.5	8.8	9.2	19.9	18.1	6.2	5.4	12.9	11.2	13.3	6.4	8	4.8	5.9	15.3	8.9	11.7	8.1	16.9	8.2	13.2	12.9	15.2	11.9	21.6	16.9	31.8	12.9	12.8	9.7	24.4	7.6	20.5	14.5	7.7	14.4	10.3	13.8	13.3	6.9	10.8	14.3	11.9	40.6	10.3	13.3	3.9	13.3	7.9	10.4	11.5	7.5	13.4	9.3	8.8	10.5	9.1	7.7	9.6
STK40	"MGC4796, SgK495"	ENSG00000196182	Serine/threonine kinase 40	Q8N2I9	1	36339624-36385896	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 19.2	Group enriched	Detected in all	5	granulocytes: 19.2;monocytes: 8.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008026	Uncertain		Supported	"Nucleoplasm,Cytosol"				Cytosol	Nucleoplasm	HPA008026: AB_1857603	unprognostic (3.32e-1)	unprognostic (3.00e-1)	unprognostic (6.47e-2)	unprognostic (4.55e-1)	unprognostic (1.38e-1)	unprognostic (4.43e-2)	unprognostic (2.69e-3)	unprognostic (6.09e-2)	unprognostic (2.09e-1)	unprognostic (5.96e-2)	prognostic favourable (5.59e-4)	unprognostic (1.19e-1)	unprognostic (2.75e-2)	unprognostic (7.06e-2)	unprognostic (2.64e-1)	unprognostic (1.07e-2)	unprognostic (2.51e-2)	22.9	7.2	9.8	15.3	9.4	9.2	26.5	8.9	11.1	10.2	19.1	7.4	16.7	9.4	11.8	12.2	22.3	11.3	18.2	25.6	10	7.1	14.3	23.5	16.6	15.4	13.1	7.4	22.2	34.4	9.2	14.7	19.2	12.1	15.7	9.1	9	25.1	17.7	53.9	17.2	10.8	26	10.3	17.2	17	32	8.9	9.2	14.6	20.7	16.6	19.5	26.6	2.4	2.7	19.2	8.5	1.6	2.9	2.4	7	3.1	15.6	16.2	11.1	6.4	8.8	7.2	9.8	8.7	9.4	17.1	10.2	30	5.9	6.7	7.1	14.2	3.1	6.4	13	11.1	19.6	2.9	21.8	11	11.4	26.2	5.8	11.8	6.7	3.5	5.4	24	10.9	5.4	11.1	11.8	15.1	10	4.3	13.6	10.6	19.9	5.4	8	19.1	9.7	5.5	8.7	23.9	5.9	13.5	9	5.5	11.5	16.1	15.8	11.4	6.4	25.3	28.6	10	18	1	3	4.9	2.6	6.7	2.9	2.3	1.7	1.7	2.7	2.4	1	1.5	19.2	1.6	8.5	2.6	1	2.4	9.8	9.4	8.9	11.1	10	7.1	13.1	7.4	12.1	8.9
STKLD1	"C9orf96, MGC43306, SGK071"	ENSG00000198870	Serine/threonine kinase like domain containing 1	Q8NE28	9	133376367-133406096	"Enzymes, Predicted intracellular proteins"				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	testis: 16.2	Low cell line specificity	Detected in some			Low cancer specificity	Detected in single			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in single			Low region specificity	Detected in all			HPA029902	Uncertain									HPA029902: AB_10603554	unprognostic (6.65e-2)	unprognostic (9.43e-3)	unprognostic (7.54e-4)	unprognostic (8.15e-2)	unprognostic (9.51e-2)	unprognostic (1.39e-2)	unprognostic (1.99e-2)	unprognostic (1.41e-3)	unprognostic (6.05e-2)	unprognostic (2.94e-4)	unprognostic (1.92e-4)	unprognostic (1.19e-1)	unprognostic (7.93e-2)	unprognostic (4.69e-2)	unprognostic (3.65e-1)	unprognostic (5.86e-2)	unprognostic (4.52e-2)	0.4	0.4	0.4	0.2	1.4	0.5	0.4	0.7	2.2	0.4	0.3	2.2	1.3	0.5	0.9	2.1	0.3	0.6	0.5	0.3	0.8	0.3	0.3	0.4	0.3	0.8	0.5	1.3	0.8	0.4	0.1	0.3	0.5	1.5	0.5	0.1	0.8	0.6	0.4	0.6	0.8	0.5	0.3	0.5	0.4	0.4	16.2	0.7	0	0.3	0	0.3	0.3	0.3	0.6	0.4	0	0.2	0.2	0.6	0	0	0.6	0.4	0.6	0.5	0.5	1.1	0.2	0	0.1	0.2	0.9	0.3	0.3	0.2	0	0.6	0.1	0	0	0.4	0.8	0.7	0.9	0.5	0.3	0.5	0.4	0.4	0.1	0	0.1	0	0.8	1	0	0.2	0.6	0.8	0.3	1	0.3	0.3	0.8	0.1	0.1	1	1	0.3	0.9	2.1	1.3	0.2	0.6	1	0.6	0.9	0.1	2.2	2.1	0.6	0.4	0.4	0.3	0	0.2	0	0.3	0	0.2	0.2	0.4	0.2	0.1	0.6	0.6	0.2	0	0.2	0.1	0.4	0	0	0.4	1.4	0.7	2.2	0.8	0.3	0.5	1.3	1.5	0.7
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	STE20-related kinase adaptor alpha	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Cell cycle			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031637	Approved		Supported	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA031637: AB_10601718	unprognostic (1.59e-1)	unprognostic (2.19e-1)	unprognostic (5.59e-3)	unprognostic (5.52e-2)	unprognostic (8.91e-2)	unprognostic (7.56e-5)	unprognostic (6.79e-4)	unprognostic (3.68e-2)	unprognostic (1.70e-1)	unprognostic (2.28e-1)	prognostic favourable (5.34e-5)	unprognostic (7.29e-2)	prognostic unfavourable (6.08e-7)	unprognostic (1.40e-1)	unprognostic (1.44e-1)	unprognostic (1.25e-1)	prognostic favourable (6.43e-4)	13.3	17.7	19.4	14.6	23.7	17.5	13	25	28.4	15.2	13.2	27.1	8.7	9.5	16.1	20.6	14.3	20.9	14.5	15.1	18.9	20.2	14.7	13	13.9	19.6	20.9	21.7	18.5	12.5	21.9	17.5	14.4	26	13.8	13.1	22.2	12.6	16.7	10.3	20.1	12	19.1	19.4	20.7	12.6	55.4	21.4	16.2	13.3	8.9	21.3	12.9	12.8	11.2	16.2	18.6	10	15.6	11.7	7.5	7.2	21.7	18.9	19	18.6	13.9	7.4	13.8	12.7	19.9	17.8	5.6	8.4	11	8.6	11.7	6	12.5	13.3	19.8	12.2	12.1	21.8	15.2	13.4	13.2	20.6	15.7	14.5	11.5	22.6	13	22	13.9	11.8	18.8	13.4	24.2	14.1	9.4	12.3	15.8	30.1	13.5	17.8	14.3	20.7	23.2	9.4	15.5	15.1	11.4	15	17.6	19	13.5	15.3	11.4	11.8	12.5	13.9	14.1	12.5	14.9	18.6	9.5	8.6	10.5	7.1	9.7	11.2	9.7	11.7	16.2	9	9.6	8.5	11.4	15.6	10	13.7	7.2	7.5	19.4	23.7	25	28.4	18.9	20.2	20.9	21.7	26	21.4
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	STE20-related kinase adaptor beta	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	Cell cycle			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		LHCN-M2: 59.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA026549, HPA028520"	Approved		Supported	"Aggresome,Cytosol"				Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	unprognostic (6.34e-2)	unprognostic (2.48e-1)	unprognostic (2.63e-1)	unprognostic (3.56e-3)	unprognostic (4.04e-2)	unprognostic (7.64e-2)	unprognostic (1.35e-1)	unprognostic (1.58e-1)	unprognostic (2.63e-3)	unprognostic (2.65e-2)	unprognostic (6.21e-2)	unprognostic (2.74e-2)	prognostic unfavourable (1.35e-4)	unprognostic (1.08e-1)	unprognostic (7.83e-2)	prognostic favourable (4.45e-4)	unprognostic (4.93e-2)	13.8	28.6	13.8	7.9	11.7	32.7	9.2	8.8	13.5	6.4	13.7	16.9	4.9	18.8	10.3	9.5	8.9	5.7	7.9	15.2	15.3	11.5	35.2	50.5	7.2	10.1	15.8	11	7.8	9.1	3.9	14.1	11.6	12.7	7.1	15.9	10.1	7.1	7.7	48.3	4.4	21.3	7.4	21	7.3	4.7	7.8	9.4	8.3	9.7	7.8	7.7	6.2	6.2	24.1	10.4	9.7	8.6	16.3	10.4	9.6	3.9	6.8	11.8	15.1	19.3	24.5	8.3	8	13.9	11.1	16.8	8.9	3.8	0	5.2	12.6	4	11.4	7.5	20.2	4.6	9.3	4.7	3.2	19.7	14.6	5.6	5.4	20.7	6.9	14.2	12.8	8.3	10.1	1.7	59.9	2.1	5.1	9.8	15.9	7	7	4.6	2.9	9.4	3.2	1.9	9.7	5.5	4.2	23.4	2.2	10.7	8	6.8	5.2	8.6	6.1	6.6	11.7	1.8	11.5	2.5	6.4	3.4	8	9.7	6	8.6	5.4	16.7	8	8.6	10.4	24.1	10.4	10.3	1.6	16.3	7.5	4.6	9.5	9.6	13.8	11.7	8.8	13.5	15.3	11.5	15.8	11	12.7	9.4
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	Serine/threonine/tyrosine kinase 1	Q6J9G0	12	10618939-10674318	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 15.8;stomach 1: 16.0	Cell line enhanced	Detected in many		CAPAN-2: 18.2;HDLM-2: 10.8;HMC-1: 11.9;HUVEC TERT2: 16.4;TIME: 15.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in some	7	NK-cell: 12.5	Lineage enriched	Detected in many	7	NK-cells: 12.5	Region enhanced	Detected in single		basal ganglia: 2.3	Not detected	Not detected			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Plasma membrane	Nucleoplasm	"HPA040468: , HPA048569: "	unprognostic (2.30e-1)	unprognostic (2.22e-1)	unprognostic (1.21e-1)	unprognostic (1.75e-1)	unprognostic (3.11e-2)	unprognostic (3.35e-2)	unprognostic (6.85e-2)	unprognostic (5.08e-3)	unprognostic (3.37e-1)	unprognostic (3.50e-1)	unprognostic (2.21e-3)	unprognostic (1.02e-1)	unprognostic (1.70e-14)	unprognostic (5.18e-3)	unprognostic (1.22e-1)	unprognostic (2.33e-1)	unprognostic (1.45e-2)	0.6	0.3	2.6	2.3	10.6	1	3.8	0.1	13.4	2.2	14.4	0.7	0.5	2.1	0.5	1.1	8.9	1.9	6.2	0.1	1.8	1.6	0.5	0.3	1.2	2.4	1.8	4.2	0.4	0.3	0	8.4	3.4	2.1	10.6	15.8	0	7.8	2.6	0.2	2.6	10.3	0.6	0.6	1	16	0.3	0.7	0	0.4	0.6	2.8	4.3	3.6	0	0	0.4	0	12.5	1.9	0.2	2.9	0.1	0	0.4	0	0	0.9	4.8	0.5	2.2	2.1	1.6	18.2	0.2	3.1	1.2	0.8	0.9	5	4.8	10.8	0.3	0.7	1.3	0.1	0	1.4	11.9	0.2	0.2	3.4	0.2	16.4	0.2	0.2	5.2	1.7	0.1	0.8	2.7	1.3	0	1.4	0.2	1.6	9.4	0.6	0	2.7	2.9	0	2.3	0.3	15.2	0.6	2.5	0.3	0.6	0	0.6	0.1	2.1	0.1	3.5	0	0	0	1.9	0	0	0	0	1.4	0	0	0	1.3	0.4	12.5	0	0	0	0.2	2.6	10.6	0.1	13.4	1.8	1.6	1.8	4.2	2.1	0.7
SYK		ENSG00000165025	Spleen associated tyrosine kinase	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 38.5	Cell line enhanced	Detected in many		Daudi: 38.7;HEL: 22.3;HL-60: 30.8;HMC-1: 20.5;REH: 25.8;THP-1: 23.7;U-698: 18.3;U-937: 21.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	15	classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5	Low lineage specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		1000000	1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	unprognostic (1.01e-1)	unprognostic (5.45e-2)	unprognostic (2.10e-1)	unprognostic (2.69e-2)	unprognostic (2.31e-1)	unprognostic (7.92e-2)	unprognostic (1.06e-1)	unprognostic (1.34e-1)	unprognostic (6.41e-2)	unprognostic (1.78e-2)	unprognostic (7.20e-2)	unprognostic (9.93e-2)	unprognostic (2.55e-3)	unprognostic (8.77e-2)	unprognostic (5.36e-3)	unprognostic (3.41e-2)	unprognostic (1.06e-2)	7.2	3.3	6	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	6.9	0	0	0	0	0	0	0	0	0	0	0	4.5	38.7	1.1	0	6	0.8	3.2	0	0	5.3	22.3	0	0	0	30.8	20.5	0	4.4	0	0.4	0	0.6	3.1	0	4.7	0	13.5	0.2	0	25.8	0	10.6	0.8	5.8	2	1.8	0	2.7	0	2.5	23.7	0	0	0.1	0	0	0	0	18.3	0	21.7	0	1.4	21.4	23.3	0.1	19	0.1	23.1	0	0	24.9	17.5	0	0	32.8	8.7	16.4	18.5	0	10.2	6	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9
TAOK1	"FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1"	ENSG00000160551	TAO kinase 1	Q7L7X3	17	29390464-29551904	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007669	Approved		Approved	Vesicles		13000	13000	Vesicles		HPA007669: AB_1080201	unprognostic (1.46e-1)	unprognostic (7.15e-3)	unprognostic (2.70e-2)	unprognostic (1.52e-1)	unprognostic (1.81e-2)	unprognostic (4.85e-2)	unprognostic (1.28e-2)	unprognostic (4.31e-2)	unprognostic (1.15e-1)	unprognostic (6.91e-2)	unprognostic (1.61e-1)	unprognostic (1.36e-1)	unprognostic (2.85e-2)	unprognostic (5.53e-3)	unprognostic (3.57e-1)	unprognostic (1.66e-1)	unprognostic (2.62e-1)	17.2	11.5	19.1	11.9	25	12.7	13.3	20.1	24.4	15.8	11.9	22.2	7.9	7.1	14.9	10.8	12.7	11	11.6	15.3	18.7	15.5	13.6	10.6	13.2	11.1	30	17.6	13.5	9.3	31.7	13.7	14.3	21.8	12	10.7	10.9	11.1	13.3	15	13.8	9.8	17.7	21	13	10.8	14.3	23.5	11.7	17.7	6	11.2	14.5	17.1	2.4	4.8	5.5	2.1	1.4	3	0.9	13.6	24.3	19.2	8.2	14.3	18.1	8.1	12.9	13.8	11.9	12.5	13.1	4.8	8.5	12.7	21	10.7	17.5	8.9	21.4	17.6	12.9	13.5	14.1	7	10.4	14.9	12.5	11.9	11.5	17.5	18	16.2	13.8	7.7	15.5	9.1	11.7	5.5	8.1	6.2	10.9	27.1	5.9	11.2	19.7	10.6	13	22.2	20.8	13.4	15	13.8	23.5	18.2	14.8	15.9	18	7.1	15.3	9.8	13.3	9.4	16.4	1.7	1.9	1.5	2	2.1	1.6	1.6	2	2.4	1.7	2.4	3	2.2	5.5	1.4	1.9	4.8	1.2	0.9	19.1	25	20.1	22.7	18.7	15.5	30	17.6	21.8	23.5
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	TAO kinase 2	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010650	Approved		Supported	"Nucleoplasm,Nucleoli,Cytosol"				"Nucleoplasm, Cytosol"	Nucleoli	HPA010650: AB_1080204	unprognostic (7.30e-2)	unprognostic (1.78e-1)	prognostic unfavourable (2.51e-4)	prognostic favourable (3.87e-5)	unprognostic (8.46e-2)	unprognostic (2.14e-3)	unprognostic (6.08e-2)	unprognostic (1.12e-3)	unprognostic (1.01e-2)	unprognostic (1.60e-1)	prognostic favourable (4.78e-4)	unprognostic (3.85e-3)	prognostic favourable (3.66e-4)	unprognostic (7.42e-3)	unprognostic (3.17e-1)	unprognostic (7.47e-2)	unprognostic (1.37e-1)	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13	12.4	14.1	15.1	17.6	25	18.2	13.9	10.4	23	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15	17.1	15.9	22.8	20	19.3	14.8	14.9	26.3	16	21.2	20.2	14	15.9	9.8	11.5	12.8	18	2.6	3.3	4.8	2.8	2	3.2	2	11.2	21.5	11.8	18.5	13.8	9.3	18.1	20.6	11	14	13.1	17.2	15	12.2	17.5	14.8	17.5	10.7	10.4	7.5	18.9	22.7	13.1	21.7	17.2	10.1	12.8	25.2	10.9	9	14.8	6	23.3	11.7	12.4	13.3	20.7	14.9	18.3	11.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.1	11.8	15.8	6.1	19.8	14.6	32.5	24.1	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.5	1.3	2.8	1.5	2.9	2.7	3.1	2	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2	1.4	3.3	3.2	2	26.2	26.7	29.2	30.6	25	18.2	22.1	22.7	20.7	20.2
TAOK3	"DPK, JIK, MAP3K18"	ENSG00000135090	TAO kinase 3	Q9H2K8	12	118149801-118372945	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HMC-1: 41.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA017160	Approved		Uncertain	Mitochondria				Mitochondria		HPA017160: AB_1851994	unprognostic (3.21e-1)	unprognostic (1.31e-1)	unprognostic (1.65e-1)	unprognostic (3.74e-2)	unprognostic (5.18e-2)	unprognostic (2.09e-1)	unprognostic (4.80e-1)	unprognostic (5.86e-2)	unprognostic (1.00e-1)	unprognostic (7.38e-2)	unprognostic (2.76e-2)	unprognostic (8.23e-2)	unprognostic (1.08e-2)	unprognostic (2.08e-2)	unprognostic (4.14e-3)	unprognostic (2.56e-1)	unprognostic (1.44e-1)	14.6	16.2	31.9	24.1	31	30.8	14.6	44.3	33.5	11.6	21.2	17.2	10.3	23.1	15.2	11.4	16	9.8	16.9	15.1	27.8	31.7	14	15.3	19.4	26.3	25.7	20.8	17.5	10.9	20.2	23.6	11.9	20.7	25.6	21.3	12	13.6	14.6	18.5	17	31.6	15.3	23.7	24.2	20.9	8.9	28.6	28.3	18.1	9.9	26.9	18.5	18.3	20.9	22.4	38.2	37.8	36.4	27.8	17.1	8.2	5.7	4.3	3.7	10.5	12.8	4.9	8.6	9.8	5	6.6	2.9	12.8	25.2	2.8	11.5	7.4	3.7	7.7	7.9	9.1	3.2	29.7	2.9	3.7	12.3	30.4	41.9	8.7	9.3	15.9	23.3	16.1	17.2	3	9.2	5.8	16	20	1.6	3	9.4	5.8	2.6	4.7	14.3	0.8	4.2	8	3.6	11	7.4	22.8	24.9	8.7	1.5	8.1	7.4	2.9	2.8	19.9	12.3	21	11.6	38.2	17	37.6	27.8	23.3	26.2	20.9	21.2	24.1	22.4	19.3	18.8	24.5	37.7	36.4	37.8	20.9	19.3	17.1	31.9	31	44.3	33.5	27.8	31.7	25.7	20.8	20.7	28.6
TBCK	"HSPC302, MGC16169"	ENSG00000145348	TBC1 domain containing kinase	Q8TEA7	4	106041599-106321495	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		BJ hTERT+ SV40 Large T+: 24.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.6;HBF TERT88: 29.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: "	unprognostic (1.65e-1)	unprognostic (2.60e-2)	unprognostic (8.47e-2)	unprognostic (1.12e-1)	unprognostic (8.06e-2)	unprognostic (1.13e-3)	unprognostic (1.55e-1)	unprognostic (3.81e-1)	unprognostic (8.68e-2)	unprognostic (1.85e-1)	unprognostic (3.67e-2)	unprognostic (1.80e-1)	prognostic favourable (3.20e-4)	unprognostic (8.17e-3)	unprognostic (1.69e-1)	unprognostic (1.12e-1)	unprognostic (2.29e-1)	12.8	19	14.2	7.6	15.2	3.4	10	16.3	15.2	13.5	8.3	10	11	4.4	10.9	14.9	10.6	13	13.2	9.3	12.1	11.1	17.8	10.5	9.6	6.9	15	8.5	17.5	8.2	12.6	24.2	13.7	12.1	11.9	9.1	9	9.1	14.6	4.2	8.5	7.2	13.3	10.3	8.5	8.1	12	13.8	18.5	13.9	4.6	8.9	14.5	10.7	10.7	6.3	11.9	6.8	5.9	8.4	4.2	0.9	2.5	5.1	1.9	19.2	12	0.9	3.8	6.2	24.8	43.6	4.4	3.8	1.7	5.8	13	2.2	3.4	4.7	29.8	2.3	1	5.3	2	4.6	5	2.2	3.1	11.2	3.9	2.3	3.9	6.4	4.1	2.1	7.5	3.3	2.8	2	1.2	1.7	2.1	3.2	3.5	6.5	4.4	2.7	2.2	3.4	2.4	3.3	3.3	4.8	3.7	4.4	2.2	1	1.9	1	2.8	3.7	6	3.2	2.3	11.9	6.4	6.3	6.2	6.8	7.2	6.2	6.8	8.4	6.3	10.7	7.4	6.7	0.5	5.9	4.6	6.1	6.7	4.2	14.2	15.2	16.3	15.2	12.1	11.1	15	8.5	12.1	13.8
TBK1	NAK	ENSG00000183735	TANK binding kinase 1	Q9UHD2	12	64451880-64502108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA045797, HPA060211"	Uncertain		Enhanced	"Nucleoplasm,Vesicles"				Nucleoplasm	Vesicles	"HPA045797: , HPA060211: "	unprognostic (4.73e-2)	unprognostic (8.46e-2)	unprognostic (6.07e-3)	unprognostic (1.90e-1)	unprognostic (1.94e-1)	unprognostic (1.28e-1)	prognostic unfavourable (3.30e-4)	unprognostic (1.26e-1)	prognostic unfavourable (3.48e-4)	unprognostic (1.69e-1)	unprognostic (2.54e-2)	unprognostic (1.24e-2)	prognostic unfavourable (4.20e-6)	unprognostic (4.35e-2)	unprognostic (1.30e-1)	unprognostic (1.26e-2)	unprognostic (9.56e-3)	19.1	23.3	13.7	16.8	17.1	32.3	19.1	17.8	20.5	14.9	18.3	10	14.1	18	17	15.1	15.3	13.8	15.6	11.7	14.7	15.6	15.4	20.8	17.8	18.3	20.2	13.6	15.6	11.1	13.1	27.2	40.6	21.1	16.3	12.9	10.1	15	18.3	24.8	12.1	21.4	17.2	18.8	24.6	14.5	27.9	16.9	3.4	13.3	12.6	16.7	18.4	19.6	9.7	8.2	22.5	11.9	16.3	11.8	5.9	13.4	15.5	8.8	12.9	15.8	16	19.5	14.8	21.5	13.9	13.3	8.7	8.2	18.9	12.9	16	12.7	11.4	12.4	16.5	17.3	10.8	20.2	11.2	12	17.4	20.6	25.3	12	11.4	13.9	13.4	18.5	15.5	27.5	17.9	16.5	0.6	16.2	17.7	9.1	9.6	9.8	18.2	15.2	24.5	7.4	10.7	19.5	20	14.3	20.5	15	17.1	12.6	12.2	10.1	14.4	17.4	30.3	18.4	15.9	11.4	16.2	22.5	7.3	16.6	11	11.9	11.8	9.7	8	11	8.2	7.6	2.8	7.1	15.1	16.3	10.6	1.9	9.5	5.9	13.7	17.1	17.8	20.5	14.7	15.6	20.2	13.6	21.1	16.9
TEC	PSCTK4	ENSG00000135605	Tec protein tyrosine kinase	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		HEL: 10.4;HMC-1: 16.4;U-266/70: 16.3;U-266/84: 11.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	4	basophil: 13.3;eosinophil: 11.0	Lineage enriched	Detected in many	5	granulocytes: 13.3	Low region specificity	Detected in many			Low region specificity	Detected in many			"HPA005733, HPA024657"	Approved		Supported	Plasma membrane				Plasma membrane		"HPA005733: AB_1857878, HPA024657: "	unprognostic (7.19e-2)	unprognostic (1.44e-1)	unprognostic (1.41e-2)	unprognostic (4.07e-3)	unprognostic (4.21e-2)	unprognostic (8.57e-2)	unprognostic (3.14e-1)	unprognostic (1.67e-1)	unprognostic (8.36e-2)	prognostic favourable (7.12e-4)	unprognostic (7.46e-3)	unprognostic (7.83e-2)	unprognostic (1.01e-4)	unprognostic (4.24e-2)	unprognostic (2.16e-1)	unprognostic (7.39e-2)	unprognostic (4.96e-3)	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2	3.4	4.8	0.5	8.4	2.8	3	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4	5.7	6.4	7	1.5	0.3	2.9	2.9	2.6	6.4	2	3.2	2	2.5	3	6.8	4.7	2.1	8.1	6.5	3	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0	0	0	0	0.1	0.4	1.8	1	2.2	0	1.7	1.5	1.6	0	0.5	0.9	0	1.5	0.1	0.7	10.4	0.7	0.1	0	1.7	16.4	0	0.2	1.4	0	0	5.7	0.4	3.2	0.7	1	3.7	0.3	0.7	2.4	2.2	0	2.8	0.7	0	0.2	0.5	0.2	0.4	0.6	3.3	0	0	0	2.2	0	16.3	11.6	2.1	0	2.3	0.1	13.3	0.5	11	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0	0.3	0.8	1.1	0.6	2	0.9	0.9	1.5	0.3	3.2	0.6
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	TEK receptor tyrosine kinase	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Group enriched	Detected in some	9	HUVEC TERT2: 35.8;NTERA-2: 17.8;TIME: 38.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in single		neutrophil: 2.2	Lineage enhanced	Detected in single		granulocytes: 2.2	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	Secreted to blood	8300000	8300000	Plasma membrane	Centriolar satellite	"CAB010359: AB_2203226, HPA073265: "	unprognostic (2.24e-1)	unprognostic (1.74e-1)	unprognostic (5.55e-2)	unprognostic (1.83e-2)	unprognostic (1.68e-1)	unprognostic (1.26e-3)	prognostic favourable (2.31e-5)	unprognostic (7.48e-2)	unprognostic (1.72e-2)	unprognostic (1.41e-1)	unprognostic (5.58e-2)	unprognostic (2.72e-1)	prognostic favourable (7.81e-4)	unprognostic (7.50e-3)	unprognostic (6.87e-3)	unprognostic (1.83e-1)	unprognostic (5.24e-3)	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3	5.3	10.6	5.3	23.4	4	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0	0.1	2.2	0.6	0	0	0	0.1	0	1.4	0	0.2	2.3	0	1.2	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	2.3	1	0	0.6	0	0	0.7	0	0.8	0.3	35.8	0	0	0.3	0	0	0	17.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	38.8	0	0.2	3.6	0	0	0	0	0.6	0	0	0	0	0	0	0.6	0	0	0	0	0.1	0	0	0	2.2	0	0	0	0	0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5
TESK1		ENSG00000107140	Testis-specific kinase 1	Q15569	9	35605305-35610041	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all														unprognostic (5.17e-2)	unprognostic (2.82e-1)	unprognostic (4.96e-3)	unprognostic (5.18e-2)	unprognostic (2.04e-2)	unprognostic (8.76e-2)	prognostic unfavourable (9.68e-4)	unprognostic (1.82e-2)	unprognostic (1.24e-1)	unprognostic (2.66e-3)	unprognostic (1.22e-2)	unprognostic (2.56e-1)	unprognostic (5.57e-2)	unprognostic (1.74e-2)	unprognostic (2.34e-1)	unprognostic (1.43e-2)	unprognostic (1.25e-3)	30.9	19.4	13.5	10.8	20.5	5.6	25.4	13.4	26.4	14.3	15.2	15	9.7	13.7	15.3	13.4	11	12	13	12.8	13.7	13.1	10.5	10	11.5	10.7	14.1	10.3	17	16	13.1	15.7	12.3	12.6	15.1	8.8	14.2	14.6	21	47.2	13.7	12.7	16.9	7.3	11	12.9	28.4	12.9	9.2	13	12.3	9	16.6	20.9	1	2.3	0.3	1.8	2.1	4.9	1.5	9.9	9.3	6.4	10.6	25.7	10.7	7.3	11.4	10.2	10.6	6.8	5.4	2.8	18.1	6.5	11.4	3.4	4	8.2	2	11.6	5.4	2.6	8.8	4.7	15	2.2	8.7	10.4	13	8.3	11.4	7.4	3	6.5	10.5	11	5	11	3.9	10.9	7.8	3.9	4.2	7.8	4.6	5.2	6.4	6.5	7.9	4.8	9.4	3.3	6.4	23.6	10.1	16.9	6.8	4	5.6	6.7	17.1	2.6	5.3	0	1.8	0.3	3.4	0.4	3	0.8	1.4	4.9	2.1	1	1.5	1.6	0	2.1	0.8	2.3	0.3	1.5	13.5	20.5	13.4	26.4	13.7	13.1	14.1	10.3	12.6	12.9
TESK2		ENSG00000070759	Testis-specific kinase 2	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		BEWO: 13.0;RT4: 12.7;SK-MEL-30: 12.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in many			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027257: AB_10602477, HPA063869: "	unprognostic (2.95e-1)	prognostic favourable (2.22e-4)	unprognostic (3.90e-2)	unprognostic (5.04e-3)	unprognostic (6.03e-2)	unprognostic (1.87e-3)	unprognostic (3.22e-2)	unprognostic (1.43e-2)	unprognostic (5.15e-2)	unprognostic (2.96e-1)	unprognostic (2.28e-1)	unprognostic (2.86e-1)	unprognostic (4.36e-2)	unprognostic (2.49e-2)	unprognostic (1.13e-1)	unprognostic (4.37e-2)	unprognostic (2.01e-1)	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2	15.9	5.9	1.1	3.7	2.6	1.6	0	0.8	0	3.2	1.7	13	0.6	4.3	1.9	3.2	3.6	1.5	5.2	0.6	1.5	2	3.4	2.7	1.5	3.7	4.3	3.5	1.8	2.7	1.7	1.2	9.8	1.8	2.9	2.1	3	1.5	0.6	10.9	1.2	0.6	3	2.4	3.4	1.5	4.4	0.1	1.4	1.7	12.7	0.3	1.4	3.3	6.4	12.1	9.9	1.5	0	0.2	2	1.6	1.1	7.1	4.2	1	1	0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	35	testis: 52.7	Cell line enhanced	Detected in some		HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA030620: AB_10601598, HPA077020: "	unprognostic (1.21e-2)	unprognostic (2.12e-1)	unprognostic (2.06e-1)	unprognostic (9.49e-2)	unprognostic (2.48e-1)	unprognostic (1.23e-2)	unprognostic (1.10e-1)	unprognostic (6.17e-2)	unprognostic (2.07e-2)	unprognostic (1.61e-3)	unprognostic (2.67e-2)	unprognostic (8.10e-2)	unprognostic (1.76e-9)	unprognostic (1.77e-1)	unprognostic (2.54e-1)	unprognostic (5.00e-3)	unprognostic (5.88e-2)	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0	0.1	0.1	0.4	0.2	0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0.8	0.2	0.1	0	0.2	2.5	0	0	0.3	0	0	0.1	0.2	0	0	0.7	0.2	0	0	0.3	0	0.2	8.9	1.3	0.3	0	0	0	0.2	0.1	0	0	1.2	0	0	0.1	11.6	0	4.7	0.4	0.1	0.6	0.1	0.5	0.4	1.7	0	0.1	1.4	0.2	0	0	0.6	0.4	0.1	0	0.1	0.3	0	0	2	0.5	1.1	0.1	0.1	0.1	0	0.2	0	0.2	0	0.5	0	0.8	0.4	0	0	0.3	0.1	0	0	0	0	0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	Transforming growth factor beta receptor 1	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease mutation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		RH-30: 67.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	Plasma membrane	Intracellular and membrane			Plasma membrane		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: "	unprognostic (2.58e-3)	unprognostic (1.20e-2)	unprognostic (3.64e-3)	unprognostic (2.80e-1)	unprognostic (8.63e-2)	unprognostic (3.36e-2)	unprognostic (1.97e-2)	unprognostic (1.32e-3)	unprognostic (1.97e-1)	unprognostic (1.45e-1)	unprognostic (8.21e-3)	unprognostic (1.82e-1)	unprognostic (1.18e-1)	unprognostic (1.01e-3)	unprognostic (3.40e-2)	unprognostic (3.19e-2)	unprognostic (1.14e-2)	11.1	6.9	10.3	11.5	14.6	20	15.4	12.6	11.3	14.4	20	11	5.5	7.4	18.8	8	13.2	10.9	14.9	9.7	7.8	7.5	16	9.8	19.2	18.9	15.8	4.3	13.3	8.8	6.5	13.5	50.9	14.1	12.3	9.2	10.4	10.2	12.2	8.4	6.6	11	28.6	17.9	13.9	25.5	11.4	12.4	10.8	7.7	8.1	11.5	13	10.2	1.6	2	13.1	2.4	4	8.3	1.9	3.3	5	30.8	9.5	7.2	5.3	4.6	11.5	12.6	10.7	12.1	5.1	2.4	7.5	3.6	9	8	10.4	8.9	14.6	19.5	3.2	11.2	5.6	4.5	11.9	6.9	27.3	11	9.6	16.8	7.9	1.9	15.5	3.2	14.7	5.2	1	7.8	6.5	3	2.8	67.2	3.2	2.6	0.8	8.3	9.7	8.9	39.9	11.9	7.4	9.4	3.5	8	6.9	34.3	7	3.2	3.2	5.1	16.8	11.9	6.9	13.1	2.4	9.1	8.3	1.6	7.2	1.6	3.6	6.1	2	1.3	3.5	6.7	4.9	4	1.9	1.4	2.2	1.9	10.3	14.6	12.6	11.3	7.8	7.5	15.8	4.3	14.1	12.4
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	Transforming growth factor beta receptor 2	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		ASC diff: 53.4;ASC TERT1: 80.5;HSkMC: 69.5;LHCN-M2: 65.8;TIME: 60.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB073537			Supported	Plasma membrane		560000	560000	Plasma membrane		CAB073537: 	unprognostic (1.74e-1)	unprognostic (1.84e-2)	unprognostic (3.70e-1)	unprognostic (3.02e-2)	unprognostic (1.92e-1)	unprognostic (2.26e-1)	unprognostic (1.96e-1)	unprognostic (1.62e-1)	unprognostic (1.40e-1)	unprognostic (2.24e-2)	unprognostic (7.36e-2)	unprognostic (1.12e-1)	unprognostic (1.65e-2)	unprognostic (4.72e-2)	unprognostic (1.81e-2)	unprognostic (8.81e-2)	unprognostic (8.02e-2)	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17	31.3	37.2	12	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48	82	5.3	6.8	20	6.6	1.4	19.7	3.9	2.4	14.4	0.9	0	53.4	80.5	2.4	12.5	17.6	4.3	4.3	3.2	13.3	0.3	45.3	16.8	5	0.6	18.3	7.2	1	1.3	1.4	1.6	16.2	22.8	2.2	11.8	69.5	16.3	18.6	18	46.7	0.2	0	65.8	0.2	2.3	1.6	0.4	5.8	2	5.8	0.3	23.2	5.8	0	0.9	3.7	1	3.5	0	2.4	60.3	21.2	5.2	9.6	4.7	0.4	0	2	12.7	2.5	8.5	6.9	2.9	20	3.5	3	3.2	4	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2
TIE1	"JTK14, TIE"	ENSG00000066056	Tyrosine kinase with immunoglobulin like and EGF like domains 1	P35590	1	43300993-43323108	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Group enriched	Detected in some	5	EFO-21: 27.9;HUVEC TERT2: 61.6;TIME: 53.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	22	basophil: 3.4;NK-cell: 5.4	Group enriched	Detected in many	22	granulocytes: 3.4;NK-cells: 5.4	Low region specificity	Detected in all			Low region specificity	Detected in all								Intracellular and membrane	75000000	75000000				unprognostic (1.88e-1)	unprognostic (1.26e-1)	unprognostic (7.60e-3)	unprognostic (1.01e-1)	unprognostic (3.91e-2)	unprognostic (1.53e-3)	unprognostic (1.19e-2)	unprognostic (7.83e-2)	unprognostic (2.02e-1)	unprognostic (9.34e-2)	unprognostic (1.91e-2)	unprognostic (2.25e-1)	unprognostic (1.17e-3)	unprognostic (2.16e-2)	unprognostic (1.89e-1)	unprognostic (1.29e-2)	unprognostic (2.35e-2)	39.4	5.4	3.9	6.6	6	1	43.6	2.5	6	10.8	8.4	4.5	4.2	4.5	18.6	10.9	7.8	10.2	11.1	15.1	4.9	4.2	9.4	10.8	22	13.1	6.4	3.1	7	3	2.7	5.1	39.9	5.5	8.6	3	6.9	6	6.9	17.8	4.2	5.8	12.1	5.3	14.8	5.1	5.1	3.8	1.1	13.9	10.2	3.1	9	14.7	0	0.2	3.4	0	5.4	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	27.9	0	0	0	0	0.4	0	0	10.5	0	0.1	0.1	0	0	0	0	0	0	61.6	0	0	0	0	0	5.1	0.3	0	2	4.1	0	0	0	0	0	0	0	0	0	0	53.5	0.3	0.1	0	0	0	0	0.1	0	0	1	3.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	5.4	0	0.1	0	0	3.9	6	2.5	6	4.9	4.2	6.4	3.1	5.5	3.8
TLK1	"KIAA0137, PKU-BETA"	ENSG00000198586	Tousled like kinase 1	Q9UKI8	2	170990823-171231314	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016043	Approved		Supported	Nucleoplasm				Nucleoplasm		HPA016043: AB_1858027	unprognostic (2.13e-2)	unprognostic (3.87e-1)	unprognostic (7.36e-2)	unprognostic (6.00e-3)	unprognostic (2.00e-1)	unprognostic (6.78e-2)	unprognostic (2.47e-2)	unprognostic (7.60e-2)	unprognostic (1.61e-1)	unprognostic (5.26e-2)	unprognostic (2.57e-1)	unprognostic (1.11e-1)	unprognostic (6.13e-2)	unprognostic (2.08e-1)	unprognostic (1.55e-1)	unprognostic (2.63e-1)	unprognostic (1.53e-1)	13.8	20.1	22	32.9	21	14.4	26.2	18.3	23.2	19.6	20.2	8.4	22.3	13.7	16.1	16.1	14.1	14.4	16.2	12.7	20.6	19.3	19.5	21.4	22.1	33.7	21.7	20.8	21.5	19.8	37.8	21	36	18.3	18	18.2	10.8	16.4	30.3	18.6	15.4	18.9	20.5	18.7	26	19.9	24.2	12.2	28	25.7	11.1	21.7	21.9	19.1	10.5	5.3	11.3	5.5	9.5	12.3	6.6	8.5	8.3	12.1	9.4	8.6	8.7	13.4	11.8	17.3	12	10.1	11.5	13.9	17.7	9.7	17.8	7.3	15.3	13.2	13.2	21	7.7	20.5	10.4	14.9	9.3	25.9	10.4	9.4	13.5	23.8	15.7	13.1	21	15.1	7.2	10.6	21.7	8.3	11.1	4.7	16.4	14.7	18.2	9.9	16.5	13.8	10.7	12.9	9.2	8.8	7.5	9.1	17.8	10.7	13.1	7	9.2	12.7	21.3	32.1	13.3	10.7	10.8	11.3	3.9	6.5	6.6	3	9.1	10.5	10.7	7.2	3.5	10.5	12.3	8.1	5	9.5	5.5	5.3	10	6.6	22	21	18.3	23.2	20.6	19.3	21.7	20.8	18.3	12.2
TLK2	"MGC44450, PKU-ALPHA"	ENSG00000146872	Tousled like kinase 2	Q86UE8	17	62458658-62615481	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 47.9	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all														unprognostic (2.50e-2)	unprognostic (2.12e-1)	unprognostic (7.06e-2)	unprognostic (1.48e-2)	unprognostic (9.53e-3)	unprognostic (6.57e-2)	prognostic unfavourable (9.40e-4)	unprognostic (4.53e-2)	unprognostic (5.28e-2)	unprognostic (2.32e-1)	unprognostic (2.82e-2)	unprognostic (4.78e-2)	unprognostic (5.32e-2)	unprognostic (9.79e-2)	unprognostic (4.32e-2)	unprognostic (4.88e-1)	unprognostic (7.30e-2)	7.4	6.4	8.3	7.3	7.2	12	12.5	7.8	14	5.8	7.8	4	3.1	7.4	9	3.1	9	6.2	9.9	17.8	7.7	7.4	5.7	5	6.9	8.7	7.7	7.3	8.5	8.9	5.6	6.9	9	10.4	6.6	5.3	7.5	8.6	8.7	11.7	8.7	10.1	6.5	8.6	8.9	6.7	47.9	5.7	4.1	11.7	3.1	10	8.5	7.2	4.6	3.6	8.6	2.8	6.6	4.9	1.5	15.5	14.3	24.8	26.2	8.1	10.5	14.4	17.2	13.4	20.4	18.7	14.9	14	30.5	8.8	11.2	10.6	17.5	7.3	19.5	16.1	13.9	20.7	13.5	15	14.5	21.8	13.2	9	10	13.7	16.6	10.1	20.5	13.9	10.9	33.9	31.1	7.8	15.7	12	21.3	32.6	9.7	9.6	15.7	26.7	36.2	14.7	10	22.1	17	19.6	13.6	28.6	27.2	12.9	19.4	16.1	20.1	28	11.8	11.2	14.9	3.7	2.8	8.6	2.5	2.2	2.6	4.5	4.4	3.1	2.5	4.6	3.5	4.6	5.5	6.6	2.4	3.6	4.9	1.5	8.3	7.2	7.8	14	7.7	7.4	7.7	7.3	10.4	5.7
TNIK	KIAA0551	ENSG00000154310	TRAF2 and NCK interacting kinase	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.9	Cell line enhanced	Detected in many		AF22: 19.6;HEL: 26.6;HMC-1: 30.3;HUVEC TERT2: 19.5;WM-115: 22.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	23	basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3	Group enriched	Detected in many	29	granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA012128, HPA012297"	Approved		Supported	"Nucleoplasm,Cytosol"		9100	9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	unprognostic (2.29e-1)	unprognostic (1.12e-2)	unprognostic (1.32e-1)	unprognostic (5.90e-2)	unprognostic (5.25e-2)	unprognostic (9.23e-2)	unprognostic (4.91e-2)	unprognostic (2.41e-3)	unprognostic (1.91e-1)	unprognostic (7.81e-2)	unprognostic (5.91e-2)	unprognostic (1.96e-2)	unprognostic (3.34e-3)	unprognostic (2.41e-1)	unprognostic (1.64e-1)	unprognostic (2.13e-2)	unprognostic (3.97e-2)	2.2	5.4	29	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.6	2	0.3	0	4.6	4.1	1.1	3.2	2.2	17.5	7.3	0	1.4	3.7	6	2.8	1.1	3.5	0.1	4.3	26.6	1.5	0	9.4	5.2	30.3	2.8	2.9	1.9	0.4	19.5	9.6	0	0.5	0.4	1.6	6.7	8	7.6	0	5	7	6.3	0	0.9	1	2.5	0.2	4.3	8.8	1.3	0.2	0	3.4	8.9	3	0	0	0	0.9	5.9	22.7	4.4	0.1	10.5	4.2	0	5.2	0	5	3.7	0	0.2	6.7	3.8	0.1	2.7	0.1	0	5.3	1.1	29	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1
TNK1		ENSG00000174292	Tyrosine kinase non receptor 1	Q13470	17	7380534-7389774	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enhanced	Detected in many		A-431: 6.4;HaCaT: 10.4;HBEC3-KT: 6.9;hTCEpi: 7.8;T-47d: 8.6	Low cancer specificity	Detected in many			Group enriched	Detected in many	4	basal ganglia: 6.4;cerebellum: 11.4;cerebral cortex: 4.0;pons and medulla: 4.3	Low cell type specificity	Detected in many			Group enriched	Detected in many	6	B-cells: 1.6;T-cells: 3.8	Not detected	Not detected			Low region specificity	Detected in many			"HPA012065, HPA056452"	Uncertain		Approved	Cell Junctions				Cell Junctions		"HPA012065: AB_1858165, HPA056452: "	unprognostic (4.90e-2)	unprognostic (1.93e-1)	unprognostic (2.95e-1)	prognostic favourable (4.28e-4)	unprognostic (2.84e-1)	unprognostic (1.60e-1)	unprognostic (1.41e-2)	unprognostic (3.65e-1)	unprognostic (2.20e-1)	unprognostic (2.52e-2)	unprognostic (2.43e-1)	unprognostic (3.10e-1)	prognostic favourable (6.40e-4)	unprognostic (1.77e-3)	unprognostic (1.61e-1)	unprognostic (1.38e-1)	prognostic favourable (1.52e-4)	3.4	0.6	1.1	2.2	6.4	0.4	7.9	11.4	4	5.4	11.7	0.4	7.7	7.1	5.1	5.3	7.2	3.5	6.3	2	1	0.4	4.6	6.9	3.2	2.7	1.5	0.8	4.4	6.8	5.4	2.7	2.5	4.3	8.9	4.5	7.7	10.5	4.8	1.8	8.3	11.3	5.1	0.7	2.4	9.6	2.2	0.6	0.6	11.6	5.7	5.2	4.5	4.4	1.6	0.1	0.4	0	0	3.8	0.6	6.4	1	0.2	0.4	0	0	4.3	0.2	0	0.4	0.4	3.3	3	0	2.6	0.3	10.4	0	6.9	0.1	0.7	1.5	0	3.7	1.8	0.4	0	0.2	0.1	7.8	0	1.2	0	0.8	0	0	4.9	0.6	0	0.9	0.9	0.2	0.2	0.7	4.8	3	0.2	0.5	3.5	5.2	1	8.6	0.1	1.7	0.2	0.8	0.2	0	0.5	1	0.1	0.1	0.4	0.5	0	0	0	1	0	1.9	1.6	1.8	1.2	0.1	1.5	3.3	3.8	0.4	0	0	0	0.8	0.6	1.1	6.4	11.4	4	1	0.4	1.5	0.8	4.3	0.6
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	Tyrosine kinase non receptor 2	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041954	Approved		Approved	Cytosol				Cytosol		HPA041954: AB_10794164	unprognostic (1.97e-2)	unprognostic (1.05e-1)	unprognostic (1.15e-3)	prognostic unfavourable (8.96e-4)	unprognostic (1.34e-1)	unprognostic (8.92e-2)	unprognostic (1.45e-1)	unprognostic (1.30e-1)	unprognostic (8.89e-3)	unprognostic (1.13e-1)	unprognostic (8.92e-3)	unprognostic (4.49e-2)	prognostic unfavourable (1.30e-4)	unprognostic (6.82e-2)	unprognostic (9.76e-2)	unprognostic (1.44e-1)	prognostic favourable (1.00e-4)	9.2	7.6	36.3	16.2	27.6	38.9	8.5	20.7	43.7	6	6.3	17.6	3.8	6.6	8	6.6	13	10.7	6.5	10.6	28.4	21.8	4.1	7.2	9.3	18.1	21.6	31.8	8.6	7.8	5.1	19.3	8.4	20	10.8	3.9	5.3	16.8	8.2	30.5	37.1	6.9	7.6	10.3	17	12.1	7.7	21.8	3.4	4.6	9.8	12.8	7.7	12.3	6.1	3.1	6.3	3.2	0.9	1.9	1.2	31.3	3	5.1	5.4	7.1	4.5	30.5	6	5.8	3.6	3.3	4.8	24.3	9.1	21.2	8.2	11.2	4.4	7.5	1.1	21.4	5.6	8.2	10.2	3.5	3.2	4.2	4.1	3.3	11.9	5	6	4.6	3.3	12.7	3.4	23.1	1.8	15.4	4.8	11.3	5.3	6.1	9.2	3.2	15.2	6.2	6.3	3.9	15.9	7.8	26	5.3	7.5	8.4	4.9	4.4	16.8	27.6	3	5.6	7.5	13.8	6.2	2	2.4	0.9	1.9	3.2	1.1	2.7	1.8	1	1.1	6.1	1.4	1.3	6.3	0.9	2.8	3.1	0.2	1.2	36.3	27.6	20.7	33.3	28.4	21.8	21.6	31.8	20	21.8
TNNI3K	CARK	ENSG00000116783	TNNI3 interacting kinase	Q59H18	1	74235401-74544428	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	heart muscle: 44.6	Cell line enhanced	Detected in some		CAPAN-2: 3.9;HSkMC: 2.7;RPTEC TERT1: 2.6	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		intermediate monocyte: 2.3;plasmacytoid DC: 1.9	Group enriched	Detected in many	5	dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0																				unprognostic (1.04e-2)	unprognostic (1.34e-2)	unprognostic (3.83e-1)	unprognostic (2.20e-1)	unprognostic (3.46e-1)	unprognostic (3.40e-2)	unprognostic (3.05e-1)	unprognostic (2.48e-3)	unprognostic (2.00e-1)	unprognostic (9.66e-2)	unprognostic (5.04e-2)	unprognostic (1.80e-1)	unprognostic (3.59e-3)	unprognostic (4.88e-3)	unprognostic (1.20e-1)	unprognostic (8.80e-2)	unprognostic (8.77e-2)	0.7	0.6	1.1	0.5	1.5	0	1	6	1.7	0.5	0.5	0.5	0.5	0.2	0.5	1.7	0.5	0.7	0.5	44.6	1.1	1.3	2.2	0.5	0.5	0.5	0.6	0.5	0.7	0.5	0.3	0.6	0.5	0.9	0.5	0.3	0.5	0.5	1.2	0.5	0.9	0.5	0.6	0.5	0.5	0.1	1.8	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.3	1.9	0	2.3	0	1	0.1	0	0.6	0.7	0	0.5	1.6	0	0	1.3	0.3	1	0	3.9	0	0	0.4	0	0	0	0	0	0	0.5	0	0	0	0.7	0.5	2.7	1.6	0.2	0	0.5	0	0.8	1.1	0	0.2	0.2	1.1	0	0.2	0	0	2.6	0	0.3	0.9	0	0	0	0	0.8	1.3	0	0.1	0.2	0.4	0.2	0	0	0	0.5	0.3	0	0.2	0	0.1	2.3	0	0.1	0.3	1	0.1	0.3	0.2	0.4	0	0	0.2	1.9	0	0.1	1.1	1.5	6	1.7	1.1	1.3	0.6	0.5	0.9	0.5
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk"	ENSG00000172315	TP53 regulating kinase	Q96S44	20	46684365-46689779	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	tRNA processing	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		HMC-1: 69.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all							Low region specificity	Detected in all			"CAB004688, HPA015837"	Approved									"CAB004688: AB_426116, HPA015837: AB_1855776"	unprognostic (9.45e-2)	unprognostic (3.73e-1)	unprognostic (9.76e-2)	prognostic unfavourable (6.70e-5)	unprognostic (4.41e-2)	unprognostic (2.63e-1)	prognostic unfavourable (6.27e-5)	unprognostic (9.16e-3)	unprognostic (6.11e-2)	unprognostic (2.10e-1)	unprognostic (2.36e-1)	unprognostic (5.72e-2)	unprognostic (1.25e-2)	unprognostic (3.37e-2)	unprognostic (1.75e-1)	unprognostic (1.59e-1)	unprognostic (1.74e-2)	11.2	14.5	12.7	12.6	15.3	9.6	16.8	8.1	20.3	14.1	11.7	13.7	5.3	8.8	14.8	8.9	16.9	12.2	12.6	9.9	12.1	11.3	12.7	13.6	10.6	18.2	13.1	12.8	15.3	10.1	11.8	15.7	14.9	12.1	15.5	11.4	12.6	13.8	12.2	12.4	16.8	11.2	12.7	10.6	13.2	13.3	26.4	11.8	21.9	16.6	13.1	21.1	14.3	12.7	14.7	19.1	21.7	12.4	16.2	18.5	12.2	3.9	2.7	5.8	5.1	6.1	5.1	5.2	5.5	5.2	7.4	5.4	7.7	2.5	9.5	8.4	4.6	6.2	7.4	6.4	6.4	2.3	3.7	9.6	2.7	6.9	8.1	6.2	69	6.7	7.8	5.1	5	4.8	6.4	4.2	6.2	5.8	9.3	10.3	4.7	9.2	5.4	5.2	5.6	4.9	4.3	6.9	3.6	6.7	13.6	27	4.9	6.8	4.9	8.6	5	5.6	6.1	4.6	5.7	7.6	5	4.7	4	21.7	12.4	20.6	13.7	11.5	15.8	14.7	14.8	15.6	12.6	14.2	16.4	14	2	16.2	10.2	19.1	18.5	12.2	12.7	15.3	8.1	20.3	12.1	11.3	13.1	12.8	12.1	11.8
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	Tribbles pseudokinase 1	Q96RU8	8	125430321-125438405	"Enzymes, Predicted intracellular proteins"		Protein kinase inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 84.2;thyroid gland: 90.7	Cell line enhanced	Detected in many		HEL: 54.0;U-266/70: 33.1;U-266/84: 33.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	5	eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1	Group enriched	Detected in many	11	granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA063982			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		HPA063982: 	unprognostic (1.90e-3)	unprognostic (1.45e-1)	unprognostic (8.80e-3)	unprognostic (1.34e-2)	unprognostic (3.56e-1)	unprognostic (2.32e-1)	unprognostic (2.00e-1)	unprognostic (4.57e-2)	unprognostic (4.12e-2)	unprognostic (1.62e-2)	unprognostic (6.81e-3)	unprognostic (9.36e-2)	unprognostic (2.97e-3)	unprognostic (1.94e-1)	unprognostic (1.04e-2)	unprognostic (5.55e-2)	unprognostic (2.08e-2)	26.7	6.5	5.9	17.6	6.5	84.2	13.3	4.3	6.1	10.4	12.4	4.4	6.6	4.9	6.2	6.7	10.9	10.9	21	11.1	4.3	4	16.6	63.5	28.9	14.6	4.2	3.9	6.4	23.6	20.9	7.2	15.5	4.5	12.1	13.3	15	14.5	9.1	22.3	10.4	16.9	11.3	3.1	15.9	18.5	5.6	3.1	9.2	90.7	17.6	12.1	12.4	9	0.2	0.5	10.8	3.7	0	3.1	0.1	4	4.6	0.6	1.3	1.3	2.6	7.3	2.6	3.7	1.9	0.6	6.2	5.4	7.4	2.5	1.9	3.1	2	2.6	1.7	3.2	9.7	54	2	12	3.4	27	4.9	2.5	3.9	8.1	18.4	5.7	4.7	23.5	0.2	4.3	2.5	4.2	4.5	9	5.1	0.9	8	15.9	15.5	3.9	1.4	6.5	7.1	25.7	1.8	1.3	2.9	2.1	2.8	2.1	3.3	33.1	33	10.3	3.8	0.1	5	0	0.9	10.8	0	1.2	0	0.2	0.1	0	0.5	0	0	0	5.8	0	3.7	0.3	3.1	0.1	5.9	6.5	4.3	6.1	4.3	4	4.2	3.9	4.5	3.1
TRIB2	"GS3955, TRB2"	ENSG00000071575	Tribbles pseudokinase 2	Q92519	2	12716889-12742734	"Enzymes, Predicted membrane proteins"		Protein kinase inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		AN3-CA: 40.2;HEL: 39.4;K-562: 53.6;SK-MEL-30: 39.1;WM-115: 53.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		T-reg: 24.8	Group enriched	Detected in many	9	B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001305	Approved		Approved	"Nucleoplasm,Cytosol"				"Nucleoplasm, Cytosol"		HPA001305: AB_1080371	unprognostic (1.84e-1)	unprognostic (2.49e-2)	unprognostic (4.31e-3)	unprognostic (1.86e-3)	unprognostic (6.68e-3)	unprognostic (3.93e-2)	unprognostic (4.10e-1)	unprognostic (1.53e-1)	unprognostic (2.80e-2)	unprognostic (3.32e-2)	unprognostic (2.52e-3)	unprognostic (1.67e-2)	unprognostic (1.08e-3)	unprognostic (1.30e-1)	unprognostic (8.71e-2)	unprognostic (9.59e-2)	unprognostic (2.13e-2)	19.6	30.9	13.2	17.7	13.3	7	23.2	23.2	23	10.8	12.3	10.5	6.7	8.7	23	22.6	8.1	11.6	14.5	18.2	15	10.8	24.8	10.6	18.9	33	13.4	16.2	52.3	14.4	6.6	11.3	23	15.5	16.3	6.9	35.7	9.9	13.6	6.9	8.2	11.9	17.6	10.4	38.9	19.5	13.9	10.1	37.3	12.1	6.2	33.4	21.9	23.2	7.1	0.6	1.5	0.1	9.5	24.8	4.5	0	0	30.6	40.2	11	10.2	0	1.7	1.6	1	1.7	0.1	3.3	3.4	1.2	3.6	0.5	2.2	3.4	0.9	3.8	6.3	39.4	0.1	0.5	13.7	2.2	15.1	9.4	3.5	4.4	1.2	4.8	53.6	0	1.7	0.3	5	9.4	14.5	3.9	0	10.2	1.4	7	5	26.4	12.6	0.2	1.6	39.1	0	0.2	3	14.6	7.3	0.1	3.8	0	0	4.9	7.8	7.7	53.8	0.8	0.1	1.5	7.3	0	8.8	5.3	14.4	7.7	0.6	7.1	8.5	5.2	0.3	9.5	0.1	0	24.8	4.5	13.2	13.3	23.2	23	15	10.8	13.4	16.2	15.5	10.1
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	Tribbles pseudokinase 3	Q96RU7	20	362835-397559	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	Protein kinase inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		liver: 39.0;salivary gland: 47.5	Cell line enhanced	Detected in many		HHSteC: 87.0;hTCEpi: 53.9;hTERT-HME1: 62.7;SK-MEL-30: 79.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in all			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015272: AB_1858269, HPA055442: "	unprognostic (5.40e-2)	unprognostic (1.89e-1)	unprognostic (1.57e-1)	unprognostic (2.25e-3)	unprognostic (1.92e-1)	prognostic unfavourable (1.70e-4)	prognostic unfavourable (6.75e-5)	unprognostic (1.52e-3)	unprognostic (1.76e-1)	unprognostic (1.24e-1)	unprognostic (7.95e-2)	unprognostic (1.79e-1)	prognostic unfavourable (2.07e-13)	unprognostic (7.62e-2)	unprognostic (2.79e-2)	unprognostic (2.31e-1)	unprognostic (4.05e-3)	4.8	8.7	1.6	2.8	1.5	9.7	6	3.8	4.2	2.5	1.8	1.2	3.6	1	2.1	3.1	9.8	1.1	2.7	3	1.4	2	3.3	39	8.2	7.3	1	2.4	4.4	13.8	2	10.5	6.2	1.6	3.9	1.6	3.7	47.5	5.3	1.5	6.5	2.5	1.3	0.7	7.9	4.4	2.7	0.6	6.7	27.2	4.1	7	2.7	5.3	15.5	4.7	3.3	4.4	6.6	11.4	5.1	10.9	5.5	0.7	1.6	1.9	2.5	4.7	3.2	8.7	3.1	6.5	11.5	5.4	4.7	3.2	2.9	8.8	3	14.6	2.9	1.7	2.1	3.6	1.2	18.7	87	9.2	1.8	10.1	53.9	5.8	62.7	6	12.6	21.3	0.3	10.1	0.5	11.2	1.6	18.1	2.1	0.9	10.1	3.6	4.4	2	3.2	0.7	26.5	79.1	7.7	24.5	3.4	1.7	2.9	0	5	7.4	9.5	8.4	1.4	8.1	6	2.5	4.4	1	10	3.4	7.1	15.5	9.3	11.4	4.7	10.2	10.7	7.6	3.3	6.6	1.7	2.1	6.4	5.1	1.6	1.5	3.8	4.2	1.4	2	1	2.4	1.6	0.6
TRIO	ARHGEF23	ENSG00000038382	Trio Rho guanine nucleotide exchange factor	O75962	5	14143702-14532128	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in many		U-87 MG: 62.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA008157, HPA064664"	Supported		Approved	"Vesicles,Cytosol"				Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: "	unprognostic (6.65e-2)	unprognostic (4.21e-3)	unprognostic (1.65e-1)	prognostic unfavourable (1.90e-4)	unprognostic (9.39e-2)	unprognostic (4.13e-1)	unprognostic (2.18e-3)	unprognostic (2.55e-1)	unprognostic (7.52e-2)	unprognostic (1.63e-1)	unprognostic (2.02e-1)	unprognostic (1.82e-1)	prognostic unfavourable (3.11e-5)	unprognostic (1.78e-2)	unprognostic (1.96e-1)	unprognostic (4.58e-3)	unprognostic (2.23e-1)	29.7	13.7	27.6	15.8	18.9	5.8	30.3	32.6	29.7	13.7	18.5	11.3	9.2	8.3	23.1	19.3	10.4	12.2	25.2	15.1	18.9	15	11.7	12.6	15.8	10.9	11	17.7	28.9	11.5	17.2	19.6	13.7	12.3	16.3	16.5	23.3	10.5	14	19.8	16	15.6	22.7	11.6	24.2	13.7	11.3	11.5	7.4	10	11.9	12.3	15.6	16.9	3.8	2.7	0.3	1.9	4.3	0.6	0.4	12.2	4.4	10.6	5	22.7	29.8	12.1	11.3	13.5	9.1	10.5	2.8	4.8	2.8	8.5	15.4	3.7	1.7	5.3	18.9	7.8	2.5	1.5	11.8	3.5	11.8	3.7	4.2	13.9	5.6	32.2	10.3	8	0.3	1.9	22	2.3	0	2.6	2.6	4	2.8	6.4	9.4	8.9	5.5	4.8	19.5	9.6	2.5	5	1.5	0.5	18.6	17.6	11.2	12.7	13.3	0	0.6	3.6	62.5	2.4	4.1	0.3	1.5	0	0.1	1.9	0.3	2	0	0	1.4	3.8	0	0	0	4.3	1.4	2.7	0.6	0.4	27.6	18.9	32.6	29.7	18.9	15	11	17.7	12.3	11.5
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	Transient receptor potential cation channel subfamily M member 6	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 16.1;intestine: 19.5	Cell line enhanced	Detected in some		BEWO: 7.5;HeLa: 4.4;Karpas-707: 2.5;RT4: 7.2;U-266/70: 2.7	Cancer enhanced	Detected in some		testis cancer: 1.8	Low region specificity	Detected in many			Group enriched	Detected in some	6	basophil: 16.1;neutrophil: 6.6	Lineage enriched	Detected in single	30	granulocytes: 16.1	Low region specificity	Detected in single			Low region specificity	Detected in all														unprognostic (3.95e-2)	unprognostic (1.46e-1)	unprognostic (1.76e-1)	unprognostic (1.65e-1)	unprognostic (7.80e-2)	unprognostic (9.20e-2)	unprognostic (1.59e-2)	unprognostic (1.72e-1)	unprognostic (2.82e-1)	unprognostic (1.84e-1)	unprognostic (5.72e-4)	unprognostic (1.58e-1)	unprognostic (1.71e-2)	unprognostic (8.10e-2)	unprognostic (7.54e-2)	unprognostic (1.89e-2)	unprognostic (2.11e-2)	2.9	0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1	7.2	0.4	0.2	0.6	0.4	1	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0	1.6	0.8	19.5	0.7	5	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0	0	1.6	0.2	0.2	0	0	7.5	0.1	0	0	0.1	2.1	0.2	0.6	0	0.1	0.3	0.5	0.5	0	0.1	0.2	0.2	4.4	0.3	0.1	0.1	0.2	0.3	0.2	0	0	0.2	0	2.5	0.1	0.9	0	0.1	0.6	0.2	0	0	0.3	0	7.2	0.3	0	0	0.1	0.1	0.3	0	0	0.2	1.1	0.2	0	2.7	0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0	0.1	0.1	0.1	0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0	0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0	1.6	0.5
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	Transient receptor potential cation channel subfamily M member 7	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		parathyroid gland: 91.8	Cell line enhanced	Detected in all		U-2197: 49.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"				Plasma membrane	"Vesicles, Cytosol"	"HPA035522: , HPA052173: "	unprognostic (3.14e-2)	unprognostic (1.86e-1)	unprognostic (1.58e-1)	unprognostic (1.42e-2)	unprognostic (1.89e-1)	unprognostic (1.60e-2)	unprognostic (1.85e-2)	unprognostic (2.59e-2)	unprognostic (5.46e-3)	unprognostic (2.64e-1)	unprognostic (2.91e-1)	unprognostic (1.59e-2)	unprognostic (3.20e-2)	unprognostic (2.08e-1)	unprognostic (7.59e-2)	unprognostic (9.45e-2)	unprognostic (1.97e-1)	13.3	10.8	6.6	14.7	9	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11	8.2	19.1	5.5	4.9	16	20	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10	14.5	12.6	6.9	12.6	12.9	12.3	7	4.7	4.4	3.4	5.7	7.6	2	8.3	8.3	7	7.7	20.2	15.2	8.5	10.6	14.7	6.7	8.9	11.4	4.6	18.2	5.2	12.2	14.1	9.3	7.8	9.7	10.1	5.6	14.5	12.8	6	18.4	15	11.3	14.1	9.2	7.6	14.4	5.4	16.4	14	12.2	13.1	9.6	7.3	5.3	5.1	10.6	9.7	8.9	9.4	19.8	5.8	7.4	7.3	11.6	14.2	7.3	16.3	8.2	10.7	5.1	49.9	12.1	9.5	21	17.5	11.7	30.7	9.9	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2	6.6	9	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10
TSSK1B	"FKSG81, SPOGA4, STK22D, TSSK1"	ENSG00000212122	Testis specific serine kinase 1B	Q9BXA7	5	113432554-113435031	"Enzymes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	50	testis: 59.9	Cell line enhanced	Detected in some		CAPAN-2: 1.3;EFO-21: 2.1;RT4: 1.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			HPA027827	Enhanced									HPA027827: AB_10603138																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	59.9	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0.4	0	0	0.2	0.6	0.1	0.2	0	1	0	0	0	0.2	0	1.3	0.2	2.1	0	0.4	0.2	0.3	0	0	0.6	0	0	0	0	0	0	0	1	0	0	0	0.7	0.1	0	0	0.1	0	0.2	0	0	0	0	0	1.9	0.4	0.5	0.1	0	0.1	0.3	0	0.4	0	0.5	0.2	0.2	0.3	0.1	0	0.4	0	0.4	0	0	0	0	0	0	0.1	0	0.4	0.1	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0
TSSK2	"FLJ38613, SPOGA2, STK22B"	ENSG00000206203	Testis specific serine kinase 2	Q96PF2	22	19130808-19132623	"Enzymes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	57	testis: 95.7	Cell line enhanced	Detected in some		HL-60: 1.7;SCLC-21H: 3.4;THP-1: 3.2	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in some		NK-cell: 1.6	Low lineage specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all																															0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	1.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	95.7	0	0	0	0	0	0	0	0.7	0.3	1	0	1.6	0.8	0	0	0.8	0	0	0	0	1.3	0	0	0	0	0	0	1.2	0	0	1.6	0	0	0	0	0	0.4	0	0	0	1.7	0.3	0	0	0	0	0	0	1.2	0	0	0.7	0	1.2	0	0.8	0	0.5	0	0	3.4	0	0	0	0	0.7	3.2	0.8	1.4	0.5	0	0.2	0.1	0.9	0.3	0	0.3	1.2	0	0	1	0.4	0	0	0.5	0.1	0.8	0.3	0.7	0.2	0.5	0.2	1.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	Testis specific serine kinase 3	Q96PN8	1	32351521-32364312	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	testis: 68.1	Cell line enhanced	Detected in many		HeLa: 9.8	Not detected	Not detected			Low region specificity	Detected in some			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.3	Low lineage specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli"	Nuclear bodies	HPA037516: 	unprognostic (5.71e-2)	unprognostic (1.42e-1)	unprognostic (2.32e-1)	unprognostic (1.37e-1)	unprognostic (7.69e-2)	unprognostic (2.02e-4)	unprognostic (2.06e-1)	unprognostic (1.98e-3)	unprognostic (2.05e-2)	unprognostic (1.11e-1)	unprognostic (1.46e-2)	unprognostic (9.20e-2)	unprognostic (1.02e-3)	unprognostic (1.11e-2)	unprognostic (1.51e-1)	unprognostic (1.88e-1)	unprognostic (2.68e-3)	1.1	2	0.8	1.7	0.8	8.2	1.1	3.9	0.8	1.3	0.9	0.8	1.4	2.5	1.8	2.9	0.8	1.3	1	0.9	0.8	0	0.9	1.3	1.4	2.4	0.8	0.8	2	1.2	0	0.8	0.8	1	1	0	0.8	1.4	0.8	1.7	3.4	2.9	0.8	0.8	3.4	1.2	68.1	0.8	0.8	1.3	0.8	0.8	0.9	1.1	0.6	0.1	0.1	0.7	0.3	2.3	0.1	2.3	2.3	6	3.6	0	1.2	5.4	0.7	1.1	0	0	0.5	1.2	1.2	0.9	0	3.7	0	0	0	3.5	7.2	2.7	9.8	3.7	4.4	1.1	3.4	0.1	0.9	0	1.3	0	3.1	5.8	0	0.6	1.4	1.5	1.5	1.2	1.9	1.7	4.4	0	1.9	1.8	3.8	0.8	2.8	4.1	1.9	2.7	2.9	2.1	3.4	3	2.4	8.5	2.8	1.8	3.7	3.9	0.5	0	0.1	0	1.1	0.7	0	0	0.2	0	0.1	0.6	2.3	0.9	0.1	0.3	0.5	0	0	0.1	0.8	0.8	3.9	0.8	0.8	0	0.8	0.8	1	0.8
TSSK4	"C14orf20, STK22E"	ENSG00000139908	Testis specific serine kinase 4	Q6SA08	14	24205697-24208362	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	10	testis: 46.1	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in all			"HPA060660, HPA077103"	Approved		Approved	Cell Junctions				Cell Junctions		"HPA060660: , HPA077103: "	unprognostic (1.95e-1)	unprognostic (4.30e-2)	unprognostic (1.52e-1)	unprognostic (5.69e-2)	unprognostic (2.36e-1)	unprognostic (3.38e-5)	unprognostic (1.06e-1)	unprognostic (6.25e-3)	unprognostic (1.64e-1)	unprognostic (3.39e-1)	unprognostic (7.03e-3)	unprognostic (1.27e-3)	unprognostic (3.42e-1)	unprognostic (4.30e-2)	unprognostic (6.28e-2)	unprognostic (8.98e-2)	unprognostic (7.26e-2)	0.6	0.9	0.6	1.7	0.6	3.1	0.6	1.5	1.8	0.6	0.6	0.6	0.6	1.5	0.8	0.9	1.4	0.8	1.7	0.6	0.6	0.4	0.6	0.6	0.8	2.8	0.6	0.6	0.8	0.9	0	0.6	0.6	0.6	0.6	0	0.6	1.4	0.6	1	4.7	1.6	0.6	0.6	1.5	0.6	46.1	0.6	0.6	1.4	0.6	0.6	1	0.6	2.1	1.7	2	1	1.8	2	0.7	1	4	3.9	1.5	0.1	0	4.3	1.6	0.1	0	0	2.1	3.7	3.1	0.9	0.1	3.8	0	0.1	0	1.6	3	3.4	4.8	3	0	1.5	3.7	0	0	0	0.6	0.1	1.3	2	0	3.8	3.6	1.6	0.7	3.2	2.9	1.5	2.6	0	5.2	2.2	2	2.7	2.5	0.8	1.6	1.7	1.4	2.9	1.8	3.7	1.3	4.2	4.8	4.7	1	2.8	0.9	0	1	2	2	1	0.7	2	1.6	1.6	0.6	2.1	1.6	1.7	2	1.8	0.9	1.7	0.7	0.7	0.6	0.6	1.5	0.6	0.6	0.4	0.6	0.6	0.6	0.6
TSSK6	"CT72, FLJ24002, SSTK"	ENSG00000178093	Testis specific serine kinase 6	Q9BXA6	19	19512418-19515685	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	13	testis: 50.8	Cell line enhanced	Detected in many		BEWO: 8.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Not detected	Not detected			Not detected	Not detected														unprognostic (2.12e-1)	unprognostic (7.89e-2)	unprognostic (7.26e-2)	unprognostic (6.64e-2)	unprognostic (3.39e-1)	unprognostic (7.20e-5)	unprognostic (3.38e-1)	unprognostic (5.51e-3)	unprognostic (5.17e-2)	unprognostic (1.46e-1)	unprognostic (3.98e-4)	unprognostic (2.28e-2)	unprognostic (5.34e-3)	unprognostic (2.74e-3)	unprognostic (2.78e-2)	unprognostic (1.52e-3)	unprognostic (9.89e-2)	0.9	1.2	1	1.2	1.5	1.3	1	0.9	1.9	0.9	1.1	2.2	1.6	2.1	0.9	3.7	1.1	1.1	1	0.7	1.2	0.8	1.8	2.2	0.7	1.2	2.5	1	0.9	3.3	1.1	1	0.6	1.3	1.4	0.6	0.9	1.3	1	1	2.7	1.9	1.2	1.9	2.1	1.7	50.8	1.7	3.1	2	0.1	1.7	1.1	1	3.1	1	2.2	0.7	0.4	3.8	0.8	1.7	2.7	0.1	1.1	0.4	1	8.1	1.1	0.5	0.6	0.3	4.3	1.3	1.4	2	0.1	1.4	0.5	1.1	0.2	1.1	2	0.7	1.7	0.9	1.2	0.9	3.2	0.7	1	0.6	1.9	0.3	1.9	0.8	0	0.5	3.4	2	3.7	4.5	2.8	0.7	1.2	0.1	0.5	0.6	2.9	1.6	0.4	1.4	2.7	0.7	0.3	2	0.6	4	1.7	3.6	1.5	0.8	2.2	1.2	1.9	0	0.6	2.2	0.8	0.2	1.1	3.1	1.7	2	0.3	1.9	3.8	2.1	1.1	0.4	0.7	1	1	0.8	1	1.5	0.9	1.9	1.2	0.8	2.5	1	1.3	1.7
TTBK1	KIAA1855	ENSG00000146216	Tau tubulin kinase 1	Q5TCY1	6	43243680-43288259	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 28.9	Group enriched	Detected in some	9	SCLC-21H: 20.8;SH-SY5Y: 7.9	Cancer enhanced	Detected in some		glioma: 3.0	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA031735, HPA031736"	Enhanced		Supported	"Nucleoplasm,Cytosol"				Cytosol	Nucleoplasm	"HPA031735: , HPA031736: AB_10670294"	unprognostic (1.68e-1)	unprognostic (7.88e-3)	unprognostic (7.01e-2)	unprognostic (1.62e-3)	unprognostic (2.18e-1)	unprognostic (2.24e-4)	unprognostic (2.46e-3)	unprognostic (3.01e-2)	unprognostic (3.09e-1)	unprognostic (1.85e-1)	unprognostic (3.01e-2)	unprognostic (2.12e-4)	unprognostic (7.42e-2)	unprognostic (3.68e-1)	unprognostic (1.32e-1)	unprognostic (2.64e-3)	unprognostic (3.04e-4)	1.1	3.9	12.4	1.3	12.9	0.9	1	14.9	28.9	1	1.4	8.2	0	4.6	1	1	1	1.1	1.4	1.3	10.3	7.5	1.7	3.5	1.1	1.2	7.1	12.5	1	1.4	1.6	7.7	1	9	1.3	1.3	0.7	1	1.2	1	1	6.8	1.1	6.2	1.2	1.3	2.3	8.3	0	1	0	1.3	1.1	0.1	0	0	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0.3	0	0	0.7	0	0.2	0.1	0.7	0	0	0.1	0	0	0	0	0	0	0.3	0	0.1	0	0	0.3	0	0.1	0	0	0	0	20.8	7.9	0	0	0	0	0.1	0	0	0	0	0	0.5	1.6	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	12.4	12.9	14.9	21.7	10.3	7.5	7.1	12.5	9	8.3
TTBK2	"KIAA0847, SCA11"	ENSG00000128881	Tau tubulin kinase 2	Q6IQ55	15	42738734-42920809	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Cilium biogenesis/degradation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Spinocerebellar ataxia"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 41.8	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA018113, HPA049866"	Approved		Uncertain	Intermediate filaments				Intermediate filaments		"HPA018113: AB_1858421, HPA049866: "	unprognostic (2.15e-1)	unprognostic (1.67e-1)	unprognostic (1.08e-1)	unprognostic (6.30e-2)	unprognostic (7.73e-2)	unprognostic (4.26e-1)	unprognostic (6.64e-2)	unprognostic (5.11e-2)	unprognostic (1.32e-1)	unprognostic (2.43e-2)	unprognostic (2.78e-2)	unprognostic (8.62e-2)	unprognostic (3.46e-2)	unprognostic (7.29e-2)	unprognostic (3.63e-2)	unprognostic (2.18e-1)	unprognostic (1.38e-1)	6.7	7.3	8.7	5.1	14	8	6	17.8	22	7	7.2	10.9	3.8	3.3	8.5	6.2	4.2	7.8	6.2	10.7	9.4	11.5	6.1	4.3	6.1	5.5	11.1	14.8	11.5	3.3	9	13.9	8.8	24.7	8.2	5.6	7.6	4.8	6.5	11.6	6.3	4.6	8.4	10.9	7.1	4.9	41.8	10.8	3.6	6.7	1.9	5.4	6.8	8.7	2.5	1.4	1.3	3	2.1	3.1	0.7	6.1	3.4	9.2	4.9	6.3	6.6	1.9	5.1	7.2	4.4	6.6	4.6	1.4	4	6.4	4.8	4.1	8.1	6	6.7	12.9	5.7	4.9	7.6	1.9	4.9	7	8.6	5.2	6.2	3.9	20.8	5.5	7.4	6.5	4.1	0.8	4.7	5	2.6	3.8	7.9	8.7	1.9	5.5	3.8	6.9	7.8	12.4	0.9	2.6	3.2	8.7	6.7	5.7	5.7	7	7	7.5	10	5.9	4.2	5.5	3.6	0.4	3	1.2	1.7	1.4	3.1	1.5	1.6	1.3	0.8	2.5	2.1	1.5	1.3	2.1	1.5	1.4	0.5	0.7	8.7	14	17.8	22	9.4	11.5	11.1	14.8	24.7	10.8
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	TTK protein kinase	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 58.3;testis: 31.7	Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in many		T-reg: 4.0	Low lineage specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in many			"CAB010166, CAB013229"	Enhanced		Approved	"Nucleoli,Cytosol"				"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	unprognostic (4.27e-2)	unprognostic (8.71e-2)	unprognostic (1.04e-2)	prognostic unfavourable (1.44e-5)	unprognostic (7.97e-2)	unprognostic (4.78e-2)	prognostic unfavourable (3.84e-10)	unprognostic (1.56e-3)	unprognostic (7.95e-2)	unprognostic (2.02e-3)	prognostic unfavourable (2.54e-4)	unprognostic (1.54e-1)	unprognostic (0.00e+0)	unprognostic (3.51e-2)	unprognostic (1.06e-1)	unprognostic (1.46e-1)	unprognostic (1.66e-1)	1.1	1.4	0.3	3.2	0.4	13.9	1	0.3	0.4	1	2.7	0.2	0.2	2.2	0.5	1	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0	0.3	3	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0	1.1	0	1.1	4	0.8	13.3	8	24	19.7	1.1	3.5	13.6	15.5	9.6	22.7	27.8	10.9	10.2	19.8	12.1	6.6	17.4	21.2	9.5	31.7	18	17.1	18.3	10.7	8.9	0	21.5	12	0.4	1	15.9	10.2	12.8	20	20.5	19.3	9.9	12.3	15.6	14.2	9.7	11	43.9	8.2	5.7	8.6	16.6	9.7	9.1	9.9	5.6	9.3	16.4	5.3	10.2	10.2	6.6	24.8	4.6	15.5	11	3.6	20.1	8.7	0	0	1.1	0.6	0	0.6	0.9	1	1.6	0	1.7	0.3	0.5	0.3	1.1	0	0	4	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0	Cell line enhanced	Detected in many		RH-30: 4.8	Cancer enhanced	Detected in single		head and neck cancer: 1.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Not detected	Not detected							"HPA007042, CAB022682, HPA030048"	Enhanced					25000000	25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: "	unprognostic (1.00e-2)	unprognostic (3.92e-1)	unprognostic (1.77e-1)	unprognostic (7.11e-2)	unprognostic (3.71e-2)	unprognostic (1.49e-2)	unprognostic (6.62e-2)	unprognostic (1.84e-1)	unprognostic (2.49e-2)	unprognostic (1.86e-1)	unprognostic (2.79e-1)	unprognostic (2.65e-1)	unprognostic (3.49e-4)	unprognostic (1.99e-1)	unprognostic (1.15e-1)	unprognostic (1.09e-1)	unprognostic (1.34e-2)	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0	0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0	0.3	0.4	0.2	0.3	0.3	0	0.7	0.2	0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0	0	5.6	227	15.8	0.3	0.2	7	0.3	1.9	0.3	5	7.3	0.1	0.7	0.3	1.9	1	0	0	3.4	0.6	0	0	0	1.8	0.3	2.4	0.6	0	1.7	0	0	0	2.3	2	3.7	2.6	1	0	0.3	0.8	2.4	0	0	0	1.4	2.1	1.2	0.4	0.4	1.6	2.5	0.4	1.8	1.3	4.8	1.3	0	0.6	1	1.7	0.4	1.3	0	0.7	2.4	1.6	0	0	0.9	0.4	3.5	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7	2.7	3.5	1.3	5	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0	0	0
TXK	"BTKL, PSCTK5, PTK4, RLK, TKL"	ENSG00000074966	TXK tyrosine kinase	P42681	4	48066393-48134256	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4	Cell line enhanced	Detected in some		CAPAN-2: 4.7;HMC-1: 11.0;U-266/70: 5.4;U-266/84: 6.7;WM-115: 24.8	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in many		NK-cell: 43.5	Group enriched	Detected in many	26	NK-cells: 43.5;T-cells: 17.5	Not detected	Not detected			Low region specificity	Detected in all			HPA062482			Approved	Vesicles				Vesicles		HPA062482: 	unprognostic (1.04e-2)	unprognostic (2.21e-2)	unprognostic (4.13e-2)	unprognostic (9.24e-3)	unprognostic (1.09e-2)	unprognostic (2.58e-4)	unprognostic (1.32e-1)	unprognostic (1.94e-1)	unprognostic (1.50e-1)	unprognostic (6.39e-3)	unprognostic (8.13e-2)	unprognostic (4.06e-1)	unprognostic (1.33e-1)	unprognostic (1.37e-1)	unprognostic (1.61e-1)	unprognostic (2.59e-1)	unprognostic (2.04e-2)	1.8	1.5	0.3	15.3	0.4	3.9	1.5	0.2	0.6	0.8	2.1	0.3	0.2	1.3	1.3	11.6	2.4	2.6	1.7	0.7	0.2	0.4	2.1	2.8	4	49.1	0.5	0.5	0.5	1	0.4	1.3	28.4	0.6	0.9	1	1	6.1	0.2	0.5	1.7	7.9	0.4	0.4	17.8	1	1.7	0.2	14	1.9	0.2	19.3	2.4	1.4	0	0.1	1.1	0	43.5	17.5	10.6	2.3	0.1	0	0	0	0	0	0.1	0	0.1	0.4	0	4.7	0	1.4	0	0.2	0	0	0.4	0.2	0.1	2.3	0	0	0	0.3	11	0	0	0.1	0	0.1	0.2	0	0.6	0	0	2	0	0.8	0.3	0	0	1.3	1.2	0	0.2	0	0	1.1	0	0.1	0.4	0	0	0.3	0.1	5.4	6.7	0.4	0	0.4	24.8	1.1	0	0.3	13.2	0	17.4	0	6.8	6.4	0	0	17.5	11.9	0.8	43.5	0	0.1	5.1	10.6	0.3	0.4	0.2	0.6	0.2	0.4	0.5	0.5	0.6	0.2
TYK2	JTK1	ENSG00000105397	Tyrosine kinase 2	P29597	19	10350529-10380676	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell line enhanced	Detected in all		NB-4: 62.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA005157	Uncertain		Approved	Cytosol				Cytosol		HPA005157: AB_1858480	unprognostic (1.60e-2)	unprognostic (6.12e-3)	unprognostic (3.67e-2)	prognostic favourable (9.62e-4)	unprognostic (7.61e-2)	prognostic favourable (1.05e-5)	unprognostic (1.20e-2)	unprognostic (6.16e-3)	unprognostic (4.93e-2)	unprognostic (1.90e-2)	prognostic favourable (1.02e-4)	unprognostic (1.24e-2)	prognostic unfavourable (4.43e-4)	unprognostic (2.10e-3)	unprognostic (1.78e-1)	unprognostic (4.19e-1)	prognostic favourable (4.16e-4)	16.8	19	22.9	36	22.6	49.4	17.5	24.4	23.9	17.8	19.4	26.7	13.9	20	19.3	20.2	15	16.8	21.8	17	18.3	14	24	34.4	27.5	31.5	24.7	17.4	20	21.3	19	24.8	13.9	19.1	21.1	18.6	21.6	24.4	15.4	15.6	24.4	23.8	16.7	17.9	47.9	18.5	6.4	22.8	33.9	20.9	13.5	34.7	16.7	15.1	5.8	15.8	22.9	13.4	5.3	9.1	7.3	8.5	12.5	7.5	11.7	10	14.1	7.2	11.7	12	14.9	16.4	9.6	5.7	13	13.8	13.1	8.6	9	13.8	7.9	22.9	14	24	24.9	23.5	15.6	10.1	27.7	13.6	9.8	16.9	10	14.4	10.1	36.4	13.1	26.9	14.8	62.3	2.4	21.9	14.8	6.4	13.3	12.1	27.6	7	8.7	11.5	12.1	8.4	6.7	17.2	12.2	20.1	7.2	23.1	13.7	30	23.3	11.9	10	21.1	11.2	6.6	13.4	17	9.1	10.2	5.9	5.6	5.5	8.1	15.8	5.8	3.8	5.1	22.9	5.3	9.7	9	6.8	7.3	22.9	22.6	24.4	23.9	18.3	14	24.7	17.4	19.1	22.8
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	TYRO3 protein tyrosine kinase	Q06418	15	41557675-41583586	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 39.2;ovary: 48.2	Cell line enhanced	Detected in many		BEWO: 33.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 5.0	Lineage enriched	Detected in many	4	granulocytes: 5.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA071245	Approved					6400000	6400000			HPA071245: 	unprognostic (1.26e-1)	unprognostic (6.34e-2)	unprognostic (1.47e-1)	unprognostic (2.68e-1)	unprognostic (3.29e-1)	unprognostic (6.77e-2)	unprognostic (1.56e-3)	unprognostic (5.41e-2)	unprognostic (3.72e-1)	unprognostic (3.21e-1)	unprognostic (2.69e-1)	unprognostic (1.37e-1)	unprognostic (1.92e-10)	unprognostic (7.59e-2)	unprognostic (5.22e-1)	unprognostic (4.04e-3)	unprognostic (1.84e-2)	18.3	4.1	18.7	2.1	16.6	1.5	7.7	27.3	39.2	2.3	1.8	25.6	1.2	2.3	5	4.2	12.7	11.7	3.1	2.5	15.1	7.8	6.4	1.6	3.2	1.9	19.6	18.2	48.2	9.5	1.3	0.8	5.9	14	3.3	1.7	1.7	2.4	6.7	1.4	13	2.9	4.8	23.1	5.4	3.6	17.9	16.6	0	1.8	2.2	4.1	2.9	2.8	1.2	1	5	0.9	1	0.8	0.2	4.7	3.1	9.9	10.8	9.3	6.4	33.5	6.9	4.4	6.9	6.4	17.6	1.6	0.1	8.9	5.6	11.2	11.1	1.7	3.2	2.7	7.4	1.4	10	8.3	6.6	2.4	0.2	2	3.5	5.2	1.8	5.1	8.7	2	3.7	4.5	1.1	0.4	22.9	3.2	14.7	9	1.7	0.6	9.2	11.9	3.4	6.5	10.3	7.7	8.5	2.8	3.9	13.7	6	10.1	10.4	0.8	1.6	1.4	8.3	15.8	8.2	2.6	0.9	0.8	0.6	0.5	0.6	0.7	0.6	0.8	0.3	1.2	0.7	0.7	5	1	0.5	1	0.5	0.2	18.7	16.6	27.3	32.7	15.1	7.8	19.6	18.2	14	16.6
UHMK1	"KIS, Kist"	ENSG00000152332	U2AF homology motif kinase 1	Q8TAS1	1	162497251-162529629	"Enzymes, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA071190			Approved	"Nucleoplasm,Golgi apparatus,Midbody"				"Nucleoplasm, Golgi apparatus"	Midbody	HPA071190: 	unprognostic (6.69e-2)	unprognostic (1.28e-1)	unprognostic (1.05e-1)	unprognostic (1.46e-1)	unprognostic (1.28e-1)	unprognostic (1.33e-1)	unprognostic (2.08e-2)	unprognostic (8.16e-2)	unprognostic (9.63e-2)	unprognostic (1.82e-1)	unprognostic (7.81e-3)	unprognostic (9.10e-2)	unprognostic (3.11e-1)	unprognostic (3.44e-2)	unprognostic (9.08e-2)	unprognostic (8.77e-2)	unprognostic (4.66e-2)	21.6	22	23.5	18.9	26.2	30.1	23.5	10.8	30.5	14.3	16.3	17.2	30.8	16.3	11.5	12.9	16	12.9	12.1	11.4	27	31.8	27.9	32.4	16.9	24.3	30.6	20.3	12.1	11.8	25	12.5	16.5	33.4	14.7	17.4	14.1	15.9	22.9	30.6	11.5	21.8	9.6	20.5	21.3	16.8	10.4	14.1	23	17.1	11.7	24.1	16.1	12.8	5.7	4.3	4.5	9.2	5.9	8.5	4	20.8	9.8	5.1	12.5	14.7	11.6	11.6	27.7	15.1	22.7	16.3	6.3	13.1	17.1	24.2	20.6	12.1	9.8	15.2	36.6	23.4	7.1	16.9	12.2	5.7	11.3	24.6	19.8	11.9	16.2	22.3	21.4	13	14.7	23.8	38.9	8.8	13	6.5	6.8	13.3	8.4	22.9	14.2	15.1	21.6	9.3	8.6	24.4	22.7	17.8	19.6	27.6	20.2	26	14.7	17.9	38.5	24.7	34.2	20.2	21.6	12.1	23.4	4.5	3.3	3.7	8.2	8.6	8.5	5.4	6.2	6.8	3.6	5.7	6.3	7.1	2	5.9	9.2	4.3	4.9	4	23.5	26.2	10.8	30.5	27	31.8	30.6	20.3	33.4	14.1
ULK1	"ATG1, ATG1A"	ENSG00000177169	Unc-51 like autophagy activating kinase 1	O75385	12	131894651-131923167	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 6.9;plasmacytoid DC: 6.4	Low lineage specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA063990			Approved	Cytosol				Cytosol		HPA063990: 	unprognostic (1.53e-1)	unprognostic (5.19e-2)	unprognostic (2.52e-3)	unprognostic (2.21e-3)	unprognostic (8.01e-3)	unprognostic (5.48e-2)	unprognostic (2.74e-2)	unprognostic (5.04e-3)	unprognostic (3.94e-3)	unprognostic (2.03e-2)	unprognostic (9.09e-3)	unprognostic (8.19e-2)	unprognostic (6.25e-2)	unprognostic (2.38e-1)	unprognostic (2.75e-1)	unprognostic (1.82e-2)	unprognostic (3.16e-1)	10.9	18.6	14.6	9.2	49.6	33.2	8.9	24	24.4	14.4	11.8	6.9	13.3	11.7	16.5	10.7	9.8	10.6	16.2	17.4	11.5	8.3	9	15.8	9	8.3	7.9	12	18.2	59.6	13.8	23.8	17.2	11.6	13.4	4	13.9	18.1	13.4	33.4	24.3	11.5	10.2	5.4	16.5	11.4	11.4	11.4	13.8	10.7	9.6	6.5	12.1	10.9	0.6	6.4	6.9	1.7	0.2	0.8	0.6	5.1	16.6	7.7	9.6	3.5	2.8	10.5	8.2	5.9	3.5	2.8	3.6	5.3	1.4	8.6	5.7	5.1	1.7	3.2	1	5.5	10	3.4	13.6	4.8	6.5	2.5	7.6	5.2	9	3.9	1.6	4.3	4.5	4.1	2.3	11.7	15.3	14.5	8.5	15.9	11.6	2.8	6.8	2	6.4	19.6	10.8	8.7	9	4.5	13.7	16.8	8.2	8.4	5	14.6	3.7	18.3	6.6	1.8	14.2	4.3	9.6	0.2	1.7	2.3	0.8	0.7	0.2	0.1	0.7	0.7	0.3	0.6	0.5	0.5	6.9	0.2	0.7	6.4	0.5	0.6	14.6	49.6	24	24.4	11.5	8.3	7.9	12	11.6	11.4
ULK2	"ATG1B, KIAA0623, Unc51.2"	ENSG00000083290	Unc-51 like autophagy activating kinase 2	Q8IYT8	17	19770829-19867936	"Enzymes, Predicted intracellular proteins"	"Autophagy, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		intermediate monocyte: 6.9;non-classical monocyte: 5.8	Lineage enriched	Detected in many	4	monocytes: 6.9	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB037021	Approved									CAB037021: AB_1841237	unprognostic (1.47e-1)	unprognostic (1.88e-1)	unprognostic (2.56e-1)	unprognostic (1.03e-1)	unprognostic (1.23e-1)	unprognostic (1.31e-1)	unprognostic (6.53e-2)	unprognostic (1.07e-1)	unprognostic (5.83e-2)	unprognostic (1.39e-2)	unprognostic (5.11e-3)	unprognostic (1.39e-1)	unprognostic (1.16e-1)	unprognostic (3.44e-1)	unprognostic (2.69e-1)	unprognostic (3.23e-1)	unprognostic (1.38e-2)	10.3	7.1	15.5	4.4	19.1	2.8	7.6	15.5	21.8	9.3	7.2	28.3	6.7	3.1	9.5	8.4	6.8	11.5	7.7	8.3	15	10.9	7	3.7	8.8	4.6	15.8	12	12.4	7.5	14.2	4.2	8.5	15.9	9	4.8	8.5	5.3	11	13.5	7.8	3.6	9.9	28.3	7.1	5.5	33	14.6	2	7	1.4	3.8	7.7	6.3	0.1	1.4	0.5	6.9	0.4	1.6	0.6	8.6	8.9	12.8	1.8	7.5	14.2	0	7.2	8.9	7.5	7.1	0.1	1.8	0	3.8	9.2	4.1	0	1.4	7.1	7.1	9.3	0.2	3.8	0	9.8	0	4.4	9.2	11.2	3.8	3.2	5.2	0	0	6.3	2.4	0	0.4	1.9	2.3	0.5	0	0	5.4	3.8	3.2	13.3	11.3	1.4	4	8.8	3.3	8.3	0	1.1	2.8	4.3	0	0	0	1.1	0	2.6	0	1.5	0.3	0.6	6.9	0.2	0.1	1	1	1.4	0.1	1.6	1	0.5	0.4	5.8	0.1	0.2	0.6	15.5	19.1	15.5	21.8	15	10.9	15.8	12	15.9	14.6
ULK3	"DKFZP434C131, FLJ90566"	ENSG00000140474	Unc-51 like kinase 3	Q6PHR2	15	74836116-74843346	"Enzymes, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040474	Approved									HPA040474: 	unprognostic (3.67e-2)	unprognostic (8.90e-3)	unprognostic (2.65e-3)	unprognostic (1.59e-2)	unprognostic (1.70e-1)	unprognostic (2.07e-3)	unprognostic (1.19e-1)	unprognostic (1.58e-2)	unprognostic (1.47e-2)	unprognostic (4.18e-2)	prognostic favourable (7.47e-4)	unprognostic (1.97e-2)	unprognostic (2.70e-2)	unprognostic (1.30e-2)	unprognostic (1.63e-1)	unprognostic (1.16e-1)	unprognostic (4.97e-3)	7	11.7	11.8	8.4	15.4	2.9	7.4	21.3	20.4	7.9	13.8	9	9	7.9	5.3	9.5	33.9	6.7	9.6	14.1	11.8	8.9	13.4	9.3	6.4	7.9	11.2	15.3	4.9	14.7	12.1	12.3	5.7	21.1	8.2	14.4	10.4	10.4	7.4	19.1	24.6	20.3	7.2	5.8	9.9	11.1	6	7.6	4.2	6.1	10.9	13.7	8.6	10.6	3.8	4.2	3.8	7.8	5.8	12.6	4.9	3.8	10.5	5.5	9.5	6.3	4.1	3.6	3.1	4.5	6.4	7	4.1	8.8	8.3	5.9	3.4	3.9	15.4	4.3	2.7	16	15.2	24.9	13.5	5	9.2	5.9	15.9	5.5	8.5	5.6	5.3	9.7	6.9	9.1	5.2	5.8	4.3	6.1	6.2	5.4	12.8	6.7	15.9	4.1	4.9	10.3	13	6	5.7	19	8.3	14.9	5.4	8.6	5.5	8.4	6.6	12.6	11.4	6.1	4.8	17.4	7.4	3.8	3.6	1.4	12.6	7.8	10.1	3.8	7.4	10.3	4	3.5	8.1	5.5	0.9	5.8	6.2	4.2	9.7	4.9	11.8	15.4	21.3	20.4	11.8	8.9	11.2	15.3	21.1	7.6
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	Unc-51 like kinase 4	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA017930	Uncertain		Approved	"Nucleoplasm,Mitochondria,Cytosol"				"Nucleoplasm, Mitochondria, Cytosol"		HPA017930: AB_1858615	unprognostic (3.16e-2)	unprognostic (2.98e-3)	unprognostic (9.72e-3)	unprognostic (3.46e-2)	unprognostic (2.58e-1)	unprognostic (8.68e-2)	unprognostic (1.87e-1)	unprognostic (3.50e-2)	unprognostic (1.80e-1)	unprognostic (1.41e-1)	unprognostic (3.75e-3)	unprognostic (3.43e-1)	unprognostic (1.91e-2)	unprognostic (5.46e-2)	unprognostic (1.61e-1)	unprognostic (2.53e-1)	unprognostic (6.12e-2)	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4	6	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.2	1.7	2.6	3	1.1	1.7	4.5	2.5	2.6	3	2.6	0.9	2.1	8.4	1.4	5.7	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.3	2.8	3.9	5.5	1.7	1.6	2.2	14.7	3	2.1	1.8	7	2.2	5.8	6.9	4.4	3.2	3	1.5	8.4	3.7	6.4	7	1.3	9.7	2.5	1.2	2	2.9	1.8	6.1	1.9	2.2	13	2	4.2	7.9	3.5	10.8	5.8	2.3	5.7	5.8	5.8	8	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3	3.1	4.2	5.8	3.4
VRK1		ENSG00000100749	Vaccinia related kinase 1	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 39.0	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA000660, HPA017929"	Enhanced		Supported	"Nucleoplasm,Cytosol"				Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	unprognostic (1.03e-1)	unprognostic (1.17e-2)	unprognostic (1.84e-2)	unprognostic (2.24e-3)	unprognostic (5.42e-2)	unprognostic (1.19e-2)	prognostic unfavourable (4.15e-4)	unprognostic (4.20e-2)	unprognostic (2.11e-2)	unprognostic (5.47e-2)	unprognostic (5.14e-2)	unprognostic (1.60e-1)	unprognostic (2.53e-2)	unprognostic (6.70e-2)	unprognostic (4.56e-2)	unprognostic (3.36e-2)	unprognostic (1.58e-1)	6	4.4	7.1	9.8	17.1	39	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.7	9.1	22.5	10	2.7	5	14	11.9	9.3	19.1	19	10.8	15.6	40.1	8.1	7	17.5	21	15.5	26.3	22.8	11.3	25	6	11.1	2.9	48	15.7	2.7	2.8	14.4	10.6	13.2	21.2	25.4	16.4	18	38.1	20.7	14.4	17.3	35.7	39.4	13.6	8.7	16.2	15.9	9	10.5	10.8	8	12.3	19	7.1	8.7	7.8	15	11.9	13.3	15.7	38.8	13.6	21	10.3	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9
VRK2		ENSG00000028116	Vaccinia related kinase 2	Q86Y07	2	57907651-58159920	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Host-virus interaction	"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB046459, HPA047503"	Approved		Supported	Endoplasmic reticulum				Endoplasmic reticulum		"CAB046459: AB_1858773, HPA047503: "	unprognostic (1.87e-1)	unprognostic (5.84e-2)	unprognostic (4.65e-2)	unprognostic (1.33e-3)	unprognostic (1.27e-1)	unprognostic (1.60e-2)	prognostic unfavourable (6.32e-6)	unprognostic (3.90e-2)	unprognostic (4.76e-2)	unprognostic (2.96e-2)	prognostic unfavourable (4.65e-4)	unprognostic (1.36e-1)	prognostic unfavourable (4.66e-5)	unprognostic (3.48e-1)	unprognostic (1.62e-1)	unprognostic (2.99e-1)	unprognostic (3.56e-1)	18.7	17.7	10.9	21.9	28.3	14.9	16.1	2.4	15.1	15.6	13.5	27.3	16.3	9.9	18.4	16.7	26.8	13.2	10.9	21.6	14.4	8.9	12.4	15.2	15.6	19.5	29.2	13.5	14.2	20	16.1	18.7	16.1	18.7	15.7	15.6	9.3	20.5	17.6	21.5	12.8	12.9	20.1	19	20.1	13.5	12.5	31.2	13.6	17.4	16.7	23	18.1	19.4	19.7	17	21.6	21.3	11.3	12.2	9.2	14.1	9.5	1.1	6.3	7.1	13.1	19.6	13.1	13.2	9.1	9.3	19.3	15.1	17.3	17.3	11.5	10.8	13.7	14.3	13.7	31.1	9.2	19.5	7.6	13.8	11.3	16.5	11.6	7.2	17.1	14.6	21	26.1	19.1	11.1	15.1	8.1	0.1	12.7	12	4.8	18.9	4.8	11.8	15.1	11.7	3.8	0.1	20.8	12.4	10.5	8.7	10.2	14.5	0.2	30.2	8.1	0.2	16.4	12.9	9.3	7.3	20.5	15	13.7	16.8	21.6	10.1	21.3	12.2	19.7	9.8	11.8	16.6	19	7.4	9.5	6	11.3	20.6	17	11.5	9.2	10.9	28.3	2.4	15.1	14.4	8.9	29.2	13.5	18.7	31.2
VRK3		ENSG00000105053	Vaccinia related kinase 3	Q8IV63	19	49976467-50025946	"Enzymes, Plasma proteins, Predicted intracellular proteins"				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 77.2	Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA056489	Approved		Supported	"Nucleoplasm,Vesicles"				"Nucleoplasm, Vesicles"		HPA056489: 	unprognostic (2.09e-1)	unprognostic (3.14e-2)	unprognostic (1.26e-1)	unprognostic (4.94e-3)	unprognostic (1.23e-1)	unprognostic (2.22e-3)	unprognostic (9.78e-2)	unprognostic (3.47e-1)	unprognostic (8.79e-2)	unprognostic (2.48e-1)	unprognostic (1.31e-2)	unprognostic (1.43e-1)	prognostic favourable (1.83e-4)	unprognostic (9.38e-2)	unprognostic (2.15e-1)	unprognostic (1.06e-1)	prognostic favourable (5.66e-4)	9.7	11.9	9.2	9.4	12.7	10.7	8.3	12	14.1	8.9	13.4	11.9	9.3	13.4	15.7	10.8	8.4	18	12.2	7.4	9.3	11.1	16.7	16.2	8.5	13.4	10.4	9.9	11.2	11.5	7.1	11.8	10.7	9.8	9.4	11.7	14.2	14.3	8.5	11.8	7.7	17.3	7.5	11	12.8	10.9	77.2	9.1	24.7	14.1	6	12.9	9.9	8	24.5	19.7	47.3	20.9	33.5	30.1	18.1	16.3	16.9	12.4	13.4	16.5	15.3	12.9	11.8	14.1	17.5	19.3	9	18.3	19.7	8.4	11.4	12.2	11.5	10	14.2	17.2	23.7	15.3	10.2	15.6	12.4	19.1	27	13.7	15.1	10.1	10.7	14.4	18.6	29.4	12.6	6.9	25.8	12.9	6.7	14.6	20.8	13.1	25.1	15	17.3	14	6.8	11.5	14.2	12.8	13.1	20.4	10.9	18	10.5	7.2	9.1	19.1	24.3	10.3	14.4	11.8	12.3	37	17.8	32.4	23.8	18.8	19.1	24.5	21.7	22.7	19.7	21.9	22.1	20.4	47.3	33.5	20.9	18.8	30.1	18.1	9.2	12.7	12	14.1	9.3	11.1	10.4	9.9	9.8	9.1
WEE1	WEE1A	ENSG00000166483	WEE1 G2 checkpoint kinase	P30291	11	9573681-9593457	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low region specificity	Detected in all							"CAB004619, HPA068845"	Approved		Approved	Nucleoli				Nucleoli		"CAB004619: AB_628447, HPA068845: "	unprognostic (6.04e-2)	unprognostic (1.90e-3)	unprognostic (1.09e-2)	unprognostic (9.29e-2)	unprognostic (1.26e-1)	unprognostic (1.39e-2)	unprognostic (3.79e-3)	unprognostic (2.48e-2)	unprognostic (1.22e-1)	unprognostic (1.79e-2)	unprognostic (3.21e-3)	unprognostic (3.73e-1)	prognostic unfavourable (5.19e-4)	unprognostic (1.07e-1)	unprognostic (3.06e-1)	unprognostic (2.08e-1)	unprognostic (3.80e-1)	6.9	3.5	2	26.1	2.1	6.6	27.4	5.3	1.6	12.8	18	2.5	15.4	3.7	21.9	14.3	22.1	12.4	20.2	23	2	2.2	6.8	19.3	10.2	10.9	1.8	1.2	11.1	4.4	4.9	6.1	42.7	4.7	17	4.7	5.9	12.8	17.8	12	33.3	10.4	22.9	2.4	8	12.5	28.3	2	35.9	12	26.8	26.4	19.8	14.7	8.5	0.1	6.4	0	2.1	7.8	0.6	14.2	5.5	21.2	11.7	18.6	9.3	42	17.6	13.6	9.9	9.8	10.1	17.5	33.4	6.6	7.7	17.3	14.5	6.8	12.7	11.9	11.9	13.1	8.9	6.7	2	19.8	13.1	3.1	7.4	4.6	16.4	6.1	21.3	23.3	17.2	3.4	20.2	10.7	31.9	6.3	19.5	16.6	7.2	7.8	30.1	7.9	10.5	11.9	14.1	8.6	8.9	9.5	7	17.8	12.5	7.2	14.1	5.5	16.3	44.2	7.6	10.9	12.5	0	0	6.4	2	0	0.2	8.5	2	3.3	0.1	3.6	0.1	1.6	0.1	2.1	0	0.1	7.8	0.6	2	2.1	5.3	1.6	2	2.2	1.8	1.2	4.7	2
WEE2	FLJ16107	ENSG00000214102	WEE1 homolog 2	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell line enriched	Detected in some	5	CACO-2: 8.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in some			Low region specificity	Detected in all			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027418: AB_10603144, HPA054280: "	unprognostic (6.35e-2)	unprognostic (1.47e-1)	unprognostic (1.89e-1)	unprognostic (3.18e-1)	unprognostic (2.33e-1)	unprognostic (4.00e-2)	unprognostic (2.90e-1)	unprognostic (1.97e-2)	unprognostic (3.23e-2)	unprognostic (3.02e-2)	unprognostic (2.61e-1)	unprognostic (1.76e-2)	unprognostic (1.73e-1)	unprognostic (3.25e-2)	unprognostic (2.66e-1)	unprognostic (6.07e-2)	unprognostic (2.88e-3)	0.6	0.1	0.5	0.3	1	0	0.4	0.8	0.6	0.6	0.1			0	0.7	0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0	1	0		0.3	0		0.9	0	0.7	2.8	0.4	0	0.8	0.4	0.8	1.3			2		0	0.5	0.3	0.2	0	0	0	0.5	0.6	0	0	0	1.3	0.9	0	0	0.5	0	0	0	0	8	0.4	0.3	0.2	0	0	0	0	0	0.7	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0.1	0	0.3	1	0.3	0.1	0.2	0.1	0.1	0.1	0	0.3	0.5	1.6	1.1	0	0	0.1	0	0.9	0	0	0.2	0.1	1.7	1.1	0.5	0	0.3	0.7	0	0	0	0.4	0	0.1	0.2	0.4	0.6	0	0.1	0.1	0.6	0	0.5	0	0	0.2	0										
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	WNK lysine deficient protein kinase 1	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in all			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low region specificity	Detected in all							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol				Cytosol		"HPA046541: , HPA059157: "	unprognostic (1.40e-1)	unprognostic (1.54e-2)	unprognostic (4.82e-2)	unprognostic (1.75e-1)	unprognostic (1.27e-1)	unprognostic (7.68e-2)	unprognostic (1.05e-3)	unprognostic (1.57e-1)	unprognostic (1.24e-1)	prognostic unfavourable (9.67e-4)	unprognostic (1.84e-1)	unprognostic (2.49e-1)	unprognostic (4.38e-1)	unprognostic (1.40e-1)	unprognostic (1.32e-1)	unprognostic (5.17e-2)	unprognostic (1.30e-2)	30	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18	33	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.2	27	35.7	3.3	25.8	24.8	13.6	14.2	17.1	15.4	14.4	15.2	16.3	20.1	5	30.5	10.8	24.1	16.4	21.7	34.8	14.4	44.9	35.9	13.1	18.9	24.2	19.6	19.2	25	25.5	45.8	20.8	20.4	48.6	23.3	13.1	43.5	4.1	29.1	6.5	20.8	39.6	5.4	22.2	30.9	10.4	12.2	33.2	21.5	9.6	23.7	24.9	23	19.1	22.2	26.8	20.9	7.4	12.3	30.5	18.2	12.8	15.5	0.9	2.7	2.6	3.8	4	5.2	3	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	WNK lysine deficient protein kinase 2	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7	Cell line enhanced	Detected in many		Daudi: 11.2;Hep G2: 18.4;SCLC-21H: 23.4	Low cancer specificity	Detected in many							Cell type enriched	Detected in single	5	neutrophil: 1.9	Lineage enriched	Detected in single	5	granulocytes: 1.9	Low region specificity	Detected in all			Low region specificity	Detected in all			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol				Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	unprognostic (5.02e-2)	unprognostic (1.32e-2)	unprognostic (2.61e-1)	unprognostic (1.95e-1)	unprognostic (2.28e-1)	unprognostic (1.01e-1)	unprognostic (2.04e-1)	unprognostic (1.79e-3)	unprognostic (1.94e-1)	unprognostic (2.81e-2)	unprognostic (1.31e-3)	unprognostic (2.23e-1)	unprognostic (4.48e-3)	unprognostic (6.51e-2)	unprognostic (1.44e-1)	unprognostic (4.38e-4)	unprognostic (1.62e-1)	0	0.7	3.9	0.9	3.8	0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4	4.2	0	0	0	0	2.6		0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3	6.2	1.6	1.1	0.5	3	1.5			0		0	1	0.1	0	0	1.9	0	0	0.3	0	4.4	4	2.8	8.1	0	0	5.4	0	0	0	0	1.6	0.1	11.2	1.5	0	0.2	6.4	0	0	0	7.4	0	3.5	18.4	0	0	2.1	0	0	0	0	0	7.1	0	0	5.8	0.1	0.1	7.1	0.2	0	0	9.1	0	0.6	23.4	9.2	1.4	6.3	0.6	0.8	1.3	0.1	0	3.1	0.1	0	0	0	5.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0.3	0										
WNK3	PRKWNK3	ENSG00000196632	WNK lysine deficient protein kinase 3	Q9BYP7	X	54192823-54358642	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 31.6;testis: 26.7	Cell line enhanced	Detected in some		AF22: 5.8;AN3-CA: 4.4;HAP1: 6.7;NTERA-2: 11.9;SiHa: 5.8;U-2 OS: 5.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 1.9	Group enriched	Detected in many	10	B-cells: 1.1;T-cells: 1.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA077678	Approved		Approved	Vesicles				Vesicles		HPA077678: 	unprognostic (1.86e-1)	unprognostic (1.68e-3)	unprognostic (2.44e-1)	unprognostic (7.87e-5)	unprognostic (4.82e-3)	unprognostic (1.85e-3)	unprognostic (1.85e-2)	unprognostic (3.32e-2)	unprognostic (3.38e-1)	unprognostic (3.03e-2)	unprognostic (5.78e-4)	unprognostic (2.22e-1)	unprognostic (2.64e-2)	unprognostic (5.61e-2)	unprognostic (9.99e-2)	unprognostic (7.63e-2)	unprognostic (8.74e-2)	0.9	5	3.9	0.9	4.3	0.8	1.7	3	3.6	1.5	0.7	1.7	13.9	1	1.3	31.6	1.1	1.8	1.1	1.5	3.9	3.4	2.8	8.7	0.9	1	2.3	3	5.7	0.9	2.2	14	1.2	3.9	2.2	0.7	1.3	1.2	4.8	0.7	0.9	0.7	1.5	3.3	1	1.2	26.7	3.5	0	1.7	0	0.8	1.3	1.9	1.1	0	0.1	0	0.1	1.9	0.1	0	0	5.8	4.4	0	0	0	0.2	0	0.1	0	0	0	0	0.2	0	0	6.7	0.1	0.2	0	1.2	0	0	0.1	0.2	0	0.2	0.4	0	0.2	0	0	0.3	0	0	0	0	0	11.9	0	2.8	0.8	0	1.1	0.2	1.9	1.8	5.8	0	0.7	0.5	0	0.3	0	5.2	0	1.2	0	4	0	1.6	0	2.5	0.1	0	0	0.4	0	0	0	0.6	0	0	1.1	1.9	0.4	0.1	0.1	0	0	0	0.1	3.9	4.3	3	3.6	3.9	3.4	2.3	3	3.9	3.5
WNK4	PRKWNK4	ENSG00000126562	WNK lysine deficient protein kinase 4	Q96J92	17	42780678-42796936	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		kidney: 28.1;ovary: 14.6	Cell line enhanced	Detected in many		fHDF/TERT166: 19.4;K-562: 21.7;TIME: 21.0;WM-115: 14.1	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in single		memory CD4 T-cell: 1.0	Low lineage specificity	Detected in single			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA016500	Approved									HPA016500: AB_10962984	unprognostic (6.34e-3)	unprognostic (1.35e-1)	unprognostic (2.15e-1)	unprognostic (5.58e-2)	unprognostic (1.78e-2)	unprognostic (1.96e-1)	unprognostic (2.48e-1)	unprognostic (1.69e-1)	unprognostic (5.84e-2)	unprognostic (3.94e-1)	unprognostic (2.08e-3)	unprognostic (4.33e-3)	unprognostic (7.70e-3)	unprognostic (1.62e-1)	unprognostic (6.11e-2)	unprognostic (1.43e-1)	unprognostic (7.99e-2)	1.1	0	0.8	5.8	0.2	0	2.6	0.6	0.3	0.7	12.9	0.4	0.4	2.1	0.2	2.8	8.7	0.5	1	0.2	2.6	0	28.1	0.2	0.4	0.1	0.1	0.3	14.6	1	0	2.4	0	1.7	11.1	11.7	12.2	1.4	1.2	0	0.5	3.3	0.4	0.8	0.1	2.6	0.4	0.2	0	0	0.2	2	0.3	0.4	0.4	0	0	0.3	0	1	0	1.2	0.6	0.2	0	0.2	0.1	2.9	7.2	2.8	2.7	0.8	0.4	0.5	0.2	4.3	19.4	0	0.1	0.2	4.7	0.4	0.9	0	0	2.8	4.6	0	0.4	2.5	0.4	3.9	1.2	0.2	21.7	0.7	0	0.6	0	0.5	0.2	4.9	0.3	0.7	0	0	0.2	0	0.1	0	0.1	0.9	1.4	1.5	21	0.2	1.9	0.2	0.1	3.5	3	0.6	0	1.2	14.1	0	0.3	0	0	0	0.7	0.4	1	0	0	0	0.3	0	0	0	0	0	0	0	0.8	0.2	0.6	0.3	2.6	0	0.1	0.3	1.7	0.2
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Low cell line specificity	Detected in many			Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	6	basophil: 14.7	Lineage enriched	Detected in many	6	granulocytes: 14.7	Low region specificity	Detected in all			Low region specificity	Detected in all			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		4300000	4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	unprognostic (3.28e-1)	unprognostic (1.62e-2)	unprognostic (5.87e-2)	unprognostic (2.47e-2)	unprognostic (6.24e-2)	unprognostic (4.24e-2)	unprognostic (6.01e-2)	unprognostic (1.03e-2)	unprognostic (1.95e-2)	unprognostic (1.85e-3)	prognostic unfavourable (2.46e-4)	unprognostic (2.14e-1)	unprognostic (8.12e-2)	unprognostic (4.65e-2)	unprognostic (1.81e-1)	unprognostic (4.79e-2)	unprognostic (4.11e-1)	26.2	13.1	17	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0	1	2.5	0.6	14.2	7.1	22.4	17.5	13.5	16.7	26.4	9.5	19.4	11.2	15.4	16.8	10.5	0	10.1	16.1	8.3	20.9	16.8	22	0	7.1	4.2	7	11.7	11	3.2	7.6	12.7	18.1	16.9	18.9	37.8	18.4	6.3	15.9	9.8	1.9	4.2	14.2	9.1	2.4	17.6	1.2	16.3	16.9	4.6	5.3	19.6	14.9	12.4	10.3	6.8	32.5	27.7	30.7	20.8	25.5	5.5	2.7	0.8	10.5	4.7	16.4	14.7	0	0.9	2.5	0	1.6	0.1	0.5	1.4	0	0	1.2	1.9	0	1	0	0.1	0.1	0.6	17	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	Zeta chain of T cell receptor associated protein kinase 70	P43403	2	97713560-97739862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, SCID"	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	blood: 37.4;lymphoid tissue: 107.1	Cell line enriched	Detected in some	13	MOLT-4: 61.5	Low cancer specificity	Detected in many			Not detected	Not detected			Group enriched	Detected in many	41	gdT-cell: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9	Group enriched	Detected in many	53	NK-cells: 26.4;T-cells: 37.4	Low region specificity	Detected in many			Low region specificity	Detected in some			"CAB002625, HPA003134"	Enhanced									"CAB002625: , HPA003134: AB_1080629"	unprognostic (4.11e-3)	prognostic favourable (6.89e-5)	unprognostic (3.82e-3)	prognostic favourable (9.66e-8)	unprognostic (5.78e-2)	prognostic favourable (3.93e-6)	unprognostic (2.30e-3)	unprognostic (1.09e-3)	unprognostic (3.30e-1)	unprognostic (1.37e-2)	unprognostic (9.23e-3)	unprognostic (2.70e-1)	prognostic unfavourable (3.02e-8)	unprognostic (1.29e-1)	unprognostic (1.65e-1)	unprognostic (6.40e-2)	unprognostic (5.83e-3)	2.2	0.5	0.3	18.1	0.6	11.2	1.5	0.7	0.6	1.2	3.7	0.7	0.3	2.9	1.2	1.1	1.7	1.5	2.8	0.9	0.4	0.8	2.2	2.3	5.8	28.1	0.8	0.6	0.9	1.3	0	0.7	0.9	0.6	2.1	0.6	1	5.5	1	0.7	1	12.3	0.7	0.7	24.8	3.2	1.4	0.6	107.1	2.5	1.1	20.8	3	1.7	0.4	0.2	0.5	0.2	26.4	37.4	14.3	0	0	0	0	0	0	0.1	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	61.5	0.1	0	0	2.4	0	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.7	0	0	0	0	0	0.1	37.4	0.1	25.4	0	19.6	29.2	0	0.4	14.3	21.9	0.5	26.4	0.2	0.2	19.9	14.3	0.3	0.6	0.7	0.6	0.4	0.8	0.8	0.6	0.6	0.6
